data_2lxu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lxu _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 120.44 0.162 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.494 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.5 t -102.09 143.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.99 0.916 . . . . 0.0 109.184 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.481 HG22 HD11 ' A' ' 61' ' ' LEU . 29.8 m -110.14 160.41 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.053 0.541 . . . . 0.0 110.758 162.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 87.4 tttt -109.13 121.41 45.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.84 111.72 37.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.463 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 3.7 tmt_? -121.96 140.67 52.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.21 18.27 29.41 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 118.2 0.454 . . . . 0.0 113.316 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.17 138.37 56.38 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 123.356 0.662 . . . . 0.0 109.765 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HG3' ' HA3' ' A' ' 79' ' ' GLY . 45.1 Cg_endo -64.79 146.52 88.44 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.346 2.031 . . . . 0.0 111.454 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -64.37 -19.71 65.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.162 0.985 . . . . 0.0 110.62 175.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 p -90.7 4.75 50.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.394 1.078 . . . . 0.0 113.146 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 22.0 p -104.4 145.75 29.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.827 0.739 . . . . 0.0 111.13 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -105.81 178.52 4.54 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.763 1.225 . . . . 0.0 109.028 172.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.67 -31.49 62.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.441 0.696 . . . . 0.0 112.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.92 -47.34 68.08 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.181 0.993 . . . . 0.0 113.118 176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 78' ' ' MET . 1.7 mp0 -69.88 -38.02 76.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.15 0.58 . . . . 0.0 111.592 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.61 -34.76 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.712 . . . . 0.0 110.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.578 ' HG3' HD12 ' A' ' 36' ' ' ILE . 44.2 tt0 -69.36 -41.31 76.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.312 176.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -63.09 -36.33 83.23 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.081 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.98 -43.83 98.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.015 0.526 . . . . 0.0 110.39 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 36' ' ' ILE . 79.6 m-85 -95.72 38.96 1.14 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.998 0.519 . . . . 0.0 110.515 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.7 t -59.76 -34.2 72.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 111.248 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.22 5.96 10.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 112.448 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HB3' HD21 ' A' ' 61' ' ' LEU . 58.1 m -127.38 136.23 51.59 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.086 0.954 . . . . 0.0 110.07 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -80.36 98.46 7.48 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.578 HD12 ' HG3' ' A' ' 28' ' ' GLN . 61.8 mt -80.65 122.61 36.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.994 0.918 . . . . 0.0 109.687 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.7 126.42 27.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.213 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.2 t30 63.48 17.55 10.42 Favored 'General case' 0 CA--C 1.559 1.327 0 O-C-N 124.79 1.307 . . . . 0.0 111.89 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.44 -136.16 47.53 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.239 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.71 -18.8 45.49 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.26 -21.03 54.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.967 0.507 . . . . 0.0 110.295 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 -21.13 76.59 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.255 0.347 . . . . 0.0 112.472 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 59' ' ' VAL . 43.4 mt -91.27 127.75 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.568 0.747 . . . . 0.0 110.043 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.1 110.02 6.12 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.081 0.953 . . . . 0.0 110.008 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -66.48 140.09 57.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.0 88.82 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -82.86 135.9 34.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.1 p -83.76 -178.17 6.93 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.856 0.862 . . . . 0.0 110.919 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 49' ' ' ARG . 1.5 tmt_? -67.18 -16.73 64.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.161 0.584 . . . . 0.0 109.603 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 13.4 mm-40 -84.36 1.56 44.53 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.742 0.817 . . . . 0.0 110.911 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.03 20.1 76.03 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 50' ' ' GLU . 19.4 ptp180 -126.74 141.3 39.94 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.335 0.654 . . . . 0.0 109.79 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.48 148.36 42.61 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.447 2.098 . . . . 0.0 111.523 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -75.65 -0.44 20.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.616 0.766 . . . . 0.0 111.749 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.54 81.83 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 37.7 mt-10 -119.63 155.61 31.99 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 110.809 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.36 28.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.771 1.228 . . . . 0.0 110.313 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.33 120.9 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.484 1.113 . . . . 0.0 109.168 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 43' ' ' ILE . 68.9 t -106.71 123.67 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 108.953 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 12' ' ' VAL . 64.5 mt-10 -82.98 151.23 25.95 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.481 HD11 HG22 ' A' ' 13' ' ' VAL . 4.6 mp -135.87 152.29 50.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.084 0.954 . . . . 0.0 109.312 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -32.22 73.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.732 0.813 . . . . 0.0 111.805 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.479 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 42.0 m -144.96 155.62 43.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.531 0.332 . . . . 0.0 111.265 -171.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.96 -27.29 68.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.623 0.769 . . . . 0.0 110.431 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.39 -47.57 75.9 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 47.2 mm-40 -54.62 -37.88 66.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.538 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 78.4 t -60.27 -46.06 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.077 0.551 . . . . 0.0 110.03 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.584 ' HD3' HD11 ' A' ' 71' ' ' LEU . 32.3 mmtp -60.99 -37.79 83.73 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.788 0.835 . . . . 0.0 112.552 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.47 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 85.9 mt -65.88 -31.94 73.16 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.502 0.721 . . . . 0.0 111.746 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 13' ' ' VAL . . . -69.13 -44.04 73.18 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.255 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.584 HD11 ' HD3' ' A' ' 68' ' ' LYS . 96.8 mt -65.9 -26.12 67.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.14 0.976 . . . . 0.0 112.83 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 19.9 pttp -77.54 -16.88 58.41 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.105 0.411 . . . . 0.0 109.915 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -95.15 0.49 54.22 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.214 1.005 . . . . 0.0 111.032 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 11.1 t70 -60.17 101.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.32 0.648 . . . . 0.0 110.238 168.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 36.9 ttt180 150.64 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 127.115 2.166 . . . . 0.0 108.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -55.43 147.33 17.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.235 -167.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 p -89.11 120.03 30.15 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.518 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.478 ' HB3' HG21 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -124.64 125.0 43.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.342 1.057 . . . . 0.0 108.513 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.61 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 84.82 -50.31 4.38 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.451 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -179.04 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.77 1.228 . . . . 0.0 108.85 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -91.47 166.94 12.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.038 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.88 139.47 39.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 78' ' ' MET . 53.1 t -112.05 129.51 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.16 0.505 . . . . 0.0 110.678 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.01 121.6 37.93 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.342 1.057 . . . . 0.0 109.196 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.0 112.81 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.571 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.8 m-85 -103.03 178.4 4.57 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.35 120.5 42.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 61.1 m -110.73 147.71 33.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.733 0.813 . . . . 0.0 111.275 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -91.54 155.28 18.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -56.53 -35.32 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.238 0.615 . . . . 0.0 110.169 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.11 -46.37 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.889 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.62 -52.11 48.81 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.458 0.474 . . . . 0.0 110.005 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -49.63 -53.64 23.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.8 1.24 . . . . 0.0 111.367 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.0 -43.02 86.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.987 0.915 . . . . 0.0 111.679 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -74.13 -35.99 64.13 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.99 -21.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.014 0.435 . . . . 0.0 110.502 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.3 -40.76 64.28 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -77.13 -32.02 56.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.06 0.544 . . . . 0.0 111.295 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.3 t60 . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -171.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 . . . . . 0 CA--C 1.55 0.973 0 CA-C-O 120.62 0.247 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.28 138.02 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.527 1.131 . . . . 0.0 109.167 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.07 168.89 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.037 0.535 . . . . 0.0 110.635 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 60.2 tttt -116.84 123.38 46.94 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.452 HG11 HG12 ' A' ' 83' ' ' VAL . 92.2 t -114.6 138.67 43.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.463 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 3.8 ptp180 -150.99 161.31 42.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.975 0.51 . . . . 0.0 109.633 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 18.45 36.57 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -169.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -88.88 127.69 54.97 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 27.4 Cg_endo -61.19 161.5 22.8 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.232 1.955 . . . . 0.0 111.968 172.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -71.66 -24.46 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.287 0.635 . . . . 0.0 111.176 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -82.45 -6.0 59.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.685 0.794 . . . . 0.0 111.404 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 44.2 t -76.08 120.41 21.35 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.102 0.561 . . . . 0.0 109.743 -177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t -98.88 174.68 6.25 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.767 0.827 . . . . 0.0 109.186 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.24 74.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.707 0.803 . . . . 0.0 112.41 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.4 t70 -60.53 -39.32 87.45 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.879 0.872 . . . . 0.0 111.787 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -59.53 -46.31 89.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.216 0.606 . . . . 0.0 111.083 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 43' ' ' ILE . 58.4 t -71.68 -31.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.42 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.432 ' NE2' HD11 ' A' ' 36' ' ' ILE . 9.3 tp-100 -64.34 -42.81 96.06 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.916 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 19.3 mmt180 -67.11 -38.11 85.06 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.695 0.398 . . . . 0.0 111.179 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -67.71 -29.66 68.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.034 0.534 . . . . 0.0 111.5 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.541 ' HB2' HD12 ' A' ' 36' ' ' ILE . 93.4 m-85 -115.38 35.02 4.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.61 0.764 . . . . 0.0 110.184 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 t -59.51 -29.2 67.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.62 0.768 . . . . 0.0 113.01 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.77 -25.72 35.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.853 0.461 . . . . 0.0 110.614 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.58 126.79 31.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 35' ' ' LYS . 10.4 mptt -79.24 87.75 4.94 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 31' ' ' PHE . 41.1 mt -76.86 132.79 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.275 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.02 118.37 5.33 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.947 0.899 . . . . 0.0 110.425 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 63.52 23.02 13.46 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -131.66 41.85 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.596 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.64 30.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 0.0 113.161 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -80.7 -10.45 59.73 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.198 0.599 . . . . 0.0 112.411 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.93 36.3 4.35 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.473 HD11 ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt -127.85 116.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 22.3 mmt180 -116.6 92.99 4.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.288 0.635 . . . . 0.0 110.251 -169.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.426 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 98.2 m-85 -71.23 127.85 33.93 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 mt -74.8 86.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.05 149.37 41.21 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.706 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -94.77 178.71 5.49 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.434 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -68.76 -8.85 46.87 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 122.846 0.458 . . . . 0.0 111.893 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.55 -0.41 43.29 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.257 1.023 . . . . 0.0 109.916 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.41 59.92 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.969 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -126.15 132.75 24.42 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 53.5 Cg_endo -66.5 153.21 78.82 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.302 2.002 . . . . 0.0 111.568 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -78.41 6.11 9.16 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.56 0.744 . . . . 0.0 111.37 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.07 1.13 79.88 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 30.6 mt-10 -111.59 146.68 36.96 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.669 1.187 . . . . 0.0 110.806 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.58 31.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.55 1.14 . . . . 0.0 109.7 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 69.3 m-85 -102.61 117.74 35.34 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.9 t -98.46 110.78 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.39 136.46 38.42 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.562 1.145 . . . . 0.0 108.413 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 66' ' ' GLU . 44.1 mt -135.76 137.58 41.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.448 0.699 . . . . 0.0 109.744 -169.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.87 -12.47 61.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -168.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.0 p -160.45 172.45 17.22 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.11 0.564 . . . . 0.0 109.99 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.0 tm-20 -68.5 -21.05 64.61 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.209 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.68 -46.79 89.02 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.235 0.471 . . . . 0.0 110.403 172.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB3' HD22 ' A' ' 61' ' ' LEU . 1.1 mp0 -62.38 -32.5 73.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.53 173.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.47 -44.08 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.652 0.381 . . . . 0.0 110.028 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 82.2 mttt -54.63 -49.66 69.98 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.723 0.809 . . . . 0.0 110.649 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.78 -35.44 74.65 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.354 1.062 . . . . 0.0 112.089 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.75 69.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.031 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.75 -13.38 59.25 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.22 1.008 . . . . 0.0 112.254 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.16 -23.68 64.89 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.301 0.501 . . . . 0.0 110.697 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 76' ' ' GLU . 3.9 mptp? -88.03 -1.28 57.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.536 0.734 . . . . 0.0 112.069 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -32.28 -25.05 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 169.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -142.77 -6.4 0.88 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -57.81 143.18 43.2 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 175.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 p -95.37 121.85 37.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.45 1.1 . . . . 0.0 111.86 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.16 114.35 27.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.184 0.993 . . . . 0.0 109.264 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.17 -89.81 0.17 Allowed Glycine 0 C--N 1.345 1.058 0 O-C-N 123.416 0.448 . . . . 0.0 112.999 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -130.77 -5.85 4.06 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -117.49 154.05 32.1 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.236 0.614 . . . . 0.0 110.929 -172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -82.04 143.5 31.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.583 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.452 HG12 HG11 ' A' ' 15' ' ' VAL . 69.4 t -109.02 120.48 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.474 0.71 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -95.39 121.47 37.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 39.8 t -119.01 121.46 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.325 0.65 . . . . 0.0 109.984 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -118.93 149.94 40.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.711 0.805 . . . . 0.0 110.905 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.05 116.85 5.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.369 0.667 . . . . 0.0 110.146 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 15.6 m -125.67 -154.1 0.6 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.68 173.64 12.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.486 ' HA ' ' HE1' ' A' ' 93' ' ' MET . 30.4 t30 -64.06 -31.05 72.1 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.989 0.915 . . . . 0.0 110.432 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.1 t -65.92 -47.61 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.247 1.019 . . . . 0.0 110.346 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.38 -47.97 74.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.286 1.034 . . . . 0.0 110.077 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.486 ' HE1' ' HA ' ' A' ' 90' ' ' ASN . 54.2 ttp -52.54 -44.6 65.88 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.463 1.102 . . . . 0.0 110.639 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.62 -45.95 77.45 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.434 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.54 -42.05 95.72 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.604 0.762 . . . . 0.0 112.3 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.08 -23.55 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 123.508 0.505 . . . . 0.0 110.827 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.11 -23.74 35.52 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 121.98 -0.45 . . . . 0.0 111.138 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -80.33 -38.77 29.93 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.284 0.564 . . . . 0.0 109.971 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 . . . . . 0 C--O 1.239 0.52 0 C-N-CA 124.483 1.113 . . . . 0.0 108.027 -173.427 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -93.94 133.49 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 110.135 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -105.01 163.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.373 0.669 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 4.7 ttmp? -108.05 127.18 53.56 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -119.49 140.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 124.107 0.963 . . . . 0.0 108.757 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.568 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 14.8 ptm180 -147.43 167.23 24.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.03 0.932 . . . . 0.0 109.262 174.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.91 18.71 62.74 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.61 155.24 91.72 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.854 0.862 . . . . 0.0 110.236 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.0 152.13 77.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.147 1.898 . . . . 0.0 111.22 169.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.2 p90 -56.18 -30.91 62.89 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.725 1.21 . . . . 0.0 112.098 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 p -104.21 25.52 9.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 111.508 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.2 p -52.39 118.03 3.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.493 1.117 . . . . 0.0 112.811 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.424 ' HB3' ' HG3' ' A' ' 26' ' ' GLU . 46.8 t -104.18 152.2 22.43 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.29 -39.52 75.9 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.315 0.384 . . . . 0.0 111.003 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -49.51 -47.63 48.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.329 1.052 . . . . 0.0 112.695 170.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 45.3 mt-10 -65.43 -39.68 92.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.194 0.598 . . . . 0.0 111.265 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.514 ' HB ' HD12 ' A' ' 43' ' ' ILE . 61.1 t -68.55 -34.94 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.403 0.681 . . . . 0.0 110.077 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -64.94 -49.75 69.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.769 0.827 . . . . 0.0 111.033 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -37.17 81.35 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.51 0.507 . . . . 0.0 110.719 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.75 -43.76 95.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.027 0.531 . . . . 0.0 111.107 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 36' ' ' ILE . 59.5 m-85 -99.73 35.68 1.96 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.624 0.77 . . . . 0.0 110.083 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -60.7 -24.81 65.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.355 0.525 . . . . 0.0 112.186 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.86 -47.7 68.18 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.992 0.917 . . . . 0.0 110.736 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 61.3 m -79.77 130.69 35.55 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.385 0.612 . . . . 0.0 110.432 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 13.9 mmmm -78.44 91.2 4.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' A' ' 31' ' ' PHE . 46.4 mt -69.74 111.0 3.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 33.6 tt0 -63.14 134.5 56.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.878 0.736 . . . . 0.0 110.458 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 65.37 10.14 6.29 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 124.654 1.221 . . . . 0.0 112.148 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 -128.04 44.91 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.51 0.576 . . . . 0.0 112.716 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.03 64.75 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.855 0.862 . . . . 0.0 112.483 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -73.8 -19.72 60.68 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.123 0.569 . . . . 0.0 111.644 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.99 -23.81 56.58 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 120.271 -0.183 . . . . 0.0 112.961 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.514 HD12 ' HB ' ' A' ' 27' ' ' VAL . 59.8 mt -83.35 119.36 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.266 0.627 . . . . 0.0 109.613 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HG3' ' SD ' ' A' ' 93' ' ' MET . 21.0 mmt180 -127.29 94.71 4.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.481 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.79 135.86 46.86 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.531 HD13 ' HB2' ' A' ' 56' ' ' GLU . 43.0 mt -75.91 92.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -84.26 134.49 34.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 52' ' ' ARG . 59.7 p -90.84 -169.99 2.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.701 0.8 . . . . 0.0 110.442 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.71 -18.01 64.63 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -105.67 10.06 32.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 0.0 109.212 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.15 63.96 Favored Glycine 0 C--N 1.36 1.917 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 12.0 mmp_? -101.27 125.49 37.7 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.591 0.756 . . . . 0.0 110.021 -172.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.08 116.89 3.56 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.666 2.244 . . . . 0.0 110.488 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 t -83.52 18.13 1.97 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.678 0.791 . . . . 0.0 111.581 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.1 30.19 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 122.854 0.264 . . . . 0.0 113.033 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 31.8 mt-10 -112.3 150.15 31.39 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.455 1.102 . . . . 0.0 111.128 -174.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.55 153.9 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.527 1.131 . . . . 0.0 110.043 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -106.14 110.31 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.051 0.941 . . . . 0.0 108.463 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.07 110.92 25.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' HB2' ' HE1' ' A' ' 93' ' ' MET . 43.5 tt0 -79.76 135.99 36.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 36' ' ' ILE . 53.9 mt -126.71 147.91 49.91 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.458 0.703 . . . . 0.0 110.032 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -67.06 -19.81 65.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.763 0.825 . . . . 0.0 112.917 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -159.34 171.24 20.15 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.07 -23.75 67.26 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.999 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.81 -52.56 64.54 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.372 0.669 . . . . 0.0 110.157 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 1.5 mp0 -60.25 -31.61 70.37 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.048 0.843 . . . . 0.0 112.894 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.4 t -61.44 -48.83 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.659 0.384 . . . . 0.0 110.158 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.8 mmpt? -50.98 -46.07 61.16 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.015 0.822 . . . . 0.0 111.753 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 mt -63.06 -47.44 82.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.59 0.756 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.06 87.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.021 0.928 . . . . 0.0 111.524 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.44 -38.44 77.47 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.148 0.979 . . . . 0.0 111.659 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -69.06 -19.97 64.09 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 123.63 0.581 . . . . 0.0 111.587 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -91.77 17.34 9.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.929 0.892 . . . . 0.0 112.329 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.93 23.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -142.86 -23.66 0.63 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.751 0.705 . . . . 0.0 110.865 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -46.3 134.75 8.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.931 1.293 . . . . 0.0 112.02 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -91.26 131.64 36.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.782 0.833 . . . . 0.0 111.15 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ttt -128.61 122.14 30.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.704 1.202 . . . . 0.0 109.415 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -75.34 1.92 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -145.33 -36.29 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.37 1.068 . . . . 0.0 110.1 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -87.0 167.49 14.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -80.68 136.81 36.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.7 t -100.02 117.12 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 25.1 mt-10 -98.37 122.18 41.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.175 1.39 . . . . 0.0 108.508 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.94 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 110.14 -172.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.06 179.09 4.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.464 1.506 . . . . 0.0 107.54 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -112.55 135.41 53.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.57 ' HB2' ' HG2' ' A' ' 92' ' ' GLU . 76.8 p -134.87 -149.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 109.038 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.87 169.42 24.45 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -61.36 -34.22 74.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.841 0.856 . . . . 0.0 111.276 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.7 -40.79 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.113 0.965 . . . . 0.0 110.168 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 88' ' ' SER . 4.7 tp10 -63.93 -50.36 68.97 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.409 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.564 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 45.3 ttm -54.95 -51.74 65.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.947 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.35 -45.87 91.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.621 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -52.58 -51.56 59.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.635 1.574 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.7 t -71.19 -33.13 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.091 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 44' ' ' ARG . 88.6 mt -69.38 -27.55 65.41 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.314 0.245 . . . . 0.0 111.042 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -69.05 -23.89 64.11 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.247 0.619 . . . . 0.0 111.752 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 123.501 0.72 . . . . 0.0 109.219 178.906 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.328 0.585 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG21 ' HG3' ' A' ' 60' ' ' GLU . 50.7 t -126.23 134.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.54 160.33 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.006 0.522 . . . . 0.0 110.769 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 5.1 ttmp? -109.75 116.03 30.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.4 t -114.62 135.77 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 125.056 1.342 . . . . 0.0 108.524 -168.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.682 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 12.3 ptm180 -149.95 162.58 40.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.855 0.462 . . . . 0.0 111.547 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.64 15.06 51.4 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.456 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.65 135.94 42.75 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 29.8 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.171 1.914 . . . . 0.0 111.783 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -70.43 -19.96 62.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.345 1.058 . . . . 0.0 111.32 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -93.63 10.55 32.28 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.703 0.801 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 50.6 t -87.03 133.95 33.54 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.019 0.528 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m -105.83 169.98 8.16 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.006 0.922 . . . . 0.0 109.511 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.38 69.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.008 0.923 . . . . 0.0 111.893 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 3.3 m-20 -48.03 -48.72 32.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.405 1.082 . . . . 0.0 112.445 175.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -69.79 -34.16 73.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.866 0.867 . . . . 0.0 111.912 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.553 ' HB ' HD12 ' A' ' 43' ' ' ILE . 39.0 t -73.95 -30.53 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 123.162 0.585 . . . . 0.0 110.128 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -67.19 -38.78 85.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.368 0.667 . . . . 0.0 110.013 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 95.1 mtt180 -59.6 -46.06 90.09 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.887 0.742 . . . . 0.0 111.191 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 77.0 t80 -63.52 -46.37 86.37 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.88 0.371 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -94.83 37.07 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.795 0.838 . . . . 0.0 110.556 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 t -60.44 -34.14 73.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.35 0.66 . . . . 0.0 112.446 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -69.19 -36.97 77.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.122 0.487 . . . . 0.0 109.887 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.0 m -72.86 175.32 6.66 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.057 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 7.9 mtpm? -136.01 97.51 3.64 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.512 HG22 HG13 ' A' ' 43' ' ' ILE . 3.5 mp -73.21 118.51 18.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.535 -172.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.522 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 7.8 tp60 -64.69 124.2 21.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.715 . . . . 0.0 109.367 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 76.01 16.63 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.715 1.606 . . . . 0.0 111.94 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.56 -134.24 47.55 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.356 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -37.46 32.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.609 1.164 . . . . 0.0 112.804 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.85 -8.18 59.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.537 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 37' ' ' GLN . . . -84.33 -13.87 72.69 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.623 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 ' HB ' ' A' ' 27' ' ' VAL . 62.3 mt -89.62 101.2 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.157 0.583 . . . . 0.0 109.575 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.13 96.59 9.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.249 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -67.42 129.22 39.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.5 mt -71.24 92.32 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -79.99 146.83 31.82 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.961 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.6 p -83.5 -172.97 4.44 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.31 1.044 . . . . 0.0 109.678 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -71.1 -6.06 36.37 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.896 0.478 . . . . 0.0 111.145 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.5 -6.96 32.54 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.615 1.166 . . . . 0.0 109.939 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 33.49 50.09 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -124.96 132.63 24.35 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.916 0.886 . . . . 0.0 110.37 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -67.55 139.11 47.82 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.487 2.125 . . . . 0.0 111.232 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -78.77 -2.04 37.6 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.076 0.55 . . . . 0.0 111.178 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.3 60.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.878 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.682 ' HG3' ' HB3' ' A' ' 16' ' ' ARG . 8.0 mp0 -105.43 149.69 25.93 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.552 1.141 . . . . 0.0 109.618 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 163.3 38.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.75 116.01 29.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.033 0.933 . . . . 0.0 109.106 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -95.86 108.2 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 45.6 tt0 -83.14 145.08 29.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.3 mt -138.83 145.87 40.56 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.385 1.074 . . . . 0.0 108.649 -168.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.95 -26.54 63.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -152.28 163.3 39.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.453 0.701 . . . . 0.0 110.134 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 35.0 tt0 -69.53 -16.73 63.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.212 0.605 . . . . 0.0 112.594 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.6 t70 -59.77 -51.42 69.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -52.98 -39.76 63.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.931 1.292 . . . . 0.0 111.863 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 65.4 t -63.39 -42.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.125 0.57 . . . . 0.0 111.065 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 74.9 mmtt -58.62 -45.43 89.21 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.953 0.901 . . . . 0.0 111.211 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 62.5 mt -61.52 -36.76 81.45 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.911 0.884 . . . . 0.0 111.062 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.25 83.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 0.0 110.321 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.1 mt -62.57 -30.82 71.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.008 0.923 . . . . 0.0 111.828 175.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 56.3 mtpt -67.86 -30.78 70.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.318 0.58 . . . . 0.0 110.377 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.467 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 41.2 mttp -84.15 -4.26 58.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.02 0.928 . . . . 0.0 111.563 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -52.63 -33.44 46.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.461 0.704 . . . . 0.0 112.668 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -95.84 -31.59 13.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.902 -0.498 . . . . 0.0 111.598 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.07 142.24 47.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.661 0.785 . . . . 0.0 112.093 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 43.2 p -95.03 135.63 36.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.59 0.756 . . . . 0.0 110.758 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.409 ' HE3' ' SG ' ' A' ' 22' ' ' CYS . 19.5 ttt -70.9 -86.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 110.374 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.19 1.78 5.4 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-O 120.03 -0.317 . . . . 0.0 112.729 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -170.22 -55.67 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.018 0.927 . . . . 0.0 108.931 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -87.8 167.65 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.299 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.7 p90 -98.68 138.78 35.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.1 t -91.85 125.87 44.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.603 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 22.5 mt-10 -95.13 118.68 32.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.61 117.81 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.591 0.756 . . . . 0.0 110.065 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -68.33 136.27 53.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.075 0.852 . . . . 0.0 110.875 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -136.11 -151.58 0.42 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.52 1.128 . . . . 0.0 108.824 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -165.13 167.99 17.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 110.33 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.85 -37.04 85.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.399 1.079 . . . . 0.0 111.989 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.56 -42.84 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.204 0.602 . . . . 0.0 110.975 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.96 -38.6 76.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.1 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.407 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 55.9 ttp -53.31 -51.15 63.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.8 0.84 . . . . 0.0 110.037 175.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.27 -42.88 96.31 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.275 0.985 . . . . 0.0 111.144 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -58.58 -47.5 84.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.275 0.985 . . . . 0.0 110.8 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.9 t -71.42 -32.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.713 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 93' ' ' MET . 79.1 mt -73.02 -32.05 64.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.904 -0.498 . . . . 0.0 112.083 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.54 -18.23 61.56 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.3 m80 . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 124.469 1.108 . . . . 0.0 108.216 174.645 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.501 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.56 0.695 . . . . 0.0 111.392 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 60' ' ' GLU . 47.1 t -123.05 139.53 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -116.6 167.9 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.667 -0.646 . . . . 0.0 111.009 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -119.34 123.45 44.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.44 119.12 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -124.87 149.35 47.61 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.548 1.139 . . . . 0.0 108.967 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.02 57.53 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.48 135.84 81.35 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 123.224 0.609 . . . . 0.0 110.038 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 42.5 Cg_endo -69.1 133.83 27.8 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.998 1.798 . . . . 0.0 110.693 173.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -58.19 -29.56 65.76 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.593 1.157 . . . . 0.0 111.193 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -81.94 8.28 10.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.073 0.949 . . . . 0.0 112.553 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 12.9 p -113.85 142.06 46.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.68 -170.07 1.63 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.64 0.776 . . . . 0.0 109.322 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -43.37 70.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.404 1.081 . . . . 0.0 113.4 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.48 -38.23 83.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.28 0.632 . . . . 0.0 111.81 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -70.03 -37.6 75.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.737 0.815 . . . . 0.0 110.958 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.61 -35.7 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.226 0.61 . . . . 0.0 110.673 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HG3' HD11 ' A' ' 36' ' ' ILE . 41.5 tt0 -66.81 -39.74 87.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -61.14 -39.19 89.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.735 1.214 . . . . 0.0 111.149 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.24 -42.05 99.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.526 0.33 . . . . 0.0 110.357 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' HB2' HD12 ' A' ' 36' ' ' ILE . 83.9 m-85 -94.97 32.49 1.66 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.004 0.522 . . . . 0.0 111.117 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 t -76.84 87.86 3.43 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 167.38 -55.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -159.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.415 ' HB3' HD21 ' A' ' 61' ' ' LEU . 58.0 m -82.55 171.73 13.76 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.138 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -123.15 72.91 1.13 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 31' ' ' PHE . 44.2 mt -56.27 126.72 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.208 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -48.85 117.72 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.556 1.16 . . . . 0.0 111.397 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.3 t30 60.75 26.3 16.11 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 124.495 1.122 . . . . 0.0 111.991 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.4 -134.4 30.88 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.43 -0.805 . . . . 0.0 113.02 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.87 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.613 1.165 . . . . 0.0 113.531 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -72.48 -16.8 61.8 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.62 24.3 32.67 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -126.11 90.78 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.22 98.72 7.91 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.234 1.014 . . . . 0.0 109.628 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.89 138.36 55.97 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.655 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.2 mt -76.68 90.7 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -75.79 148.0 38.78 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.547 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.5 t -106.8 174.37 5.92 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.041 0.936 . . . . 0.0 109.433 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -57.28 -19.6 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.888 1.275 . . . . 0.0 112.918 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.34 -4.45 58.47 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.343 1.057 . . . . 0.0 111.209 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.89 30.57 51.49 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.14 0.3 . . . . 0.0 112.986 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.75 151.29 73.92 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.028 0.931 . . . . 0.0 110.482 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 145.63 53.34 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.192 1.928 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.1 p -74.48 -38.74 62.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.418 0.628 . . . . 0.0 110.409 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.49 -10.78 2.7 Favored Glycine 0 N--CA 1.468 0.771 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.757 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.58 150.72 24.4 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.196 0.998 . . . . 0.0 109.534 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.56 167.61 24.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.235 1.014 . . . . 0.0 109.885 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -111.7 122.63 48.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.93 107.88 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 12' ' ' VAL . 42.0 mt-10 -85.21 151.29 24.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' A' ' 34' ' ' CYS . 73.6 mt -139.5 148.26 42.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.676 0.791 . . . . 0.0 109.213 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.65 -21.62 61.06 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -144.9 156.58 44.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.516 0.674 . . . . 0.0 110.811 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.55 -18.75 63.67 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.788 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.26 -55.65 32.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.322 0.649 . . . . 0.0 109.583 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.551 ' HA ' HD13 ' A' ' 69' ' ' LEU . 36.3 mt-10 -52.11 -36.0 49.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.779 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 11' ' ' PHE . 76.0 t -60.83 -52.04 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.44 0.296 . . . . 0.0 110.706 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -57.42 -37.23 72.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.38 0.672 . . . . 0.0 112.619 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 66' ' ' GLU . 84.7 mt -60.55 -52.65 64.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.956 0.502 . . . . 0.0 110.558 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.83 79.1 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.677 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -57.58 -32.8 67.52 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.613 1.165 . . . . 0.0 111.843 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -76.48 -18.89 58.52 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.526 0.33 . . . . 0.0 111.082 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -88.46 9.96 21.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.65 8.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -129.56 -37.36 1.59 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.204 0.602 . . . . 0.0 110.192 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -52.04 143.29 14.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.428 1.091 . . . . 0.0 113.066 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.9 p -90.06 110.45 21.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.204 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.51 91.68 1.83 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 171.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.54 -96.25 1.14 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -164.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.99 -0.03 5.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.07 0.948 . . . . 0.0 109.911 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.25 114.91 19.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.064 0.946 . . . . 0.0 109.226 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.07 108.03 4.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.0 t -108.08 122.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.536 0.735 . . . . 0.0 110.062 -170.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.98 137.49 35.98 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.761 1.224 . . . . 0.0 109.129 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.5 t -124.17 116.16 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -104.03 -176.93 3.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.127 1.371 . . . . 0.0 107.699 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -109.53 136.97 48.06 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -128.59 148.84 50.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.754 0.822 . . . . 0.0 109.31 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -93.31 173.88 7.49 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -64.24 -19.21 65.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.77 171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.36 -54.91 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 123.785 0.834 . . . . 0.0 110.504 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.35 -45.05 70.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.295 0.638 . . . . 0.0 110.53 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -57.03 -48.68 77.92 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.456 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.03 -53.99 51.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.509 0.724 . . . . 0.0 111.122 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -65.02 -41.95 94.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.143 0.977 . . . . 0.0 112.888 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.4 t -82.71 -22.9 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.841 0.456 . . . . 0.0 111.174 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.48 -22.94 46.72 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 122.373 -0.204 . . . . 0.0 110.821 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.6 mmpt? -73.46 -38.94 65.3 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.5 t60 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -173.149 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 64' ' ' GLU . 10.5 m-30 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 122.052 0.93 . . . . 0.0 108.537 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.04 138.54 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.878 1.271 . . . . 0.0 108.719 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 70' ' ' ALA . 28.5 m -110.44 177.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.341 0.656 . . . . 0.0 110.446 165.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 19.6 ptmt -136.93 140.07 41.99 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.95 129.99 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.703 0.801 . . . . 0.0 109.134 -170.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.778 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 30.1 mtp-105 -129.94 159.43 36.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.111 0.964 . . . . 0.0 108.447 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.47 18.05 67.25 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.61 141.85 65.48 Favored Pre-proline 0 C--N 1.349 0.585 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.89 140.39 91.73 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 121.904 1.736 . . . . 0.0 111.47 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HZ3' HH22 ' A' ' 81' ' ' ARG . 1.6 m-90 -68.07 -19.33 64.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.369 0.668 . . . . 0.0 110.099 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -97.97 12.4 34.31 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.511 1.125 . . . . 0.0 111.55 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 53.4 t -90.53 140.29 29.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.115 0.566 . . . . 0.0 109.676 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.6 p -117.14 172.4 7.31 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.082 0.953 . . . . 0.0 109.661 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -40.98 58.81 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.674 1.19 . . . . 0.0 114.138 -171.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.34 -39.95 73.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.984 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 1.8 mp0 -71.28 -41.04 70.53 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 0.0 111.322 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 43' ' ' ILE . 56.5 t -72.71 -30.31 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.13 -42.69 62.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.1 0.96 . . . . 0.0 110.173 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.58 -48.25 82.6 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.172 0.989 . . . . 0.0 110.677 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 79.2 t80 -63.35 -57.34 10.68 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -85.38 37.25 0.67 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.314 0.645 . . . . 0.0 111.368 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -57.59 -31.83 66.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.445 0.698 . . . . 0.0 110.692 166.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.11 -16.15 63.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.956 1.302 . . . . 0.0 112.329 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.1 m -114.23 130.49 56.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.961 . . . . 0.0 109.158 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 13.9 mmmm -75.3 90.0 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.501 ' HA ' HD21 ' A' ' 61' ' ' LEU . 20.8 mt -73.89 129.75 36.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -44.19 -68.25 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.928 1.392 . . . . 0.0 113.413 -163.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -108.73 43.29 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.469 0.708 . . . . 0.0 109.852 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.23 -125.35 37.52 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.718 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.8 68.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.926 0.89 . . . . 0.0 112.022 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -77.58 -19.71 55.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.725 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.67 -20.67 75.94 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 116.525 -0.307 . . . . 0.0 112.38 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.554 HG21 HG21 ' A' ' 59' ' ' VAL . 46.4 mt -79.89 140.66 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.544 0.738 . . . . 0.0 109.158 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 97' ' ' LEU . 28.4 mmt180 -127.26 96.76 4.68 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.961 0.504 . . . . 0.0 110.078 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 94.0 m-85 -77.87 136.91 38.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.464 0.306 . . . . 0.0 110.28 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.55 85.88 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.24 145.62 43.94 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.196 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 52' ' ' ARG . 8.9 t -109.42 178.87 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.1 0.56 . . . . 0.0 110.132 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.65 -5.53 8.67 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' H ' HG21 ' A' ' 48' ' ' THR . 10.3 tp10 -90.42 -17.43 27.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.93 0.892 . . . . 0.0 110.325 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.09 4.96 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.141 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' O ' HG22 ' A' ' 48' ' ' THR . 17.8 ptt85 -163.19 155.51 15.64 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.878 0.871 . . . . 0.0 111.225 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.552 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 36.2 Cg_endo -62.95 149.14 92.44 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.719 2.279 . . . . 0.0 112.015 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.0 p -95.15 19.55 10.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.192 0.997 . . . . 0.0 111.556 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 -17.13 49.37 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 120.034 -0.314 . . . . 0.0 113.622 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 38.9 tt0 -107.6 147.2 30.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.587 0.755 . . . . 0.0 110.111 175.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.92 36.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.467 1.107 . . . . 0.0 109.76 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.5 112.53 23.11 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.554 HG21 HG21 ' A' ' 43' ' ' ILE . 72.2 t -93.96 116.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.726 ' HB2' ' HE1' ' A' ' 93' ' ' MET . 18.4 tt0 -86.93 137.41 32.4 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.449 0.468 . . . . 0.0 109.823 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' A' ' 36' ' ' ILE . 56.4 mt -127.3 148.17 50.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.288 1.035 . . . . 0.0 108.555 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.13 -24.89 47.22 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.602 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.9 m -133.76 143.8 48.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.588 0.755 . . . . 0.0 110.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . 30.6 tt0 -77.03 -10.93 59.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.039 0.447 . . . . 0.0 111.695 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 25.9 t70 -65.72 -35.43 80.73 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 169.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.602 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 18.1 mm-40 -68.16 -31.27 70.71 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.952 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.24 -51.83 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.485 0.714 . . . . 0.0 110.645 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 18.8 ptpt -54.06 -38.7 65.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 123.286 0.366 . . . . 0.0 111.355 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 41.4 mt -64.06 -50.14 69.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.322 1.049 . . . . 0.0 110.955 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 13' ' ' VAL . . . -56.53 -44.8 81.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.686 0.794 . . . . 0.0 111.946 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD21 HG11 ' A' ' 85' ' ' VAL . 93.2 mt -59.87 -34.93 73.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.431 1.092 . . . . 0.0 111.472 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -76.83 -17.85 58.75 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.254 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 29.5 mtpp -89.42 3.33 52.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.268 0.627 . . . . 0.0 111.352 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.61 -59.13 4.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.866 0.866 . . . . 0.0 111.796 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -79.19 -11.47 59.97 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 157.03 18.17 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.67 0.747 . . . . 0.0 111.621 165.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.3 p -93.82 122.67 36.53 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.227 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.611 ' HB2' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -62.26 -77.36 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.628 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.58 87.72 0.29 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 166.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 78.39 -52.36 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.672 1.589 . . . . 0.0 112.062 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.411 HH22 ' HZ3' ' A' ' 20' ' ' TRP . 47.6 mtm180 -78.94 154.48 29.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.916 0.487 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -84.12 151.92 24.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.65 0.78 . . . . 0.0 109.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 78' ' ' MET . 12.2 t -96.52 156.93 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 111.087 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.778 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 29.0 mm-40 -115.27 115.0 25.94 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 161.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.446 HG11 HD21 ' A' ' 71' ' ' LEU . 34.7 t -117.56 117.33 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.25 -178.11 3.37 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.63 135.56 50.4 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.8 m -130.11 -160.7 1.06 Allowed 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.022 0.929 . . . . 0.0 110.324 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -160.69 160.42 31.46 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.155 0.982 . . . . 0.0 113.08 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.94 -51.71 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.633 0.773 . . . . 0.0 110.852 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 95' ' ' TRP . 11.5 pm0 -83.99 -20.61 32.53 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.959 0.503 . . . . 0.0 110.752 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.726 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 50.1 ttm -60.06 -56.01 26.89 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.44 -41.2 98.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.98 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.491 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 65.0 t-105 -58.77 -53.65 56.02 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.162 0.585 . . . . 0.0 111.0 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.76 -25.68 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.476 0.71 . . . . 0.0 111.963 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 44' ' ' ARG . 85.0 mt -76.75 -43.61 36.45 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.599 0.36 . . . . 0.0 111.095 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.74 -32.84 27.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.254 1.022 . . . . 0.0 110.701 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 C--O 1.24 0.585 0 C-N-CA 125.243 1.417 . . . . 0.0 107.387 -178.033 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.3 p90 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.95 133.82 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 168.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.495 HG12 HG13 ' A' ' 67' ' ' VAL . 23.1 m -96.2 155.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 122.608 0.363 . . . . 0.0 110.847 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 36.7 ttpt -109.0 117.65 34.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG11 HG12 ' A' ' 83' ' ' VAL . 58.4 t -105.34 136.85 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.02 0.928 . . . . 0.0 108.636 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -140.41 134.51 30.9 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 111.72 81.55 1.16 Allowed Glycine 0 C--O 1.236 0.264 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -168.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.0 mt -139.67 135.34 16.71 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 114.097 -1.051 . . . . 0.0 109.164 -171.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 30.9 Cg_endo -65.74 131.41 27.46 Favored 'Trans proline' 0 C--N 1.361 1.217 0 N-CA-C 108.285 -1.467 . . . . 0.0 108.285 154.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -63.7 -24.71 67.89 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.63 0.772 . . . . 0.0 111.193 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -97.41 26.82 4.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.875 0.87 . . . . 0.0 111.624 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.546 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 27.4 p -78.95 155.25 29.05 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.223 0.609 . . . . 0.0 111.166 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -105.48 159.11 16.18 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.315 1.046 . . . . 0.0 109.553 171.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 -38.59 66.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.255 0.622 . . . . 0.0 110.794 169.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.97 -35.88 67.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.023 0.929 . . . . 0.0 112.129 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -64.55 -47.76 77.58 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.054 0.454 . . . . 0.0 111.349 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.74 -24.54 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.204 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.26 -49.7 40.42 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 109.96 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -58.05 -40.67 81.51 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.256 0.972 . . . . 0.0 110.26 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -59.78 -56.05 26.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 36' ' ' ILE . 65.9 m-85 -93.98 25.84 3.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.259 0.624 . . . . 0.0 111.858 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 t -64.01 -21.78 66.65 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.93 -43.02 84.32 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 81.8 m -75.0 140.05 43.34 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.182 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -84.28 90.97 7.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 31' ' ' PHE . 55.0 mt -64.71 121.84 14.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.212 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -59.49 124.3 19.6 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.132 0.895 . . . . 0.0 110.474 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.59 20.61 12.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.325 1.05 . . . . 0.0 111.278 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.57 -131.09 49.14 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.053 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.33 -29.93 25.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.293 1.037 . . . . 0.0 113.23 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -75.01 -21.83 58.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.396 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.27 -21.71 79.19 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.404 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.93 121.31 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 108.98 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.566 ' HD3' HD11 ' A' ' 97' ' ' LEU . 83.2 mtt180 -128.52 96.9 4.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.924 0.89 . . . . 0.0 110.005 -169.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.5 132.1 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.43 83.97 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 84.4 m-85 -72.97 143.64 47.55 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.502 177.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.4 p -98.14 179.16 4.85 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.523 0.729 . . . . 0.0 109.427 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -68.85 -9.01 48.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.653 0.781 . . . . 0.0 111.765 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 13.9 tp10 -83.05 -14.17 54.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.072 0.949 . . . . 0.0 110.453 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.0 23.41 59.43 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 113.537 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.448 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 7.2 mpt_? -133.29 143.46 48.32 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 42.3 Cg_endo -65.44 155.79 66.92 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.88 1.72 . . . . 0.0 111.009 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.9 t -72.01 -3.82 25.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.294 0.638 . . . . 0.0 111.6 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.38 66.21 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -166.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.09 149.43 35.55 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.006 1.323 . . . . 0.0 111.148 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.39 166.79 27.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.118 1.367 . . . . 0.0 109.873 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -121.48 128.71 52.38 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.15 118.25 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -82.34 141.11 33.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -126.35 163.22 23.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.904 0.482 . . . . 0.0 110.405 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -31.22 70.77 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.977 0.911 . . . . 0.0 110.612 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 t -160.2 164.42 32.83 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 108.999 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -74.93 -13.66 60.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 0.0 110.729 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.62 -42.24 98.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.582 0.753 . . . . 0.0 110.582 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 7.9 mm-40 -59.7 -32.39 70.47 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.547 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.598 HG12 ' HZ1' ' A' ' 87' ' ' LYS . 76.0 t -67.63 -41.61 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.042 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 89.5 mttt -53.4 -46.63 69.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.778 0.831 . . . . 0.0 111.442 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.9 -46.26 85.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.658 0.783 . . . . 0.0 111.202 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.4 80.28 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.378 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 96.6 mt -59.2 -39.17 81.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.333 1.053 . . . . 0.0 111.281 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 61.3 mttp -64.81 -29.14 70.1 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.674 0.609 . . . . 0.0 111.466 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HZ2' ' HA ' ' A' ' 31' ' ' PHE . 62.9 pttt -111.41 37.49 2.86 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.409 0.623 . . . . 0.0 111.351 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 85' ' ' VAL . 6.5 p-10 -75.43 18.58 0.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.394 0.677 . . . . 0.0 111.873 165.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -117.95 -29.49 5.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.539 1.535 . . . . 0.0 108.866 -168.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -58.94 146.01 39.44 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.241 1.017 . . . . 0.0 112.829 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 p -95.19 143.62 26.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.347 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ttt -112.11 98.22 7.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.31 1.06 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -151.46 15.55 0.69 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.135 0.974 . . . . 0.0 109.944 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -107.36 -145.2 0.39 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 81.0 m-85 -157.81 128.75 6.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -160.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.404 HG12 HG11 ' A' ' 15' ' ' VAL . 95.9 t -104.71 116.46 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 119.72 1.145 . . . . 0.0 109.293 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -96.82 118.23 32.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 107.622 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 33.2 t -114.06 116.83 53.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -111.04 -178.9 3.58 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HZ1' HG12 ' A' ' 67' ' ' VAL . 22.5 ttmm -100.88 118.88 37.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.9 t -92.5 -178.79 5.01 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.906 0.86 . . . . 0.0 109.742 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -142.22 154.39 44.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.26 -38.14 79.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.98 -47.39 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 110.655 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -54.26 38.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.129 0.572 . . . . 0.0 111.193 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 42.1 ttp -55.26 -42.35 73.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.17 0.988 . . . . 0.0 111.385 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.68 -45.46 89.39 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.269 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -62.55 -44.81 95.42 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.749 0.656 . . . . 0.0 111.944 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.13 -25.12 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 123.748 0.655 . . . . 0.0 111.227 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.566 HD11 ' HD3' ' A' ' 44' ' ' ARG . 86.6 mt -79.52 -29.08 41.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.912 0.485 . . . . 0.0 111.067 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -80.13 -28.3 38.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.022 0.529 . . . . 0.0 110.963 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 t60 . . . . . 0 C--O 1.237 0.438 0 C-N-CA 124.02 0.928 . . . . 0.0 108.656 -179.206 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.574 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.985 0.898 . . . . 0.0 112.273 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.21 133.93 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' HB1' ' A' ' 70' ' ' ALA . 28.9 m -105.08 168.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.095 0.474 . . . . 0.0 110.865 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -126.5 125.84 42.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -111.93 123.28 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 123.517 0.727 . . . . 0.0 109.174 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 52.5 ttt180 -127.86 147.55 50.45 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 22.88 34.52 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.78 137.27 54.44 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.43 0.692 . . . . 0.0 109.758 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 36.7 Cg_endo -67.08 135.92 39.07 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.516 2.144 . . . . 0.0 111.195 169.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 53' ' ' PRO . 26.8 p90 -60.73 -27.4 67.9 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 m -78.76 1.88 21.63 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.494 1.117 . . . . 0.0 112.976 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.512 ' SG ' ' HG2' ' A' ' 19' ' ' PRO . 14.9 p -119.07 152.31 36.7 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 m -116.7 -168.34 1.44 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.107 0.963 . . . . 0.0 109.808 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.3 61.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.882 1.273 . . . . 0.0 113.505 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.3 m-20 -51.08 -55.33 18.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.906 0.882 . . . . 0.0 112.931 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.92 -33.52 74.85 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.911 0.484 . . . . 0.0 111.682 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.98 -39.28 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.051 0.54 . . . . 0.0 109.856 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.83 -42.85 97.53 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.246 0.618 . . . . 0.0 110.756 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 33.2 mmt180 -66.36 -38.09 86.8 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.241 0.616 . . . . 0.0 111.06 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -65.03 -39.23 93.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.67 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 58.3 m-85 -95.13 28.8 2.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.469 0.707 . . . . 0.0 111.668 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 95.35 2.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 166.7 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.423 2.289 . . . . 0.0 107.396 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.1 p -115.82 136.84 52.67 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.548 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.567 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 9.0 mtpm? -81.68 98.35 8.35 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.516 ' HA ' HD21 ' A' ' 61' ' ' LEU . 30.5 mt -77.98 115.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 45.8 tt0 -66.56 129.49 40.03 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.544 0.527 . . . . 0.0 110.535 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' ND2' ' HG2' ' A' ' 37' ' ' GLN . 35.5 m-80 75.07 16.77 2.78 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.591 1.556 . . . . 0.0 110.425 -173.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.77 -137.85 39.45 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.926 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.55 63.41 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.863 0.865 . . . . 0.0 112.218 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -75.46 -10.86 59.83 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.942 0.497 . . . . 0.0 111.789 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.96 -17.7 74.13 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.061 0.226 . . . . 0.0 112.757 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -84.14 116.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.573 0.749 . . . . 0.0 109.183 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -116.04 95.55 5.15 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.26 0.624 . . . . 0.0 109.873 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -73.29 139.42 46.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.892 0.477 . . . . 0.0 110.491 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.3 mm -79.26 112.9 17.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 165.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.88 167.1 11.63 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.512 0.725 . . . . 0.0 109.381 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -90.45 -176.61 4.83 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.514 0.726 . . . . 0.0 109.345 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.68 -14.09 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.107 0.412 . . . . 0.0 110.838 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.33 52.79 0.71 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.654 0.221 . . . . 0.0 113.654 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -115.99 131.26 23.83 Favored Pre-proline 0 N--CA 1.483 1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HB2' ' HA ' ' A' ' 20' ' ' TRP . 32.3 Cg_exo -57.54 123.36 13.58 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.64 2.226 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -78.21 -45.61 22.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.97 0.508 . . . . 0.0 110.163 -171.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.73 -12.73 1.51 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.24 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 16' ' ' ARG . 43.1 mt-10 -107.38 151.67 25.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.841 . . . . 0.0 110.218 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.72 167.03 30.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.615 1.166 . . . . 0.0 110.044 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.23 115.5 23.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.681 0.792 . . . . 0.0 108.923 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.1 t -97.16 115.63 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.1 tt0 -78.95 130.67 35.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.271 1.028 . . . . 0.0 109.564 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 36' ' ' ILE . 96.9 mt -130.13 140.41 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.222 0.609 . . . . 0.0 110.105 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.72 -20.11 59.97 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.476 0.711 . . . . 0.0 112.827 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.572 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 38.7 m -140.73 150.49 43.48 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.95 -12.69 61.36 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 120.888 0.375 . . . . 0.0 111.044 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.07 -52.22 50.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 169.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.572 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 5.2 mm-40 -47.71 -38.99 16.36 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.46 1.1 . . . . 0.0 111.532 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 11' ' ' PHE . 25.2 t -62.99 -52.95 52.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.237 0 C-N-CA 123.71 0.804 . . . . 0.0 111.471 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -57.09 -37.82 72.45 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.042 0.537 . . . . 0.0 112.404 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.23 -37.7 84.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.632 0.773 . . . . 0.0 111.686 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -64.65 -44.12 91.44 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 82.4 mt -62.48 -29.88 70.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -66.31 -21.67 66.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.219 1.008 . . . . 0.0 110.894 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 66.2 mttm -84.4 -4.17 58.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.928 0.891 . . . . 0.0 112.35 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 21.0 t70 -68.29 91.29 0.38 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.715 0.406 . . . . 0.0 110.192 173.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 145.43 -38.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 128.317 2.647 . . . . 0.0 109.021 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.66 144.07 39.13 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 p -92.59 120.8 33.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.198 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.456 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 ttt -61.65 -73.19 0.1 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.097 0.559 . . . . 0.0 110.851 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.84 -17.54 0.72 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 168.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -142.45 -66.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.668 1.187 . . . . 0.0 108.374 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -77.85 155.42 31.02 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.207 -172.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -81.25 127.38 32.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 90.9 t -88.96 120.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -170.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 28.9 mt-10 -94.91 116.69 29.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 t -117.03 114.52 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -106.08 144.67 32.46 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.445 1.098 . . . . 0.0 108.526 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.86 125.59 27.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 163.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.7 m -128.18 163.4 24.77 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.593 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -103.89 153.0 21.28 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.54 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.41 -32.75 72.7 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.221 1.008 . . . . 0.0 109.889 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.28 -44.01 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.639 0.776 . . . . 0.0 109.897 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.86 -38.48 83.15 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.1 ttm -56.01 -48.51 75.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.039 0.536 . . . . 0.0 110.01 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.89 -46.8 84.35 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.248 1.019 . . . . 0.0 110.53 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -58.31 -52.53 65.19 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.988 0.805 . . . . 0.0 111.816 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 99' ' ' HIS . 24.6 t -79.14 -25.22 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 -37.96 75.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.747 0.419 . . . . 0.0 110.409 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -90.68 -15.63 30.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.798 0.839 . . . . 0.0 111.428 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 23.7 t-80 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.607 1.163 . . . . 0.0 108.567 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 122.435 1.112 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -130.9 134.56 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.925 1.69 . . . . 0.0 107.582 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 70' ' ' ALA . 17.5 m -112.61 -175.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.858 0.863 . . . . 0.0 109.523 171.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.53 142.43 31.12 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.68 0.753 . . . . 0.0 109.54 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -111.49 119.43 59.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 108.611 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 61.1 mtp180 -123.98 148.56 46.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.25 1.02 . . . . 0.0 109.723 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.33 25.81 35.35 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -59.32 143.72 84.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.121 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.52 174.19 13.24 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.463 2.108 . . . . 0.0 111.275 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -68.75 -24.61 64.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.449 0.642 . . . . 0.0 109.536 171.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.0 m -81.41 1.43 33.06 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.447 1.099 . . . . 0.0 112.482 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.2 p -49.02 126.05 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.561 0.744 . . . . 0.0 112.881 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.505 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 45.7 t -146.3 158.91 43.93 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.919 1.287 . . . . 0.0 108.35 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.95 -42.95 69.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.019 0.527 . . . . 0.0 110.688 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 6.8 m-20 -54.33 -43.62 71.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 112.658 173.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 13.3 mm-40 -68.04 -36.35 79.75 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.866 0.467 . . . . 0.0 110.875 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 ' HB ' HD12 ' A' ' 43' ' ' ILE . 93.0 t -66.78 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 123.33 0.652 . . . . 0.0 110.673 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.47 HE21 HD11 ' A' ' 43' ' ' ILE . 27.4 mm-40 -56.92 -53.83 53.52 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.97 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 36.0 mmt180 -56.56 -46.17 80.88 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.41 1.084 . . . . 0.0 111.228 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.405 ' CE1' ' HB ' ' A' ' 83' ' ' VAL . 71.8 t80 -58.59 -40.47 83.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.821 1.248 . . . . 0.0 112.233 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -97.45 35.56 1.62 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.054 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 83.06 4.6 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 169.05 -62.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.003 1.721 . . . . 0.0 106.739 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.9 m -74.58 -177.66 3.25 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.207 168.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 126.74 17.03 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.831 0.824 . . . . 0.0 109.199 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.438 HD13 ' NE2' ' A' ' 28' ' ' GLN . 55.2 mt -86.27 128.68 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.419 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -42.76 -61.74 1.18 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.963 1.705 . . . . 0.0 113.965 -160.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -116.52 40.81 2.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.231 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.25 -130.02 32.05 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.333 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' HD13 ' A' ' 43' ' ' ILE . . . -64.11 -14.52 55.37 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.09 -21.68 50.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.769 0.428 . . . . 0.0 111.501 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 28.89 7.71 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 40' ' ' ALA . 61.2 mt -128.51 127.46 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.1 tpp180 -131.29 96.68 4.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.694 0.621 . . . . 0.0 110.024 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.64 134.86 36.45 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.7 113.48 24.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -95.82 164.59 12.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.8 p -107.95 172.88 6.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 108.874 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 1.6 15.59 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -85.53 -6.41 59.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.74 0.816 . . . . 0.0 110.683 167.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.38 32.63 42.09 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.069 0.231 . . . . 0.0 113.1 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -135.3 139.64 32.13 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.573 0.749 . . . . 0.0 111.414 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -58.07 134.1 59.91 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 122.868 2.379 . . . . 0.0 112.187 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -69.29 -44.52 71.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.15 0.98 . . . . 0.0 110.986 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.53 -10.0 3.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.091 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 43.7 mt-10 -108.67 148.6 30.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.448 1.099 . . . . 0.0 110.137 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.81 152.18 32.31 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 124.38 1.072 . . . . 0.0 108.265 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.49 126.77 52.51 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.9 t -106.45 142.9 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -123.67 120.01 31.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -167.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.1 mt -117.37 161.07 20.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.376 0.67 . . . . 0.0 110.737 -165.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.68 -29.83 69.56 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -160.45 167.2 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.315 0.384 . . . . 0.0 110.543 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -73.02 -17.84 61.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.207 0.603 . . . . 0.0 111.305 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -44.66 89.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.59 -31.03 71.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.198 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.75 -40.9 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.589 0.756 . . . . 0.0 110.535 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -65.08 -38.15 89.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.36 0.664 . . . . 0.0 111.372 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 96.6 mt -65.66 -31.97 73.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.624 0.769 . . . . 0.0 111.324 172.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.488 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -69.04 -42.57 76.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.635 173.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 87' ' ' LYS . 84.9 mt -62.01 -39.71 93.21 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.687 0.795 . . . . 0.0 112.174 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.7 ptmt -75.03 -18.29 60.36 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.999 0.428 . . . . 0.0 110.475 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.18 6.28 23.16 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.518 1.127 . . . . 0.0 111.2 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -68.52 80.43 0.26 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.294 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 163.94 -44.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.869 0.867 . . . . 0.0 110.055 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -42.17 140.46 1.13 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.013 1.725 . . . . 0.0 113.36 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.6 p -100.37 110.53 22.74 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 -172.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.1 ttm -78.44 91.96 4.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.94 -86.54 1.27 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.999 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -132.14 7.26 4.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.881 0.872 . . . . 0.0 109.988 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -105.69 132.71 51.5 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.101 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -76.47 133.37 39.83 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 30' ' ' PHE . 84.8 t -131.89 133.45 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.144 0.497 . . . . 0.0 110.392 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -98.53 148.2 24.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.695 1.198 . . . . 0.0 109.277 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.488 HG13 ' HB1' ' A' ' 70' ' ' ALA . 46.7 t -130.76 118.98 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.04 144.55 42.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 87.7 tttt -67.68 138.22 56.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -122.95 -160.54 0.9 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.12 159.42 41.58 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -60.71 -40.5 92.5 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.441 0.696 . . . . 0.0 110.723 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.16 -37.29 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.524 1.13 . . . . 0.0 110.976 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -68.75 -46.9 67.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 0.0 110.264 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.26 -45.66 87.44 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.114 0.966 . . . . 0.0 110.14 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.32 -43.36 99.01 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.13 0.972 . . . . 0.0 110.79 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.27 -54.49 45.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.167 0.987 . . . . 0.0 111.919 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.22 -35.28 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 0.0 111.617 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HG2' ' A' ' 44' ' ' ARG . 88.5 mt -67.13 -36.42 81.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.059 0.543 . . . . 0.0 111.105 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -81.82 -32.14 31.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.962 0.905 . . . . 0.0 110.044 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 t60 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.462 -170.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HA ' HG21 ' A' ' 67' ' ' VAL . 17.8 p90 . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 122.178 0.99 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG21 ' HG3' ' A' ' 60' ' ' GLU . 78.8 t -135.32 143.41 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 168.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.28 173.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.398 -0.814 . . . . 0.0 110.441 168.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 17.7 ptpt -126.9 139.97 52.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.469 ' HB ' HD12 ' A' ' 18' ' ' LEU . 3.7 t -124.92 130.57 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.584 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 32.6 mtm180 -130.78 156.29 45.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.685 0.794 . . . . 0.0 108.891 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.46 -33.97 6.11 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.469 HD12 ' HB ' ' A' ' 15' ' ' VAL . 52.4 mt -34.77 112.36 0.44 Allowed Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.746 1.218 . . . . 0.0 112.594 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.69 163.98 19.9 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.686 2.257 . . . . 0.0 113.223 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -57.22 -34.74 68.85 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.871 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 t -95.55 13.54 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.601 0.761 . . . . 0.0 111.825 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -72.61 168.72 18.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.055 0.542 . . . . 0.0 111.224 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -137.63 156.53 47.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.949 0.899 . . . . 0.0 109.783 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.32 69.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.501 0.721 . . . . 0.0 111.188 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -50.76 -47.94 59.36 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.053 . . . . 0.0 112.741 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -68.01 -41.09 82.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.797 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.469 ' HB ' HD13 ' A' ' 43' ' ' ILE . 33.4 t -72.05 -36.27 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.532 0.733 . . . . 0.0 110.282 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HG2' HD12 ' A' ' 36' ' ' ILE . 26.1 tm0? -65.73 -43.43 89.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.809 . . . . 0.0 110.0 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -61.56 -42.28 98.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.865 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 59.5 t80 -61.31 -29.28 69.78 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.753 0.821 . . . . 0.0 111.638 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.94 37.65 2.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.576 0.751 . . . . 0.0 111.831 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 p -77.15 85.89 3.62 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.486 0.66 . . . . 0.0 109.58 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 168.95 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 126.721 2.008 . . . . 0.0 106.099 -161.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.3 m -78.81 169.67 17.87 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.977 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.8 94.35 3.93 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.523 HD12 ' HG2' ' A' ' 28' ' ' GLN . 14.6 mt -75.97 133.99 30.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.06 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -47.62 -55.96 8.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.193 1.397 . . . . 0.0 112.777 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -125.54 65.23 1.17 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.381 0.61 . . . . 0.0 109.424 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.48 -143.08 42.24 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.353 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.78 -14.77 60.24 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.867 0.867 . . . . 0.0 112.942 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.04 -19.54 58.54 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.111 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.88 -7.89 71.55 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.817 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.502 HG12 HG23 ' A' ' 59' ' ' VAL . 46.3 mt -93.23 134.21 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 124.181 0.992 . . . . 0.0 110.288 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -128.81 96.12 4.28 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.82 0.848 . . . . 0.0 111.588 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -73.84 117.44 15.62 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.517 HG13 HD22 ' A' ' 97' ' ' LEU . 2.4 mp -67.27 99.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -79.78 134.65 36.37 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.3 p -85.25 176.88 8.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.359 0.664 . . . . 0.0 111.531 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -68.37 -21.46 64.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.061 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 9.4 tp10 -80.03 -13.9 58.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.655 1.182 . . . . 0.0 110.716 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.93 11.34 73.7 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.424 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 3.7 mpt_? -106.43 141.5 22.92 Favored Pre-proline 0 N--CA 1.485 1.318 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.67 132.32 49.5 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.062 1.841 . . . . 0.0 110.12 167.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 t -76.13 9.56 2.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.249 1.02 . . . . 0.0 112.142 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 16' ' ' ARG . . . 85.92 -13.42 56.74 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.99 139.24 37.88 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.251 1.42 . . . . 0.0 109.721 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.78 136.92 29.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.545 0.738 . . . . 0.0 109.232 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -96.2 106.87 19.12 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 43' ' ' ILE . 60.1 t -91.19 122.27 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG3' HG21 ' A' ' 12' ' ' VAL . 44.0 tt0 -101.56 136.58 41.17 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.9 mt -125.7 162.47 24.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.13 0.491 . . . . 0.0 110.698 -166.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.92 -35.13 57.55 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.01 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -154.13 167.95 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.677 0.751 . . . . 0.0 112.457 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 60.1 mm-40 -61.85 -32.36 72.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.36 1.464 . . . . 0.0 113.169 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.69 -46.68 88.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.33 -33.93 71.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.85 170.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 80.9 t -62.14 -52.36 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 118.605 0.638 . . . . 0.0 110.532 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mttt -53.89 -41.27 67.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.427 1.091 . . . . 0.0 111.686 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.1 -41.56 86.06 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.036 0.534 . . . . 0.0 110.92 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.99 94.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.17 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 67.9 mt -57.78 -22.82 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.374 1.07 . . . . 0.0 112.775 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -74.78 -13.72 60.62 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.059 0.543 . . . . 0.0 111.401 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 3.8 mptp? -88.17 -2.47 58.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 118.89 -0.576 . . . . 0.0 112.254 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -53.05 -59.25 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -18.02 64.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 112.515 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -59.41 153.51 18.99 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.602 0.715 . . . . 0.0 112.496 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -100.45 150.92 22.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.639 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.63 114.09 6.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 108.535 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.39 -81.57 1.2 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -159.42 19.62 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.871 0.868 . . . . 0.0 109.735 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.85 139.76 47.07 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.307 0.643 . . . . 0.0 109.862 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -78.38 129.57 35.12 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.8 t -87.12 165.35 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.333 0.653 . . . . 0.0 109.697 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 49.0 mt-10 -135.19 117.32 15.44 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.4 t -116.76 115.66 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' A' ' 84' ' ' GLU . 92.3 m-85 -117.05 179.59 3.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 120.62 40.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -109.61 140.56 43.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.786 0.834 . . . . 0.0 111.363 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -96.36 166.01 11.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.188 0.995 . . . . 0.0 109.018 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -62.67 -38.0 88.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.401 0.68 . . . . 0.0 110.746 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.24 -43.11 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.371 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -68.52 -41.65 79.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.329 1.052 . . . . 0.0 109.903 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 51.4 ttp -60.74 -52.89 63.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.892 1.277 . . . . 0.0 110.626 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.25 -45.57 92.78 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.776 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -60.94 -40.78 94.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.498 1.119 . . . . 0.0 111.605 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.4 t -81.08 -28.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.352 0.661 . . . . 0.0 111.678 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.517 HD22 HG13 ' A' ' 46' ' ' ILE . 69.8 mt -71.23 -43.47 67.27 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.94 -0.475 . . . . 0.0 110.948 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -82.46 -35.34 27.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.508 0.723 . . . . 0.0 112.74 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 119.243 -0.408 . . . . 0.0 112.062 -166.734 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.392 0.615 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.51 139.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.961 1.305 . . . . 0.0 107.898 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.465 HG13 ' HB1' ' A' ' 70' ' ' ALA . 30.2 m -107.25 169.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 167.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 79.7 tttt -124.66 125.4 44.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.66 125.42 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 108.929 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 76.3 mtp180 -117.7 149.36 40.87 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.03 19.68 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.588 -176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.33 121.96 64.08 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -54.1 149.91 33.77 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.948 2.432 . . . . 0.0 113.066 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -63.37 -25.93 68.52 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.537 0.684 . . . . 0.0 111.086 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 t -109.03 19.21 19.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.202 1.001 . . . . 0.0 111.025 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.7 p -78.29 177.84 8.11 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.635 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.2 t -128.21 148.45 50.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.546 0.738 . . . . 0.0 109.645 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.41 71.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.8 m-20 -54.85 -47.59 73.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 111.262 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 11.2 mm-40 -69.01 -41.25 78.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.412 0.685 . . . . 0.0 111.478 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.501 ' HB ' HD13 ' A' ' 43' ' ' ILE . 45.5 t -69.14 -31.85 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.02 0.528 . . . . 0.0 109.691 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.64 -41.85 87.64 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.798 0.839 . . . . 0.0 110.598 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 67.6 mmt-85 -65.99 -37.2 85.35 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 0.0 111.262 176.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -68.13 -33.81 75.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.374 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -101.99 35.53 2.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.591 . . . . 0.0 110.684 175.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -82.34 79.76 8.71 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t70 170.54 -38.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.816 -158.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.8 m -102.11 173.05 6.56 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.344 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 6.0 mtpm? -126.78 95.14 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.53 ' HA ' HD21 ' A' ' 61' ' ' LEU . 21.5 mt -76.62 139.51 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.659 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -45.89 -69.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.894 1.371 . . . . 0.0 112.112 -169.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' GLN . 1.2 t-20 -106.34 35.48 2.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.861 0.464 . . . . 0.0 110.278 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.66 -125.92 31.67 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.33 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -29.96 71.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.006 0.903 . . . . 0.0 111.063 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.6 mp0 -73.53 -18.01 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.17 0.588 . . . . 0.0 110.916 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.74 -15.7 81.37 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.208 0.317 . . . . 0.0 112.907 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.501 HD13 ' HB ' ' A' ' 27' ' ' VAL . 63.7 mt -83.53 141.32 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.875 0.87 . . . . 0.0 109.424 178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' HG2' HD12 ' A' ' 97' ' ' LEU . 3.3 tpp180 -133.96 95.23 3.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -73.58 128.4 35.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.918 0.487 . . . . 0.0 110.198 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.27 118.67 32.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 89.0 m-85 -90.01 172.09 9.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.256 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -101.29 173.09 6.61 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.639 165.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -68.59 -11.18 59.66 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.274 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -85.2 -2.64 58.26 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.819 0.848 . . . . 0.0 111.57 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.4 37.35 41.7 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -145.6 135.03 11.41 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.146 0.578 . . . . 0.0 111.21 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 87.6 Cg_exo -49.08 133.96 29.38 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.6 2.866 . . . . 0.0 113.76 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 p -67.72 -26.09 65.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.179 0.992 . . . . 0.0 111.386 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.99 -16.79 7.23 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -170.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -105.44 153.12 22.12 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.977 0.911 . . . . 0.0 110.574 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.76 168.82 25.56 Favored 'General case' 0 C--O 1.213 -0.854 0 C-N-CA 124.69 1.196 . . . . 0.0 108.979 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -119.37 124.45 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.673 0.789 . . . . 0.0 109.674 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.87 111.75 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.93 136.0 35.98 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 36' ' ' ILE . 70.3 mt -126.9 144.22 51.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.519 0.728 . . . . 0.0 109.819 -171.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -66.38 -17.64 64.89 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.8 p -166.65 170.36 12.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.96 0.504 . . . . 0.0 110.945 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.59 -21.14 65.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.443 1.097 . . . . 0.0 113.367 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -49.0 77.71 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mp0 -59.4 -33.11 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.831 0.852 . . . . 0.0 112.51 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 55.3 t -60.06 -48.61 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.426 0.454 . . . . 0.0 109.916 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.32 -36.74 83.09 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.974 0.91 . . . . 0.0 112.048 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.26 -41.57 99.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.404 0.682 . . . . 0.0 111.607 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB1' HG13 ' A' ' 13' ' ' VAL . . . -64.02 -43.98 93.96 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.059 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 98.0 mt -64.31 -33.32 75.57 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.996 0.918 . . . . 0.0 112.747 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -16.26 50.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.909 -0.494 . . . . 0.0 110.123 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -83.58 -9.36 58.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.912 0.885 . . . . 0.0 111.002 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.481 ' HB2' ' HB ' ' A' ' 85' ' ' VAL . 5.0 t70 -62.14 100.09 0.16 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 149.38 -49.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.387 2.275 . . . . 0.0 108.67 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -55.52 146.29 20.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.034 1.333 . . . . 0.0 113.56 -168.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 25.7 p -98.6 121.39 40.49 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.803 0.841 . . . . 0.0 110.904 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ptp -83.81 74.59 10.17 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 122.005 0.907 . . . . 0.0 108.949 164.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.05 -89.95 1.38 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.126 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.98 -23.26 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.508 0.723 . . . . 0.0 111.867 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -122.35 139.24 54.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.063 0.545 . . . . 0.0 111.761 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 21.4 p90 -85.71 142.84 28.72 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.607 1.163 . . . . 0.0 108.815 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.7 t -103.88 131.6 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.579 0.752 . . . . 0.0 111.54 -170.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.786 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 26.4 tp10 -104.78 119.33 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 108.783 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 74' ' ' ASP . 56.3 t -118.33 117.05 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.083 0.553 . . . . 0.0 110.62 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.75 139.83 44.35 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.967 . . . . 0.0 109.564 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -68.02 126.41 29.41 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -132.91 -162.12 1.21 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.044 0.938 . . . . 0.0 109.466 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.54 162.82 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.297 0.639 . . . . 0.0 109.401 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.7 -31.46 71.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.841 0.856 . . . . 0.0 110.498 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.57 -42.13 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.362 0.665 . . . . 0.0 110.98 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 96' ' ' VAL . 18.1 tp10 -64.51 -49.54 70.92 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.0 -46.06 68.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.107 1.363 . . . . 0.0 111.391 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.9 -44.13 97.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.812 0.845 . . . . 0.0 111.331 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -63.46 -39.66 95.06 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.565 0.746 . . . . 0.0 111.406 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 92' ' ' GLU . 5.2 t -79.05 -18.95 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.739 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.49 HD12 ' HG2' ' A' ' 44' ' ' ARG . 97.8 mt -78.63 -30.0 46.21 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.957 0.503 . . . . 0.0 111.118 168.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -78.85 -35.85 43.26 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.573 0.749 . . . . 0.0 109.592 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.747 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.79 0.329 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG23 ' HG2' ' A' ' 60' ' ' GLU . 28.4 t -134.28 140.48 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.296 1.038 . . . . 0.0 108.58 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.508 HG22 HD13 ' A' ' 61' ' ' LEU . 30.0 m -107.48 167.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 0.0 110.549 164.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.455 ' HE3' ' HD2' ' A' ' 16' ' ' ARG . 3.7 tmmm? -119.82 122.72 41.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.54 123.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 108.611 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HD2' ' HE3' ' A' ' 14' ' ' LYS . 12.0 ptm180 -139.95 154.71 47.27 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.17 21.06 23.82 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.21 138.09 30.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.209 1.004 . . . . 0.0 108.775 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 157.21 62.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.718 2.279 . . . . 0.0 112.307 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -52.28 -35.78 51.08 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.432 1.093 . . . . 0.0 111.851 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.6 p -93.2 17.26 11.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.015 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.48 166.17 15.27 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 123.393 0.677 . . . . 0.0 111.53 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.1 m -151.02 163.04 39.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 108.976 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -44.1 69.19 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 111.209 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.08 -40.42 73.57 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.167 0.987 . . . . 0.0 113.379 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -55.96 -48.19 76.24 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.447 0.641 . . . . 0.0 110.926 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.1 t -81.83 -22.98 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.699 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -71.26 -48.25 52.18 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.375 0.67 . . . . 0.0 109.949 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -63.91 -38.46 91.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.48 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.44 -46.49 88.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.499 ' HB2' HD11 ' A' ' 36' ' ' ILE . 96.3 m-85 -99.07 38.16 1.43 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.859 0.863 . . . . 0.0 110.698 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -66.13 -29.07 69.31 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.78 0.432 . . . . 0.0 110.764 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.69 -10.96 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.981 1.312 . . . . 0.0 112.23 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.5 m -121.85 139.78 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.791 0.837 . . . . 0.0 109.213 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.06 92.1 6.19 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.8 mt -69.03 144.14 14.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.916 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.22 100.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.716 0.806 . . . . 0.0 110.003 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 36.0 m-80 54.28 35.29 22.41 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 124.269 0.981 . . . . 0.0 111.756 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -121.54 24.58 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.651 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -27.62 17.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 10.1 tp60 -68.41 -21.7 64.66 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.18 -21.37 45.72 Favored Glycine 0 N--CA 1.471 1.023 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.423 HG21 HG23 ' A' ' 59' ' ' VAL . 56.7 mt -83.46 107.78 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.116 0.567 . . . . 0.0 110.139 -173.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.49 98.01 5.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.45 0.7 . . . . 0.0 110.927 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -75.22 151.7 38.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.037 0.535 . . . . 0.0 111.646 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.84 86.36 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 165.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.67 147.84 45.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.0 t -109.17 -179.3 3.81 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -176.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -77.1 -2.83 36.24 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.506 0.722 . . . . 0.0 111.59 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' H ' HG23 ' A' ' 48' ' ' THR . 40.1 tt0 -89.03 -19.12 26.04 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.684 1.194 . . . . 0.0 110.043 172.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 45.89 5.98 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.732 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -144.4 157.22 56.55 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 124.24 1.016 . . . . 0.0 109.923 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.89 135.97 73.79 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.436 2.091 . . . . 0.0 111.348 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -100.12 36.94 1.74 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.479 1.111 . . . . 0.0 110.495 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.29 -40.49 2.88 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.562 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.31 155.18 19.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 110.985 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 161.62 42.37 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 109.261 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -120.8 113.37 20.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.246 1.018 . . . . 0.0 108.616 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.423 HG23 HG21 ' A' ' 43' ' ' ILE . 77.9 t -107.47 121.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.0 0.92 . . . . 0.0 108.823 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 12' ' ' VAL . 29.4 mt-10 -86.09 156.41 20.39 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.048 0.539 . . . . 0.0 109.795 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD11 HG22 ' A' ' 67' ' ' VAL . 3.6 mp -138.21 156.71 47.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.937 0.895 . . . . 0.0 109.681 -176.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.18 -26.47 47.61 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.937 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.8 m -145.59 153.72 41.37 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -31.28 72.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.58 1.152 . . . . 0.0 111.158 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.11 -49.13 77.14 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.19 0.519 . . . . 0.0 110.097 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -58.06 -35.22 71.04 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.795 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 HD11 ' A' ' 61' ' ' LEU . 79.3 t -61.62 -50.22 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -56.75 -36.98 70.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.668 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.45 -42.3 87.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.362 0.665 . . . . 0.0 111.035 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -61.78 -40.19 94.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.801 0.84 . . . . 0.0 111.024 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 81.1 mt -61.62 -23.5 66.08 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.25 1.02 . . . . 0.0 112.547 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.25 -4.85 56.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.618 0.367 . . . . 0.0 111.776 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.68 4.94 49.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.062 0.945 . . . . 0.0 111.781 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.511 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 26.8 t70 -38.83 -12.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 170.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -144.78 -11.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.134 -0.979 . . . . 0.0 111.553 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -52.12 139.73 22.59 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.146 0.978 . . . . 0.0 111.708 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.8 p -93.01 127.71 38.62 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.945 0.898 . . . . 0.0 112.435 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -94.02 102.64 14.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.88 -90.2 0.32 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.51 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -120.43 -4.32 9.88 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.102 0.961 . . . . 0.0 111.354 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -124.75 147.88 48.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.615 0.366 . . . . 0.0 110.849 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -79.91 141.29 36.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.39 123.84 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 34.9 mt-10 -95.46 129.02 42.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.247 1.019 . . . . 0.0 108.977 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.511 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 27.8 t -127.01 118.53 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -113.87 177.67 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -111.89 128.8 56.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.1 m -122.9 -166.31 1.43 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.15 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -136.46 161.46 35.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -63.21 -35.12 79.28 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.75 -41.92 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.185 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.96 -51.75 65.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.156 0.982 . . . . 0.0 110.518 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.475 ' HB2' HG11 ' A' ' 12' ' ' VAL . 10.9 tmm? -57.62 -50.52 72.88 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.25 1.42 . . . . 0.0 111.183 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.31 -39.51 92.59 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.526 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -61.2 -50.9 71.25 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 0.0 111.504 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.19 -39.1 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.484 0.49 . . . . 0.0 111.376 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 93' ' ' MET . 94.0 mt -65.41 -29.27 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.296 0.238 . . . . 0.0 111.383 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -86.67 -33.16 20.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.442 0.697 . . . . 0.0 110.62 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 124.969 1.308 . . . . 0.0 108.294 -178.42 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 CA--C 1.551 1.008 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.36 138.65 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.828 0.851 . . . . 0.0 109.959 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -107.37 162.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.201 0.601 . . . . 0.0 110.32 165.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 38.4 ttpt -113.6 120.63 41.58 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.5 118.36 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -122.1 147.7 45.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.423 1.489 . . . . 0.0 107.188 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.5 20.0 21.15 Favored Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.5 mt -92.74 117.01 67.41 Favored Pre-proline 0 C--O 1.244 0.781 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.147 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.72 157.74 7.12 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.017 2.478 . . . . 0.0 113.222 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -61.96 -18.78 61.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.604 0.762 . . . . 0.0 112.285 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 m -110.97 14.7 22.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.746 0.819 . . . . 0.0 112.168 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.64 170.67 6.02 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.205 0.457 . . . . 0.0 111.303 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -139.73 156.11 46.97 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.116 0.566 . . . . 0.0 109.492 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.25 84.28 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.828 0.705 . . . . 0.0 110.721 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.8 m-20 -53.8 -42.61 68.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.516 0.726 . . . . 0.0 112.563 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.98 -39.96 95.32 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.115 0.566 . . . . 0.0 111.876 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.2 t -68.61 -35.23 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.54 0.736 . . . . 0.0 110.096 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -65.38 -40.54 93.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.303 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 70.6 mtp180 -59.99 -47.15 87.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.187 0.595 . . . . 0.0 111.045 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.93 -34.16 74.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.475 0.71 . . . . 0.0 111.488 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.721 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 63.2 m-85 -108.35 24.9 12.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.693 0.797 . . . . 0.0 111.655 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.2 p -74.16 90.61 2.06 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.7 t70 166.08 -53.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -160.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 16.8 p -76.68 -175.56 3.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.451 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 33.3 mmtp -129.17 96.11 4.23 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' HA ' HD22 ' A' ' 61' ' ' LEU . 24.4 mt -76.45 139.04 19.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -66.06 110.28 2.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.955 0.902 . . . . 0.0 110.31 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 85.9 m-20 60.04 31.52 20.66 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.903 0.881 . . . . 0.0 111.179 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 -125.24 34.09 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.699 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.9 -24.21 22.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.035 0.934 . . . . 0.0 113.46 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 6.9 tp60 -71.33 -18.05 62.41 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.694 0.397 . . . . 0.0 112.053 -176.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.67 -18.29 58.64 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.63 -0.259 . . . . 0.0 112.625 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.453 HD13 ' HB ' ' A' ' 27' ' ' VAL . 54.5 mt -85.18 110.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.0 109.675 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -123.24 99.7 6.48 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.553 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -78.31 138.83 38.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.953 0.501 . . . . 0.0 110.417 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.56 99.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.26 153.85 28.24 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.826 0.346 . . . . 0.0 110.707 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.6 p -87.03 -172.95 4.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.603 0.761 . . . . 0.0 109.515 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -76.65 -0.12 22.3 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.675 0.39 . . . . 0.0 111.568 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -101.55 -20.73 14.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.033 0.933 . . . . 0.0 109.462 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.21 45.14 4.51 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.29 138.91 26.12 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.18 0.992 . . . . 0.0 109.234 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.08 120.91 8.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.66 2.24 . . . . 0.0 111.168 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.6 m -82.91 25.35 0.68 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.049 0.94 . . . . 0.0 112.064 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.41 -33.43 4.12 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.159 0.409 . . . . 0.0 112.476 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -111.18 156.08 21.95 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.592 1.157 . . . . 0.0 110.761 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.68 169.39 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.058 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -121.69 115.98 23.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.765 0.826 . . . . 0.0 109.472 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.89 112.51 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -84.02 141.9 30.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.797 0.839 . . . . 0.0 109.015 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 36' ' ' ILE . 39.7 mt -131.54 165.27 23.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.919 0.887 . . . . 0.0 110.22 -168.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.88 -39.73 87.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.406 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 t -164.74 174.79 10.32 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.818 0.447 . . . . 0.0 110.122 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 7.6 pt-20 -60.54 -27.71 67.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.167 0.987 . . . . 0.0 112.57 -174.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.35 -50.93 41.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 14.3 mp0 -51.59 -37.24 48.98 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.313 1.045 . . . . 0.0 111.637 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.437 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 44.3 t -60.11 -52.51 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.369 172.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -57.3 -40.09 77.09 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.62 0.768 . . . . 0.0 111.948 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 66' ' ' GLU . 86.1 mt -58.64 -45.34 89.5 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.997 0.919 . . . . 0.0 110.641 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.36 84.49 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.478 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 92.1 mt -58.35 -37.13 74.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.679 1.192 . . . . 0.0 112.096 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -72.4 -5.66 38.09 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -98.98 9.61 43.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.252 1.021 . . . . 0.0 112.774 172.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.76 10.01 0.15 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -123.02 -23.18 5.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.31 0.644 . . . . 0.0 110.781 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.27 148.18 45.75 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.776 0.798 . . . . 0.0 112.216 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -99.79 137.79 37.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.309 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.2 ttt -142.59 111.42 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.614 1.166 . . . . 0.0 109.114 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.2 58.25 7.55 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.041 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 t60 71.89 -7.49 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 125.073 1.349 . . . . 0.0 112.809 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -116.85 149.59 39.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.518 1.127 . . . . 0.0 110.162 -172.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -80.78 138.89 36.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.51 123.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -95.26 119.48 33.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.7 t -113.2 114.14 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.4 m-85 -103.39 171.81 7.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.609 1.164 . . . . 0.0 110.355 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -97.14 104.57 16.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -106.2 -171.7 1.95 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.015 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.85 163.44 34.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.732 1.213 . . . . 0.0 108.934 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -61.13 -38.39 86.22 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.15 -49.44 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.161 -1.382 . . . . 0.0 110.521 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.81 -42.42 95.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.1 ttp -52.58 -56.86 12.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.066 0.946 . . . . 0.0 111.554 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.86 -46.0 80.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.901 0.751 . . . . 0.0 111.759 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -69.19 -44.93 71.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.202 0.601 . . . . 0.0 112.543 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.09 -42.65 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 122.673 0.389 . . . . 0.0 110.656 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -38.74 85.49 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.195 0.598 . . . . 0.0 110.188 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.57 -18.78 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.681 0.793 . . . . 0.0 109.984 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 CA--C 1.555 1.139 0 C-N-CA 123.315 0.646 . . . . 0.0 109.288 172.722 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -98.97 138.56 23.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.775 1.23 . . . . 0.0 109.247 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -108.75 173.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.768 0.827 . . . . 0.0 109.121 165.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 18.1 ptpt -121.53 129.54 52.97 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.69 117.55 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.12 158.24 18.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -172.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 73.25 32.65 59.95 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 121.464 0.48 . . . . 0.0 112.874 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.25 133.42 38.72 Favored Pre-proline 0 C--O 1.243 0.736 0 C-N-CA 123.753 0.821 . . . . 0.0 109.041 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -54.7 145.44 60.04 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.71 2.274 . . . . 0.0 112.468 170.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -58.7 -30.52 67.47 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.158 0.983 . . . . 0.0 111.011 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.6 p -105.81 20.05 19.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.461 1.104 . . . . 0.0 111.64 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -68.65 169.99 10.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.333 0.653 . . . . 0.0 111.009 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.2 p -126.39 156.92 39.78 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -35.2 67.42 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.441 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.14 -40.32 70.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.78 1.232 . . . . 0.0 112.957 173.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -64.35 -40.11 95.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.336 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 43' ' ' ILE . 46.7 t -76.77 -26.12 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' NE2' HD12 ' A' ' 36' ' ' ILE . 15.5 mm-40 -64.07 -53.6 47.15 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.256 1.023 . . . . 0.0 110.134 173.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -58.65 -46.92 86.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.158 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -68.17 -44.27 76.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.076 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -97.24 36.22 1.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.738 0.815 . . . . 0.0 110.301 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 p -59.58 -23.37 62.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.164 0.585 . . . . 0.0 112.295 173.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.05 -49.96 73.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.409 0.684 . . . . 0.0 110.331 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.2 m -82.92 131.57 35.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.619 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -79.54 105.23 10.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.461 HD12 ' NE2' ' A' ' 28' ' ' GLN . 47.3 mt -83.77 147.19 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.508 0.723 . . . . 0.0 109.44 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -41.73 -70.18 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 126.512 1.925 . . . . 0.0 114.172 -166.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -118.71 48.02 1.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 168.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.97 -120.5 23.02 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.515 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.511 ' HA ' HD11 ' A' ' 43' ' ' ILE . . . -62.5 -31.41 72.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.629 0.772 . . . . 0.0 112.068 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.94 -19.66 58.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.452 0.701 . . . . 0.0 111.222 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -16.01 79.67 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.661 -0.245 . . . . 0.0 112.795 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' A' ' 27' ' ' VAL . 66.1 mt -85.55 127.92 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.225 1.01 . . . . 0.0 109.545 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' NH1' ' SD ' ' A' ' 93' ' ' MET . 55.1 mtt180 -130.66 98.74 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 109.786 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.29 142.94 43.2 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.744 0.418 . . . . 0.0 110.489 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.66 HD12 ' HG2' ' A' ' 56' ' ' GLU . 61.4 mt -86.31 90.6 3.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -72.37 156.27 39.26 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.825 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.7 p -84.63 -173.17 4.58 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.552 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -63.89 -17.65 63.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB3' ' NH2' ' A' ' 52' ' ' ARG . 70.7 mm-40 -88.52 -5.92 57.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.777 1.231 . . . . 0.0 111.468 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.47 63.43 Favored Glycine 0 C--N 1.352 1.436 0 O-C-N 123.429 0.456 . . . . 0.0 113.268 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.491 ' NH2' ' HB3' ' A' ' 50' ' ' GLU . 48.8 mtm180 -137.85 139.59 26.88 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 110.013 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.77 128.6 29.12 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.288 2.659 . . . . 0.0 112.045 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -74.84 -68.18 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.45 -11.94 0.02 OUTLIER Glycine 0 N--CA 1.474 1.187 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.108 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.66 ' HG2' HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -128.95 168.24 16.27 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 111.225 177.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HA ' HG13 ' A' ' 46' ' ' ILE . . . -152.91 172.02 17.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.976 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.401 ' HE2' ' HB3' ' A' ' 88' ' ' SER . 48.6 m-85 -120.75 122.04 39.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 0.0 109.064 166.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.527 HG23 HG23 ' A' ' 43' ' ' ILE . 81.1 t -116.25 117.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.064 0.946 . . . . 0.0 108.521 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 33.1 tt0 -86.34 147.26 26.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 83.4 mt -130.01 156.14 44.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.172 0.989 . . . . 0.0 110.347 -169.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.32 -26.21 64.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.064 0.946 . . . . 0.0 111.551 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 74.4 m -148.53 160.64 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.557 0.743 . . . . 0.0 110.278 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.75 -15.14 61.67 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.262 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 22.9 t70 -72.22 -38.88 68.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.886 0.474 . . . . 0.0 110.304 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 22.4 mm-40 -61.18 -33.47 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.96 169.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 54.5 t -63.11 -37.19 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.075 0.55 . . . . 0.0 110.004 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 67.9 mmtt -57.98 -48.44 79.99 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.829 0.452 . . . . 0.0 111.036 171.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.1 -26.24 68.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.659 0.784 . . . . 0.0 112.07 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.509 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -78.2 -45.24 23.57 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.523 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 55.9 mt -67.03 -28.73 68.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -78.12 -15.34 58.95 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.005 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -87.3 -8.22 56.96 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.736 1.215 . . . . 0.0 110.804 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.3 93.15 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.584 0.754 . . . . 0.0 108.988 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 154.12 -53.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.721 2.008 . . . . 0.0 108.869 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.14 141.63 22.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 113.397 -167.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.4 p -83.28 126.18 32.4 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.26 1.024 . . . . 0.0 112.385 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.2 tpp -82.64 85.9 6.93 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.44 -75.9 0.66 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -114.33 -45.2 3.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.082 0.953 . . . . 0.0 109.669 171.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -67.06 -145.85 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.422 1.489 . . . . 0.0 112.092 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.491 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 32.5 t80 -160.98 120.54 2.64 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.837 -1.164 . . . . 0.0 108.388 -158.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 98.4 t -99.41 130.23 48.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 123.573 0.749 . . . . 0.0 110.381 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.85 121.59 40.35 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -118.36 122.91 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -119.37 142.43 48.17 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.423 ' HB2' HD13 ' A' ' 71' ' ' LEU . 19.5 ttmm -57.9 116.79 3.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.859 0.863 . . . . 0.0 109.762 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.401 ' HB3' ' HE2' ' A' ' 58' ' ' PHE . 20.1 m -114.55 -174.28 2.45 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.482 0.658 . . . . 0.0 110.921 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -131.62 152.0 51.17 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.37 -33.01 74.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.304 0.642 . . . . 0.0 109.919 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.0 -48.21 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.611 1.164 . . . . 0.0 110.249 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.46 -34.82 74.94 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.676 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' ' NH1' ' A' ' 44' ' ' ARG . 54.9 ttp -57.35 -55.19 37.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.865 0.866 . . . . 0.0 110.935 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.05 -39.86 93.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.769 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 44.0 t90 -57.33 -42.68 82.37 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.171 0.92 . . . . 0.0 111.714 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -80.96 -40.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.42 -176.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.69 -17.34 63.47 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.692 -0.63 . . . . 0.0 111.482 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -68.9 -39.42 79.73 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.034 0.933 . . . . 0.0 112.304 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.9 t60 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 123.344 0.657 . . . . 0.0 109.427 -168.452 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 60' ' ' GLU . 17.3 t -114.65 145.15 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 108.549 -174.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.22 175.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.497 0.719 . . . . 0.0 109.82 162.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -127.58 140.31 52.2 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 3.4 t -113.52 113.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -174.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -112.22 147.2 36.71 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 81' ' ' ARG . . . 90.32 27.42 20.56 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 121.407 0.448 . . . . 0.0 112.394 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.39 146.1 46.78 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 123.737 0.815 . . . . 0.0 109.304 172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HD3' ' HG3' ' A' ' 81' ' ' ARG . 1.3 Cg_endo -51.47 149.83 16.96 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.337 2.025 . . . . 0.0 111.872 165.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -59.83 -26.49 65.85 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.471 0.708 . . . . 0.0 111.964 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -119.13 36.9 4.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.227 1.011 . . . . 0.0 109.74 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.27 151.1 48.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.674 0.389 . . . . 0.0 110.347 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.7 t -111.13 146.41 36.89 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.576 0.75 . . . . 0.0 109.047 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -34.4 66.62 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.66 0.6 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 11.2 m-20 -54.98 -49.35 71.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.867 0.867 . . . . 0.0 112.261 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 12.2 mm-40 -69.25 -34.39 74.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.893 0.477 . . . . 0.0 111.101 -174.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.36 -37.9 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.202 0.601 . . . . 0.0 109.711 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.24 -44.49 88.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.151 0.98 . . . . 0.0 111.266 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 29.6 mmt85 -62.39 -39.84 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.477 0.711 . . . . 0.0 110.839 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -38.18 87.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.466 0.707 . . . . 0.0 110.045 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.668 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 59.1 m-85 -101.43 28.75 5.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.239 0.615 . . . . 0.0 112.019 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 t -80.98 83.25 6.74 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 171.22 -39.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.884 1.274 . . . . 0.0 108.268 -161.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 23.4 p -114.92 127.44 55.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.843 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.61 100.47 6.15 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.295 0.638 . . . . 0.0 109.598 -171.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.591 ' HA ' HD22 ' A' ' 61' ' ' LEU . 45.9 mt -74.05 127.6 35.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.338 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.04 121.15 13.45 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.111 0.882 . . . . 0.0 109.377 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 69.28 12.59 8.42 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.944 1.298 . . . . 0.0 112.056 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.27 -134.17 42.51 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.82 -19.57 64.2 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.489 0.716 . . . . 0.0 112.309 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -73.74 -16.93 61.16 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.149 0.58 . . . . 0.0 112.091 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.63 -6.39 76.98 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 123.533 0.52 . . . . 0.0 112.424 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.515 HG12 HG23 ' A' ' 59' ' ' VAL . 51.5 mt -92.05 123.69 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 110.686 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -132.4 105.62 7.39 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.926 1.29 . . . . 0.0 109.366 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -68.6 143.65 54.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.3 93.75 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.1 134.4 37.72 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.635 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p -75.64 -172.03 1.74 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.53 0.732 . . . . 0.0 110.95 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.2 -20.4 66.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -91.4 0.98 57.44 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.851 0.86 . . . . 0.0 110.396 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.22 71.04 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -107.94 134.49 20.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.493 0.717 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.54 121.34 9.87 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.562 2.175 . . . . 0.0 111.179 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.0 p -73.04 -8.85 57.59 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.8 0.84 . . . . 0.0 112.224 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.15 54.81 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 10.1 mp0 -109.15 154.22 22.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.498 1.119 . . . . 0.0 109.535 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.07 169.43 21.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 110.469 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.03 127.55 53.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.797 1.239 . . . . 0.0 109.125 165.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.515 HG23 HG12 ' A' ' 43' ' ' ILE . 55.3 t -118.12 119.75 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 12' ' ' VAL . 44.0 mt-10 -79.87 146.47 32.18 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' A' ' 36' ' ' ILE . 71.8 mt -136.13 136.55 40.17 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.04 -10.59 41.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -167.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 66' ' ' GLU . 97.1 p -153.51 161.42 42.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.324 0.649 . . . . 0.0 110.433 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 37.1 tt0 -71.41 -16.93 62.42 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.454 0.702 . . . . 0.0 111.056 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.41 -48.66 55.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 41.3 mm-40 -54.08 -34.99 61.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 123.831 0.707 . . . . 0.0 111.829 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 37.6 t -60.75 -49.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.05 0.54 . . . . 0.0 110.738 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 92.3 mttt -59.76 -36.75 77.29 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.584 0.754 . . . . 0.0 112.167 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 93.6 mt -63.48 -43.99 95.71 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.43 0.692 . . . . 0.0 111.444 174.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.6 -46.8 86.24 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.004 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 87' ' ' LYS . 82.6 mt -62.77 -30.67 71.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.301 1.041 . . . . 0.0 112.984 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 20.0 ptmt -78.67 -13.01 60.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 120.72 0.295 . . . . 0.0 110.783 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.22 3.78 54.79 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.831 0.852 . . . . 0.0 111.08 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 90.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.384 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 164.44 -52.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.863 1.265 . . . . 0.0 111.224 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.83 169.97 16.85 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.435 0.636 . . . . 0.0 112.674 -165.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -113.12 139.23 48.9 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.371 -162.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -103.15 67.54 0.94 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.947 1.299 . . . . 0.0 108.859 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.15 58.12 3.26 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.799 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.0 m80 72.62 -7.71 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.684 1.594 . . . . 0.0 112.763 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.477 ' HG3' ' HD3' ' A' ' 19' ' ' PRO . 23.0 mmt180 -77.98 104.87 8.81 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -66.16 112.38 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.51 133.26 47.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.96 130.43 55.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 108.86 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.93 116.27 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.47 137.7 54.79 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 71' ' ' LEU . 77.9 tttt -67.2 136.28 54.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -121.3 155.96 33.58 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.063 0.945 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -91.58 158.68 16.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.3 175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -66.07 -30.71 71.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -44.5 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.885 1.274 . . . . 0.0 110.643 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.415 ' O ' HG21 ' A' ' 96' ' ' VAL . 55.1 tt0 -69.53 -45.55 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.234 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 58.1 ttp -55.44 -45.88 76.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.785 0.834 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.73 -51.86 68.17 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.367 1.067 . . . . 0.0 110.183 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -56.09 -53.52 56.06 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.079 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 92' ' ' GLU . 38.2 t -74.43 -36.34 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.33 0.652 . . . . 0.0 112.195 -169.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.26 -33.62 71.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.645 0.26 . . . . 0.0 110.899 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -89.65 -24.47 21.63 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.767 0.827 . . . . 0.0 111.362 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.5 t60 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 124.421 1.088 . . . . 0.0 108.153 -177.651 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.239 0.542 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 t -108.43 139.04 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 109.861 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.5 178.36 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.514 0.726 . . . . 0.0 110.025 167.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -134.95 125.39 26.56 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.01 129.13 69.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 124.068 0.947 . . . . 0.0 108.806 -166.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.55 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -123.1 153.1 40.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.345 1.058 . . . . 0.0 108.178 -172.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.15 22.52 35.03 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.68 110.82 47.84 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.96 150.65 22.78 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.893 2.395 . . . . 0.0 113.468 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.7 p90 -55.31 -31.49 61.69 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 111.632 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 t -108.78 24.92 12.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.636 0.775 . . . . 0.0 111.128 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -78.96 176.88 9.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.446 0.698 . . . . 0.0 110.23 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.606 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 44.9 t -128.63 152.26 48.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.458 0.703 . . . . 0.0 109.396 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.29 70.18 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.056 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.61 -42.13 82.68 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.92 0.888 . . . . 0.0 112.081 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 32.7 mm-40 -64.09 -45.28 89.38 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.755 0.659 . . . . 0.0 110.496 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.409 ' HB ' HD12 ' A' ' 43' ' ' ILE . 43.8 t -68.99 -38.13 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.732 0.813 . . . . 0.0 110.495 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.493 ' HG3' ' HB1' ' A' ' 40' ' ' ALA . 24.7 tm0? -63.91 -51.54 64.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.136 0.974 . . . . 0.0 110.033 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 -63.33 -41.39 98.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.848 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.1 -40.92 95.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.827 0.851 . . . . 0.0 111.053 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 47.0 m-85 -88.06 37.05 0.79 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.777 0.831 . . . . 0.0 111.44 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 t -77.04 82.2 3.55 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 172.23 -39.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.265 1.426 . . . . 0.0 107.871 -162.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.29 169.91 8.27 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.269 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -117.82 85.87 2.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HA ' HD23 ' A' ' 61' ' ' LEU . 32.7 mt -65.28 126.18 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -42.31 -68.21 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.928 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -104.53 41.3 1.34 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.159 0.584 . . . . 0.0 110.477 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.77 -137.17 36.37 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HB1' ' HG3' ' A' ' 28' ' ' GLN . . . -70.0 -4.59 21.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 117.739 0.77 . . . . 0.0 112.375 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -83.52 -1.5 53.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.218 0.607 . . . . 0.0 111.326 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.04 5.29 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 ' HB ' ' A' ' 27' ' ' VAL . 69.0 mt -131.86 105.31 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.038 0.935 . . . . 0.0 109.218 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.2 95.34 5.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.327 1.051 . . . . 0.0 110.318 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.08 124.15 21.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.564 HD13 ' HG3' ' A' ' 56' ' ' GLU . 71.1 mt -70.97 90.98 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -76.73 142.6 40.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.855 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.2 p -75.9 -177.09 3.68 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.842 0.857 . . . . 0.0 110.084 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.8 -8.97 48.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.7 14.1 22.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.97 0.908 . . . . 0.0 110.294 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.35 36.25 91.38 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -114.15 134.42 22.21 Favored Pre-proline 0 N--CA 1.484 1.243 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.794 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.71 127.52 22.85 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.293 1.995 . . . . 0.0 110.953 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 t -81.28 21.88 0.72 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.864 0.866 . . . . 0.0 111.565 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.26 -6.62 75.34 Favored Glycine 0 C--N 1.353 1.514 0 C-N-CA 123.186 0.422 . . . . 0.0 112.966 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.564 ' HG3' HD13 ' A' ' 46' ' ' ILE . 11.7 pt-20 -139.32 169.77 17.17 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.41 28.15 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.81 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -108.47 136.64 47.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.95 114.94 44.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.94 148.16 32.74 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 36' ' ' ILE . 77.1 mt -133.62 170.94 14.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.757 0.823 . . . . 0.0 110.205 -173.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.79 -39.47 61.7 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.02 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 t -160.42 174.11 14.61 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.32 -13.3 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.928 0.491 . . . . 0.0 111.596 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.81 -40.93 88.23 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.679 0.752 . . . . 0.0 109.706 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -62.29 -40.96 97.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.91 169.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 58.0 t -60.47 -53.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 123.526 0.516 . . . . 0.0 110.93 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.34 -39.03 66.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.79 -36.01 64.97 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.262 0.625 . . . . 0.0 111.663 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 85' ' ' VAL . . . -57.21 -49.29 76.45 Favored 'General case' 0 CA--C 1.55 0.977 0 O-C-N 123.799 0.687 . . . . 0.0 109.875 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 42.7 mt -59.74 -44.56 93.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.622 0.769 . . . . 0.0 111.644 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.653 ' HZ2' ' HB3' ' A' ' 73' ' ' LYS . 1.7 pptp? -70.64 -26.28 63.39 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.564 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.653 ' HB3' ' HZ2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -90.08 20.46 4.28 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.041 -178.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.88 -23.32 55.6 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.78 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -57.81 -43.6 85.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.761 0.824 . . . . 0.0 110.892 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.45 178.61 5.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.521 1.128 . . . . 0.0 113.361 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 p -112.88 136.74 52.19 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.678 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.6 tpt -57.54 -66.2 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.214 1.006 . . . . 0.0 109.546 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.55 -33.95 0.47 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 164.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -146.46 -46.06 0.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.904 0.882 . . . . 0.0 109.083 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -61.85 135.22 57.49 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.7 0.8 . . . . 0.0 110.759 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 126.72 31.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.32 116.64 28.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -95.57 117.28 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' A' ' 70' ' ' ALA . 23.2 t -115.98 114.85 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -108.76 132.96 53.46 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.178 0.991 . . . . 0.0 109.878 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -59.96 110.61 1.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.078 0.951 . . . . 0.0 109.91 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 m -116.37 -168.26 1.41 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.385 0.674 . . . . 0.0 110.542 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -140.26 156.87 46.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.544 1.137 . . . . 0.0 108.587 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -71.22 -32.17 68.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 0.0 109.949 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -55.66 -47.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.171 0.988 . . . . 0.0 109.909 170.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.2 -49.78 58.6 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.115 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -54.35 -49.28 70.15 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.589 1.155 . . . . 0.0 111.24 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.68 -42.11 95.59 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.009 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -63.51 -37.24 86.55 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 124.163 0.914 . . . . 0.0 110.809 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.1 t -78.3 -30.15 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 122.83 0.452 . . . . 0.0 111.435 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.77 -16.68 61.16 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.397 -0.815 . . . . 0.0 111.083 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -94.11 -33.59 13.29 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.855 0.862 . . . . 0.0 110.633 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.1 t60 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.694 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.545 ' HA ' HG23 ' A' ' 67' ' ' VAL . 1.7 p90 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 93' ' ' MET . 26.1 t -99.95 132.65 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.36 167.78 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.376 1.07 . . . . 0.0 110.57 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -117.14 126.47 52.86 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 5.1 t -106.13 108.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 107.974 -173.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -119.16 142.45 47.94 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 124.595 1.158 . . . . 0.0 108.939 -167.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.91 27.87 15.38 Favored Glycine 0 N--CA 1.473 1.129 0 CA-C-O 121.627 0.571 . . . . 0.0 111.753 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.42 143.05 33.65 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 123.853 0.861 . . . . 0.0 109.132 174.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.459 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 31.0 Cg_endo -63.92 146.1 91.01 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.916 1.744 . . . . 0.0 110.645 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.588 ' HE1' ' HB3' ' A' ' 52' ' ' ARG . 83.6 t90 -52.41 -45.96 66.1 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.248 1.019 . . . . 0.0 111.212 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 p -92.99 35.28 1.06 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.432 1.093 . . . . 0.0 112.03 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 14.2 p -73.65 -170.87 0.92 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.224 0.61 . . . . 0.0 110.622 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.579 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 46.4 m -146.46 154.55 41.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.013 0.925 . . . . 0.0 109.012 173.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.25 -38.05 79.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.694 0.798 . . . . 0.0 111.457 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.99 -38.77 87.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.686 0.794 . . . . 0.0 111.371 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 34.2 mm-40 -67.61 -40.86 84.69 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.404 0.681 . . . . 0.0 110.855 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.53 -35.55 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.527 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.34 -45.97 92.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.473 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -63.57 -36.96 85.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.089 0.556 . . . . 0.0 110.901 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -60.13 -39.78 87.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.905 0.482 . . . . 0.0 110.289 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.586 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 67.9 m-85 -90.03 40.17 0.99 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.14 0.576 . . . . 0.0 111.792 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 p -74.51 87.22 2.09 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 166.4 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.339 2.256 . . . . 0.0 106.697 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HG ' ' HB2' ' A' ' 69' ' ' LEU . 18.9 m -89.08 127.76 35.72 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.956 -169.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 94.71 2.96 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.522 ' HA ' HD21 ' A' ' 61' ' ' LEU . 18.5 mt -74.93 147.91 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.855 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.405 ' HG2' ' ND2' ' A' ' 38' ' ' ASN . 28.6 tt0 -39.24 -68.54 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.906 1.682 . . . . 0.0 112.323 -172.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.405 ' ND2' ' HG2' ' A' ' 37' ' ' GLN . 62.9 m-80 -128.57 51.02 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.05 -128.07 33.62 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.193 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.8 66.86 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.715 0.758 . . . . 0.0 112.031 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.33 -17.38 60.26 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.879 0.472 . . . . 0.0 111.413 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 29.25 9.33 Favored Glycine 0 C--N 1.351 1.393 0 O-C-N 123.266 0.353 . . . . 0.0 112.287 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 59' ' ' VAL . 52.7 mt -130.37 131.38 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.149 1.38 . . . . 0.0 108.3 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 103.58 4.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.58 0.752 . . . . 0.0 109.563 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CE2' ' SG ' ' A' ' 22' ' ' CYS . 64.7 m-85 -69.06 145.7 53.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.276 0.63 . . . . 0.0 110.263 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' A' ' 56' ' ' GLU . 45.7 mt -73.7 91.34 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -78.47 146.72 34.27 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.784 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -84.79 -178.83 6.96 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.147 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -75.07 5.17 5.58 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.594 0.358 . . . . 0.0 111.945 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -102.6 -4.64 24.91 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.532 0.733 . . . . 0.0 109.756 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.6 37.95 38.97 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.418 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.588 ' HB3' ' HE1' ' A' ' 20' ' ' TRP . 76.0 mtt180 -120.48 130.68 24.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.983 -173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.7 132.23 41.75 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.083 2.522 . . . . 0.0 112.171 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 p -79.29 12.51 2.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.161 0.985 . . . . 0.0 113.021 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 -6.69 83.38 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HG3' HD13 ' A' ' 46' ' ' ILE . 5.0 pt-20 -133.76 163.08 30.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.0 0.92 . . . . 0.0 111.579 175.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 167.96 24.68 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.687 -170.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -118.8 111.79 18.89 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.845 0.858 . . . . 0.0 110.315 171.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 43' ' ' ILE . 44.4 t -96.53 146.67 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.46 1.104 . . . . 0.0 108.181 171.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 12' ' ' VAL . 35.4 tt0 -126.72 144.09 51.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 36' ' ' ILE . 50.8 mt -129.38 146.3 51.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.356 0.662 . . . . 0.0 109.601 -167.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -72.9 -19.05 61.35 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.6 m -147.7 151.47 36.17 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.693 0.797 . . . . 0.0 109.119 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.81 -3.68 51.95 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 120.802 0.334 . . . . 0.0 111.628 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.26 -50.07 73.19 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.36 -31.56 65.89 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.359 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 11' ' ' PHE . 53.2 t -66.14 -41.85 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.163 0.585 . . . . 0.0 110.679 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -57.22 -41.06 78.75 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.739 0.416 . . . . 0.0 110.904 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.418 ' HB2' ' HG ' ' A' ' 34' ' ' CYS . 57.9 mt -68.95 -32.58 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.634 0.774 . . . . 0.0 111.043 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.1 -52.55 33.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.951 0.901 . . . . 0.0 110.845 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 76.0 mt -61.03 -28.2 68.88 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.663 1.185 . . . . 0.0 111.387 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.0 -25.28 66.23 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.48 1.112 . . . . 0.0 110.8 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 67.3 mttm -83.76 6.92 19.44 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.186 0.994 . . . . 0.0 113.503 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.47 -2.47 0.5 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -121.01 -24.39 5.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.343 0.657 . . . . 0.0 111.889 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' A' ' 73' ' ' LYS . 6.6 mm-40 -59.26 148.53 31.58 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.6 p -98.66 126.98 44.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.841 0.856 . . . . 0.0 110.535 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -68.95 -78.48 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.93 89.42 0.29 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 170.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.6 m80 76.35 -54.35 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.056 1.742 . . . . 0.0 111.284 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -70.18 147.16 50.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.923 0.889 . . . . 0.0 111.396 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.25 142.31 28.66 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 108.681 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.0 t -120.14 131.13 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.516 0.726 . . . . 0.0 109.824 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.8 141.84 28.16 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.391 1.477 . . . . 0.0 108.562 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.61 123.25 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -125.1 146.73 49.33 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.332 1.053 . . . . 0.0 108.814 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.448 ' HE2' HG11 ' A' ' 67' ' ' VAL . 39.9 ttmt -68.53 120.73 15.05 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.778 0.323 . . . . 0.0 110.491 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.1 m -86.54 -61.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.833 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.1 t30 83.31 148.07 0.08 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.883 1.673 . . . . 0.0 108.54 -163.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -57.92 -34.33 69.73 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.395 1.078 . . . . 0.0 112.408 -173.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.9 -41.96 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.755 0.822 . . . . 0.0 110.368 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -67.6 -43.67 79.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.777 0.831 . . . . 0.0 110.612 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.477 ' HB2' HG13 ' A' ' 12' ' ' VAL . 16.4 tmm? -54.23 -53.13 57.79 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.061 0.85 . . . . 0.0 110.918 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.6 -51.6 66.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.032 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -63.99 -51.95 61.87 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.122 0.969 . . . . 0.0 111.808 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.88 -48.66 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.429 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.99 -43.14 83.73 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.682 0.614 . . . . 0.0 110.18 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -70.96 -6.48 38.99 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 112.017 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.804 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.49 133.58 7.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 70' ' ' ALA . 27.2 m -108.36 163.73 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.319 0.581 . . . . 0.0 110.427 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -122.15 126.56 48.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 24.1 t -110.15 126.23 67.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 124.672 1.189 . . . . 0.0 108.673 -168.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -133.52 135.48 44.43 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.19 10.2 Favored Glycine 0 N--CA 1.47 0.94 0 O-C-N 123.427 0.454 . . . . 0.0 112.202 -168.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.45 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 88.0 mt -87.18 125.45 66.03 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.01 153.65 56.35 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.005 1.803 . . . . 0.0 111.615 171.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -54.99 -46.65 75.15 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.408 0.683 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -86.15 17.16 3.76 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.443 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 18' ' ' LEU . 18.8 p -86.98 137.98 31.9 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 t -89.27 163.71 15.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.298 0.639 . . . . 0.0 110.202 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.63 -39.91 71.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.631 0.773 . . . . 0.0 110.873 172.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.43 -38.19 88.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 0.0 111.992 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -66.77 -43.11 84.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.984 0.514 . . . . 0.0 110.908 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.43 -38.7 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.648 0.779 . . . . 0.0 110.069 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.467 ' HG3' HD13 ' A' ' 36' ' ' ILE . 50.3 tt0 -69.42 -40.08 77.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.678 0.791 . . . . 0.0 110.213 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -58.26 -47.44 83.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.252 1.021 . . . . 0.0 110.064 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.29 -43.78 98.3 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.596 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 38.7 m-85 -87.5 29.59 0.87 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.052 0.941 . . . . 0.0 112.191 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.8 m -80.31 90.53 5.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 167.45 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.126 1.771 . . . . 0.0 107.014 -167.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 32.0 p -85.57 130.67 34.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.443 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -74.15 90.39 2.04 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.467 HD13 ' HG3' ' A' ' 28' ' ' GLN . 16.9 mt -68.96 129.69 33.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -48.73 -58.44 4.76 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.61 1.194 . . . . 0.0 113.382 -160.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.09 41.14 3.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.204 0.602 . . . . 0.0 109.614 170.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.14 -128.63 28.44 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.67 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.68 63.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.67 0.788 . . . . 0.0 112.853 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.4 -21.18 63.79 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.704 0.402 . . . . 0.0 110.554 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.35 36.69 4.21 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 123.259 0.457 . . . . 0.0 112.131 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.29 108.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 73.6 mtt-85 -118.07 92.61 3.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -166.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -68.67 135.46 51.4 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -74.46 93.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.94 132.95 34.72 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.426 ' HG1' ' HB3' ' A' ' 52' ' ' ARG . 76.4 p -82.23 -176.0 5.96 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.679 0.792 . . . . 0.0 110.906 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -68.74 -14.0 62.74 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.18 0.592 . . . . 0.0 111.663 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -87.26 -14.49 40.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.501 0.72 . . . . 0.0 110.39 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.91 26.05 46.84 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.009 -171.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HB3' ' HG1' ' A' ' 48' ' ' THR . 33.1 ttm180 -100.98 125.71 37.42 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.56 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.86 129.14 19.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.914 1.743 . . . . 0.0 109.866 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -75.89 -3.87 37.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.951 0.9 . . . . 0.0 112.019 -172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 6.01 77.66 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 44.8 mt-10 -115.51 150.62 36.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.2 1.0 . . . . 0.0 109.829 173.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.25 161.67 39.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.047 0.939 . . . . 0.0 110.047 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 93.9 m-85 -109.83 105.35 14.52 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.48 102.41 13.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -78.38 132.57 37.42 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.343 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.75 152.11 37.72 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.752 0.421 . . . . 0.0 110.925 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.87 -35.9 79.35 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.48 1.112 . . . . 0.0 112.502 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 17.3 m -142.17 152.35 43.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.577 -169.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -67.08 -25.79 66.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.793 0.837 . . . . 0.0 112.46 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.563 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 6.1 p-10 -73.05 -36.79 66.98 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 68.7 mm-40 -54.49 -39.09 67.21 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 167.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.3 -53.4 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.604 0.761 . . . . 0.0 111.733 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 18.1 ptpt -55.22 -38.54 68.57 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.647 0.592 . . . . 0.0 112.019 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.8 mt -71.81 -36.69 70.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.861 0.864 . . . . 0.0 111.18 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -62.25 -36.58 82.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.021 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.405 HD12 ' HE3' ' A' ' 87' ' ' LYS . 64.0 mt -64.98 -32.32 73.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.882 0.473 . . . . 0.0 111.046 173.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 57.8 mttm -78.75 -17.1 56.35 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.389 0.676 . . . . 0.0 110.489 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 60.8 tttp -80.97 -1.3 43.16 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 0.0 111.162 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.18 -17.32 52.43 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.942 0.897 . . . . 0.0 112.732 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -86.41 -37.69 18.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.711 0.804 . . . . 0.0 111.221 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.59 157.13 24.6 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -101.16 133.67 45.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.811 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.571 ' HB2' HG21 ' A' ' 83' ' ' VAL . 25.3 ttt -61.19 -70.31 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.567 0.542 . . . . 0.0 110.147 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.27 -40.37 0.55 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 172.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -150.29 -46.53 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.718 0.807 . . . . 0.0 109.306 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -61.07 140.2 57.91 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.899 0.879 . . . . 0.0 110.744 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -81.54 125.54 30.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 78' ' ' MET . 67.8 t -106.91 107.66 23.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.03 137.73 35.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.675 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.26 119.17 53.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.599 -165.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -115.57 140.51 49.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.574 1.15 . . . . 0.0 108.657 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HE3' HD12 ' A' ' 71' ' ' LEU . 29.3 ttmt -62.23 123.16 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.882 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.9 p -110.93 -172.62 2.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.551 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -145.29 169.07 18.97 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.8 -44.3 97.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.46 -46.21 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.68 0.792 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -65.13 -53.92 37.75 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.799 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.09 -37.62 85.74 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 122.636 0.374 . . . . 0.0 111.623 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.47 -45.83 91.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.637 0.375 . . . . 0.0 110.649 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -63.81 -53.68 46.96 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.047 0.842 . . . . 0.0 111.733 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.43 -37.84 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.462 0.705 . . . . 0.0 111.202 -170.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.5 -41.61 65.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.626 0.37 . . . . 0.0 111.249 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -75.81 -32.27 59.76 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.659 0.384 . . . . 0.0 110.971 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.291 0.636 . . . . 0.0 110.965 -175.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 121.833 0.825 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.6 142.36 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.39 1.476 . . . . 0.0 107.097 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.447 HG13 HG12 ' A' ' 67' ' ' VAL . 32.6 m -108.4 -176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.95 0.5 . . . . 0.0 110.449 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -144.8 144.44 31.16 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 t -118.37 136.3 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.867 1.267 . . . . 0.0 107.885 -168.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 137.69 47.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.01 15.91 8.84 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.27 122.0 57.15 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.39 166.13 26.55 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 122.077 1.851 . . . . 0.0 112.356 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -28.6 66.26 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.469 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.1 p -89.74 7.32 37.44 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.16 0.984 . . . . 0.0 112.974 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 p -71.63 167.52 19.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.835 0.743 . . . . 0.0 111.993 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 23.4 m -120.67 148.96 43.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.856 0.862 . . . . 0.0 109.81 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.4 67.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.168 0.587 . . . . 0.0 111.239 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 33.1 t70 -54.94 -49.89 70.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 23' ' ' SER . 12.3 pt-20 -72.91 -35.58 67.11 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.823 -174.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.46 -35.04 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.515 ' HG3' HD13 ' A' ' 36' ' ' ILE . 34.6 tt0 -72.93 -29.69 63.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 67.0 mtt180 -68.61 -33.81 74.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.017 0.527 . . . . 0.0 110.82 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -68.95 -26.72 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.118 0.567 . . . . 0.0 110.098 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -110.46 26.66 10.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.654 0.782 . . . . 0.0 111.267 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -83.18 84.85 7.33 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.8 t70 159.82 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.625 1.57 . . . . 0.0 107.684 -159.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.1 m -82.63 175.86 9.83 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.295 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.46 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 3.6 mppt? -130.89 98.88 4.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.515 HD13 ' HG3' ' A' ' 28' ' ' GLN . 16.7 mt -82.15 134.34 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.477 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -82.01 34.44 0.41 Allowed 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 124.175 0.99 . . . . 0.0 111.831 -168.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 173.29 -7.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.497 1.519 . . . . 0.0 110.523 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.6 17.7 Favored Glycine 0 C--N 1.359 1.814 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.68 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.47 72.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.248 0.619 . . . . 0.0 111.184 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.69 -13.31 60.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.57 -176.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.35 -12.14 61.78 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 116.746 -0.206 . . . . 0.0 112.808 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 mt -81.64 90.16 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 18.3 tpp180 -84.25 92.24 7.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.412 -171.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.88 127.12 31.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.799 0.44 . . . . 0.0 110.706 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 56' ' ' GLU . 41.9 mt -71.25 96.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 41.0 m-85 -82.92 133.96 35.09 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -77.27 -170.83 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.175 0.922 . . . . 0.0 111.691 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -55.06 -28.72 54.47 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.094 0.958 . . . . 0.0 112.138 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -104.17 4.13 33.69 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.575 0.75 . . . . 0.0 110.272 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 47' ' ' TYR . . . 73.89 32.89 58.38 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 114.002 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -94.92 141.63 23.55 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.759 0.824 . . . . 0.0 109.746 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.31 110.32 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.938 1.759 . . . . 0.0 109.681 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.4 t -63.25 -8.2 7.8 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.608 1.163 . . . . 0.0 113.165 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -14.83 51.91 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HB2' HD13 ' A' ' 46' ' ' ILE . 40.0 mt-10 -121.65 159.73 25.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.369 1.068 . . . . 0.0 111.642 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.26 149.98 27.54 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.181 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 98.5 m-85 -91.54 155.57 18.29 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -136.06 109.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -78.85 119.26 21.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 109.407 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -116.09 154.43 29.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.339 0.655 . . . . 0.0 110.296 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.1 -30.25 70.72 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 111.393 -175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 162.98 39.98 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.82 0.848 . . . . 0.0 110.472 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.49 -13.88 62.3 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 122.946 0.499 . . . . 0.0 111.497 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t70 -60.07 -53.4 58.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 2.1 mp0 -59.5 -32.68 70.51 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.321 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 13' ' ' VAL . 54.4 t -61.85 -49.52 83.9 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 123.647 0.592 . . . . 0.0 110.332 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -53.02 -44.04 67.0 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 64.5 mt -60.88 -46.91 88.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.493 0.717 . . . . 0.0 110.099 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' HG11 ' A' ' 85' ' ' VAL . . . -59.4 -46.55 88.38 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.741 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 95.3 mt -57.12 -35.83 69.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.686 1.195 . . . . 0.0 111.792 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -77.3 -18.55 57.42 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.875 0.47 . . . . 0.0 111.654 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -88.61 6.99 35.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.1 0.56 . . . . 0.0 110.938 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 p-10 -65.53 -15.61 62.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.989 0.515 . . . . 0.0 111.642 173.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.26 -31.11 17.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.066 0.946 . . . . 0.0 110.925 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.12 151.92 34.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.672 0.789 . . . . 0.0 112.294 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -116.37 130.69 56.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.125 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 89.7 mmm -79.31 83.18 5.37 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.81 -96.47 2.1 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -170.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -126.01 3.73 7.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.813 0.845 . . . . 0.0 110.031 168.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.406 ' O ' HG21 ' A' ' 83' ' ' VAL . 20.3 mmt180 -70.93 110.39 5.62 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -70.2 109.48 4.67 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 81' ' ' ARG . 55.7 t -114.36 115.32 49.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 123.296 0.639 . . . . 0.0 109.487 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 2.1 pm0 -99.56 146.22 26.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.385 1.074 . . . . 0.0 109.724 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 70' ' ' ALA . 45.4 t -129.89 124.74 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -107.67 178.39 4.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.716 1.206 . . . . 0.0 108.235 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -106.94 127.7 53.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -113.67 -164.54 0.93 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.216 1.006 . . . . 0.0 110.883 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -147.18 159.99 42.98 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.07 -35.78 81.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 0.0 109.835 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.05 -41.81 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.641 0.776 . . . . 0.0 110.162 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.51 -44.15 97.07 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 44.3 ttp -58.96 -36.2 74.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.107 0.963 . . . . 0.0 110.532 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.1 -55.73 19.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.102 0.561 . . . . 0.0 110.951 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -63.86 -31.65 72.9 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.971 0.908 . . . . 0.0 112.525 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.87 -42.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.309 0.643 . . . . 0.0 110.999 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.74 -22.3 59.93 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.468 0.307 . . . . 0.0 111.175 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -91.61 -30.33 16.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.876 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.243 0.75 0 C-N-CA 123.691 0.796 . . . . 0.0 108.95 177.177 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.4 t -145.71 143.27 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 70' ' ' ALA . 25.4 m -113.15 172.18 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 121.094 0.474 . . . . 0.0 111.966 169.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 40.8 mtpt -116.36 135.4 53.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.01 117.39 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 41.1 ttp180 -127.4 152.27 47.73 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.38 12.59 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -166.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 22' ' ' CYS . 86.0 mt -97.53 134.04 22.98 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.308 1.043 . . . . 0.0 109.406 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 22' ' ' CYS . 33.9 Cg_exo -61.42 163.57 17.42 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.776 2.317 . . . . 0.0 112.606 168.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -74.35 -8.09 55.07 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.059 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -113.32 16.12 19.07 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.286 1.034 . . . . 0.0 111.278 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.476 ' SG ' HD21 ' A' ' 18' ' ' LEU . 52.0 t -67.19 155.48 38.7 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.924 0.489 . . . . 0.0 111.632 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.1 m -133.73 152.69 51.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.529 1.132 . . . . 0.0 110.555 -173.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.65 67.38 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.402 1.081 . . . . 0.0 112.788 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.91 -47.78 67.73 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.536 1.135 . . . . 0.0 113.47 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 23' ' ' SER . 13.7 pt-20 -72.19 -35.49 68.96 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.8 -46.38 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.157 0.583 . . . . 0.0 110.032 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.569 ' HG3' HD13 ' A' ' 36' ' ' ILE . 28.2 tt0 -63.95 -40.76 97.18 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.617 0.767 . . . . 0.0 111.341 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -57.87 -46.8 84.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.795 0.684 . . . . 0.0 110.866 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.17 -32.92 74.66 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.741 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.632 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 93.4 m-85 -105.34 35.96 2.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.925 0.89 . . . . 0.0 110.659 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -60.59 -27.6 67.85 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.524 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.55 -18.13 65.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.2 p -111.44 135.49 51.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.311 0.644 . . . . 0.0 109.958 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -75.56 96.0 3.44 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.569 HD13 ' HG3' ' A' ' 28' ' ' GLN . 43.9 mt -78.85 123.41 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.81 125.85 25.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.302 1.041 . . . . 0.0 110.971 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 60.74 23.15 13.07 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.177 1.391 . . . . 0.0 111.552 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.26 -134.96 45.5 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.379 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.48 -22.68 22.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.064 0.946 . . . . 0.0 113.274 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.05 -21.92 64.98 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.419 0.288 . . . . 0.0 110.875 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.73 -16.84 79.62 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.016 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 mt -86.64 119.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 109.633 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.0 97.55 5.49 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.163 0.985 . . . . 0.0 109.695 177.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -66.16 142.9 57.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.029 0.532 . . . . 0.0 109.724 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 56' ' ' GLU . 23.6 mt -77.16 87.18 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -75.34 134.29 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.0 t -78.48 -175.54 4.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.414 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 3.4 tmm_? -68.94 -5.8 23.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.3 0.64 . . . . 0.0 110.973 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' H ' HG23 ' A' ' 48' ' ' THR . 37.6 mt-10 -100.31 -2.6 33.23 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.698 1.199 . . . . 0.0 110.96 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.95 36.81 31.07 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 115.072 0.789 . . . . 0.0 115.072 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -132.17 138.18 31.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.708 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.52 118.0 4.43 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.046 2.497 . . . . 0.0 111.695 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.8 p -93.3 40.25 1.06 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.72 0.808 . . . . 0.0 111.129 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.82 -37.23 3.58 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.0 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HB2' HD13 ' A' ' 46' ' ' ILE . 36.5 mt-10 -110.13 161.56 15.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.803 0.811 . . . . 0.0 112.392 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.03 165.53 31.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.449 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -110.47 145.39 37.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 108.09 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 105.83 6.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -81.63 139.64 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.453 HD21 ' HA ' ' A' ' 36' ' ' ILE . 74.8 mt -128.89 142.24 51.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.683 1.193 . . . . 0.0 109.283 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.29 -27.66 68.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.309 0.644 . . . . 0.0 111.54 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.573 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.5 m -136.52 150.44 48.65 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.17 0.588 . . . . 0.0 109.661 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 15.9 tt0 -77.68 -8.34 57.77 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 120.915 0.388 . . . . 0.0 111.201 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -65.39 -48.52 72.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 4.0 mm-40 -52.77 -38.29 60.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.668 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.403 HG22 HD11 ' A' ' 61' ' ' LEU . 66.7 t -64.22 -46.09 94.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 123.31 0.644 . . . . 0.0 110.411 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.7 mttt -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.384 0.674 . . . . 0.0 112.154 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.47 -50.22 70.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.89 0.876 . . . . 0.0 111.178 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' HG11 ' A' ' 13' ' ' VAL . . . -58.99 -45.29 91.0 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.144 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.05 -24.61 40.66 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.295 1.438 . . . . 0.0 113.425 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.18 -9.84 59.73 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.151 0.58 . . . . 0.0 112.005 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -90.52 6.08 45.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 111.356 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -57.88 -9.37 1.28 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.785 1.234 . . . . 0.0 113.69 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -116.63 -40.15 3.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.371 1.068 . . . . 0.0 111.11 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.41 163.67 15.28 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -105.41 130.82 53.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.067 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.462 ' HG3' HG23 ' A' ' 83' ' ' VAL . 53.4 mtp -64.83 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 163.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.03 -103.34 2.02 Favored Glycine 0 N--CA 1.468 0.777 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -96.01 -1.61 48.57 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.24 1.016 . . . . 0.0 109.344 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -106.19 133.54 50.72 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.926 0.89 . . . . 0.0 109.631 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -80.36 135.59 36.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.462 HG23 ' HG3' ' A' ' 78' ' ' MET . 98.7 t -97.79 130.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 32.8 mt-10 -97.45 117.35 31.51 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.9 t -114.66 120.04 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -113.83 177.59 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -101.88 116.12 32.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -87.05 161.55 18.1 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.14 0.971 . . . . 0.0 110.503 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -127.99 158.21 38.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.005 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -64.84 -34.34 78.13 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.927 0.491 . . . . 0.0 110.759 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.53 -41.84 89.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 110.753 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.44 -56.3 7.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.961 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . 0.415 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 44.9 ttm -52.11 -51.29 58.72 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 123.967 0.792 . . . . 0.0 111.72 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 28.3 t70 -62.42 -43.01 99.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 0.0 110.53 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -60.6 -38.59 85.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.143 0.577 . . . . 0.0 111.147 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 76.4 t -82.36 -30.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.702 0.801 . . . . 0.0 111.86 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 93' ' ' MET . 83.0 mt -75.69 -26.44 57.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.38 -0.825 . . . . 0.0 110.654 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 1.2 mptm? -90.09 -25.17 20.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.756 0.823 . . . . 0.0 111.082 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.5 m80 . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.022 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -143.1 131.0 21.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.902 0.881 . . . . 0.0 109.92 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 67.7 mtt -134.99 131.54 37.26 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.92 -45.09 12.59 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA3' ' HB2' ' A' ' 89' ' ' ASN . . . 167.97 167.08 28.1 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.086 -0.557 . . . . 0.0 112.592 175.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.603 ' HA ' ' HE2' ' A' ' 87' ' ' LYS . 33.7 tt0 -69.74 104.4 2.42 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -154.5 171.47 32.96 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -89.81 7.91 34.64 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.736 0.815 . . . . 0.0 111.03 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.494 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.5 t -102.09 143.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.99 0.916 . . . . 0.0 109.184 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.481 HG22 HD11 ' A' ' 61' ' ' LEU . 29.8 m -110.14 160.41 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.053 0.541 . . . . 0.0 110.758 162.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 87.4 tttt -109.13 121.41 45.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.84 111.72 37.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.463 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 3.7 tmt_? -121.96 140.67 52.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.21 18.27 29.41 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 118.2 0.454 . . . . 0.0 113.316 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.17 138.37 56.38 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 123.356 0.662 . . . . 0.0 109.765 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HG3' ' HA3' ' A' ' 79' ' ' GLY . 45.1 Cg_endo -64.79 146.52 88.44 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.346 2.031 . . . . 0.0 111.454 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -64.37 -19.71 65.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.162 0.985 . . . . 0.0 110.62 175.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 p -90.7 4.75 50.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.394 1.078 . . . . 0.0 113.146 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 22.0 p -104.4 145.75 29.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.827 0.739 . . . . 0.0 111.13 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -105.81 178.52 4.54 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.763 1.225 . . . . 0.0 109.028 172.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.67 -31.49 62.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.441 0.696 . . . . 0.0 112.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.92 -47.34 68.08 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.181 0.993 . . . . 0.0 113.118 176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 78' ' ' MET . 1.7 mp0 -69.88 -38.02 76.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.15 0.58 . . . . 0.0 111.592 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.61 -34.76 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.712 . . . . 0.0 110.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.578 ' HG3' HD12 ' A' ' 36' ' ' ILE . 44.2 tt0 -69.36 -41.31 76.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.312 176.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -63.09 -36.33 83.23 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.081 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.98 -43.83 98.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.015 0.526 . . . . 0.0 110.39 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.552 ' HB2' HD13 ' A' ' 36' ' ' ILE . 79.6 m-85 -95.72 38.96 1.14 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.998 0.519 . . . . 0.0 110.515 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.7 t -59.76 -34.2 72.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 111.248 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.22 5.96 10.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 112.448 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.471 ' HB3' HD21 ' A' ' 61' ' ' LEU . 58.1 m -127.38 136.23 51.59 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.086 0.954 . . . . 0.0 110.07 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -80.36 98.46 7.48 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.578 HD12 ' HG3' ' A' ' 28' ' ' GLN . 61.8 mt -80.65 122.61 36.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.994 0.918 . . . . 0.0 109.687 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.7 126.42 27.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.213 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.2 t30 63.48 17.55 10.42 Favored 'General case' 0 CA--C 1.559 1.327 0 O-C-N 124.79 1.307 . . . . 0.0 111.89 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.44 -136.16 47.53 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.239 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.71 -18.8 45.49 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.26 -21.03 54.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.967 0.507 . . . . 0.0 110.295 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 -21.13 76.59 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.255 0.347 . . . . 0.0 112.472 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 59' ' ' VAL . 43.4 mt -91.27 127.75 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.568 0.747 . . . . 0.0 110.043 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.1 110.02 6.12 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.081 0.953 . . . . 0.0 110.008 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -66.48 140.09 57.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.0 88.82 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -82.86 135.9 34.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.1 p -83.76 -178.17 6.93 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.856 0.862 . . . . 0.0 110.919 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 49' ' ' ARG . 1.5 tmt_? -67.18 -16.73 64.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.161 0.584 . . . . 0.0 109.603 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 13.4 mm-40 -84.36 1.56 44.53 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.742 0.817 . . . . 0.0 110.911 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.03 20.1 76.03 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 50' ' ' GLU . 19.4 ptp180 -126.74 141.3 39.94 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.335 0.654 . . . . 0.0 109.79 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.48 148.36 42.61 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.447 2.098 . . . . 0.0 111.523 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -75.65 -0.44 20.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.616 0.766 . . . . 0.0 111.749 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.54 81.83 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 37.7 mt-10 -119.63 155.61 31.99 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 110.809 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.36 28.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.771 1.228 . . . . 0.0 110.313 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.33 120.9 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.484 1.113 . . . . 0.0 109.168 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 43' ' ' ILE . 68.9 t -106.71 123.67 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 108.953 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 12' ' ' VAL . 64.5 mt-10 -82.98 151.23 25.95 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.481 HD11 HG22 ' A' ' 13' ' ' VAL . 4.6 mp -135.87 152.29 50.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.084 0.954 . . . . 0.0 109.312 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -32.22 73.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.732 0.813 . . . . 0.0 111.805 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.479 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 42.0 m -144.96 155.62 43.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.531 0.332 . . . . 0.0 111.265 -171.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.96 -27.29 68.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.623 0.769 . . . . 0.0 110.431 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.39 -47.57 75.9 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 47.2 mm-40 -54.62 -37.88 66.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.538 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.415 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 78.4 t -60.27 -46.06 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.077 0.551 . . . . 0.0 110.03 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.584 ' HD3' HD11 ' A' ' 71' ' ' LEU . 32.3 mmtp -60.99 -37.79 83.73 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.788 0.835 . . . . 0.0 112.552 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.47 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 85.9 mt -65.88 -31.94 73.16 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.502 0.721 . . . . 0.0 111.746 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 13' ' ' VAL . . . -69.13 -44.04 73.18 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.255 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.584 HD11 ' HD3' ' A' ' 68' ' ' LYS . 96.8 mt -65.9 -26.12 67.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.14 0.976 . . . . 0.0 112.83 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 19.9 pttp -77.54 -16.88 58.41 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.105 0.411 . . . . 0.0 109.915 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -95.15 0.49 54.22 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.214 1.005 . . . . 0.0 111.032 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 11.1 t70 -60.17 101.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.32 0.648 . . . . 0.0 110.238 168.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 36.9 ttt180 150.64 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 127.115 2.166 . . . . 0.0 108.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -55.43 147.33 17.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.235 -167.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 p -89.11 120.03 30.15 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.518 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.478 ' HB3' HG21 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -124.64 125.0 43.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.342 1.057 . . . . 0.0 108.513 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.61 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 84.82 -50.31 4.38 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.451 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -179.04 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.77 1.228 . . . . 0.0 108.85 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -91.47 166.94 12.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.038 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.88 139.47 39.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 78' ' ' MET . 53.1 t -112.05 129.51 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.16 0.505 . . . . 0.0 110.678 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.01 121.6 37.93 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.342 1.057 . . . . 0.0 109.196 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.0 112.81 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.571 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.8 m-85 -103.03 178.4 4.57 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 87.8 tttt -110.35 120.5 42.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 61.1 m -110.73 147.71 33.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.733 0.813 . . . . 0.0 111.275 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.427 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 37.5 t-20 -91.54 155.28 18.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -56.53 -35.32 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.238 0.615 . . . . 0.0 110.169 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.11 -46.37 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.889 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.62 -52.11 48.81 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.458 0.474 . . . . 0.0 110.005 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -49.63 -53.64 23.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.8 1.24 . . . . 0.0 111.367 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.0 -43.02 86.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.987 0.915 . . . . 0.0 111.679 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -74.13 -35.99 64.13 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.434 HG13 ' H ' ' A' ' 101' ' ' GLY . 43.6 t -82.99 -21.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.014 0.435 . . . . 0.0 110.502 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.3 -40.76 64.28 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -77.13 -32.02 56.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.06 0.544 . . . . 0.0 111.295 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -144.14 89.6 2.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 t -56.41 94.15 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.886 0.85 . . . . 0.0 111.229 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.434 ' H ' HG13 ' A' ' 96' ' ' VAL . . . -160.4 114.23 0.6 Allowed Glycine 0 C--N 1.344 0.977 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.019 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.33 -0.01 9.92 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.822 2.348 . . . . 0.0 113.355 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.49 112.03 6.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.389 0.675 . . . . 0.0 109.928 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.9 p -70.43 149.16 95.68 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.259 1.024 . . . . 0.0 111.619 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 71.13 4.94 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 122.68 2.253 . . . . 0.0 111.309 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -72.69 107.58 5.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.45 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.2 m -145.1 107.91 4.48 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.978 0.911 . . . . 0.0 108.701 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.89 66.71 1.55 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.463 0.705 . . . . 0.0 109.135 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -67.39 88.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.639 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -131.98 142.54 49.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.834 -0.981 . . . . 0.0 110.65 -178.596 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.245 0.831 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -58.13 118.65 5.67 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ttt -64.59 135.56 56.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.103 0.561 . . . . 0.0 110.435 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.34 -121.52 6.36 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.599 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.28 135.02 1.1 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.56 28.79 0.46 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.496 0.718 . . . . 0.0 110.832 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 88' ' ' SER . . . -78.83 98.97 1.61 Allowed Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.053 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -84.07 4.4 30.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.83 0.852 . . . . 0.0 110.498 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.28 138.02 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.527 1.131 . . . . 0.0 109.167 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.07 168.89 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.037 0.535 . . . . 0.0 110.635 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 60.2 tttt -116.84 123.38 46.94 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.452 HG11 HG12 ' A' ' 83' ' ' VAL . 92.2 t -114.6 138.67 43.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.463 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 3.8 ptp180 -150.99 161.31 42.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.975 0.51 . . . . 0.0 109.633 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 18.45 36.57 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -169.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -88.88 127.69 54.97 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 27.4 Cg_endo -61.19 161.5 22.8 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.232 1.955 . . . . 0.0 111.968 172.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -71.66 -24.46 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.287 0.635 . . . . 0.0 111.176 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -82.45 -6.0 59.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.685 0.794 . . . . 0.0 111.404 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 44.2 t -76.08 120.41 21.35 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.102 0.561 . . . . 0.0 109.743 -177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t -98.88 174.68 6.25 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.767 0.827 . . . . 0.0 109.186 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.24 74.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.707 0.803 . . . . 0.0 112.41 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.4 t70 -60.53 -39.32 87.45 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.879 0.872 . . . . 0.0 111.787 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -59.53 -46.31 89.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.216 0.606 . . . . 0.0 111.083 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' A' ' 43' ' ' ILE . 58.4 t -71.68 -31.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.42 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.432 ' NE2' HD11 ' A' ' 36' ' ' ILE . 9.3 tp-100 -64.34 -42.81 96.06 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.916 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 19.3 mmt180 -67.11 -38.11 85.06 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.695 0.398 . . . . 0.0 111.179 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -67.71 -29.66 68.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.034 0.534 . . . . 0.0 111.5 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.541 ' HB2' HD12 ' A' ' 36' ' ' ILE . 93.4 m-85 -115.38 35.02 4.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.61 0.764 . . . . 0.0 110.184 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 t -59.51 -29.2 67.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.62 0.768 . . . . 0.0 113.01 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.77 -25.72 35.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.853 0.461 . . . . 0.0 110.614 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.58 126.79 31.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 35' ' ' LYS . 10.4 mptt -79.24 87.75 4.94 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 31' ' ' PHE . 41.1 mt -76.86 132.79 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.275 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.02 118.37 5.33 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.947 0.899 . . . . 0.0 110.425 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 63.52 23.02 13.46 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -131.66 41.85 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.596 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.64 30.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 0.0 113.161 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -80.7 -10.45 59.73 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.198 0.599 . . . . 0.0 112.411 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.93 36.3 4.35 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.473 HD11 ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt -127.85 116.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.448 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 22.3 mmt180 -116.6 92.99 4.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.288 0.635 . . . . 0.0 110.251 -169.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.426 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 98.2 m-85 -71.23 127.85 33.93 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 mt -74.8 86.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.05 149.37 41.21 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.706 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -94.77 178.71 5.49 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.434 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -68.76 -8.85 46.87 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 122.846 0.458 . . . . 0.0 111.893 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.55 -0.41 43.29 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.257 1.023 . . . . 0.0 109.916 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.41 59.92 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.969 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -126.15 132.75 24.42 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 53.5 Cg_endo -66.5 153.21 78.82 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.302 2.002 . . . . 0.0 111.568 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -78.41 6.11 9.16 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.56 0.744 . . . . 0.0 111.37 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.07 1.13 79.88 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -171.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 30.6 mt-10 -111.59 146.68 36.96 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.669 1.187 . . . . 0.0 110.806 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.58 31.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.55 1.14 . . . . 0.0 109.7 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 69.3 m-85 -102.61 117.74 35.34 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.9 t -98.46 110.78 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.39 136.46 38.42 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.562 1.145 . . . . 0.0 108.413 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 66' ' ' GLU . 44.1 mt -135.76 137.58 41.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.448 0.699 . . . . 0.0 109.744 -169.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.87 -12.47 61.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -168.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.0 p -160.45 172.45 17.22 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.11 0.564 . . . . 0.0 109.99 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.0 tm-20 -68.5 -21.05 64.61 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.209 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.68 -46.79 89.02 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.235 0.471 . . . . 0.0 110.403 172.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB3' HD22 ' A' ' 61' ' ' LEU . 1.1 mp0 -62.38 -32.5 73.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.53 173.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.47 -44.08 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.652 0.381 . . . . 0.0 110.028 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 82.2 mttt -54.63 -49.66 69.98 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.723 0.809 . . . . 0.0 110.649 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.78 -35.44 74.65 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.354 1.062 . . . . 0.0 112.089 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.75 69.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.031 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.75 -13.38 59.25 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.22 1.008 . . . . 0.0 112.254 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.16 -23.68 64.89 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.301 0.501 . . . . 0.0 110.697 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 76' ' ' GLU . 3.9 mptp? -88.03 -1.28 57.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.536 0.734 . . . . 0.0 112.069 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -32.28 -25.05 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 169.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -142.77 -6.4 0.88 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -57.81 143.18 43.2 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 175.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 p -95.37 121.85 37.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.45 1.1 . . . . 0.0 111.86 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.16 114.35 27.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.184 0.993 . . . . 0.0 109.264 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.17 -89.81 0.17 Allowed Glycine 0 C--N 1.345 1.058 0 O-C-N 123.416 0.448 . . . . 0.0 112.999 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -130.77 -5.85 4.06 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -117.49 154.05 32.1 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.236 0.614 . . . . 0.0 110.929 -172.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -82.04 143.5 31.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.583 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.452 HG12 HG11 ' A' ' 15' ' ' VAL . 69.4 t -109.02 120.48 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.474 0.71 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -95.39 121.47 37.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 39.8 t -119.01 121.46 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.325 0.65 . . . . 0.0 109.984 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -118.93 149.94 40.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.711 0.805 . . . . 0.0 110.905 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.05 116.85 5.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.369 0.667 . . . . 0.0 110.146 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 15.6 m -125.67 -154.1 0.6 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.68 173.64 12.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.486 ' HA ' ' HE1' ' A' ' 93' ' ' MET . 30.4 t30 -64.06 -31.05 72.1 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.989 0.915 . . . . 0.0 110.432 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.1 t -65.92 -47.61 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.247 1.019 . . . . 0.0 110.346 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.411 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 33.3 tt0 -65.38 -47.97 74.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.286 1.034 . . . . 0.0 110.077 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.486 ' HE1' ' HA ' ' A' ' 90' ' ' ASN . 54.2 ttp -52.54 -44.6 65.88 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.463 1.102 . . . . 0.0 110.639 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.62 -45.95 77.45 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.434 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.54 -42.05 95.72 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.604 0.762 . . . . 0.0 112.3 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.08 -23.55 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 123.508 0.505 . . . . 0.0 110.827 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.11 -23.74 35.52 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 121.98 -0.45 . . . . 0.0 111.138 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -80.33 -38.77 29.93 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.284 0.564 . . . . 0.0 109.971 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -140.98 90.37 2.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.483 1.113 . . . . 0.0 108.027 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -65.06 86.13 0.06 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.284 1.04 . . . . 0.0 110.449 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.53 -86.18 0.13 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.155 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.4 92.82 0.19 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.928 2.419 . . . . 0.0 113.027 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.411 ' OD1' ' HG3' ' A' ' 92' ' ' GLU . 35.9 t30 -77.03 124.32 27.62 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.1 m 61.15 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.562 1.164 . . . . 0.0 108.91 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.78 91.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.639 2.892 . . . . 0.0 114.136 -171.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -102.02 132.98 47.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -48.46 -27.03 2.42 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.61 -177.52 6.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.252 0.621 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -97.34 155.82 16.72 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.317 0.647 . . . . 0.0 111.278 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 66.44 95.34 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.769 1.228 . . . . 0.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.301 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.944 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.553 1.082 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -93.94 137.98 32.56 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.2 ttt -90.06 -51.52 5.42 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.84 42.84 15.77 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.422 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.21 -130.7 3.52 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -70.15 -50.22 42.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.88 63.25 4.14 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 111.685 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -61.34 -23.16 65.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.075 0.95 . . . . 0.0 112.159 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -93.94 133.49 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 110.135 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -105.01 163.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.373 0.669 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 4.7 ttmp? -108.05 127.18 53.56 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -119.49 140.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 124.107 0.963 . . . . 0.0 108.757 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.568 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 14.8 ptm180 -147.43 167.23 24.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.03 0.932 . . . . 0.0 109.262 174.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.91 18.71 62.74 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.61 155.24 91.72 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.854 0.862 . . . . 0.0 110.236 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.0 152.13 77.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.147 1.898 . . . . 0.0 111.22 169.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.2 p90 -56.18 -30.91 62.89 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.725 1.21 . . . . 0.0 112.098 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 p -104.21 25.52 9.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 111.508 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.2 p -52.39 118.03 3.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.493 1.117 . . . . 0.0 112.811 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.424 ' HB3' ' HG3' ' A' ' 26' ' ' GLU . 46.8 t -104.18 152.2 22.43 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.29 -39.52 75.9 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.315 0.384 . . . . 0.0 111.003 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -49.51 -47.63 48.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.329 1.052 . . . . 0.0 112.695 170.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 45.3 mt-10 -65.43 -39.68 92.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.194 0.598 . . . . 0.0 111.265 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.514 ' HB ' HD12 ' A' ' 43' ' ' ILE . 61.1 t -68.55 -34.94 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.403 0.681 . . . . 0.0 110.077 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -64.94 -49.75 69.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.769 0.827 . . . . 0.0 111.033 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -37.17 81.35 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.51 0.507 . . . . 0.0 110.719 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.75 -43.76 95.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.027 0.531 . . . . 0.0 111.107 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 36' ' ' ILE . 59.5 m-85 -99.73 35.68 1.96 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.624 0.77 . . . . 0.0 110.083 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -60.7 -24.81 65.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.355 0.525 . . . . 0.0 112.186 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.86 -47.7 68.18 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.992 0.917 . . . . 0.0 110.736 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 61.3 m -79.77 130.69 35.55 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.385 0.612 . . . . 0.0 110.432 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 13.9 mmmm -78.44 91.2 4.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.49 HD11 ' HB2' ' A' ' 31' ' ' PHE . 46.4 mt -69.74 111.0 3.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.524 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 33.6 tt0 -63.14 134.5 56.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.878 0.736 . . . . 0.0 110.458 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 65.37 10.14 6.29 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 124.654 1.221 . . . . 0.0 112.148 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 -128.04 44.91 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.51 0.576 . . . . 0.0 112.716 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.03 64.75 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.855 0.862 . . . . 0.0 112.483 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -73.8 -19.72 60.68 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.123 0.569 . . . . 0.0 111.644 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.99 -23.81 56.58 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 120.271 -0.183 . . . . 0.0 112.961 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.514 HD12 ' HB ' ' A' ' 27' ' ' VAL . 59.8 mt -83.35 119.36 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.266 0.627 . . . . 0.0 109.613 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HG3' ' SD ' ' A' ' 93' ' ' MET . 21.0 mmt180 -127.29 94.71 4.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.481 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.79 135.86 46.86 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.531 HD13 ' HB2' ' A' ' 56' ' ' GLU . 43.0 mt -75.91 92.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -84.26 134.49 34.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 52' ' ' ARG . 59.7 p -90.84 -169.99 2.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.701 0.8 . . . . 0.0 110.442 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.71 -18.01 64.63 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -105.67 10.06 32.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 0.0 109.212 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.15 63.96 Favored Glycine 0 C--N 1.36 1.917 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 12.0 mmp_? -101.27 125.49 37.7 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.591 0.756 . . . . 0.0 110.021 -172.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.08 116.89 3.56 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.666 2.244 . . . . 0.0 110.488 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 t -83.52 18.13 1.97 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.678 0.791 . . . . 0.0 111.581 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.1 30.19 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 122.854 0.264 . . . . 0.0 113.033 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 31.8 mt-10 -112.3 150.15 31.39 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.455 1.102 . . . . 0.0 111.128 -174.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.55 153.9 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.527 1.131 . . . . 0.0 110.043 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -106.14 110.31 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.051 0.941 . . . . 0.0 108.463 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.07 110.92 25.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' HB2' ' HE1' ' A' ' 93' ' ' MET . 43.5 tt0 -79.76 135.99 36.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 36' ' ' ILE . 53.9 mt -126.71 147.91 49.91 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.458 0.703 . . . . 0.0 110.032 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -67.06 -19.81 65.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.763 0.825 . . . . 0.0 112.917 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -159.34 171.24 20.15 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.07 -23.75 67.26 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.999 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.81 -52.56 64.54 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.372 0.669 . . . . 0.0 110.157 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.404 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 1.5 mp0 -60.25 -31.61 70.37 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.048 0.843 . . . . 0.0 112.894 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.4 t -61.44 -48.83 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.659 0.384 . . . . 0.0 110.158 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.8 mmpt? -50.98 -46.07 61.16 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.015 0.822 . . . . 0.0 111.753 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 mt -63.06 -47.44 82.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.59 0.756 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.06 87.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.021 0.928 . . . . 0.0 111.524 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.44 -38.44 77.47 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.148 0.979 . . . . 0.0 111.659 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -69.06 -19.97 64.09 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 123.63 0.581 . . . . 0.0 111.587 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -91.77 17.34 9.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.929 0.892 . . . . 0.0 112.329 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.93 23.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -142.86 -23.66 0.63 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.751 0.705 . . . . 0.0 110.865 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -46.3 134.75 8.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.931 1.293 . . . . 0.0 112.02 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -91.26 131.64 36.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.782 0.833 . . . . 0.0 111.15 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ttt -128.61 122.14 30.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.704 1.202 . . . . 0.0 109.415 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -75.34 1.92 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -145.33 -36.29 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.37 1.068 . . . . 0.0 110.1 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -87.0 167.49 14.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -80.68 136.81 36.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.7 t -100.02 117.12 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.548 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 25.1 mt-10 -98.37 122.18 41.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.175 1.39 . . . . 0.0 108.508 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.94 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 110.14 -172.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.06 179.09 4.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.464 1.506 . . . . 0.0 107.54 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -112.55 135.41 53.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.57 ' HB2' ' HG2' ' A' ' 92' ' ' GLU . 76.8 p -134.87 -149.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 109.038 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.87 169.42 24.45 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -61.36 -34.22 74.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.841 0.856 . . . . 0.0 111.276 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.7 -40.79 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.113 0.965 . . . . 0.0 110.168 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 88' ' ' SER . 4.7 tp10 -63.93 -50.36 68.97 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.409 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.564 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 45.3 ttm -54.95 -51.74 65.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.947 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.35 -45.87 91.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.621 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -52.58 -51.56 59.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.635 1.574 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.7 t -71.19 -33.13 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.091 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.492 HD22 ' HB3' ' A' ' 44' ' ' ARG . 88.6 mt -69.38 -27.55 65.41 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.314 0.245 . . . . 0.0 111.042 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -69.05 -23.89 64.11 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.247 0.619 . . . . 0.0 111.752 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.449 ' HD2' HG21 ' A' ' 100' ' ' THR . 49.1 t60 -171.95 -71.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.501 0.72 . . . . 0.0 109.219 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.449 HG21 ' HD2' ' A' ' 99' ' ' HIS . 8.9 t 179.26 -167.7 0.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.041 1.337 . . . . 0.0 108.709 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.07 65.44 1.28 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.226 -0.764 . . . . 0.0 113.702 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.53 117.02 3.9 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.081 1.854 . . . . 0.0 110.832 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.419 HD21 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -64.89 -49.84 68.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.149 -176.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.9 m 56.25 92.47 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.756 1.222 . . . . 0.0 111.85 175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.32 -27.53 58.04 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.575 2.184 . . . . 0.0 113.228 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.12 58.56 4.91 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 124.68 1.238 . . . . 0.0 108.25 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 m -62.6 90.02 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.743 -1.572 . . . . 0.0 111.179 -167.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.01 25.93 2.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.723 1.209 . . . . 0.0 110.014 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.68 90.58 2.31 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 65.6 -176.99 0.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.266 1.426 . . . . 0.0 111.268 -171.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.987 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.167 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -66.74 101.18 0.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.158 0.504 . . . . 0.0 110.575 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 35.3 ttm -97.77 87.16 3.95 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.48 -42.61 98.92 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.794 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.58 166.36 39.03 Favored Glycine 0 C--O 1.242 0.611 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.56 98.17 0.85 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.712 0.768 . . . . 0.0 109.794 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.33 100.65 0.2 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -81.67 68.86 8.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.217 0.607 . . . . 0.0 110.378 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG21 ' HG3' ' A' ' 60' ' ' GLU . 50.7 t -126.23 134.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.54 160.33 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.006 0.522 . . . . 0.0 110.769 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.565 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 5.1 ttmp? -109.75 116.03 30.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.4 t -114.62 135.77 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 125.056 1.342 . . . . 0.0 108.524 -168.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.682 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 12.3 ptm180 -149.95 162.58 40.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.855 0.462 . . . . 0.0 111.547 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.64 15.06 51.4 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.456 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.65 135.94 42.75 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 29.8 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.171 1.914 . . . . 0.0 111.783 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -70.43 -19.96 62.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.345 1.058 . . . . 0.0 111.32 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -93.63 10.55 32.28 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.703 0.801 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 50.6 t -87.03 133.95 33.54 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.019 0.528 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m -105.83 169.98 8.16 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.006 0.922 . . . . 0.0 109.511 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.38 69.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.008 0.923 . . . . 0.0 111.893 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 3.3 m-20 -48.03 -48.72 32.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.405 1.082 . . . . 0.0 112.445 175.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -69.79 -34.16 73.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.866 0.867 . . . . 0.0 111.912 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.553 ' HB ' HD12 ' A' ' 43' ' ' ILE . 39.0 t -73.95 -30.53 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 123.162 0.585 . . . . 0.0 110.128 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -67.19 -38.78 85.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.368 0.667 . . . . 0.0 110.013 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 95.1 mtt180 -59.6 -46.06 90.09 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.887 0.742 . . . . 0.0 111.191 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 77.0 t80 -63.52 -46.37 86.37 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.88 0.371 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -94.83 37.07 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.795 0.838 . . . . 0.0 110.556 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 t -60.44 -34.14 73.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.35 0.66 . . . . 0.0 112.446 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -69.19 -36.97 77.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.122 0.487 . . . . 0.0 109.887 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.0 m -72.86 175.32 6.66 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.057 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.571 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 7.9 mtpm? -136.01 97.51 3.64 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.512 HG22 HG13 ' A' ' 43' ' ' ILE . 3.5 mp -73.21 118.51 18.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.535 -172.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.522 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 7.8 tp60 -64.69 124.2 21.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.715 . . . . 0.0 109.367 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 76.01 16.63 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.715 1.606 . . . . 0.0 111.94 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.56 -134.24 47.55 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.356 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -37.46 32.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.609 1.164 . . . . 0.0 112.804 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.85 -8.18 59.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.537 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 37' ' ' GLN . . . -84.33 -13.87 72.69 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.623 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 HD12 ' HB ' ' A' ' 27' ' ' VAL . 62.3 mt -89.62 101.2 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.157 0.583 . . . . 0.0 109.575 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.13 96.59 9.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.249 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -67.42 129.22 39.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.5 mt -71.24 92.32 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -79.99 146.83 31.82 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.961 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.6 p -83.5 -172.97 4.44 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.31 1.044 . . . . 0.0 109.678 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -71.1 -6.06 36.37 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.896 0.478 . . . . 0.0 111.145 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.5 -6.96 32.54 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.615 1.166 . . . . 0.0 109.939 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 33.49 50.09 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -124.96 132.63 24.35 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.916 0.886 . . . . 0.0 110.37 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -67.55 139.11 47.82 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.487 2.125 . . . . 0.0 111.232 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -78.77 -2.04 37.6 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.076 0.55 . . . . 0.0 111.178 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.3 60.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.878 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.682 ' HG3' ' HB3' ' A' ' 16' ' ' ARG . 8.0 mp0 -105.43 149.69 25.93 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.552 1.141 . . . . 0.0 109.618 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 163.3 38.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.75 116.01 29.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.033 0.933 . . . . 0.0 109.106 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -95.86 108.2 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 45.6 tt0 -83.14 145.08 29.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.3 mt -138.83 145.87 40.56 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.385 1.074 . . . . 0.0 108.649 -168.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.95 -26.54 63.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -152.28 163.3 39.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.453 0.701 . . . . 0.0 110.134 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 35.0 tt0 -69.53 -16.73 63.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.212 0.605 . . . . 0.0 112.594 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.6 t70 -59.77 -51.42 69.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -52.98 -39.76 63.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.931 1.292 . . . . 0.0 111.863 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 65.4 t -63.39 -42.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.125 0.57 . . . . 0.0 111.065 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 74.9 mmtt -58.62 -45.43 89.21 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.953 0.901 . . . . 0.0 111.211 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 62.5 mt -61.52 -36.76 81.45 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.911 0.884 . . . . 0.0 111.062 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.25 83.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 0.0 110.321 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.1 mt -62.57 -30.82 71.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.008 0.923 . . . . 0.0 111.828 175.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 56.3 mtpt -67.86 -30.78 70.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.318 0.58 . . . . 0.0 110.377 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.467 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 41.2 mttp -84.15 -4.26 58.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.02 0.928 . . . . 0.0 111.563 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -52.63 -33.44 46.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.461 0.704 . . . . 0.0 112.668 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -95.84 -31.59 13.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.902 -0.498 . . . . 0.0 111.598 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.07 142.24 47.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.661 0.785 . . . . 0.0 112.093 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 43.2 p -95.03 135.63 36.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.59 0.756 . . . . 0.0 110.758 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.409 ' HE3' ' SG ' ' A' ' 22' ' ' CYS . 19.5 ttt -70.9 -86.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 110.374 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.19 1.78 5.4 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-O 120.03 -0.317 . . . . 0.0 112.729 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -170.22 -55.67 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.018 0.927 . . . . 0.0 108.931 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -87.8 167.65 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.299 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.7 p90 -98.68 138.78 35.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.1 t -91.85 125.87 44.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.603 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 22.5 mt-10 -95.13 118.68 32.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.61 117.81 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.591 0.756 . . . . 0.0 110.065 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -68.33 136.27 53.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.075 0.852 . . . . 0.0 110.875 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -136.11 -151.58 0.42 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.52 1.128 . . . . 0.0 108.824 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -165.13 167.99 17.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 110.33 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.85 -37.04 85.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.399 1.079 . . . . 0.0 111.989 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.56 -42.84 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.204 0.602 . . . . 0.0 110.975 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.96 -38.6 76.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.1 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.407 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 55.9 ttp -53.31 -51.15 63.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.8 0.84 . . . . 0.0 110.037 175.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.27 -42.88 96.31 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.275 0.985 . . . . 0.0 111.144 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -58.58 -47.5 84.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.275 0.985 . . . . 0.0 110.8 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 102' ' ' PRO . 99.9 t -71.42 -32.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.713 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 93' ' ' MET . 79.1 mt -73.02 -32.05 64.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.904 -0.498 . . . . 0.0 112.083 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.54 -18.23 61.56 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -156.74 -86.79 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.469 1.108 . . . . 0.0 108.216 174.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.9 t -163.36 -163.42 0.83 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.67 125.16 28.88 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.035 -0.869 . . . . 0.0 111.56 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 96' ' ' VAL . 40.3 Cg_endo -85.27 53.77 3.63 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.468 2.779 . . . . 0.0 112.623 -170.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 67.19 132.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.706 1.603 . . . . 0.0 110.934 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.9 p -59.88 119.67 43.25 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.741 0.816 . . . . 0.0 110.213 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.22 76.18 2.69 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.427 2.085 . . . . 0.0 110.295 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.44 -29.52 70.79 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.275 1.03 . . . . 0.0 111.356 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -160.22 158.11 29.43 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 110.058 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -129.0 24.39 5.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 107.986 168.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 68.99 116.24 0.04 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.843 1.657 . . . . 0.0 110.044 -167.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.95 -31.53 66.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.842 0.857 . . . . 0.0 110.819 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.107 -0.829 . . . . 0.0 111.133 174.795 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 67.57 -179.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.538 1.135 . . . . 0.0 110.627 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ttt 73.59 131.61 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.989 1.316 . . . . 0.0 111.599 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.88 66.6 2.71 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.918 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.73 -39.11 94.84 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 124.173 0.572 . . . . 0.0 112.053 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -116.96 76.88 1.07 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.181 0.992 . . . . 0.0 108.797 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.5 150.83 22.01 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.501 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -142.95 49.47 1.47 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.56 0.695 . . . . 0.0 111.392 -177.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 60' ' ' GLU . 47.1 t -123.05 139.53 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -116.6 167.9 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.667 -0.646 . . . . 0.0 111.009 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -119.34 123.45 44.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.44 119.12 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -124.87 149.35 47.61 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.548 1.139 . . . . 0.0 108.967 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.02 57.53 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.48 135.84 81.35 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 123.224 0.609 . . . . 0.0 110.038 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 42.5 Cg_endo -69.1 133.83 27.8 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.998 1.798 . . . . 0.0 110.693 173.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -58.19 -29.56 65.76 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.593 1.157 . . . . 0.0 111.193 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -81.94 8.28 10.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.073 0.949 . . . . 0.0 112.553 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 12.9 p -113.85 142.06 46.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.68 -170.07 1.63 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.64 0.776 . . . . 0.0 109.322 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -43.37 70.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.404 1.081 . . . . 0.0 113.4 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.48 -38.23 83.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.28 0.632 . . . . 0.0 111.81 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -70.03 -37.6 75.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.737 0.815 . . . . 0.0 110.958 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.61 -35.7 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.226 0.61 . . . . 0.0 110.673 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HG3' HD11 ' A' ' 36' ' ' ILE . 41.5 tt0 -66.81 -39.74 87.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -61.14 -39.19 89.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.735 1.214 . . . . 0.0 111.149 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.24 -42.05 99.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.526 0.33 . . . . 0.0 110.357 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' HB2' HD12 ' A' ' 36' ' ' ILE . 83.9 m-85 -94.97 32.49 1.66 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.004 0.522 . . . . 0.0 111.117 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 t -76.84 87.86 3.43 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 167.38 -55.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -159.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.415 ' HB3' HD21 ' A' ' 61' ' ' LEU . 58.0 m -82.55 171.73 13.76 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.138 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -123.15 72.91 1.13 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 31' ' ' PHE . 44.2 mt -56.27 126.72 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.208 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -48.85 117.72 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.556 1.16 . . . . 0.0 111.397 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.3 t30 60.75 26.3 16.11 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 124.495 1.122 . . . . 0.0 111.991 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.4 -134.4 30.88 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.43 -0.805 . . . . 0.0 113.02 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.87 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.613 1.165 . . . . 0.0 113.531 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -72.48 -16.8 61.8 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.62 24.3 32.67 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -126.11 90.78 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.22 98.72 7.91 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.234 1.014 . . . . 0.0 109.628 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.89 138.36 55.97 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.655 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.2 mt -76.68 90.7 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -75.79 148.0 38.78 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.547 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.5 t -106.8 174.37 5.92 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.041 0.936 . . . . 0.0 109.433 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -57.28 -19.6 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.888 1.275 . . . . 0.0 112.918 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.34 -4.45 58.47 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.343 1.057 . . . . 0.0 111.209 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.89 30.57 51.49 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.14 0.3 . . . . 0.0 112.986 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.75 151.29 73.92 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.028 0.931 . . . . 0.0 110.482 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 145.63 53.34 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.192 1.928 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.1 p -74.48 -38.74 62.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.418 0.628 . . . . 0.0 110.409 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.49 -10.78 2.7 Favored Glycine 0 N--CA 1.468 0.771 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.757 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.58 150.72 24.4 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.196 0.998 . . . . 0.0 109.534 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.56 167.61 24.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.235 1.014 . . . . 0.0 109.885 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -111.7 122.63 48.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.93 107.88 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 12' ' ' VAL . 42.0 mt-10 -85.21 151.29 24.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' A' ' 34' ' ' CYS . 73.6 mt -139.5 148.26 42.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.676 0.791 . . . . 0.0 109.213 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.65 -21.62 61.06 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -144.9 156.58 44.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.516 0.674 . . . . 0.0 110.811 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.55 -18.75 63.67 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.788 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.26 -55.65 32.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.322 0.649 . . . . 0.0 109.583 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.551 ' HA ' HD13 ' A' ' 69' ' ' LEU . 36.3 mt-10 -52.11 -36.0 49.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.779 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 11' ' ' PHE . 76.0 t -60.83 -52.04 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.44 0.296 . . . . 0.0 110.706 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -57.42 -37.23 72.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.38 0.672 . . . . 0.0 112.619 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 66' ' ' GLU . 84.7 mt -60.55 -52.65 64.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.956 0.502 . . . . 0.0 110.558 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.83 79.1 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.677 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -57.58 -32.8 67.52 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.613 1.165 . . . . 0.0 111.843 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -76.48 -18.89 58.52 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.526 0.33 . . . . 0.0 111.082 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -88.46 9.96 21.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.65 8.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -129.56 -37.36 1.59 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.204 0.602 . . . . 0.0 110.192 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -52.04 143.29 14.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.428 1.091 . . . . 0.0 113.066 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.9 p -90.06 110.45 21.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.204 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.51 91.68 1.83 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 171.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.54 -96.25 1.14 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -164.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.99 -0.03 5.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.07 0.948 . . . . 0.0 109.911 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.25 114.91 19.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.064 0.946 . . . . 0.0 109.226 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.07 108.03 4.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.0 t -108.08 122.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.536 0.735 . . . . 0.0 110.062 -170.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.98 137.49 35.98 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.761 1.224 . . . . 0.0 109.129 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.5 t -124.17 116.16 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -104.03 -176.93 3.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.127 1.371 . . . . 0.0 107.699 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -109.53 136.97 48.06 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -128.59 148.84 50.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.754 0.822 . . . . 0.0 109.31 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -93.31 173.88 7.49 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -64.24 -19.21 65.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.77 171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.36 -54.91 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 123.785 0.834 . . . . 0.0 110.504 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.35 -45.05 70.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.295 0.638 . . . . 0.0 110.53 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -57.03 -48.68 77.92 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.456 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.03 -53.99 51.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.509 0.724 . . . . 0.0 111.122 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -65.02 -41.95 94.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.143 0.977 . . . . 0.0 112.888 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 35.4 t -82.71 -22.9 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.841 0.456 . . . . 0.0 111.174 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.48 -22.94 46.72 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 122.373 -0.204 . . . . 0.0 110.821 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.6 mmpt? -73.46 -38.94 65.3 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.5 t60 176.31 -78.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 10.2 t 173.9 50.35 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.072 1.749 . . . . 0.0 107.589 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.59 -147.72 51.0 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 118.743 -1.031 . . . . 0.0 110.561 -167.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.54 -49.75 5.31 Favored 'Trans proline' 0 C--N 1.367 1.543 0 CA-C-N 119.852 1.826 . . . . 0.0 110.239 165.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -178.23 102.53 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -67.67 115.22 25.14 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.0 0.52 . . . . 0.0 111.124 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.83 -171.21 1.14 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.613 2.209 . . . . 0.0 111.404 171.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.95 -52.07 40.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.273 0.629 . . . . 0.0 109.923 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.6 m -150.63 106.67 3.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.298 1.039 . . . . 0.0 108.912 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.34 80.35 6.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.63 174.39 7.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.577 0.751 . . . . 0.0 111.721 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -100.08 -168.54 1.61 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.806 0.842 . . . . 0.0 109.617 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 CA-C-O 119.268 -0.74 . . . . 0.0 114.119 179.8 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -83.65 88.2 7.05 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.229 1.014 . . . . 0.0 109.477 176.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 mtm -114.16 4.38 15.54 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.92 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.47 49.38 4.06 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.478 -176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 131.71 2.3 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.02 106.34 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.914 0.485 . . . . 0.0 110.244 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.25 106.46 1.51 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 64' ' ' GLU . 10.5 m-30 -83.48 61.66 6.34 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.052 0.93 . . . . 0.0 108.537 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.04 138.54 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.878 1.271 . . . . 0.0 108.719 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 70' ' ' ALA . 28.5 m -110.44 177.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.341 0.656 . . . . 0.0 110.446 165.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 19.6 ptmt -136.93 140.07 41.99 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.95 129.99 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.703 0.801 . . . . 0.0 109.134 -170.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.778 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 30.1 mtp-105 -129.94 159.43 36.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.111 0.964 . . . . 0.0 108.447 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.47 18.05 67.25 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.61 141.85 65.48 Favored Pre-proline 0 C--N 1.349 0.585 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.89 140.39 91.73 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 121.904 1.736 . . . . 0.0 111.47 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HZ3' HH22 ' A' ' 81' ' ' ARG . 1.6 m-90 -68.07 -19.33 64.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.369 0.668 . . . . 0.0 110.099 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -97.97 12.4 34.31 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.511 1.125 . . . . 0.0 111.55 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 53.4 t -90.53 140.29 29.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.115 0.566 . . . . 0.0 109.676 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.6 p -117.14 172.4 7.31 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.082 0.953 . . . . 0.0 109.661 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -40.98 58.81 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.674 1.19 . . . . 0.0 114.138 -171.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.34 -39.95 73.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.984 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 1.8 mp0 -71.28 -41.04 70.53 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 0.0 111.322 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 43' ' ' ILE . 56.5 t -72.71 -30.31 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.13 -42.69 62.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.1 0.96 . . . . 0.0 110.173 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.58 -48.25 82.6 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.172 0.989 . . . . 0.0 110.677 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 79.2 t80 -63.35 -57.34 10.68 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -85.38 37.25 0.67 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.314 0.645 . . . . 0.0 111.368 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -57.59 -31.83 66.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.445 0.698 . . . . 0.0 110.692 166.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.11 -16.15 63.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.956 1.302 . . . . 0.0 112.329 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.1 m -114.23 130.49 56.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.961 . . . . 0.0 109.158 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 13.9 mmmm -75.3 90.0 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.501 ' HA ' HD21 ' A' ' 61' ' ' LEU . 20.8 mt -73.89 129.75 36.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -44.19 -68.25 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.928 1.392 . . . . 0.0 113.413 -163.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -108.73 43.29 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.469 0.708 . . . . 0.0 109.852 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.23 -125.35 37.52 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.718 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.8 68.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.926 0.89 . . . . 0.0 112.022 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -77.58 -19.71 55.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.725 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.67 -20.67 75.94 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 116.525 -0.307 . . . . 0.0 112.38 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.554 HG21 HG21 ' A' ' 59' ' ' VAL . 46.4 mt -79.89 140.66 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.544 0.738 . . . . 0.0 109.158 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' HB3' HD12 ' A' ' 97' ' ' LEU . 28.4 mmt180 -127.26 96.76 4.68 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.961 0.504 . . . . 0.0 110.078 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 94.0 m-85 -77.87 136.91 38.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.464 0.306 . . . . 0.0 110.28 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.55 85.88 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.24 145.62 43.94 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.196 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 52' ' ' ARG . 8.9 t -109.42 178.87 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.1 0.56 . . . . 0.0 110.132 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.65 -5.53 8.67 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' H ' HG21 ' A' ' 48' ' ' THR . 10.3 tp10 -90.42 -17.43 27.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.93 0.892 . . . . 0.0 110.325 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.09 4.96 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.141 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' O ' HG22 ' A' ' 48' ' ' THR . 17.8 ptt85 -163.19 155.51 15.64 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.878 0.871 . . . . 0.0 111.225 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.552 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 36.2 Cg_endo -62.95 149.14 92.44 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.719 2.279 . . . . 0.0 112.015 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.0 p -95.15 19.55 10.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.192 0.997 . . . . 0.0 111.556 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 -17.13 49.37 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 120.034 -0.314 . . . . 0.0 113.622 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 38.9 tt0 -107.6 147.2 30.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.587 0.755 . . . . 0.0 110.111 175.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.92 36.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.467 1.107 . . . . 0.0 109.76 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.5 112.53 23.11 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.554 HG21 HG21 ' A' ' 43' ' ' ILE . 72.2 t -93.96 116.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.726 ' HB2' ' HE1' ' A' ' 93' ' ' MET . 18.4 tt0 -86.93 137.41 32.4 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.449 0.468 . . . . 0.0 109.823 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.501 HD21 ' HA ' ' A' ' 36' ' ' ILE . 56.4 mt -127.3 148.17 50.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.288 1.035 . . . . 0.0 108.555 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.13 -24.89 47.22 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.602 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.9 m -133.76 143.8 48.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.588 0.755 . . . . 0.0 110.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . 30.6 tt0 -77.03 -10.93 59.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.039 0.447 . . . . 0.0 111.695 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 25.9 t70 -65.72 -35.43 80.73 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 169.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.602 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 18.1 mm-40 -68.16 -31.27 70.71 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.952 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.24 -51.83 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.485 0.714 . . . . 0.0 110.645 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 18.8 ptpt -54.06 -38.7 65.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 123.286 0.366 . . . . 0.0 111.355 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 41.4 mt -64.06 -50.14 69.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.322 1.049 . . . . 0.0 110.955 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB2' HG11 ' A' ' 13' ' ' VAL . . . -56.53 -44.8 81.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.686 0.794 . . . . 0.0 111.946 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD21 HG11 ' A' ' 85' ' ' VAL . 93.2 mt -59.87 -34.93 73.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.431 1.092 . . . . 0.0 111.472 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -76.83 -17.85 58.75 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.254 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 29.5 mtpp -89.42 3.33 52.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.268 0.627 . . . . 0.0 111.352 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.61 -59.13 4.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.866 0.866 . . . . 0.0 111.796 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -79.19 -11.47 59.97 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 157.03 18.17 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.67 0.747 . . . . 0.0 111.621 165.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.3 p -93.82 122.67 36.53 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.227 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.611 ' HB2' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -62.26 -77.36 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.628 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.58 87.72 0.29 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 166.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 78.39 -52.36 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.672 1.589 . . . . 0.0 112.062 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.411 HH22 ' HZ3' ' A' ' 20' ' ' TRP . 47.6 mtm180 -78.94 154.48 29.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.916 0.487 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -84.12 151.92 24.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.65 0.78 . . . . 0.0 109.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 78' ' ' MET . 12.2 t -96.52 156.93 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 111.087 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.778 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 29.0 mm-40 -115.27 115.0 25.94 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 161.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.446 HG11 HD21 ' A' ' 71' ' ' LEU . 34.7 t -117.56 117.33 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.25 -178.11 3.37 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.63 135.56 50.4 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.8 m -130.11 -160.7 1.06 Allowed 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.022 0.929 . . . . 0.0 110.324 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -160.69 160.42 31.46 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.155 0.982 . . . . 0.0 113.08 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.94 -51.71 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.633 0.773 . . . . 0.0 110.852 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.491 ' HA ' ' HB3' ' A' ' 95' ' ' TRP . 11.5 pm0 -83.99 -20.61 32.53 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.959 0.503 . . . . 0.0 110.752 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.726 ' HE1' ' HB2' ' A' ' 60' ' ' GLU . 50.1 ttm -60.06 -56.01 26.89 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.44 -41.2 98.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.98 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.491 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 65.0 t-105 -58.77 -53.65 56.02 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.162 0.585 . . . . 0.0 111.0 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.76 -25.68 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.476 0.71 . . . . 0.0 111.963 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 44' ' ' ARG . 85.0 mt -76.75 -43.61 36.45 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.599 0.36 . . . . 0.0 111.095 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.74 -32.84 27.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.254 1.022 . . . . 0.0 110.701 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -136.0 88.02 2.36 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.243 1.417 . . . . 0.0 107.387 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 p -67.82 85.81 0.22 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.6 -179.95 41.22 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.451 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.19 -176.58 3.35 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.543 2.829 . . . . 0.0 113.748 -173.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.26 121.08 18.57 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.99 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -61.9 145.22 92.9 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.727 0.811 . . . . 0.0 111.38 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -44.36 123.96 4.83 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.923 3.082 . . . . 0.0 114.063 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.98 90.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.15 0.98 . . . . 0.0 109.716 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.5 m 67.68 130.51 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.359 1.464 . . . . 0.0 109.972 -169.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.81 92.26 0.15 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.431 0.693 . . . . 0.0 111.198 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -99.15 174.85 6.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.295 0.638 . . . . 0.0 110.983 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.32 162.82 23.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.899 0.88 . . . . 0.0 110.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.34 -178.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.7 m80 66.97 160.92 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.962 1.305 . . . . 0.0 111.044 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 tpp -86.17 83.38 7.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.32 0.581 . . . . 0.0 109.752 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.79 -28.53 54.55 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.77 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.16 -78.04 0.43 Allowed Glycine 0 C--N 1.352 1.43 0 C-N-CA 123.717 0.675 . . . . 0.0 112.394 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -155.84 135.02 12.17 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.05 127.42 1.41 Allowed Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -92.73 17.88 9.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 112.045 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.95 133.82 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 168.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.495 HG12 HG13 ' A' ' 67' ' ' VAL . 23.1 m -96.2 155.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 122.608 0.363 . . . . 0.0 110.847 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 36.7 ttpt -109.0 117.65 34.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG11 HG12 ' A' ' 83' ' ' VAL . 58.4 t -105.34 136.85 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.02 0.928 . . . . 0.0 108.636 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -140.41 134.51 30.9 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 111.72 81.55 1.16 Allowed Glycine 0 C--O 1.236 0.264 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -168.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.0 mt -139.67 135.34 16.71 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 114.097 -1.051 . . . . 0.0 109.164 -171.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 30.9 Cg_endo -65.74 131.41 27.46 Favored 'Trans proline' 0 C--N 1.361 1.217 0 N-CA-C 108.285 -1.467 . . . . 0.0 108.285 154.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -63.7 -24.71 67.89 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.63 0.772 . . . . 0.0 111.193 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -97.41 26.82 4.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.875 0.87 . . . . 0.0 111.624 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.546 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 27.4 p -78.95 155.25 29.05 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.223 0.609 . . . . 0.0 111.166 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -105.48 159.11 16.18 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.315 1.046 . . . . 0.0 109.553 171.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 -38.59 66.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.255 0.622 . . . . 0.0 110.794 169.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.97 -35.88 67.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.023 0.929 . . . . 0.0 112.129 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -64.55 -47.76 77.58 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.054 0.454 . . . . 0.0 111.349 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.74 -24.54 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.204 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.26 -49.7 40.42 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 109.96 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -58.05 -40.67 81.51 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.256 0.972 . . . . 0.0 110.26 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -59.78 -56.05 26.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 36' ' ' ILE . 65.9 m-85 -93.98 25.84 3.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.259 0.624 . . . . 0.0 111.858 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 t -64.01 -21.78 66.65 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.93 -43.02 84.32 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 81.8 m -75.0 140.05 43.34 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.182 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -84.28 90.97 7.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 31' ' ' PHE . 55.0 mt -64.71 121.84 14.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.212 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -59.49 124.3 19.6 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.132 0.895 . . . . 0.0 110.474 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.59 20.61 12.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.325 1.05 . . . . 0.0 111.278 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.57 -131.09 49.14 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.053 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.33 -29.93 25.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.293 1.037 . . . . 0.0 113.23 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -75.01 -21.83 58.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.396 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.27 -21.71 79.19 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.404 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.93 121.31 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 108.98 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.566 ' HD3' HD11 ' A' ' 97' ' ' LEU . 83.2 mtt180 -128.52 96.9 4.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.924 0.89 . . . . 0.0 110.005 -169.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.5 132.1 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.43 83.97 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 84.4 m-85 -72.97 143.64 47.55 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.502 177.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.4 p -98.14 179.16 4.85 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.523 0.729 . . . . 0.0 109.427 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -68.85 -9.01 48.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.653 0.781 . . . . 0.0 111.765 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 13.9 tp10 -83.05 -14.17 54.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.072 0.949 . . . . 0.0 110.453 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.0 23.41 59.43 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 113.537 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.448 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 7.2 mpt_? -133.29 143.46 48.32 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 42.3 Cg_endo -65.44 155.79 66.92 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.88 1.72 . . . . 0.0 111.009 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.9 t -72.01 -3.82 25.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.294 0.638 . . . . 0.0 111.6 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.38 66.21 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -166.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.09 149.43 35.55 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.006 1.323 . . . . 0.0 111.148 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.39 166.79 27.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.118 1.367 . . . . 0.0 109.873 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -121.48 128.71 52.38 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.15 118.25 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -82.34 141.11 33.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -126.35 163.22 23.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.904 0.482 . . . . 0.0 110.405 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -31.22 70.77 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.977 0.911 . . . . 0.0 110.612 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 t -160.2 164.42 32.83 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 108.999 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -74.93 -13.66 60.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 0.0 110.729 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.62 -42.24 98.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.582 0.753 . . . . 0.0 110.582 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 7.9 mm-40 -59.7 -32.39 70.47 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.547 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.598 HG12 ' HZ1' ' A' ' 87' ' ' LYS . 76.0 t -67.63 -41.61 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.042 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 89.5 mttt -53.4 -46.63 69.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.778 0.831 . . . . 0.0 111.442 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.9 -46.26 85.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.658 0.783 . . . . 0.0 111.202 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.43 -46.4 80.28 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.378 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 96.6 mt -59.2 -39.17 81.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.333 1.053 . . . . 0.0 111.281 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 61.3 mttp -64.81 -29.14 70.1 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.674 0.609 . . . . 0.0 111.466 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HZ2' ' HA ' ' A' ' 31' ' ' PHE . 62.9 pttt -111.41 37.49 2.86 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.409 0.623 . . . . 0.0 111.351 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 85' ' ' VAL . 6.5 p-10 -75.43 18.58 0.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.394 0.677 . . . . 0.0 111.873 165.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -117.95 -29.49 5.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.539 1.535 . . . . 0.0 108.866 -168.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -58.94 146.01 39.44 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.241 1.017 . . . . 0.0 112.829 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 p -95.19 143.62 26.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.347 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ttt -112.11 98.22 7.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.31 1.06 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -151.46 15.55 0.69 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.135 0.974 . . . . 0.0 109.944 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -107.36 -145.2 0.39 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 81.0 m-85 -157.81 128.75 6.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -160.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.404 HG12 HG11 ' A' ' 15' ' ' VAL . 95.9 t -104.71 116.46 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 119.72 1.145 . . . . 0.0 109.293 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -96.82 118.23 32.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 107.622 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 33.2 t -114.06 116.83 53.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -111.04 -178.9 3.58 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.598 ' HZ1' HG12 ' A' ' 67' ' ' VAL . 22.5 ttmm -100.88 118.88 37.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.9 t -92.5 -178.79 5.01 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.906 0.86 . . . . 0.0 109.742 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -142.22 154.39 44.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.26 -38.14 79.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.98 -47.39 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 110.655 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -54.26 38.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.129 0.572 . . . . 0.0 111.193 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 42.1 ttp -55.26 -42.35 73.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.17 0.988 . . . . 0.0 111.385 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.68 -45.46 89.39 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.269 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -62.55 -44.81 95.42 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.749 0.656 . . . . 0.0 111.944 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.51 HG13 ' H ' ' A' ' 101' ' ' GLY . 15.7 t -76.13 -25.12 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 123.748 0.655 . . . . 0.0 111.227 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.566 HD11 ' HD3' ' A' ' 44' ' ' ARG . 86.6 mt -79.52 -29.08 41.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.912 0.485 . . . . 0.0 111.067 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -80.13 -28.3 38.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.022 0.529 . . . . 0.0 110.963 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -160.55 107.66 1.55 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.02 0.928 . . . . 0.0 108.656 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.4 p -47.72 100.34 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.313 1.045 . . . . 0.0 111.591 176.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.51 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 125.12 -153.29 17.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -84.94 158.39 11.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.564 2.176 . . . . 0.0 112.913 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -119.55 -69.13 0.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.392 1.077 . . . . 0.0 108.378 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.7 p -113.22 146.15 34.66 Favored Pre-proline 0 C--O 1.242 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 109.311 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.27 119.72 7.08 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.09 1.86 . . . . 0.0 110.124 172.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.55 -31.57 62.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.356 0.662 . . . . 0.0 111.366 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 m -107.19 73.25 0.92 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.7 -11.58 13.5 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.829 0.852 . . . . 0.0 111.332 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -144.37 121.15 11.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.434 0.693 . . . . 0.0 109.584 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -146.28 150.15 35.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.699 0.799 . . . . 0.0 108.933 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.387 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -175.733 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.238 0.455 0 CA-C-O 120.565 0.222 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -131.04 94.18 3.54 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 108.805 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.3 ttt -57.85 -37.21 73.46 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.66 171.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.41 124.95 3.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.424 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.42 78.68 0.83 Allowed Glycine 0 C--N 1.348 1.25 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.22 121.18 36.22 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -173.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.19 54.96 0.42 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.574 ' HA ' HG23 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -89.1 44.61 1.22 Allowed 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.985 0.898 . . . . 0.0 112.273 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.21 133.93 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.483 HG12 ' HB1' ' A' ' 70' ' ' ALA . 28.9 m -105.08 168.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.095 0.474 . . . . 0.0 110.865 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 102' ' ' PRO . 85.4 tttt -126.5 125.84 42.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -111.93 123.28 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 123.517 0.727 . . . . 0.0 109.174 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 52.5 ttt180 -127.86 147.55 50.45 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 22.88 34.52 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.78 137.27 54.44 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.43 0.692 . . . . 0.0 109.758 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 36.7 Cg_endo -67.08 135.92 39.07 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.516 2.144 . . . . 0.0 111.195 169.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 53' ' ' PRO . 26.8 p90 -60.73 -27.4 67.9 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 m -78.76 1.88 21.63 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.494 1.117 . . . . 0.0 112.976 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.512 ' SG ' ' HG2' ' A' ' 19' ' ' PRO . 14.9 p -119.07 152.31 36.7 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 m -116.7 -168.34 1.44 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.107 0.963 . . . . 0.0 109.808 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.3 61.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.882 1.273 . . . . 0.0 113.505 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.3 m-20 -51.08 -55.33 18.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.906 0.882 . . . . 0.0 112.931 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.92 -33.52 74.85 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.911 0.484 . . . . 0.0 111.682 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.98 -39.28 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.051 0.54 . . . . 0.0 109.856 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.83 -42.85 97.53 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.246 0.618 . . . . 0.0 110.756 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 33.2 mmt180 -66.36 -38.09 86.8 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.241 0.616 . . . . 0.0 111.06 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -65.03 -39.23 93.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.67 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 58.3 m-85 -95.13 28.8 2.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.469 0.707 . . . . 0.0 111.668 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 95.35 2.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 166.7 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.423 2.289 . . . . 0.0 107.396 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.1 p -115.82 136.84 52.67 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.548 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.567 ' HZ2' ' HB3' ' A' ' 35' ' ' LYS . 9.0 mtpm? -81.68 98.35 8.35 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.516 ' HA ' HD21 ' A' ' 61' ' ' LEU . 30.5 mt -77.98 115.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 45.8 tt0 -66.56 129.49 40.03 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.544 0.527 . . . . 0.0 110.535 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' ND2' ' HG2' ' A' ' 37' ' ' GLN . 35.5 m-80 75.07 16.77 2.78 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.591 1.556 . . . . 0.0 110.425 -173.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.77 -137.85 39.45 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.926 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.55 63.41 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.863 0.865 . . . . 0.0 112.218 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -75.46 -10.86 59.83 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.942 0.497 . . . . 0.0 111.789 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.96 -17.7 74.13 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.061 0.226 . . . . 0.0 112.757 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -84.14 116.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.573 0.749 . . . . 0.0 109.183 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -116.04 95.55 5.15 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.26 0.624 . . . . 0.0 109.873 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -73.29 139.42 46.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.892 0.477 . . . . 0.0 110.491 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.3 mm -79.26 112.9 17.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 165.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.88 167.1 11.63 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.512 0.725 . . . . 0.0 109.381 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -90.45 -176.61 4.83 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.514 0.726 . . . . 0.0 109.345 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.68 -14.09 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.107 0.412 . . . . 0.0 110.838 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.33 52.79 0.71 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.654 0.221 . . . . 0.0 113.654 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -115.99 131.26 23.83 Favored Pre-proline 0 N--CA 1.483 1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HB2' ' HA ' ' A' ' 20' ' ' TRP . 32.3 Cg_exo -57.54 123.36 13.58 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.64 2.226 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -78.21 -45.61 22.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.97 0.508 . . . . 0.0 110.163 -171.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.73 -12.73 1.51 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.24 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 16' ' ' ARG . 43.1 mt-10 -107.38 151.67 25.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.841 . . . . 0.0 110.218 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.72 167.03 30.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.615 1.166 . . . . 0.0 110.044 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.23 115.5 23.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.681 0.792 . . . . 0.0 108.923 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.1 t -97.16 115.63 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.1 tt0 -78.95 130.67 35.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.271 1.028 . . . . 0.0 109.564 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 36' ' ' ILE . 96.9 mt -130.13 140.41 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.222 0.609 . . . . 0.0 110.105 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.72 -20.11 59.97 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.476 0.711 . . . . 0.0 112.827 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.572 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 38.7 m -140.73 150.49 43.48 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.95 -12.69 61.36 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 120.888 0.375 . . . . 0.0 111.044 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.07 -52.22 50.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 169.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.572 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 5.2 mm-40 -47.71 -38.99 16.36 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.46 1.1 . . . . 0.0 111.532 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 11' ' ' PHE . 25.2 t -62.99 -52.95 52.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.237 0 C-N-CA 123.71 0.804 . . . . 0.0 111.471 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -57.09 -37.82 72.45 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.042 0.537 . . . . 0.0 112.404 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.23 -37.7 84.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.632 0.773 . . . . 0.0 111.686 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' HB1' HG12 ' A' ' 13' ' ' VAL . . . -64.65 -44.12 91.44 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 82.4 mt -62.48 -29.88 70.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -66.31 -21.67 66.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.219 1.008 . . . . 0.0 110.894 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 66.2 mttm -84.4 -4.17 58.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.928 0.891 . . . . 0.0 112.35 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 21.0 t70 -68.29 91.29 0.38 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.715 0.406 . . . . 0.0 110.192 173.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 145.43 -38.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 128.317 2.647 . . . . 0.0 109.021 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.66 144.07 39.13 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 p -92.59 120.8 33.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.198 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.456 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 ttt -61.65 -73.19 0.1 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.097 0.559 . . . . 0.0 110.851 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.84 -17.54 0.72 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 168.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -142.45 -66.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.668 1.187 . . . . 0.0 108.374 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -77.85 155.42 31.02 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.207 -172.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -81.25 127.38 32.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 90.9 t -88.96 120.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -170.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 28.9 mt-10 -94.91 116.69 29.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 t -117.03 114.52 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -106.08 144.67 32.46 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.445 1.098 . . . . 0.0 108.526 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.86 125.59 27.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 163.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.7 m -128.18 163.4 24.77 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.593 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -103.89 153.0 21.28 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.54 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.41 -32.75 72.7 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.221 1.008 . . . . 0.0 109.889 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.28 -44.01 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.639 0.776 . . . . 0.0 109.897 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.86 -38.48 83.15 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.1 ttm -56.01 -48.51 75.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.039 0.536 . . . . 0.0 110.01 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.89 -46.8 84.35 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.248 1.019 . . . . 0.0 110.53 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -58.31 -52.53 65.19 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.988 0.805 . . . . 0.0 111.816 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.52 HG12 ' H ' ' A' ' 101' ' ' GLY . 24.6 t -79.14 -25.22 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 -37.96 75.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.747 0.419 . . . . 0.0 110.409 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -90.68 -15.63 30.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.798 0.839 . . . . 0.0 111.428 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.475 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 23.7 t-80 -150.45 92.08 1.82 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.607 1.163 . . . . 0.0 108.567 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.7 p -56.14 90.57 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.151 0.98 . . . . 0.0 111.802 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.52 ' H ' HG12 ' A' ' 96' ' ' VAL . . . 150.26 129.45 1.67 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.426 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 50.1 Cg_endo -84.94 41.39 0.95 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 0.0 113.15 -174.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -84.29 49.51 1.68 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.823 0.821 . . . . 0.0 109.124 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -76.34 117.48 64.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.103 0.961 . . . . 0.0 109.359 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.2 170.57 11.7 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.716 2.278 . . . . 0.0 111.103 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 63.22 62.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.621 0.768 . . . . 0.0 110.284 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 m -83.07 109.5 17.18 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.29 -35.82 70.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 112.286 -174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.76 53.14 7.35 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.448 1.099 . . . . 0.0 110.971 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.29 149.93 33.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.308 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.884 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.282 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 120.71 0.29 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -86.0 103.89 15.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 19.3 ptp -160.96 -175.02 4.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.283 1.033 . . . . 0.0 109.928 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 56.55 14.77 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.64 -35.29 89.15 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.118 0.54 . . . . 0.0 113.696 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.44 83.93 3.86 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.269 0.557 . . . . 0.0 109.67 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 79.65 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -84.03 60.57 5.94 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.435 1.112 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -130.9 134.56 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.925 1.69 . . . . 0.0 107.582 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 70' ' ' ALA . 17.5 m -112.61 -175.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.858 0.863 . . . . 0.0 109.523 171.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.53 142.43 31.12 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.68 0.753 . . . . 0.0 109.54 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -111.49 119.43 59.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 108.611 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 61.1 mtp180 -123.98 148.56 46.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.25 1.02 . . . . 0.0 109.723 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.33 25.81 35.35 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -59.32 143.72 84.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.121 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.52 174.19 13.24 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.463 2.108 . . . . 0.0 111.275 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -68.75 -24.61 64.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.449 0.642 . . . . 0.0 109.536 171.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.0 m -81.41 1.43 33.06 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.447 1.099 . . . . 0.0 112.482 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.2 p -49.02 126.05 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.561 0.744 . . . . 0.0 112.881 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.505 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 45.7 t -146.3 158.91 43.93 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.919 1.287 . . . . 0.0 108.35 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.95 -42.95 69.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.019 0.527 . . . . 0.0 110.688 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 6.8 m-20 -54.33 -43.62 71.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 112.658 173.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 13.3 mm-40 -68.04 -36.35 79.75 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.866 0.467 . . . . 0.0 110.875 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' HB ' HD12 ' A' ' 43' ' ' ILE . 93.0 t -66.78 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 123.33 0.652 . . . . 0.0 110.673 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.47 HE21 HD11 ' A' ' 43' ' ' ILE . 27.4 mm-40 -56.92 -53.83 53.52 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.97 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 36.0 mmt180 -56.56 -46.17 80.88 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.41 1.084 . . . . 0.0 111.228 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.405 ' CE1' ' HB ' ' A' ' 83' ' ' VAL . 71.8 t80 -58.59 -40.47 83.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.821 1.248 . . . . 0.0 112.233 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -97.45 35.56 1.62 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.054 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 83.06 4.6 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 169.05 -62.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.003 1.721 . . . . 0.0 106.739 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.9 m -74.58 -177.66 3.25 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.207 168.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 126.74 17.03 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.831 0.824 . . . . 0.0 109.199 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 HD13 ' NE2' ' A' ' 28' ' ' GLN . 55.2 mt -86.27 128.68 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.419 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -42.76 -61.74 1.18 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.963 1.705 . . . . 0.0 113.965 -160.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -116.52 40.81 2.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.231 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.25 -130.02 32.05 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.333 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' HD13 ' A' ' 43' ' ' ILE . . . -64.11 -14.52 55.37 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.09 -21.68 50.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.769 0.428 . . . . 0.0 111.501 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 28.89 7.71 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 40' ' ' ALA . 61.2 mt -128.51 127.46 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.1 tpp180 -131.29 96.68 4.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.694 0.621 . . . . 0.0 110.024 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.64 134.86 36.45 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.7 113.48 24.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -95.82 164.59 12.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.8 p -107.95 172.88 6.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 108.874 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 1.6 15.59 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -85.53 -6.41 59.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.74 0.816 . . . . 0.0 110.683 167.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.38 32.63 42.09 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.069 0.231 . . . . 0.0 113.1 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -135.3 139.64 32.13 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.573 0.749 . . . . 0.0 111.414 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -58.07 134.1 59.91 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 122.868 2.379 . . . . 0.0 112.187 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -69.29 -44.52 71.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.15 0.98 . . . . 0.0 110.986 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.53 -10.0 3.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.091 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.54 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 43.7 mt-10 -108.67 148.6 30.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.448 1.099 . . . . 0.0 110.137 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.81 152.18 32.31 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 124.38 1.072 . . . . 0.0 108.265 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.49 126.77 52.51 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.9 t -106.45 142.9 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -123.67 120.01 31.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -167.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.1 mt -117.37 161.07 20.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.376 0.67 . . . . 0.0 110.737 -165.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.68 -29.83 69.56 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -160.45 167.2 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.315 0.384 . . . . 0.0 110.543 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -73.02 -17.84 61.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.207 0.603 . . . . 0.0 111.305 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -44.66 89.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.59 -31.03 71.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.198 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.75 -40.9 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.589 0.756 . . . . 0.0 110.535 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -65.08 -38.15 89.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.36 0.664 . . . . 0.0 111.372 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.446 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 96.6 mt -65.66 -31.97 73.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.624 0.769 . . . . 0.0 111.324 172.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.488 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -69.04 -42.57 76.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.635 173.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 87' ' ' LYS . 84.9 mt -62.01 -39.71 93.21 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.687 0.795 . . . . 0.0 112.174 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.7 ptmt -75.03 -18.29 60.36 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.999 0.428 . . . . 0.0 110.475 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.18 6.28 23.16 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.518 1.127 . . . . 0.0 111.2 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -68.52 80.43 0.26 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.294 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 163.94 -44.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.869 0.867 . . . . 0.0 110.055 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -42.17 140.46 1.13 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.013 1.725 . . . . 0.0 113.36 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.6 p -100.37 110.53 22.74 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 -172.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.1 ttm -78.44 91.96 4.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.94 -86.54 1.27 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.999 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -132.14 7.26 4.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.881 0.872 . . . . 0.0 109.988 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -105.69 132.71 51.5 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.101 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -76.47 133.37 39.83 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 30' ' ' PHE . 84.8 t -131.89 133.45 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.144 0.497 . . . . 0.0 110.392 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -98.53 148.2 24.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.695 1.198 . . . . 0.0 109.277 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.488 HG13 ' HB1' ' A' ' 70' ' ' ALA . 46.7 t -130.76 118.98 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.04 144.55 42.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 87.7 tttt -67.68 138.22 56.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -122.95 -160.54 0.9 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.12 159.42 41.58 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -60.71 -40.5 92.5 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.441 0.696 . . . . 0.0 110.723 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.16 -37.29 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.524 1.13 . . . . 0.0 110.976 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -68.75 -46.9 67.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 0.0 110.264 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.26 -45.66 87.44 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.114 0.966 . . . . 0.0 110.14 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.32 -43.36 99.01 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.13 0.972 . . . . 0.0 110.79 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.27 -54.49 45.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.167 0.987 . . . . 0.0 111.919 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.22 -35.28 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 0.0 111.617 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HG2' ' A' ' 44' ' ' ARG . 88.5 mt -67.13 -36.42 81.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.059 0.543 . . . . 0.0 111.105 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -81.82 -32.14 31.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.962 0.905 . . . . 0.0 110.044 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -166.49 99.39 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.462 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -78.4 171.69 14.71 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.88 -173.29 31.15 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.665 -0.519 . . . . 0.0 111.945 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.85 138.3 37.22 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.597 2.198 . . . . 0.0 110.866 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -59.96 120.98 10.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.084 0.469 . . . . 0.0 109.938 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -134.06 72.69 71.67 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.734 0.814 . . . . 0.0 108.941 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -91.3 97.49 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.87 2.38 . . . . 0.0 111.883 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.37 110.03 9.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.5 p -98.92 120.75 39.89 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.648 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -95.83 101.22 12.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.605 0.762 . . . . 0.0 109.812 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -97.22 169.64 9.65 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.04 0.936 . . . . 0.0 109.968 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -160.24 118.54 2.63 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.668 -176.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -70.78 -45.36 64.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.342 0.657 . . . . 0.0 110.786 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.2 ttp -75.41 94.73 3.13 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.04 -46.22 1.1 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.607 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.61 -69.2 2.09 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.924 0.426 . . . . 0.0 112.317 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -65.77 150.02 49.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.225 1.01 . . . . 0.0 109.997 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.93 89.86 0.11 Allowed Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HA ' HG21 ' A' ' 67' ' ' VAL . 17.8 p90 -85.08 47.71 1.45 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.178 0.99 . . . . 0.0 111.563 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG21 ' HG3' ' A' ' 60' ' ' GLU . 78.8 t -135.32 143.41 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 168.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.28 173.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.398 -0.814 . . . . 0.0 110.441 168.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 17.7 ptpt -126.9 139.97 52.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.469 ' HB ' HD12 ' A' ' 18' ' ' LEU . 3.7 t -124.92 130.57 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.584 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 32.6 mtm180 -130.78 156.29 45.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.685 0.794 . . . . 0.0 108.891 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.46 -33.97 6.11 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.469 HD12 ' HB ' ' A' ' 15' ' ' VAL . 52.4 mt -34.77 112.36 0.44 Allowed Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.746 1.218 . . . . 0.0 112.594 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.69 163.98 19.9 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.686 2.257 . . . . 0.0 113.223 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -57.22 -34.74 68.85 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.871 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 t -95.55 13.54 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.601 0.761 . . . . 0.0 111.825 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -72.61 168.72 18.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.055 0.542 . . . . 0.0 111.224 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -137.63 156.53 47.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.949 0.899 . . . . 0.0 109.783 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.32 69.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.501 0.721 . . . . 0.0 111.188 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -50.76 -47.94 59.36 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.053 . . . . 0.0 112.741 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -68.01 -41.09 82.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.797 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' HB ' HD13 ' A' ' 43' ' ' ILE . 33.4 t -72.05 -36.27 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.532 0.733 . . . . 0.0 110.282 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HG2' HD12 ' A' ' 36' ' ' ILE . 26.1 tm0? -65.73 -43.43 89.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.809 . . . . 0.0 110.0 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -61.56 -42.28 98.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.865 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 59.5 t80 -61.31 -29.28 69.78 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.753 0.821 . . . . 0.0 111.638 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.94 37.65 2.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.576 0.751 . . . . 0.0 111.831 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 p -77.15 85.89 3.62 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.486 0.66 . . . . 0.0 109.58 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 168.95 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 126.721 2.008 . . . . 0.0 106.099 -161.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.3 m -78.81 169.67 17.87 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.977 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.8 94.35 3.93 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.523 HD12 ' HG2' ' A' ' 28' ' ' GLN . 14.6 mt -75.97 133.99 30.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.06 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -47.62 -55.96 8.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.193 1.397 . . . . 0.0 112.777 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -125.54 65.23 1.17 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.381 0.61 . . . . 0.0 109.424 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.48 -143.08 42.24 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.353 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.78 -14.77 60.24 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.867 0.867 . . . . 0.0 112.942 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.04 -19.54 58.54 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.111 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.88 -7.89 71.55 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.817 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.502 HG12 HG23 ' A' ' 59' ' ' VAL . 46.3 mt -93.23 134.21 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 124.181 0.992 . . . . 0.0 110.288 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -128.81 96.12 4.28 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.82 0.848 . . . . 0.0 111.588 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -73.84 117.44 15.62 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.517 HG13 HD22 ' A' ' 97' ' ' LEU . 2.4 mp -67.27 99.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -79.78 134.65 36.37 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.3 p -85.25 176.88 8.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.359 0.664 . . . . 0.0 111.531 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -68.37 -21.46 64.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.061 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 9.4 tp10 -80.03 -13.9 58.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.655 1.182 . . . . 0.0 110.716 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.93 11.34 73.7 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.424 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 3.7 mpt_? -106.43 141.5 22.92 Favored Pre-proline 0 N--CA 1.485 1.318 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.67 132.32 49.5 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.062 1.841 . . . . 0.0 110.12 167.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 t -76.13 9.56 2.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.249 1.02 . . . . 0.0 112.142 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 16' ' ' ARG . . . 85.92 -13.42 56.74 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -173.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.99 139.24 37.88 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.251 1.42 . . . . 0.0 109.721 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.78 136.92 29.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.545 0.738 . . . . 0.0 109.232 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -96.2 106.87 19.12 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.502 HG23 HG12 ' A' ' 43' ' ' ILE . 60.1 t -91.19 122.27 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG3' HG21 ' A' ' 12' ' ' VAL . 44.0 tt0 -101.56 136.58 41.17 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.9 mt -125.7 162.47 24.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.13 0.491 . . . . 0.0 110.698 -166.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.92 -35.13 57.55 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.01 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -154.13 167.95 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.677 0.751 . . . . 0.0 112.457 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 60.1 mm-40 -61.85 -32.36 72.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.36 1.464 . . . . 0.0 113.169 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.69 -46.68 88.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.33 -33.93 71.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.85 170.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.495 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 80.9 t -62.14 -52.36 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 118.605 0.638 . . . . 0.0 110.532 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mttt -53.89 -41.27 67.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.427 1.091 . . . . 0.0 111.686 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.1 -41.56 86.06 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.036 0.534 . . . . 0.0 110.92 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.99 94.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.17 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 67.9 mt -57.78 -22.82 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.374 1.07 . . . . 0.0 112.775 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -74.78 -13.72 60.62 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.059 0.543 . . . . 0.0 111.401 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.415 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 3.8 mptp? -88.17 -2.47 58.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 118.89 -0.576 . . . . 0.0 112.254 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -53.05 -59.25 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -18.02 64.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 112.515 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -59.41 153.51 18.99 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.602 0.715 . . . . 0.0 112.496 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -100.45 150.92 22.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.639 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.63 114.09 6.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 108.535 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.39 -81.57 1.2 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -159.42 19.62 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.871 0.868 . . . . 0.0 109.735 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.85 139.76 47.07 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.307 0.643 . . . . 0.0 109.862 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -78.38 129.57 35.12 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.8 t -87.12 165.35 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.333 0.653 . . . . 0.0 109.697 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 49.0 mt-10 -135.19 117.32 15.44 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.4 t -116.76 115.66 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' A' ' 84' ' ' GLU . 92.3 m-85 -117.05 179.59 3.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 120.62 40.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -109.61 140.56 43.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.786 0.834 . . . . 0.0 111.363 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -96.36 166.01 11.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.188 0.995 . . . . 0.0 109.018 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -62.67 -38.0 88.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.401 0.68 . . . . 0.0 110.746 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.24 -43.11 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.371 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -68.52 -41.65 79.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.329 1.052 . . . . 0.0 109.903 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 51.4 ttp -60.74 -52.89 63.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.892 1.277 . . . . 0.0 110.626 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.25 -45.57 92.78 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.776 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -60.94 -40.78 94.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.498 1.119 . . . . 0.0 111.605 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.448 HG21 ' HA2' ' A' ' 101' ' ' GLY . 71.4 t -81.08 -28.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.352 0.661 . . . . 0.0 111.678 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.517 HD22 HG13 ' A' ' 46' ' ' ILE . 69.8 mt -71.23 -43.47 67.27 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.94 -0.475 . . . . 0.0 110.948 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -82.46 -35.34 27.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.508 0.723 . . . . 0.0 112.74 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.558 ' HD1' ' HG3' ' A' ' 102' ' ' PRO . 51.6 t-80 -118.16 -4.33 10.99 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 119.243 -0.408 . . . . 0.0 112.062 -166.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p 58.34 131.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.73 1.612 . . . . 0.0 111.317 -168.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.448 ' HA2' HG21 ' A' ' 96' ' ' VAL . . . -46.5 101.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.635 0 O-C-N 124.128 0.892 . . . . 0.0 115.098 -171.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.558 ' HG3' ' HD1' ' A' ' 99' ' ' HIS . 85.0 Cg_endo -100.27 67.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 124.135 3.223 . . . . 0.0 110.651 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.6 m120 72.99 105.95 0.07 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.829 1.252 . . . . 0.0 110.384 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -99.68 102.56 17.37 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.369 0.668 . . . . 0.0 109.285 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.68 111.83 2.59 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.665 2.243 . . . . 0.0 112.566 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.75 -15.52 59.07 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.461 0.705 . . . . 0.0 110.944 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.6 p -63.61 95.53 0.11 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.219 0.608 . . . . 0.0 109.808 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.19 171.82 7.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.057 0.943 . . . . 0.0 110.016 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.94 164.94 27.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.988 0.515 . . . . 0.0 111.489 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.66 160.14 17.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.981 0.912 . . . . 0.0 110.936 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 CA-C-O 118.798 -1.001 . . . . 0.0 112.046 173.819 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -101.93 118.34 36.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.895 0.878 . . . . 0.0 109.432 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.9 tpt 64.35 22.0 12.65 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.1 1.36 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.515 ' HA2' ' HB2' ' A' ' 89' ' ' ASN . . . -84.11 -20.87 58.36 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.162 -0.926 . . . . 0.0 114.326 -173.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.05 -13.07 75.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -108.01 -3.46 18.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 117.978 0.889 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.06 156.11 45.17 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 114.377 0.511 . . . . 0.0 114.377 -170.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -96.63 15.13 22.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.908 0.883 . . . . 0.0 110.724 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.51 139.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.961 1.305 . . . . 0.0 107.898 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.465 HG13 ' HB1' ' A' ' 70' ' ' ALA . 30.2 m -107.25 169.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 167.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 79.7 tttt -124.66 125.4 44.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.66 125.42 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 108.929 -171.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 76.3 mtp180 -117.7 149.36 40.87 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.03 19.68 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.588 -176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.33 121.96 64.08 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -54.1 149.91 33.77 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.948 2.432 . . . . 0.0 113.066 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -63.37 -25.93 68.52 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.537 0.684 . . . . 0.0 111.086 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 t -109.03 19.21 19.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.202 1.001 . . . . 0.0 111.025 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.7 p -78.29 177.84 8.11 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.635 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.2 t -128.21 148.45 50.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.546 0.738 . . . . 0.0 109.645 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.41 71.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.8 m-20 -54.85 -47.59 73.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 111.262 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.635 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 11.2 mm-40 -69.01 -41.25 78.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.412 0.685 . . . . 0.0 111.478 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.501 ' HB ' HD13 ' A' ' 43' ' ' ILE . 45.5 t -69.14 -31.85 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.02 0.528 . . . . 0.0 109.691 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.64 -41.85 87.64 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.798 0.839 . . . . 0.0 110.598 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 67.6 mmt-85 -65.99 -37.2 85.35 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 0.0 111.262 176.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -68.13 -33.81 75.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.374 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -101.99 35.53 2.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.591 . . . . 0.0 110.684 175.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -82.34 79.76 8.71 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t70 170.54 -38.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.816 -158.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.8 m -102.11 173.05 6.56 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.344 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 6.0 mtpm? -126.78 95.14 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.53 ' HA ' HD21 ' A' ' 61' ' ' LEU . 21.5 mt -76.62 139.51 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.659 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -45.89 -69.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.894 1.371 . . . . 0.0 112.112 -169.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' A' ' 41' ' ' GLN . 1.2 t-20 -106.34 35.48 2.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.861 0.464 . . . . 0.0 110.278 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.66 -125.92 31.67 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.33 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -29.96 71.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.006 0.903 . . . . 0.0 111.063 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.6 mp0 -73.53 -18.01 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.17 0.588 . . . . 0.0 110.916 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.74 -15.7 81.37 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.208 0.317 . . . . 0.0 112.907 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.501 HD13 ' HB ' ' A' ' 27' ' ' VAL . 63.7 mt -83.53 141.32 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.875 0.87 . . . . 0.0 109.424 178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' HG2' HD12 ' A' ' 97' ' ' LEU . 3.3 tpp180 -133.96 95.23 3.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -73.58 128.4 35.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.918 0.487 . . . . 0.0 110.198 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.27 118.67 32.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 89.0 m-85 -90.01 172.09 9.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.256 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -101.29 173.09 6.61 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.639 165.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -68.59 -11.18 59.66 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.274 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -85.2 -2.64 58.26 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.819 0.848 . . . . 0.0 111.57 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.4 37.35 41.7 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -145.6 135.03 11.41 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.146 0.578 . . . . 0.0 111.21 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 87.6 Cg_exo -49.08 133.96 29.38 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.6 2.866 . . . . 0.0 113.76 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 p -67.72 -26.09 65.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.179 0.992 . . . . 0.0 111.386 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.99 -16.79 7.23 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -170.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -105.44 153.12 22.12 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.977 0.911 . . . . 0.0 110.574 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.76 168.82 25.56 Favored 'General case' 0 C--O 1.213 -0.854 0 C-N-CA 124.69 1.196 . . . . 0.0 108.979 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -119.37 124.45 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.673 0.789 . . . . 0.0 109.674 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.87 111.75 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.93 136.0 35.98 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 36' ' ' ILE . 70.3 mt -126.9 144.22 51.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.519 0.728 . . . . 0.0 109.819 -171.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -66.38 -17.64 64.89 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.8 p -166.65 170.36 12.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.96 0.504 . . . . 0.0 110.945 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.59 -21.14 65.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.443 1.097 . . . . 0.0 113.367 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -49.0 77.71 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mp0 -59.4 -33.11 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.831 0.852 . . . . 0.0 112.51 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 55.3 t -60.06 -48.61 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.426 0.454 . . . . 0.0 109.916 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.32 -36.74 83.09 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.974 0.91 . . . . 0.0 112.048 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.26 -41.57 99.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.404 0.682 . . . . 0.0 111.607 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB1' HG13 ' A' ' 13' ' ' VAL . . . -64.02 -43.98 93.96 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.059 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 98.0 mt -64.31 -33.32 75.57 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.996 0.918 . . . . 0.0 112.747 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -16.26 50.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.909 -0.494 . . . . 0.0 110.123 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -83.58 -9.36 58.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.912 0.885 . . . . 0.0 111.002 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.481 ' HB2' ' HB ' ' A' ' 85' ' ' VAL . 5.0 t70 -62.14 100.09 0.16 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 149.38 -49.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.387 2.275 . . . . 0.0 108.67 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -55.52 146.29 20.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.034 1.333 . . . . 0.0 113.56 -168.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 25.7 p -98.6 121.39 40.49 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.803 0.841 . . . . 0.0 110.904 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ptp -83.81 74.59 10.17 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 122.005 0.907 . . . . 0.0 108.949 164.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.05 -89.95 1.38 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.126 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.98 -23.26 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.508 0.723 . . . . 0.0 111.867 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -122.35 139.24 54.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.063 0.545 . . . . 0.0 111.761 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 21.4 p90 -85.71 142.84 28.72 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.607 1.163 . . . . 0.0 108.815 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 37.7 t -103.88 131.6 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.579 0.752 . . . . 0.0 111.54 -170.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.786 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 26.4 tp10 -104.78 119.33 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 108.783 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 74' ' ' ASP . 56.3 t -118.33 117.05 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.083 0.553 . . . . 0.0 110.62 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.75 139.83 44.35 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.967 . . . . 0.0 109.564 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -68.02 126.41 29.41 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -132.91 -162.12 1.21 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.044 0.938 . . . . 0.0 109.466 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.515 ' HB2' ' HA2' ' A' ' 7' ' ' GLY . 59.6 t30 -146.54 162.82 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.297 0.639 . . . . 0.0 109.401 -172.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.7 -31.46 71.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.841 0.856 . . . . 0.0 110.498 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.57 -42.13 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.362 0.665 . . . . 0.0 110.98 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 96' ' ' VAL . 18.1 tp10 -64.51 -49.54 70.92 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.0 -46.06 68.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.107 1.363 . . . . 0.0 111.391 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.9 -44.13 97.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.812 0.845 . . . . 0.0 111.331 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -63.46 -39.66 95.06 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.565 0.746 . . . . 0.0 111.406 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 92' ' ' GLU . 5.2 t -79.05 -18.95 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.739 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.49 HD12 ' HG2' ' A' ' 44' ' ' ARG . 97.8 mt -78.63 -30.0 46.21 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.957 0.503 . . . . 0.0 111.118 168.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -78.85 -35.85 43.26 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.573 0.749 . . . . 0.0 109.592 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -134.1 90.69 2.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.4 p -65.14 99.26 0.36 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.88 155.4 26.4 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.695 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.62 89.92 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.874 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -91.76 56.08 2.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.646 0.778 . . . . 0.0 109.872 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.7 m -69.37 113.13 14.64 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.63 0.772 . . . . 0.0 110.094 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.7 151.82 83.33 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.41 2.073 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 -70.87 0.13 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -176.31 164.7 2.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.21 85.22 1.0 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 108.124 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -153.1 137.05 16.26 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.969 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -79.81 124.37 28.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.699 0.799 . . . . 0.0 109.673 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.895 178.755 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 t60 63.46 121.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.675 1.59 . . . . 0.0 110.109 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.84 114.09 2.61 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.837 0.455 . . . . 0.0 110.364 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.85 162.03 23.45 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.034 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.18 -36.05 0.22 Allowed Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.704 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -74.57 69.34 1.71 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 90' ' ' ASN . . . 102.73 124.31 5.42 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -170.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -78.08 90.58 4.23 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.481 0.713 . . . . 0.0 110.56 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG23 ' HG2' ' A' ' 60' ' ' GLU . 28.4 t -134.28 140.48 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.296 1.038 . . . . 0.0 108.58 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.508 HG22 HD13 ' A' ' 61' ' ' LEU . 30.0 m -107.48 167.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 0.0 110.549 164.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.455 ' HE3' ' HD2' ' A' ' 16' ' ' ARG . 3.7 tmmm? -119.82 122.72 41.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.54 123.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 108.611 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HD2' ' HE3' ' A' ' 14' ' ' LYS . 12.0 ptm180 -139.95 154.71 47.27 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.17 21.06 23.82 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.21 138.09 30.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.209 1.004 . . . . 0.0 108.775 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 157.21 62.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.718 2.279 . . . . 0.0 112.307 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -52.28 -35.78 51.08 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.432 1.093 . . . . 0.0 111.851 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.6 p -93.2 17.26 11.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.015 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.48 166.17 15.27 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 123.393 0.677 . . . . 0.0 111.53 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.1 m -151.02 163.04 39.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 108.976 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -44.1 69.19 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 111.209 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.08 -40.42 73.57 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.167 0.987 . . . . 0.0 113.379 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -55.96 -48.19 76.24 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.447 0.641 . . . . 0.0 110.926 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.1 t -81.83 -22.98 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.699 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -71.26 -48.25 52.18 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.375 0.67 . . . . 0.0 109.949 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -63.91 -38.46 91.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.48 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.44 -46.49 88.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.499 ' HB2' HD11 ' A' ' 36' ' ' ILE . 96.3 m-85 -99.07 38.16 1.43 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.859 0.863 . . . . 0.0 110.698 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -66.13 -29.07 69.31 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.78 0.432 . . . . 0.0 110.764 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.69 -10.96 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.981 1.312 . . . . 0.0 112.23 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 39.5 m -121.85 139.78 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.791 0.837 . . . . 0.0 109.213 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.06 92.1 6.19 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.499 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.8 mt -69.03 144.14 14.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.916 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.22 100.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.716 0.806 . . . . 0.0 110.003 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 36.0 m-80 54.28 35.29 22.41 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 124.269 0.981 . . . . 0.0 111.756 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -121.54 24.58 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.651 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -27.62 17.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 10.1 tp60 -68.41 -21.7 64.66 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.18 -21.37 45.72 Favored Glycine 0 N--CA 1.471 1.023 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.423 HG21 HG23 ' A' ' 59' ' ' VAL . 56.7 mt -83.46 107.78 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.116 0.567 . . . . 0.0 110.139 -173.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.49 98.01 5.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.45 0.7 . . . . 0.0 110.927 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -75.22 151.7 38.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.037 0.535 . . . . 0.0 111.646 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.84 86.36 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 165.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.67 147.84 45.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.0 t -109.17 -179.3 3.81 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -176.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -77.1 -2.83 36.24 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.506 0.722 . . . . 0.0 111.59 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' H ' HG23 ' A' ' 48' ' ' THR . 40.1 tt0 -89.03 -19.12 26.04 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.684 1.194 . . . . 0.0 110.043 172.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 45.89 5.98 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.732 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -144.4 157.22 56.55 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 124.24 1.016 . . . . 0.0 109.923 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.89 135.97 73.79 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.436 2.091 . . . . 0.0 111.348 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -100.12 36.94 1.74 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.479 1.111 . . . . 0.0 110.495 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.29 -40.49 2.88 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.562 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.31 155.18 19.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 110.985 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 161.62 42.37 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 109.261 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -120.8 113.37 20.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.246 1.018 . . . . 0.0 108.616 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.423 HG23 HG21 ' A' ' 43' ' ' ILE . 77.9 t -107.47 121.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.0 0.92 . . . . 0.0 108.823 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' A' ' 12' ' ' VAL . 29.4 mt-10 -86.09 156.41 20.39 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.048 0.539 . . . . 0.0 109.795 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD11 HG22 ' A' ' 67' ' ' VAL . 3.6 mp -138.21 156.71 47.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.937 0.895 . . . . 0.0 109.681 -176.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.18 -26.47 47.61 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.937 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.8 m -145.59 153.72 41.37 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -31.28 72.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.58 1.152 . . . . 0.0 111.158 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.11 -49.13 77.14 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.19 0.519 . . . . 0.0 110.097 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -58.06 -35.22 71.04 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.795 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 HD11 ' A' ' 61' ' ' LEU . 79.3 t -61.62 -50.22 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -56.75 -36.98 70.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.668 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.45 -42.3 87.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.362 0.665 . . . . 0.0 111.035 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -61.78 -40.19 94.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.801 0.84 . . . . 0.0 111.024 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 81.1 mt -61.62 -23.5 66.08 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.25 1.02 . . . . 0.0 112.547 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.25 -4.85 56.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.618 0.367 . . . . 0.0 111.776 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.68 4.94 49.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.062 0.945 . . . . 0.0 111.781 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.511 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 26.8 t70 -38.83 -12.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 170.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -144.78 -11.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.134 -0.979 . . . . 0.0 111.553 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -52.12 139.73 22.59 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.146 0.978 . . . . 0.0 111.708 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.8 p -93.01 127.71 38.62 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.945 0.898 . . . . 0.0 112.435 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -94.02 102.64 14.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.88 -90.2 0.32 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.51 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -120.43 -4.32 9.88 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.102 0.961 . . . . 0.0 111.354 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -124.75 147.88 48.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.615 0.366 . . . . 0.0 110.849 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -79.91 141.29 36.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.39 123.84 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 34.9 mt-10 -95.46 129.02 42.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.247 1.019 . . . . 0.0 108.977 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.511 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 27.8 t -127.01 118.53 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -113.87 177.67 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -111.89 128.8 56.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.1 m -122.9 -166.31 1.43 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.15 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -136.46 161.46 35.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 25.7 t-20 -63.21 -35.12 79.28 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.75 -41.92 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.185 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -62.96 -51.75 65.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.156 0.982 . . . . 0.0 110.518 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.475 ' HB2' HG11 ' A' ' 12' ' ' VAL . 10.9 tmm? -57.62 -50.52 72.88 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.25 1.42 . . . . 0.0 111.183 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.31 -39.51 92.59 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.526 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -61.2 -50.9 71.25 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 0.0 111.504 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 103' ' ' ASN . 22.5 t -68.19 -39.1 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.484 0.49 . . . . 0.0 111.376 -177.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 93' ' ' MET . 94.0 mt -65.41 -29.27 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.296 0.238 . . . . 0.0 111.383 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -86.67 -33.16 20.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.442 0.697 . . . . 0.0 110.62 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -150.94 92.9 1.87 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.969 1.308 . . . . 0.0 108.294 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 p -65.46 102.92 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.72 -167.37 10.96 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.79 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.8 112.74 2.76 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.679 2.253 . . . . 0.0 110.902 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.444 HD22 HG21 ' A' ' 96' ' ' VAL . 23.2 m120 -59.23 99.54 0.06 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.9 p -60.8 109.77 2.37 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 124.316 1.01 . . . . 0.0 109.016 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.48 148.43 73.03 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.624 2.216 . . . . 0.0 112.051 -173.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.44 -29.39 70.48 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.725 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 m 62.59 28.0 16.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.448 1.099 . . . . 0.0 111.091 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.78 88.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.37 0.668 . . . . 0.0 110.519 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 57.18 32.35 21.56 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 124.49 1.118 . . . . 0.0 110.412 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.36 -40.34 67.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.554 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.093 172.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.546 0.788 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -127.44 9.08 6.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.594 0.758 . . . . 0.0 109.491 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.3 mmt -95.84 10.64 36.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 0.0 110.167 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.45 -91.77 1.68 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -172.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.35 7.67 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.987 -0.149 . . . . 0.0 112.995 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -79.96 76.12 6.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.121 0.962 . . . . 0.0 109.506 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.8 175.84 20.06 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.399 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -87.53 1.47 53.45 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.432 0.693 . . . . 0.0 111.601 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.36 138.65 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.828 0.851 . . . . 0.0 109.959 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -107.37 162.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.201 0.601 . . . . 0.0 110.32 165.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 38.4 ttpt -113.6 120.63 41.58 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.5 118.36 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -122.1 147.7 45.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.423 1.489 . . . . 0.0 107.188 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.5 20.0 21.15 Favored Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.5 mt -92.74 117.01 67.41 Favored Pre-proline 0 C--O 1.244 0.781 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.147 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.72 157.74 7.12 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.017 2.478 . . . . 0.0 113.222 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -61.96 -18.78 61.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.604 0.762 . . . . 0.0 112.285 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 m -110.97 14.7 22.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.746 0.819 . . . . 0.0 112.168 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.64 170.67 6.02 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.205 0.457 . . . . 0.0 111.303 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -139.73 156.11 46.97 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.116 0.566 . . . . 0.0 109.492 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.25 84.28 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.828 0.705 . . . . 0.0 110.721 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.8 m-20 -53.8 -42.61 68.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.516 0.726 . . . . 0.0 112.563 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.98 -39.96 95.32 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.115 0.566 . . . . 0.0 111.876 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.2 t -68.61 -35.23 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.54 0.736 . . . . 0.0 110.096 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -65.38 -40.54 93.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.303 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 70.6 mtp180 -59.99 -47.15 87.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.187 0.595 . . . . 0.0 111.045 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.93 -34.16 74.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.475 0.71 . . . . 0.0 111.488 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.721 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 63.2 m-85 -108.35 24.9 12.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.693 0.797 . . . . 0.0 111.655 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.2 p -74.16 90.61 2.06 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.7 t70 166.08 -53.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -160.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.721 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 16.8 p -76.68 -175.56 3.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.451 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 33.3 mmtp -129.17 96.11 4.23 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' HA ' HD22 ' A' ' 61' ' ' LEU . 24.4 mt -76.45 139.04 19.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -66.06 110.28 2.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.955 0.902 . . . . 0.0 110.31 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 85.9 m-20 60.04 31.52 20.66 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.903 0.881 . . . . 0.0 111.179 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 -125.24 34.09 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.699 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.9 -24.21 22.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.035 0.934 . . . . 0.0 113.46 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 6.9 tp60 -71.33 -18.05 62.41 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.694 0.397 . . . . 0.0 112.053 -176.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.67 -18.29 58.64 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.63 -0.259 . . . . 0.0 112.625 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.453 HD13 ' HB ' ' A' ' 27' ' ' VAL . 54.5 mt -85.18 110.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.0 109.675 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -123.24 99.7 6.48 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.553 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -78.31 138.83 38.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.953 0.501 . . . . 0.0 110.417 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.56 99.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.26 153.85 28.24 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.826 0.346 . . . . 0.0 110.707 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.6 p -87.03 -172.95 4.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.603 0.761 . . . . 0.0 109.515 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -76.65 -0.12 22.3 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.675 0.39 . . . . 0.0 111.568 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -101.55 -20.73 14.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.033 0.933 . . . . 0.0 109.462 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.21 45.14 4.51 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.29 138.91 26.12 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.18 0.992 . . . . 0.0 109.234 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.08 120.91 8.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.66 2.24 . . . . 0.0 111.168 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.6 m -82.91 25.35 0.68 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.049 0.94 . . . . 0.0 112.064 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.41 -33.43 4.12 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.159 0.409 . . . . 0.0 112.476 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -111.18 156.08 21.95 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.592 1.157 . . . . 0.0 110.761 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.68 169.39 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.058 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -121.69 115.98 23.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.765 0.826 . . . . 0.0 109.472 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.89 112.51 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -84.02 141.9 30.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.797 0.839 . . . . 0.0 109.015 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 HD22 ' HA ' ' A' ' 36' ' ' ILE . 39.7 mt -131.54 165.27 23.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.919 0.887 . . . . 0.0 110.22 -168.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.88 -39.73 87.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.406 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 t -164.74 174.79 10.32 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.818 0.447 . . . . 0.0 110.122 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 7.6 pt-20 -60.54 -27.71 67.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.167 0.987 . . . . 0.0 112.57 -174.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.35 -50.93 41.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 14.3 mp0 -51.59 -37.24 48.98 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.313 1.045 . . . . 0.0 111.637 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 44.3 t -60.11 -52.51 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.369 172.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -57.3 -40.09 77.09 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.62 0.768 . . . . 0.0 111.948 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.427 HD12 ' HA ' ' A' ' 66' ' ' GLU . 86.1 mt -58.64 -45.34 89.5 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.997 0.919 . . . . 0.0 110.641 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.36 84.49 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.478 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 92.1 mt -58.35 -37.13 74.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.679 1.192 . . . . 0.0 112.096 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -72.4 -5.66 38.09 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -98.98 9.61 43.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.252 1.021 . . . . 0.0 112.774 172.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.76 10.01 0.15 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -123.02 -23.18 5.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.31 0.644 . . . . 0.0 110.781 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.27 148.18 45.75 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.776 0.798 . . . . 0.0 112.216 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -99.79 137.79 37.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.309 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.2 ttt -142.59 111.42 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.614 1.166 . . . . 0.0 109.114 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.2 58.25 7.55 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.041 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 t60 71.89 -7.49 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 125.073 1.349 . . . . 0.0 112.809 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -116.85 149.59 39.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.518 1.127 . . . . 0.0 110.162 -172.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -80.78 138.89 36.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.51 123.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -95.26 119.48 33.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.7 t -113.2 114.14 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.4 m-85 -103.39 171.81 7.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.609 1.164 . . . . 0.0 110.355 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -97.14 104.57 16.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -106.2 -171.7 1.95 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.015 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.85 163.44 34.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.732 1.213 . . . . 0.0 108.934 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -61.13 -38.39 86.22 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.15 -49.44 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.161 -1.382 . . . . 0.0 110.521 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.81 -42.42 95.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.1 ttp -52.58 -56.86 12.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.066 0.946 . . . . 0.0 111.554 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.86 -46.0 80.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.901 0.751 . . . . 0.0 111.759 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -69.19 -44.93 71.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.202 0.601 . . . . 0.0 112.543 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.09 -42.65 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 122.673 0.389 . . . . 0.0 110.656 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -38.74 85.49 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.195 0.598 . . . . 0.0 110.188 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.57 -18.78 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.681 0.793 . . . . 0.0 109.984 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -90.64 -4.91 56.45 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.315 0.646 . . . . 0.0 109.288 172.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.5 p 57.74 22.31 8.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.9 2.08 . . . . 0.0 112.723 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.61 148.79 4.82 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.37 124.85 6.05 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.327 2.018 . . . . 0.0 112.287 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.71 -5.02 56.48 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.521 0.729 . . . . 0.0 110.711 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.6 m 75.29 144.44 0.1 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.856 1.662 . . . . 0.0 110.931 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.74 99.95 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.617 2.211 . . . . 0.0 111.675 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.71 -38.36 88.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.251 -169.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.4 p -76.53 97.75 4.44 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.78 64.51 1.24 Allowed 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -104.14 111.19 23.68 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.149 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.34 121.79 28.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -175.841 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.7 m170 71.68 143.91 0.06 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.277 1.431 . . . . 0.0 110.307 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.8 ttt -100.27 126.18 46.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.05 60.4 4.45 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.07 -36.99 86.88 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 53.35 37.66 25.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.287 1.435 . . . . 0.0 112.955 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -62.37 139.41 45.73 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.142 173.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.01 4.64 4.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.073 0.549 . . . . 0.0 112.339 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -98.97 138.56 23.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.775 1.23 . . . . 0.0 109.247 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -108.75 173.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.768 0.827 . . . . 0.0 109.121 165.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 18.1 ptpt -121.53 129.54 52.97 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.69 117.55 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.12 158.24 18.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -172.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 73.25 32.65 59.95 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 121.464 0.48 . . . . 0.0 112.874 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.25 133.42 38.72 Favored Pre-proline 0 C--O 1.243 0.736 0 C-N-CA 123.753 0.821 . . . . 0.0 109.041 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -54.7 145.44 60.04 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.71 2.274 . . . . 0.0 112.468 170.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -58.7 -30.52 67.47 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.158 0.983 . . . . 0.0 111.011 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.6 p -105.81 20.05 19.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.461 1.104 . . . . 0.0 111.64 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -68.65 169.99 10.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.333 0.653 . . . . 0.0 111.009 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.2 p -126.39 156.92 39.78 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -35.2 67.42 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.441 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.14 -40.32 70.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.78 1.232 . . . . 0.0 112.957 173.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -64.35 -40.11 95.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.336 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.556 ' HB ' HD13 ' A' ' 43' ' ' ILE . 46.7 t -76.77 -26.12 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' NE2' HD12 ' A' ' 36' ' ' ILE . 15.5 mm-40 -64.07 -53.6 47.15 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.256 1.023 . . . . 0.0 110.134 173.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -58.65 -46.92 86.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.158 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -68.17 -44.27 76.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.076 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -97.24 36.22 1.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.738 0.815 . . . . 0.0 110.301 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 p -59.58 -23.37 62.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.164 0.585 . . . . 0.0 112.295 173.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.05 -49.96 73.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.409 0.684 . . . . 0.0 110.331 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 34.2 m -82.92 131.57 35.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.619 -172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -79.54 105.23 10.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.461 HD12 ' NE2' ' A' ' 28' ' ' GLN . 47.3 mt -83.77 147.19 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.508 0.723 . . . . 0.0 109.44 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -41.73 -70.18 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 126.512 1.925 . . . . 0.0 114.172 -166.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -118.71 48.02 1.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 168.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.97 -120.5 23.02 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.515 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.511 ' HA ' HD11 ' A' ' 43' ' ' ILE . . . -62.5 -31.41 72.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.629 0.772 . . . . 0.0 112.068 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.94 -19.66 58.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.452 0.701 . . . . 0.0 111.222 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -16.01 79.67 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.661 -0.245 . . . . 0.0 112.795 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.556 HD13 ' HB ' ' A' ' 27' ' ' VAL . 66.1 mt -85.55 127.92 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.225 1.01 . . . . 0.0 109.545 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' NH1' ' SD ' ' A' ' 93' ' ' MET . 55.1 mtt180 -130.66 98.74 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 109.786 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.29 142.94 43.2 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.744 0.418 . . . . 0.0 110.489 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.66 HD12 ' HG2' ' A' ' 56' ' ' GLU . 61.4 mt -86.31 90.6 3.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -72.37 156.27 39.26 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.825 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.7 p -84.63 -173.17 4.58 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.552 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -63.89 -17.65 63.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' HB3' ' NH2' ' A' ' 52' ' ' ARG . 70.7 mm-40 -88.52 -5.92 57.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.777 1.231 . . . . 0.0 111.468 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.47 63.43 Favored Glycine 0 C--N 1.352 1.436 0 O-C-N 123.429 0.456 . . . . 0.0 113.268 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.491 ' NH2' ' HB3' ' A' ' 50' ' ' GLU . 48.8 mtm180 -137.85 139.59 26.88 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 110.013 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.77 128.6 29.12 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.288 2.659 . . . . 0.0 112.045 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -74.84 -68.18 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.45 -11.94 0.02 OUTLIER Glycine 0 N--CA 1.474 1.187 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.108 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.66 ' HG2' HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -128.95 168.24 16.27 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 111.225 177.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.472 ' HA ' HG13 ' A' ' 46' ' ' ILE . . . -152.91 172.02 17.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.976 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.401 ' HE2' ' HB3' ' A' ' 88' ' ' SER . 48.6 m-85 -120.75 122.04 39.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 0.0 109.064 166.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.527 HG23 HG23 ' A' ' 43' ' ' ILE . 81.1 t -116.25 117.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.064 0.946 . . . . 0.0 108.521 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 33.1 tt0 -86.34 147.26 26.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 83.4 mt -130.01 156.14 44.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.172 0.989 . . . . 0.0 110.347 -169.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.32 -26.21 64.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.064 0.946 . . . . 0.0 111.551 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 74.4 m -148.53 160.64 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.557 0.743 . . . . 0.0 110.278 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.75 -15.14 61.67 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.262 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 22.9 t70 -72.22 -38.88 68.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.886 0.474 . . . . 0.0 110.304 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 22.4 mm-40 -61.18 -33.47 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.96 169.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.464 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 54.5 t -63.11 -37.19 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.075 0.55 . . . . 0.0 110.004 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 67.9 mmtt -57.98 -48.44 79.99 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.829 0.452 . . . . 0.0 111.036 171.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.1 -26.24 68.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.659 0.784 . . . . 0.0 112.07 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -78.2 -45.24 23.57 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.523 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 55.9 mt -67.03 -28.73 68.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -78.12 -15.34 58.95 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.005 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -87.3 -8.22 56.96 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.736 1.215 . . . . 0.0 110.804 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.3 93.15 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.584 0.754 . . . . 0.0 108.988 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 154.12 -53.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.721 2.008 . . . . 0.0 108.869 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.14 141.63 22.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 113.397 -167.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.4 p -83.28 126.18 32.4 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.26 1.024 . . . . 0.0 112.385 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.2 tpp -82.64 85.9 6.93 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.44 -75.9 0.66 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -114.33 -45.2 3.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.082 0.953 . . . . 0.0 109.669 171.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -67.06 -145.85 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.422 1.489 . . . . 0.0 112.092 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.491 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 32.5 t80 -160.98 120.54 2.64 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.837 -1.164 . . . . 0.0 108.388 -158.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 98.4 t -99.41 130.23 48.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 123.573 0.749 . . . . 0.0 110.381 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.85 121.59 40.35 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -118.36 122.91 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -119.37 142.43 48.17 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.423 ' HB2' HD13 ' A' ' 71' ' ' LEU . 19.5 ttmm -57.9 116.79 3.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.859 0.863 . . . . 0.0 109.762 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.401 ' HB3' ' HE2' ' A' ' 58' ' ' PHE . 20.1 m -114.55 -174.28 2.45 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.482 0.658 . . . . 0.0 110.921 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.502 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 45.5 t-20 -131.62 152.0 51.17 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.37 -33.01 74.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.304 0.642 . . . . 0.0 109.919 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.0 -48.21 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.611 1.164 . . . . 0.0 110.249 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.46 -34.82 74.94 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.676 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' ' NH1' ' A' ' 44' ' ' ARG . 54.9 ttp -57.35 -55.19 37.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.865 0.866 . . . . 0.0 110.935 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.05 -39.86 93.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.769 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 44.0 t90 -57.33 -42.68 82.37 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.171 0.92 . . . . 0.0 111.714 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 100' ' ' THR . 84.0 t -80.96 -40.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.42 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.69 -17.34 63.47 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.692 -0.63 . . . . 0.0 111.482 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -68.9 -39.42 79.73 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.034 0.933 . . . . 0.0 112.304 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -179.78 55.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.344 0.657 . . . . 0.0 109.427 -168.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 57.7 p 49.67 -173.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.412 1.485 . . . . 0.0 112.278 -174.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.64 93.49 0.95 Allowed Glycine 0 N--CA 1.463 0.461 0 CA-C-O 118.6 -1.111 . . . . 0.0 110.843 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -58.68 102.86 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.374 2.049 . . . . 0.0 110.909 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -68.47 105.29 2.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.976 0.91 . . . . 0.0 109.727 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.5 p -116.98 87.82 23.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.916 0.886 . . . . 0.0 108.936 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.55 -166.86 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.203 2.602 . . . . 0.0 111.812 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 67.17 3.0 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.445 1.098 . . . . 0.0 112.919 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -83.76 86.9 7.07 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.1 159.24 21.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.531 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.81 108.02 6.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.333 0.653 . . . . 0.0 110.051 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -77.6 120.3 22.36 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.026 -177.339 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 60.78 79.17 0.25 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 109.397 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.06 -16.42 59.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.85 1.26 . . . . 0.0 111.94 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' HA3' HD22 ' A' ' 89' ' ' ASN . . . 115.58 -85.41 0.39 Allowed Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.74 -68.3 2.52 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -61.32 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.404 1.082 . . . . 0.0 111.054 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.89 106.32 0.19 Allowed Glycine 0 C--N 1.343 0.961 0 C-N-CA 121.762 -0.256 . . . . 0.0 112.702 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -101.54 26.89 6.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.445 HG22 ' HG2' ' A' ' 60' ' ' GLU . 17.3 t -114.65 145.15 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 108.549 -174.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.22 175.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.497 0.719 . . . . 0.0 109.82 162.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.713 ' HZ3' ' HB3' ' A' ' 105' ' ' PRO . 6.4 ptpp? -127.58 140.31 52.2 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 3.4 t -113.52 113.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -174.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -112.22 147.2 36.71 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 81' ' ' ARG . . . 90.32 27.42 20.56 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 121.407 0.448 . . . . 0.0 112.394 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.39 146.1 46.78 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 123.737 0.815 . . . . 0.0 109.304 172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HD3' ' HG3' ' A' ' 81' ' ' ARG . 1.3 Cg_endo -51.47 149.83 16.96 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.337 2.025 . . . . 0.0 111.872 165.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -59.83 -26.49 65.85 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.471 0.708 . . . . 0.0 111.964 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -119.13 36.9 4.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.227 1.011 . . . . 0.0 109.74 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.27 151.1 48.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.674 0.389 . . . . 0.0 110.347 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.7 t -111.13 146.41 36.89 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.576 0.75 . . . . 0.0 109.047 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -34.4 66.62 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.66 0.6 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 11.2 m-20 -54.98 -49.35 71.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.867 0.867 . . . . 0.0 112.261 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 12.2 mm-40 -69.25 -34.39 74.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.893 0.477 . . . . 0.0 111.101 -174.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.36 -37.9 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.202 0.601 . . . . 0.0 109.711 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.24 -44.49 88.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.151 0.98 . . . . 0.0 111.266 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 29.6 mmt85 -62.39 -39.84 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.477 0.711 . . . . 0.0 110.839 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -38.18 87.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.466 0.707 . . . . 0.0 110.045 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.668 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 59.1 m-85 -101.43 28.75 5.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.239 0.615 . . . . 0.0 112.019 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 t -80.98 83.25 6.74 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 171.22 -39.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.884 1.274 . . . . 0.0 108.268 -161.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 23.4 p -114.92 127.44 55.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.843 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.61 100.47 6.15 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.295 0.638 . . . . 0.0 109.598 -171.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.591 ' HA ' HD22 ' A' ' 61' ' ' LEU . 45.9 mt -74.05 127.6 35.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.338 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.04 121.15 13.45 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.111 0.882 . . . . 0.0 109.377 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 69.28 12.59 8.42 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.944 1.298 . . . . 0.0 112.056 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.27 -134.17 42.51 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.82 -19.57 64.2 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.489 0.716 . . . . 0.0 112.309 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -73.74 -16.93 61.16 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.149 0.58 . . . . 0.0 112.091 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.63 -6.39 76.98 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 123.533 0.52 . . . . 0.0 112.424 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.515 HG12 HG23 ' A' ' 59' ' ' VAL . 51.5 mt -92.05 123.69 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 110.686 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -132.4 105.62 7.39 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.926 1.29 . . . . 0.0 109.366 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -68.6 143.65 54.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.3 93.75 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.1 134.4 37.72 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.635 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p -75.64 -172.03 1.74 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.53 0.732 . . . . 0.0 110.95 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.2 -20.4 66.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -91.4 0.98 57.44 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.851 0.86 . . . . 0.0 110.396 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.22 71.04 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -107.94 134.49 20.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.493 0.717 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.54 121.34 9.87 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.562 2.175 . . . . 0.0 111.179 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.0 p -73.04 -8.85 57.59 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.8 0.84 . . . . 0.0 112.224 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.15 54.81 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -169.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 10.1 mp0 -109.15 154.22 22.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.498 1.119 . . . . 0.0 109.535 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.07 169.43 21.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 110.469 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.03 127.55 53.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.797 1.239 . . . . 0.0 109.125 165.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.515 HG23 HG12 ' A' ' 43' ' ' ILE . 55.3 t -118.12 119.75 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 12' ' ' VAL . 44.0 mt-10 -79.87 146.47 32.18 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.591 HD22 ' HA ' ' A' ' 36' ' ' ILE . 71.8 mt -136.13 136.55 40.17 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.04 -10.59 41.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -167.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 66' ' ' GLU . 97.1 p -153.51 161.42 42.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.324 0.649 . . . . 0.0 110.433 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 37.1 tt0 -71.41 -16.93 62.42 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.454 0.702 . . . . 0.0 111.056 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.41 -48.66 55.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.437 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 41.3 mm-40 -54.08 -34.99 61.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 123.831 0.707 . . . . 0.0 111.829 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 37.6 t -60.75 -49.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.05 0.54 . . . . 0.0 110.738 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 92.3 mttt -59.76 -36.75 77.29 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.584 0.754 . . . . 0.0 112.167 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 93.6 mt -63.48 -43.99 95.71 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.43 0.692 . . . . 0.0 111.444 174.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.6 -46.8 86.24 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.004 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD11 ' HB2' ' A' ' 87' ' ' LYS . 82.6 mt -62.77 -30.67 71.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.301 1.041 . . . . 0.0 112.984 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 20.0 ptmt -78.67 -13.01 60.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 120.72 0.295 . . . . 0.0 110.783 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.22 3.78 54.79 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.831 0.852 . . . . 0.0 111.08 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 90.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.384 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 164.44 -52.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.863 1.265 . . . . 0.0 111.224 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.83 169.97 16.85 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.435 0.636 . . . . 0.0 112.674 -165.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -113.12 139.23 48.9 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.371 -162.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -103.15 67.54 0.94 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.947 1.299 . . . . 0.0 108.859 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.15 58.12 3.26 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.799 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.0 m80 72.62 -7.71 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.684 1.594 . . . . 0.0 112.763 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.477 ' HG3' ' HD3' ' A' ' 19' ' ' PRO . 23.0 mmt180 -77.98 104.87 8.81 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -66.16 112.38 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.51 133.26 47.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.96 130.43 55.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 108.86 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.93 116.27 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.47 137.7 54.79 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 71' ' ' LEU . 77.9 tttt -67.2 136.28 54.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -121.3 155.96 33.58 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.063 0.945 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.401 HD22 ' HA3' ' A' ' 7' ' ' GLY . 23.2 m120 -91.58 158.68 16.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.3 175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -66.07 -30.71 71.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -44.5 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.885 1.274 . . . . 0.0 110.643 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.415 ' O ' HG21 ' A' ' 96' ' ' VAL . 55.1 tt0 -69.53 -45.55 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.234 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 58.1 ttp -55.44 -45.88 76.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.785 0.834 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.73 -51.86 68.17 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.367 1.067 . . . . 0.0 110.183 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -56.09 -53.52 56.06 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.079 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.417 HG11 ' H ' ' A' ' 101' ' ' GLY . 38.2 t -74.43 -36.34 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.33 0.652 . . . . 0.0 112.195 -169.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.26 -33.62 71.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.645 0.26 . . . . 0.0 110.899 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -89.65 -24.47 21.63 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.767 0.827 . . . . 0.0 111.362 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -148.41 93.41 2.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.421 1.088 . . . . 0.0 108.153 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.2 p -53.59 101.86 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.513 1.125 . . . . 0.0 112.886 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.417 ' H ' HG11 ' A' ' 96' ' ' VAL . . . 172.51 94.75 0.1 OUTLIER Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.944 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.72 96.64 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.045 2.496 . . . . 0.0 111.739 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.96 -61.84 1.83 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.76 0.824 . . . . 0.0 110.889 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -162.33 129.54 2.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.88 0.472 . . . . 0.0 109.951 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.713 ' HB3' ' HZ3' ' A' ' 14' ' ' LYS . 69.3 Cg_endo -68.8 170.6 15.04 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.443 2.095 . . . . 0.0 111.679 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.16 98.28 0.22 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.3 p -77.05 98.31 4.95 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.027 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.27 83.63 0.25 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.196 0.598 . . . . 0.0 110.177 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.435 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.0 OUTLIER -61.85 131.47 49.88 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.109 0.964 . . . . 0.0 111.362 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.43 119.69 30.77 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 119.35 -0.694 . . . . 0.0 111.383 -179.147 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 58.61 -163.87 0.2 Allowed 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.176 0.99 . . . . 0.0 110.221 -173.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 9' ' ' GLU . 28.2 ttt -74.31 88.3 2.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.43 114.02 6.16 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.695 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.96 22.6 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.829 0.252 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.495 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -62.37 124.36 20.69 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.642 ' HA3' ' HB2' ' A' ' 90' ' ' ASN . . . 69.52 -0.4 19.06 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-O 119.429 -0.65 . . . . 0.0 114.633 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 58.97 47.51 12.12 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.956 1.302 . . . . 0.0 112.128 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 t -108.43 139.04 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 109.861 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.5 178.36 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.514 0.726 . . . . 0.0 110.025 167.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -134.95 125.39 26.56 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.01 129.13 69.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 124.068 0.947 . . . . 0.0 108.806 -166.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.55 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -123.1 153.1 40.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.345 1.058 . . . . 0.0 108.178 -172.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.15 22.52 35.03 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.68 110.82 47.84 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.96 150.65 22.78 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.893 2.395 . . . . 0.0 113.468 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.7 p90 -55.31 -31.49 61.69 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 111.632 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 t -108.78 24.92 12.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.636 0.775 . . . . 0.0 111.128 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -78.96 176.88 9.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.446 0.698 . . . . 0.0 110.23 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.606 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 44.9 t -128.63 152.26 48.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.458 0.703 . . . . 0.0 109.396 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.29 70.18 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.056 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.61 -42.13 82.68 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.92 0.888 . . . . 0.0 112.081 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 32.7 mm-40 -64.09 -45.28 89.38 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.755 0.659 . . . . 0.0 110.496 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.409 ' HB ' HD12 ' A' ' 43' ' ' ILE . 43.8 t -68.99 -38.13 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.732 0.813 . . . . 0.0 110.495 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.493 ' HG3' ' HB1' ' A' ' 40' ' ' ALA . 24.7 tm0? -63.91 -51.54 64.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.136 0.974 . . . . 0.0 110.033 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 -63.33 -41.39 98.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.848 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.1 -40.92 95.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.827 0.851 . . . . 0.0 111.053 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 47.0 m-85 -88.06 37.05 0.79 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.777 0.831 . . . . 0.0 111.44 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 t -77.04 82.2 3.55 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 172.23 -39.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.265 1.426 . . . . 0.0 107.871 -162.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.29 169.91 8.27 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.269 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -117.82 85.87 2.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HA ' HD23 ' A' ' 61' ' ' LEU . 32.7 mt -65.28 126.18 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -42.31 -68.21 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.928 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -104.53 41.3 1.34 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.159 0.584 . . . . 0.0 110.477 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.77 -137.17 36.37 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HB1' ' HG3' ' A' ' 28' ' ' GLN . . . -70.0 -4.59 21.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 117.739 0.77 . . . . 0.0 112.375 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -83.52 -1.5 53.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.218 0.607 . . . . 0.0 111.326 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.04 5.29 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 ' HB ' ' A' ' 27' ' ' VAL . 69.0 mt -131.86 105.31 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.038 0.935 . . . . 0.0 109.218 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.2 95.34 5.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.327 1.051 . . . . 0.0 110.318 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.08 124.15 21.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.564 HD13 ' HG3' ' A' ' 56' ' ' GLU . 71.1 mt -70.97 90.98 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -76.73 142.6 40.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.855 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.2 p -75.9 -177.09 3.68 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.842 0.857 . . . . 0.0 110.084 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.8 -8.97 48.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.7 14.1 22.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.97 0.908 . . . . 0.0 110.294 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.35 36.25 91.38 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -114.15 134.42 22.21 Favored Pre-proline 0 N--CA 1.484 1.243 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.794 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.71 127.52 22.85 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.293 1.995 . . . . 0.0 110.953 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 t -81.28 21.88 0.72 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.864 0.866 . . . . 0.0 111.565 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.26 -6.62 75.34 Favored Glycine 0 C--N 1.353 1.514 0 C-N-CA 123.186 0.422 . . . . 0.0 112.966 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.564 ' HG3' HD13 ' A' ' 46' ' ' ILE . 11.7 pt-20 -139.32 169.77 17.17 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.41 28.15 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.81 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -108.47 136.64 47.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.95 114.94 44.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.94 148.16 32.74 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 36' ' ' ILE . 77.1 mt -133.62 170.94 14.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.757 0.823 . . . . 0.0 110.205 -173.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.79 -39.47 61.7 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.02 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 t -160.42 174.11 14.61 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.32 -13.3 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.928 0.491 . . . . 0.0 111.596 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.81 -40.93 88.23 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.679 0.752 . . . . 0.0 109.706 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -62.29 -40.96 97.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.91 169.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.492 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 58.0 t -60.47 -53.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 123.526 0.516 . . . . 0.0 110.93 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.34 -39.03 66.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.8 mt -73.79 -36.01 64.97 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.262 0.625 . . . . 0.0 111.663 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 85' ' ' VAL . . . -57.21 -49.29 76.45 Favored 'General case' 0 CA--C 1.55 0.977 0 O-C-N 123.799 0.687 . . . . 0.0 109.875 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 42.7 mt -59.74 -44.56 93.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.622 0.769 . . . . 0.0 111.644 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.653 ' HZ2' ' HB3' ' A' ' 73' ' ' LYS . 1.7 pptp? -70.64 -26.28 63.39 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.564 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.653 ' HB3' ' HZ2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -90.08 20.46 4.28 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.041 -178.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.88 -23.32 55.6 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.78 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -57.81 -43.6 85.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.761 0.824 . . . . 0.0 110.892 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.45 178.61 5.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.521 1.128 . . . . 0.0 113.361 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 p -112.88 136.74 52.19 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.678 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.6 tpt -57.54 -66.2 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.214 1.006 . . . . 0.0 109.546 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.55 -33.95 0.47 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 164.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -146.46 -46.06 0.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.904 0.882 . . . . 0.0 109.083 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -61.85 135.22 57.49 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.7 0.8 . . . . 0.0 110.759 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 126.72 31.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.32 116.64 28.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -95.57 117.28 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.465 HG13 ' HB3' ' A' ' 70' ' ' ALA . 23.2 t -115.98 114.85 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -108.76 132.96 53.46 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.178 0.991 . . . . 0.0 109.878 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -59.96 110.61 1.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.078 0.951 . . . . 0.0 109.91 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 m -116.37 -168.26 1.41 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.385 0.674 . . . . 0.0 110.542 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -140.26 156.87 46.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.544 1.137 . . . . 0.0 108.587 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.642 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 20.9 t-20 -71.22 -32.17 68.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 0.0 109.949 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -55.66 -47.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.171 0.988 . . . . 0.0 109.909 170.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.533 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 14.8 tp10 -68.2 -49.78 58.6 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.115 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -54.35 -49.28 70.15 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.589 1.155 . . . . 0.0 111.24 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.68 -42.11 95.59 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.009 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -63.51 -37.24 86.55 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 124.163 0.914 . . . . 0.0 110.809 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.1 t -78.3 -30.15 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 122.83 0.452 . . . . 0.0 111.435 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.77 -16.68 61.16 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.397 -0.815 . . . . 0.0 111.083 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -94.11 -33.59 13.29 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.855 0.862 . . . . 0.0 110.633 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -134.21 83.51 2.04 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.4 p -70.2 76.76 0.52 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 0.0 111.881 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.65 71.61 0.27 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.32 100.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.872 2.381 . . . . 0.0 112.475 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -94.91 -14.97 24.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 110.355 169.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m 75.17 148.26 0.12 Allowed Pre-proline 0 C--N 1.367 1.365 0 C-N-CA 125.766 1.626 . . . . 0.0 111.545 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.533 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 89.5 Cg_endo -79.74 -24.43 6.1 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.08 1.853 . . . . 0.0 111.866 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t70 55.97 81.69 0.12 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.978 1.311 . . . . 0.0 109.645 -173.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.9 p -83.32 59.7 5.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.02 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.03 91.14 3.06 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -77.31 85.03 3.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.495 -173.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.0 -32.13 56.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.145 0.978 . . . . 0.0 110.221 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.818 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -60.16 124.45 20.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.171 0.988 . . . . 0.0 110.245 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 13.8 tpt 76.74 -59.49 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 126.148 1.779 . . . . 0.0 110.308 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.61 -72.68 0.25 Allowed Glycine 0 C--O 1.243 0.669 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -110.82 0.45 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.308 -0.446 . . . . 0.0 113.168 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 59.12 15.21 3.94 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.884 1.674 . . . . 0.0 111.841 -166.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.27 89.11 0.43 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 108.494 -1.843 . . . . 0.0 108.494 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.545 ' HA ' HG23 ' A' ' 67' ' ' VAL . 1.7 p90 -81.0 24.02 0.53 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -167.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG13 ' HB2' ' A' ' 93' ' ' MET . 26.1 t -99.95 132.65 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.36 167.78 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.376 1.07 . . . . 0.0 110.57 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -117.14 126.47 52.86 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 5.1 t -106.13 108.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 107.974 -173.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -119.16 142.45 47.94 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 124.595 1.158 . . . . 0.0 108.939 -167.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.91 27.87 15.38 Favored Glycine 0 N--CA 1.473 1.129 0 CA-C-O 121.627 0.571 . . . . 0.0 111.753 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.42 143.05 33.65 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 123.853 0.861 . . . . 0.0 109.132 174.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.459 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 31.0 Cg_endo -63.92 146.1 91.01 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.916 1.744 . . . . 0.0 110.645 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.588 ' HE1' ' HB3' ' A' ' 52' ' ' ARG . 83.6 t90 -52.41 -45.96 66.1 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.248 1.019 . . . . 0.0 111.212 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 p -92.99 35.28 1.06 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.432 1.093 . . . . 0.0 112.03 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.459 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 14.2 p -73.65 -170.87 0.92 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.224 0.61 . . . . 0.0 110.622 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.579 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 46.4 m -146.46 154.55 41.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.013 0.925 . . . . 0.0 109.012 173.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.25 -38.05 79.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.694 0.798 . . . . 0.0 111.457 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.99 -38.77 87.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.686 0.794 . . . . 0.0 111.371 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 34.2 mm-40 -67.61 -40.86 84.69 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.404 0.681 . . . . 0.0 110.855 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.53 -35.55 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.527 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.34 -45.97 92.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.473 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -63.57 -36.96 85.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.089 0.556 . . . . 0.0 110.901 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -60.13 -39.78 87.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.905 0.482 . . . . 0.0 110.289 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.586 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 67.9 m-85 -90.03 40.17 0.99 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.14 0.576 . . . . 0.0 111.792 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 p -74.51 87.22 2.09 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 166.4 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.339 2.256 . . . . 0.0 106.697 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HG ' ' HB2' ' A' ' 69' ' ' LEU . 18.9 m -89.08 127.76 35.72 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.956 -169.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 94.71 2.96 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.522 ' HA ' HD21 ' A' ' 61' ' ' LEU . 18.5 mt -74.93 147.91 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.855 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.405 ' HG2' ' ND2' ' A' ' 38' ' ' ASN . 28.6 tt0 -39.24 -68.54 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.906 1.682 . . . . 0.0 112.323 -172.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.405 ' ND2' ' HG2' ' A' ' 37' ' ' GLN . 62.9 m-80 -128.57 51.02 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.05 -128.07 33.62 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.193 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.8 66.86 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.715 0.758 . . . . 0.0 112.031 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.33 -17.38 60.26 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.879 0.472 . . . . 0.0 111.413 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 29.25 9.33 Favored Glycine 0 C--N 1.351 1.393 0 O-C-N 123.266 0.353 . . . . 0.0 112.287 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 59' ' ' VAL . 52.7 mt -130.37 131.38 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.149 1.38 . . . . 0.0 108.3 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 103.58 4.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.58 0.752 . . . . 0.0 109.563 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' CE2' ' SG ' ' A' ' 22' ' ' CYS . 64.7 m-85 -69.06 145.7 53.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.276 0.63 . . . . 0.0 110.263 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.492 HD13 ' HG3' ' A' ' 56' ' ' GLU . 45.7 mt -73.7 91.34 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -78.47 146.72 34.27 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.784 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -84.79 -178.83 6.96 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.147 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -75.07 5.17 5.58 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.594 0.358 . . . . 0.0 111.945 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -102.6 -4.64 24.91 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.532 0.733 . . . . 0.0 109.756 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.6 37.95 38.97 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.418 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.588 ' HB3' ' HE1' ' A' ' 20' ' ' TRP . 76.0 mtt180 -120.48 130.68 24.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.983 -173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.7 132.23 41.75 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.083 2.522 . . . . 0.0 112.171 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 p -79.29 12.51 2.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.161 0.985 . . . . 0.0 113.021 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 -6.69 83.38 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HG3' HD13 ' A' ' 46' ' ' ILE . 5.0 pt-20 -133.76 163.08 30.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.0 0.92 . . . . 0.0 111.579 175.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 167.96 24.68 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.687 -170.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -118.8 111.79 18.89 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.845 0.858 . . . . 0.0 110.315 171.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 43' ' ' ILE . 44.4 t -96.53 146.67 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.46 1.104 . . . . 0.0 108.181 171.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HG3' HG22 ' A' ' 12' ' ' VAL . 35.4 tt0 -126.72 144.09 51.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 36' ' ' ILE . 50.8 mt -129.38 146.3 51.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.356 0.662 . . . . 0.0 109.601 -167.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -72.9 -19.05 61.35 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.6 m -147.7 151.47 36.17 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.693 0.797 . . . . 0.0 109.119 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.81 -3.68 51.95 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 120.802 0.334 . . . . 0.0 111.628 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.26 -50.07 73.19 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.36 -31.56 65.89 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.359 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 11' ' ' PHE . 53.2 t -66.14 -41.85 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.163 0.585 . . . . 0.0 110.679 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -57.22 -41.06 78.75 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.739 0.416 . . . . 0.0 110.904 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.418 ' HB2' ' HG ' ' A' ' 34' ' ' CYS . 57.9 mt -68.95 -32.58 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.634 0.774 . . . . 0.0 111.043 176.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.1 -52.55 33.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.951 0.901 . . . . 0.0 110.845 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 76.0 mt -61.03 -28.2 68.88 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.663 1.185 . . . . 0.0 111.387 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.0 -25.28 66.23 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.48 1.112 . . . . 0.0 110.8 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 67.3 mttm -83.76 6.92 19.44 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.186 0.994 . . . . 0.0 113.503 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.47 -2.47 0.5 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -121.01 -24.39 5.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.343 0.657 . . . . 0.0 111.889 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.539 ' HG2' ' HA ' ' A' ' 73' ' ' LYS . 6.6 mm-40 -59.26 148.53 31.58 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.6 p -98.66 126.98 44.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.841 0.856 . . . . 0.0 110.535 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -68.95 -78.48 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.93 89.42 0.29 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 170.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.6 m80 76.35 -54.35 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.056 1.742 . . . . 0.0 111.284 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -70.18 147.16 50.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.923 0.889 . . . . 0.0 111.396 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.25 142.31 28.66 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 108.681 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.0 t -120.14 131.13 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.516 0.726 . . . . 0.0 109.824 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.8 141.84 28.16 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.391 1.477 . . . . 0.0 108.562 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.61 123.25 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -125.1 146.73 49.33 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.332 1.053 . . . . 0.0 108.814 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.448 ' HE2' HG11 ' A' ' 67' ' ' VAL . 39.9 ttmt -68.53 120.73 15.05 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.778 0.323 . . . . 0.0 110.491 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.1 m -86.54 -61.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.833 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.1 t30 83.31 148.07 0.08 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.883 1.673 . . . . 0.0 108.54 -163.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -57.92 -34.33 69.73 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.395 1.078 . . . . 0.0 112.408 -173.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.9 -41.96 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.755 0.822 . . . . 0.0 110.368 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -67.6 -43.67 79.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.777 0.831 . . . . 0.0 110.612 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.477 ' HB2' HG13 ' A' ' 12' ' ' VAL . 16.4 tmm? -54.23 -53.13 57.79 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.061 0.85 . . . . 0.0 110.918 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.6 -51.6 66.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.032 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -63.99 -51.95 61.87 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.122 0.969 . . . . 0.0 111.808 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.88 -48.66 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.429 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.99 -43.14 83.73 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.682 0.614 . . . . 0.0 110.18 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -70.96 -6.48 38.99 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 112.017 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -96.72 -92.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.6 t 170.93 -35.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.235 1.014 . . . . 0.0 110.517 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.39 155.41 16.12 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.115 -0.825 . . . . 0.0 112.842 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.83 137.75 22.54 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.977 2.451 . . . . 0.0 113.444 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -87.09 -20.29 27.32 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.627 0.771 . . . . 0.0 109.578 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.1 m -44.5 118.28 3.24 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.535 1.534 . . . . 0.0 111.958 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.68 79.57 0.91 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.02 87.54 2.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.827 -171.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 p -152.35 95.64 2.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.227 1.411 . . . . 0.0 107.912 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.8 -77.24 0.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 48.11 83.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.884 1.274 . . . . 0.0 112.645 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -123.38 121.71 36.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.495 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.601 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.243 0.726 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 72.99 132.02 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.194 1.398 . . . . 0.0 111.923 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -137.44 174.91 10.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.311 1.044 . . . . 0.0 109.43 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.26 -61.76 1.82 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 108' ' ' ALA . . . 161.1 -112.16 0.51 Allowed Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.976 -0.346 . . . . 0.0 112.777 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 58.9 177.86 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.123 1.369 . . . . 0.0 112.088 -168.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.21 -70.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 58.0 7.71 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.902 1.281 . . . . 0.0 113.701 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.49 133.58 7.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.486 HG12 ' HB3' ' A' ' 70' ' ' ALA . 27.2 m -108.36 163.73 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.319 0.581 . . . . 0.0 110.427 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 104' ' ' SER . 35.3 ttpt -122.15 126.56 48.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 24.1 t -110.15 126.23 67.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 124.672 1.189 . . . . 0.0 108.673 -168.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -133.52 135.48 44.43 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.19 10.2 Favored Glycine 0 N--CA 1.47 0.94 0 O-C-N 123.427 0.454 . . . . 0.0 112.202 -168.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.45 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 88.0 mt -87.18 125.45 66.03 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.01 153.65 56.35 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.005 1.803 . . . . 0.0 111.615 171.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -54.99 -46.65 75.15 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.408 0.683 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -86.15 17.16 3.76 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.443 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 18' ' ' LEU . 18.8 p -86.98 137.98 31.9 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 t -89.27 163.71 15.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.298 0.639 . . . . 0.0 110.202 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.63 -39.91 71.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.631 0.773 . . . . 0.0 110.873 172.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.43 -38.19 88.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 0.0 111.992 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -66.77 -43.11 84.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.984 0.514 . . . . 0.0 110.908 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.43 -38.7 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.648 0.779 . . . . 0.0 110.069 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.467 ' HG3' HD13 ' A' ' 36' ' ' ILE . 50.3 tt0 -69.42 -40.08 77.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.678 0.791 . . . . 0.0 110.213 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -58.26 -47.44 83.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.252 1.021 . . . . 0.0 110.064 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.29 -43.78 98.3 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.596 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 38.7 m-85 -87.5 29.59 0.87 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.052 0.941 . . . . 0.0 112.191 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.8 m -80.31 90.53 5.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 167.45 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.126 1.771 . . . . 0.0 107.014 -167.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 32.0 p -85.57 130.67 34.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.443 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -74.15 90.39 2.04 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.467 HD13 ' HG3' ' A' ' 28' ' ' GLN . 16.9 mt -68.96 129.69 33.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -48.73 -58.44 4.76 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.61 1.194 . . . . 0.0 113.382 -160.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.09 41.14 3.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.204 0.602 . . . . 0.0 109.614 170.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.14 -128.63 28.44 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.67 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.68 63.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.67 0.788 . . . . 0.0 112.853 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.4 -21.18 63.79 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.704 0.402 . . . . 0.0 110.554 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.35 36.69 4.21 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 123.259 0.457 . . . . 0.0 112.131 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.29 108.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 73.6 mtt-85 -118.07 92.61 3.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -166.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -68.67 135.46 51.4 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -74.46 93.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.94 132.95 34.72 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.426 ' HG1' ' HB3' ' A' ' 52' ' ' ARG . 76.4 p -82.23 -176.0 5.96 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.679 0.792 . . . . 0.0 110.906 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -68.74 -14.0 62.74 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.18 0.592 . . . . 0.0 111.663 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -87.26 -14.49 40.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.501 0.72 . . . . 0.0 110.39 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.91 26.05 46.84 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.009 -171.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.426 ' HB3' ' HG1' ' A' ' 48' ' ' THR . 33.1 ttm180 -100.98 125.71 37.42 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.56 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.86 129.14 19.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.914 1.743 . . . . 0.0 109.866 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -75.89 -3.87 37.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.951 0.9 . . . . 0.0 112.019 -172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 6.01 77.66 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 44.8 mt-10 -115.51 150.62 36.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.2 1.0 . . . . 0.0 109.829 173.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.25 161.67 39.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.047 0.939 . . . . 0.0 110.047 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.41 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 93.9 m-85 -109.83 105.35 14.52 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.48 102.41 13.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -78.38 132.57 37.42 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.343 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.75 152.11 37.72 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.752 0.421 . . . . 0.0 110.925 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.87 -35.9 79.35 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.48 1.112 . . . . 0.0 112.502 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 17.3 m -142.17 152.35 43.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.577 -169.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -67.08 -25.79 66.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.793 0.837 . . . . 0.0 112.46 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 6.1 p-10 -73.05 -36.79 66.98 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 68.7 mm-40 -54.49 -39.09 67.21 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 167.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -67.3 -53.4 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.604 0.761 . . . . 0.0 111.733 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.563 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 18.1 ptpt -55.22 -38.54 68.57 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.647 0.592 . . . . 0.0 112.019 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.8 mt -71.81 -36.69 70.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.861 0.864 . . . . 0.0 111.18 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.486 ' HB3' HG12 ' A' ' 13' ' ' VAL . . . -62.25 -36.58 82.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.021 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.405 HD12 ' HE3' ' A' ' 87' ' ' LYS . 64.0 mt -64.98 -32.32 73.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.882 0.473 . . . . 0.0 111.046 173.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 57.8 mttm -78.75 -17.1 56.35 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.389 0.676 . . . . 0.0 110.489 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 60.8 tttp -80.97 -1.3 43.16 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 0.0 111.162 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.18 -17.32 52.43 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.942 0.897 . . . . 0.0 112.732 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -86.41 -37.69 18.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.711 0.804 . . . . 0.0 111.221 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.59 157.13 24.6 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -101.16 133.67 45.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.811 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.571 ' HB2' HG21 ' A' ' 83' ' ' VAL . 25.3 ttt -61.19 -70.31 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.567 0.542 . . . . 0.0 110.147 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.27 -40.37 0.55 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 172.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -150.29 -46.53 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.718 0.807 . . . . 0.0 109.306 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -61.07 140.2 57.91 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.899 0.879 . . . . 0.0 110.744 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -81.54 125.54 30.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.571 HG21 ' HB2' ' A' ' 78' ' ' MET . 67.8 t -106.91 107.66 23.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.03 137.73 35.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.675 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.26 119.17 53.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.599 -165.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -115.57 140.51 49.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.574 1.15 . . . . 0.0 108.657 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.405 ' HE3' HD12 ' A' ' 71' ' ' LEU . 29.3 ttmt -62.23 123.16 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.882 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.9 p -110.93 -172.62 2.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.551 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -145.29 169.07 18.97 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.8 -44.3 97.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.46 -46.21 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.68 0.792 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.65 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 38.2 tt0 -65.13 -53.92 37.75 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.799 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.09 -37.62 85.74 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 122.636 0.374 . . . . 0.0 111.623 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.47 -45.83 91.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.637 0.375 . . . . 0.0 110.649 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -63.81 -53.68 46.96 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.047 0.842 . . . . 0.0 111.733 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.5 t -67.43 -37.84 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.462 0.705 . . . . 0.0 111.202 -170.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.5 -41.61 65.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.626 0.37 . . . . 0.0 111.249 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -75.81 -32.27 59.76 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.659 0.384 . . . . 0.0 110.971 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -96.81 -16.63 20.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.291 0.636 . . . . 0.0 110.965 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.4 p 49.04 63.16 2.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.399 1.479 . . . . 0.0 111.611 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -141.45 128.18 3.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 118.486 -1.174 . . . . 0.0 111.139 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.86 83.15 0.91 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.881 2.388 . . . . 0.0 111.098 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -148.0 146.45 28.93 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.642 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.444 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 60.8 p -131.56 104.66 14.51 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.512 0.725 . . . . 0.0 110.041 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.65 ' HD2' ' HG3' ' A' ' 92' ' ' GLU . 50.1 Cg_exo -58.58 130.27 36.45 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.462 2.108 . . . . 0.0 111.222 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -51.63 -61.36 2.3 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.004 1.322 . . . . 0.0 111.359 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m 54.51 53.28 10.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.933 1.293 . . . . 0.0 112.095 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.478 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . . . -139.41 -97.45 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.104 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.54 90.01 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.961 0.904 . . . . 0.0 111.671 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.4 97.56 9.56 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.507 0 CA-C-O 119.449 -0.639 . . . . 0.0 112.792 -178.088 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.245 0.83 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -64.97 99.93 0.38 Allowed 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.587 0.554 . . . . 0.0 110.386 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.9 mtt -67.1 106.24 1.92 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.17 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.04 136.85 2.57 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.79 78.46 0.22 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 117.038 0.419 . . . . 0.0 112.791 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.57 -17.99 60.64 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.858 0.863 . . . . 0.0 109.957 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -119.33 135.05 11.05 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.111 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -100.07 21.94 12.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.866 0.866 . . . . 0.0 109.709 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.6 142.36 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.39 1.476 . . . . 0.0 107.097 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.447 HG13 HG12 ' A' ' 67' ' ' VAL . 32.6 m -108.4 -176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.95 0.5 . . . . 0.0 110.449 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -144.8 144.44 31.16 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 t -118.37 136.3 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.867 1.267 . . . . 0.0 107.885 -168.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 137.69 47.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.01 15.91 8.84 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.27 122.0 57.15 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.39 166.13 26.55 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 122.077 1.851 . . . . 0.0 112.356 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -28.6 66.26 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.469 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.1 p -89.74 7.32 37.44 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.16 0.984 . . . . 0.0 112.974 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 p -71.63 167.52 19.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.835 0.743 . . . . 0.0 111.993 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 23.4 m -120.67 148.96 43.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.856 0.862 . . . . 0.0 109.81 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.4 67.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.168 0.587 . . . . 0.0 111.239 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 33.1 t70 -54.94 -49.89 70.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 23' ' ' SER . 12.3 pt-20 -72.91 -35.58 67.11 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.823 -174.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.46 -35.04 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.515 ' HG3' HD13 ' A' ' 36' ' ' ILE . 34.6 tt0 -72.93 -29.69 63.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 67.0 mtt180 -68.61 -33.81 74.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.017 0.527 . . . . 0.0 110.82 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -68.95 -26.72 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.118 0.567 . . . . 0.0 110.098 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -110.46 26.66 10.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.654 0.782 . . . . 0.0 111.267 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.7 t -83.18 84.85 7.33 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.8 t70 159.82 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.625 1.57 . . . . 0.0 107.684 -159.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.1 m -82.63 175.86 9.83 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.295 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.46 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 3.6 mppt? -130.89 98.88 4.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.515 HD13 ' HG3' ' A' ' 28' ' ' GLN . 16.7 mt -82.15 134.34 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.477 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -82.01 34.44 0.41 Allowed 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 124.175 0.99 . . . . 0.0 111.831 -168.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 173.29 -7.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.497 1.519 . . . . 0.0 110.523 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.6 17.7 Favored Glycine 0 C--N 1.359 1.814 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.68 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.47 72.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.248 0.619 . . . . 0.0 111.184 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.69 -13.31 60.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.57 -176.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.35 -12.14 61.78 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 116.746 -0.206 . . . . 0.0 112.808 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 mt -81.64 90.16 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 18.3 tpp180 -84.25 92.24 7.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.412 -171.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.88 127.12 31.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.799 0.44 . . . . 0.0 110.706 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 56' ' ' GLU . 41.9 mt -71.25 96.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.487 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 41.0 m-85 -82.92 133.96 35.09 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -77.27 -170.83 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.175 0.922 . . . . 0.0 111.691 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -55.06 -28.72 54.47 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.094 0.958 . . . . 0.0 112.138 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -104.17 4.13 33.69 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.575 0.75 . . . . 0.0 110.272 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 47' ' ' TYR . . . 73.89 32.89 58.38 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 114.002 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -94.92 141.63 23.55 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.759 0.824 . . . . 0.0 109.746 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.31 110.32 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.938 1.759 . . . . 0.0 109.681 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.4 t -63.25 -8.2 7.8 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.608 1.163 . . . . 0.0 113.165 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -14.83 51.91 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HB2' HD13 ' A' ' 46' ' ' ILE . 40.0 mt-10 -121.65 159.73 25.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.369 1.068 . . . . 0.0 111.642 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.26 149.98 27.54 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.181 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 98.5 m-85 -91.54 155.57 18.29 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -136.06 109.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -78.85 119.26 21.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 109.407 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -116.09 154.43 29.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.339 0.655 . . . . 0.0 110.296 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.1 -30.25 70.72 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 111.393 -175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 162.98 39.98 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.82 0.848 . . . . 0.0 110.472 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.49 -13.88 62.3 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 122.946 0.499 . . . . 0.0 111.497 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t70 -60.07 -53.4 58.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 2.1 mp0 -59.5 -32.68 70.51 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.321 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.447 HG12 HG13 ' A' ' 13' ' ' VAL . 54.4 t -61.85 -49.52 83.9 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 123.647 0.592 . . . . 0.0 110.332 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -53.02 -44.04 67.0 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 64.5 mt -60.88 -46.91 88.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.493 0.717 . . . . 0.0 110.099 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB2' HG11 ' A' ' 85' ' ' VAL . . . -59.4 -46.55 88.38 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.741 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 95.3 mt -57.12 -35.83 69.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.686 1.195 . . . . 0.0 111.792 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -77.3 -18.55 57.42 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.875 0.47 . . . . 0.0 111.654 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -88.61 6.99 35.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.1 0.56 . . . . 0.0 110.938 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.466 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 p-10 -65.53 -15.61 62.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.989 0.515 . . . . 0.0 111.642 173.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.26 -31.11 17.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.066 0.946 . . . . 0.0 110.925 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.12 151.92 34.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.672 0.789 . . . . 0.0 112.294 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -116.37 130.69 56.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.125 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 89.7 mmm -79.31 83.18 5.37 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.81 -96.47 2.1 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -170.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -126.01 3.73 7.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.813 0.845 . . . . 0.0 110.031 168.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.406 ' O ' HG21 ' A' ' 83' ' ' VAL . 20.3 mmt180 -70.93 110.39 5.62 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -70.2 109.48 4.67 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 81' ' ' ARG . 55.7 t -114.36 115.32 49.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 123.296 0.639 . . . . 0.0 109.487 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 2.1 pm0 -99.56 146.22 26.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.385 1.074 . . . . 0.0 109.724 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 70' ' ' ALA . 45.4 t -129.89 124.74 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -107.67 178.39 4.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.716 1.206 . . . . 0.0 108.235 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -106.94 127.7 53.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -113.67 -164.54 0.93 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.216 1.006 . . . . 0.0 110.883 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.504 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 49.3 t-20 -147.18 159.99 42.98 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.07 -35.78 81.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 0.0 109.835 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.05 -41.81 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.641 0.776 . . . . 0.0 110.162 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.51 -44.15 97.07 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 44.3 ttp -58.96 -36.2 74.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.107 0.963 . . . . 0.0 110.532 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.1 -55.73 19.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.102 0.561 . . . . 0.0 110.951 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.452 ' HE3' HD22 ' A' ' 103' ' ' ASN . 14.0 m0 -63.86 -31.65 72.9 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.971 0.908 . . . . 0.0 112.525 -173.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.87 -42.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.309 0.643 . . . . 0.0 110.999 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.74 -22.3 59.93 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.468 0.307 . . . . 0.0 111.175 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -91.61 -30.33 16.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.876 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -137.43 86.45 2.19 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.691 0.796 . . . . 0.0 108.95 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 t -79.97 83.11 5.93 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 122.46 1.124 . . . . 0.0 110.261 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.05 -136.37 4.03 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.485 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.26 -40.68 31.14 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.102 2.535 . . . . 0.0 112.75 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.452 HD22 ' HE3' ' A' ' 95' ' ' TRP . 42.4 t30 70.96 143.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.218 1.407 . . . . 0.0 112.039 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.6 m 72.68 135.75 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.617 1.567 . . . . 0.0 112.543 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -64.59 177.47 2.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.923 2.416 . . . . 0.0 113.274 174.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.72 -48.58 69.47 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.446 1.098 . . . . 0.0 112.037 -174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.5 m 69.19 -67.59 0.21 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.526 1.53 . . . . 0.0 111.263 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.71 154.66 42.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.838 1.255 . . . . 0.0 109.307 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -79.61 78.31 6.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.392 0.615 . . . . 0.0 110.634 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -152.41 14.7 0.59 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.125 0.97 . . . . 0.0 110.071 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.317 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.272 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.2 p . . . . . 0 C--O 1.244 0.768 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 61.17 -142.68 0.48 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.358 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.8 mtt 66.62 -74.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.329 1.052 . . . . 0.0 111.404 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.96 89.46 0.03 OUTLIER Glycine 0 C--N 1.354 1.544 0 C-N-CA 124.015 0.817 . . . . 0.0 113.902 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.99 -50.86 0.06 OUTLIER Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.1 97.8 11.4 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.439 ' HA3' ' HD3' ' A' ' 87' ' ' LYS . . . -82.47 -91.92 0.61 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.07 13.52 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.075 1.35 . . . . 0.0 112.055 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 37.4 t -145.71 143.27 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 70' ' ' ALA . 25.4 m -113.15 172.18 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 121.094 0.474 . . . . 0.0 111.966 169.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 40.8 mtpt -116.36 135.4 53.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.01 117.39 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 41.1 ttp180 -127.4 152.27 47.73 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.38 12.59 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -166.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 22' ' ' CYS . 86.0 mt -97.53 134.04 22.98 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.308 1.043 . . . . 0.0 109.406 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 22' ' ' CYS . 33.9 Cg_exo -61.42 163.57 17.42 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.776 2.317 . . . . 0.0 112.606 168.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -74.35 -8.09 55.07 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.059 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -113.32 16.12 19.07 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.286 1.034 . . . . 0.0 111.278 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.476 ' SG ' HD21 ' A' ' 18' ' ' LEU . 52.0 t -67.19 155.48 38.7 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.924 0.489 . . . . 0.0 111.632 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.473 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.1 m -133.73 152.69 51.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.529 1.132 . . . . 0.0 110.555 -173.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.65 67.38 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.402 1.081 . . . . 0.0 112.788 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.91 -47.78 67.73 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.536 1.135 . . . . 0.0 113.47 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 23' ' ' SER . 13.7 pt-20 -72.19 -35.49 68.96 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.8 -46.38 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.157 0.583 . . . . 0.0 110.032 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.569 ' HG3' HD13 ' A' ' 36' ' ' ILE . 28.2 tt0 -63.95 -40.76 97.18 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.617 0.767 . . . . 0.0 111.341 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -57.87 -46.8 84.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.795 0.684 . . . . 0.0 110.866 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.17 -32.92 74.66 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.741 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.632 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 93.4 m-85 -105.34 35.96 2.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.925 0.89 . . . . 0.0 110.659 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -60.59 -27.6 67.85 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.524 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.55 -18.13 65.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.2 p -111.44 135.49 51.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.311 0.644 . . . . 0.0 109.958 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -75.56 96.0 3.44 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.569 HD13 ' HG3' ' A' ' 28' ' ' GLN . 43.9 mt -78.85 123.41 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.81 125.85 25.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.302 1.041 . . . . 0.0 110.971 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 60.74 23.15 13.07 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.177 1.391 . . . . 0.0 111.552 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.26 -134.96 45.5 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.379 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.48 -22.68 22.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.064 0.946 . . . . 0.0 113.274 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.05 -21.92 64.98 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.419 0.288 . . . . 0.0 110.875 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.73 -16.84 79.62 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.016 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 mt -86.64 119.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 109.633 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.0 97.55 5.49 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.163 0.985 . . . . 0.0 109.695 177.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -66.16 142.9 57.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.029 0.532 . . . . 0.0 109.724 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 56' ' ' GLU . 23.6 mt -77.16 87.18 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.458 ' O ' ' HB ' ' A' ' 100' ' ' THR . 92.1 m-85 -75.34 134.29 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.456 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.0 t -78.48 -175.54 4.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.414 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 3.4 tmm_? -68.94 -5.8 23.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.3 0.64 . . . . 0.0 110.973 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' H ' HG23 ' A' ' 48' ' ' THR . 37.6 mt-10 -100.31 -2.6 33.23 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.698 1.199 . . . . 0.0 110.96 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.95 36.81 31.07 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 115.072 0.789 . . . . 0.0 115.072 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -132.17 138.18 31.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.708 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.52 118.0 4.43 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.046 2.497 . . . . 0.0 111.695 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.8 p -93.3 40.25 1.06 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.72 0.808 . . . . 0.0 111.129 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.82 -37.23 3.58 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.0 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.533 ' HB2' HD13 ' A' ' 46' ' ' ILE . 36.5 mt-10 -110.13 161.56 15.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.803 0.811 . . . . 0.0 112.392 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.03 165.53 31.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.449 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -110.47 145.39 37.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 108.09 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 105.83 6.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -81.63 139.64 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.453 HD21 ' HA ' ' A' ' 36' ' ' ILE . 74.8 mt -128.89 142.24 51.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.683 1.193 . . . . 0.0 109.283 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.29 -27.66 68.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.309 0.644 . . . . 0.0 111.54 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.573 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.5 m -136.52 150.44 48.65 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.17 0.588 . . . . 0.0 109.661 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 15.9 tt0 -77.68 -8.34 57.77 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 120.915 0.388 . . . . 0.0 111.201 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -65.39 -48.52 72.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 4.0 mm-40 -52.77 -38.29 60.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.668 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.403 HG22 HD11 ' A' ' 61' ' ' LEU . 66.7 t -64.22 -46.09 94.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 123.31 0.644 . . . . 0.0 110.411 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.7 mttt -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.384 0.674 . . . . 0.0 112.154 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.47 -50.22 70.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.89 0.876 . . . . 0.0 111.178 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.482 ' HB2' HG11 ' A' ' 13' ' ' VAL . . . -58.99 -45.29 91.0 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.144 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.05 -24.61 40.66 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.295 1.438 . . . . 0.0 113.425 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.18 -9.84 59.73 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.151 0.58 . . . . 0.0 112.005 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -90.52 6.08 45.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 111.356 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -57.88 -9.37 1.28 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.785 1.234 . . . . 0.0 113.69 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -116.63 -40.15 3.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.371 1.068 . . . . 0.0 111.11 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.41 163.67 15.28 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -105.41 130.82 53.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.067 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.462 ' HG3' HG23 ' A' ' 83' ' ' VAL . 53.4 mtp -64.83 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 163.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.03 -103.34 2.02 Favored Glycine 0 N--CA 1.468 0.777 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -96.01 -1.61 48.57 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.24 1.016 . . . . 0.0 109.344 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -106.19 133.54 50.72 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.926 0.89 . . . . 0.0 109.631 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -80.36 135.59 36.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.462 HG23 ' HG3' ' A' ' 78' ' ' MET . 98.7 t -97.79 130.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 32.8 mt-10 -97.45 117.35 31.51 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.9 t -114.66 120.04 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -113.83 177.59 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 40.1 ttmt -101.88 116.12 32.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -87.05 161.55 18.1 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.14 0.971 . . . . 0.0 110.503 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -127.99 158.21 38.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.005 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -64.84 -34.34 78.13 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.927 0.491 . . . . 0.0 110.759 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.53 -41.84 89.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 110.753 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.64 ' HG3' HD21 ' A' ' 103' ' ' ASN . 40.1 tt0 -69.44 -56.3 7.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.961 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.415 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 44.9 ttm -52.11 -51.29 58.72 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 123.967 0.792 . . . . 0.0 111.72 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.402 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 28.3 t70 -62.42 -43.01 99.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 0.0 110.53 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -60.6 -38.59 85.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.143 0.577 . . . . 0.0 111.147 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 76.4 t -82.36 -30.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.702 0.801 . . . . 0.0 111.86 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 93' ' ' MET . 83.0 mt -75.69 -26.44 57.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.38 -0.825 . . . . 0.0 110.654 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 1.2 mptm? -90.09 -25.17 20.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.756 0.823 . . . . 0.0 111.082 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -135.41 86.49 2.25 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 47' ' ' TYR . 42.5 p -67.48 99.62 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.81 0.844 . . . . 0.0 112.769 -170.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.27 167.93 40.99 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.887 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.38 158.07 55.15 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.377 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.64 HD21 ' HG3' ' A' ' 92' ' ' GLU . 52.9 t30 -155.46 151.72 28.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.594 0.758 . . . . 0.0 109.394 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.8 p -110.13 112.38 57.55 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 109.109 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -93.05 30.27 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.204 2.603 . . . . 0.0 112.707 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.79 78.23 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.692 0.797 . . . . 0.0 109.354 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.6 m -160.71 119.84 2.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.646 1.178 . . . . 0.0 108.808 -167.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.7 71.14 0.86 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.247 0.619 . . . . 0.0 110.576 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.27 78.76 8.89 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -88.12 112.45 22.7 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.252 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.227 179.934 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 120.44 0.162 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.5 t -102.09 143.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.99 0.916 . . . . 0.0 109.184 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 61' ' ' LEU . 29.8 m -110.14 160.41 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.053 0.541 . . . . 0.0 110.758 162.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 87.4 tttt -109.13 121.41 45.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.84 111.72 37.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 3.7 tmt_? -121.96 140.67 52.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.21 18.27 29.41 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 118.2 0.454 . . . . 0.0 113.316 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.17 138.37 56.38 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 123.356 0.662 . . . . 0.0 109.765 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.612 ' HG3' ' HA3' ' A' ' 79' ' ' GLY . 45.1 Cg_endo -64.79 146.52 88.44 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.346 2.031 . . . . 0.0 111.454 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -64.37 -19.71 65.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.162 0.985 . . . . 0.0 110.62 175.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 p -90.7 4.75 50.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.394 1.078 . . . . 0.0 113.146 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 22.0 p -104.4 145.75 29.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.827 0.739 . . . . 0.0 111.13 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -105.81 178.52 4.54 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.763 1.225 . . . . 0.0 109.028 172.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.67 -31.49 62.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.441 0.696 . . . . 0.0 112.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.92 -47.34 68.08 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.181 0.993 . . . . 0.0 113.118 176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.88 -38.02 76.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.15 0.58 . . . . 0.0 111.592 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.61 -34.76 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.712 . . . . 0.0 110.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.597 ' HG3' HD12 ' A' ' 36' ' ' ILE . 44.2 tt0 -69.36 -41.31 76.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.312 176.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -63.09 -36.33 83.23 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.081 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.98 -43.83 98.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.015 0.526 . . . . 0.0 110.39 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 36' ' ' ILE . 79.6 m-85 -95.72 38.96 1.14 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.998 0.519 . . . . 0.0 110.515 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.7 t -59.76 -34.2 72.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 111.248 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.22 5.96 10.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 112.448 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' HB3' HD23 ' A' ' 61' ' ' LEU . 58.1 m -127.38 136.23 51.59 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.086 0.954 . . . . 0.0 110.07 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -80.36 98.46 7.48 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.597 HD12 ' HG3' ' A' ' 28' ' ' GLN . 61.8 mt -80.65 122.61 36.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.994 0.918 . . . . 0.0 109.687 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.7 126.42 27.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.213 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.2 t30 63.48 17.55 10.42 Favored 'General case' 0 CA--C 1.559 1.327 0 O-C-N 124.79 1.307 . . . . 0.0 111.89 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.44 -136.16 47.53 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.239 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.71 -18.8 45.49 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.26 -21.03 54.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.967 0.507 . . . . 0.0 110.295 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 -21.13 76.59 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.255 0.347 . . . . 0.0 112.472 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.493 HG12 HG22 ' A' ' 59' ' ' VAL . 43.4 mt -91.27 127.75 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.568 0.747 . . . . 0.0 110.043 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.1 110.02 6.12 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.081 0.953 . . . . 0.0 110.008 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -66.48 140.09 57.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.0 88.82 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -82.86 135.9 34.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.1 p -83.76 -178.17 6.93 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.856 0.862 . . . . 0.0 110.919 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 1.5 tmt_? -67.18 -16.73 64.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.161 0.584 . . . . 0.0 109.603 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 13.4 mm-40 -84.36 1.56 44.53 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.742 0.817 . . . . 0.0 110.911 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.03 20.1 76.03 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 50' ' ' GLU . 19.4 ptp180 -126.74 141.3 39.94 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.335 0.654 . . . . 0.0 109.79 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.48 148.36 42.61 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.447 2.098 . . . . 0.0 111.523 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -75.65 -0.44 20.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.616 0.766 . . . . 0.0 111.749 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.54 81.83 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 37.7 mt-10 -119.63 155.61 31.99 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 110.809 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.36 28.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.771 1.228 . . . . 0.0 110.313 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.33 120.9 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.484 1.113 . . . . 0.0 109.168 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 43' ' ' ILE . 68.9 t -106.71 123.67 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 108.953 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HG2' HG22 ' A' ' 12' ' ' VAL . 64.5 mt-10 -82.98 151.23 25.95 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 34' ' ' CYS . 4.6 mp -135.87 152.29 50.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.084 0.954 . . . . 0.0 109.312 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -32.22 73.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.732 0.813 . . . . 0.0 111.805 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.485 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 42.0 m -144.96 155.62 43.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.531 0.332 . . . . 0.0 111.265 -171.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.96 -27.29 68.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.623 0.769 . . . . 0.0 110.431 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.39 -47.57 75.9 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 47.2 mm-40 -54.62 -37.88 66.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.538 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 78.4 t -60.27 -46.06 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.077 0.551 . . . . 0.0 110.03 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.59 ' HD3' HD12 ' A' ' 71' ' ' LEU . 32.3 mmtp -60.99 -37.79 83.73 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.788 0.835 . . . . 0.0 112.552 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 85.9 mt -65.88 -31.94 73.16 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.502 0.721 . . . . 0.0 111.746 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -69.13 -44.04 73.18 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.255 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.59 HD12 ' HD3' ' A' ' 68' ' ' LYS . 96.8 mt -65.9 -26.12 67.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.14 0.976 . . . . 0.0 112.83 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 19.9 pttp -77.54 -16.88 58.41 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.105 0.411 . . . . 0.0 109.915 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -95.15 0.49 54.22 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.214 1.005 . . . . 0.0 111.032 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 11.1 t70 -60.17 101.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.32 0.648 . . . . 0.0 110.238 168.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 36.9 ttt180 150.64 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 127.115 2.166 . . . . 0.0 108.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -55.43 147.33 17.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.235 -167.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 p -89.11 120.03 30.15 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.518 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -124.64 125.0 43.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.342 1.057 . . . . 0.0 108.513 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.612 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 84.82 -50.31 4.38 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.451 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -179.04 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.77 1.228 . . . . 0.0 108.85 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -91.47 166.94 12.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.038 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.88 139.47 39.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 78' ' ' MET . 53.1 t -112.05 129.51 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.16 0.505 . . . . 0.0 110.678 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.01 121.6 37.93 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.342 1.057 . . . . 0.0 109.196 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.0 112.81 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.8 m-85 -103.03 178.4 4.57 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.35 120.5 42.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 61.1 m -110.73 147.71 33.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.733 0.813 . . . . 0.0 111.275 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -91.54 155.28 18.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -56.53 -35.32 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.238 0.615 . . . . 0.0 110.169 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.11 -46.37 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.889 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.62 -52.11 48.81 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.458 0.474 . . . . 0.0 110.005 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -49.63 -53.64 23.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.8 1.24 . . . . 0.0 111.367 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.0 -43.02 86.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.987 0.915 . . . . 0.0 111.679 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -74.13 -35.99 64.13 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.99 -21.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.014 0.435 . . . . 0.0 110.502 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.3 -40.76 64.28 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -77.13 -32.02 56.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.06 0.544 . . . . 0.0 111.295 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.3 t60 . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -171.935 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 . . . . . 0 CA--C 1.55 0.973 0 CA-C-O 120.62 0.247 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG21 ' HE2' ' A' ' 93' ' ' MET . 39.1 t -112.28 138.02 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.527 1.131 . . . . 0.0 109.167 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.07 168.89 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.037 0.535 . . . . 0.0 110.635 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 60.2 tttt -116.84 123.38 46.94 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 83' ' ' VAL . 92.2 t -114.6 138.67 43.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.47 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 3.8 ptp180 -150.99 161.31 42.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.975 0.51 . . . . 0.0 109.633 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 18.45 36.57 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -169.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -88.88 127.69 54.97 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 27.4 Cg_endo -61.19 161.5 22.8 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.232 1.955 . . . . 0.0 111.968 172.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -71.66 -24.46 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.287 0.635 . . . . 0.0 111.176 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -82.45 -6.0 59.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.685 0.794 . . . . 0.0 111.404 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.438 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 44.2 t -76.08 120.41 21.35 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.102 0.561 . . . . 0.0 109.743 -177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t -98.88 174.68 6.25 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.767 0.827 . . . . 0.0 109.186 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.24 74.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.707 0.803 . . . . 0.0 112.41 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.4 t70 -60.53 -39.32 87.45 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.879 0.872 . . . . 0.0 111.787 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -59.53 -46.31 89.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.216 0.606 . . . . 0.0 111.083 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' A' ' 43' ' ' ILE . 58.4 t -71.68 -31.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.42 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -64.34 -42.81 96.06 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.916 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 19.3 mmt180 -67.11 -38.11 85.06 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.695 0.398 . . . . 0.0 111.179 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -67.71 -29.66 68.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.034 0.534 . . . . 0.0 111.5 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 36' ' ' ILE . 93.4 m-85 -115.38 35.02 4.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.61 0.764 . . . . 0.0 110.184 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 t -59.51 -29.2 67.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.62 0.768 . . . . 0.0 113.01 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.77 -25.72 35.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.853 0.461 . . . . 0.0 110.614 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.58 126.79 31.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 10.4 mptt -79.24 87.75 4.94 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 31' ' ' PHE . 41.1 mt -76.86 132.79 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.275 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.02 118.37 5.33 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.947 0.899 . . . . 0.0 110.425 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 63.52 23.02 13.46 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -131.66 41.85 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.596 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.64 30.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 0.0 113.161 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -80.7 -10.45 59.73 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.198 0.599 . . . . 0.0 112.411 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.93 36.3 4.35 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.498 HD13 ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt -127.85 116.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.453 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 22.3 mmt180 -116.6 92.99 4.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.288 0.635 . . . . 0.0 110.251 -169.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 98.2 m-85 -71.23 127.85 33.93 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 mt -74.8 86.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.05 149.37 41.21 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.706 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -94.77 178.71 5.49 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.434 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -68.76 -8.85 46.87 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 122.846 0.458 . . . . 0.0 111.893 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.55 -0.41 43.29 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.257 1.023 . . . . 0.0 109.916 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.41 59.92 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.969 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -126.15 132.75 24.42 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 53.5 Cg_endo -66.5 153.21 78.82 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.302 2.002 . . . . 0.0 111.568 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -78.41 6.11 9.16 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.56 0.744 . . . . 0.0 111.37 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.07 1.13 79.88 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -171.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 30.6 mt-10 -111.59 146.68 36.96 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.669 1.187 . . . . 0.0 110.806 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.58 31.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.55 1.14 . . . . 0.0 109.7 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 69.3 m-85 -102.61 117.74 35.34 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.9 t -98.46 110.78 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.39 136.46 38.42 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.562 1.145 . . . . 0.0 108.413 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 66' ' ' GLU . 44.1 mt -135.76 137.58 41.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.448 0.699 . . . . 0.0 109.744 -169.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.87 -12.47 61.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -168.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.0 p -160.45 172.45 17.22 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.11 0.564 . . . . 0.0 109.99 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.0 tm-20 -68.5 -21.05 64.61 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.209 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.68 -46.79 89.02 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.235 0.471 . . . . 0.0 110.403 172.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HB3' HD22 ' A' ' 61' ' ' LEU . 1.1 mp0 -62.38 -32.5 73.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.53 173.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.47 -44.08 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.652 0.381 . . . . 0.0 110.028 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 82.2 mttt -54.63 -49.66 69.98 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.723 0.809 . . . . 0.0 110.649 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.78 -35.44 74.65 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.354 1.062 . . . . 0.0 112.089 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.75 69.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.031 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.75 -13.38 59.25 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.22 1.008 . . . . 0.0 112.254 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.16 -23.68 64.89 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.301 0.501 . . . . 0.0 110.697 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 76' ' ' GLU . 3.9 mptp? -88.03 -1.28 57.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.536 0.734 . . . . 0.0 112.069 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -32.28 -25.05 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 169.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -142.77 -6.4 0.88 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -57.81 143.18 43.2 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 175.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 p -95.37 121.85 37.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.45 1.1 . . . . 0.0 111.86 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.16 114.35 27.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.184 0.993 . . . . 0.0 109.264 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.17 -89.81 0.17 Allowed Glycine 0 C--N 1.345 1.058 0 O-C-N 123.416 0.448 . . . . 0.0 112.999 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -130.77 -5.85 4.06 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -117.49 154.05 32.1 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.236 0.614 . . . . 0.0 110.929 -172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -82.04 143.5 31.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.583 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 15' ' ' VAL . 69.4 t -109.02 120.48 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.474 0.71 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -95.39 121.47 37.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.01 121.46 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.325 0.65 . . . . 0.0 109.984 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -118.93 149.94 40.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.711 0.805 . . . . 0.0 110.905 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.05 116.85 5.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.369 0.667 . . . . 0.0 110.146 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 15.6 m -125.67 -154.1 0.6 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.68 173.64 12.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.06 -31.05 72.1 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.989 0.915 . . . . 0.0 110.432 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.1 t -65.92 -47.61 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.247 1.019 . . . . 0.0 110.346 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.38 -47.97 74.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.286 1.034 . . . . 0.0 110.077 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.46 ' HE2' HG21 ' A' ' 12' ' ' VAL . 54.2 ttp -52.54 -44.6 65.88 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.463 1.102 . . . . 0.0 110.639 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.62 -45.95 77.45 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.434 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.54 -42.05 95.72 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.604 0.762 . . . . 0.0 112.3 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.08 -23.55 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 123.508 0.505 . . . . 0.0 110.827 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.11 -23.74 35.52 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 121.98 -0.45 . . . . 0.0 111.138 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -80.33 -38.77 29.93 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.284 0.564 . . . . 0.0 109.971 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 . . . . . 0 C--O 1.239 0.52 0 C-N-CA 124.483 1.113 . . . . 0.0 108.027 -173.427 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -93.94 133.49 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 110.135 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -105.01 163.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.373 0.669 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -108.05 127.18 53.56 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -119.49 140.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 124.107 0.963 . . . . 0.0 108.757 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.579 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 14.8 ptm180 -147.43 167.23 24.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.03 0.932 . . . . 0.0 109.262 174.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.91 18.71 62.74 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.61 155.24 91.72 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.854 0.862 . . . . 0.0 110.236 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.0 152.13 77.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.147 1.898 . . . . 0.0 111.22 169.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.2 p90 -56.18 -30.91 62.89 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.725 1.21 . . . . 0.0 112.098 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 p -104.21 25.52 9.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 111.508 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.2 p -52.39 118.03 3.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.493 1.117 . . . . 0.0 112.811 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.432 ' HB3' ' HG3' ' A' ' 26' ' ' GLU . 46.8 t -104.18 152.2 22.43 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.29 -39.52 75.9 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.315 0.384 . . . . 0.0 111.003 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -49.51 -47.63 48.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.329 1.052 . . . . 0.0 112.695 170.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 45.3 mt-10 -65.43 -39.68 92.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.194 0.598 . . . . 0.0 111.265 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' HD13 ' A' ' 43' ' ' ILE . 61.1 t -68.55 -34.94 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.403 0.681 . . . . 0.0 110.077 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HA ' HD12 ' A' ' 36' ' ' ILE . 97.0 mt-30 -64.94 -49.75 69.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.769 0.827 . . . . 0.0 111.033 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -37.17 81.35 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.51 0.507 . . . . 0.0 110.719 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.75 -43.76 95.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.027 0.531 . . . . 0.0 111.107 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HB2' HD11 ' A' ' 36' ' ' ILE . 59.5 m-85 -99.73 35.68 1.96 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.624 0.77 . . . . 0.0 110.083 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -60.7 -24.81 65.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.355 0.525 . . . . 0.0 112.186 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.86 -47.7 68.18 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.992 0.917 . . . . 0.0 110.736 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 61.3 m -79.77 130.69 35.55 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.385 0.612 . . . . 0.0 110.432 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 13.9 mmmm -78.44 91.2 4.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 31' ' ' PHE . 46.4 mt -69.74 111.0 3.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.516 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 33.6 tt0 -63.14 134.5 56.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.878 0.736 . . . . 0.0 110.458 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 65.37 10.14 6.29 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 124.654 1.221 . . . . 0.0 112.148 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 -128.04 44.91 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.51 0.576 . . . . 0.0 112.716 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.03 64.75 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.855 0.862 . . . . 0.0 112.483 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -73.8 -19.72 60.68 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.123 0.569 . . . . 0.0 111.644 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.99 -23.81 56.58 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 120.271 -0.183 . . . . 0.0 112.961 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.525 HD13 ' HB ' ' A' ' 27' ' ' VAL . 59.8 mt -83.35 119.36 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.266 0.627 . . . . 0.0 109.613 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.549 ' HG3' ' SD ' ' A' ' 93' ' ' MET . 21.0 mmt180 -127.29 94.71 4.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.481 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.79 135.86 46.86 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 56' ' ' GLU . 43.0 mt -75.91 92.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -84.26 134.49 34.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.429 ' OG1' ' HB2' ' A' ' 52' ' ' ARG . 59.7 p -90.84 -169.99 2.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.701 0.8 . . . . 0.0 110.442 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.71 -18.01 64.63 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -105.67 10.06 32.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 0.0 109.212 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.15 63.96 Favored Glycine 0 C--N 1.36 1.917 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 12.0 mmp_? -101.27 125.49 37.7 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.591 0.756 . . . . 0.0 110.021 -172.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.08 116.89 3.56 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.666 2.244 . . . . 0.0 110.488 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 t -83.52 18.13 1.97 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.678 0.791 . . . . 0.0 111.581 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.1 30.19 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 122.854 0.264 . . . . 0.0 113.033 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 31.8 mt-10 -112.3 150.15 31.39 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.455 1.102 . . . . 0.0 111.128 -174.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.55 153.9 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.527 1.131 . . . . 0.0 110.043 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -106.14 110.31 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.051 0.941 . . . . 0.0 108.463 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.07 110.92 25.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.5 tt0 -79.76 135.99 36.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.9 mt -126.71 147.91 49.91 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.458 0.703 . . . . 0.0 110.032 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -67.06 -19.81 65.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.763 0.825 . . . . 0.0 112.917 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -159.34 171.24 20.15 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.07 -23.75 67.26 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.999 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.81 -52.56 64.54 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.372 0.669 . . . . 0.0 110.157 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 1.5 mp0 -60.25 -31.61 70.37 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.048 0.843 . . . . 0.0 112.894 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.4 t -61.44 -48.83 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.659 0.384 . . . . 0.0 110.158 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.8 mmpt? -50.98 -46.07 61.16 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.015 0.822 . . . . 0.0 111.753 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 mt -63.06 -47.44 82.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.59 0.756 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.06 87.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.021 0.928 . . . . 0.0 111.524 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.44 -38.44 77.47 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.148 0.979 . . . . 0.0 111.659 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -69.06 -19.97 64.09 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 123.63 0.581 . . . . 0.0 111.587 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -91.77 17.34 9.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.929 0.892 . . . . 0.0 112.329 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.93 23.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -142.86 -23.66 0.63 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.751 0.705 . . . . 0.0 110.865 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -46.3 134.75 8.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.931 1.293 . . . . 0.0 112.02 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -91.26 131.64 36.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.782 0.833 . . . . 0.0 111.15 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ttt -128.61 122.14 30.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.704 1.202 . . . . 0.0 109.415 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -75.34 1.92 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -145.33 -36.29 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.37 1.068 . . . . 0.0 110.1 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -87.0 167.49 14.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -80.68 136.81 36.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.7 t -100.02 117.12 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 25.1 mt-10 -98.37 122.18 41.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.175 1.39 . . . . 0.0 108.508 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.94 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 110.14 -172.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.06 179.09 4.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.464 1.506 . . . . 0.0 107.54 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -112.55 135.41 53.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' A' ' 92' ' ' GLU . 76.8 p -134.87 -149.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 109.038 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.87 169.42 24.45 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -61.36 -34.22 74.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.841 0.856 . . . . 0.0 111.276 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.7 -40.79 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.113 0.965 . . . . 0.0 110.168 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 88' ' ' SER . 4.7 tp10 -63.93 -50.36 68.97 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.409 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.549 ' SD ' ' HG3' ' A' ' 44' ' ' ARG . 45.3 ttm -54.95 -51.74 65.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.947 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.35 -45.87 91.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.621 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -52.58 -51.56 59.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.635 1.574 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 92' ' ' GLU . 40.7 t -71.19 -33.13 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.091 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 44' ' ' ARG . 88.6 mt -69.38 -27.55 65.41 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.314 0.245 . . . . 0.0 111.042 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -69.05 -23.89 64.11 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.247 0.619 . . . . 0.0 111.752 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 123.501 0.72 . . . . 0.0 109.219 178.906 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.328 0.585 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.23 134.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.54 160.33 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.006 0.522 . . . . 0.0 110.769 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -109.75 116.03 30.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG13 ' CG1' ' A' ' 83' ' ' VAL . 87.4 t -114.62 135.77 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 125.056 1.342 . . . . 0.0 108.524 -168.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.703 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 12.3 ptm180 -149.95 162.58 40.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.855 0.462 . . . . 0.0 111.547 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.64 15.06 51.4 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.456 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.65 135.94 42.75 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 29.8 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.171 1.914 . . . . 0.0 111.783 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -70.43 -19.96 62.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.345 1.058 . . . . 0.0 111.32 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -93.63 10.55 32.28 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.703 0.801 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.59 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 50.6 t -87.03 133.95 33.54 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.019 0.528 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m -105.83 169.98 8.16 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.006 0.922 . . . . 0.0 109.511 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.38 69.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.008 0.923 . . . . 0.0 111.893 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 3.3 m-20 -48.03 -48.72 32.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.405 1.082 . . . . 0.0 112.445 175.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -69.79 -34.16 73.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.866 0.867 . . . . 0.0 111.912 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 43' ' ' ILE . 39.0 t -73.95 -30.53 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 123.162 0.585 . . . . 0.0 110.128 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -67.19 -38.78 85.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.368 0.667 . . . . 0.0 110.013 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 95.1 mtt180 -59.6 -46.06 90.09 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.887 0.742 . . . . 0.0 111.191 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 77.0 t80 -63.52 -46.37 86.37 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.88 0.371 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -94.83 37.07 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.795 0.838 . . . . 0.0 110.556 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 t -60.44 -34.14 73.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.35 0.66 . . . . 0.0 112.446 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -69.19 -36.97 77.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.122 0.487 . . . . 0.0 109.887 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.0 m -72.86 175.32 6.66 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.057 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -136.01 97.51 3.64 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.529 HG21 HG13 ' A' ' 43' ' ' ILE . 3.5 mp -73.21 118.51 18.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.535 -172.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 7.8 tp60 -64.69 124.2 21.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.715 . . . . 0.0 109.367 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.3 m120 76.01 16.63 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.715 1.606 . . . . 0.0 111.94 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.56 -134.24 47.55 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.356 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -37.46 32.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.609 1.164 . . . . 0.0 112.804 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.85 -8.18 59.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.537 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 37' ' ' GLN . . . -84.33 -13.87 72.69 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.623 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.564 HD13 ' HB ' ' A' ' 27' ' ' VAL . 62.3 mt -89.62 101.2 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.157 0.583 . . . . 0.0 109.575 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.13 96.59 9.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.249 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -67.42 129.22 39.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.5 mt -71.24 92.32 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -79.99 146.83 31.82 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.961 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.6 p -83.5 -172.97 4.44 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.31 1.044 . . . . 0.0 109.678 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -71.1 -6.06 36.37 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.896 0.478 . . . . 0.0 111.145 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.5 -6.96 32.54 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.615 1.166 . . . . 0.0 109.939 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 33.49 50.09 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -124.96 132.63 24.35 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.916 0.886 . . . . 0.0 110.37 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -67.55 139.11 47.82 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.487 2.125 . . . . 0.0 111.232 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -78.77 -2.04 37.6 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.076 0.55 . . . . 0.0 111.178 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.3 60.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.878 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.703 ' HG3' ' HB3' ' A' ' 16' ' ' ARG . 8.0 mp0 -105.43 149.69 25.93 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.552 1.141 . . . . 0.0 109.618 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 163.3 38.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.75 116.01 29.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.033 0.933 . . . . 0.0 109.106 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -95.86 108.2 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 45.6 tt0 -83.14 145.08 29.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.3 mt -138.83 145.87 40.56 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.385 1.074 . . . . 0.0 108.649 -168.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.95 -26.54 63.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -152.28 163.3 39.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.453 0.701 . . . . 0.0 110.134 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 35.0 tt0 -69.53 -16.73 63.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.212 0.605 . . . . 0.0 112.594 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.6 t70 -59.77 -51.42 69.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -52.98 -39.76 63.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.931 1.292 . . . . 0.0 111.863 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 65.4 t -63.39 -42.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.125 0.57 . . . . 0.0 111.065 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 74.9 mmtt -58.62 -45.43 89.21 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.953 0.901 . . . . 0.0 111.211 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 62.5 mt -61.52 -36.76 81.45 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.911 0.884 . . . . 0.0 111.062 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.25 83.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 0.0 110.321 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.1 mt -62.57 -30.82 71.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.008 0.923 . . . . 0.0 111.828 175.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 56.3 mtpt -67.86 -30.78 70.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.318 0.58 . . . . 0.0 110.377 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 41.2 mttp -84.15 -4.26 58.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.02 0.928 . . . . 0.0 111.563 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -52.63 -33.44 46.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.461 0.704 . . . . 0.0 112.668 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -95.84 -31.59 13.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.902 -0.498 . . . . 0.0 111.598 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.07 142.24 47.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.661 0.785 . . . . 0.0 112.093 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 43.2 p -95.03 135.63 36.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.59 0.756 . . . . 0.0 110.758 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.5 ttt -70.9 -86.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 110.374 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.19 1.78 5.4 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-O 120.03 -0.317 . . . . 0.0 112.729 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -170.22 -55.67 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.018 0.927 . . . . 0.0 108.931 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -87.8 167.65 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.299 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.7 p90 -98.68 138.78 35.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.4 ' CG1' HG13 ' A' ' 15' ' ' VAL . 45.1 t -91.85 125.87 44.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -172.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.613 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 22.5 mt-10 -95.13 118.68 32.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.61 117.81 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.591 0.756 . . . . 0.0 110.065 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -68.33 136.27 53.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.075 0.852 . . . . 0.0 110.875 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -136.11 -151.58 0.42 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.52 1.128 . . . . 0.0 108.824 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -165.13 167.99 17.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 110.33 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.85 -37.04 85.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.399 1.079 . . . . 0.0 111.989 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.56 -42.84 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.204 0.602 . . . . 0.0 110.975 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.96 -38.6 76.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.1 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 55.9 ttp -53.31 -51.15 63.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.8 0.84 . . . . 0.0 110.037 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.27 -42.88 96.31 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.275 0.985 . . . . 0.0 111.144 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -58.58 -47.5 84.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.275 0.985 . . . . 0.0 110.8 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.9 t -71.42 -32.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.713 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 79.1 mt -73.02 -32.05 64.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.904 -0.498 . . . . 0.0 112.083 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.54 -18.23 61.56 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.3 m80 . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 124.469 1.108 . . . . 0.0 108.216 174.645 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.514 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.56 0.695 . . . . 0.0 111.392 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 60' ' ' GLU . 47.1 t -123.05 139.53 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -116.6 167.9 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.667 -0.646 . . . . 0.0 111.009 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -119.34 123.45 44.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.44 119.12 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -124.87 149.35 47.61 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.548 1.139 . . . . 0.0 108.967 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.02 57.53 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.48 135.84 81.35 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 123.224 0.609 . . . . 0.0 110.038 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 42.5 Cg_endo -69.1 133.83 27.8 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.998 1.798 . . . . 0.0 110.693 173.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -58.19 -29.56 65.76 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.593 1.157 . . . . 0.0 111.193 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -81.94 8.28 10.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.073 0.949 . . . . 0.0 112.553 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.49 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 12.9 p -113.85 142.06 46.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.68 -170.07 1.63 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.64 0.776 . . . . 0.0 109.322 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -43.37 70.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.404 1.081 . . . . 0.0 113.4 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.48 -38.23 83.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.28 0.632 . . . . 0.0 111.81 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -70.03 -37.6 75.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.737 0.815 . . . . 0.0 110.958 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.61 -35.7 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.226 0.61 . . . . 0.0 110.673 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG3' HD12 ' A' ' 36' ' ' ILE . 41.5 tt0 -66.81 -39.74 87.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -61.14 -39.19 89.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.735 1.214 . . . . 0.0 111.149 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.24 -42.05 99.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.526 0.33 . . . . 0.0 110.357 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.557 ' HB2' HD11 ' A' ' 36' ' ' ILE . 83.9 m-85 -94.97 32.49 1.66 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.004 0.522 . . . . 0.0 111.117 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 t -76.84 87.86 3.43 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 167.38 -55.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -159.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.421 ' HB3' HD22 ' A' ' 61' ' ' LEU . 58.0 m -82.55 171.73 13.76 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.138 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -123.15 72.91 1.13 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.2 mt -56.27 126.72 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.208 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -48.85 117.72 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.556 1.16 . . . . 0.0 111.397 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.3 t30 60.75 26.3 16.11 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 124.495 1.122 . . . . 0.0 111.991 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.4 -134.4 30.88 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.43 -0.805 . . . . 0.0 113.02 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.87 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.613 1.165 . . . . 0.0 113.531 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -72.48 -16.8 61.8 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.62 24.3 32.67 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -126.11 90.78 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.22 98.72 7.91 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.234 1.014 . . . . 0.0 109.628 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.89 138.36 55.97 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.655 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.2 mt -76.68 90.7 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -75.79 148.0 38.78 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.547 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.5 t -106.8 174.37 5.92 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.041 0.936 . . . . 0.0 109.433 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -57.28 -19.6 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.888 1.275 . . . . 0.0 112.918 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.34 -4.45 58.47 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.343 1.057 . . . . 0.0 111.209 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.89 30.57 51.49 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.14 0.3 . . . . 0.0 112.986 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.75 151.29 73.92 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.028 0.931 . . . . 0.0 110.482 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 145.63 53.34 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.192 1.928 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.1 p -74.48 -38.74 62.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.418 0.628 . . . . 0.0 110.409 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.49 -10.78 2.7 Favored Glycine 0 N--CA 1.468 0.771 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.757 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.58 150.72 24.4 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.196 0.998 . . . . 0.0 109.534 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.56 167.61 24.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.235 1.014 . . . . 0.0 109.885 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -111.7 122.63 48.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.93 107.88 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 12' ' ' VAL . 42.0 mt-10 -85.21 151.29 24.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 34' ' ' CYS . 73.6 mt -139.5 148.26 42.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.676 0.791 . . . . 0.0 109.213 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.65 -21.62 61.06 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -144.9 156.58 44.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.516 0.674 . . . . 0.0 110.811 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.55 -18.75 63.67 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.788 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.26 -55.65 32.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.322 0.649 . . . . 0.0 109.583 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 69' ' ' LEU . 36.3 mt-10 -52.11 -36.0 49.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.779 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 11' ' ' PHE . 76.0 t -60.83 -52.04 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.44 0.296 . . . . 0.0 110.706 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -57.42 -37.23 72.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.38 0.672 . . . . 0.0 112.619 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 66' ' ' GLU . 84.7 mt -60.55 -52.65 64.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.956 0.502 . . . . 0.0 110.558 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -56.14 -46.83 79.1 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.677 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.7 mt -57.58 -32.8 67.52 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.613 1.165 . . . . 0.0 111.843 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -76.48 -18.89 58.52 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.526 0.33 . . . . 0.0 111.082 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -88.46 9.96 21.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.65 8.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -129.56 -37.36 1.59 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.204 0.602 . . . . 0.0 110.192 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -52.04 143.29 14.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.428 1.091 . . . . 0.0 113.066 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.9 p -90.06 110.45 21.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.204 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.51 91.68 1.83 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 171.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.54 -96.25 1.14 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -164.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.99 -0.03 5.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.07 0.948 . . . . 0.0 109.911 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.25 114.91 19.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.064 0.946 . . . . 0.0 109.226 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.07 108.03 4.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.0 t -108.08 122.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.536 0.735 . . . . 0.0 110.062 -170.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.98 137.49 35.98 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.761 1.224 . . . . 0.0 109.129 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.5 t -124.17 116.16 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -104.03 -176.93 3.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.127 1.371 . . . . 0.0 107.699 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -109.53 136.97 48.06 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -128.59 148.84 50.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.754 0.822 . . . . 0.0 109.31 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -93.31 173.88 7.49 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -64.24 -19.21 65.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.77 171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.36 -54.91 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 123.785 0.834 . . . . 0.0 110.504 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.35 -45.05 70.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.295 0.638 . . . . 0.0 110.53 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -57.03 -48.68 77.92 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.456 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.03 -53.99 51.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.509 0.724 . . . . 0.0 111.122 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -65.02 -41.95 94.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.143 0.977 . . . . 0.0 112.888 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.4 t -82.71 -22.9 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.841 0.456 . . . . 0.0 111.174 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.48 -22.94 46.72 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 122.373 -0.204 . . . . 0.0 110.821 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.6 mmpt? -73.46 -38.94 65.3 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.5 t60 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -173.149 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 64' ' ' GLU . 10.5 m-30 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 122.052 0.93 . . . . 0.0 108.537 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.04 138.54 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.878 1.271 . . . . 0.0 108.719 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 70' ' ' ALA . 28.5 m -110.44 177.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.341 0.656 . . . . 0.0 110.446 165.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 19.6 ptmt -136.93 140.07 41.99 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.95 129.99 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.703 0.801 . . . . 0.0 109.134 -170.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.779 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 30.1 mtp-105 -129.94 159.43 36.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.111 0.964 . . . . 0.0 108.447 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.47 18.05 67.25 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.61 141.85 65.48 Favored Pre-proline 0 C--N 1.349 0.585 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.89 140.39 91.73 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 121.904 1.736 . . . . 0.0 111.47 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.43 ' HZ3' HH22 ' A' ' 81' ' ' ARG . 1.6 m-90 -68.07 -19.33 64.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.369 0.668 . . . . 0.0 110.099 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -97.97 12.4 34.31 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.511 1.125 . . . . 0.0 111.55 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 53.4 t -90.53 140.29 29.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.115 0.566 . . . . 0.0 109.676 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.6 p -117.14 172.4 7.31 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.082 0.953 . . . . 0.0 109.661 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -40.98 58.81 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.674 1.19 . . . . 0.0 114.138 -171.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.34 -39.95 73.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.984 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 1.8 mp0 -71.28 -41.04 70.53 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 0.0 111.322 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 43' ' ' ILE . 56.5 t -72.71 -30.31 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.13 -42.69 62.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.1 0.96 . . . . 0.0 110.173 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.58 -48.25 82.6 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.172 0.989 . . . . 0.0 110.677 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 79.2 t80 -63.35 -57.34 10.68 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -85.38 37.25 0.67 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.314 0.645 . . . . 0.0 111.368 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -57.59 -31.83 66.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.445 0.698 . . . . 0.0 110.692 166.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.11 -16.15 63.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.956 1.302 . . . . 0.0 112.329 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 70' ' ' ALA . 39.1 m -114.23 130.49 56.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.961 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 13.9 mmmm -75.3 90.0 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HA ' HD23 ' A' ' 61' ' ' LEU . 20.8 mt -73.89 129.75 36.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -44.19 -68.25 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.928 1.392 . . . . 0.0 113.413 -163.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -108.73 43.29 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.469 0.708 . . . . 0.0 109.852 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.23 -125.35 37.52 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.718 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.8 68.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.926 0.89 . . . . 0.0 112.022 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -77.58 -19.71 55.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.725 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.67 -20.67 75.94 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 116.525 -0.307 . . . . 0.0 112.38 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 59' ' ' VAL . 46.4 mt -79.89 140.66 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.544 0.738 . . . . 0.0 109.158 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 97' ' ' LEU . 28.4 mmt180 -127.26 96.76 4.68 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.961 0.504 . . . . 0.0 110.078 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 94.0 m-85 -77.87 136.91 38.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.464 0.306 . . . . 0.0 110.28 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.55 85.88 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.24 145.62 43.94 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.196 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 50' ' ' GLU . 8.9 t -109.42 178.87 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.1 0.56 . . . . 0.0 110.132 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.65 -5.53 8.67 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' H ' HG23 ' A' ' 48' ' ' THR . 10.3 tp10 -90.42 -17.43 27.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.93 0.892 . . . . 0.0 110.325 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.09 4.96 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.141 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HG22 ' A' ' 48' ' ' THR . 17.8 ptt85 -163.19 155.51 15.64 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.878 0.871 . . . . 0.0 111.225 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 36.2 Cg_endo -62.95 149.14 92.44 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.719 2.279 . . . . 0.0 112.015 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.0 p -95.15 19.55 10.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.192 0.997 . . . . 0.0 111.556 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 -17.13 49.37 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 120.034 -0.314 . . . . 0.0 113.622 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 38.9 tt0 -107.6 147.2 30.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.587 0.755 . . . . 0.0 110.111 175.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.92 36.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.467 1.107 . . . . 0.0 109.76 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.5 112.53 23.11 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 43' ' ' ILE . 72.2 t -93.96 116.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -86.93 137.41 32.4 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.449 0.468 . . . . 0.0 109.823 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 36' ' ' ILE . 56.4 mt -127.3 148.17 50.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.288 1.035 . . . . 0.0 108.555 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.13 -24.89 47.22 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.615 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.9 m -133.76 143.8 48.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.588 0.755 . . . . 0.0 110.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . 30.6 tt0 -77.03 -10.93 59.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.039 0.447 . . . . 0.0 111.695 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 25.9 t70 -65.72 -35.43 80.73 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 169.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 18.1 mm-40 -68.16 -31.27 70.71 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.952 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.24 -51.83 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.485 0.714 . . . . 0.0 110.645 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 18.8 ptpt -54.06 -38.7 65.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 123.286 0.366 . . . . 0.0 111.355 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 41.4 mt -64.06 -50.14 69.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.322 1.049 . . . . 0.0 110.955 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -56.53 -44.8 81.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.686 0.794 . . . . 0.0 111.946 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 85' ' ' VAL . 93.2 mt -59.87 -34.93 73.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.431 1.092 . . . . 0.0 111.472 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -76.83 -17.85 58.75 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.254 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 29.5 mtpp -89.42 3.33 52.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.268 0.627 . . . . 0.0 111.352 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.61 -59.13 4.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.866 0.866 . . . . 0.0 111.796 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -79.19 -11.47 59.97 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 157.03 18.17 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.67 0.747 . . . . 0.0 111.621 165.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.3 p -93.82 122.67 36.53 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.227 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.638 ' HB2' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -62.26 -77.36 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.628 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.58 87.72 0.29 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 166.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 78.39 -52.36 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.672 1.589 . . . . 0.0 112.062 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.43 HH22 ' HZ3' ' A' ' 20' ' ' TRP . 47.6 mtm180 -78.94 154.48 29.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.916 0.487 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -84.12 151.92 24.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.65 0.78 . . . . 0.0 109.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 78' ' ' MET . 12.2 t -96.52 156.93 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 111.087 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 29.0 mm-40 -115.27 115.0 25.94 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 161.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 71' ' ' LEU . 34.7 t -117.56 117.33 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.25 -178.11 3.37 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.63 135.56 50.4 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.8 m -130.11 -160.7 1.06 Allowed 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.022 0.929 . . . . 0.0 110.324 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -160.69 160.42 31.46 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.155 0.982 . . . . 0.0 113.08 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.94 -51.71 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.633 0.773 . . . . 0.0 110.852 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 95' ' ' TRP . 11.5 pm0 -83.99 -20.61 32.53 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.959 0.503 . . . . 0.0 110.752 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.467 ' SD ' ' HG3' ' A' ' 44' ' ' ARG . 50.1 ttm -60.06 -56.01 26.89 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.44 -41.2 98.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.98 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 65.0 t-105 -58.77 -53.65 56.02 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.162 0.585 . . . . 0.0 111.0 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.76 -25.68 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.476 0.71 . . . . 0.0 111.963 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 44' ' ' ARG . 85.0 mt -76.75 -43.61 36.45 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.599 0.36 . . . . 0.0 111.095 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.74 -32.84 27.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.254 1.022 . . . . 0.0 110.701 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 C--O 1.24 0.585 0 C-N-CA 125.243 1.417 . . . . 0.0 107.387 -178.033 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.3 p90 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.95 133.82 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 168.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 67' ' ' VAL . 23.1 m -96.2 155.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 122.608 0.363 . . . . 0.0 110.847 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 36.7 ttpt -109.0 117.65 34.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 83' ' ' VAL . 58.4 t -105.34 136.85 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.02 0.928 . . . . 0.0 108.636 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -140.41 134.51 30.9 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 111.72 81.55 1.16 Allowed Glycine 0 C--O 1.236 0.264 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -168.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.0 mt -139.67 135.34 16.71 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 114.097 -1.051 . . . . 0.0 109.164 -171.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.556 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 30.9 Cg_endo -65.74 131.41 27.46 Favored 'Trans proline' 0 C--N 1.361 1.217 0 N-CA-C 108.285 -1.467 . . . . 0.0 108.285 154.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -63.7 -24.71 67.89 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.63 0.772 . . . . 0.0 111.193 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -97.41 26.82 4.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.875 0.87 . . . . 0.0 111.624 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 27.4 p -78.95 155.25 29.05 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.223 0.609 . . . . 0.0 111.166 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -105.48 159.11 16.18 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.315 1.046 . . . . 0.0 109.553 171.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 -38.59 66.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.255 0.622 . . . . 0.0 110.794 169.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.97 -35.88 67.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.023 0.929 . . . . 0.0 112.129 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -64.55 -47.76 77.58 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.054 0.454 . . . . 0.0 111.349 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.74 -24.54 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.204 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -71.26 -49.7 40.42 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 109.96 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -58.05 -40.67 81.51 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.256 0.972 . . . . 0.0 110.26 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -59.78 -56.05 26.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HB2' HD11 ' A' ' 36' ' ' ILE . 65.9 m-85 -93.98 25.84 3.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.259 0.624 . . . . 0.0 111.858 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 t -64.01 -21.78 66.65 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.93 -43.02 84.32 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 81.8 m -75.0 140.05 43.34 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.182 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 12.4 mptt -84.28 90.97 7.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 31' ' ' PHE . 55.0 mt -64.71 121.84 14.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.212 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -59.49 124.3 19.6 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.132 0.895 . . . . 0.0 110.474 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.59 20.61 12.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.325 1.05 . . . . 0.0 111.278 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.57 -131.09 49.14 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.053 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.33 -29.93 25.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.293 1.037 . . . . 0.0 113.23 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -75.01 -21.83 58.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.396 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.27 -21.71 79.19 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.404 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.93 121.31 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 108.98 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 97' ' ' LEU . 83.2 mtt180 -128.52 96.9 4.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.924 0.89 . . . . 0.0 110.005 -169.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.5 132.1 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.43 83.97 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 84.4 m-85 -72.97 143.64 47.55 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.502 177.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.4 p -98.14 179.16 4.85 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.523 0.729 . . . . 0.0 109.427 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -68.85 -9.01 48.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.653 0.781 . . . . 0.0 111.765 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 13.9 tp10 -83.05 -14.17 54.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.072 0.949 . . . . 0.0 110.453 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.0 23.41 59.43 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 113.537 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 7.2 mpt_? -133.29 143.46 48.32 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 42.3 Cg_endo -65.44 155.79 66.92 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.88 1.72 . . . . 0.0 111.009 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.9 t -72.01 -3.82 25.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.294 0.638 . . . . 0.0 111.6 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.38 66.21 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -166.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.09 149.43 35.55 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.006 1.323 . . . . 0.0 111.148 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.39 166.79 27.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.118 1.367 . . . . 0.0 109.873 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -121.48 128.71 52.38 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.15 118.25 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -82.34 141.11 33.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -126.35 163.22 23.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.904 0.482 . . . . 0.0 110.405 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -31.22 70.77 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.977 0.911 . . . . 0.0 110.612 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 t -160.2 164.42 32.83 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 108.999 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -74.93 -13.66 60.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 0.0 110.729 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.62 -42.24 98.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.582 0.753 . . . . 0.0 110.582 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 7.9 mm-40 -59.7 -32.39 70.47 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.547 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 13' ' ' VAL . 76.0 t -67.63 -41.61 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.042 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -53.4 -46.63 69.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.778 0.831 . . . . 0.0 111.442 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.9 -46.26 85.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.658 0.783 . . . . 0.0 111.202 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -56.43 -46.4 80.28 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.378 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 96.6 mt -59.2 -39.17 81.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.333 1.053 . . . . 0.0 111.281 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -64.81 -29.14 70.1 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.674 0.609 . . . . 0.0 111.466 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -111.41 37.49 2.86 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.409 0.623 . . . . 0.0 111.351 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 85' ' ' VAL . 6.5 p-10 -75.43 18.58 0.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.394 0.677 . . . . 0.0 111.873 165.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -117.95 -29.49 5.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.539 1.535 . . . . 0.0 108.866 -168.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -58.94 146.01 39.44 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.241 1.017 . . . . 0.0 112.829 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 p -95.19 143.62 26.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.347 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ttt -112.11 98.22 7.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.31 1.06 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -151.46 15.55 0.69 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.135 0.974 . . . . 0.0 109.944 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 20.9 ttt180 -107.36 -145.2 0.39 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.505 ' H ' ' HG2' ' A' ' 81' ' ' ARG . 81.0 m-85 -157.81 128.75 6.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -160.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 15' ' ' VAL . 95.9 t -104.71 116.46 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 119.72 1.145 . . . . 0.0 109.293 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -96.82 118.23 32.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 107.622 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 33.2 t -114.06 116.83 53.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -111.04 -178.9 3.58 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' NZ ' HG11 ' A' ' 67' ' ' VAL . 22.5 ttmm -100.88 118.88 37.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.9 t -92.5 -178.79 5.01 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.906 0.86 . . . . 0.0 109.742 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -142.22 154.39 44.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.26 -38.14 79.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.98 -47.39 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 110.655 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -54.26 38.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.129 0.572 . . . . 0.0 111.193 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 42.1 ttp -55.26 -42.35 73.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.17 0.988 . . . . 0.0 111.385 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.68 -45.46 89.39 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.269 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -62.55 -44.81 95.42 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.749 0.656 . . . . 0.0 111.944 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.13 -25.12 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 123.748 0.655 . . . . 0.0 111.227 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HD3' ' A' ' 44' ' ' ARG . 86.6 mt -79.52 -29.08 41.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.912 0.485 . . . . 0.0 111.067 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -80.13 -28.3 38.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.022 0.529 . . . . 0.0 110.963 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 t60 . . . . . 0 C--O 1.237 0.438 0 C-N-CA 124.02 0.928 . . . . 0.0 108.656 -179.206 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.615 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.985 0.898 . . . . 0.0 112.273 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.21 133.93 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' A' ' 70' ' ' ALA . 28.9 m -105.08 168.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.095 0.474 . . . . 0.0 110.865 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -126.5 125.84 42.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -111.93 123.28 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 123.517 0.727 . . . . 0.0 109.174 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.702 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 52.5 ttt180 -127.86 147.55 50.45 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 22.88 34.52 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.78 137.27 54.44 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.43 0.692 . . . . 0.0 109.758 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 36.7 Cg_endo -67.08 135.92 39.07 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.516 2.144 . . . . 0.0 111.195 169.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' PRO . 26.8 p90 -60.73 -27.4 67.9 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 m -78.76 1.88 21.63 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.494 1.117 . . . . 0.0 112.976 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.504 ' SG ' ' HG2' ' A' ' 19' ' ' PRO . 14.9 p -119.07 152.31 36.7 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 m -116.7 -168.34 1.44 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.107 0.963 . . . . 0.0 109.808 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.3 61.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.882 1.273 . . . . 0.0 113.505 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.3 m-20 -51.08 -55.33 18.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.906 0.882 . . . . 0.0 112.931 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.92 -33.52 74.85 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.911 0.484 . . . . 0.0 111.682 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.98 -39.28 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.051 0.54 . . . . 0.0 109.856 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.83 -42.85 97.53 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.246 0.618 . . . . 0.0 110.756 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 33.2 mmt180 -66.36 -38.09 86.8 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.241 0.616 . . . . 0.0 111.06 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -65.03 -39.23 93.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.678 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 58.3 m-85 -95.13 28.8 2.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.469 0.707 . . . . 0.0 111.668 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 95.35 2.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 166.7 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.423 2.289 . . . . 0.0 107.396 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.1 p -115.82 136.84 52.67 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.548 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -81.68 98.35 8.35 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 61' ' ' LEU . 30.5 mt -77.98 115.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 45.8 tt0 -66.56 129.49 40.03 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.544 0.527 . . . . 0.0 110.535 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.6 m120 75.07 16.77 2.78 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.591 1.556 . . . . 0.0 110.425 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.77 -137.85 39.45 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.926 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.55 63.41 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.863 0.865 . . . . 0.0 112.218 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -75.46 -10.86 59.83 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.942 0.497 . . . . 0.0 111.789 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.96 -17.7 74.13 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.061 0.226 . . . . 0.0 112.757 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -84.14 116.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.573 0.749 . . . . 0.0 109.183 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -116.04 95.55 5.15 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.26 0.624 . . . . 0.0 109.873 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -73.29 139.42 46.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.892 0.477 . . . . 0.0 110.491 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.3 mm -79.26 112.9 17.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 165.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.88 167.1 11.63 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.512 0.725 . . . . 0.0 109.381 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -90.45 -176.61 4.83 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.514 0.726 . . . . 0.0 109.345 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.68 -14.09 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.107 0.412 . . . . 0.0 110.838 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.33 52.79 0.71 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.654 0.221 . . . . 0.0 113.654 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -115.99 131.26 23.83 Favored Pre-proline 0 N--CA 1.483 1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HB2' ' HA ' ' A' ' 20' ' ' TRP . 32.3 Cg_exo -57.54 123.36 13.58 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.64 2.226 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -78.21 -45.61 22.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.97 0.508 . . . . 0.0 110.163 -171.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.73 -12.73 1.51 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.24 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 16' ' ' ARG . 43.1 mt-10 -107.38 151.67 25.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.841 . . . . 0.0 110.218 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.72 167.03 30.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.615 1.166 . . . . 0.0 110.044 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.23 115.5 23.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.681 0.792 . . . . 0.0 108.923 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.1 t -97.16 115.63 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.1 tt0 -78.95 130.67 35.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.271 1.028 . . . . 0.0 109.564 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 36' ' ' ILE . 96.9 mt -130.13 140.41 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.222 0.609 . . . . 0.0 110.105 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.72 -20.11 59.97 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.476 0.711 . . . . 0.0 112.827 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 38.7 m -140.73 150.49 43.48 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.95 -12.69 61.36 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 120.888 0.375 . . . . 0.0 111.044 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.07 -52.22 50.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 169.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.581 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 5.2 mm-40 -47.71 -38.99 16.36 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.46 1.1 . . . . 0.0 111.532 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 11' ' ' PHE . 25.2 t -62.99 -52.95 52.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.237 0 C-N-CA 123.71 0.804 . . . . 0.0 111.471 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -57.09 -37.82 72.45 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.042 0.537 . . . . 0.0 112.404 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.23 -37.7 84.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.632 0.773 . . . . 0.0 111.686 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -64.65 -44.12 91.44 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 82.4 mt -62.48 -29.88 70.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -66.31 -21.67 66.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.219 1.008 . . . . 0.0 110.894 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 66.2 mttm -84.4 -4.17 58.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.928 0.891 . . . . 0.0 112.35 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 21.0 t70 -68.29 91.29 0.38 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.715 0.406 . . . . 0.0 110.192 173.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 145.43 -38.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 128.317 2.647 . . . . 0.0 109.021 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.66 144.07 39.13 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 p -92.59 120.8 33.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.198 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.472 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 ttt -61.65 -73.19 0.1 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.097 0.559 . . . . 0.0 110.851 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.84 -17.54 0.72 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 168.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -142.45 -66.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.668 1.187 . . . . 0.0 108.374 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -77.85 155.42 31.02 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.207 -172.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -81.25 127.38 32.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 90.9 t -88.96 120.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -170.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 28.9 mt-10 -94.91 116.69 29.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.409 HG12 HD23 ' A' ' 71' ' ' LEU . 11.5 t -117.03 114.52 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -106.08 144.67 32.46 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.445 1.098 . . . . 0.0 108.526 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.86 125.59 27.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 163.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.7 m -128.18 163.4 24.77 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.593 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -103.89 153.0 21.28 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.54 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.41 -32.75 72.7 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.221 1.008 . . . . 0.0 109.889 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.28 -44.01 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.639 0.776 . . . . 0.0 109.897 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.86 -38.48 83.15 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.1 ttm -56.01 -48.51 75.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.039 0.536 . . . . 0.0 110.01 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.89 -46.8 84.35 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.248 1.019 . . . . 0.0 110.53 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -58.31 -52.53 65.19 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.988 0.805 . . . . 0.0 111.816 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' HIS . 24.6 t -79.14 -25.22 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 -37.96 75.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.747 0.419 . . . . 0.0 110.409 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -90.68 -15.63 30.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.798 0.839 . . . . 0.0 111.428 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 23.7 t-80 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.607 1.163 . . . . 0.0 108.567 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 122.435 1.112 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -130.9 134.56 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.925 1.69 . . . . 0.0 107.582 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 70' ' ' ALA . 17.5 m -112.61 -175.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.858 0.863 . . . . 0.0 109.523 171.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.53 142.43 31.12 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.68 0.753 . . . . 0.0 109.54 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -111.49 119.43 59.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 108.611 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 61.1 mtp180 -123.98 148.56 46.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.25 1.02 . . . . 0.0 109.723 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.33 25.81 35.35 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -59.32 143.72 84.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.121 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.52 174.19 13.24 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.463 2.108 . . . . 0.0 111.275 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -68.75 -24.61 64.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.449 0.642 . . . . 0.0 109.536 171.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.0 m -81.41 1.43 33.06 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.447 1.099 . . . . 0.0 112.482 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.2 p -49.02 126.05 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.561 0.744 . . . . 0.0 112.881 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.52 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 45.7 t -146.3 158.91 43.93 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.919 1.287 . . . . 0.0 108.35 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . -53.95 -42.95 69.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.019 0.527 . . . . 0.0 110.688 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 6.8 m-20 -54.33 -43.62 71.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 112.658 173.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 13.3 mm-40 -68.04 -36.35 79.75 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.866 0.467 . . . . 0.0 110.875 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.0 t -66.78 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 123.33 0.652 . . . . 0.0 110.673 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 14.8 mm100 -56.92 -53.83 53.52 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.97 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 36.0 mmt180 -56.56 -46.17 80.88 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.41 1.084 . . . . 0.0 111.228 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.59 -40.47 83.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.821 1.248 . . . . 0.0 112.233 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -97.45 35.56 1.62 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.054 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 83.06 4.6 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 169.05 -62.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.003 1.721 . . . . 0.0 106.739 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.9 m -74.58 -177.66 3.25 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.207 168.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 126.74 17.03 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.831 0.824 . . . . 0.0 109.199 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.27 128.68 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.419 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -42.76 -61.74 1.18 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.963 1.705 . . . . 0.0 113.965 -160.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -116.52 40.81 2.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.231 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.25 -130.02 32.05 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.333 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -64.11 -14.52 55.37 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.09 -21.68 50.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.769 0.428 . . . . 0.0 111.501 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 28.89 7.71 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 40' ' ' ALA . 61.2 mt -128.51 127.46 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.615 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.1 tpp180 -131.29 96.68 4.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.694 0.621 . . . . 0.0 110.024 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.64 134.86 36.45 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.7 113.48 24.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -95.82 164.59 12.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.8 p -107.95 172.88 6.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 108.874 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 1.6 15.59 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -85.53 -6.41 59.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.74 0.816 . . . . 0.0 110.683 167.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.38 32.63 42.09 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.069 0.231 . . . . 0.0 113.1 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -135.3 139.64 32.13 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.573 0.749 . . . . 0.0 111.414 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -58.07 134.1 59.91 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 122.868 2.379 . . . . 0.0 112.187 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -69.29 -44.52 71.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.15 0.98 . . . . 0.0 110.986 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.53 -10.0 3.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.091 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 43.7 mt-10 -108.67 148.6 30.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.448 1.099 . . . . 0.0 110.137 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.81 152.18 32.31 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 124.38 1.072 . . . . 0.0 108.265 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.49 126.77 52.51 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.9 t -106.45 142.9 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -123.67 120.01 31.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -167.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.1 mt -117.37 161.07 20.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.376 0.67 . . . . 0.0 110.737 -165.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.68 -29.83 69.56 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -160.45 167.2 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.315 0.384 . . . . 0.0 110.543 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -73.02 -17.84 61.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.207 0.603 . . . . 0.0 111.305 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -44.66 89.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.59 -31.03 71.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.198 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.75 -40.9 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.589 0.756 . . . . 0.0 110.535 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -65.08 -38.15 89.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.36 0.664 . . . . 0.0 111.372 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 96.6 mt -65.66 -31.97 73.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.624 0.769 . . . . 0.0 111.324 172.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -69.04 -42.57 76.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.635 173.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 87' ' ' LYS . 84.9 mt -62.01 -39.71 93.21 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.687 0.795 . . . . 0.0 112.174 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.7 ptmt -75.03 -18.29 60.36 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.999 0.428 . . . . 0.0 110.475 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.18 6.28 23.16 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.518 1.127 . . . . 0.0 111.2 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -68.52 80.43 0.26 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.294 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 163.94 -44.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.869 0.867 . . . . 0.0 110.055 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -42.17 140.46 1.13 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.013 1.725 . . . . 0.0 113.36 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.6 p -100.37 110.53 22.74 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 -172.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.1 ttm -78.44 91.96 4.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.94 -86.54 1.27 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.999 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -132.14 7.26 4.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.881 0.872 . . . . 0.0 109.988 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -105.69 132.71 51.5 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.101 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -76.47 133.37 39.83 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.8 t -131.89 133.45 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.144 0.497 . . . . 0.0 110.392 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -98.53 148.2 24.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.695 1.198 . . . . 0.0 109.277 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' A' ' 70' ' ' ALA . 46.7 t -130.76 118.98 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.04 144.55 42.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' HD21 ' A' ' 71' ' ' LEU . 87.7 tttt -67.68 138.22 56.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -122.95 -160.54 0.9 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.12 159.42 41.58 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -60.71 -40.5 92.5 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.441 0.696 . . . . 0.0 110.723 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.16 -37.29 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.524 1.13 . . . . 0.0 110.976 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -68.75 -46.9 67.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 0.0 110.264 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.26 -45.66 87.44 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.114 0.966 . . . . 0.0 110.14 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.32 -43.36 99.01 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.13 0.972 . . . . 0.0 110.79 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.27 -54.49 45.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.167 0.987 . . . . 0.0 111.919 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.22 -35.28 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 0.0 111.617 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.615 HD11 ' HG2' ' A' ' 44' ' ' ARG . 88.5 mt -67.13 -36.42 81.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.059 0.543 . . . . 0.0 111.105 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -81.82 -32.14 31.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.962 0.905 . . . . 0.0 110.044 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 t60 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.462 -170.698 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HA ' HG21 ' A' ' 67' ' ' VAL . 17.8 p90 . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 122.178 0.99 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 60' ' ' GLU . 78.8 t -135.32 143.41 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 168.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.28 173.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.398 -0.814 . . . . 0.0 110.441 168.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -126.9 139.97 52.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.476 ' HB ' HD11 ' A' ' 18' ' ' LEU . 3.7 t -124.92 130.57 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.582 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 32.6 mtm180 -130.78 156.29 45.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.685 0.794 . . . . 0.0 108.891 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.46 -33.97 6.11 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.476 HD11 ' HB ' ' A' ' 15' ' ' VAL . 52.4 mt -34.77 112.36 0.44 Allowed Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.746 1.218 . . . . 0.0 112.594 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.69 163.98 19.9 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.686 2.257 . . . . 0.0 113.223 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -57.22 -34.74 68.85 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.871 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 t -95.55 13.54 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.601 0.761 . . . . 0.0 111.825 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -72.61 168.72 18.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.055 0.542 . . . . 0.0 111.224 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -137.63 156.53 47.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.949 0.899 . . . . 0.0 109.783 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.32 69.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.501 0.721 . . . . 0.0 111.188 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -50.76 -47.94 59.36 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.053 . . . . 0.0 112.741 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -68.01 -41.09 82.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.797 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 43' ' ' ILE . 33.4 t -72.05 -36.27 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.532 0.733 . . . . 0.0 110.282 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.564 ' HG2' HD12 ' A' ' 36' ' ' ILE . 26.1 tm0? -65.73 -43.43 89.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.809 . . . . 0.0 110.0 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -61.56 -42.28 98.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.865 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 59.5 t80 -61.31 -29.28 69.78 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.753 0.821 . . . . 0.0 111.638 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.94 37.65 2.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.576 0.751 . . . . 0.0 111.831 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 p -77.15 85.89 3.62 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.486 0.66 . . . . 0.0 109.58 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 168.95 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 126.721 2.008 . . . . 0.0 106.099 -161.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.3 m -78.81 169.67 17.87 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.977 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -127.8 94.35 3.93 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' A' ' 28' ' ' GLN . 14.6 mt -75.97 133.99 30.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.06 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -47.62 -55.96 8.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.193 1.397 . . . . 0.0 112.777 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -125.54 65.23 1.17 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.381 0.61 . . . . 0.0 109.424 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.48 -143.08 42.24 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.353 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.78 -14.77 60.24 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.867 0.867 . . . . 0.0 112.942 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.04 -19.54 58.54 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.111 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.88 -7.89 71.55 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.817 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.504 HG12 HG22 ' A' ' 59' ' ' VAL . 46.3 mt -93.23 134.21 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 124.181 0.992 . . . . 0.0 110.288 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -128.81 96.12 4.28 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.82 0.848 . . . . 0.0 111.588 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -73.84 117.44 15.62 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.537 HG13 HD23 ' A' ' 97' ' ' LEU . 2.4 mp -67.27 99.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -79.78 134.65 36.37 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.3 p -85.25 176.88 8.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.359 0.664 . . . . 0.0 111.531 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -68.37 -21.46 64.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.061 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 9.4 tp10 -80.03 -13.9 58.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.655 1.182 . . . . 0.0 110.716 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.93 11.34 73.7 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 3.7 mpt_? -106.43 141.5 22.92 Favored Pre-proline 0 N--CA 1.485 1.318 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.67 132.32 49.5 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.062 1.841 . . . . 0.0 110.12 167.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 t -76.13 9.56 2.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.249 1.02 . . . . 0.0 112.142 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 16' ' ' ARG . . . 85.92 -13.42 56.74 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.99 139.24 37.88 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.251 1.42 . . . . 0.0 109.721 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.78 136.92 29.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.545 0.738 . . . . 0.0 109.232 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD2' HD11 ' A' ' 46' ' ' ILE . 40.3 m-85 -96.2 106.87 19.12 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 HG12 ' A' ' 43' ' ' ILE . 60.1 t -91.19 122.27 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 12' ' ' VAL . 44.0 tt0 -101.56 136.58 41.17 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.9 mt -125.7 162.47 24.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.13 0.491 . . . . 0.0 110.698 -166.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.92 -35.13 57.55 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.01 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -154.13 167.95 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.677 0.751 . . . . 0.0 112.457 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 60.1 mm-40 -61.85 -32.36 72.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.36 1.464 . . . . 0.0 113.169 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.69 -46.68 88.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 1.6 mp0 -59.33 -33.93 71.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.85 170.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 80.9 t -62.14 -52.36 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 118.605 0.638 . . . . 0.0 110.532 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mttt -53.89 -41.27 67.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.427 1.091 . . . . 0.0 111.686 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.1 -41.56 86.06 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.036 0.534 . . . . 0.0 110.92 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.99 94.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.17 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 67.9 mt -57.78 -22.82 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.374 1.07 . . . . 0.0 112.775 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -74.78 -13.72 60.62 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.059 0.543 . . . . 0.0 111.401 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 3.8 mptp? -88.17 -2.47 58.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 118.89 -0.576 . . . . 0.0 112.254 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -53.05 -59.25 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -18.02 64.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 112.515 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -59.41 153.51 18.99 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.602 0.715 . . . . 0.0 112.496 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -100.45 150.92 22.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.639 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.63 114.09 6.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 108.535 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.39 -81.57 1.2 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -159.42 19.62 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.871 0.868 . . . . 0.0 109.735 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.85 139.76 47.07 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.307 0.643 . . . . 0.0 109.862 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -78.38 129.57 35.12 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.8 t -87.12 165.35 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.333 0.653 . . . . 0.0 109.697 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 49.0 mt-10 -135.19 117.32 15.44 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 115.66 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 84' ' ' GLU . 92.3 m-85 -117.05 179.59 3.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 120.62 40.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -109.61 140.56 43.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.786 0.834 . . . . 0.0 111.363 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -96.36 166.01 11.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.188 0.995 . . . . 0.0 109.018 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -62.67 -38.0 88.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.401 0.68 . . . . 0.0 110.746 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.24 -43.11 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.371 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -68.52 -41.65 79.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.329 1.052 . . . . 0.0 109.903 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 51.4 ttp -60.74 -52.89 63.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.892 1.277 . . . . 0.0 110.626 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.25 -45.57 92.78 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.776 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -60.94 -40.78 94.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.498 1.119 . . . . 0.0 111.605 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.4 t -81.08 -28.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.352 0.661 . . . . 0.0 111.678 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.537 HD23 HG13 ' A' ' 46' ' ' ILE . 69.8 mt -71.23 -43.47 67.27 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.94 -0.475 . . . . 0.0 110.948 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -82.46 -35.34 27.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.508 0.723 . . . . 0.0 112.74 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 119.243 -0.408 . . . . 0.0 112.062 -166.734 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.392 0.615 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.51 139.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.961 1.305 . . . . 0.0 107.898 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 70' ' ' ALA . 30.2 m -107.25 169.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 167.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 79.7 tttt -124.66 125.4 44.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 83' ' ' VAL . 59.5 t -112.66 125.42 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 108.929 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.794 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 76.3 mtp180 -117.7 149.36 40.87 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.03 19.68 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.588 -176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.33 121.96 64.08 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -54.1 149.91 33.77 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.948 2.432 . . . . 0.0 113.066 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -63.37 -25.93 68.52 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.537 0.684 . . . . 0.0 111.086 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 t -109.03 19.21 19.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.202 1.001 . . . . 0.0 111.025 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.7 p -78.29 177.84 8.11 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.655 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.2 t -128.21 148.45 50.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.546 0.738 . . . . 0.0 109.645 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.41 71.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.8 m-20 -54.85 -47.59 73.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 111.262 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 11.2 mm-40 -69.01 -41.25 78.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.412 0.685 . . . . 0.0 111.478 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 43' ' ' ILE . 45.5 t -69.14 -31.85 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.02 0.528 . . . . 0.0 109.691 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.64 -41.85 87.64 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.798 0.839 . . . . 0.0 110.598 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 67.6 mmt-85 -65.99 -37.2 85.35 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 0.0 111.262 176.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -68.13 -33.81 75.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.374 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -101.99 35.53 2.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.591 . . . . 0.0 110.684 175.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -82.34 79.76 8.71 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t70 170.54 -38.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.816 -158.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.8 m -102.11 173.05 6.56 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.344 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.529 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 6.0 mtpm? -126.78 95.14 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HA ' HD23 ' A' ' 61' ' ' LEU . 21.5 mt -76.62 139.51 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.659 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -45.89 -69.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.894 1.371 . . . . 0.0 112.112 -169.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 41' ' ' GLN . 1.2 t-20 -106.34 35.48 2.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.861 0.464 . . . . 0.0 110.278 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.66 -125.92 31.67 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.33 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -29.96 71.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.006 0.903 . . . . 0.0 111.063 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.2 mp0 -73.53 -18.01 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.17 0.588 . . . . 0.0 110.916 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.74 -15.7 81.37 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.208 0.317 . . . . 0.0 112.907 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 27' ' ' VAL . 63.7 mt -83.53 141.32 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.875 0.87 . . . . 0.0 109.424 178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HG2' HD11 ' A' ' 97' ' ' LEU . 3.3 tpp180 -133.96 95.23 3.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -73.58 128.4 35.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.918 0.487 . . . . 0.0 110.198 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.27 118.67 32.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 89.0 m-85 -90.01 172.09 9.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.256 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -101.29 173.09 6.61 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.639 165.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -68.59 -11.18 59.66 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.274 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -85.2 -2.64 58.26 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.819 0.848 . . . . 0.0 111.57 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.4 37.35 41.7 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -145.6 135.03 11.41 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.146 0.578 . . . . 0.0 111.21 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 87.6 Cg_exo -49.08 133.96 29.38 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.6 2.866 . . . . 0.0 113.76 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 p -67.72 -26.09 65.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.179 0.992 . . . . 0.0 111.386 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.99 -16.79 7.23 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -170.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB3' ' HE2' ' A' ' 14' ' ' LYS . 41.2 mt-10 -105.44 153.12 22.12 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.977 0.911 . . . . 0.0 110.574 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.76 168.82 25.56 Favored 'General case' 0 C--O 1.213 -0.854 0 C-N-CA 124.69 1.196 . . . . 0.0 108.979 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -119.37 124.45 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.673 0.789 . . . . 0.0 109.674 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.87 111.75 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.93 136.0 35.98 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 36' ' ' ILE . 70.3 mt -126.9 144.22 51.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.519 0.728 . . . . 0.0 109.819 -171.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -66.38 -17.64 64.89 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.8 p -166.65 170.36 12.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.96 0.504 . . . . 0.0 110.945 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.59 -21.14 65.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.443 1.097 . . . . 0.0 113.367 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -49.0 77.71 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mp0 -59.4 -33.11 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.831 0.852 . . . . 0.0 112.51 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 55.3 t -60.06 -48.61 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.426 0.454 . . . . 0.0 109.916 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.32 -36.74 83.09 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.974 0.91 . . . . 0.0 112.048 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.26 -41.57 99.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.404 0.682 . . . . 0.0 111.607 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -64.02 -43.98 93.96 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.059 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 98.0 mt -64.31 -33.32 75.57 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.996 0.918 . . . . 0.0 112.747 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -16.26 50.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.909 -0.494 . . . . 0.0 110.123 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -83.58 -9.36 58.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.912 0.885 . . . . 0.0 111.002 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.493 ' HB2' ' HB ' ' A' ' 85' ' ' VAL . 5.0 t70 -62.14 100.09 0.16 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 149.38 -49.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.387 2.275 . . . . 0.0 108.67 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -55.52 146.29 20.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.034 1.333 . . . . 0.0 113.56 -168.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 25.7 p -98.6 121.39 40.49 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.803 0.841 . . . . 0.0 110.904 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ptp -83.81 74.59 10.17 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 122.005 0.907 . . . . 0.0 108.949 164.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.05 -89.95 1.38 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.126 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.98 -23.26 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.508 0.723 . . . . 0.0 111.867 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -122.35 139.24 54.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.063 0.545 . . . . 0.0 111.761 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 21.4 p90 -85.71 142.84 28.72 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.607 1.163 . . . . 0.0 108.815 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 15' ' ' VAL . 37.7 t -103.88 131.6 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.579 0.752 . . . . 0.0 111.54 -170.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 26.4 tp10 -104.78 119.33 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 108.783 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 74' ' ' ASP . 56.3 t -118.33 117.05 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.083 0.553 . . . . 0.0 110.62 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.75 139.83 44.35 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.967 . . . . 0.0 109.564 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -68.02 126.41 29.41 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -132.91 -162.12 1.21 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.044 0.938 . . . . 0.0 109.466 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.54 162.82 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.297 0.639 . . . . 0.0 109.401 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.7 -31.46 71.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.841 0.856 . . . . 0.0 110.498 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.57 -42.13 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.362 0.665 . . . . 0.0 110.98 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 96' ' ' VAL . 18.1 tp10 -64.51 -49.54 70.92 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.0 -46.06 68.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.107 1.363 . . . . 0.0 111.391 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.9 -44.13 97.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.812 0.845 . . . . 0.0 111.331 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -63.46 -39.66 95.06 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.565 0.746 . . . . 0.0 111.406 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 92' ' ' GLU . 5.2 t -79.05 -18.95 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.739 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.516 HD11 ' HG2' ' A' ' 44' ' ' ARG . 97.8 mt -78.63 -30.0 46.21 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.957 0.503 . . . . 0.0 111.118 168.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -78.85 -35.85 43.26 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.573 0.749 . . . . 0.0 109.592 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.747 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.79 0.329 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.4 t -134.28 140.48 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.296 1.038 . . . . 0.0 108.58 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 61' ' ' LEU . 30.0 m -107.48 167.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 0.0 110.549 164.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HE3' ' HD2' ' A' ' 16' ' ' ARG . 3.7 tmmm? -119.82 122.72 41.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.54 123.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 108.611 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HD2' ' HE3' ' A' ' 14' ' ' LYS . 12.0 ptm180 -139.95 154.71 47.27 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.17 21.06 23.82 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.21 138.09 30.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.209 1.004 . . . . 0.0 108.775 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 157.21 62.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.718 2.279 . . . . 0.0 112.307 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -52.28 -35.78 51.08 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.432 1.093 . . . . 0.0 111.851 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.6 p -93.2 17.26 11.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.015 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.48 166.17 15.27 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 123.393 0.677 . . . . 0.0 111.53 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.1 m -151.02 163.04 39.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 108.976 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -44.1 69.19 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 111.209 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.08 -40.42 73.57 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.167 0.987 . . . . 0.0 113.379 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -55.96 -48.19 76.24 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.447 0.641 . . . . 0.0 110.926 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.1 t -81.83 -22.98 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.699 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -71.26 -48.25 52.18 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.375 0.67 . . . . 0.0 109.949 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -63.91 -38.46 91.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.48 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.44 -46.49 88.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.539 ' HB2' HD11 ' A' ' 36' ' ' ILE . 96.3 m-85 -99.07 38.16 1.43 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.859 0.863 . . . . 0.0 110.698 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -66.13 -29.07 69.31 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.78 0.432 . . . . 0.0 110.764 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.69 -10.96 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.981 1.312 . . . . 0.0 112.23 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.419 ' HB3' HD23 ' A' ' 61' ' ' LEU . 39.5 m -121.85 139.78 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.791 0.837 . . . . 0.0 109.213 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.06 92.1 6.19 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.8 mt -69.03 144.14 14.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.916 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.22 100.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.716 0.806 . . . . 0.0 110.003 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 36.0 m-80 54.28 35.29 22.41 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 124.269 0.981 . . . . 0.0 111.756 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -121.54 24.58 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.651 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -27.62 17.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 3.5 tp-100 -68.41 -21.7 64.66 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.18 -21.37 45.72 Favored Glycine 0 N--CA 1.471 1.023 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.423 HG23 HG22 ' A' ' 59' ' ' VAL . 56.7 mt -83.46 107.78 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.116 0.567 . . . . 0.0 110.139 -173.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.49 98.01 5.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.45 0.7 . . . . 0.0 110.927 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -75.22 151.7 38.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.037 0.535 . . . . 0.0 111.646 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.84 86.36 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 165.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.67 147.84 45.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.0 t -109.17 -179.3 3.81 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -176.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -77.1 -2.83 36.24 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.506 0.722 . . . . 0.0 111.59 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 48' ' ' THR . 40.1 tt0 -89.03 -19.12 26.04 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.684 1.194 . . . . 0.0 110.043 172.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 45.89 5.98 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.732 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -144.4 157.22 56.55 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 124.24 1.016 . . . . 0.0 109.923 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.89 135.97 73.79 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.436 2.091 . . . . 0.0 111.348 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -100.12 36.94 1.74 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.479 1.111 . . . . 0.0 110.495 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.29 -40.49 2.88 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.562 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.31 155.18 19.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 110.985 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 161.62 42.37 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 109.261 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -120.8 113.37 20.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.246 1.018 . . . . 0.0 108.616 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 43' ' ' ILE . 77.9 t -107.47 121.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.0 0.92 . . . . 0.0 108.823 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.517 ' HG2' HG22 ' A' ' 12' ' ' VAL . 29.4 mt-10 -86.09 156.41 20.39 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.048 0.539 . . . . 0.0 109.795 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.584 HD13 HG22 ' A' ' 67' ' ' VAL . 3.6 mp -138.21 156.71 47.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.937 0.895 . . . . 0.0 109.681 -176.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.18 -26.47 47.61 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.937 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.8 m -145.59 153.72 41.37 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -31.28 72.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.58 1.152 . . . . 0.0 111.158 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.11 -49.13 77.14 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.19 0.519 . . . . 0.0 110.097 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -58.06 -35.22 71.04 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.795 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG22 HD13 ' A' ' 61' ' ' LEU . 79.3 t -61.62 -50.22 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -56.75 -36.98 70.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.668 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.45 -42.3 87.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.362 0.665 . . . . 0.0 111.035 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -61.78 -40.19 94.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.801 0.84 . . . . 0.0 111.024 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 81.1 mt -61.62 -23.5 66.08 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.25 1.02 . . . . 0.0 112.547 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.25 -4.85 56.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.618 0.367 . . . . 0.0 111.776 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.68 4.94 49.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.062 0.945 . . . . 0.0 111.781 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.567 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 26.8 t70 -38.83 -12.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 170.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -144.78 -11.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.134 -0.979 . . . . 0.0 111.553 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -52.12 139.73 22.59 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.146 0.978 . . . . 0.0 111.708 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.8 p -93.01 127.71 38.62 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.945 0.898 . . . . 0.0 112.435 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -94.02 102.64 14.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.88 -90.2 0.32 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.51 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -120.43 -4.32 9.88 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.102 0.961 . . . . 0.0 111.354 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -124.75 147.88 48.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.615 0.366 . . . . 0.0 110.849 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -79.91 141.29 36.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.39 123.84 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 34.9 mt-10 -95.46 129.02 42.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.247 1.019 . . . . 0.0 108.977 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.567 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 27.8 t -127.01 118.53 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -113.87 177.67 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -111.89 128.8 56.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.1 m -122.9 -166.31 1.43 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.15 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.513 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 23.9 m-80 -136.46 161.46 35.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -63.21 -35.12 79.28 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.75 -41.92 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.185 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.513 ' HB3' ' H ' ' A' ' 89' ' ' ASN . 8.9 tp10 -62.96 -51.75 65.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.156 0.982 . . . . 0.0 110.518 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.486 ' HB2' HG11 ' A' ' 12' ' ' VAL . 10.9 tmm? -57.62 -50.52 72.88 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.25 1.42 . . . . 0.0 111.183 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.31 -39.51 92.59 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.526 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -61.2 -50.9 71.25 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 0.0 111.504 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.19 -39.1 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.484 0.49 . . . . 0.0 111.376 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.421 HD12 ' SD ' ' A' ' 93' ' ' MET . 94.0 mt -65.41 -29.27 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.296 0.238 . . . . 0.0 111.383 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -86.67 -33.16 20.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.442 0.697 . . . . 0.0 110.62 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 124.969 1.308 . . . . 0.0 108.294 -178.42 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 CA--C 1.551 1.008 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.36 138.65 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.828 0.851 . . . . 0.0 109.959 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -107.37 162.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.201 0.601 . . . . 0.0 110.32 165.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 38.4 ttpt -113.6 120.63 41.58 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.5 118.36 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -169.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -122.1 147.7 45.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.423 1.489 . . . . 0.0 107.188 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.5 20.0 21.15 Favored Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.5 mt -92.74 117.01 67.41 Favored Pre-proline 0 C--O 1.244 0.781 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.147 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.72 157.74 7.12 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.017 2.478 . . . . 0.0 113.222 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -61.96 -18.78 61.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.604 0.762 . . . . 0.0 112.285 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 m -110.97 14.7 22.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.746 0.819 . . . . 0.0 112.168 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.64 170.67 6.02 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.205 0.457 . . . . 0.0 111.303 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -139.73 156.11 46.97 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.116 0.566 . . . . 0.0 109.492 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.25 84.28 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.828 0.705 . . . . 0.0 110.721 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.8 m-20 -53.8 -42.61 68.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.516 0.726 . . . . 0.0 112.563 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.98 -39.96 95.32 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.115 0.566 . . . . 0.0 111.876 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.2 t -68.61 -35.23 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.54 0.736 . . . . 0.0 110.096 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -65.38 -40.54 93.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.303 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 70.6 mtp180 -59.99 -47.15 87.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.187 0.595 . . . . 0.0 111.045 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.93 -34.16 74.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.475 0.71 . . . . 0.0 111.488 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.733 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 63.2 m-85 -108.35 24.9 12.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.693 0.797 . . . . 0.0 111.655 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.2 p -74.16 90.61 2.06 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.7 t70 166.08 -53.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -160.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 16.8 p -76.68 -175.56 3.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 33.3 mmtp -129.17 96.11 4.23 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 61' ' ' LEU . 24.4 mt -76.45 139.04 19.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -66.06 110.28 2.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.955 0.902 . . . . 0.0 110.31 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 85.9 m-20 60.04 31.52 20.66 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.903 0.881 . . . . 0.0 111.179 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 -125.24 34.09 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.699 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.9 -24.21 22.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.035 0.934 . . . . 0.0 113.46 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 2.6 tp-100 -71.33 -18.05 62.41 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.694 0.397 . . . . 0.0 112.053 -176.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.67 -18.29 58.64 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.63 -0.259 . . . . 0.0 112.625 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' A' ' 27' ' ' VAL . 54.5 mt -85.18 110.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.0 109.675 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -123.24 99.7 6.48 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.553 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -78.31 138.83 38.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.953 0.501 . . . . 0.0 110.417 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.56 99.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.26 153.85 28.24 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.826 0.346 . . . . 0.0 110.707 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.6 p -87.03 -172.95 4.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.603 0.761 . . . . 0.0 109.515 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -76.65 -0.12 22.3 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.675 0.39 . . . . 0.0 111.568 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -101.55 -20.73 14.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.033 0.933 . . . . 0.0 109.462 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.21 45.14 4.51 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.29 138.91 26.12 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.18 0.992 . . . . 0.0 109.234 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.08 120.91 8.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.66 2.24 . . . . 0.0 111.168 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.6 m -82.91 25.35 0.68 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.049 0.94 . . . . 0.0 112.064 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.41 -33.43 4.12 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.159 0.409 . . . . 0.0 112.476 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -111.18 156.08 21.95 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.592 1.157 . . . . 0.0 110.761 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.68 169.39 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.058 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -121.69 115.98 23.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.765 0.826 . . . . 0.0 109.472 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.89 112.51 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -84.02 141.9 30.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.797 0.839 . . . . 0.0 109.015 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 36' ' ' ILE . 39.7 mt -131.54 165.27 23.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.919 0.887 . . . . 0.0 110.22 -168.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.88 -39.73 87.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.406 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 t -164.74 174.79 10.32 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.818 0.447 . . . . 0.0 110.122 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 7.6 pt-20 -60.54 -27.71 67.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.167 0.987 . . . . 0.0 112.57 -174.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.35 -50.93 41.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 14.3 mp0 -51.59 -37.24 48.98 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.313 1.045 . . . . 0.0 111.637 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 44.3 t -60.11 -52.51 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.369 172.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -57.3 -40.09 77.09 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.62 0.768 . . . . 0.0 111.948 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 66' ' ' GLU . 86.1 mt -58.64 -45.34 89.5 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.997 0.919 . . . . 0.0 110.641 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.36 84.49 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.478 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 92.1 mt -58.35 -37.13 74.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.679 1.192 . . . . 0.0 112.096 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -72.4 -5.66 38.09 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -98.98 9.61 43.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.252 1.021 . . . . 0.0 112.774 172.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.76 10.01 0.15 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -123.02 -23.18 5.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.31 0.644 . . . . 0.0 110.781 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.27 148.18 45.75 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.776 0.798 . . . . 0.0 112.216 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -99.79 137.79 37.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.309 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.2 ttt -142.59 111.42 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.614 1.166 . . . . 0.0 109.114 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.2 58.25 7.55 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.041 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 t60 71.89 -7.49 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 125.073 1.349 . . . . 0.0 112.809 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -116.85 149.59 39.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.518 1.127 . . . . 0.0 110.162 -172.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -80.78 138.89 36.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.51 123.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -95.26 119.48 33.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.7 t -113.2 114.14 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.4 m-85 -103.39 171.81 7.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.609 1.164 . . . . 0.0 110.355 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -97.14 104.57 16.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -106.2 -171.7 1.95 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.015 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.85 163.44 34.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.732 1.213 . . . . 0.0 108.934 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -61.13 -38.39 86.22 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.15 -49.44 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.161 -1.382 . . . . 0.0 110.521 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.81 -42.42 95.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.1 ttp -52.58 -56.86 12.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.066 0.946 . . . . 0.0 111.554 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 17.4 t70 -65.86 -46.0 80.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.901 0.751 . . . . 0.0 111.759 -173.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -69.19 -44.93 71.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.202 0.601 . . . . 0.0 112.543 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.09 -42.65 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 122.673 0.389 . . . . 0.0 110.656 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -38.74 85.49 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.195 0.598 . . . . 0.0 110.188 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -78.57 -18.78 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.681 0.793 . . . . 0.0 109.984 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 CA--C 1.555 1.139 0 C-N-CA 123.315 0.646 . . . . 0.0 109.288 172.722 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -98.97 138.56 23.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.775 1.23 . . . . 0.0 109.247 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -108.75 173.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.768 0.827 . . . . 0.0 109.121 165.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 18.1 ptpt -121.53 129.54 52.97 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.69 117.55 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.12 158.24 18.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -172.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 73.25 32.65 59.95 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 121.464 0.48 . . . . 0.0 112.874 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.25 133.42 38.72 Favored Pre-proline 0 C--O 1.243 0.736 0 C-N-CA 123.753 0.821 . . . . 0.0 109.041 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -54.7 145.44 60.04 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.71 2.274 . . . . 0.0 112.468 170.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -58.7 -30.52 67.47 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.158 0.983 . . . . 0.0 111.011 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.6 p -105.81 20.05 19.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.461 1.104 . . . . 0.0 111.64 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -68.65 169.99 10.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.333 0.653 . . . . 0.0 111.009 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 26' ' ' GLU . 88.2 p -126.39 156.92 39.78 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -35.2 67.42 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.441 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.14 -40.32 70.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.78 1.232 . . . . 0.0 112.957 173.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG2' ' OG ' ' A' ' 23' ' ' SER . 58.6 mm-40 -64.35 -40.11 95.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.336 177.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 43' ' ' ILE . 46.7 t -76.77 -26.12 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -64.07 -53.6 47.15 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.256 1.023 . . . . 0.0 110.134 173.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -58.65 -46.92 86.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.158 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -68.17 -44.27 76.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.076 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -97.24 36.22 1.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.738 0.815 . . . . 0.0 110.301 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 p -59.58 -23.37 62.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.164 0.585 . . . . 0.0 112.295 173.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.05 -49.96 73.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.409 0.684 . . . . 0.0 110.331 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' HD22 ' A' ' 61' ' ' LEU . 34.2 m -82.92 131.57 35.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.619 -172.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -79.54 105.23 10.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -83.77 147.19 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.508 0.723 . . . . 0.0 109.44 -177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -41.73 -70.18 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 126.512 1.925 . . . . 0.0 114.172 -166.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -118.71 48.02 1.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 168.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.97 -120.5 23.02 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.515 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -62.5 -31.41 72.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.629 0.772 . . . . 0.0 112.068 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.94 -19.66 58.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.452 0.701 . . . . 0.0 111.222 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -16.01 79.67 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.661 -0.245 . . . . 0.0 112.795 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 ' HB ' ' A' ' 27' ' ' VAL . 66.1 mt -85.55 127.92 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.225 1.01 . . . . 0.0 109.545 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' NH1' ' SD ' ' A' ' 93' ' ' MET . 55.1 mtt180 -130.66 98.74 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 109.786 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.29 142.94 43.2 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.744 0.418 . . . . 0.0 110.489 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.719 HD12 ' HG2' ' A' ' 56' ' ' GLU . 61.4 mt -86.31 90.6 3.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -72.37 156.27 39.26 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.825 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.7 p -84.63 -173.17 4.58 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.552 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -63.89 -17.65 63.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB3' ' NH2' ' A' ' 52' ' ' ARG . 70.7 mm-40 -88.52 -5.92 57.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.777 1.231 . . . . 0.0 111.468 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.47 63.43 Favored Glycine 0 C--N 1.352 1.436 0 O-C-N 123.429 0.456 . . . . 0.0 113.268 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 50' ' ' GLU . 48.8 mtm180 -137.85 139.59 26.88 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 110.013 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.77 128.6 29.12 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.288 2.659 . . . . 0.0 112.045 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -74.84 -68.18 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.45 -11.94 0.02 OUTLIER Glycine 0 N--CA 1.474 1.187 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.108 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.719 ' HG2' HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -128.95 168.24 16.27 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 111.225 177.132 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HA ' HG13 ' A' ' 46' ' ' ILE . . . -152.91 172.02 17.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.976 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -120.75 122.04 39.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 0.0 109.064 166.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 43' ' ' ILE . 81.1 t -116.25 117.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.064 0.946 . . . . 0.0 108.521 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 33.1 tt0 -86.34 147.26 26.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 83.4 mt -130.01 156.14 44.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.172 0.989 . . . . 0.0 110.347 -169.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.32 -26.21 64.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.064 0.946 . . . . 0.0 111.551 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 74.4 m -148.53 160.64 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.557 0.743 . . . . 0.0 110.278 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.75 -15.14 61.67 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.262 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 22.9 t70 -72.22 -38.88 68.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.886 0.474 . . . . 0.0 110.304 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 22.4 mm-40 -61.18 -33.47 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.96 169.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 54.5 t -63.11 -37.19 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.075 0.55 . . . . 0.0 110.004 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 67.9 mmtt -57.98 -48.44 79.99 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.829 0.452 . . . . 0.0 111.036 171.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.1 -26.24 68.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.659 0.784 . . . . 0.0 112.07 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -78.2 -45.24 23.57 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.523 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 55.9 mt -67.03 -28.73 68.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -78.12 -15.34 58.95 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.005 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -87.3 -8.22 56.96 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.736 1.215 . . . . 0.0 110.804 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.3 93.15 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.584 0.754 . . . . 0.0 108.988 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 154.12 -53.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.721 2.008 . . . . 0.0 108.869 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.14 141.63 22.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 113.397 -167.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.4 p -83.28 126.18 32.4 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.26 1.024 . . . . 0.0 112.385 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.2 tpp -82.64 85.9 6.93 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.44 -75.9 0.66 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -114.33 -45.2 3.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.082 0.953 . . . . 0.0 109.669 171.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -67.06 -145.85 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.422 1.489 . . . . 0.0 112.092 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 32.5 t80 -160.98 120.54 2.64 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.837 -1.164 . . . . 0.0 108.388 -158.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 98.4 t -99.41 130.23 48.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 123.573 0.749 . . . . 0.0 110.381 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.85 121.59 40.35 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.572 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -118.36 122.91 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -119.37 142.43 48.17 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.444 ' HB2' HD11 ' A' ' 71' ' ' LEU . 19.5 ttmm -57.9 116.79 3.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.859 0.863 . . . . 0.0 109.762 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.1 m -114.55 -174.28 2.45 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.482 0.658 . . . . 0.0 110.921 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -131.62 152.0 51.17 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.37 -33.01 74.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.304 0.642 . . . . 0.0 109.919 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.0 -48.21 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.611 1.164 . . . . 0.0 110.249 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.46 -34.82 74.94 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.676 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' ' NH1' ' A' ' 44' ' ' ARG . 54.9 ttp -57.35 -55.19 37.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.865 0.866 . . . . 0.0 110.935 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.05 -39.86 93.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.769 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 44.0 t90 -57.33 -42.68 82.37 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.171 0.92 . . . . 0.0 111.714 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -80.96 -40.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.42 -176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.69 -17.34 63.47 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.692 -0.63 . . . . 0.0 111.482 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -68.9 -39.42 79.73 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.034 0.933 . . . . 0.0 112.304 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.9 t60 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 123.344 0.657 . . . . 0.0 109.427 -168.452 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 60' ' ' GLU . 17.3 t -114.65 145.15 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 108.549 -174.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.22 175.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.497 0.719 . . . . 0.0 109.82 162.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -127.58 140.31 52.2 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.52 113.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -112.22 147.2 36.71 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 81' ' ' ARG . . . 90.32 27.42 20.56 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 121.407 0.448 . . . . 0.0 112.394 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.39 146.1 46.78 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 123.737 0.815 . . . . 0.0 109.304 172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HG3' ' A' ' 81' ' ' ARG . 1.3 Cg_endo -51.47 149.83 16.96 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.337 2.025 . . . . 0.0 111.872 165.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -59.83 -26.49 65.85 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.471 0.708 . . . . 0.0 111.964 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -119.13 36.9 4.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.227 1.011 . . . . 0.0 109.74 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.27 151.1 48.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.674 0.389 . . . . 0.0 110.347 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.7 t -111.13 146.41 36.89 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.576 0.75 . . . . 0.0 109.047 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -34.4 66.62 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.66 0.6 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 11.2 m-20 -54.98 -49.35 71.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.867 0.867 . . . . 0.0 112.261 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 12.2 mm-40 -69.25 -34.39 74.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.893 0.477 . . . . 0.0 111.101 -174.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.36 -37.9 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.202 0.601 . . . . 0.0 109.711 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.24 -44.49 88.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.151 0.98 . . . . 0.0 111.266 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 29.6 mmt85 -62.39 -39.84 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.477 0.711 . . . . 0.0 110.839 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -38.18 87.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.466 0.707 . . . . 0.0 110.045 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 59.1 m-85 -101.43 28.75 5.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.239 0.615 . . . . 0.0 112.019 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 t -80.98 83.25 6.74 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 171.22 -39.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.884 1.274 . . . . 0.0 108.268 -161.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 23.4 p -114.92 127.44 55.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.843 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.61 100.47 6.15 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.295 0.638 . . . . 0.0 109.598 -171.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.626 ' HA ' HD23 ' A' ' 61' ' ' LEU . 45.9 mt -74.05 127.6 35.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.338 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.04 121.15 13.45 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.111 0.882 . . . . 0.0 109.377 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 69.28 12.59 8.42 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.944 1.298 . . . . 0.0 112.056 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.27 -134.17 42.51 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.82 -19.57 64.2 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.489 0.716 . . . . 0.0 112.309 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -73.74 -16.93 61.16 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.149 0.58 . . . . 0.0 112.091 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.63 -6.39 76.98 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 123.533 0.52 . . . . 0.0 112.424 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 59' ' ' VAL . 51.5 mt -92.05 123.69 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 110.686 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -132.4 105.62 7.39 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.926 1.29 . . . . 0.0 109.366 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -68.6 143.65 54.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.3 93.75 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.1 134.4 37.72 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.635 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p -75.64 -172.03 1.74 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.53 0.732 . . . . 0.0 110.95 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.2 -20.4 66.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -91.4 0.98 57.44 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.851 0.86 . . . . 0.0 110.396 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.22 71.04 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -107.94 134.49 20.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.493 0.717 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.54 121.34 9.87 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.562 2.175 . . . . 0.0 111.179 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.0 p -73.04 -8.85 57.59 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.8 0.84 . . . . 0.0 112.224 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.15 54.81 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -109.15 154.22 22.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.498 1.119 . . . . 0.0 109.535 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.07 169.43 21.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 110.469 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.03 127.55 53.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.797 1.239 . . . . 0.0 109.125 165.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 43' ' ' ILE . 55.3 t -118.12 119.75 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG2' HG22 ' A' ' 12' ' ' VAL . 44.0 mt-10 -79.87 146.47 32.18 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 36' ' ' ILE . 71.8 mt -136.13 136.55 40.17 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.04 -10.59 41.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -167.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.442 ' OG ' ' HG2' ' A' ' 66' ' ' GLU . 97.1 p -153.51 161.42 42.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.324 0.649 . . . . 0.0 110.433 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 37.1 tt0 -71.41 -16.93 62.42 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.454 0.702 . . . . 0.0 111.056 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.41 -48.66 55.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 41.3 mm-40 -54.08 -34.99 61.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 123.831 0.707 . . . . 0.0 111.829 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 37.6 t -60.75 -49.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.05 0.54 . . . . 0.0 110.738 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 92.3 mttt -59.76 -36.75 77.29 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.584 0.754 . . . . 0.0 112.167 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 93.6 mt -63.48 -43.99 95.71 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.43 0.692 . . . . 0.0 111.444 174.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.6 -46.8 86.24 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.004 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 87' ' ' LYS . 82.6 mt -62.77 -30.67 71.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.301 1.041 . . . . 0.0 112.984 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 20.0 ptmt -78.67 -13.01 60.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 120.72 0.295 . . . . 0.0 110.783 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.22 3.78 54.79 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.831 0.852 . . . . 0.0 111.08 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 90.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.384 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 164.44 -52.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.863 1.265 . . . . 0.0 111.224 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.83 169.97 16.85 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.435 0.636 . . . . 0.0 112.674 -165.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -113.12 139.23 48.9 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.371 -162.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -103.15 67.54 0.94 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.947 1.299 . . . . 0.0 108.859 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.15 58.12 3.26 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.799 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.0 m80 72.62 -7.71 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.684 1.594 . . . . 0.0 112.763 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 23.0 mmt180 -77.98 104.87 8.81 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -66.16 112.38 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.51 133.26 47.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.96 130.43 55.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 108.86 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.93 116.27 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.47 137.7 54.79 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 71' ' ' LEU . 77.9 tttt -67.2 136.28 54.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -121.3 155.96 33.58 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.063 0.945 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' H ' ' A' ' 92' ' ' GLU . 23.2 m120 -91.58 158.68 16.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.3 175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -66.07 -30.71 71.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -44.5 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.885 1.274 . . . . 0.0 110.643 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 96' ' ' VAL . 55.1 tt0 -69.53 -45.55 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.234 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 58.1 ttp -55.44 -45.88 76.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.785 0.834 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.73 -51.86 68.17 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.367 1.067 . . . . 0.0 110.183 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -56.09 -53.52 56.06 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.079 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 92' ' ' GLU . 38.2 t -74.43 -36.34 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.33 0.652 . . . . 0.0 112.195 -169.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.26 -33.62 71.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.645 0.26 . . . . 0.0 110.899 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -89.65 -24.47 21.63 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.767 0.827 . . . . 0.0 111.362 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.5 t60 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 124.421 1.088 . . . . 0.0 108.153 -177.651 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.239 0.542 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 t -108.43 139.04 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 109.861 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.5 178.36 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.514 0.726 . . . . 0.0 110.025 167.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -134.95 125.39 26.56 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.01 129.13 69.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 124.068 0.947 . . . . 0.0 108.806 -166.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.563 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -123.1 153.1 40.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.345 1.058 . . . . 0.0 108.178 -172.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.15 22.52 35.03 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.68 110.82 47.84 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.96 150.65 22.78 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.893 2.395 . . . . 0.0 113.468 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.7 p90 -55.31 -31.49 61.69 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 111.632 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 t -108.78 24.92 12.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.636 0.775 . . . . 0.0 111.128 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -78.96 176.88 9.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.446 0.698 . . . . 0.0 110.23 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.625 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 44.9 t -128.63 152.26 48.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.458 0.703 . . . . 0.0 109.396 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.29 70.18 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.056 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.61 -42.13 82.68 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.92 0.888 . . . . 0.0 112.081 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.625 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 32.7 mm-40 -64.09 -45.28 89.38 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.755 0.659 . . . . 0.0 110.496 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' HB ' HD13 ' A' ' 43' ' ' ILE . 43.8 t -68.99 -38.13 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.732 0.813 . . . . 0.0 110.495 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.52 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 24.7 tm0? -63.91 -51.54 64.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.136 0.974 . . . . 0.0 110.033 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 -63.33 -41.39 98.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.848 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.1 -40.92 95.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.827 0.851 . . . . 0.0 111.053 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 47.0 m-85 -88.06 37.05 0.79 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.777 0.831 . . . . 0.0 111.44 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 t -77.04 82.2 3.55 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 172.23 -39.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.265 1.426 . . . . 0.0 107.871 -162.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.29 169.91 8.27 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.269 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 31.3 mmmt -117.82 85.87 2.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HA ' HD23 ' A' ' 61' ' ' LEU . 32.7 mt -65.28 126.18 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -42.31 -68.21 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.928 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -104.53 41.3 1.34 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.159 0.584 . . . . 0.0 110.477 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.77 -137.17 36.37 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB2' ' HG3' ' A' ' 28' ' ' GLN . . . -70.0 -4.59 21.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 117.739 0.77 . . . . 0.0 112.375 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -83.52 -1.5 53.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.218 0.607 . . . . 0.0 111.326 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.04 5.29 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.426 HD13 ' HB ' ' A' ' 27' ' ' VAL . 69.0 mt -131.86 105.31 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.038 0.935 . . . . 0.0 109.218 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.2 95.34 5.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.327 1.051 . . . . 0.0 110.318 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.08 124.15 21.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.566 HD12 ' HG3' ' A' ' 56' ' ' GLU . 71.1 mt -70.97 90.98 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -76.73 142.6 40.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.855 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.2 p -75.9 -177.09 3.68 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.842 0.857 . . . . 0.0 110.084 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.8 -8.97 48.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.7 14.1 22.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.97 0.908 . . . . 0.0 110.294 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.35 36.25 91.38 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -114.15 134.42 22.21 Favored Pre-proline 0 N--CA 1.484 1.243 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.794 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.71 127.52 22.85 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.293 1.995 . . . . 0.0 110.953 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 t -81.28 21.88 0.72 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.864 0.866 . . . . 0.0 111.565 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.26 -6.62 75.34 Favored Glycine 0 C--N 1.353 1.514 0 C-N-CA 123.186 0.422 . . . . 0.0 112.966 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG3' HD12 ' A' ' 46' ' ' ILE . 11.7 pt-20 -139.32 169.77 17.17 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.41 28.15 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.81 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -108.47 136.64 47.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.95 114.94 44.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.94 148.16 32.74 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 36' ' ' ILE . 77.1 mt -133.62 170.94 14.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.757 0.823 . . . . 0.0 110.205 -173.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.79 -39.47 61.7 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.02 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 t -160.42 174.11 14.61 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.32 -13.3 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.928 0.491 . . . . 0.0 111.596 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.81 -40.93 88.23 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.679 0.752 . . . . 0.0 109.706 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 35' ' ' LYS . 6.6 mp0 -62.29 -40.96 97.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.91 169.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 58.0 t -60.47 -53.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 123.526 0.516 . . . . 0.0 110.93 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.34 -39.03 66.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.406 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 94.8 mt -73.79 -36.01 64.97 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.262 0.625 . . . . 0.0 111.663 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -57.21 -49.29 76.45 Favored 'General case' 0 CA--C 1.55 0.977 0 O-C-N 123.799 0.687 . . . . 0.0 109.875 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 42.7 mt -59.74 -44.56 93.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.622 0.769 . . . . 0.0 111.644 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 1.7 pptp? -70.64 -26.28 63.39 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.564 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -90.08 20.46 4.28 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.041 -178.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.88 -23.32 55.6 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.78 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -57.81 -43.6 85.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.761 0.824 . . . . 0.0 110.892 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.45 178.61 5.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.521 1.128 . . . . 0.0 113.361 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 p -112.88 136.74 52.19 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.678 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.6 tpt -57.54 -66.2 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.214 1.006 . . . . 0.0 109.546 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.55 -33.95 0.47 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 164.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -146.46 -46.06 0.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.904 0.882 . . . . 0.0 109.083 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -61.85 135.22 57.49 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.7 0.8 . . . . 0.0 110.759 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 126.72 31.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.32 116.64 28.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -95.57 117.28 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB1' ' A' ' 70' ' ' ALA . 23.2 t -115.98 114.85 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -108.76 132.96 53.46 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.178 0.991 . . . . 0.0 109.878 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -59.96 110.61 1.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.078 0.951 . . . . 0.0 109.91 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 m -116.37 -168.26 1.41 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.385 0.674 . . . . 0.0 110.542 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -140.26 156.87 46.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.544 1.137 . . . . 0.0 108.587 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -71.22 -32.17 68.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 0.0 109.949 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -55.66 -47.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.171 0.988 . . . . 0.0 109.909 170.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.2 -49.78 58.6 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.115 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -54.35 -49.28 70.15 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.589 1.155 . . . . 0.0 111.24 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.68 -42.11 95.59 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.009 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -63.51 -37.24 86.55 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 124.163 0.914 . . . . 0.0 110.809 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.1 t -78.3 -30.15 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 122.83 0.452 . . . . 0.0 111.435 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.77 -16.68 61.16 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.397 -0.815 . . . . 0.0 111.083 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -94.11 -33.59 13.29 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.855 0.862 . . . . 0.0 110.633 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.1 t60 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.694 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HA ' HG21 ' A' ' 67' ' ' VAL . 1.7 p90 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 93' ' ' MET . 26.1 t -99.95 132.65 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.36 167.78 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.376 1.07 . . . . 0.0 110.57 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -117.14 126.47 52.86 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 5.1 t -106.13 108.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 107.974 -173.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -119.16 142.45 47.94 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 124.595 1.158 . . . . 0.0 108.939 -167.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.91 27.87 15.38 Favored Glycine 0 N--CA 1.473 1.129 0 CA-C-O 121.627 0.571 . . . . 0.0 111.753 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.42 143.05 33.65 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 123.853 0.861 . . . . 0.0 109.132 174.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 31.0 Cg_endo -63.92 146.1 91.01 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.916 1.744 . . . . 0.0 110.645 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.627 ' HE1' ' HB3' ' A' ' 52' ' ' ARG . 83.6 t90 -52.41 -45.96 66.1 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.248 1.019 . . . . 0.0 111.212 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 p -92.99 35.28 1.06 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.432 1.093 . . . . 0.0 112.03 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.458 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 14.2 p -73.65 -170.87 0.92 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.224 0.61 . . . . 0.0 110.622 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.593 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 46.4 m -146.46 154.55 41.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.013 0.925 . . . . 0.0 109.012 173.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.25 -38.05 79.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.694 0.798 . . . . 0.0 111.457 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.99 -38.77 87.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.686 0.794 . . . . 0.0 111.371 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 34.2 mm-40 -67.61 -40.86 84.69 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.404 0.681 . . . . 0.0 110.855 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.53 -35.55 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.527 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.34 -45.97 92.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.473 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -63.57 -36.96 85.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.089 0.556 . . . . 0.0 110.901 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -60.13 -39.78 87.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.905 0.482 . . . . 0.0 110.289 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 67.9 m-85 -90.03 40.17 0.99 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.14 0.576 . . . . 0.0 111.792 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 p -74.51 87.22 2.09 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 166.4 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.339 2.256 . . . . 0.0 106.697 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.9 m -89.08 127.76 35.72 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.956 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 94.71 2.96 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 61' ' ' LEU . 18.5 mt -74.93 147.91 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.855 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -39.24 -68.54 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.906 1.682 . . . . 0.0 112.323 -172.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -128.57 51.02 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.05 -128.07 33.62 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.193 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.8 66.86 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.715 0.758 . . . . 0.0 112.031 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.33 -17.38 60.26 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.879 0.472 . . . . 0.0 111.413 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 29.25 9.33 Favored Glycine 0 C--N 1.351 1.393 0 O-C-N 123.266 0.353 . . . . 0.0 112.287 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 59' ' ' VAL . 52.7 mt -130.37 131.38 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.149 1.38 . . . . 0.0 108.3 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 103.58 4.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.58 0.752 . . . . 0.0 109.563 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -69.06 145.7 53.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.276 0.63 . . . . 0.0 110.263 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 56' ' ' GLU . 45.7 mt -73.7 91.34 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -78.47 146.72 34.27 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.784 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -84.79 -178.83 6.96 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.147 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -75.07 5.17 5.58 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.594 0.358 . . . . 0.0 111.945 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -102.6 -4.64 24.91 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.532 0.733 . . . . 0.0 109.756 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.6 37.95 38.97 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.418 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.627 ' HB3' ' HE1' ' A' ' 20' ' ' TRP . 76.0 mtt180 -120.48 130.68 24.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.983 -173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.7 132.23 41.75 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.083 2.522 . . . . 0.0 112.171 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 p -79.29 12.51 2.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.161 0.985 . . . . 0.0 113.021 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 -6.69 83.38 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' HD12 ' A' ' 46' ' ' ILE . 5.0 pt-20 -133.76 163.08 30.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.0 0.92 . . . . 0.0 111.579 175.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 167.96 24.68 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.687 -170.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -118.8 111.79 18.89 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.845 0.858 . . . . 0.0 110.315 171.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 43' ' ' ILE . 44.4 t -96.53 146.67 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.46 1.104 . . . . 0.0 108.181 171.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HG3' HG22 ' A' ' 12' ' ' VAL . 35.4 tt0 -126.72 144.09 51.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 36' ' ' ILE . 50.8 mt -129.38 146.3 51.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.356 0.662 . . . . 0.0 109.601 -167.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -72.9 -19.05 61.35 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.6 m -147.7 151.47 36.17 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.693 0.797 . . . . 0.0 109.119 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.81 -3.68 51.95 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 120.802 0.334 . . . . 0.0 111.628 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.26 -50.07 73.19 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.36 -31.56 65.89 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.359 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.568 HG21 ' HA ' ' A' ' 11' ' ' PHE . 53.2 t -66.14 -41.85 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.163 0.585 . . . . 0.0 110.679 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -57.22 -41.06 78.75 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.739 0.416 . . . . 0.0 110.904 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 mt -68.95 -32.58 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.634 0.774 . . . . 0.0 111.043 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.1 -52.55 33.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.951 0.901 . . . . 0.0 110.845 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 76.0 mt -61.03 -28.2 68.88 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.663 1.185 . . . . 0.0 111.387 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.0 -25.28 66.23 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.48 1.112 . . . . 0.0 110.8 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 67.3 mttm -83.76 6.92 19.44 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.186 0.994 . . . . 0.0 113.503 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.47 -2.47 0.5 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -121.01 -24.39 5.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.343 0.657 . . . . 0.0 111.889 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' A' ' 73' ' ' LYS . 6.6 mm-40 -59.26 148.53 31.58 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.6 p -98.66 126.98 44.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.841 0.856 . . . . 0.0 110.535 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -68.95 -78.48 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.93 89.42 0.29 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 170.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.6 m80 76.35 -54.35 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.056 1.742 . . . . 0.0 111.284 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -70.18 147.16 50.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.923 0.889 . . . . 0.0 111.396 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.25 142.31 28.66 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 108.681 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.0 t -120.14 131.13 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.516 0.726 . . . . 0.0 109.824 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.8 141.84 28.16 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.391 1.477 . . . . 0.0 108.562 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.61 123.25 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -125.1 146.73 49.33 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.332 1.053 . . . . 0.0 108.814 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HE2' HG11 ' A' ' 67' ' ' VAL . 39.9 ttmt -68.53 120.73 15.05 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.778 0.323 . . . . 0.0 110.491 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.1 m -86.54 -61.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.833 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.1 t30 83.31 148.07 0.08 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.883 1.673 . . . . 0.0 108.54 -163.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -57.92 -34.33 69.73 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.395 1.078 . . . . 0.0 112.408 -173.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.9 -41.96 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.755 0.822 . . . . 0.0 110.368 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -67.6 -43.67 79.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.777 0.831 . . . . 0.0 110.612 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.488 ' HB2' HG11 ' A' ' 12' ' ' VAL . 16.4 tmm? -54.23 -53.13 57.79 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.061 0.85 . . . . 0.0 110.918 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.6 -51.6 66.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.032 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -63.99 -51.95 61.87 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.122 0.969 . . . . 0.0 111.808 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.88 -48.66 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.429 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.99 -43.14 83.73 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.682 0.614 . . . . 0.0 110.18 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -70.96 -6.48 38.99 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 112.017 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.804 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.49 133.58 7.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' ' 70' ' ' ALA . 27.2 m -108.36 163.73 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.319 0.581 . . . . 0.0 110.427 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -122.15 126.56 48.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 24.1 t -110.15 126.23 67.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 124.672 1.189 . . . . 0.0 108.673 -168.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -133.52 135.48 44.43 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.19 10.2 Favored Glycine 0 N--CA 1.47 0.94 0 O-C-N 123.427 0.454 . . . . 0.0 112.202 -168.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 88.0 mt -87.18 125.45 66.03 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.01 153.65 56.35 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.005 1.803 . . . . 0.0 111.615 171.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -54.99 -46.65 75.15 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.408 0.683 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -86.15 17.16 3.76 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.443 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 18' ' ' LEU . 18.8 p -86.98 137.98 31.9 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 t -89.27 163.71 15.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.298 0.639 . . . . 0.0 110.202 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.63 -39.91 71.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.631 0.773 . . . . 0.0 110.873 172.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.43 -38.19 88.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 0.0 111.992 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -66.77 -43.11 84.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.984 0.514 . . . . 0.0 110.908 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.43 -38.7 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.648 0.779 . . . . 0.0 110.069 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.487 ' HG3' HD12 ' A' ' 36' ' ' ILE . 50.3 tt0 -69.42 -40.08 77.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.678 0.791 . . . . 0.0 110.213 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -58.26 -47.44 83.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.252 1.021 . . . . 0.0 110.064 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.29 -43.78 98.3 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 38.7 m-85 -87.5 29.59 0.87 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.052 0.941 . . . . 0.0 112.191 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.8 m -80.31 90.53 5.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 167.45 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.126 1.771 . . . . 0.0 107.014 -167.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 32.0 p -85.57 130.67 34.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.443 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -74.15 90.39 2.04 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 HD12 ' HG3' ' A' ' 28' ' ' GLN . 16.9 mt -68.96 129.69 33.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -48.73 -58.44 4.76 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.61 1.194 . . . . 0.0 113.382 -160.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.09 41.14 3.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.204 0.602 . . . . 0.0 109.614 170.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.14 -128.63 28.44 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.67 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.68 63.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.67 0.788 . . . . 0.0 112.853 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.4 -21.18 63.79 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.704 0.402 . . . . 0.0 110.554 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.35 36.69 4.21 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 123.259 0.457 . . . . 0.0 112.131 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.29 108.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 73.6 mtt-85 -118.07 92.61 3.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -166.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -68.67 135.46 51.4 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -74.46 93.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.94 132.95 34.72 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.4 p -82.23 -176.0 5.96 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.679 0.792 . . . . 0.0 110.906 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -68.74 -14.0 62.74 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.18 0.592 . . . . 0.0 111.663 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -87.26 -14.49 40.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.501 0.72 . . . . 0.0 110.39 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.91 26.05 46.84 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.009 -171.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -100.98 125.71 37.42 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.56 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.86 129.14 19.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.914 1.743 . . . . 0.0 109.866 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -75.89 -3.87 37.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.951 0.9 . . . . 0.0 112.019 -172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 6.01 77.66 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 44.8 mt-10 -115.51 150.62 36.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.2 1.0 . . . . 0.0 109.829 173.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.25 161.67 39.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.047 0.939 . . . . 0.0 110.047 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 93.9 m-85 -109.83 105.35 14.52 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.48 102.41 13.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -78.38 132.57 37.42 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.343 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.75 152.11 37.72 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.752 0.421 . . . . 0.0 110.925 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.87 -35.9 79.35 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.48 1.112 . . . . 0.0 112.502 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.517 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 17.3 m -142.17 152.35 43.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.577 -169.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -67.08 -25.79 66.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.793 0.837 . . . . 0.0 112.46 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.58 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 6.1 p-10 -73.05 -36.79 66.98 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 68.7 mm-40 -54.49 -39.09 67.21 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 167.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 88.1 t -67.3 -53.4 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.604 0.761 . . . . 0.0 111.733 -175.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 18.1 ptpt -55.22 -38.54 68.57 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.647 0.592 . . . . 0.0 112.019 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.8 mt -71.81 -36.69 70.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.861 0.864 . . . . 0.0 111.18 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -62.25 -36.58 82.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.021 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD11 ' HE3' ' A' ' 87' ' ' LYS . 64.0 mt -64.98 -32.32 73.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.882 0.473 . . . . 0.0 111.046 173.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 57.8 mttm -78.75 -17.1 56.35 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.389 0.676 . . . . 0.0 110.489 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 60.8 tttp -80.97 -1.3 43.16 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 0.0 111.162 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.18 -17.32 52.43 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.942 0.897 . . . . 0.0 112.732 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -86.41 -37.69 18.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.711 0.804 . . . . 0.0 111.221 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.59 157.13 24.6 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -101.16 133.67 45.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.811 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.616 ' HB2' HG21 ' A' ' 83' ' ' VAL . 25.3 ttt -61.19 -70.31 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.567 0.542 . . . . 0.0 110.147 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.27 -40.37 0.55 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 172.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -150.29 -46.53 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.718 0.807 . . . . 0.0 109.306 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -61.07 140.2 57.91 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.899 0.879 . . . . 0.0 110.744 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -81.54 125.54 30.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.616 HG21 ' HB2' ' A' ' 78' ' ' MET . 67.8 t -106.91 107.66 23.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.03 137.73 35.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.675 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.26 119.17 53.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.599 -165.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -115.57 140.51 49.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.574 1.15 . . . . 0.0 108.657 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' HE3' HD11 ' A' ' 71' ' ' LEU . 29.3 ttmt -62.23 123.16 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.882 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.9 p -110.93 -172.62 2.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.551 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -145.29 169.07 18.97 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.8 -44.3 97.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.46 -46.21 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.68 0.792 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 96' ' ' VAL . 38.2 tt0 -65.13 -53.92 37.75 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.799 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.09 -37.62 85.74 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 122.636 0.374 . . . . 0.0 111.623 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.47 -45.83 91.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.637 0.375 . . . . 0.0 110.649 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -63.81 -53.68 46.96 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.047 0.842 . . . . 0.0 111.733 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 92' ' ' GLU . 61.5 t -67.43 -37.84 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.462 0.705 . . . . 0.0 111.202 -170.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.5 -41.61 65.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.626 0.37 . . . . 0.0 111.249 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -75.81 -32.27 59.76 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.659 0.384 . . . . 0.0 110.971 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.291 0.636 . . . . 0.0 110.965 -175.596 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 121.833 0.825 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.6 142.36 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.39 1.476 . . . . 0.0 107.097 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.46 HG12 HG13 ' A' ' 67' ' ' VAL . 32.6 m -108.4 -176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.95 0.5 . . . . 0.0 110.449 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -144.8 144.44 31.16 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 t -118.37 136.3 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.867 1.267 . . . . 0.0 107.885 -168.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 137.69 47.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.01 15.91 8.84 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.27 122.0 57.15 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.39 166.13 26.55 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 122.077 1.851 . . . . 0.0 112.356 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -28.6 66.26 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.469 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.1 p -89.74 7.32 37.44 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.16 0.984 . . . . 0.0 112.974 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 p -71.63 167.52 19.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.835 0.743 . . . . 0.0 111.993 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 23.4 m -120.67 148.96 43.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.856 0.862 . . . . 0.0 109.81 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.4 67.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.168 0.587 . . . . 0.0 111.239 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 33.1 t70 -54.94 -49.89 70.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 23' ' ' SER . 12.3 pt-20 -72.91 -35.58 67.11 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.823 -174.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.46 -35.04 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.54 ' HG3' HD12 ' A' ' 36' ' ' ILE . 34.6 tt0 -72.93 -29.69 63.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 67.0 mtt180 -68.61 -33.81 74.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.017 0.527 . . . . 0.0 110.82 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -68.95 -26.72 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.118 0.567 . . . . 0.0 110.098 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -110.46 26.66 10.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.654 0.782 . . . . 0.0 111.267 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 29' ' ' ARG . 10.7 t -83.18 84.85 7.33 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HB3' ' HZ1' ' A' ' 73' ' ' LYS . 24.8 t70 159.82 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.625 1.57 . . . . 0.0 107.684 -159.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.1 m -82.63 175.86 9.83 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.295 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 3.6 mppt? -130.89 98.88 4.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 28' ' ' GLN . 16.7 mt -82.15 134.34 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.477 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -82.01 34.44 0.41 Allowed 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 124.175 0.99 . . . . 0.0 111.831 -168.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 173.29 -7.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.497 1.519 . . . . 0.0 110.523 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.6 17.7 Favored Glycine 0 C--N 1.359 1.814 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.68 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.47 72.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.248 0.619 . . . . 0.0 111.184 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.69 -13.31 60.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.57 -176.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.35 -12.14 61.78 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 116.746 -0.206 . . . . 0.0 112.808 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 mt -81.64 90.16 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 18.3 tpp180 -84.25 92.24 7.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.412 -171.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.88 127.12 31.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.799 0.44 . . . . 0.0 110.706 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 56' ' ' GLU . 41.9 mt -71.25 96.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 41.0 m-85 -82.92 133.96 35.09 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -77.27 -170.83 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.175 0.922 . . . . 0.0 111.691 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -55.06 -28.72 54.47 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.094 0.958 . . . . 0.0 112.138 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -104.17 4.13 33.69 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.575 0.75 . . . . 0.0 110.272 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 47' ' ' TYR . . . 73.89 32.89 58.38 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 114.002 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -94.92 141.63 23.55 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.759 0.824 . . . . 0.0 109.746 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.31 110.32 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.938 1.759 . . . . 0.0 109.681 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.4 t -63.25 -8.2 7.8 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.608 1.163 . . . . 0.0 113.165 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -14.83 51.91 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.537 ' HB2' HD12 ' A' ' 46' ' ' ILE . 40.0 mt-10 -121.65 159.73 25.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.369 1.068 . . . . 0.0 111.642 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.26 149.98 27.54 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.181 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 98.5 m-85 -91.54 155.57 18.29 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -136.06 109.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -78.85 119.26 21.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 109.407 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -116.09 154.43 29.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.339 0.655 . . . . 0.0 110.296 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.1 -30.25 70.72 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 111.393 -175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 162.98 39.98 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.82 0.848 . . . . 0.0 110.472 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.49 -13.88 62.3 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 122.946 0.499 . . . . 0.0 111.497 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t70 -60.07 -53.4 58.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 2.1 mp0 -59.5 -32.68 70.51 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.321 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 13' ' ' VAL . 54.4 t -61.85 -49.52 83.9 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 123.647 0.592 . . . . 0.0 110.332 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -53.02 -44.04 67.0 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 64.5 mt -60.88 -46.91 88.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.493 0.717 . . . . 0.0 110.099 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -59.4 -46.55 88.38 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.741 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 95.3 mt -57.12 -35.83 69.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.686 1.195 . . . . 0.0 111.792 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -77.3 -18.55 57.42 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.875 0.47 . . . . 0.0 111.654 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HZ1' ' HB3' ' A' ' 33' ' ' ASP . 90.4 mttt -88.61 6.99 35.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.1 0.56 . . . . 0.0 110.938 175.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 p-10 -65.53 -15.61 62.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.989 0.515 . . . . 0.0 111.642 173.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.26 -31.11 17.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.066 0.946 . . . . 0.0 110.925 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.12 151.92 34.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.672 0.789 . . . . 0.0 112.294 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -116.37 130.69 56.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.125 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 89.7 mmm -79.31 83.18 5.37 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.81 -96.47 2.1 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -170.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -126.01 3.73 7.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.813 0.845 . . . . 0.0 110.031 168.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 83' ' ' VAL . 20.3 mmt180 -70.93 110.39 5.62 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -70.2 109.48 4.67 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 81' ' ' ARG . 55.7 t -114.36 115.32 49.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 123.296 0.639 . . . . 0.0 109.487 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 2.1 pm0 -99.56 146.22 26.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.385 1.074 . . . . 0.0 109.724 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.599 HG11 ' HB1' ' A' ' 70' ' ' ALA . 45.4 t -129.89 124.74 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -107.67 178.39 4.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.716 1.206 . . . . 0.0 108.235 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -106.94 127.7 53.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -113.67 -164.54 0.93 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.216 1.006 . . . . 0.0 110.883 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -147.18 159.99 42.98 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.07 -35.78 81.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 0.0 109.835 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.05 -41.81 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.641 0.776 . . . . 0.0 110.162 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.51 -44.15 97.07 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 44.3 ttp -58.96 -36.2 74.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.107 0.963 . . . . 0.0 110.532 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.1 -55.73 19.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.102 0.561 . . . . 0.0 110.951 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -63.86 -31.65 72.9 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.971 0.908 . . . . 0.0 112.525 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.87 -42.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.309 0.643 . . . . 0.0 110.999 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.74 -22.3 59.93 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.468 0.307 . . . . 0.0 111.175 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -91.61 -30.33 16.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.876 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.243 0.75 0 C-N-CA 123.691 0.796 . . . . 0.0 108.95 177.177 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.437 HG12 ' HB3' ' A' ' 88' ' ' SER . 37.4 t -145.71 143.27 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 70' ' ' ALA . 25.4 m -113.15 172.18 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 121.094 0.474 . . . . 0.0 111.966 169.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 40.8 mtpt -116.36 135.4 53.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.01 117.39 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 41.1 ttp180 -127.4 152.27 47.73 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.38 12.59 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -166.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.488 HD22 ' SG ' ' A' ' 22' ' ' CYS . 86.0 mt -97.53 134.04 22.98 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.308 1.043 . . . . 0.0 109.406 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.42 163.57 17.42 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.776 2.317 . . . . 0.0 112.606 168.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -74.35 -8.09 55.07 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.059 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -113.32 16.12 19.07 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.286 1.034 . . . . 0.0 111.278 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.488 ' SG ' HD22 ' A' ' 18' ' ' LEU . 52.0 t -67.19 155.48 38.7 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.924 0.489 . . . . 0.0 111.632 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.1 m -133.73 152.69 51.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.529 1.132 . . . . 0.0 110.555 -173.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.65 67.38 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.402 1.081 . . . . 0.0 112.788 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.91 -47.78 67.73 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.536 1.135 . . . . 0.0 113.47 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 23' ' ' SER . 13.7 pt-20 -72.19 -35.49 68.96 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.8 -46.38 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.157 0.583 . . . . 0.0 110.032 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.601 ' HG3' HD12 ' A' ' 36' ' ' ILE . 28.2 tt0 -63.95 -40.76 97.18 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.617 0.767 . . . . 0.0 111.341 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -57.87 -46.8 84.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.795 0.684 . . . . 0.0 110.866 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.17 -32.92 74.66 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.741 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.643 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 93.4 m-85 -105.34 35.96 2.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.925 0.89 . . . . 0.0 110.659 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -60.59 -27.6 67.85 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.524 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.55 -18.13 65.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.2 p -111.44 135.49 51.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.311 0.644 . . . . 0.0 109.958 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -75.56 96.0 3.44 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.601 HD12 ' HG3' ' A' ' 28' ' ' GLN . 43.9 mt -78.85 123.41 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.81 125.85 25.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.302 1.041 . . . . 0.0 110.971 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 60.74 23.15 13.07 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.177 1.391 . . . . 0.0 111.552 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.26 -134.96 45.5 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.379 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.48 -22.68 22.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.064 0.946 . . . . 0.0 113.274 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.05 -21.92 64.98 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.419 0.288 . . . . 0.0 110.875 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.405 ' HA2' ' NH1' ' A' ' 44' ' ' ARG . . . -77.73 -16.84 79.62 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.016 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 mt -86.64 119.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 109.633 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.405 ' NH1' ' HA2' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -123.0 97.55 5.49 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.163 0.985 . . . . 0.0 109.695 177.458 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -66.16 142.9 57.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.029 0.532 . . . . 0.0 109.724 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.586 HD12 ' HB2' ' A' ' 56' ' ' GLU . 23.6 mt -77.16 87.18 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -75.34 134.29 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.0 t -78.48 -175.54 4.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 3.4 tmm_? -68.94 -5.8 23.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.3 0.64 . . . . 0.0 110.973 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' H ' HG23 ' A' ' 48' ' ' THR . 37.6 mt-10 -100.31 -2.6 33.23 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.698 1.199 . . . . 0.0 110.96 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.95 36.81 31.07 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 115.072 0.789 . . . . 0.0 115.072 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -132.17 138.18 31.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.708 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.52 118.0 4.43 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.046 2.497 . . . . 0.0 111.695 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.8 p -93.3 40.25 1.06 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.72 0.808 . . . . 0.0 111.129 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.82 -37.23 3.58 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.0 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' HD12 ' A' ' 46' ' ' ILE . 36.5 mt-10 -110.13 161.56 15.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.803 0.811 . . . . 0.0 112.392 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.03 165.53 31.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.449 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -110.47 145.39 37.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 108.09 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 105.83 6.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -81.63 139.64 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 36' ' ' ILE . 74.8 mt -128.89 142.24 51.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.683 1.193 . . . . 0.0 109.283 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.29 -27.66 68.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.309 0.644 . . . . 0.0 111.54 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.5 m -136.52 150.44 48.65 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.17 0.588 . . . . 0.0 109.661 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 15.9 tt0 -77.68 -8.34 57.77 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 120.915 0.388 . . . . 0.0 111.201 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -65.39 -48.52 72.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.631 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 4.0 mm-40 -52.77 -38.29 60.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.668 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG22 HD12 ' A' ' 61' ' ' LEU . 66.7 t -64.22 -46.09 94.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 123.31 0.644 . . . . 0.0 110.411 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.7 mttt -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.384 0.674 . . . . 0.0 112.154 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.47 -50.22 70.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.89 0.876 . . . . 0.0 111.178 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -58.99 -45.29 91.0 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.144 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 85' ' ' VAL . 91.8 mt -56.05 -24.61 40.66 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.295 1.438 . . . . 0.0 113.425 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.18 -9.84 59.73 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.151 0.58 . . . . 0.0 112.005 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -90.52 6.08 45.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 111.356 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -57.88 -9.37 1.28 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.785 1.234 . . . . 0.0 113.69 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -116.63 -40.15 3.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.371 1.068 . . . . 0.0 111.11 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.41 163.67 15.28 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -105.41 130.82 53.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.067 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.442 ' HG3' HG21 ' A' ' 83' ' ' VAL . 53.4 mtp -64.83 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 163.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.03 -103.34 2.02 Favored Glycine 0 N--CA 1.468 0.777 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -96.01 -1.61 48.57 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.24 1.016 . . . . 0.0 109.344 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -106.19 133.54 50.72 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.926 0.89 . . . . 0.0 109.631 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -80.36 135.59 36.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 78' ' ' MET . 98.7 t -97.79 130.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 32.8 mt-10 -97.45 117.35 31.51 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.9 t -114.66 120.04 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -113.83 177.59 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -101.88 116.12 32.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.437 ' HB3' HG12 ' A' ' 12' ' ' VAL . 46.4 t -87.05 161.55 18.1 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.14 0.971 . . . . 0.0 110.503 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -127.99 158.21 38.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.005 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -64.84 -34.34 78.13 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.927 0.491 . . . . 0.0 110.759 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.53 -41.84 89.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 110.753 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.44 -56.3 7.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.961 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 44.9 ttm -52.11 -51.29 58.72 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 123.967 0.792 . . . . 0.0 111.72 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 28.3 t70 -62.42 -43.01 99.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 0.0 110.53 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -60.6 -38.59 85.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.143 0.577 . . . . 0.0 111.147 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 76.4 t -82.36 -30.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.702 0.801 . . . . 0.0 111.86 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 93' ' ' MET . 83.0 mt -75.69 -26.44 57.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.38 -0.825 . . . . 0.0 110.654 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 1.2 mptm? -90.09 -25.17 20.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.756 0.823 . . . . 0.0 111.082 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.5 m80 . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.022 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -143.1 131.0 21.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.902 0.881 . . . . 0.0 109.92 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 67.7 mtt -134.99 131.54 37.26 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.92 -45.09 12.59 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 89' ' ' ASN . . . 167.97 167.08 28.1 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.086 -0.557 . . . . 0.0 112.592 175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.594 ' HA ' ' HE2' ' A' ' 87' ' ' LYS . 33.7 tt0 -69.74 104.4 2.42 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -154.5 171.47 32.96 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -89.81 7.91 34.64 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.736 0.815 . . . . 0.0 111.03 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.5 t -102.09 143.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.99 0.916 . . . . 0.0 109.184 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 61' ' ' LEU . 29.8 m -110.14 160.41 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.053 0.541 . . . . 0.0 110.758 162.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 87.4 tttt -109.13 121.41 45.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.84 111.72 37.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 3.7 tmt_? -121.96 140.67 52.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.21 18.27 29.41 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 118.2 0.454 . . . . 0.0 113.316 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.17 138.37 56.38 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 123.356 0.662 . . . . 0.0 109.765 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.612 ' HG3' ' HA3' ' A' ' 79' ' ' GLY . 45.1 Cg_endo -64.79 146.52 88.44 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.346 2.031 . . . . 0.0 111.454 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -64.37 -19.71 65.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.162 0.985 . . . . 0.0 110.62 175.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 p -90.7 4.75 50.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.394 1.078 . . . . 0.0 113.146 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 22.0 p -104.4 145.75 29.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.827 0.739 . . . . 0.0 111.13 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -105.81 178.52 4.54 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.763 1.225 . . . . 0.0 109.028 172.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.67 -31.49 62.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.441 0.696 . . . . 0.0 112.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.92 -47.34 68.08 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.181 0.993 . . . . 0.0 113.118 176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.88 -38.02 76.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.15 0.58 . . . . 0.0 111.592 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.61 -34.76 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.712 . . . . 0.0 110.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.597 ' HG3' HD12 ' A' ' 36' ' ' ILE . 44.2 tt0 -69.36 -41.31 76.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.312 176.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -63.09 -36.33 83.23 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.081 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.98 -43.83 98.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.015 0.526 . . . . 0.0 110.39 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 36' ' ' ILE . 79.6 m-85 -95.72 38.96 1.14 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.998 0.519 . . . . 0.0 110.515 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.7 t -59.76 -34.2 72.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 111.248 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.22 5.96 10.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 112.448 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.514 ' HB3' HD23 ' A' ' 61' ' ' LEU . 58.1 m -127.38 136.23 51.59 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.086 0.954 . . . . 0.0 110.07 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -80.36 98.46 7.48 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.597 HD12 ' HG3' ' A' ' 28' ' ' GLN . 61.8 mt -80.65 122.61 36.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.994 0.918 . . . . 0.0 109.687 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.7 126.42 27.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.213 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.2 t30 63.48 17.55 10.42 Favored 'General case' 0 CA--C 1.559 1.327 0 O-C-N 124.79 1.307 . . . . 0.0 111.89 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.44 -136.16 47.53 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.239 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.71 -18.8 45.49 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.26 -21.03 54.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.967 0.507 . . . . 0.0 110.295 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 -21.13 76.59 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.255 0.347 . . . . 0.0 112.472 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.493 HG12 HG22 ' A' ' 59' ' ' VAL . 43.4 mt -91.27 127.75 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.568 0.747 . . . . 0.0 110.043 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.1 110.02 6.12 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.081 0.953 . . . . 0.0 110.008 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -66.48 140.09 57.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.0 88.82 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -82.86 135.9 34.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.1 p -83.76 -178.17 6.93 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.856 0.862 . . . . 0.0 110.919 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 1.5 tmt_? -67.18 -16.73 64.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.161 0.584 . . . . 0.0 109.603 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 13.4 mm-40 -84.36 1.56 44.53 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.742 0.817 . . . . 0.0 110.911 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.03 20.1 76.03 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 50' ' ' GLU . 19.4 ptp180 -126.74 141.3 39.94 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.335 0.654 . . . . 0.0 109.79 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.48 148.36 42.61 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.447 2.098 . . . . 0.0 111.523 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -75.65 -0.44 20.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.616 0.766 . . . . 0.0 111.749 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.54 81.83 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 37.7 mt-10 -119.63 155.61 31.99 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 110.809 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.36 28.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.771 1.228 . . . . 0.0 110.313 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.33 120.9 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.484 1.113 . . . . 0.0 109.168 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 43' ' ' ILE . 68.9 t -106.71 123.67 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 108.953 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HG2' HG22 ' A' ' 12' ' ' VAL . 64.5 mt-10 -82.98 151.23 25.95 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 34' ' ' CYS . 4.6 mp -135.87 152.29 50.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.084 0.954 . . . . 0.0 109.312 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -32.22 73.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.732 0.813 . . . . 0.0 111.805 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.485 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 42.0 m -144.96 155.62 43.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.531 0.332 . . . . 0.0 111.265 -171.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.96 -27.29 68.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.623 0.769 . . . . 0.0 110.431 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.39 -47.57 75.9 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 47.2 mm-40 -54.62 -37.88 66.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.538 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 78.4 t -60.27 -46.06 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.077 0.551 . . . . 0.0 110.03 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.59 ' HD3' HD12 ' A' ' 71' ' ' LEU . 32.3 mmtp -60.99 -37.79 83.73 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.788 0.835 . . . . 0.0 112.552 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 85.9 mt -65.88 -31.94 73.16 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.502 0.721 . . . . 0.0 111.746 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -69.13 -44.04 73.18 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.255 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.59 HD12 ' HD3' ' A' ' 68' ' ' LYS . 96.8 mt -65.9 -26.12 67.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.14 0.976 . . . . 0.0 112.83 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 19.9 pttp -77.54 -16.88 58.41 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.105 0.411 . . . . 0.0 109.915 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -95.15 0.49 54.22 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.214 1.005 . . . . 0.0 111.032 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 11.1 t70 -60.17 101.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.32 0.648 . . . . 0.0 110.238 168.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 36.9 ttt180 150.64 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 127.115 2.166 . . . . 0.0 108.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -55.43 147.33 17.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.235 -167.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 p -89.11 120.03 30.15 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.518 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -124.64 125.0 43.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.342 1.057 . . . . 0.0 108.513 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.612 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 84.82 -50.31 4.38 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.451 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -179.04 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.77 1.228 . . . . 0.0 108.85 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -91.47 166.94 12.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.038 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.88 139.47 39.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 78' ' ' MET . 53.1 t -112.05 129.51 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.16 0.505 . . . . 0.0 110.678 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.01 121.6 37.93 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.342 1.057 . . . . 0.0 109.196 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.0 112.81 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.8 m-85 -103.03 178.4 4.57 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 87.8 tttt -110.35 120.5 42.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 61.1 m -110.73 147.71 33.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.733 0.813 . . . . 0.0 111.275 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.419 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 37.5 t-20 -91.54 155.28 18.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -56.53 -35.32 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.238 0.615 . . . . 0.0 110.169 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.11 -46.37 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.889 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.62 -52.11 48.81 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.458 0.474 . . . . 0.0 110.005 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -49.63 -53.64 23.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.8 1.24 . . . . 0.0 111.367 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.0 -43.02 86.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.987 0.915 . . . . 0.0 111.679 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -74.13 -35.99 64.13 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.479 HG13 ' H ' ' A' ' 101' ' ' GLY . 43.6 t -82.99 -21.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.014 0.435 . . . . 0.0 110.502 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.3 -40.76 64.28 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -77.13 -32.02 56.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.06 0.544 . . . . 0.0 111.295 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -144.14 89.6 2.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 t -56.41 94.15 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.886 0.85 . . . . 0.0 111.229 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' H ' HG13 ' A' ' 96' ' ' VAL . . . -160.4 114.23 0.6 Allowed Glycine 0 C--N 1.344 0.977 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.019 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.33 -0.01 9.92 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.822 2.348 . . . . 0.0 113.355 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.49 112.03 6.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.389 0.675 . . . . 0.0 109.928 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.9 p -70.43 149.16 95.68 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.259 1.024 . . . . 0.0 111.619 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 71.13 4.94 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 122.68 2.253 . . . . 0.0 111.309 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -72.69 107.58 5.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.45 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.2 m -145.1 107.91 4.48 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.978 0.911 . . . . 0.0 108.701 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.89 66.71 1.55 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.463 0.705 . . . . 0.0 109.135 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -67.39 88.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.639 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -131.98 142.54 49.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.834 -0.981 . . . . 0.0 110.65 -178.596 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.245 0.831 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -58.13 118.65 5.67 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ttt -64.59 135.56 56.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.103 0.561 . . . . 0.0 110.435 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.34 -121.52 6.36 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.599 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.28 135.02 1.1 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.56 28.79 0.46 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.496 0.718 . . . . 0.0 110.832 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 88' ' ' SER . . . -78.83 98.97 1.61 Allowed Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.053 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -84.07 4.4 30.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.83 0.852 . . . . 0.0 110.498 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG21 ' HE2' ' A' ' 93' ' ' MET . 39.1 t -112.28 138.02 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.527 1.131 . . . . 0.0 109.167 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.07 168.89 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.037 0.535 . . . . 0.0 110.635 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 60.2 tttt -116.84 123.38 46.94 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 83' ' ' VAL . 92.2 t -114.6 138.67 43.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 3.8 ptp180 -150.99 161.31 42.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.975 0.51 . . . . 0.0 109.633 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 18.45 36.57 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -169.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -88.88 127.69 54.97 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 27.4 Cg_endo -61.19 161.5 22.8 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.232 1.955 . . . . 0.0 111.968 172.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -71.66 -24.46 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.287 0.635 . . . . 0.0 111.176 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -82.45 -6.0 59.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.685 0.794 . . . . 0.0 111.404 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.438 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 44.2 t -76.08 120.41 21.35 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.102 0.561 . . . . 0.0 109.743 -177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t -98.88 174.68 6.25 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.767 0.827 . . . . 0.0 109.186 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.24 74.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.707 0.803 . . . . 0.0 112.41 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.4 t70 -60.53 -39.32 87.45 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.879 0.872 . . . . 0.0 111.787 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -59.53 -46.31 89.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.216 0.606 . . . . 0.0 111.083 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' A' ' 43' ' ' ILE . 58.4 t -71.68 -31.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.42 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -64.34 -42.81 96.06 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.916 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 19.3 mmt180 -67.11 -38.11 85.06 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.695 0.398 . . . . 0.0 111.179 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -67.71 -29.66 68.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.034 0.534 . . . . 0.0 111.5 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 36' ' ' ILE . 93.4 m-85 -115.38 35.02 4.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.61 0.764 . . . . 0.0 110.184 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 t -59.51 -29.2 67.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.62 0.768 . . . . 0.0 113.01 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.77 -25.72 35.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.853 0.461 . . . . 0.0 110.614 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.58 126.79 31.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 10.4 mptt -79.24 87.75 4.94 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 31' ' ' PHE . 41.1 mt -76.86 132.79 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.275 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.02 118.37 5.33 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.947 0.899 . . . . 0.0 110.425 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 63.52 23.02 13.46 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -131.66 41.85 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.596 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.64 30.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 0.0 113.161 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -80.7 -10.45 59.73 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.198 0.599 . . . . 0.0 112.411 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.93 36.3 4.35 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.498 HD13 ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt -127.85 116.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.453 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 22.3 mmt180 -116.6 92.99 4.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.288 0.635 . . . . 0.0 110.251 -169.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 98.2 m-85 -71.23 127.85 33.93 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 mt -74.8 86.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.05 149.37 41.21 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.706 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -94.77 178.71 5.49 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.434 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -68.76 -8.85 46.87 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 122.846 0.458 . . . . 0.0 111.893 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.55 -0.41 43.29 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.257 1.023 . . . . 0.0 109.916 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.41 59.92 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.969 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -126.15 132.75 24.42 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 53.5 Cg_endo -66.5 153.21 78.82 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.302 2.002 . . . . 0.0 111.568 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -78.41 6.11 9.16 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.56 0.744 . . . . 0.0 111.37 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.07 1.13 79.88 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -171.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 30.6 mt-10 -111.59 146.68 36.96 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.669 1.187 . . . . 0.0 110.806 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.58 31.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.55 1.14 . . . . 0.0 109.7 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 69.3 m-85 -102.61 117.74 35.34 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.9 t -98.46 110.78 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.39 136.46 38.42 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.562 1.145 . . . . 0.0 108.413 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 66' ' ' GLU . 44.1 mt -135.76 137.58 41.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.448 0.699 . . . . 0.0 109.744 -169.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.87 -12.47 61.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -168.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.0 p -160.45 172.45 17.22 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.11 0.564 . . . . 0.0 109.99 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.0 tm-20 -68.5 -21.05 64.61 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.209 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.68 -46.79 89.02 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.235 0.471 . . . . 0.0 110.403 172.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HB3' HD22 ' A' ' 61' ' ' LEU . 1.1 mp0 -62.38 -32.5 73.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.53 173.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.47 -44.08 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.652 0.381 . . . . 0.0 110.028 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 82.2 mttt -54.63 -49.66 69.98 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.723 0.809 . . . . 0.0 110.649 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.78 -35.44 74.65 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.354 1.062 . . . . 0.0 112.089 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.75 69.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.031 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.75 -13.38 59.25 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.22 1.008 . . . . 0.0 112.254 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.16 -23.68 64.89 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.301 0.501 . . . . 0.0 110.697 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 76' ' ' GLU . 3.9 mptp? -88.03 -1.28 57.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.536 0.734 . . . . 0.0 112.069 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -32.28 -25.05 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 169.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -142.77 -6.4 0.88 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -57.81 143.18 43.2 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 175.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 p -95.37 121.85 37.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.45 1.1 . . . . 0.0 111.86 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.16 114.35 27.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.184 0.993 . . . . 0.0 109.264 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.17 -89.81 0.17 Allowed Glycine 0 C--N 1.345 1.058 0 O-C-N 123.416 0.448 . . . . 0.0 112.999 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -130.77 -5.85 4.06 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -117.49 154.05 32.1 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.236 0.614 . . . . 0.0 110.929 -172.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -82.04 143.5 31.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.583 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 15' ' ' VAL . 69.4 t -109.02 120.48 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.474 0.71 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -95.39 121.47 37.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.01 121.46 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.325 0.65 . . . . 0.0 109.984 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -118.93 149.94 40.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.711 0.805 . . . . 0.0 110.905 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.05 116.85 5.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.369 0.667 . . . . 0.0 110.146 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.492 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 15.6 m -125.67 -154.1 0.6 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.68 173.64 12.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.06 -31.05 72.1 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.989 0.915 . . . . 0.0 110.432 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.1 t -65.92 -47.61 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.247 1.019 . . . . 0.0 110.346 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 33.3 tt0 -65.38 -47.97 74.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.286 1.034 . . . . 0.0 110.077 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.46 ' HE2' HG21 ' A' ' 12' ' ' VAL . 54.2 ttp -52.54 -44.6 65.88 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.463 1.102 . . . . 0.0 110.639 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.62 -45.95 77.45 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.434 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.54 -42.05 95.72 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.604 0.762 . . . . 0.0 112.3 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.08 -23.55 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 123.508 0.505 . . . . 0.0 110.827 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.11 -23.74 35.52 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 121.98 -0.45 . . . . 0.0 111.138 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -80.33 -38.77 29.93 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.284 0.564 . . . . 0.0 109.971 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -140.98 90.37 2.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.483 1.113 . . . . 0.0 108.027 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -65.06 86.13 0.06 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.284 1.04 . . . . 0.0 110.449 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.53 -86.18 0.13 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.155 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.4 92.82 0.19 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.928 2.419 . . . . 0.0 113.027 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.413 ' OD1' ' HG3' ' A' ' 92' ' ' GLU . 35.9 t30 -77.03 124.32 27.62 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.1 m 61.15 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.562 1.164 . . . . 0.0 108.91 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.78 91.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.639 2.892 . . . . 0.0 114.136 -171.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -102.02 132.98 47.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -48.46 -27.03 2.42 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.61 -177.52 6.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.252 0.621 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -97.34 155.82 16.72 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.317 0.647 . . . . 0.0 111.278 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 66.44 95.34 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.769 1.228 . . . . 0.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.301 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.944 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.553 1.082 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -93.94 137.98 32.56 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.2 ttt -90.06 -51.52 5.42 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.84 42.84 15.77 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.422 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.21 -130.7 3.52 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -70.15 -50.22 42.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.88 63.25 4.14 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 111.685 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -61.34 -23.16 65.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.075 0.95 . . . . 0.0 112.159 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -93.94 133.49 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 110.135 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -105.01 163.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.373 0.669 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -108.05 127.18 53.56 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -119.49 140.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 124.107 0.963 . . . . 0.0 108.757 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.579 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 14.8 ptm180 -147.43 167.23 24.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.03 0.932 . . . . 0.0 109.262 174.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.91 18.71 62.74 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.61 155.24 91.72 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.854 0.862 . . . . 0.0 110.236 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.0 152.13 77.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.147 1.898 . . . . 0.0 111.22 169.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.2 p90 -56.18 -30.91 62.89 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.725 1.21 . . . . 0.0 112.098 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 p -104.21 25.52 9.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 111.508 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.2 p -52.39 118.03 3.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.493 1.117 . . . . 0.0 112.811 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.432 ' HB3' ' HG3' ' A' ' 26' ' ' GLU . 46.8 t -104.18 152.2 22.43 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.29 -39.52 75.9 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.315 0.384 . . . . 0.0 111.003 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -49.51 -47.63 48.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.329 1.052 . . . . 0.0 112.695 170.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 45.3 mt-10 -65.43 -39.68 92.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.194 0.598 . . . . 0.0 111.265 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' HD13 ' A' ' 43' ' ' ILE . 61.1 t -68.55 -34.94 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.403 0.681 . . . . 0.0 110.077 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HA ' HD12 ' A' ' 36' ' ' ILE . 97.0 mt-30 -64.94 -49.75 69.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.769 0.827 . . . . 0.0 111.033 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -37.17 81.35 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.51 0.507 . . . . 0.0 110.719 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.75 -43.76 95.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.027 0.531 . . . . 0.0 111.107 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HB2' HD11 ' A' ' 36' ' ' ILE . 59.5 m-85 -99.73 35.68 1.96 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.624 0.77 . . . . 0.0 110.083 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -60.7 -24.81 65.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.355 0.525 . . . . 0.0 112.186 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.86 -47.7 68.18 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.992 0.917 . . . . 0.0 110.736 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 61.3 m -79.77 130.69 35.55 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.385 0.612 . . . . 0.0 110.432 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 13.9 mmmm -78.44 91.2 4.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 31' ' ' PHE . 46.4 mt -69.74 111.0 3.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.516 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 33.6 tt0 -63.14 134.5 56.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.878 0.736 . . . . 0.0 110.458 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 65.37 10.14 6.29 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 124.654 1.221 . . . . 0.0 112.148 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 -128.04 44.91 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.51 0.576 . . . . 0.0 112.716 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.03 64.75 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.855 0.862 . . . . 0.0 112.483 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -73.8 -19.72 60.68 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.123 0.569 . . . . 0.0 111.644 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.99 -23.81 56.58 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 120.271 -0.183 . . . . 0.0 112.961 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.525 HD13 ' HB ' ' A' ' 27' ' ' VAL . 59.8 mt -83.35 119.36 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.266 0.627 . . . . 0.0 109.613 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.549 ' HG3' ' SD ' ' A' ' 93' ' ' MET . 21.0 mmt180 -127.29 94.71 4.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.481 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.79 135.86 46.86 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 56' ' ' GLU . 43.0 mt -75.91 92.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -84.26 134.49 34.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.429 ' OG1' ' HB2' ' A' ' 52' ' ' ARG . 59.7 p -90.84 -169.99 2.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.701 0.8 . . . . 0.0 110.442 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.71 -18.01 64.63 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -105.67 10.06 32.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 0.0 109.212 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.15 63.96 Favored Glycine 0 C--N 1.36 1.917 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 12.0 mmp_? -101.27 125.49 37.7 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.591 0.756 . . . . 0.0 110.021 -172.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.08 116.89 3.56 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.666 2.244 . . . . 0.0 110.488 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 t -83.52 18.13 1.97 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.678 0.791 . . . . 0.0 111.581 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.1 30.19 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 122.854 0.264 . . . . 0.0 113.033 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 31.8 mt-10 -112.3 150.15 31.39 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.455 1.102 . . . . 0.0 111.128 -174.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.55 153.9 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.527 1.131 . . . . 0.0 110.043 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -106.14 110.31 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.051 0.941 . . . . 0.0 108.463 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.07 110.92 25.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.5 tt0 -79.76 135.99 36.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.9 mt -126.71 147.91 49.91 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.458 0.703 . . . . 0.0 110.032 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -67.06 -19.81 65.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.763 0.825 . . . . 0.0 112.917 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -159.34 171.24 20.15 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.07 -23.75 67.26 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.999 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.81 -52.56 64.54 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.372 0.669 . . . . 0.0 110.157 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 1.5 mp0 -60.25 -31.61 70.37 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.048 0.843 . . . . 0.0 112.894 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.4 t -61.44 -48.83 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.659 0.384 . . . . 0.0 110.158 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.8 mmpt? -50.98 -46.07 61.16 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.015 0.822 . . . . 0.0 111.753 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 mt -63.06 -47.44 82.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.59 0.756 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.06 87.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.021 0.928 . . . . 0.0 111.524 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.44 -38.44 77.47 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.148 0.979 . . . . 0.0 111.659 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -69.06 -19.97 64.09 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 123.63 0.581 . . . . 0.0 111.587 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -91.77 17.34 9.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.929 0.892 . . . . 0.0 112.329 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.93 23.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -142.86 -23.66 0.63 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.751 0.705 . . . . 0.0 110.865 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -46.3 134.75 8.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.931 1.293 . . . . 0.0 112.02 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -91.26 131.64 36.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.782 0.833 . . . . 0.0 111.15 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ttt -128.61 122.14 30.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.704 1.202 . . . . 0.0 109.415 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -75.34 1.92 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -145.33 -36.29 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.37 1.068 . . . . 0.0 110.1 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -87.0 167.49 14.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -80.68 136.81 36.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.7 t -100.02 117.12 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 25.1 mt-10 -98.37 122.18 41.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.175 1.39 . . . . 0.0 108.508 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.94 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 110.14 -172.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.06 179.09 4.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.464 1.506 . . . . 0.0 107.54 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -112.55 135.41 53.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' A' ' 92' ' ' GLU . 76.8 p -134.87 -149.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 109.038 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.87 169.42 24.45 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -61.36 -34.22 74.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.841 0.856 . . . . 0.0 111.276 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.7 -40.79 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.113 0.965 . . . . 0.0 110.168 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 88' ' ' SER . 4.7 tp10 -63.93 -50.36 68.97 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.409 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.549 ' SD ' ' HG3' ' A' ' 44' ' ' ARG . 45.3 ttm -54.95 -51.74 65.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.947 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.35 -45.87 91.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.621 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -52.58 -51.56 59.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.635 1.574 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 92' ' ' GLU . 40.7 t -71.19 -33.13 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.091 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 44' ' ' ARG . 88.6 mt -69.38 -27.55 65.41 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.314 0.245 . . . . 0.0 111.042 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -69.05 -23.89 64.11 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.247 0.619 . . . . 0.0 111.752 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -171.95 -71.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.501 0.72 . . . . 0.0 109.219 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 8.9 t 179.26 -167.7 0.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.041 1.337 . . . . 0.0 108.709 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.07 65.44 1.28 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.226 -0.764 . . . . 0.0 113.702 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.53 117.02 3.9 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.081 1.854 . . . . 0.0 110.832 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -64.89 -49.84 68.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.149 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 23.9 m 56.25 92.47 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.756 1.222 . . . . 0.0 111.85 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 12.7 Cg_endo -55.32 -27.53 58.04 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.575 2.184 . . . . 0.0 113.228 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.12 58.56 4.91 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 124.68 1.238 . . . . 0.0 108.25 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 m -62.6 90.02 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.743 -1.572 . . . . 0.0 111.179 -167.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.01 25.93 2.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.723 1.209 . . . . 0.0 110.014 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.68 90.58 2.31 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 65.6 -176.99 0.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.266 1.426 . . . . 0.0 111.268 -171.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.987 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.167 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -66.74 101.18 0.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.158 0.504 . . . . 0.0 110.575 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 35.3 ttm -97.77 87.16 3.95 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.48 -42.61 98.92 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.794 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.58 166.36 39.03 Favored Glycine 0 C--O 1.242 0.611 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.56 98.17 0.85 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.712 0.768 . . . . 0.0 109.794 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.33 100.65 0.2 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -81.67 68.86 8.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.217 0.607 . . . . 0.0 110.378 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.23 134.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.54 160.33 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.006 0.522 . . . . 0.0 110.769 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -109.75 116.03 30.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG13 ' CG1' ' A' ' 83' ' ' VAL . 87.4 t -114.62 135.77 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 125.056 1.342 . . . . 0.0 108.524 -168.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.703 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 12.3 ptm180 -149.95 162.58 40.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.855 0.462 . . . . 0.0 111.547 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.64 15.06 51.4 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.456 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.65 135.94 42.75 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 29.8 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.171 1.914 . . . . 0.0 111.783 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -70.43 -19.96 62.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.345 1.058 . . . . 0.0 111.32 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -93.63 10.55 32.28 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.703 0.801 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.59 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 50.6 t -87.03 133.95 33.54 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.019 0.528 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m -105.83 169.98 8.16 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.006 0.922 . . . . 0.0 109.511 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.38 69.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.008 0.923 . . . . 0.0 111.893 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 3.3 m-20 -48.03 -48.72 32.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.405 1.082 . . . . 0.0 112.445 175.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -69.79 -34.16 73.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.866 0.867 . . . . 0.0 111.912 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 43' ' ' ILE . 39.0 t -73.95 -30.53 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 123.162 0.585 . . . . 0.0 110.128 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -67.19 -38.78 85.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.368 0.667 . . . . 0.0 110.013 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 95.1 mtt180 -59.6 -46.06 90.09 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.887 0.742 . . . . 0.0 111.191 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 77.0 t80 -63.52 -46.37 86.37 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.88 0.371 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -94.83 37.07 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.795 0.838 . . . . 0.0 110.556 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 t -60.44 -34.14 73.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.35 0.66 . . . . 0.0 112.446 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -69.19 -36.97 77.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.122 0.487 . . . . 0.0 109.887 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.0 m -72.86 175.32 6.66 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.057 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -136.01 97.51 3.64 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.529 HG21 HG13 ' A' ' 43' ' ' ILE . 3.5 mp -73.21 118.51 18.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.535 -172.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 7.8 tp60 -64.69 124.2 21.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.715 . . . . 0.0 109.367 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.3 m120 76.01 16.63 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.715 1.606 . . . . 0.0 111.94 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.56 -134.24 47.55 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.356 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -37.46 32.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.609 1.164 . . . . 0.0 112.804 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.85 -8.18 59.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.537 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 37' ' ' GLN . . . -84.33 -13.87 72.69 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.623 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.564 HD13 ' HB ' ' A' ' 27' ' ' VAL . 62.3 mt -89.62 101.2 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.157 0.583 . . . . 0.0 109.575 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.13 96.59 9.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.249 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -67.42 129.22 39.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.5 mt -71.24 92.32 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -79.99 146.83 31.82 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.961 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.6 p -83.5 -172.97 4.44 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.31 1.044 . . . . 0.0 109.678 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -71.1 -6.06 36.37 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.896 0.478 . . . . 0.0 111.145 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.5 -6.96 32.54 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.615 1.166 . . . . 0.0 109.939 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 33.49 50.09 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -124.96 132.63 24.35 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.916 0.886 . . . . 0.0 110.37 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -67.55 139.11 47.82 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.487 2.125 . . . . 0.0 111.232 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -78.77 -2.04 37.6 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.076 0.55 . . . . 0.0 111.178 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.3 60.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.878 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.703 ' HG3' ' HB3' ' A' ' 16' ' ' ARG . 8.0 mp0 -105.43 149.69 25.93 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.552 1.141 . . . . 0.0 109.618 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 163.3 38.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.75 116.01 29.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.033 0.933 . . . . 0.0 109.106 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -95.86 108.2 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 45.6 tt0 -83.14 145.08 29.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.3 mt -138.83 145.87 40.56 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.385 1.074 . . . . 0.0 108.649 -168.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.95 -26.54 63.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -152.28 163.3 39.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.453 0.701 . . . . 0.0 110.134 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 35.0 tt0 -69.53 -16.73 63.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.212 0.605 . . . . 0.0 112.594 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.6 t70 -59.77 -51.42 69.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -52.98 -39.76 63.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.931 1.292 . . . . 0.0 111.863 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 65.4 t -63.39 -42.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.125 0.57 . . . . 0.0 111.065 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 74.9 mmtt -58.62 -45.43 89.21 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.953 0.901 . . . . 0.0 111.211 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 62.5 mt -61.52 -36.76 81.45 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.911 0.884 . . . . 0.0 111.062 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.25 83.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 0.0 110.321 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.1 mt -62.57 -30.82 71.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.008 0.923 . . . . 0.0 111.828 175.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 56.3 mtpt -67.86 -30.78 70.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.318 0.58 . . . . 0.0 110.377 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 41.2 mttp -84.15 -4.26 58.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.02 0.928 . . . . 0.0 111.563 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -52.63 -33.44 46.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.461 0.704 . . . . 0.0 112.668 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -95.84 -31.59 13.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.902 -0.498 . . . . 0.0 111.598 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.07 142.24 47.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.661 0.785 . . . . 0.0 112.093 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 43.2 p -95.03 135.63 36.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.59 0.756 . . . . 0.0 110.758 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.5 ttt -70.9 -86.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 110.374 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.19 1.78 5.4 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-O 120.03 -0.317 . . . . 0.0 112.729 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -170.22 -55.67 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.018 0.927 . . . . 0.0 108.931 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -87.8 167.65 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.299 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.7 p90 -98.68 138.78 35.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.4 ' CG1' HG13 ' A' ' 15' ' ' VAL . 45.1 t -91.85 125.87 44.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -172.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.613 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 22.5 mt-10 -95.13 118.68 32.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.61 117.81 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.591 0.756 . . . . 0.0 110.065 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -68.33 136.27 53.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.075 0.852 . . . . 0.0 110.875 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -136.11 -151.58 0.42 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.52 1.128 . . . . 0.0 108.824 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -165.13 167.99 17.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 110.33 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.85 -37.04 85.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.399 1.079 . . . . 0.0 111.989 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.56 -42.84 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.204 0.602 . . . . 0.0 110.975 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.96 -38.6 76.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.1 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 55.9 ttp -53.31 -51.15 63.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.8 0.84 . . . . 0.0 110.037 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.27 -42.88 96.31 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.275 0.985 . . . . 0.0 111.144 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -58.58 -47.5 84.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.275 0.985 . . . . 0.0 110.8 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.519 HG22 ' HD3' ' A' ' 102' ' ' PRO . 99.9 t -71.42 -32.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.713 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 79.1 mt -73.02 -32.05 64.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.904 -0.498 . . . . 0.0 112.083 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.54 -18.23 61.56 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -156.74 -86.79 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.469 1.108 . . . . 0.0 108.216 174.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.9 t -163.36 -163.42 0.83 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.67 125.16 28.88 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.035 -0.869 . . . . 0.0 111.56 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.519 ' HD3' HG22 ' A' ' 96' ' ' VAL . 40.3 Cg_endo -85.27 53.77 3.63 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.468 2.779 . . . . 0.0 112.623 -170.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 67.19 132.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.706 1.603 . . . . 0.0 110.934 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.9 p -59.88 119.67 43.25 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.741 0.816 . . . . 0.0 110.213 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.22 76.18 2.69 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.427 2.085 . . . . 0.0 110.295 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.44 -29.52 70.79 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.275 1.03 . . . . 0.0 111.356 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -160.22 158.11 29.43 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 110.058 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -129.0 24.39 5.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 107.986 168.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 68.99 116.24 0.04 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.843 1.657 . . . . 0.0 110.044 -167.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.95 -31.53 66.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.842 0.857 . . . . 0.0 110.819 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.107 -0.829 . . . . 0.0 111.133 174.795 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 67.57 -179.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.538 1.135 . . . . 0.0 110.627 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ttt 73.59 131.61 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.989 1.316 . . . . 0.0 111.599 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.88 66.6 2.71 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.918 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.73 -39.11 94.84 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 124.173 0.572 . . . . 0.0 112.053 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -116.96 76.88 1.07 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.181 0.992 . . . . 0.0 108.797 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.5 150.83 22.01 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.514 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -142.95 49.47 1.47 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.56 0.695 . . . . 0.0 111.392 -177.322 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 60' ' ' GLU . 47.1 t -123.05 139.53 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -116.6 167.9 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.667 -0.646 . . . . 0.0 111.009 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -119.34 123.45 44.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.44 119.12 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -124.87 149.35 47.61 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.548 1.139 . . . . 0.0 108.967 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.02 57.53 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.48 135.84 81.35 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 123.224 0.609 . . . . 0.0 110.038 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 42.5 Cg_endo -69.1 133.83 27.8 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.998 1.798 . . . . 0.0 110.693 173.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -58.19 -29.56 65.76 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.593 1.157 . . . . 0.0 111.193 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -81.94 8.28 10.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.073 0.949 . . . . 0.0 112.553 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.49 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 12.9 p -113.85 142.06 46.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.68 -170.07 1.63 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.64 0.776 . . . . 0.0 109.322 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -43.37 70.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.404 1.081 . . . . 0.0 113.4 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.48 -38.23 83.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.28 0.632 . . . . 0.0 111.81 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -70.03 -37.6 75.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.737 0.815 . . . . 0.0 110.958 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.61 -35.7 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.226 0.61 . . . . 0.0 110.673 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG3' HD12 ' A' ' 36' ' ' ILE . 41.5 tt0 -66.81 -39.74 87.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -61.14 -39.19 89.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.735 1.214 . . . . 0.0 111.149 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.24 -42.05 99.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.526 0.33 . . . . 0.0 110.357 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.557 ' HB2' HD11 ' A' ' 36' ' ' ILE . 83.9 m-85 -94.97 32.49 1.66 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.004 0.522 . . . . 0.0 111.117 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 t -76.84 87.86 3.43 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 167.38 -55.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -159.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.421 ' HB3' HD22 ' A' ' 61' ' ' LEU . 58.0 m -82.55 171.73 13.76 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.138 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -123.15 72.91 1.13 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.2 mt -56.27 126.72 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.208 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -48.85 117.72 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.556 1.16 . . . . 0.0 111.397 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.3 t30 60.75 26.3 16.11 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 124.495 1.122 . . . . 0.0 111.991 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.4 -134.4 30.88 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.43 -0.805 . . . . 0.0 113.02 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.87 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.613 1.165 . . . . 0.0 113.531 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -72.48 -16.8 61.8 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.62 24.3 32.67 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -126.11 90.78 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.22 98.72 7.91 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.234 1.014 . . . . 0.0 109.628 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.89 138.36 55.97 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.655 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.2 mt -76.68 90.7 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -75.79 148.0 38.78 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.547 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.5 t -106.8 174.37 5.92 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.041 0.936 . . . . 0.0 109.433 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -57.28 -19.6 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.888 1.275 . . . . 0.0 112.918 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.34 -4.45 58.47 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.343 1.057 . . . . 0.0 111.209 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.89 30.57 51.49 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.14 0.3 . . . . 0.0 112.986 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.75 151.29 73.92 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.028 0.931 . . . . 0.0 110.482 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 145.63 53.34 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.192 1.928 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.1 p -74.48 -38.74 62.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.418 0.628 . . . . 0.0 110.409 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.49 -10.78 2.7 Favored Glycine 0 N--CA 1.468 0.771 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.757 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.58 150.72 24.4 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.196 0.998 . . . . 0.0 109.534 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.56 167.61 24.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.235 1.014 . . . . 0.0 109.885 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -111.7 122.63 48.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.93 107.88 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 12' ' ' VAL . 42.0 mt-10 -85.21 151.29 24.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 34' ' ' CYS . 73.6 mt -139.5 148.26 42.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.676 0.791 . . . . 0.0 109.213 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.65 -21.62 61.06 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -144.9 156.58 44.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.516 0.674 . . . . 0.0 110.811 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.55 -18.75 63.67 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.788 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.26 -55.65 32.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.322 0.649 . . . . 0.0 109.583 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 69' ' ' LEU . 36.3 mt-10 -52.11 -36.0 49.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.779 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 11' ' ' PHE . 76.0 t -60.83 -52.04 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.44 0.296 . . . . 0.0 110.706 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -57.42 -37.23 72.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.38 0.672 . . . . 0.0 112.619 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 66' ' ' GLU . 84.7 mt -60.55 -52.65 64.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.956 0.502 . . . . 0.0 110.558 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -56.14 -46.83 79.1 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.677 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.7 mt -57.58 -32.8 67.52 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.613 1.165 . . . . 0.0 111.843 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -76.48 -18.89 58.52 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.526 0.33 . . . . 0.0 111.082 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -88.46 9.96 21.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.65 8.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -129.56 -37.36 1.59 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.204 0.602 . . . . 0.0 110.192 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -52.04 143.29 14.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.428 1.091 . . . . 0.0 113.066 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.9 p -90.06 110.45 21.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.204 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.51 91.68 1.83 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 171.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.54 -96.25 1.14 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -164.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.99 -0.03 5.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.07 0.948 . . . . 0.0 109.911 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.25 114.91 19.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.064 0.946 . . . . 0.0 109.226 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.07 108.03 4.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.0 t -108.08 122.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.536 0.735 . . . . 0.0 110.062 -170.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.98 137.49 35.98 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.761 1.224 . . . . 0.0 109.129 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.5 t -124.17 116.16 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -104.03 -176.93 3.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.127 1.371 . . . . 0.0 107.699 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -109.53 136.97 48.06 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -128.59 148.84 50.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.754 0.822 . . . . 0.0 109.31 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -93.31 173.88 7.49 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -64.24 -19.21 65.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.77 171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.36 -54.91 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 123.785 0.834 . . . . 0.0 110.504 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.35 -45.05 70.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.295 0.638 . . . . 0.0 110.53 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -57.03 -48.68 77.92 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.456 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.03 -53.99 51.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.509 0.724 . . . . 0.0 111.122 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -65.02 -41.95 94.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.143 0.977 . . . . 0.0 112.888 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 35.4 t -82.71 -22.9 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.841 0.456 . . . . 0.0 111.174 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.48 -22.94 46.72 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 122.373 -0.204 . . . . 0.0 110.821 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.6 mmpt? -73.46 -38.94 65.3 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.5 t60 176.31 -78.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 10.2 t 173.9 50.35 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.072 1.749 . . . . 0.0 107.589 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.59 -147.72 51.0 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 118.743 -1.031 . . . . 0.0 110.561 -167.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.54 -49.75 5.31 Favored 'Trans proline' 0 C--N 1.367 1.543 0 CA-C-N 119.852 1.826 . . . . 0.0 110.239 165.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -178.23 102.53 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -67.67 115.22 25.14 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.0 0.52 . . . . 0.0 111.124 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.83 -171.21 1.14 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.613 2.209 . . . . 0.0 111.404 171.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.95 -52.07 40.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.273 0.629 . . . . 0.0 109.923 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.6 m -150.63 106.67 3.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.298 1.039 . . . . 0.0 108.912 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.34 80.35 6.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.63 174.39 7.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.577 0.751 . . . . 0.0 111.721 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -100.08 -168.54 1.61 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.806 0.842 . . . . 0.0 109.617 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 CA-C-O 119.268 -0.74 . . . . 0.0 114.119 179.8 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -83.65 88.2 7.05 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.229 1.014 . . . . 0.0 109.477 176.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 mtm -114.16 4.38 15.54 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.92 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.47 49.38 4.06 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.478 -176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 131.71 2.3 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.02 106.34 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.914 0.485 . . . . 0.0 110.244 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.25 106.46 1.51 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 64' ' ' GLU . 10.5 m-30 -83.48 61.66 6.34 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.052 0.93 . . . . 0.0 108.537 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.04 138.54 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.878 1.271 . . . . 0.0 108.719 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 70' ' ' ALA . 28.5 m -110.44 177.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.341 0.656 . . . . 0.0 110.446 165.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 19.6 ptmt -136.93 140.07 41.99 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.95 129.99 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.703 0.801 . . . . 0.0 109.134 -170.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.779 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 30.1 mtp-105 -129.94 159.43 36.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.111 0.964 . . . . 0.0 108.447 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.47 18.05 67.25 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.61 141.85 65.48 Favored Pre-proline 0 C--N 1.349 0.585 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.89 140.39 91.73 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 121.904 1.736 . . . . 0.0 111.47 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.43 ' HZ3' HH22 ' A' ' 81' ' ' ARG . 1.6 m-90 -68.07 -19.33 64.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.369 0.668 . . . . 0.0 110.099 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -97.97 12.4 34.31 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.511 1.125 . . . . 0.0 111.55 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 53.4 t -90.53 140.29 29.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.115 0.566 . . . . 0.0 109.676 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.6 p -117.14 172.4 7.31 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.082 0.953 . . . . 0.0 109.661 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -40.98 58.81 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.674 1.19 . . . . 0.0 114.138 -171.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.34 -39.95 73.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.984 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 1.8 mp0 -71.28 -41.04 70.53 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 0.0 111.322 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 43' ' ' ILE . 56.5 t -72.71 -30.31 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.13 -42.69 62.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.1 0.96 . . . . 0.0 110.173 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.58 -48.25 82.6 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.172 0.989 . . . . 0.0 110.677 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 79.2 t80 -63.35 -57.34 10.68 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -85.38 37.25 0.67 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.314 0.645 . . . . 0.0 111.368 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -57.59 -31.83 66.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.445 0.698 . . . . 0.0 110.692 166.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.11 -16.15 63.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.956 1.302 . . . . 0.0 112.329 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 70' ' ' ALA . 39.1 m -114.23 130.49 56.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.961 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 13.9 mmmm -75.3 90.0 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HA ' HD23 ' A' ' 61' ' ' LEU . 20.8 mt -73.89 129.75 36.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -44.19 -68.25 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.928 1.392 . . . . 0.0 113.413 -163.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -108.73 43.29 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.469 0.708 . . . . 0.0 109.852 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.23 -125.35 37.52 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.718 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.8 68.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.926 0.89 . . . . 0.0 112.022 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -77.58 -19.71 55.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.725 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.67 -20.67 75.94 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 116.525 -0.307 . . . . 0.0 112.38 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 59' ' ' VAL . 46.4 mt -79.89 140.66 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.544 0.738 . . . . 0.0 109.158 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 97' ' ' LEU . 28.4 mmt180 -127.26 96.76 4.68 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.961 0.504 . . . . 0.0 110.078 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 94.0 m-85 -77.87 136.91 38.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.464 0.306 . . . . 0.0 110.28 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.55 85.88 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.24 145.62 43.94 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.196 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 50' ' ' GLU . 8.9 t -109.42 178.87 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.1 0.56 . . . . 0.0 110.132 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.65 -5.53 8.67 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' H ' HG23 ' A' ' 48' ' ' THR . 10.3 tp10 -90.42 -17.43 27.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.93 0.892 . . . . 0.0 110.325 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.09 4.96 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.141 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HG22 ' A' ' 48' ' ' THR . 17.8 ptt85 -163.19 155.51 15.64 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.878 0.871 . . . . 0.0 111.225 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 36.2 Cg_endo -62.95 149.14 92.44 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.719 2.279 . . . . 0.0 112.015 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.0 p -95.15 19.55 10.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.192 0.997 . . . . 0.0 111.556 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 -17.13 49.37 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 120.034 -0.314 . . . . 0.0 113.622 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 38.9 tt0 -107.6 147.2 30.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.587 0.755 . . . . 0.0 110.111 175.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.92 36.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.467 1.107 . . . . 0.0 109.76 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.5 112.53 23.11 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 43' ' ' ILE . 72.2 t -93.96 116.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -86.93 137.41 32.4 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.449 0.468 . . . . 0.0 109.823 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 36' ' ' ILE . 56.4 mt -127.3 148.17 50.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.288 1.035 . . . . 0.0 108.555 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.13 -24.89 47.22 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.615 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.9 m -133.76 143.8 48.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.588 0.755 . . . . 0.0 110.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . 30.6 tt0 -77.03 -10.93 59.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.039 0.447 . . . . 0.0 111.695 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 25.9 t70 -65.72 -35.43 80.73 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 169.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 18.1 mm-40 -68.16 -31.27 70.71 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.952 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.24 -51.83 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.485 0.714 . . . . 0.0 110.645 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 18.8 ptpt -54.06 -38.7 65.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 123.286 0.366 . . . . 0.0 111.355 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 41.4 mt -64.06 -50.14 69.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.322 1.049 . . . . 0.0 110.955 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -56.53 -44.8 81.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.686 0.794 . . . . 0.0 111.946 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 85' ' ' VAL . 93.2 mt -59.87 -34.93 73.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.431 1.092 . . . . 0.0 111.472 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -76.83 -17.85 58.75 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.254 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 29.5 mtpp -89.42 3.33 52.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.268 0.627 . . . . 0.0 111.352 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.61 -59.13 4.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.866 0.866 . . . . 0.0 111.796 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -79.19 -11.47 59.97 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 157.03 18.17 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.67 0.747 . . . . 0.0 111.621 165.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.3 p -93.82 122.67 36.53 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.227 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.638 ' HB2' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -62.26 -77.36 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.628 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.58 87.72 0.29 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 166.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 78.39 -52.36 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.672 1.589 . . . . 0.0 112.062 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.43 HH22 ' HZ3' ' A' ' 20' ' ' TRP . 47.6 mtm180 -78.94 154.48 29.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.916 0.487 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -84.12 151.92 24.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.65 0.78 . . . . 0.0 109.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 78' ' ' MET . 12.2 t -96.52 156.93 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 111.087 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 29.0 mm-40 -115.27 115.0 25.94 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 161.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 71' ' ' LEU . 34.7 t -117.56 117.33 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.25 -178.11 3.37 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.63 135.56 50.4 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.8 m -130.11 -160.7 1.06 Allowed 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.022 0.929 . . . . 0.0 110.324 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -160.69 160.42 31.46 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.155 0.982 . . . . 0.0 113.08 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.94 -51.71 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.633 0.773 . . . . 0.0 110.852 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 95' ' ' TRP . 11.5 pm0 -83.99 -20.61 32.53 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.959 0.503 . . . . 0.0 110.752 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.467 ' SD ' ' HG3' ' A' ' 44' ' ' ARG . 50.1 ttm -60.06 -56.01 26.89 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.44 -41.2 98.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.98 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 65.0 t-105 -58.77 -53.65 56.02 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.162 0.585 . . . . 0.0 111.0 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.76 -25.68 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.476 0.71 . . . . 0.0 111.963 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 44' ' ' ARG . 85.0 mt -76.75 -43.61 36.45 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.599 0.36 . . . . 0.0 111.095 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.74 -32.84 27.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.254 1.022 . . . . 0.0 110.701 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -136.0 88.02 2.36 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.243 1.417 . . . . 0.0 107.387 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 p -67.82 85.81 0.22 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.6 -179.95 41.22 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.451 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.19 -176.58 3.35 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.543 2.829 . . . . 0.0 113.748 -173.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.26 121.08 18.57 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.99 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -61.9 145.22 92.9 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.727 0.811 . . . . 0.0 111.38 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -44.36 123.96 4.83 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.923 3.082 . . . . 0.0 114.063 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.98 90.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.15 0.98 . . . . 0.0 109.716 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.5 m 67.68 130.51 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.359 1.464 . . . . 0.0 109.972 -169.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.81 92.26 0.15 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.431 0.693 . . . . 0.0 111.198 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -99.15 174.85 6.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.295 0.638 . . . . 0.0 110.983 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.32 162.82 23.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.899 0.88 . . . . 0.0 110.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.34 -178.991 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.7 m80 66.97 160.92 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.962 1.305 . . . . 0.0 111.044 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 tpp -86.17 83.38 7.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.32 0.581 . . . . 0.0 109.752 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.79 -28.53 54.55 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.77 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.16 -78.04 0.43 Allowed Glycine 0 C--N 1.352 1.43 0 C-N-CA 123.717 0.675 . . . . 0.0 112.394 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -155.84 135.02 12.17 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.05 127.42 1.41 Allowed Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -92.73 17.88 9.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 112.045 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.95 133.82 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 168.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 67' ' ' VAL . 23.1 m -96.2 155.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 122.608 0.363 . . . . 0.0 110.847 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 36.7 ttpt -109.0 117.65 34.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 83' ' ' VAL . 58.4 t -105.34 136.85 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.02 0.928 . . . . 0.0 108.636 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -140.41 134.51 30.9 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 111.72 81.55 1.16 Allowed Glycine 0 C--O 1.236 0.264 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -168.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.0 mt -139.67 135.34 16.71 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 114.097 -1.051 . . . . 0.0 109.164 -171.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.556 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 30.9 Cg_endo -65.74 131.41 27.46 Favored 'Trans proline' 0 C--N 1.361 1.217 0 N-CA-C 108.285 -1.467 . . . . 0.0 108.285 154.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -63.7 -24.71 67.89 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.63 0.772 . . . . 0.0 111.193 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -97.41 26.82 4.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.875 0.87 . . . . 0.0 111.624 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 27.4 p -78.95 155.25 29.05 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.223 0.609 . . . . 0.0 111.166 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -105.48 159.11 16.18 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.315 1.046 . . . . 0.0 109.553 171.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 -38.59 66.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.255 0.622 . . . . 0.0 110.794 169.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.97 -35.88 67.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.023 0.929 . . . . 0.0 112.129 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -64.55 -47.76 77.58 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.054 0.454 . . . . 0.0 111.349 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.74 -24.54 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.204 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -71.26 -49.7 40.42 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 109.96 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -58.05 -40.67 81.51 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.256 0.972 . . . . 0.0 110.26 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -59.78 -56.05 26.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HB2' HD11 ' A' ' 36' ' ' ILE . 65.9 m-85 -93.98 25.84 3.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.259 0.624 . . . . 0.0 111.858 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 t -64.01 -21.78 66.65 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.93 -43.02 84.32 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 81.8 m -75.0 140.05 43.34 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.182 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 12.4 mptt -84.28 90.97 7.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 31' ' ' PHE . 55.0 mt -64.71 121.84 14.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.212 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -59.49 124.3 19.6 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.132 0.895 . . . . 0.0 110.474 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.59 20.61 12.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.325 1.05 . . . . 0.0 111.278 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.57 -131.09 49.14 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.053 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.33 -29.93 25.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.293 1.037 . . . . 0.0 113.23 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -75.01 -21.83 58.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.396 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.27 -21.71 79.19 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.404 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.93 121.31 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 108.98 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 97' ' ' LEU . 83.2 mtt180 -128.52 96.9 4.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.924 0.89 . . . . 0.0 110.005 -169.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.5 132.1 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.43 83.97 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 84.4 m-85 -72.97 143.64 47.55 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.502 177.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.4 p -98.14 179.16 4.85 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.523 0.729 . . . . 0.0 109.427 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -68.85 -9.01 48.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.653 0.781 . . . . 0.0 111.765 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 13.9 tp10 -83.05 -14.17 54.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.072 0.949 . . . . 0.0 110.453 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.0 23.41 59.43 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 113.537 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 7.2 mpt_? -133.29 143.46 48.32 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 42.3 Cg_endo -65.44 155.79 66.92 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.88 1.72 . . . . 0.0 111.009 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.9 t -72.01 -3.82 25.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.294 0.638 . . . . 0.0 111.6 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.38 66.21 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -166.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.09 149.43 35.55 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.006 1.323 . . . . 0.0 111.148 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.39 166.79 27.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.118 1.367 . . . . 0.0 109.873 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -121.48 128.71 52.38 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.15 118.25 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -82.34 141.11 33.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -126.35 163.22 23.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.904 0.482 . . . . 0.0 110.405 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -31.22 70.77 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.977 0.911 . . . . 0.0 110.612 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 t -160.2 164.42 32.83 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 108.999 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -74.93 -13.66 60.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 0.0 110.729 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.62 -42.24 98.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.582 0.753 . . . . 0.0 110.582 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 7.9 mm-40 -59.7 -32.39 70.47 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.547 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 13' ' ' VAL . 76.0 t -67.63 -41.61 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.042 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -53.4 -46.63 69.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.778 0.831 . . . . 0.0 111.442 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.9 -46.26 85.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.658 0.783 . . . . 0.0 111.202 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -56.43 -46.4 80.28 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.378 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 96.6 mt -59.2 -39.17 81.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.333 1.053 . . . . 0.0 111.281 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -64.81 -29.14 70.1 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.674 0.609 . . . . 0.0 111.466 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -111.41 37.49 2.86 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.409 0.623 . . . . 0.0 111.351 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 85' ' ' VAL . 6.5 p-10 -75.43 18.58 0.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.394 0.677 . . . . 0.0 111.873 165.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -117.95 -29.49 5.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.539 1.535 . . . . 0.0 108.866 -168.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -58.94 146.01 39.44 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.241 1.017 . . . . 0.0 112.829 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 p -95.19 143.62 26.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.347 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ttt -112.11 98.22 7.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.31 1.06 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -151.46 15.55 0.69 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.135 0.974 . . . . 0.0 109.944 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 20.9 ttt180 -107.36 -145.2 0.39 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.505 ' H ' ' HG2' ' A' ' 81' ' ' ARG . 81.0 m-85 -157.81 128.75 6.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -160.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 15' ' ' VAL . 95.9 t -104.71 116.46 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 119.72 1.145 . . . . 0.0 109.293 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -96.82 118.23 32.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 107.622 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 33.2 t -114.06 116.83 53.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -111.04 -178.9 3.58 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' NZ ' HG11 ' A' ' 67' ' ' VAL . 22.5 ttmm -100.88 118.88 37.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.9 t -92.5 -178.79 5.01 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.906 0.86 . . . . 0.0 109.742 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -142.22 154.39 44.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.26 -38.14 79.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.98 -47.39 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 110.655 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -54.26 38.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.129 0.572 . . . . 0.0 111.193 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 42.1 ttp -55.26 -42.35 73.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.17 0.988 . . . . 0.0 111.385 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.68 -45.46 89.39 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.269 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -62.55 -44.81 95.42 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.749 0.656 . . . . 0.0 111.944 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.567 HG13 ' H ' ' A' ' 101' ' ' GLY . 15.7 t -76.13 -25.12 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 123.748 0.655 . . . . 0.0 111.227 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HD3' ' A' ' 44' ' ' ARG . 86.6 mt -79.52 -29.08 41.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.912 0.485 . . . . 0.0 111.067 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -80.13 -28.3 38.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.022 0.529 . . . . 0.0 110.963 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -160.55 107.66 1.55 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.02 0.928 . . . . 0.0 108.656 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.4 p -47.72 100.34 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.313 1.045 . . . . 0.0 111.591 176.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.567 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 125.12 -153.29 17.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -84.94 158.39 11.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.564 2.176 . . . . 0.0 112.913 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -119.55 -69.13 0.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.392 1.077 . . . . 0.0 108.378 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.7 p -113.22 146.15 34.66 Favored Pre-proline 0 C--O 1.242 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 109.311 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.27 119.72 7.08 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.09 1.86 . . . . 0.0 110.124 172.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.55 -31.57 62.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.356 0.662 . . . . 0.0 111.366 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 m -107.19 73.25 0.92 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.7 -11.58 13.5 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.829 0.852 . . . . 0.0 111.332 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -144.37 121.15 11.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.434 0.693 . . . . 0.0 109.584 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -146.28 150.15 35.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.699 0.799 . . . . 0.0 108.933 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.387 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -175.733 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.238 0.455 0 CA-C-O 120.565 0.222 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -131.04 94.18 3.54 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 108.805 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.3 ttt -57.85 -37.21 73.46 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.66 171.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.41 124.95 3.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.424 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.42 78.68 0.83 Allowed Glycine 0 C--N 1.348 1.25 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.22 121.18 36.22 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -173.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.19 54.96 0.42 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.615 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -89.1 44.61 1.22 Allowed 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.985 0.898 . . . . 0.0 112.273 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.21 133.93 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' A' ' 70' ' ' ALA . 28.9 m -105.08 168.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.095 0.474 . . . . 0.0 110.865 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 102' ' ' PRO . 85.4 tttt -126.5 125.84 42.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -111.93 123.28 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 123.517 0.727 . . . . 0.0 109.174 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.702 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 52.5 ttt180 -127.86 147.55 50.45 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 22.88 34.52 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.78 137.27 54.44 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.43 0.692 . . . . 0.0 109.758 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 36.7 Cg_endo -67.08 135.92 39.07 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.516 2.144 . . . . 0.0 111.195 169.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' PRO . 26.8 p90 -60.73 -27.4 67.9 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 m -78.76 1.88 21.63 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.494 1.117 . . . . 0.0 112.976 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.504 ' SG ' ' HG2' ' A' ' 19' ' ' PRO . 14.9 p -119.07 152.31 36.7 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 m -116.7 -168.34 1.44 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.107 0.963 . . . . 0.0 109.808 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.3 61.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.882 1.273 . . . . 0.0 113.505 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.3 m-20 -51.08 -55.33 18.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.906 0.882 . . . . 0.0 112.931 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.92 -33.52 74.85 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.911 0.484 . . . . 0.0 111.682 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.98 -39.28 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.051 0.54 . . . . 0.0 109.856 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.83 -42.85 97.53 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.246 0.618 . . . . 0.0 110.756 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 33.2 mmt180 -66.36 -38.09 86.8 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.241 0.616 . . . . 0.0 111.06 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -65.03 -39.23 93.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.678 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 58.3 m-85 -95.13 28.8 2.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.469 0.707 . . . . 0.0 111.668 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 95.35 2.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 166.7 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.423 2.289 . . . . 0.0 107.396 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.1 p -115.82 136.84 52.67 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.548 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -81.68 98.35 8.35 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 61' ' ' LEU . 30.5 mt -77.98 115.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 45.8 tt0 -66.56 129.49 40.03 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.544 0.527 . . . . 0.0 110.535 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.6 m120 75.07 16.77 2.78 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.591 1.556 . . . . 0.0 110.425 -173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.77 -137.85 39.45 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.926 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.55 63.41 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.863 0.865 . . . . 0.0 112.218 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -75.46 -10.86 59.83 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.942 0.497 . . . . 0.0 111.789 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.96 -17.7 74.13 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.061 0.226 . . . . 0.0 112.757 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -84.14 116.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.573 0.749 . . . . 0.0 109.183 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -116.04 95.55 5.15 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.26 0.624 . . . . 0.0 109.873 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -73.29 139.42 46.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.892 0.477 . . . . 0.0 110.491 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.3 mm -79.26 112.9 17.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 165.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.88 167.1 11.63 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.512 0.725 . . . . 0.0 109.381 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -90.45 -176.61 4.83 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.514 0.726 . . . . 0.0 109.345 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.68 -14.09 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.107 0.412 . . . . 0.0 110.838 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.33 52.79 0.71 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.654 0.221 . . . . 0.0 113.654 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -115.99 131.26 23.83 Favored Pre-proline 0 N--CA 1.483 1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HB2' ' HA ' ' A' ' 20' ' ' TRP . 32.3 Cg_exo -57.54 123.36 13.58 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.64 2.226 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -78.21 -45.61 22.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.97 0.508 . . . . 0.0 110.163 -171.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.73 -12.73 1.51 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.24 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 16' ' ' ARG . 43.1 mt-10 -107.38 151.67 25.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.841 . . . . 0.0 110.218 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.72 167.03 30.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.615 1.166 . . . . 0.0 110.044 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.23 115.5 23.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.681 0.792 . . . . 0.0 108.923 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.1 t -97.16 115.63 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.1 tt0 -78.95 130.67 35.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.271 1.028 . . . . 0.0 109.564 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 36' ' ' ILE . 96.9 mt -130.13 140.41 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.222 0.609 . . . . 0.0 110.105 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.72 -20.11 59.97 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.476 0.711 . . . . 0.0 112.827 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 38.7 m -140.73 150.49 43.48 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.95 -12.69 61.36 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 120.888 0.375 . . . . 0.0 111.044 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.07 -52.22 50.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 169.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.581 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 5.2 mm-40 -47.71 -38.99 16.36 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.46 1.1 . . . . 0.0 111.532 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 11' ' ' PHE . 25.2 t -62.99 -52.95 52.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.237 0 C-N-CA 123.71 0.804 . . . . 0.0 111.471 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -57.09 -37.82 72.45 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.042 0.537 . . . . 0.0 112.404 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.23 -37.7 84.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.632 0.773 . . . . 0.0 111.686 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -64.65 -44.12 91.44 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 82.4 mt -62.48 -29.88 70.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -66.31 -21.67 66.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.219 1.008 . . . . 0.0 110.894 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 66.2 mttm -84.4 -4.17 58.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.928 0.891 . . . . 0.0 112.35 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 21.0 t70 -68.29 91.29 0.38 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.715 0.406 . . . . 0.0 110.192 173.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 145.43 -38.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 128.317 2.647 . . . . 0.0 109.021 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.66 144.07 39.13 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 p -92.59 120.8 33.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.198 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.472 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 ttt -61.65 -73.19 0.1 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.097 0.559 . . . . 0.0 110.851 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.84 -17.54 0.72 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 168.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -142.45 -66.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.668 1.187 . . . . 0.0 108.374 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -77.85 155.42 31.02 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.207 -172.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -81.25 127.38 32.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 90.9 t -88.96 120.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -170.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 28.9 mt-10 -94.91 116.69 29.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.409 HG12 HD23 ' A' ' 71' ' ' LEU . 11.5 t -117.03 114.52 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -106.08 144.67 32.46 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.445 1.098 . . . . 0.0 108.526 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.86 125.59 27.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 163.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.7 m -128.18 163.4 24.77 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.593 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -103.89 153.0 21.28 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.54 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.41 -32.75 72.7 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.221 1.008 . . . . 0.0 109.889 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.28 -44.01 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.639 0.776 . . . . 0.0 109.897 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.86 -38.48 83.15 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.1 ttm -56.01 -48.51 75.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.039 0.536 . . . . 0.0 110.01 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.89 -46.8 84.35 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.248 1.019 . . . . 0.0 110.53 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -58.31 -52.53 65.19 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.988 0.805 . . . . 0.0 111.816 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.598 HG13 ' H ' ' A' ' 101' ' ' GLY . 24.6 t -79.14 -25.22 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 -37.96 75.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.747 0.419 . . . . 0.0 110.409 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -90.68 -15.63 30.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.798 0.839 . . . . 0.0 111.428 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 23.7 t-80 -150.45 92.08 1.82 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.607 1.163 . . . . 0.0 108.567 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.7 p -56.14 90.57 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.151 0.98 . . . . 0.0 111.802 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.598 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 150.26 129.45 1.67 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.444 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 50.1 Cg_endo -84.94 41.39 0.95 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 0.0 113.15 -174.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -84.29 49.51 1.68 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.823 0.821 . . . . 0.0 109.124 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -76.34 117.48 64.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.103 0.961 . . . . 0.0 109.359 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.2 170.57 11.7 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.716 2.278 . . . . 0.0 111.103 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 63.22 62.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.621 0.768 . . . . 0.0 110.284 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 m -83.07 109.5 17.18 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.29 -35.82 70.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 112.286 -174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.76 53.14 7.35 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.448 1.099 . . . . 0.0 110.971 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.29 149.93 33.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.308 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.884 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.282 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 120.71 0.29 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -86.0 103.89 15.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 19.3 ptp -160.96 -175.02 4.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.283 1.033 . . . . 0.0 109.928 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 56.55 14.77 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.64 -35.29 89.15 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.118 0.54 . . . . 0.0 113.696 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.44 83.93 3.86 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.269 0.557 . . . . 0.0 109.67 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 79.65 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -84.03 60.57 5.94 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.435 1.112 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -130.9 134.56 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.925 1.69 . . . . 0.0 107.582 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 70' ' ' ALA . 17.5 m -112.61 -175.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.858 0.863 . . . . 0.0 109.523 171.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.53 142.43 31.12 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.68 0.753 . . . . 0.0 109.54 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -111.49 119.43 59.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 108.611 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 61.1 mtp180 -123.98 148.56 46.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.25 1.02 . . . . 0.0 109.723 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.33 25.81 35.35 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -59.32 143.72 84.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.121 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.52 174.19 13.24 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.463 2.108 . . . . 0.0 111.275 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -68.75 -24.61 64.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.449 0.642 . . . . 0.0 109.536 171.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.0 m -81.41 1.43 33.06 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.447 1.099 . . . . 0.0 112.482 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.2 p -49.02 126.05 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.561 0.744 . . . . 0.0 112.881 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.52 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 45.7 t -146.3 158.91 43.93 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.919 1.287 . . . . 0.0 108.35 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . -53.95 -42.95 69.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.019 0.527 . . . . 0.0 110.688 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 6.8 m-20 -54.33 -43.62 71.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 112.658 173.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 13.3 mm-40 -68.04 -36.35 79.75 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.866 0.467 . . . . 0.0 110.875 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.0 t -66.78 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 123.33 0.652 . . . . 0.0 110.673 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 14.8 mm100 -56.92 -53.83 53.52 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.97 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 36.0 mmt180 -56.56 -46.17 80.88 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.41 1.084 . . . . 0.0 111.228 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.59 -40.47 83.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.821 1.248 . . . . 0.0 112.233 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -97.45 35.56 1.62 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.054 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 83.06 4.6 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 169.05 -62.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.003 1.721 . . . . 0.0 106.739 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.9 m -74.58 -177.66 3.25 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.207 168.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 126.74 17.03 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.831 0.824 . . . . 0.0 109.199 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.27 128.68 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.419 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -42.76 -61.74 1.18 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.963 1.705 . . . . 0.0 113.965 -160.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -116.52 40.81 2.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.231 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.25 -130.02 32.05 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.333 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -64.11 -14.52 55.37 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.09 -21.68 50.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.769 0.428 . . . . 0.0 111.501 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 28.89 7.71 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 40' ' ' ALA . 61.2 mt -128.51 127.46 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.615 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.1 tpp180 -131.29 96.68 4.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.694 0.621 . . . . 0.0 110.024 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.64 134.86 36.45 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.7 113.48 24.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -95.82 164.59 12.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.8 p -107.95 172.88 6.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 108.874 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 1.6 15.59 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -85.53 -6.41 59.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.74 0.816 . . . . 0.0 110.683 167.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.38 32.63 42.09 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.069 0.231 . . . . 0.0 113.1 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -135.3 139.64 32.13 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.573 0.749 . . . . 0.0 111.414 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -58.07 134.1 59.91 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 122.868 2.379 . . . . 0.0 112.187 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -69.29 -44.52 71.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.15 0.98 . . . . 0.0 110.986 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.53 -10.0 3.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.091 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 43.7 mt-10 -108.67 148.6 30.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.448 1.099 . . . . 0.0 110.137 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.81 152.18 32.31 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 124.38 1.072 . . . . 0.0 108.265 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.49 126.77 52.51 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.9 t -106.45 142.9 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -123.67 120.01 31.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -167.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.1 mt -117.37 161.07 20.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.376 0.67 . . . . 0.0 110.737 -165.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.68 -29.83 69.56 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -160.45 167.2 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.315 0.384 . . . . 0.0 110.543 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -73.02 -17.84 61.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.207 0.603 . . . . 0.0 111.305 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -44.66 89.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.59 -31.03 71.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.198 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.75 -40.9 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.589 0.756 . . . . 0.0 110.535 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -65.08 -38.15 89.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.36 0.664 . . . . 0.0 111.372 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 96.6 mt -65.66 -31.97 73.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.624 0.769 . . . . 0.0 111.324 172.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -69.04 -42.57 76.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.635 173.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 87' ' ' LYS . 84.9 mt -62.01 -39.71 93.21 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.687 0.795 . . . . 0.0 112.174 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.7 ptmt -75.03 -18.29 60.36 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.999 0.428 . . . . 0.0 110.475 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.18 6.28 23.16 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.518 1.127 . . . . 0.0 111.2 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -68.52 80.43 0.26 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.294 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 163.94 -44.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.869 0.867 . . . . 0.0 110.055 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -42.17 140.46 1.13 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.013 1.725 . . . . 0.0 113.36 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.6 p -100.37 110.53 22.74 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 -172.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.1 ttm -78.44 91.96 4.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.94 -86.54 1.27 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.999 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -132.14 7.26 4.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.881 0.872 . . . . 0.0 109.988 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -105.69 132.71 51.5 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.101 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -76.47 133.37 39.83 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.8 t -131.89 133.45 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.144 0.497 . . . . 0.0 110.392 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -98.53 148.2 24.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.695 1.198 . . . . 0.0 109.277 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' A' ' 70' ' ' ALA . 46.7 t -130.76 118.98 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.04 144.55 42.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' HD21 ' A' ' 71' ' ' LEU . 87.7 tttt -67.68 138.22 56.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -122.95 -160.54 0.9 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.12 159.42 41.58 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -60.71 -40.5 92.5 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.441 0.696 . . . . 0.0 110.723 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.16 -37.29 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.524 1.13 . . . . 0.0 110.976 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -68.75 -46.9 67.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 0.0 110.264 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.26 -45.66 87.44 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.114 0.966 . . . . 0.0 110.14 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.32 -43.36 99.01 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.13 0.972 . . . . 0.0 110.79 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.27 -54.49 45.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.167 0.987 . . . . 0.0 111.919 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.22 -35.28 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 0.0 111.617 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.615 HD11 ' HG2' ' A' ' 44' ' ' ARG . 88.5 mt -67.13 -36.42 81.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.059 0.543 . . . . 0.0 111.105 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -81.82 -32.14 31.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.962 0.905 . . . . 0.0 110.044 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -166.49 99.39 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.462 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -78.4 171.69 14.71 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.88 -173.29 31.15 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.665 -0.519 . . . . 0.0 111.945 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.85 138.3 37.22 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.597 2.198 . . . . 0.0 110.866 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -59.96 120.98 10.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.084 0.469 . . . . 0.0 109.938 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -134.06 72.69 71.67 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.734 0.814 . . . . 0.0 108.941 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -91.3 97.49 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.87 2.38 . . . . 0.0 111.883 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.37 110.03 9.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.5 p -98.92 120.75 39.89 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.648 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -95.83 101.22 12.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.605 0.762 . . . . 0.0 109.812 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -97.22 169.64 9.65 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.04 0.936 . . . . 0.0 109.968 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -160.24 118.54 2.63 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.668 -176.55 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -70.78 -45.36 64.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.342 0.657 . . . . 0.0 110.786 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.2 ttp -75.41 94.73 3.13 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.04 -46.22 1.1 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.607 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.61 -69.2 2.09 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.924 0.426 . . . . 0.0 112.317 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -65.77 150.02 49.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.225 1.01 . . . . 0.0 109.997 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.93 89.86 0.11 Allowed Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HA ' HG21 ' A' ' 67' ' ' VAL . 17.8 p90 -85.08 47.71 1.45 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.178 0.99 . . . . 0.0 111.563 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 60' ' ' GLU . 78.8 t -135.32 143.41 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 168.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.28 173.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.398 -0.814 . . . . 0.0 110.441 168.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -126.9 139.97 52.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.476 ' HB ' HD11 ' A' ' 18' ' ' LEU . 3.7 t -124.92 130.57 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.582 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 32.6 mtm180 -130.78 156.29 45.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.685 0.794 . . . . 0.0 108.891 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.46 -33.97 6.11 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.476 HD11 ' HB ' ' A' ' 15' ' ' VAL . 52.4 mt -34.77 112.36 0.44 Allowed Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.746 1.218 . . . . 0.0 112.594 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.69 163.98 19.9 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.686 2.257 . . . . 0.0 113.223 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -57.22 -34.74 68.85 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.871 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 t -95.55 13.54 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.601 0.761 . . . . 0.0 111.825 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -72.61 168.72 18.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.055 0.542 . . . . 0.0 111.224 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -137.63 156.53 47.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.949 0.899 . . . . 0.0 109.783 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.32 69.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.501 0.721 . . . . 0.0 111.188 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -50.76 -47.94 59.36 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.053 . . . . 0.0 112.741 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -68.01 -41.09 82.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.797 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 43' ' ' ILE . 33.4 t -72.05 -36.27 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.532 0.733 . . . . 0.0 110.282 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.564 ' HG2' HD12 ' A' ' 36' ' ' ILE . 26.1 tm0? -65.73 -43.43 89.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.809 . . . . 0.0 110.0 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -61.56 -42.28 98.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.865 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 59.5 t80 -61.31 -29.28 69.78 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.753 0.821 . . . . 0.0 111.638 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.94 37.65 2.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.576 0.751 . . . . 0.0 111.831 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 p -77.15 85.89 3.62 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.486 0.66 . . . . 0.0 109.58 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 168.95 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 126.721 2.008 . . . . 0.0 106.099 -161.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.3 m -78.81 169.67 17.87 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.977 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -127.8 94.35 3.93 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' A' ' 28' ' ' GLN . 14.6 mt -75.97 133.99 30.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.06 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -47.62 -55.96 8.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.193 1.397 . . . . 0.0 112.777 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -125.54 65.23 1.17 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.381 0.61 . . . . 0.0 109.424 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.48 -143.08 42.24 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.353 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.78 -14.77 60.24 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.867 0.867 . . . . 0.0 112.942 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.04 -19.54 58.54 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.111 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.88 -7.89 71.55 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.817 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.504 HG12 HG22 ' A' ' 59' ' ' VAL . 46.3 mt -93.23 134.21 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 124.181 0.992 . . . . 0.0 110.288 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -128.81 96.12 4.28 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.82 0.848 . . . . 0.0 111.588 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -73.84 117.44 15.62 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.537 HG13 HD23 ' A' ' 97' ' ' LEU . 2.4 mp -67.27 99.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -79.78 134.65 36.37 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.3 p -85.25 176.88 8.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.359 0.664 . . . . 0.0 111.531 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -68.37 -21.46 64.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.061 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 9.4 tp10 -80.03 -13.9 58.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.655 1.182 . . . . 0.0 110.716 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.93 11.34 73.7 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 3.7 mpt_? -106.43 141.5 22.92 Favored Pre-proline 0 N--CA 1.485 1.318 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.67 132.32 49.5 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.062 1.841 . . . . 0.0 110.12 167.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 t -76.13 9.56 2.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.249 1.02 . . . . 0.0 112.142 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 16' ' ' ARG . . . 85.92 -13.42 56.74 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -173.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.99 139.24 37.88 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.251 1.42 . . . . 0.0 109.721 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.78 136.92 29.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.545 0.738 . . . . 0.0 109.232 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD2' HD11 ' A' ' 46' ' ' ILE . 40.3 m-85 -96.2 106.87 19.12 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 HG12 ' A' ' 43' ' ' ILE . 60.1 t -91.19 122.27 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 12' ' ' VAL . 44.0 tt0 -101.56 136.58 41.17 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.9 mt -125.7 162.47 24.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.13 0.491 . . . . 0.0 110.698 -166.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.92 -35.13 57.55 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.01 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -154.13 167.95 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.677 0.751 . . . . 0.0 112.457 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 60.1 mm-40 -61.85 -32.36 72.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.36 1.464 . . . . 0.0 113.169 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.69 -46.68 88.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 1.6 mp0 -59.33 -33.93 71.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.85 170.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 80.9 t -62.14 -52.36 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 118.605 0.638 . . . . 0.0 110.532 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mttt -53.89 -41.27 67.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.427 1.091 . . . . 0.0 111.686 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.1 -41.56 86.06 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.036 0.534 . . . . 0.0 110.92 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.99 94.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.17 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 67.9 mt -57.78 -22.82 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.374 1.07 . . . . 0.0 112.775 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -74.78 -13.72 60.62 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.059 0.543 . . . . 0.0 111.401 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 3.8 mptp? -88.17 -2.47 58.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 118.89 -0.576 . . . . 0.0 112.254 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -53.05 -59.25 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -18.02 64.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 112.515 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -59.41 153.51 18.99 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.602 0.715 . . . . 0.0 112.496 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -100.45 150.92 22.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.639 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.63 114.09 6.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 108.535 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.39 -81.57 1.2 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -159.42 19.62 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.871 0.868 . . . . 0.0 109.735 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.85 139.76 47.07 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.307 0.643 . . . . 0.0 109.862 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -78.38 129.57 35.12 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.8 t -87.12 165.35 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.333 0.653 . . . . 0.0 109.697 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 49.0 mt-10 -135.19 117.32 15.44 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 115.66 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 84' ' ' GLU . 92.3 m-85 -117.05 179.59 3.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 120.62 40.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -109.61 140.56 43.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.786 0.834 . . . . 0.0 111.363 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -96.36 166.01 11.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.188 0.995 . . . . 0.0 109.018 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -62.67 -38.0 88.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.401 0.68 . . . . 0.0 110.746 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.24 -43.11 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.371 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -68.52 -41.65 79.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.329 1.052 . . . . 0.0 109.903 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 51.4 ttp -60.74 -52.89 63.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.892 1.277 . . . . 0.0 110.626 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.25 -45.57 92.78 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.776 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -60.94 -40.78 94.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.498 1.119 . . . . 0.0 111.605 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.446 HG22 ' HA2' ' A' ' 101' ' ' GLY . 71.4 t -81.08 -28.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.352 0.661 . . . . 0.0 111.678 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.537 HD23 HG13 ' A' ' 46' ' ' ILE . 69.8 mt -71.23 -43.47 67.27 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.94 -0.475 . . . . 0.0 110.948 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -82.46 -35.34 27.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.508 0.723 . . . . 0.0 112.74 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -118.16 -4.33 10.99 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 119.243 -0.408 . . . . 0.0 112.062 -166.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p 58.34 131.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.73 1.612 . . . . 0.0 111.317 -168.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 96' ' ' VAL . . . -46.5 101.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.635 0 O-C-N 124.128 0.892 . . . . 0.0 115.098 -171.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -100.27 67.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 124.135 3.223 . . . . 0.0 110.651 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.6 m120 72.99 105.95 0.07 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.829 1.252 . . . . 0.0 110.384 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -99.68 102.56 17.37 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.369 0.668 . . . . 0.0 109.285 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.68 111.83 2.59 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.665 2.243 . . . . 0.0 112.566 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.75 -15.52 59.07 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.461 0.705 . . . . 0.0 110.944 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.6 p -63.61 95.53 0.11 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.219 0.608 . . . . 0.0 109.808 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.19 171.82 7.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.057 0.943 . . . . 0.0 110.016 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.94 164.94 27.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.988 0.515 . . . . 0.0 111.489 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.66 160.14 17.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.981 0.912 . . . . 0.0 110.936 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 CA-C-O 118.798 -1.001 . . . . 0.0 112.046 173.819 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -101.93 118.34 36.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.895 0.878 . . . . 0.0 109.432 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.9 tpt 64.35 22.0 12.65 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.1 1.36 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' A' ' 89' ' ' ASN . . . -84.11 -20.87 58.36 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.162 -0.926 . . . . 0.0 114.326 -173.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.05 -13.07 75.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -108.01 -3.46 18.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 117.978 0.889 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.06 156.11 45.17 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 114.377 0.511 . . . . 0.0 114.377 -170.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -96.63 15.13 22.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.908 0.883 . . . . 0.0 110.724 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.51 139.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.961 1.305 . . . . 0.0 107.898 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 70' ' ' ALA . 30.2 m -107.25 169.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 167.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 79.7 tttt -124.66 125.4 44.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 83' ' ' VAL . 59.5 t -112.66 125.42 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 108.929 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.794 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 76.3 mtp180 -117.7 149.36 40.87 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.03 19.68 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.588 -176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.33 121.96 64.08 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -54.1 149.91 33.77 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.948 2.432 . . . . 0.0 113.066 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -63.37 -25.93 68.52 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.537 0.684 . . . . 0.0 111.086 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 t -109.03 19.21 19.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.202 1.001 . . . . 0.0 111.025 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.7 p -78.29 177.84 8.11 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.655 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.2 t -128.21 148.45 50.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.546 0.738 . . . . 0.0 109.645 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.41 71.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.8 m-20 -54.85 -47.59 73.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 111.262 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 11.2 mm-40 -69.01 -41.25 78.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.412 0.685 . . . . 0.0 111.478 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 43' ' ' ILE . 45.5 t -69.14 -31.85 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.02 0.528 . . . . 0.0 109.691 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.64 -41.85 87.64 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.798 0.839 . . . . 0.0 110.598 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 67.6 mmt-85 -65.99 -37.2 85.35 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 0.0 111.262 176.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -68.13 -33.81 75.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.374 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -101.99 35.53 2.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.591 . . . . 0.0 110.684 175.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -82.34 79.76 8.71 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t70 170.54 -38.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.816 -158.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.8 m -102.11 173.05 6.56 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.344 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.529 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 6.0 mtpm? -126.78 95.14 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HA ' HD23 ' A' ' 61' ' ' LEU . 21.5 mt -76.62 139.51 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.659 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -45.89 -69.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.894 1.371 . . . . 0.0 112.112 -169.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 41' ' ' GLN . 1.2 t-20 -106.34 35.48 2.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.861 0.464 . . . . 0.0 110.278 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.66 -125.92 31.67 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.33 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -29.96 71.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.006 0.903 . . . . 0.0 111.063 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.2 mp0 -73.53 -18.01 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.17 0.588 . . . . 0.0 110.916 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.74 -15.7 81.37 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.208 0.317 . . . . 0.0 112.907 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 27' ' ' VAL . 63.7 mt -83.53 141.32 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.875 0.87 . . . . 0.0 109.424 178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HG2' HD11 ' A' ' 97' ' ' LEU . 3.3 tpp180 -133.96 95.23 3.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -73.58 128.4 35.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.918 0.487 . . . . 0.0 110.198 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.27 118.67 32.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 89.0 m-85 -90.01 172.09 9.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.256 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -101.29 173.09 6.61 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.639 165.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -68.59 -11.18 59.66 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.274 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -85.2 -2.64 58.26 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.819 0.848 . . . . 0.0 111.57 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.4 37.35 41.7 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -145.6 135.03 11.41 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.146 0.578 . . . . 0.0 111.21 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 87.6 Cg_exo -49.08 133.96 29.38 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.6 2.866 . . . . 0.0 113.76 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 p -67.72 -26.09 65.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.179 0.992 . . . . 0.0 111.386 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.99 -16.79 7.23 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -170.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB3' ' HE2' ' A' ' 14' ' ' LYS . 41.2 mt-10 -105.44 153.12 22.12 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.977 0.911 . . . . 0.0 110.574 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.76 168.82 25.56 Favored 'General case' 0 C--O 1.213 -0.854 0 C-N-CA 124.69 1.196 . . . . 0.0 108.979 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -119.37 124.45 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.673 0.789 . . . . 0.0 109.674 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.87 111.75 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.93 136.0 35.98 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 36' ' ' ILE . 70.3 mt -126.9 144.22 51.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.519 0.728 . . . . 0.0 109.819 -171.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -66.38 -17.64 64.89 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.8 p -166.65 170.36 12.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.96 0.504 . . . . 0.0 110.945 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.59 -21.14 65.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.443 1.097 . . . . 0.0 113.367 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -49.0 77.71 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mp0 -59.4 -33.11 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.831 0.852 . . . . 0.0 112.51 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 55.3 t -60.06 -48.61 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.426 0.454 . . . . 0.0 109.916 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.32 -36.74 83.09 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.974 0.91 . . . . 0.0 112.048 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.26 -41.57 99.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.404 0.682 . . . . 0.0 111.607 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -64.02 -43.98 93.96 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.059 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 98.0 mt -64.31 -33.32 75.57 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.996 0.918 . . . . 0.0 112.747 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -16.26 50.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.909 -0.494 . . . . 0.0 110.123 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -83.58 -9.36 58.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.912 0.885 . . . . 0.0 111.002 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' HB2' ' HB ' ' A' ' 85' ' ' VAL . 5.0 t70 -62.14 100.09 0.16 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 149.38 -49.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.387 2.275 . . . . 0.0 108.67 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -55.52 146.29 20.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.034 1.333 . . . . 0.0 113.56 -168.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 25.7 p -98.6 121.39 40.49 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.803 0.841 . . . . 0.0 110.904 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ptp -83.81 74.59 10.17 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 122.005 0.907 . . . . 0.0 108.949 164.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.05 -89.95 1.38 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.126 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.98 -23.26 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.508 0.723 . . . . 0.0 111.867 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -122.35 139.24 54.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.063 0.545 . . . . 0.0 111.761 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 21.4 p90 -85.71 142.84 28.72 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.607 1.163 . . . . 0.0 108.815 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 15' ' ' VAL . 37.7 t -103.88 131.6 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.579 0.752 . . . . 0.0 111.54 -170.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 26.4 tp10 -104.78 119.33 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 108.783 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 74' ' ' ASP . 56.3 t -118.33 117.05 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.083 0.553 . . . . 0.0 110.62 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.75 139.83 44.35 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.967 . . . . 0.0 109.564 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -68.02 126.41 29.41 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -132.91 -162.12 1.21 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.044 0.938 . . . . 0.0 109.466 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.548 ' HB2' ' HA2' ' A' ' 7' ' ' GLY . 59.6 t30 -146.54 162.82 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.297 0.639 . . . . 0.0 109.401 -172.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.7 -31.46 71.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.841 0.856 . . . . 0.0 110.498 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.57 -42.13 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.362 0.665 . . . . 0.0 110.98 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 96' ' ' VAL . 18.1 tp10 -64.51 -49.54 70.92 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.0 -46.06 68.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.107 1.363 . . . . 0.0 111.391 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.9 -44.13 97.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.812 0.845 . . . . 0.0 111.331 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -63.46 -39.66 95.06 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.565 0.746 . . . . 0.0 111.406 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 92' ' ' GLU . 5.2 t -79.05 -18.95 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.739 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.516 HD11 ' HG2' ' A' ' 44' ' ' ARG . 97.8 mt -78.63 -30.0 46.21 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.957 0.503 . . . . 0.0 111.118 168.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -78.85 -35.85 43.26 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.573 0.749 . . . . 0.0 109.592 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -134.1 90.69 2.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.4 p -65.14 99.26 0.36 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.88 155.4 26.4 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.695 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.62 89.92 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.874 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -91.76 56.08 2.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.646 0.778 . . . . 0.0 109.872 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.7 m -69.37 113.13 14.64 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.63 0.772 . . . . 0.0 110.094 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.7 151.82 83.33 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.41 2.073 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 -70.87 0.13 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -176.31 164.7 2.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.21 85.22 1.0 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 108.124 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -153.1 137.05 16.26 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.969 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -79.81 124.37 28.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.699 0.799 . . . . 0.0 109.673 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.895 178.755 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 t60 63.46 121.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.675 1.59 . . . . 0.0 110.109 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.84 114.09 2.61 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.837 0.455 . . . . 0.0 110.364 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.85 162.03 23.45 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.034 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.18 -36.05 0.22 Allowed Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.704 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -74.57 69.34 1.71 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 90' ' ' ASN . . . 102.73 124.31 5.42 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -170.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -78.08 90.58 4.23 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.481 0.713 . . . . 0.0 110.56 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.4 t -134.28 140.48 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.296 1.038 . . . . 0.0 108.58 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 61' ' ' LEU . 30.0 m -107.48 167.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 0.0 110.549 164.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HE3' ' HD2' ' A' ' 16' ' ' ARG . 3.7 tmmm? -119.82 122.72 41.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.54 123.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 108.611 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HD2' ' HE3' ' A' ' 14' ' ' LYS . 12.0 ptm180 -139.95 154.71 47.27 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.17 21.06 23.82 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.21 138.09 30.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.209 1.004 . . . . 0.0 108.775 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 157.21 62.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.718 2.279 . . . . 0.0 112.307 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -52.28 -35.78 51.08 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.432 1.093 . . . . 0.0 111.851 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.6 p -93.2 17.26 11.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.015 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.48 166.17 15.27 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 123.393 0.677 . . . . 0.0 111.53 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.1 m -151.02 163.04 39.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 108.976 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -44.1 69.19 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 111.209 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.08 -40.42 73.57 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.167 0.987 . . . . 0.0 113.379 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -55.96 -48.19 76.24 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.447 0.641 . . . . 0.0 110.926 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.1 t -81.83 -22.98 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.699 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -71.26 -48.25 52.18 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.375 0.67 . . . . 0.0 109.949 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -63.91 -38.46 91.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.48 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.44 -46.49 88.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.539 ' HB2' HD11 ' A' ' 36' ' ' ILE . 96.3 m-85 -99.07 38.16 1.43 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.859 0.863 . . . . 0.0 110.698 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -66.13 -29.07 69.31 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.78 0.432 . . . . 0.0 110.764 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.69 -10.96 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.981 1.312 . . . . 0.0 112.23 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.419 ' HB3' HD23 ' A' ' 61' ' ' LEU . 39.5 m -121.85 139.78 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.791 0.837 . . . . 0.0 109.213 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.06 92.1 6.19 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.8 mt -69.03 144.14 14.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.916 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.22 100.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.716 0.806 . . . . 0.0 110.003 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 36.0 m-80 54.28 35.29 22.41 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 124.269 0.981 . . . . 0.0 111.756 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -121.54 24.58 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.651 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -27.62 17.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 3.5 tp-100 -68.41 -21.7 64.66 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.18 -21.37 45.72 Favored Glycine 0 N--CA 1.471 1.023 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.423 HG23 HG22 ' A' ' 59' ' ' VAL . 56.7 mt -83.46 107.78 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.116 0.567 . . . . 0.0 110.139 -173.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.49 98.01 5.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.45 0.7 . . . . 0.0 110.927 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -75.22 151.7 38.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.037 0.535 . . . . 0.0 111.646 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.84 86.36 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 165.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.67 147.84 45.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.0 t -109.17 -179.3 3.81 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -176.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -77.1 -2.83 36.24 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.506 0.722 . . . . 0.0 111.59 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 48' ' ' THR . 40.1 tt0 -89.03 -19.12 26.04 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.684 1.194 . . . . 0.0 110.043 172.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 45.89 5.98 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.732 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -144.4 157.22 56.55 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 124.24 1.016 . . . . 0.0 109.923 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.89 135.97 73.79 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.436 2.091 . . . . 0.0 111.348 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -100.12 36.94 1.74 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.479 1.111 . . . . 0.0 110.495 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.29 -40.49 2.88 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.562 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.31 155.18 19.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 110.985 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 161.62 42.37 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 109.261 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -120.8 113.37 20.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.246 1.018 . . . . 0.0 108.616 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 43' ' ' ILE . 77.9 t -107.47 121.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.0 0.92 . . . . 0.0 108.823 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.517 ' HG2' HG22 ' A' ' 12' ' ' VAL . 29.4 mt-10 -86.09 156.41 20.39 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.048 0.539 . . . . 0.0 109.795 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.584 HD13 HG22 ' A' ' 67' ' ' VAL . 3.6 mp -138.21 156.71 47.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.937 0.895 . . . . 0.0 109.681 -176.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.18 -26.47 47.61 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.937 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.8 m -145.59 153.72 41.37 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -31.28 72.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.58 1.152 . . . . 0.0 111.158 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.11 -49.13 77.14 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.19 0.519 . . . . 0.0 110.097 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -58.06 -35.22 71.04 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.795 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG22 HD13 ' A' ' 61' ' ' LEU . 79.3 t -61.62 -50.22 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -56.75 -36.98 70.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.668 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.45 -42.3 87.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.362 0.665 . . . . 0.0 111.035 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -61.78 -40.19 94.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.801 0.84 . . . . 0.0 111.024 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 81.1 mt -61.62 -23.5 66.08 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.25 1.02 . . . . 0.0 112.547 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.25 -4.85 56.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.618 0.367 . . . . 0.0 111.776 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.68 4.94 49.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.062 0.945 . . . . 0.0 111.781 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.567 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 26.8 t70 -38.83 -12.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 170.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -144.78 -11.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.134 -0.979 . . . . 0.0 111.553 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -52.12 139.73 22.59 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.146 0.978 . . . . 0.0 111.708 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.8 p -93.01 127.71 38.62 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.945 0.898 . . . . 0.0 112.435 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -94.02 102.64 14.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.88 -90.2 0.32 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.51 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -120.43 -4.32 9.88 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.102 0.961 . . . . 0.0 111.354 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -124.75 147.88 48.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.615 0.366 . . . . 0.0 110.849 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -79.91 141.29 36.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.39 123.84 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 34.9 mt-10 -95.46 129.02 42.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.247 1.019 . . . . 0.0 108.977 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.567 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 27.8 t -127.01 118.53 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -113.87 177.67 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -111.89 128.8 56.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.1 m -122.9 -166.31 1.43 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.15 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.513 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 23.9 m-80 -136.46 161.46 35.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.493 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 25.7 t-20 -63.21 -35.12 79.28 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.75 -41.92 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.185 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.513 ' HB3' ' H ' ' A' ' 89' ' ' ASN . 8.9 tp10 -62.96 -51.75 65.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.156 0.982 . . . . 0.0 110.518 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.486 ' HB2' HG11 ' A' ' 12' ' ' VAL . 10.9 tmm? -57.62 -50.52 72.88 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.25 1.42 . . . . 0.0 111.183 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.31 -39.51 92.59 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.526 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -61.2 -50.9 71.25 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 0.0 111.504 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.19 -39.1 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.484 0.49 . . . . 0.0 111.376 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.421 HD12 ' SD ' ' A' ' 93' ' ' MET . 94.0 mt -65.41 -29.27 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.296 0.238 . . . . 0.0 111.383 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -86.67 -33.16 20.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.442 0.697 . . . . 0.0 110.62 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -150.94 92.9 1.87 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.969 1.308 . . . . 0.0 108.294 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 p -65.46 102.92 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.72 -167.37 10.96 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.79 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.8 112.74 2.76 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.679 2.253 . . . . 0.0 110.902 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -59.23 99.54 0.06 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.9 p -60.8 109.77 2.37 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 124.316 1.01 . . . . 0.0 109.016 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.48 148.43 73.03 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.624 2.216 . . . . 0.0 112.051 -173.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.44 -29.39 70.48 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.725 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 m 62.59 28.0 16.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.448 1.099 . . . . 0.0 111.091 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.78 88.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.37 0.668 . . . . 0.0 110.519 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 57.18 32.35 21.56 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 124.49 1.118 . . . . 0.0 110.412 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.36 -40.34 67.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.554 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.093 172.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.546 0.788 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -127.44 9.08 6.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.594 0.758 . . . . 0.0 109.491 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.3 mmt -95.84 10.64 36.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 0.0 110.167 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.45 -91.77 1.68 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -172.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.35 7.67 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.987 -0.149 . . . . 0.0 112.995 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -79.96 76.12 6.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.121 0.962 . . . . 0.0 109.506 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.8 175.84 20.06 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.399 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -87.53 1.47 53.45 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.432 0.693 . . . . 0.0 111.601 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.36 138.65 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.828 0.851 . . . . 0.0 109.959 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -107.37 162.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.201 0.601 . . . . 0.0 110.32 165.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 38.4 ttpt -113.6 120.63 41.58 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.5 118.36 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -169.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -122.1 147.7 45.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.423 1.489 . . . . 0.0 107.188 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.5 20.0 21.15 Favored Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.5 mt -92.74 117.01 67.41 Favored Pre-proline 0 C--O 1.244 0.781 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.147 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.72 157.74 7.12 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.017 2.478 . . . . 0.0 113.222 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -61.96 -18.78 61.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.604 0.762 . . . . 0.0 112.285 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 m -110.97 14.7 22.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.746 0.819 . . . . 0.0 112.168 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.64 170.67 6.02 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.205 0.457 . . . . 0.0 111.303 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -139.73 156.11 46.97 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.116 0.566 . . . . 0.0 109.492 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.25 84.28 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.828 0.705 . . . . 0.0 110.721 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.8 m-20 -53.8 -42.61 68.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.516 0.726 . . . . 0.0 112.563 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.98 -39.96 95.32 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.115 0.566 . . . . 0.0 111.876 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.2 t -68.61 -35.23 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.54 0.736 . . . . 0.0 110.096 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -65.38 -40.54 93.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.303 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 70.6 mtp180 -59.99 -47.15 87.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.187 0.595 . . . . 0.0 111.045 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.93 -34.16 74.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.475 0.71 . . . . 0.0 111.488 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.733 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 63.2 m-85 -108.35 24.9 12.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.693 0.797 . . . . 0.0 111.655 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.2 p -74.16 90.61 2.06 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.7 t70 166.08 -53.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -160.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 16.8 p -76.68 -175.56 3.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 33.3 mmtp -129.17 96.11 4.23 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 61' ' ' LEU . 24.4 mt -76.45 139.04 19.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -66.06 110.28 2.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.955 0.902 . . . . 0.0 110.31 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 85.9 m-20 60.04 31.52 20.66 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.903 0.881 . . . . 0.0 111.179 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 -125.24 34.09 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.699 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.9 -24.21 22.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.035 0.934 . . . . 0.0 113.46 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 2.6 tp-100 -71.33 -18.05 62.41 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.694 0.397 . . . . 0.0 112.053 -176.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.67 -18.29 58.64 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.63 -0.259 . . . . 0.0 112.625 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' A' ' 27' ' ' VAL . 54.5 mt -85.18 110.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.0 109.675 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -123.24 99.7 6.48 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.553 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -78.31 138.83 38.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.953 0.501 . . . . 0.0 110.417 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.56 99.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.26 153.85 28.24 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.826 0.346 . . . . 0.0 110.707 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.6 p -87.03 -172.95 4.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.603 0.761 . . . . 0.0 109.515 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -76.65 -0.12 22.3 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.675 0.39 . . . . 0.0 111.568 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -101.55 -20.73 14.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.033 0.933 . . . . 0.0 109.462 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.21 45.14 4.51 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.29 138.91 26.12 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.18 0.992 . . . . 0.0 109.234 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.08 120.91 8.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.66 2.24 . . . . 0.0 111.168 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.6 m -82.91 25.35 0.68 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.049 0.94 . . . . 0.0 112.064 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.41 -33.43 4.12 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.159 0.409 . . . . 0.0 112.476 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -111.18 156.08 21.95 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.592 1.157 . . . . 0.0 110.761 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.68 169.39 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.058 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -121.69 115.98 23.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.765 0.826 . . . . 0.0 109.472 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.89 112.51 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -84.02 141.9 30.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.797 0.839 . . . . 0.0 109.015 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 36' ' ' ILE . 39.7 mt -131.54 165.27 23.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.919 0.887 . . . . 0.0 110.22 -168.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.88 -39.73 87.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.406 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 t -164.74 174.79 10.32 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.818 0.447 . . . . 0.0 110.122 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 7.6 pt-20 -60.54 -27.71 67.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.167 0.987 . . . . 0.0 112.57 -174.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.35 -50.93 41.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 14.3 mp0 -51.59 -37.24 48.98 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.313 1.045 . . . . 0.0 111.637 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 44.3 t -60.11 -52.51 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.369 172.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -57.3 -40.09 77.09 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.62 0.768 . . . . 0.0 111.948 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 66' ' ' GLU . 86.1 mt -58.64 -45.34 89.5 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.997 0.919 . . . . 0.0 110.641 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.36 84.49 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.478 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 92.1 mt -58.35 -37.13 74.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.679 1.192 . . . . 0.0 112.096 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -72.4 -5.66 38.09 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -98.98 9.61 43.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.252 1.021 . . . . 0.0 112.774 172.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.76 10.01 0.15 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -123.02 -23.18 5.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.31 0.644 . . . . 0.0 110.781 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.27 148.18 45.75 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.776 0.798 . . . . 0.0 112.216 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -99.79 137.79 37.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.309 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.2 ttt -142.59 111.42 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.614 1.166 . . . . 0.0 109.114 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.2 58.25 7.55 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.041 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 t60 71.89 -7.49 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 125.073 1.349 . . . . 0.0 112.809 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -116.85 149.59 39.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.518 1.127 . . . . 0.0 110.162 -172.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -80.78 138.89 36.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.51 123.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -95.26 119.48 33.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.7 t -113.2 114.14 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.4 m-85 -103.39 171.81 7.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.609 1.164 . . . . 0.0 110.355 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -97.14 104.57 16.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -106.2 -171.7 1.95 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.015 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.85 163.44 34.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.732 1.213 . . . . 0.0 108.934 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -61.13 -38.39 86.22 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.15 -49.44 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.161 -1.382 . . . . 0.0 110.521 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.81 -42.42 95.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.1 ttp -52.58 -56.86 12.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.066 0.946 . . . . 0.0 111.554 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 17.4 t70 -65.86 -46.0 80.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.901 0.751 . . . . 0.0 111.759 -173.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -69.19 -44.93 71.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.202 0.601 . . . . 0.0 112.543 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.09 -42.65 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 122.673 0.389 . . . . 0.0 110.656 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -38.74 85.49 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.195 0.598 . . . . 0.0 110.188 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -78.57 -18.78 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.681 0.793 . . . . 0.0 109.984 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -90.64 -4.91 56.45 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.315 0.646 . . . . 0.0 109.288 172.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.5 p 57.74 22.31 8.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.9 2.08 . . . . 0.0 112.723 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.61 148.79 4.82 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.37 124.85 6.05 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.327 2.018 . . . . 0.0 112.287 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.71 -5.02 56.48 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.521 0.729 . . . . 0.0 110.711 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.6 m 75.29 144.44 0.1 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.856 1.662 . . . . 0.0 110.931 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.74 99.95 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.617 2.211 . . . . 0.0 111.675 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.71 -38.36 88.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.251 -169.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.4 p -76.53 97.75 4.44 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.78 64.51 1.24 Allowed 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -104.14 111.19 23.68 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.149 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.34 121.79 28.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -175.841 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.7 m170 71.68 143.91 0.06 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.277 1.431 . . . . 0.0 110.307 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.8 ttt -100.27 126.18 46.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.05 60.4 4.45 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.07 -36.99 86.88 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 53.35 37.66 25.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.287 1.435 . . . . 0.0 112.955 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -62.37 139.41 45.73 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.142 173.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.01 4.64 4.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.073 0.549 . . . . 0.0 112.339 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -98.97 138.56 23.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.775 1.23 . . . . 0.0 109.247 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -108.75 173.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.768 0.827 . . . . 0.0 109.121 165.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 18.1 ptpt -121.53 129.54 52.97 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.69 117.55 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.12 158.24 18.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -172.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 73.25 32.65 59.95 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 121.464 0.48 . . . . 0.0 112.874 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.25 133.42 38.72 Favored Pre-proline 0 C--O 1.243 0.736 0 C-N-CA 123.753 0.821 . . . . 0.0 109.041 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -54.7 145.44 60.04 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.71 2.274 . . . . 0.0 112.468 170.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -58.7 -30.52 67.47 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.158 0.983 . . . . 0.0 111.011 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.6 p -105.81 20.05 19.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.461 1.104 . . . . 0.0 111.64 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -68.65 169.99 10.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.333 0.653 . . . . 0.0 111.009 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 26' ' ' GLU . 88.2 p -126.39 156.92 39.78 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -35.2 67.42 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.441 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.14 -40.32 70.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.78 1.232 . . . . 0.0 112.957 173.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG2' ' OG ' ' A' ' 23' ' ' SER . 58.6 mm-40 -64.35 -40.11 95.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.336 177.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 43' ' ' ILE . 46.7 t -76.77 -26.12 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -64.07 -53.6 47.15 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.256 1.023 . . . . 0.0 110.134 173.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -58.65 -46.92 86.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.158 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -68.17 -44.27 76.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.076 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -97.24 36.22 1.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.738 0.815 . . . . 0.0 110.301 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 p -59.58 -23.37 62.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.164 0.585 . . . . 0.0 112.295 173.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.05 -49.96 73.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.409 0.684 . . . . 0.0 110.331 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' HD22 ' A' ' 61' ' ' LEU . 34.2 m -82.92 131.57 35.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.619 -172.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -79.54 105.23 10.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -83.77 147.19 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.508 0.723 . . . . 0.0 109.44 -177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -41.73 -70.18 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 126.512 1.925 . . . . 0.0 114.172 -166.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -118.71 48.02 1.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 168.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.97 -120.5 23.02 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.515 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -62.5 -31.41 72.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.629 0.772 . . . . 0.0 112.068 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.94 -19.66 58.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.452 0.701 . . . . 0.0 111.222 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -16.01 79.67 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.661 -0.245 . . . . 0.0 112.795 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 ' HB ' ' A' ' 27' ' ' VAL . 66.1 mt -85.55 127.92 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.225 1.01 . . . . 0.0 109.545 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' NH1' ' SD ' ' A' ' 93' ' ' MET . 55.1 mtt180 -130.66 98.74 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 109.786 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.29 142.94 43.2 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.744 0.418 . . . . 0.0 110.489 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.719 HD12 ' HG2' ' A' ' 56' ' ' GLU . 61.4 mt -86.31 90.6 3.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -72.37 156.27 39.26 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.825 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.7 p -84.63 -173.17 4.58 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.552 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -63.89 -17.65 63.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB3' ' NH2' ' A' ' 52' ' ' ARG . 70.7 mm-40 -88.52 -5.92 57.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.777 1.231 . . . . 0.0 111.468 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.47 63.43 Favored Glycine 0 C--N 1.352 1.436 0 O-C-N 123.429 0.456 . . . . 0.0 113.268 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 50' ' ' GLU . 48.8 mtm180 -137.85 139.59 26.88 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 110.013 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.77 128.6 29.12 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.288 2.659 . . . . 0.0 112.045 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -74.84 -68.18 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.45 -11.94 0.02 OUTLIER Glycine 0 N--CA 1.474 1.187 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.108 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.719 ' HG2' HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -128.95 168.24 16.27 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 111.225 177.132 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HA ' HG13 ' A' ' 46' ' ' ILE . . . -152.91 172.02 17.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.976 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -120.75 122.04 39.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 0.0 109.064 166.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 43' ' ' ILE . 81.1 t -116.25 117.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.064 0.946 . . . . 0.0 108.521 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 33.1 tt0 -86.34 147.26 26.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 83.4 mt -130.01 156.14 44.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.172 0.989 . . . . 0.0 110.347 -169.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.32 -26.21 64.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.064 0.946 . . . . 0.0 111.551 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 74.4 m -148.53 160.64 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.557 0.743 . . . . 0.0 110.278 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.75 -15.14 61.67 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.262 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 22.9 t70 -72.22 -38.88 68.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.886 0.474 . . . . 0.0 110.304 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 22.4 mm-40 -61.18 -33.47 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.96 169.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 54.5 t -63.11 -37.19 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.075 0.55 . . . . 0.0 110.004 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 67.9 mmtt -57.98 -48.44 79.99 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.829 0.452 . . . . 0.0 111.036 171.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.1 -26.24 68.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.659 0.784 . . . . 0.0 112.07 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -78.2 -45.24 23.57 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.523 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 55.9 mt -67.03 -28.73 68.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -78.12 -15.34 58.95 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.005 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -87.3 -8.22 56.96 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.736 1.215 . . . . 0.0 110.804 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.3 93.15 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.584 0.754 . . . . 0.0 108.988 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 154.12 -53.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.721 2.008 . . . . 0.0 108.869 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.14 141.63 22.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 113.397 -167.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.4 p -83.28 126.18 32.4 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.26 1.024 . . . . 0.0 112.385 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.2 tpp -82.64 85.9 6.93 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.44 -75.9 0.66 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -114.33 -45.2 3.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.082 0.953 . . . . 0.0 109.669 171.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -67.06 -145.85 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.422 1.489 . . . . 0.0 112.092 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 32.5 t80 -160.98 120.54 2.64 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.837 -1.164 . . . . 0.0 108.388 -158.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 98.4 t -99.41 130.23 48.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 123.573 0.749 . . . . 0.0 110.381 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.85 121.59 40.35 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.572 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -118.36 122.91 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -119.37 142.43 48.17 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.444 ' HB2' HD11 ' A' ' 71' ' ' LEU . 19.5 ttmm -57.9 116.79 3.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.859 0.863 . . . . 0.0 109.762 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.1 m -114.55 -174.28 2.45 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.482 0.658 . . . . 0.0 110.921 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 45.5 t-20 -131.62 152.0 51.17 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.37 -33.01 74.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.304 0.642 . . . . 0.0 109.919 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.0 -48.21 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.611 1.164 . . . . 0.0 110.249 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.46 -34.82 74.94 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.676 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' ' NH1' ' A' ' 44' ' ' ARG . 54.9 ttp -57.35 -55.19 37.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.865 0.866 . . . . 0.0 110.935 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.05 -39.86 93.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.769 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 44.0 t90 -57.33 -42.68 82.37 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.171 0.92 . . . . 0.0 111.714 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 100' ' ' THR . 84.0 t -80.96 -40.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.42 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.69 -17.34 63.47 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.692 -0.63 . . . . 0.0 111.482 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -68.9 -39.42 79.73 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.034 0.933 . . . . 0.0 112.304 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -179.78 55.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.344 0.657 . . . . 0.0 109.427 -168.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 57.7 p 49.67 -173.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.412 1.485 . . . . 0.0 112.278 -174.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.64 93.49 0.95 Allowed Glycine 0 N--CA 1.463 0.461 0 CA-C-O 118.6 -1.111 . . . . 0.0 110.843 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -58.68 102.86 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.374 2.049 . . . . 0.0 110.909 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -68.47 105.29 2.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.976 0.91 . . . . 0.0 109.727 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.5 p -116.98 87.82 23.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.916 0.886 . . . . 0.0 108.936 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.55 -166.86 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.203 2.602 . . . . 0.0 111.812 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 67.17 3.0 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.445 1.098 . . . . 0.0 112.919 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -83.76 86.9 7.07 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.1 159.24 21.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.531 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.81 108.02 6.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.333 0.653 . . . . 0.0 110.051 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -77.6 120.3 22.36 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.026 -177.339 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 60.78 79.17 0.25 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 109.397 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.06 -16.42 59.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.85 1.26 . . . . 0.0 111.94 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA3' HD21 ' A' ' 89' ' ' ASN . . . 115.58 -85.41 0.39 Allowed Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.74 -68.3 2.52 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -61.32 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.404 1.082 . . . . 0.0 111.054 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . 172.89 106.32 0.19 Allowed Glycine 0 C--N 1.343 0.961 0 C-N-CA 121.762 -0.256 . . . . 0.0 112.702 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -101.54 26.89 6.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 60' ' ' GLU . 17.3 t -114.65 145.15 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 108.549 -174.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.22 175.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.497 0.719 . . . . 0.0 109.82 162.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 105' ' ' PRO . 6.4 ptpp? -127.58 140.31 52.2 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.52 113.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -112.22 147.2 36.71 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 81' ' ' ARG . . . 90.32 27.42 20.56 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 121.407 0.448 . . . . 0.0 112.394 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.39 146.1 46.78 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 123.737 0.815 . . . . 0.0 109.304 172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HG3' ' A' ' 81' ' ' ARG . 1.3 Cg_endo -51.47 149.83 16.96 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.337 2.025 . . . . 0.0 111.872 165.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -59.83 -26.49 65.85 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.471 0.708 . . . . 0.0 111.964 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -119.13 36.9 4.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.227 1.011 . . . . 0.0 109.74 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.27 151.1 48.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.674 0.389 . . . . 0.0 110.347 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.7 t -111.13 146.41 36.89 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.576 0.75 . . . . 0.0 109.047 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -34.4 66.62 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.66 0.6 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 11.2 m-20 -54.98 -49.35 71.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.867 0.867 . . . . 0.0 112.261 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 12.2 mm-40 -69.25 -34.39 74.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.893 0.477 . . . . 0.0 111.101 -174.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.36 -37.9 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.202 0.601 . . . . 0.0 109.711 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.24 -44.49 88.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.151 0.98 . . . . 0.0 111.266 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 29.6 mmt85 -62.39 -39.84 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.477 0.711 . . . . 0.0 110.839 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -38.18 87.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.466 0.707 . . . . 0.0 110.045 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 59.1 m-85 -101.43 28.75 5.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.239 0.615 . . . . 0.0 112.019 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 t -80.98 83.25 6.74 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 171.22 -39.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.884 1.274 . . . . 0.0 108.268 -161.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 23.4 p -114.92 127.44 55.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.843 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.61 100.47 6.15 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.295 0.638 . . . . 0.0 109.598 -171.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.626 ' HA ' HD23 ' A' ' 61' ' ' LEU . 45.9 mt -74.05 127.6 35.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.338 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.04 121.15 13.45 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.111 0.882 . . . . 0.0 109.377 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 69.28 12.59 8.42 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.944 1.298 . . . . 0.0 112.056 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.27 -134.17 42.51 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.82 -19.57 64.2 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.489 0.716 . . . . 0.0 112.309 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -73.74 -16.93 61.16 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.149 0.58 . . . . 0.0 112.091 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.63 -6.39 76.98 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 123.533 0.52 . . . . 0.0 112.424 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 59' ' ' VAL . 51.5 mt -92.05 123.69 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 110.686 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -132.4 105.62 7.39 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.926 1.29 . . . . 0.0 109.366 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -68.6 143.65 54.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.3 93.75 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.1 134.4 37.72 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.635 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p -75.64 -172.03 1.74 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.53 0.732 . . . . 0.0 110.95 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.2 -20.4 66.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -91.4 0.98 57.44 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.851 0.86 . . . . 0.0 110.396 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.22 71.04 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -107.94 134.49 20.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.493 0.717 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.54 121.34 9.87 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.562 2.175 . . . . 0.0 111.179 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.0 p -73.04 -8.85 57.59 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.8 0.84 . . . . 0.0 112.224 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.15 54.81 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -169.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -109.15 154.22 22.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.498 1.119 . . . . 0.0 109.535 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.07 169.43 21.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 110.469 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.03 127.55 53.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.797 1.239 . . . . 0.0 109.125 165.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 43' ' ' ILE . 55.3 t -118.12 119.75 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG2' HG22 ' A' ' 12' ' ' VAL . 44.0 mt-10 -79.87 146.47 32.18 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 36' ' ' ILE . 71.8 mt -136.13 136.55 40.17 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.04 -10.59 41.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -167.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.442 ' OG ' ' HG2' ' A' ' 66' ' ' GLU . 97.1 p -153.51 161.42 42.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.324 0.649 . . . . 0.0 110.433 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 37.1 tt0 -71.41 -16.93 62.42 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.454 0.702 . . . . 0.0 111.056 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.41 -48.66 55.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 41.3 mm-40 -54.08 -34.99 61.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 123.831 0.707 . . . . 0.0 111.829 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 37.6 t -60.75 -49.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.05 0.54 . . . . 0.0 110.738 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 92.3 mttt -59.76 -36.75 77.29 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.584 0.754 . . . . 0.0 112.167 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 93.6 mt -63.48 -43.99 95.71 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.43 0.692 . . . . 0.0 111.444 174.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.6 -46.8 86.24 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.004 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 87' ' ' LYS . 82.6 mt -62.77 -30.67 71.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.301 1.041 . . . . 0.0 112.984 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 20.0 ptmt -78.67 -13.01 60.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 120.72 0.295 . . . . 0.0 110.783 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.22 3.78 54.79 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.831 0.852 . . . . 0.0 111.08 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 90.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.384 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 164.44 -52.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.863 1.265 . . . . 0.0 111.224 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.83 169.97 16.85 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.435 0.636 . . . . 0.0 112.674 -165.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -113.12 139.23 48.9 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.371 -162.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -103.15 67.54 0.94 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.947 1.299 . . . . 0.0 108.859 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.15 58.12 3.26 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.799 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.0 m80 72.62 -7.71 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.684 1.594 . . . . 0.0 112.763 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 23.0 mmt180 -77.98 104.87 8.81 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -66.16 112.38 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.51 133.26 47.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.96 130.43 55.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 108.86 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.93 116.27 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.47 137.7 54.79 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 71' ' ' LEU . 77.9 tttt -67.2 136.28 54.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -121.3 155.96 33.58 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.063 0.945 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.423 HD21 ' HA3' ' A' ' 7' ' ' GLY . 23.2 m120 -91.58 158.68 16.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.3 175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -66.07 -30.71 71.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -44.5 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.885 1.274 . . . . 0.0 110.643 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 96' ' ' VAL . 55.1 tt0 -69.53 -45.55 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.234 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 58.1 ttp -55.44 -45.88 76.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.785 0.834 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.73 -51.86 68.17 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.367 1.067 . . . . 0.0 110.183 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -56.09 -53.52 56.06 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.079 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.488 HG13 ' H ' ' A' ' 101' ' ' GLY . 38.2 t -74.43 -36.34 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.33 0.652 . . . . 0.0 112.195 -169.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.26 -33.62 71.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.645 0.26 . . . . 0.0 110.899 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -89.65 -24.47 21.63 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.767 0.827 . . . . 0.0 111.362 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -148.41 93.41 2.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.421 1.088 . . . . 0.0 108.153 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.2 p -53.59 101.86 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.513 1.125 . . . . 0.0 112.886 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.488 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 172.51 94.75 0.1 OUTLIER Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.944 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.72 96.64 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.045 2.496 . . . . 0.0 111.739 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -65.96 -61.84 1.83 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.76 0.824 . . . . 0.0 110.889 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -162.33 129.54 2.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.88 0.472 . . . . 0.0 109.951 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 69.3 Cg_endo -68.8 170.6 15.04 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.443 2.095 . . . . 0.0 111.679 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.16 98.28 0.22 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.3 p -77.05 98.31 4.95 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.027 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.27 83.63 0.25 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.196 0.598 . . . . 0.0 110.177 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -61.85 131.47 49.88 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.109 0.964 . . . . 0.0 111.362 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.43 119.69 30.77 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 119.35 -0.694 . . . . 0.0 111.383 -179.147 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 58.61 -163.87 0.2 Allowed 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.176 0.99 . . . . 0.0 110.221 -173.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 9' ' ' GLU . 28.2 ttt -74.31 88.3 2.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.43 114.02 6.16 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.695 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.96 22.6 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.829 0.252 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.495 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -62.37 124.36 20.69 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 90' ' ' ASN . . . 69.52 -0.4 19.06 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-O 119.429 -0.65 . . . . 0.0 114.633 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 58.97 47.51 12.12 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.956 1.302 . . . . 0.0 112.128 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 t -108.43 139.04 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 109.861 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.5 178.36 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.514 0.726 . . . . 0.0 110.025 167.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -134.95 125.39 26.56 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.01 129.13 69.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 124.068 0.947 . . . . 0.0 108.806 -166.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.563 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -123.1 153.1 40.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.345 1.058 . . . . 0.0 108.178 -172.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.15 22.52 35.03 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.68 110.82 47.84 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.96 150.65 22.78 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.893 2.395 . . . . 0.0 113.468 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.7 p90 -55.31 -31.49 61.69 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 111.632 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 t -108.78 24.92 12.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.636 0.775 . . . . 0.0 111.128 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -78.96 176.88 9.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.446 0.698 . . . . 0.0 110.23 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.625 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 44.9 t -128.63 152.26 48.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.458 0.703 . . . . 0.0 109.396 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.29 70.18 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.056 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.61 -42.13 82.68 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.92 0.888 . . . . 0.0 112.081 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.625 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 32.7 mm-40 -64.09 -45.28 89.38 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.755 0.659 . . . . 0.0 110.496 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' HB ' HD13 ' A' ' 43' ' ' ILE . 43.8 t -68.99 -38.13 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.732 0.813 . . . . 0.0 110.495 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.52 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 24.7 tm0? -63.91 -51.54 64.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.136 0.974 . . . . 0.0 110.033 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 -63.33 -41.39 98.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.848 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.1 -40.92 95.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.827 0.851 . . . . 0.0 111.053 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 47.0 m-85 -88.06 37.05 0.79 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.777 0.831 . . . . 0.0 111.44 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 t -77.04 82.2 3.55 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 172.23 -39.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.265 1.426 . . . . 0.0 107.871 -162.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.29 169.91 8.27 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.269 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 31.3 mmmt -117.82 85.87 2.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HA ' HD23 ' A' ' 61' ' ' LEU . 32.7 mt -65.28 126.18 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -42.31 -68.21 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.928 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -104.53 41.3 1.34 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.159 0.584 . . . . 0.0 110.477 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.77 -137.17 36.37 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB2' ' HG3' ' A' ' 28' ' ' GLN . . . -70.0 -4.59 21.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 117.739 0.77 . . . . 0.0 112.375 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -83.52 -1.5 53.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.218 0.607 . . . . 0.0 111.326 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.04 5.29 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.426 HD13 ' HB ' ' A' ' 27' ' ' VAL . 69.0 mt -131.86 105.31 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.038 0.935 . . . . 0.0 109.218 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.2 95.34 5.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.327 1.051 . . . . 0.0 110.318 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.08 124.15 21.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.566 HD12 ' HG3' ' A' ' 56' ' ' GLU . 71.1 mt -70.97 90.98 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -76.73 142.6 40.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.855 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.2 p -75.9 -177.09 3.68 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.842 0.857 . . . . 0.0 110.084 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.8 -8.97 48.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.7 14.1 22.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.97 0.908 . . . . 0.0 110.294 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.35 36.25 91.38 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -114.15 134.42 22.21 Favored Pre-proline 0 N--CA 1.484 1.243 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.794 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.71 127.52 22.85 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.293 1.995 . . . . 0.0 110.953 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 t -81.28 21.88 0.72 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.864 0.866 . . . . 0.0 111.565 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.26 -6.62 75.34 Favored Glycine 0 C--N 1.353 1.514 0 C-N-CA 123.186 0.422 . . . . 0.0 112.966 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG3' HD12 ' A' ' 46' ' ' ILE . 11.7 pt-20 -139.32 169.77 17.17 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.41 28.15 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.81 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -108.47 136.64 47.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.95 114.94 44.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.94 148.16 32.74 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 36' ' ' ILE . 77.1 mt -133.62 170.94 14.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.757 0.823 . . . . 0.0 110.205 -173.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.79 -39.47 61.7 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.02 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 t -160.42 174.11 14.61 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.32 -13.3 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.928 0.491 . . . . 0.0 111.596 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.81 -40.93 88.23 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.679 0.752 . . . . 0.0 109.706 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 35' ' ' LYS . 6.6 mp0 -62.29 -40.96 97.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.91 169.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 58.0 t -60.47 -53.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 123.526 0.516 . . . . 0.0 110.93 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.34 -39.03 66.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.406 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 94.8 mt -73.79 -36.01 64.97 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.262 0.625 . . . . 0.0 111.663 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -57.21 -49.29 76.45 Favored 'General case' 0 CA--C 1.55 0.977 0 O-C-N 123.799 0.687 . . . . 0.0 109.875 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 42.7 mt -59.74 -44.56 93.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.622 0.769 . . . . 0.0 111.644 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 1.7 pptp? -70.64 -26.28 63.39 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.564 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -90.08 20.46 4.28 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.041 -178.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.88 -23.32 55.6 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.78 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -57.81 -43.6 85.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.761 0.824 . . . . 0.0 110.892 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.45 178.61 5.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.521 1.128 . . . . 0.0 113.361 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 p -112.88 136.74 52.19 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.678 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.6 tpt -57.54 -66.2 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.214 1.006 . . . . 0.0 109.546 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.55 -33.95 0.47 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 164.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -146.46 -46.06 0.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.904 0.882 . . . . 0.0 109.083 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -61.85 135.22 57.49 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.7 0.8 . . . . 0.0 110.759 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 126.72 31.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.32 116.64 28.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -95.57 117.28 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB1' ' A' ' 70' ' ' ALA . 23.2 t -115.98 114.85 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -108.76 132.96 53.46 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.178 0.991 . . . . 0.0 109.878 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -59.96 110.61 1.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.078 0.951 . . . . 0.0 109.91 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 m -116.37 -168.26 1.41 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.385 0.674 . . . . 0.0 110.542 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -140.26 156.87 46.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.544 1.137 . . . . 0.0 108.587 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.659 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 20.9 t-20 -71.22 -32.17 68.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 0.0 109.949 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -55.66 -47.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.171 0.988 . . . . 0.0 109.909 170.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.534 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 14.8 tp10 -68.2 -49.78 58.6 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.115 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -54.35 -49.28 70.15 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.589 1.155 . . . . 0.0 111.24 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.68 -42.11 95.59 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.009 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -63.51 -37.24 86.55 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 124.163 0.914 . . . . 0.0 110.809 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.1 t -78.3 -30.15 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 122.83 0.452 . . . . 0.0 111.435 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.77 -16.68 61.16 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.397 -0.815 . . . . 0.0 111.083 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -94.11 -33.59 13.29 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.855 0.862 . . . . 0.0 110.633 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -134.21 83.51 2.04 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.4 p -70.2 76.76 0.52 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 0.0 111.881 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.65 71.61 0.27 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.32 100.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.872 2.381 . . . . 0.0 112.475 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -94.91 -14.97 24.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 110.355 169.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m 75.17 148.26 0.12 Allowed Pre-proline 0 C--N 1.367 1.365 0 C-N-CA 125.766 1.626 . . . . 0.0 111.545 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.534 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 89.5 Cg_endo -79.74 -24.43 6.1 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.08 1.853 . . . . 0.0 111.866 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t70 55.97 81.69 0.12 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.978 1.311 . . . . 0.0 109.645 -173.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.9 p -83.32 59.7 5.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.02 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.03 91.14 3.06 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -77.31 85.03 3.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.495 -173.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.0 -32.13 56.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.145 0.978 . . . . 0.0 110.221 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.818 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -60.16 124.45 20.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.171 0.988 . . . . 0.0 110.245 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 13.8 tpt 76.74 -59.49 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 126.148 1.779 . . . . 0.0 110.308 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.61 -72.68 0.25 Allowed Glycine 0 C--O 1.243 0.669 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -110.82 0.45 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.308 -0.446 . . . . 0.0 113.168 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 59.12 15.21 3.94 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.884 1.674 . . . . 0.0 111.841 -166.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.27 89.11 0.43 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 108.494 -1.843 . . . . 0.0 108.494 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HA ' HG21 ' A' ' 67' ' ' VAL . 1.7 p90 -81.0 24.02 0.53 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -167.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 93' ' ' MET . 26.1 t -99.95 132.65 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.36 167.78 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.376 1.07 . . . . 0.0 110.57 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -117.14 126.47 52.86 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 5.1 t -106.13 108.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 107.974 -173.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -119.16 142.45 47.94 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 124.595 1.158 . . . . 0.0 108.939 -167.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.91 27.87 15.38 Favored Glycine 0 N--CA 1.473 1.129 0 CA-C-O 121.627 0.571 . . . . 0.0 111.753 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.42 143.05 33.65 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 123.853 0.861 . . . . 0.0 109.132 174.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 31.0 Cg_endo -63.92 146.1 91.01 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.916 1.744 . . . . 0.0 110.645 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.627 ' HE1' ' HB3' ' A' ' 52' ' ' ARG . 83.6 t90 -52.41 -45.96 66.1 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.248 1.019 . . . . 0.0 111.212 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 p -92.99 35.28 1.06 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.432 1.093 . . . . 0.0 112.03 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.458 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 14.2 p -73.65 -170.87 0.92 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.224 0.61 . . . . 0.0 110.622 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.593 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 46.4 m -146.46 154.55 41.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.013 0.925 . . . . 0.0 109.012 173.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.25 -38.05 79.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.694 0.798 . . . . 0.0 111.457 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.99 -38.77 87.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.686 0.794 . . . . 0.0 111.371 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 34.2 mm-40 -67.61 -40.86 84.69 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.404 0.681 . . . . 0.0 110.855 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.53 -35.55 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.527 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.34 -45.97 92.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.473 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -63.57 -36.96 85.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.089 0.556 . . . . 0.0 110.901 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -60.13 -39.78 87.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.905 0.482 . . . . 0.0 110.289 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 67.9 m-85 -90.03 40.17 0.99 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.14 0.576 . . . . 0.0 111.792 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 p -74.51 87.22 2.09 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 166.4 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.339 2.256 . . . . 0.0 106.697 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.9 m -89.08 127.76 35.72 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.956 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 94.71 2.96 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 61' ' ' LEU . 18.5 mt -74.93 147.91 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.855 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -39.24 -68.54 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.906 1.682 . . . . 0.0 112.323 -172.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -128.57 51.02 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.05 -128.07 33.62 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.193 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.8 66.86 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.715 0.758 . . . . 0.0 112.031 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.33 -17.38 60.26 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.879 0.472 . . . . 0.0 111.413 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 29.25 9.33 Favored Glycine 0 C--N 1.351 1.393 0 O-C-N 123.266 0.353 . . . . 0.0 112.287 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 59' ' ' VAL . 52.7 mt -130.37 131.38 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.149 1.38 . . . . 0.0 108.3 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 103.58 4.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.58 0.752 . . . . 0.0 109.563 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -69.06 145.7 53.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.276 0.63 . . . . 0.0 110.263 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 56' ' ' GLU . 45.7 mt -73.7 91.34 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -78.47 146.72 34.27 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.784 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -84.79 -178.83 6.96 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.147 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -75.07 5.17 5.58 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.594 0.358 . . . . 0.0 111.945 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -102.6 -4.64 24.91 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.532 0.733 . . . . 0.0 109.756 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.6 37.95 38.97 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.418 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.627 ' HB3' ' HE1' ' A' ' 20' ' ' TRP . 76.0 mtt180 -120.48 130.68 24.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.983 -173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.7 132.23 41.75 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.083 2.522 . . . . 0.0 112.171 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 p -79.29 12.51 2.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.161 0.985 . . . . 0.0 113.021 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 -6.69 83.38 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' HD12 ' A' ' 46' ' ' ILE . 5.0 pt-20 -133.76 163.08 30.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.0 0.92 . . . . 0.0 111.579 175.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 167.96 24.68 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.687 -170.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -118.8 111.79 18.89 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.845 0.858 . . . . 0.0 110.315 171.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 43' ' ' ILE . 44.4 t -96.53 146.67 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.46 1.104 . . . . 0.0 108.181 171.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HG3' HG22 ' A' ' 12' ' ' VAL . 35.4 tt0 -126.72 144.09 51.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 36' ' ' ILE . 50.8 mt -129.38 146.3 51.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.356 0.662 . . . . 0.0 109.601 -167.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -72.9 -19.05 61.35 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.6 m -147.7 151.47 36.17 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.693 0.797 . . . . 0.0 109.119 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.81 -3.68 51.95 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 120.802 0.334 . . . . 0.0 111.628 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.26 -50.07 73.19 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.36 -31.56 65.89 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.359 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.568 HG21 ' HA ' ' A' ' 11' ' ' PHE . 53.2 t -66.14 -41.85 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.163 0.585 . . . . 0.0 110.679 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -57.22 -41.06 78.75 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.739 0.416 . . . . 0.0 110.904 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 mt -68.95 -32.58 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.634 0.774 . . . . 0.0 111.043 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.1 -52.55 33.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.951 0.901 . . . . 0.0 110.845 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 76.0 mt -61.03 -28.2 68.88 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.663 1.185 . . . . 0.0 111.387 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.0 -25.28 66.23 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.48 1.112 . . . . 0.0 110.8 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 67.3 mttm -83.76 6.92 19.44 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.186 0.994 . . . . 0.0 113.503 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.47 -2.47 0.5 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -121.01 -24.39 5.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.343 0.657 . . . . 0.0 111.889 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' A' ' 73' ' ' LYS . 6.6 mm-40 -59.26 148.53 31.58 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.6 p -98.66 126.98 44.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.841 0.856 . . . . 0.0 110.535 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -68.95 -78.48 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.93 89.42 0.29 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 170.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.6 m80 76.35 -54.35 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.056 1.742 . . . . 0.0 111.284 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -70.18 147.16 50.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.923 0.889 . . . . 0.0 111.396 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.25 142.31 28.66 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 108.681 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.0 t -120.14 131.13 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.516 0.726 . . . . 0.0 109.824 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.8 141.84 28.16 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.391 1.477 . . . . 0.0 108.562 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.61 123.25 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -125.1 146.73 49.33 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.332 1.053 . . . . 0.0 108.814 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HE2' HG11 ' A' ' 67' ' ' VAL . 39.9 ttmt -68.53 120.73 15.05 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.778 0.323 . . . . 0.0 110.491 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.1 m -86.54 -61.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.833 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.1 t30 83.31 148.07 0.08 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.883 1.673 . . . . 0.0 108.54 -163.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -57.92 -34.33 69.73 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.395 1.078 . . . . 0.0 112.408 -173.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.9 -41.96 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.755 0.822 . . . . 0.0 110.368 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -67.6 -43.67 79.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.777 0.831 . . . . 0.0 110.612 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.488 ' HB2' HG11 ' A' ' 12' ' ' VAL . 16.4 tmm? -54.23 -53.13 57.79 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.061 0.85 . . . . 0.0 110.918 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.6 -51.6 66.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.032 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -63.99 -51.95 61.87 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.122 0.969 . . . . 0.0 111.808 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.88 -48.66 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.429 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.99 -43.14 83.73 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.682 0.614 . . . . 0.0 110.18 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -70.96 -6.48 38.99 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 112.017 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -96.72 -92.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.6 t 170.93 -35.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.235 1.014 . . . . 0.0 110.517 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.39 155.41 16.12 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.115 -0.825 . . . . 0.0 112.842 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.83 137.75 22.54 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.977 2.451 . . . . 0.0 113.444 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -87.09 -20.29 27.32 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.627 0.771 . . . . 0.0 109.578 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 11.1 m -44.5 118.28 3.24 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.535 1.534 . . . . 0.0 111.958 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 13.0 Cg_exo -69.68 79.57 0.91 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.02 87.54 2.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.827 -171.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 p -152.35 95.64 2.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.227 1.411 . . . . 0.0 107.912 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.8 -77.24 0.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 48.11 83.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.884 1.274 . . . . 0.0 112.645 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -123.38 121.71 36.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.495 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.601 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.243 0.726 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 72.99 132.02 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.194 1.398 . . . . 0.0 111.923 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -137.44 174.91 10.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.311 1.044 . . . . 0.0 109.43 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.26 -61.76 1.82 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 108' ' ' ALA . . . 161.1 -112.16 0.51 Allowed Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.976 -0.346 . . . . 0.0 112.777 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 58.9 177.86 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.123 1.369 . . . . 0.0 112.088 -168.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.21 -70.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 58.0 7.71 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.902 1.281 . . . . 0.0 113.701 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.49 133.58 7.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' ' 70' ' ' ALA . 27.2 m -108.36 163.73 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.319 0.581 . . . . 0.0 110.427 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 104' ' ' SER . 35.3 ttpt -122.15 126.56 48.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 24.1 t -110.15 126.23 67.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 124.672 1.189 . . . . 0.0 108.673 -168.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -133.52 135.48 44.43 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.19 10.2 Favored Glycine 0 N--CA 1.47 0.94 0 O-C-N 123.427 0.454 . . . . 0.0 112.202 -168.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 88.0 mt -87.18 125.45 66.03 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.01 153.65 56.35 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.005 1.803 . . . . 0.0 111.615 171.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -54.99 -46.65 75.15 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.408 0.683 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -86.15 17.16 3.76 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.443 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 18' ' ' LEU . 18.8 p -86.98 137.98 31.9 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 t -89.27 163.71 15.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.298 0.639 . . . . 0.0 110.202 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.63 -39.91 71.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.631 0.773 . . . . 0.0 110.873 172.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.43 -38.19 88.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 0.0 111.992 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -66.77 -43.11 84.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.984 0.514 . . . . 0.0 110.908 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.43 -38.7 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.648 0.779 . . . . 0.0 110.069 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.487 ' HG3' HD12 ' A' ' 36' ' ' ILE . 50.3 tt0 -69.42 -40.08 77.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.678 0.791 . . . . 0.0 110.213 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -58.26 -47.44 83.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.252 1.021 . . . . 0.0 110.064 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.29 -43.78 98.3 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 38.7 m-85 -87.5 29.59 0.87 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.052 0.941 . . . . 0.0 112.191 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.8 m -80.31 90.53 5.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 167.45 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.126 1.771 . . . . 0.0 107.014 -167.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 32.0 p -85.57 130.67 34.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.443 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -74.15 90.39 2.04 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 HD12 ' HG3' ' A' ' 28' ' ' GLN . 16.9 mt -68.96 129.69 33.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -48.73 -58.44 4.76 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.61 1.194 . . . . 0.0 113.382 -160.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.09 41.14 3.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.204 0.602 . . . . 0.0 109.614 170.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.14 -128.63 28.44 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.67 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.68 63.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.67 0.788 . . . . 0.0 112.853 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.4 -21.18 63.79 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.704 0.402 . . . . 0.0 110.554 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.35 36.69 4.21 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 123.259 0.457 . . . . 0.0 112.131 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.29 108.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 73.6 mtt-85 -118.07 92.61 3.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -166.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -68.67 135.46 51.4 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -74.46 93.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.94 132.95 34.72 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.4 p -82.23 -176.0 5.96 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.679 0.792 . . . . 0.0 110.906 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -68.74 -14.0 62.74 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.18 0.592 . . . . 0.0 111.663 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -87.26 -14.49 40.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.501 0.72 . . . . 0.0 110.39 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.91 26.05 46.84 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.009 -171.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -100.98 125.71 37.42 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.56 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.86 129.14 19.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.914 1.743 . . . . 0.0 109.866 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -75.89 -3.87 37.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.951 0.9 . . . . 0.0 112.019 -172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 6.01 77.66 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 44.8 mt-10 -115.51 150.62 36.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.2 1.0 . . . . 0.0 109.829 173.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.25 161.67 39.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.047 0.939 . . . . 0.0 110.047 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 93.9 m-85 -109.83 105.35 14.52 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.48 102.41 13.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -78.38 132.57 37.42 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.343 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.75 152.11 37.72 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.752 0.421 . . . . 0.0 110.925 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.87 -35.9 79.35 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.48 1.112 . . . . 0.0 112.502 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.517 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 17.3 m -142.17 152.35 43.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.577 -169.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -67.08 -25.79 66.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.793 0.837 . . . . 0.0 112.46 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 6.1 p-10 -73.05 -36.79 66.98 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 68.7 mm-40 -54.49 -39.09 67.21 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 167.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 88.1 t -67.3 -53.4 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.604 0.761 . . . . 0.0 111.733 -175.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 18.1 ptpt -55.22 -38.54 68.57 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.647 0.592 . . . . 0.0 112.019 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.8 mt -71.81 -36.69 70.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.861 0.864 . . . . 0.0 111.18 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -62.25 -36.58 82.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.021 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD11 ' HE3' ' A' ' 87' ' ' LYS . 64.0 mt -64.98 -32.32 73.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.882 0.473 . . . . 0.0 111.046 173.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 57.8 mttm -78.75 -17.1 56.35 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.389 0.676 . . . . 0.0 110.489 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 60.8 tttp -80.97 -1.3 43.16 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 0.0 111.162 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.18 -17.32 52.43 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.942 0.897 . . . . 0.0 112.732 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -86.41 -37.69 18.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.711 0.804 . . . . 0.0 111.221 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.59 157.13 24.6 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -101.16 133.67 45.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.811 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.616 ' HB2' HG21 ' A' ' 83' ' ' VAL . 25.3 ttt -61.19 -70.31 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.567 0.542 . . . . 0.0 110.147 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.27 -40.37 0.55 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 172.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -150.29 -46.53 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.718 0.807 . . . . 0.0 109.306 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -61.07 140.2 57.91 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.899 0.879 . . . . 0.0 110.744 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -81.54 125.54 30.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.616 HG21 ' HB2' ' A' ' 78' ' ' MET . 67.8 t -106.91 107.66 23.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.03 137.73 35.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.675 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.26 119.17 53.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.599 -165.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -115.57 140.51 49.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.574 1.15 . . . . 0.0 108.657 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' HE3' HD11 ' A' ' 71' ' ' LEU . 29.3 ttmt -62.23 123.16 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.882 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.9 p -110.93 -172.62 2.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.551 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -145.29 169.07 18.97 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -60.8 -44.3 97.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.46 -46.21 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.68 0.792 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.655 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 38.2 tt0 -65.13 -53.92 37.75 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.799 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.09 -37.62 85.74 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 122.636 0.374 . . . . 0.0 111.623 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.47 -45.83 91.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.637 0.375 . . . . 0.0 110.649 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -63.81 -53.68 46.96 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.047 0.842 . . . . 0.0 111.733 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 92' ' ' GLU . 61.5 t -67.43 -37.84 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.462 0.705 . . . . 0.0 111.202 -170.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.5 -41.61 65.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.626 0.37 . . . . 0.0 111.249 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -75.81 -32.27 59.76 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.659 0.384 . . . . 0.0 110.971 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -96.81 -16.63 20.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.291 0.636 . . . . 0.0 110.965 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.4 p 49.04 63.16 2.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.399 1.479 . . . . 0.0 111.611 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -141.45 128.18 3.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 118.486 -1.174 . . . . 0.0 111.139 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.86 83.15 0.91 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.881 2.388 . . . . 0.0 111.098 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -148.0 146.45 28.93 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.642 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.463 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 60.8 p -131.56 104.66 14.51 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.512 0.725 . . . . 0.0 110.041 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.655 ' HD2' ' HG3' ' A' ' 92' ' ' GLU . 50.1 Cg_exo -58.58 130.27 36.45 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.462 2.108 . . . . 0.0 111.222 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -51.63 -61.36 2.3 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.004 1.322 . . . . 0.0 111.359 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m 54.51 53.28 10.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.933 1.293 . . . . 0.0 112.095 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.501 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . . . -139.41 -97.45 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.104 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.54 90.01 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.961 0.904 . . . . 0.0 111.671 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.4 97.56 9.56 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.507 0 CA-C-O 119.449 -0.639 . . . . 0.0 112.792 -178.088 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.245 0.83 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -64.97 99.93 0.38 Allowed 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.587 0.554 . . . . 0.0 110.386 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.9 mtt -67.1 106.24 1.92 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.17 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.04 136.85 2.57 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.79 78.46 0.22 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 117.038 0.419 . . . . 0.0 112.791 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.57 -17.99 60.64 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.858 0.863 . . . . 0.0 109.957 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -119.33 135.05 11.05 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.111 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -100.07 21.94 12.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.866 0.866 . . . . 0.0 109.709 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.6 142.36 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.39 1.476 . . . . 0.0 107.097 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.46 HG12 HG13 ' A' ' 67' ' ' VAL . 32.6 m -108.4 -176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.95 0.5 . . . . 0.0 110.449 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -144.8 144.44 31.16 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 t -118.37 136.3 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.867 1.267 . . . . 0.0 107.885 -168.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 137.69 47.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.01 15.91 8.84 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.27 122.0 57.15 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.39 166.13 26.55 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 122.077 1.851 . . . . 0.0 112.356 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -28.6 66.26 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.469 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.1 p -89.74 7.32 37.44 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.16 0.984 . . . . 0.0 112.974 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 p -71.63 167.52 19.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.835 0.743 . . . . 0.0 111.993 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 23.4 m -120.67 148.96 43.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.856 0.862 . . . . 0.0 109.81 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.4 67.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.168 0.587 . . . . 0.0 111.239 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 33.1 t70 -54.94 -49.89 70.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 23' ' ' SER . 12.3 pt-20 -72.91 -35.58 67.11 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.823 -174.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.46 -35.04 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.54 ' HG3' HD12 ' A' ' 36' ' ' ILE . 34.6 tt0 -72.93 -29.69 63.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 67.0 mtt180 -68.61 -33.81 74.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.017 0.527 . . . . 0.0 110.82 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -68.95 -26.72 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.118 0.567 . . . . 0.0 110.098 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -110.46 26.66 10.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.654 0.782 . . . . 0.0 111.267 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 29' ' ' ARG . 10.7 t -83.18 84.85 7.33 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HB3' ' HZ1' ' A' ' 73' ' ' LYS . 24.8 t70 159.82 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.625 1.57 . . . . 0.0 107.684 -159.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.1 m -82.63 175.86 9.83 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.295 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 3.6 mppt? -130.89 98.88 4.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 28' ' ' GLN . 16.7 mt -82.15 134.34 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.477 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -82.01 34.44 0.41 Allowed 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 124.175 0.99 . . . . 0.0 111.831 -168.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 173.29 -7.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.497 1.519 . . . . 0.0 110.523 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.6 17.7 Favored Glycine 0 C--N 1.359 1.814 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.68 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.47 72.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.248 0.619 . . . . 0.0 111.184 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.69 -13.31 60.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.57 -176.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.35 -12.14 61.78 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 116.746 -0.206 . . . . 0.0 112.808 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 mt -81.64 90.16 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 18.3 tpp180 -84.25 92.24 7.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.412 -171.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.88 127.12 31.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.799 0.44 . . . . 0.0 110.706 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 56' ' ' GLU . 41.9 mt -71.25 96.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 41.0 m-85 -82.92 133.96 35.09 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -77.27 -170.83 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.175 0.922 . . . . 0.0 111.691 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -55.06 -28.72 54.47 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.094 0.958 . . . . 0.0 112.138 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -104.17 4.13 33.69 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.575 0.75 . . . . 0.0 110.272 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 47' ' ' TYR . . . 73.89 32.89 58.38 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 114.002 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -94.92 141.63 23.55 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.759 0.824 . . . . 0.0 109.746 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.31 110.32 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.938 1.759 . . . . 0.0 109.681 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.4 t -63.25 -8.2 7.8 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.608 1.163 . . . . 0.0 113.165 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -14.83 51.91 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.537 ' HB2' HD12 ' A' ' 46' ' ' ILE . 40.0 mt-10 -121.65 159.73 25.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.369 1.068 . . . . 0.0 111.642 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.26 149.98 27.54 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.181 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 98.5 m-85 -91.54 155.57 18.29 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -136.06 109.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -78.85 119.26 21.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 109.407 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -116.09 154.43 29.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.339 0.655 . . . . 0.0 110.296 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.1 -30.25 70.72 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 111.393 -175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 162.98 39.98 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.82 0.848 . . . . 0.0 110.472 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.49 -13.88 62.3 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 122.946 0.499 . . . . 0.0 111.497 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t70 -60.07 -53.4 58.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 2.1 mp0 -59.5 -32.68 70.51 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.321 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 13' ' ' VAL . 54.4 t -61.85 -49.52 83.9 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 123.647 0.592 . . . . 0.0 110.332 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -53.02 -44.04 67.0 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 64.5 mt -60.88 -46.91 88.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.493 0.717 . . . . 0.0 110.099 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -59.4 -46.55 88.38 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.741 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 95.3 mt -57.12 -35.83 69.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.686 1.195 . . . . 0.0 111.792 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -77.3 -18.55 57.42 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.875 0.47 . . . . 0.0 111.654 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HZ1' ' HB3' ' A' ' 33' ' ' ASP . 90.4 mttt -88.61 6.99 35.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.1 0.56 . . . . 0.0 110.938 175.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 p-10 -65.53 -15.61 62.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.989 0.515 . . . . 0.0 111.642 173.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.26 -31.11 17.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.066 0.946 . . . . 0.0 110.925 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.12 151.92 34.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.672 0.789 . . . . 0.0 112.294 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -116.37 130.69 56.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.125 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 89.7 mmm -79.31 83.18 5.37 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.81 -96.47 2.1 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -170.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -126.01 3.73 7.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.813 0.845 . . . . 0.0 110.031 168.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 83' ' ' VAL . 20.3 mmt180 -70.93 110.39 5.62 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -70.2 109.48 4.67 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 81' ' ' ARG . 55.7 t -114.36 115.32 49.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 123.296 0.639 . . . . 0.0 109.487 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 2.1 pm0 -99.56 146.22 26.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.385 1.074 . . . . 0.0 109.724 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.599 HG11 ' HB1' ' A' ' 70' ' ' ALA . 45.4 t -129.89 124.74 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -107.67 178.39 4.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.716 1.206 . . . . 0.0 108.235 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -106.94 127.7 53.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -113.67 -164.54 0.93 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.216 1.006 . . . . 0.0 110.883 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.553 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 49.3 t-20 -147.18 159.99 42.98 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.07 -35.78 81.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 0.0 109.835 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.05 -41.81 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.641 0.776 . . . . 0.0 110.162 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.51 -44.15 97.07 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 44.3 ttp -58.96 -36.2 74.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.107 0.963 . . . . 0.0 110.532 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.1 -55.73 19.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.102 0.561 . . . . 0.0 110.951 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -63.86 -31.65 72.9 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.971 0.908 . . . . 0.0 112.525 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.87 -42.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.309 0.643 . . . . 0.0 110.999 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.74 -22.3 59.93 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.468 0.307 . . . . 0.0 111.175 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -91.61 -30.33 16.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.876 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -137.43 86.45 2.19 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.691 0.796 . . . . 0.0 108.95 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 t -79.97 83.11 5.93 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 122.46 1.124 . . . . 0.0 110.261 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.05 -136.37 4.03 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.485 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.26 -40.68 31.14 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.102 2.535 . . . . 0.0 112.75 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 70.96 143.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.218 1.407 . . . . 0.0 112.039 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 40.6 m 72.68 135.75 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.617 1.567 . . . . 0.0 112.543 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 26.9 Cg_exo -64.59 177.47 2.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.923 2.416 . . . . 0.0 113.274 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.72 -48.58 69.47 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.446 1.098 . . . . 0.0 112.037 -174.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.5 m 69.19 -67.59 0.21 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.526 1.53 . . . . 0.0 111.263 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.71 154.66 42.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.838 1.255 . . . . 0.0 109.307 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -79.61 78.31 6.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.392 0.615 . . . . 0.0 110.634 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -152.41 14.7 0.59 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.125 0.97 . . . . 0.0 110.071 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.317 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.272 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.2 p . . . . . 0 C--O 1.244 0.768 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 61.17 -142.68 0.48 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.358 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.8 mtt 66.62 -74.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.329 1.052 . . . . 0.0 111.404 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.96 89.46 0.03 OUTLIER Glycine 0 C--N 1.354 1.544 0 C-N-CA 124.015 0.817 . . . . 0.0 113.902 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.99 -50.86 0.06 OUTLIER Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.1 97.8 11.4 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 87' ' ' LYS . . . -82.47 -91.92 0.61 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.07 13.52 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.075 1.35 . . . . 0.0 112.055 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.437 HG12 ' HB3' ' A' ' 88' ' ' SER . 37.4 t -145.71 143.27 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 70' ' ' ALA . 25.4 m -113.15 172.18 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 121.094 0.474 . . . . 0.0 111.966 169.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 40.8 mtpt -116.36 135.4 53.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.01 117.39 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 41.1 ttp180 -127.4 152.27 47.73 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.38 12.59 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -166.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.488 HD22 ' SG ' ' A' ' 22' ' ' CYS . 86.0 mt -97.53 134.04 22.98 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.308 1.043 . . . . 0.0 109.406 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.42 163.57 17.42 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.776 2.317 . . . . 0.0 112.606 168.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -74.35 -8.09 55.07 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.059 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -113.32 16.12 19.07 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.286 1.034 . . . . 0.0 111.278 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.488 ' SG ' HD22 ' A' ' 18' ' ' LEU . 52.0 t -67.19 155.48 38.7 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.924 0.489 . . . . 0.0 111.632 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.1 m -133.73 152.69 51.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.529 1.132 . . . . 0.0 110.555 -173.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.65 67.38 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.402 1.081 . . . . 0.0 112.788 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.91 -47.78 67.73 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.536 1.135 . . . . 0.0 113.47 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 23' ' ' SER . 13.7 pt-20 -72.19 -35.49 68.96 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.8 -46.38 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.157 0.583 . . . . 0.0 110.032 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.601 ' HG3' HD12 ' A' ' 36' ' ' ILE . 28.2 tt0 -63.95 -40.76 97.18 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.617 0.767 . . . . 0.0 111.341 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -57.87 -46.8 84.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.795 0.684 . . . . 0.0 110.866 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.17 -32.92 74.66 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.741 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.643 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 93.4 m-85 -105.34 35.96 2.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.925 0.89 . . . . 0.0 110.659 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -60.59 -27.6 67.85 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.524 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.55 -18.13 65.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.2 p -111.44 135.49 51.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.311 0.644 . . . . 0.0 109.958 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -75.56 96.0 3.44 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.601 HD12 ' HG3' ' A' ' 28' ' ' GLN . 43.9 mt -78.85 123.41 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.81 125.85 25.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.302 1.041 . . . . 0.0 110.971 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 60.74 23.15 13.07 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.177 1.391 . . . . 0.0 111.552 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.26 -134.96 45.5 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.379 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.48 -22.68 22.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.064 0.946 . . . . 0.0 113.274 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.05 -21.92 64.98 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.419 0.288 . . . . 0.0 110.875 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.405 ' HA2' ' NH1' ' A' ' 44' ' ' ARG . . . -77.73 -16.84 79.62 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.016 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 mt -86.64 119.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 109.633 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' NH1' ' HA2' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -123.0 97.55 5.49 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.163 0.985 . . . . 0.0 109.695 177.458 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -66.16 142.9 57.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.029 0.532 . . . . 0.0 109.724 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.586 HD12 ' HB2' ' A' ' 56' ' ' GLU . 23.6 mt -77.16 87.18 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' O ' ' HB ' ' A' ' 100' ' ' THR . 92.1 m-85 -75.34 134.29 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.0 t -78.48 -175.54 4.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 3.4 tmm_? -68.94 -5.8 23.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.3 0.64 . . . . 0.0 110.973 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' H ' HG23 ' A' ' 48' ' ' THR . 37.6 mt-10 -100.31 -2.6 33.23 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.698 1.199 . . . . 0.0 110.96 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.95 36.81 31.07 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 115.072 0.789 . . . . 0.0 115.072 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -132.17 138.18 31.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.708 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.52 118.0 4.43 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.046 2.497 . . . . 0.0 111.695 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.8 p -93.3 40.25 1.06 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.72 0.808 . . . . 0.0 111.129 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.82 -37.23 3.58 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.0 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' HD12 ' A' ' 46' ' ' ILE . 36.5 mt-10 -110.13 161.56 15.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.803 0.811 . . . . 0.0 112.392 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.03 165.53 31.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.449 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -110.47 145.39 37.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 108.09 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 105.83 6.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -81.63 139.64 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 36' ' ' ILE . 74.8 mt -128.89 142.24 51.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.683 1.193 . . . . 0.0 109.283 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.29 -27.66 68.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.309 0.644 . . . . 0.0 111.54 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.5 m -136.52 150.44 48.65 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.17 0.588 . . . . 0.0 109.661 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 15.9 tt0 -77.68 -8.34 57.77 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 120.915 0.388 . . . . 0.0 111.201 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -65.39 -48.52 72.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.631 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 4.0 mm-40 -52.77 -38.29 60.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.668 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG22 HD12 ' A' ' 61' ' ' LEU . 66.7 t -64.22 -46.09 94.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 123.31 0.644 . . . . 0.0 110.411 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.7 mttt -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.384 0.674 . . . . 0.0 112.154 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.47 -50.22 70.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.89 0.876 . . . . 0.0 111.178 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -58.99 -45.29 91.0 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.144 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 85' ' ' VAL . 91.8 mt -56.05 -24.61 40.66 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.295 1.438 . . . . 0.0 113.425 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.18 -9.84 59.73 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.151 0.58 . . . . 0.0 112.005 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -90.52 6.08 45.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 111.356 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -57.88 -9.37 1.28 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.785 1.234 . . . . 0.0 113.69 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -116.63 -40.15 3.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.371 1.068 . . . . 0.0 111.11 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.41 163.67 15.28 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -105.41 130.82 53.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.067 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.442 ' HG3' HG21 ' A' ' 83' ' ' VAL . 53.4 mtp -64.83 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 163.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.03 -103.34 2.02 Favored Glycine 0 N--CA 1.468 0.777 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -96.01 -1.61 48.57 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.24 1.016 . . . . 0.0 109.344 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -106.19 133.54 50.72 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.926 0.89 . . . . 0.0 109.631 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -80.36 135.59 36.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 78' ' ' MET . 98.7 t -97.79 130.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 32.8 mt-10 -97.45 117.35 31.51 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.9 t -114.66 120.04 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -113.83 177.59 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.454 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 40.1 ttmt -101.88 116.12 32.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.437 ' HB3' HG12 ' A' ' 12' ' ' VAL . 46.4 t -87.05 161.55 18.1 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.14 0.971 . . . . 0.0 110.503 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -127.99 158.21 38.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.005 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -64.84 -34.34 78.13 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.927 0.491 . . . . 0.0 110.759 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.53 -41.84 89.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 110.753 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.44 -56.3 7.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.961 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 44.9 ttm -52.11 -51.29 58.72 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 123.967 0.792 . . . . 0.0 111.72 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 28.3 t70 -62.42 -43.01 99.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 0.0 110.53 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -60.6 -38.59 85.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.143 0.577 . . . . 0.0 111.147 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 76.4 t -82.36 -30.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.702 0.801 . . . . 0.0 111.86 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 93' ' ' MET . 83.0 mt -75.69 -26.44 57.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.38 -0.825 . . . . 0.0 110.654 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 1.2 mptm? -90.09 -25.17 20.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.756 0.823 . . . . 0.0 111.082 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -135.41 86.49 2.25 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 47' ' ' TYR . 42.5 p -67.48 99.62 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.81 0.844 . . . . 0.0 112.769 -170.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.27 167.93 40.99 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.887 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.38 158.07 55.15 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.377 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -155.46 151.72 28.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.594 0.758 . . . . 0.0 109.394 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.8 p -110.13 112.38 57.55 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 109.109 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -93.05 30.27 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.204 2.603 . . . . 0.0 112.707 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.79 78.23 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.692 0.797 . . . . 0.0 109.354 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.6 m -160.71 119.84 2.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.646 1.178 . . . . 0.0 108.808 -167.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.7 71.14 0.86 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.247 0.619 . . . . 0.0 110.576 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.27 78.76 8.89 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -88.12 112.45 22.7 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.252 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.227 179.934 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 N--CA 1.471 0.625 0 CA-C-O 120.44 0.162 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.5 t -102.09 143.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.99 0.916 . . . . 0.0 109.184 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 61' ' ' LEU . 29.8 m -110.14 160.41 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.053 0.541 . . . . 0.0 110.758 162.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 87.4 tttt -109.13 121.41 45.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.84 111.72 37.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 3.7 tmt_? -121.96 140.67 52.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.21 18.27 29.41 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 118.2 0.454 . . . . 0.0 113.316 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.17 138.37 56.38 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 123.356 0.662 . . . . 0.0 109.765 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.612 ' HG3' ' HA3' ' A' ' 79' ' ' GLY . 45.1 Cg_endo -64.79 146.52 88.44 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.346 2.031 . . . . 0.0 111.454 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -64.37 -19.71 65.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.162 0.985 . . . . 0.0 110.62 175.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 p -90.7 4.75 50.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.394 1.078 . . . . 0.0 113.146 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 22.0 p -104.4 145.75 29.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.827 0.739 . . . . 0.0 111.13 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -105.81 178.52 4.54 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.763 1.225 . . . . 0.0 109.028 172.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.67 -31.49 62.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.441 0.696 . . . . 0.0 112.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.92 -47.34 68.08 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.181 0.993 . . . . 0.0 113.118 176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.88 -38.02 76.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.15 0.58 . . . . 0.0 111.592 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.61 -34.76 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.712 . . . . 0.0 110.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.597 ' HG3' HD12 ' A' ' 36' ' ' ILE . 44.2 tt0 -69.36 -41.31 76.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.312 176.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -63.09 -36.33 83.23 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.081 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.98 -43.83 98.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.015 0.526 . . . . 0.0 110.39 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 36' ' ' ILE . 79.6 m-85 -95.72 38.96 1.14 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.998 0.519 . . . . 0.0 110.515 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.7 t -59.76 -34.2 72.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 111.248 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.22 5.96 10.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 112.448 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' HB3' HD23 ' A' ' 61' ' ' LEU . 58.1 m -127.38 136.23 51.59 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.086 0.954 . . . . 0.0 110.07 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -80.36 98.46 7.48 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.597 HD12 ' HG3' ' A' ' 28' ' ' GLN . 61.8 mt -80.65 122.61 36.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.994 0.918 . . . . 0.0 109.687 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.7 126.42 27.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.213 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.2 t30 63.48 17.55 10.42 Favored 'General case' 0 CA--C 1.559 1.327 0 O-C-N 124.79 1.307 . . . . 0.0 111.89 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.44 -136.16 47.53 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.239 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.71 -18.8 45.49 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.26 -21.03 54.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.967 0.507 . . . . 0.0 110.295 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 -21.13 76.59 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.255 0.347 . . . . 0.0 112.472 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.493 HG12 HG22 ' A' ' 59' ' ' VAL . 43.4 mt -91.27 127.75 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.568 0.747 . . . . 0.0 110.043 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.1 110.02 6.12 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.081 0.953 . . . . 0.0 110.008 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -66.48 140.09 57.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.0 88.82 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -82.86 135.9 34.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.1 p -83.76 -178.17 6.93 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.856 0.862 . . . . 0.0 110.919 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 1.5 tmt_? -67.18 -16.73 64.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.161 0.584 . . . . 0.0 109.603 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 13.4 mm-40 -84.36 1.56 44.53 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.742 0.817 . . . . 0.0 110.911 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.03 20.1 76.03 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 50' ' ' GLU . 19.4 ptp180 -126.74 141.3 39.94 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.335 0.654 . . . . 0.0 109.79 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.48 148.36 42.61 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.447 2.098 . . . . 0.0 111.523 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -75.65 -0.44 20.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.616 0.766 . . . . 0.0 111.749 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.54 81.83 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 37.7 mt-10 -119.63 155.61 31.99 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 110.809 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.36 28.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.771 1.228 . . . . 0.0 110.313 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.33 120.9 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.484 1.113 . . . . 0.0 109.168 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 43' ' ' ILE . 68.9 t -106.71 123.67 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 108.953 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HG2' HG22 ' A' ' 12' ' ' VAL . 64.5 mt-10 -82.98 151.23 25.95 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 34' ' ' CYS . 4.6 mp -135.87 152.29 50.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.084 0.954 . . . . 0.0 109.312 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -32.22 73.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.732 0.813 . . . . 0.0 111.805 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.485 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 42.0 m -144.96 155.62 43.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.531 0.332 . . . . 0.0 111.265 -171.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.96 -27.29 68.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.623 0.769 . . . . 0.0 110.431 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.39 -47.57 75.9 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 47.2 mm-40 -54.62 -37.88 66.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.538 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 78.4 t -60.27 -46.06 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.077 0.551 . . . . 0.0 110.03 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.59 ' HD3' HD12 ' A' ' 71' ' ' LEU . 32.3 mmtp -60.99 -37.79 83.73 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.788 0.835 . . . . 0.0 112.552 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 85.9 mt -65.88 -31.94 73.16 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.502 0.721 . . . . 0.0 111.746 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -69.13 -44.04 73.18 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.255 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.59 HD12 ' HD3' ' A' ' 68' ' ' LYS . 96.8 mt -65.9 -26.12 67.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.14 0.976 . . . . 0.0 112.83 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 19.9 pttp -77.54 -16.88 58.41 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.105 0.411 . . . . 0.0 109.915 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -95.15 0.49 54.22 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.214 1.005 . . . . 0.0 111.032 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 11.1 t70 -60.17 101.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.32 0.648 . . . . 0.0 110.238 168.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 36.9 ttt180 150.64 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 127.115 2.166 . . . . 0.0 108.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -55.43 147.33 17.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.235 -167.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 p -89.11 120.03 30.15 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.518 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -124.64 125.0 43.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.342 1.057 . . . . 0.0 108.513 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.612 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 84.82 -50.31 4.38 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.451 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -179.04 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.77 1.228 . . . . 0.0 108.85 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -91.47 166.94 12.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.038 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.88 139.47 39.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 78' ' ' MET . 53.1 t -112.05 129.51 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.16 0.505 . . . . 0.0 110.678 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.01 121.6 37.93 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.342 1.057 . . . . 0.0 109.196 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.0 112.81 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.8 m-85 -103.03 178.4 4.57 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.35 120.5 42.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 61.1 m -110.73 147.71 33.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.733 0.813 . . . . 0.0 111.275 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -91.54 155.28 18.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -56.53 -35.32 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.238 0.615 . . . . 0.0 110.169 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.11 -46.37 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.889 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.62 -52.11 48.81 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.458 0.474 . . . . 0.0 110.005 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -49.63 -53.64 23.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.8 1.24 . . . . 0.0 111.367 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.0 -43.02 86.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.987 0.915 . . . . 0.0 111.679 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -74.13 -35.99 64.13 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 43.6 t -82.99 -21.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.014 0.435 . . . . 0.0 110.502 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.3 -40.76 64.28 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -77.13 -32.02 56.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.06 0.544 . . . . 0.0 111.295 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.3 t60 . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -171.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 . . . . . 0 CA--C 1.55 0.973 0 CA-C-O 120.62 0.247 . . . . 0.0 110.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG21 ' HE2' ' A' ' 93' ' ' MET . 39.1 t -112.28 138.02 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.527 1.131 . . . . 0.0 109.167 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.07 168.89 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.037 0.535 . . . . 0.0 110.635 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 60.2 tttt -116.84 123.38 46.94 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 83' ' ' VAL . 92.2 t -114.6 138.67 43.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.47 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 3.8 ptp180 -150.99 161.31 42.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.975 0.51 . . . . 0.0 109.633 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 18.45 36.57 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -169.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -88.88 127.69 54.97 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 27.4 Cg_endo -61.19 161.5 22.8 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.232 1.955 . . . . 0.0 111.968 172.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -71.66 -24.46 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.287 0.635 . . . . 0.0 111.176 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -82.45 -6.0 59.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.685 0.794 . . . . 0.0 111.404 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.438 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 44.2 t -76.08 120.41 21.35 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.102 0.561 . . . . 0.0 109.743 -177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t -98.88 174.68 6.25 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.767 0.827 . . . . 0.0 109.186 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.24 74.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.707 0.803 . . . . 0.0 112.41 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.4 t70 -60.53 -39.32 87.45 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.879 0.872 . . . . 0.0 111.787 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -59.53 -46.31 89.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.216 0.606 . . . . 0.0 111.083 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' A' ' 43' ' ' ILE . 58.4 t -71.68 -31.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.42 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' NE2' HD12 ' A' ' 36' ' ' ILE . 9.3 tp-100 -64.34 -42.81 96.06 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.916 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 19.3 mmt180 -67.11 -38.11 85.06 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.695 0.398 . . . . 0.0 111.179 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -67.71 -29.66 68.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.034 0.534 . . . . 0.0 111.5 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 36' ' ' ILE . 93.4 m-85 -115.38 35.02 4.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.61 0.764 . . . . 0.0 110.184 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 t -59.51 -29.2 67.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.62 0.768 . . . . 0.0 113.01 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.77 -25.72 35.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.853 0.461 . . . . 0.0 110.614 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.58 126.79 31.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 10.4 mptt -79.24 87.75 4.94 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 31' ' ' PHE . 41.1 mt -76.86 132.79 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.275 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.02 118.37 5.33 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.947 0.899 . . . . 0.0 110.425 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 63.52 23.02 13.46 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -131.66 41.85 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.596 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.64 30.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 0.0 113.161 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -80.7 -10.45 59.73 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.198 0.599 . . . . 0.0 112.411 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.93 36.3 4.35 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.498 HD13 ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt -127.85 116.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.453 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 22.3 mmt180 -116.6 92.99 4.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.288 0.635 . . . . 0.0 110.251 -169.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 98.2 m-85 -71.23 127.85 33.93 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 mt -74.8 86.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.05 149.37 41.21 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.706 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -94.77 178.71 5.49 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.434 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -68.76 -8.85 46.87 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 122.846 0.458 . . . . 0.0 111.893 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.55 -0.41 43.29 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.257 1.023 . . . . 0.0 109.916 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.41 59.92 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.969 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -126.15 132.75 24.42 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 53.5 Cg_endo -66.5 153.21 78.82 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.302 2.002 . . . . 0.0 111.568 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -78.41 6.11 9.16 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.56 0.744 . . . . 0.0 111.37 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.07 1.13 79.88 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -171.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 30.6 mt-10 -111.59 146.68 36.96 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.669 1.187 . . . . 0.0 110.806 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.58 31.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.55 1.14 . . . . 0.0 109.7 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 69.3 m-85 -102.61 117.74 35.34 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.9 t -98.46 110.78 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.39 136.46 38.42 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.562 1.145 . . . . 0.0 108.413 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 66' ' ' GLU . 44.1 mt -135.76 137.58 41.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.448 0.699 . . . . 0.0 109.744 -169.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.87 -12.47 61.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -168.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.0 p -160.45 172.45 17.22 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.11 0.564 . . . . 0.0 109.99 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.0 tm-20 -68.5 -21.05 64.61 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.209 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.68 -46.79 89.02 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.235 0.471 . . . . 0.0 110.403 172.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HB3' HD22 ' A' ' 61' ' ' LEU . 1.1 mp0 -62.38 -32.5 73.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.53 173.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.47 -44.08 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.652 0.381 . . . . 0.0 110.028 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 82.2 mttt -54.63 -49.66 69.98 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.723 0.809 . . . . 0.0 110.649 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.78 -35.44 74.65 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.354 1.062 . . . . 0.0 112.089 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.75 69.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.031 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.75 -13.38 59.25 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.22 1.008 . . . . 0.0 112.254 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.16 -23.68 64.89 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.301 0.501 . . . . 0.0 110.697 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 76' ' ' GLU . 3.9 mptp? -88.03 -1.28 57.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.536 0.734 . . . . 0.0 112.069 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -32.28 -25.05 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 169.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -142.77 -6.4 0.88 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -57.81 143.18 43.2 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 175.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 p -95.37 121.85 37.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.45 1.1 . . . . 0.0 111.86 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.16 114.35 27.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.184 0.993 . . . . 0.0 109.264 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.17 -89.81 0.17 Allowed Glycine 0 C--N 1.345 1.058 0 O-C-N 123.416 0.448 . . . . 0.0 112.999 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -130.77 -5.85 4.06 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -117.49 154.05 32.1 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.236 0.614 . . . . 0.0 110.929 -172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -82.04 143.5 31.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.583 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 15' ' ' VAL . 69.4 t -109.02 120.48 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.474 0.71 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -95.39 121.47 37.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.01 121.46 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.325 0.65 . . . . 0.0 109.984 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -118.93 149.94 40.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.711 0.805 . . . . 0.0 110.905 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.05 116.85 5.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.369 0.667 . . . . 0.0 110.146 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 15.6 m -125.67 -154.1 0.6 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.68 173.64 12.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.06 -31.05 72.1 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.989 0.915 . . . . 0.0 110.432 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.1 t -65.92 -47.61 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.247 1.019 . . . . 0.0 110.346 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.38 -47.97 74.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.286 1.034 . . . . 0.0 110.077 177.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.46 ' HE2' HG21 ' A' ' 12' ' ' VAL . 54.2 ttp -52.54 -44.6 65.88 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.463 1.102 . . . . 0.0 110.639 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.62 -45.95 77.45 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.434 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.54 -42.05 95.72 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.604 0.762 . . . . 0.0 112.3 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.08 -23.55 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 123.508 0.505 . . . . 0.0 110.827 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.11 -23.74 35.52 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 121.98 -0.45 . . . . 0.0 111.138 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -80.33 -38.77 29.93 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.284 0.564 . . . . 0.0 109.971 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 . . . . . 0 C--O 1.239 0.52 0 C-N-CA 124.483 1.113 . . . . 0.0 108.027 -173.427 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -93.94 133.49 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 110.135 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -105.01 163.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.373 0.669 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -108.05 127.18 53.56 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -119.49 140.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 124.107 0.963 . . . . 0.0 108.757 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.579 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 14.8 ptm180 -147.43 167.23 24.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.03 0.932 . . . . 0.0 109.262 174.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.91 18.71 62.74 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.61 155.24 91.72 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.854 0.862 . . . . 0.0 110.236 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.0 152.13 77.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.147 1.898 . . . . 0.0 111.22 169.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.2 p90 -56.18 -30.91 62.89 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.725 1.21 . . . . 0.0 112.098 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 p -104.21 25.52 9.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 111.508 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.2 p -52.39 118.03 3.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.493 1.117 . . . . 0.0 112.811 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.432 ' HB3' ' HG3' ' A' ' 26' ' ' GLU . 46.8 t -104.18 152.2 22.43 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.29 -39.52 75.9 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.315 0.384 . . . . 0.0 111.003 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -49.51 -47.63 48.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.329 1.052 . . . . 0.0 112.695 170.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 45.3 mt-10 -65.43 -39.68 92.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.194 0.598 . . . . 0.0 111.265 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' HD13 ' A' ' 43' ' ' ILE . 61.1 t -68.55 -34.94 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.403 0.681 . . . . 0.0 110.077 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HA ' HD12 ' A' ' 36' ' ' ILE . 97.0 mt-30 -64.94 -49.75 69.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.769 0.827 . . . . 0.0 111.033 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -37.17 81.35 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.51 0.507 . . . . 0.0 110.719 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.75 -43.76 95.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.027 0.531 . . . . 0.0 111.107 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HB2' HD11 ' A' ' 36' ' ' ILE . 59.5 m-85 -99.73 35.68 1.96 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.624 0.77 . . . . 0.0 110.083 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -60.7 -24.81 65.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.355 0.525 . . . . 0.0 112.186 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.86 -47.7 68.18 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.992 0.917 . . . . 0.0 110.736 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 61.3 m -79.77 130.69 35.55 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.385 0.612 . . . . 0.0 110.432 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 13.9 mmmm -78.44 91.2 4.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 31' ' ' PHE . 46.4 mt -69.74 111.0 3.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.516 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 33.6 tt0 -63.14 134.5 56.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.878 0.736 . . . . 0.0 110.458 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 65.37 10.14 6.29 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 124.654 1.221 . . . . 0.0 112.148 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 -128.04 44.91 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.51 0.576 . . . . 0.0 112.716 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.03 64.75 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.855 0.862 . . . . 0.0 112.483 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -73.8 -19.72 60.68 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.123 0.569 . . . . 0.0 111.644 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.99 -23.81 56.58 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 120.271 -0.183 . . . . 0.0 112.961 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.525 HD13 ' HB ' ' A' ' 27' ' ' VAL . 59.8 mt -83.35 119.36 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.266 0.627 . . . . 0.0 109.613 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.549 ' HG3' ' SD ' ' A' ' 93' ' ' MET . 21.0 mmt180 -127.29 94.71 4.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.481 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.79 135.86 46.86 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 56' ' ' GLU . 43.0 mt -75.91 92.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -84.26 134.49 34.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.429 ' OG1' ' HB2' ' A' ' 52' ' ' ARG . 59.7 p -90.84 -169.99 2.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.701 0.8 . . . . 0.0 110.442 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.71 -18.01 64.63 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -105.67 10.06 32.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 0.0 109.212 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.15 63.96 Favored Glycine 0 C--N 1.36 1.917 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 12.0 mmp_? -101.27 125.49 37.7 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.591 0.756 . . . . 0.0 110.021 -172.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.08 116.89 3.56 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.666 2.244 . . . . 0.0 110.488 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 t -83.52 18.13 1.97 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.678 0.791 . . . . 0.0 111.581 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.1 30.19 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 122.854 0.264 . . . . 0.0 113.033 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 31.8 mt-10 -112.3 150.15 31.39 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.455 1.102 . . . . 0.0 111.128 -174.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.55 153.9 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.527 1.131 . . . . 0.0 110.043 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -106.14 110.31 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.051 0.941 . . . . 0.0 108.463 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.07 110.92 25.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.5 tt0 -79.76 135.99 36.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.9 mt -126.71 147.91 49.91 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.458 0.703 . . . . 0.0 110.032 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -67.06 -19.81 65.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.763 0.825 . . . . 0.0 112.917 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -159.34 171.24 20.15 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.07 -23.75 67.26 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.999 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.81 -52.56 64.54 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.372 0.669 . . . . 0.0 110.157 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 1.5 mp0 -60.25 -31.61 70.37 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.048 0.843 . . . . 0.0 112.894 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.4 t -61.44 -48.83 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.659 0.384 . . . . 0.0 110.158 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.8 mmpt? -50.98 -46.07 61.16 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.015 0.822 . . . . 0.0 111.753 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 mt -63.06 -47.44 82.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.59 0.756 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.06 87.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.021 0.928 . . . . 0.0 111.524 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.44 -38.44 77.47 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.148 0.979 . . . . 0.0 111.659 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -69.06 -19.97 64.09 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 123.63 0.581 . . . . 0.0 111.587 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -91.77 17.34 9.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.929 0.892 . . . . 0.0 112.329 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.93 23.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -142.86 -23.66 0.63 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.751 0.705 . . . . 0.0 110.865 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -46.3 134.75 8.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.931 1.293 . . . . 0.0 112.02 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -91.26 131.64 36.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.782 0.833 . . . . 0.0 111.15 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ttt -128.61 122.14 30.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.704 1.202 . . . . 0.0 109.415 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -75.34 1.92 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -145.33 -36.29 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.37 1.068 . . . . 0.0 110.1 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -87.0 167.49 14.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -80.68 136.81 36.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.7 t -100.02 117.12 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 25.1 mt-10 -98.37 122.18 41.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.175 1.39 . . . . 0.0 108.508 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.94 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 110.14 -172.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.06 179.09 4.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.464 1.506 . . . . 0.0 107.54 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -112.55 135.41 53.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' A' ' 92' ' ' GLU . 76.8 p -134.87 -149.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 109.038 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.87 169.42 24.45 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -61.36 -34.22 74.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.841 0.856 . . . . 0.0 111.276 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.7 -40.79 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.113 0.965 . . . . 0.0 110.168 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 88' ' ' SER . 4.7 tp10 -63.93 -50.36 68.97 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.409 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.549 ' SD ' ' HG3' ' A' ' 44' ' ' ARG . 45.3 ttm -54.95 -51.74 65.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.947 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.35 -45.87 91.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.621 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -52.58 -51.56 59.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.635 1.574 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 92' ' ' GLU . 40.7 t -71.19 -33.13 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.091 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 44' ' ' ARG . 88.6 mt -69.38 -27.55 65.41 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.314 0.245 . . . . 0.0 111.042 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -69.05 -23.89 64.11 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.247 0.619 . . . . 0.0 111.752 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.1 t60 . . . . . 0 N--CA 1.478 0.935 0 C-N-CA 123.501 0.72 . . . . 0.0 109.219 178.906 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 121.328 0.585 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.23 134.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.54 160.33 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.006 0.522 . . . . 0.0 110.769 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -109.75 116.03 30.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG13 ' CG1' ' A' ' 83' ' ' VAL . 87.4 t -114.62 135.77 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 125.056 1.342 . . . . 0.0 108.524 -168.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.703 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 12.3 ptm180 -149.95 162.58 40.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.855 0.462 . . . . 0.0 111.547 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.64 15.06 51.4 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.456 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.65 135.94 42.75 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 29.8 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.171 1.914 . . . . 0.0 111.783 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -70.43 -19.96 62.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.345 1.058 . . . . 0.0 111.32 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -93.63 10.55 32.28 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.703 0.801 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.59 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 50.6 t -87.03 133.95 33.54 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.019 0.528 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m -105.83 169.98 8.16 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.006 0.922 . . . . 0.0 109.511 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.38 69.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.008 0.923 . . . . 0.0 111.893 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 3.3 m-20 -48.03 -48.72 32.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.405 1.082 . . . . 0.0 112.445 175.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -69.79 -34.16 73.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.866 0.867 . . . . 0.0 111.912 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 43' ' ' ILE . 39.0 t -73.95 -30.53 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 123.162 0.585 . . . . 0.0 110.128 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -67.19 -38.78 85.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.368 0.667 . . . . 0.0 110.013 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 95.1 mtt180 -59.6 -46.06 90.09 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.887 0.742 . . . . 0.0 111.191 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 77.0 t80 -63.52 -46.37 86.37 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.88 0.371 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -94.83 37.07 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.795 0.838 . . . . 0.0 110.556 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 t -60.44 -34.14 73.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.35 0.66 . . . . 0.0 112.446 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -69.19 -36.97 77.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.122 0.487 . . . . 0.0 109.887 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.0 m -72.86 175.32 6.66 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.057 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -136.01 97.51 3.64 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.529 HG21 HG13 ' A' ' 43' ' ' ILE . 3.5 mp -73.21 118.51 18.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.535 -172.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.523 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 7.8 tp60 -64.69 124.2 21.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.715 . . . . 0.0 109.367 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 76.01 16.63 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.715 1.606 . . . . 0.0 111.94 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.56 -134.24 47.55 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.356 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -37.46 32.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.609 1.164 . . . . 0.0 112.804 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.85 -8.18 59.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.537 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 37' ' ' GLN . . . -84.33 -13.87 72.69 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.623 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.564 HD13 ' HB ' ' A' ' 27' ' ' VAL . 62.3 mt -89.62 101.2 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.157 0.583 . . . . 0.0 109.575 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.13 96.59 9.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.249 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -67.42 129.22 39.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.5 mt -71.24 92.32 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -79.99 146.83 31.82 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.961 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.6 p -83.5 -172.97 4.44 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.31 1.044 . . . . 0.0 109.678 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -71.1 -6.06 36.37 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.896 0.478 . . . . 0.0 111.145 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.5 -6.96 32.54 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.615 1.166 . . . . 0.0 109.939 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 33.49 50.09 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -124.96 132.63 24.35 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.916 0.886 . . . . 0.0 110.37 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -67.55 139.11 47.82 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.487 2.125 . . . . 0.0 111.232 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -78.77 -2.04 37.6 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.076 0.55 . . . . 0.0 111.178 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.3 60.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.878 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.703 ' HG3' ' HB3' ' A' ' 16' ' ' ARG . 8.0 mp0 -105.43 149.69 25.93 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.552 1.141 . . . . 0.0 109.618 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 163.3 38.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.75 116.01 29.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.033 0.933 . . . . 0.0 109.106 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -95.86 108.2 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 45.6 tt0 -83.14 145.08 29.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.3 mt -138.83 145.87 40.56 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.385 1.074 . . . . 0.0 108.649 -168.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.95 -26.54 63.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -152.28 163.3 39.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.453 0.701 . . . . 0.0 110.134 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 35.0 tt0 -69.53 -16.73 63.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.212 0.605 . . . . 0.0 112.594 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.6 t70 -59.77 -51.42 69.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -52.98 -39.76 63.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.931 1.292 . . . . 0.0 111.863 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 65.4 t -63.39 -42.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.125 0.57 . . . . 0.0 111.065 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 74.9 mmtt -58.62 -45.43 89.21 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.953 0.901 . . . . 0.0 111.211 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 62.5 mt -61.52 -36.76 81.45 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.911 0.884 . . . . 0.0 111.062 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.25 83.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 0.0 110.321 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.1 mt -62.57 -30.82 71.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.008 0.923 . . . . 0.0 111.828 175.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 56.3 mtpt -67.86 -30.78 70.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.318 0.58 . . . . 0.0 110.377 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 41.2 mttp -84.15 -4.26 58.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.02 0.928 . . . . 0.0 111.563 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -52.63 -33.44 46.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.461 0.704 . . . . 0.0 112.668 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -95.84 -31.59 13.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.902 -0.498 . . . . 0.0 111.598 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.07 142.24 47.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.661 0.785 . . . . 0.0 112.093 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 43.2 p -95.03 135.63 36.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.59 0.756 . . . . 0.0 110.758 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.5 ttt -70.9 -86.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 110.374 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.19 1.78 5.4 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-O 120.03 -0.317 . . . . 0.0 112.729 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -170.22 -55.67 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.018 0.927 . . . . 0.0 108.931 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -87.8 167.65 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.299 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.7 p90 -98.68 138.78 35.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.4 ' CG1' HG13 ' A' ' 15' ' ' VAL . 45.1 t -91.85 125.87 44.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -172.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.613 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 22.5 mt-10 -95.13 118.68 32.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.61 117.81 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.591 0.756 . . . . 0.0 110.065 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -68.33 136.27 53.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.075 0.852 . . . . 0.0 110.875 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -136.11 -151.58 0.42 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.52 1.128 . . . . 0.0 108.824 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -165.13 167.99 17.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 110.33 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.85 -37.04 85.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.399 1.079 . . . . 0.0 111.989 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.56 -42.84 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.204 0.602 . . . . 0.0 110.975 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.96 -38.6 76.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.1 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 55.9 ttp -53.31 -51.15 63.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.8 0.84 . . . . 0.0 110.037 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.27 -42.88 96.31 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.275 0.985 . . . . 0.0 111.144 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -58.58 -47.5 84.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.275 0.985 . . . . 0.0 110.8 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.9 t -71.42 -32.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.713 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 79.1 mt -73.02 -32.05 64.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.904 -0.498 . . . . 0.0 112.083 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.54 -18.23 61.56 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.3 m80 . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 124.469 1.108 . . . . 0.0 108.216 174.645 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.514 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.56 0.695 . . . . 0.0 111.392 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 60' ' ' GLU . 47.1 t -123.05 139.53 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -116.6 167.9 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.667 -0.646 . . . . 0.0 111.009 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -119.34 123.45 44.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.44 119.12 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -124.87 149.35 47.61 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.548 1.139 . . . . 0.0 108.967 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.02 57.53 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.48 135.84 81.35 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 123.224 0.609 . . . . 0.0 110.038 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 42.5 Cg_endo -69.1 133.83 27.8 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.998 1.798 . . . . 0.0 110.693 173.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -58.19 -29.56 65.76 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.593 1.157 . . . . 0.0 111.193 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -81.94 8.28 10.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.073 0.949 . . . . 0.0 112.553 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.49 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 12.9 p -113.85 142.06 46.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.68 -170.07 1.63 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.64 0.776 . . . . 0.0 109.322 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -43.37 70.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.404 1.081 . . . . 0.0 113.4 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.48 -38.23 83.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.28 0.632 . . . . 0.0 111.81 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -70.03 -37.6 75.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.737 0.815 . . . . 0.0 110.958 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.61 -35.7 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.226 0.61 . . . . 0.0 110.673 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG3' HD12 ' A' ' 36' ' ' ILE . 41.5 tt0 -66.81 -39.74 87.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -61.14 -39.19 89.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.735 1.214 . . . . 0.0 111.149 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.24 -42.05 99.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.526 0.33 . . . . 0.0 110.357 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.557 ' HB2' HD11 ' A' ' 36' ' ' ILE . 83.9 m-85 -94.97 32.49 1.66 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.004 0.522 . . . . 0.0 111.117 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 t -76.84 87.86 3.43 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 167.38 -55.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -159.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.421 ' HB3' HD22 ' A' ' 61' ' ' LEU . 58.0 m -82.55 171.73 13.76 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.138 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -123.15 72.91 1.13 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.2 mt -56.27 126.72 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.208 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -48.85 117.72 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.556 1.16 . . . . 0.0 111.397 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.3 t30 60.75 26.3 16.11 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 124.495 1.122 . . . . 0.0 111.991 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.4 -134.4 30.88 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.43 -0.805 . . . . 0.0 113.02 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.87 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.613 1.165 . . . . 0.0 113.531 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -72.48 -16.8 61.8 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.62 24.3 32.67 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -126.11 90.78 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.22 98.72 7.91 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.234 1.014 . . . . 0.0 109.628 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.89 138.36 55.97 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.655 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.2 mt -76.68 90.7 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -75.79 148.0 38.78 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.547 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.5 t -106.8 174.37 5.92 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.041 0.936 . . . . 0.0 109.433 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -57.28 -19.6 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.888 1.275 . . . . 0.0 112.918 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.34 -4.45 58.47 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.343 1.057 . . . . 0.0 111.209 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.89 30.57 51.49 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.14 0.3 . . . . 0.0 112.986 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.75 151.29 73.92 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.028 0.931 . . . . 0.0 110.482 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 145.63 53.34 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.192 1.928 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.1 p -74.48 -38.74 62.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.418 0.628 . . . . 0.0 110.409 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.49 -10.78 2.7 Favored Glycine 0 N--CA 1.468 0.771 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.757 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.58 150.72 24.4 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.196 0.998 . . . . 0.0 109.534 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.56 167.61 24.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.235 1.014 . . . . 0.0 109.885 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -111.7 122.63 48.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.93 107.88 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 12' ' ' VAL . 42.0 mt-10 -85.21 151.29 24.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 34' ' ' CYS . 73.6 mt -139.5 148.26 42.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.676 0.791 . . . . 0.0 109.213 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.65 -21.62 61.06 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -144.9 156.58 44.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.516 0.674 . . . . 0.0 110.811 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.55 -18.75 63.67 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.788 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.26 -55.65 32.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.322 0.649 . . . . 0.0 109.583 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 69' ' ' LEU . 36.3 mt-10 -52.11 -36.0 49.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.779 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 11' ' ' PHE . 76.0 t -60.83 -52.04 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.44 0.296 . . . . 0.0 110.706 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -57.42 -37.23 72.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.38 0.672 . . . . 0.0 112.619 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 66' ' ' GLU . 84.7 mt -60.55 -52.65 64.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.956 0.502 . . . . 0.0 110.558 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -56.14 -46.83 79.1 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.677 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.7 mt -57.58 -32.8 67.52 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.613 1.165 . . . . 0.0 111.843 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -76.48 -18.89 58.52 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.526 0.33 . . . . 0.0 111.082 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -88.46 9.96 21.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.65 8.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -129.56 -37.36 1.59 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.204 0.602 . . . . 0.0 110.192 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -52.04 143.29 14.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.428 1.091 . . . . 0.0 113.066 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.9 p -90.06 110.45 21.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.204 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.51 91.68 1.83 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 171.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.54 -96.25 1.14 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -164.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.99 -0.03 5.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.07 0.948 . . . . 0.0 109.911 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.25 114.91 19.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.064 0.946 . . . . 0.0 109.226 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.07 108.03 4.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.0 t -108.08 122.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.536 0.735 . . . . 0.0 110.062 -170.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.98 137.49 35.98 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.761 1.224 . . . . 0.0 109.129 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.5 t -124.17 116.16 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -104.03 -176.93 3.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.127 1.371 . . . . 0.0 107.699 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -109.53 136.97 48.06 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -128.59 148.84 50.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.754 0.822 . . . . 0.0 109.31 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -93.31 173.88 7.49 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -64.24 -19.21 65.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.77 171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.36 -54.91 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 123.785 0.834 . . . . 0.0 110.504 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.35 -45.05 70.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.295 0.638 . . . . 0.0 110.53 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -57.03 -48.68 77.92 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.456 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.03 -53.99 51.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.509 0.724 . . . . 0.0 111.122 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -65.02 -41.95 94.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.143 0.977 . . . . 0.0 112.888 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.4 t -82.71 -22.9 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.841 0.456 . . . . 0.0 111.174 -173.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.48 -22.94 46.72 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 122.373 -0.204 . . . . 0.0 110.821 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.6 mmpt? -73.46 -38.94 65.3 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.5 t60 . . . . . 0 CA--C 1.545 0.787 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -173.149 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 64' ' ' GLU . 10.5 m-30 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 122.052 0.93 . . . . 0.0 108.537 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.04 138.54 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.878 1.271 . . . . 0.0 108.719 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 70' ' ' ALA . 28.5 m -110.44 177.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.341 0.656 . . . . 0.0 110.446 165.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 19.6 ptmt -136.93 140.07 41.99 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.95 129.99 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.703 0.801 . . . . 0.0 109.134 -170.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.779 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 30.1 mtp-105 -129.94 159.43 36.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.111 0.964 . . . . 0.0 108.447 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.47 18.05 67.25 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.61 141.85 65.48 Favored Pre-proline 0 C--N 1.349 0.585 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.89 140.39 91.73 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 121.904 1.736 . . . . 0.0 111.47 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.43 ' HZ3' HH22 ' A' ' 81' ' ' ARG . 1.6 m-90 -68.07 -19.33 64.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.369 0.668 . . . . 0.0 110.099 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -97.97 12.4 34.31 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.511 1.125 . . . . 0.0 111.55 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 53.4 t -90.53 140.29 29.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.115 0.566 . . . . 0.0 109.676 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.6 p -117.14 172.4 7.31 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.082 0.953 . . . . 0.0 109.661 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -40.98 58.81 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.674 1.19 . . . . 0.0 114.138 -171.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.34 -39.95 73.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.984 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 1.8 mp0 -71.28 -41.04 70.53 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 0.0 111.322 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 43' ' ' ILE . 56.5 t -72.71 -30.31 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.13 -42.69 62.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.1 0.96 . . . . 0.0 110.173 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.58 -48.25 82.6 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.172 0.989 . . . . 0.0 110.677 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 79.2 t80 -63.35 -57.34 10.68 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -85.38 37.25 0.67 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.314 0.645 . . . . 0.0 111.368 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -57.59 -31.83 66.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.445 0.698 . . . . 0.0 110.692 166.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.11 -16.15 63.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.956 1.302 . . . . 0.0 112.329 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 70' ' ' ALA . 39.1 m -114.23 130.49 56.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.961 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 13.9 mmmm -75.3 90.0 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HA ' HD23 ' A' ' 61' ' ' LEU . 20.8 mt -73.89 129.75 36.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -44.19 -68.25 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.928 1.392 . . . . 0.0 113.413 -163.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -108.73 43.29 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.469 0.708 . . . . 0.0 109.852 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.23 -125.35 37.52 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.718 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.8 68.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.926 0.89 . . . . 0.0 112.022 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -77.58 -19.71 55.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.725 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.67 -20.67 75.94 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 116.525 -0.307 . . . . 0.0 112.38 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 59' ' ' VAL . 46.4 mt -79.89 140.66 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.544 0.738 . . . . 0.0 109.158 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 97' ' ' LEU . 28.4 mmt180 -127.26 96.76 4.68 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.961 0.504 . . . . 0.0 110.078 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 94.0 m-85 -77.87 136.91 38.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.464 0.306 . . . . 0.0 110.28 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.55 85.88 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.24 145.62 43.94 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.196 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 50' ' ' GLU . 8.9 t -109.42 178.87 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.1 0.56 . . . . 0.0 110.132 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.65 -5.53 8.67 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' H ' HG23 ' A' ' 48' ' ' THR . 10.3 tp10 -90.42 -17.43 27.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.93 0.892 . . . . 0.0 110.325 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.09 4.96 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.141 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HG22 ' A' ' 48' ' ' THR . 17.8 ptt85 -163.19 155.51 15.64 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.878 0.871 . . . . 0.0 111.225 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 36.2 Cg_endo -62.95 149.14 92.44 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.719 2.279 . . . . 0.0 112.015 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.0 p -95.15 19.55 10.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.192 0.997 . . . . 0.0 111.556 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 -17.13 49.37 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 120.034 -0.314 . . . . 0.0 113.622 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.451 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 38.9 tt0 -107.6 147.2 30.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.587 0.755 . . . . 0.0 110.111 175.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.92 36.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.467 1.107 . . . . 0.0 109.76 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.5 112.53 23.11 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 43' ' ' ILE . 72.2 t -93.96 116.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -86.93 137.41 32.4 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.449 0.468 . . . . 0.0 109.823 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 36' ' ' ILE . 56.4 mt -127.3 148.17 50.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.288 1.035 . . . . 0.0 108.555 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.13 -24.89 47.22 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.615 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.9 m -133.76 143.8 48.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.588 0.755 . . . . 0.0 110.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . 30.6 tt0 -77.03 -10.93 59.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.039 0.447 . . . . 0.0 111.695 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 25.9 t70 -65.72 -35.43 80.73 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 169.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 18.1 mm-40 -68.16 -31.27 70.71 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.952 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.24 -51.83 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.485 0.714 . . . . 0.0 110.645 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 18.8 ptpt -54.06 -38.7 65.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 123.286 0.366 . . . . 0.0 111.355 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 41.4 mt -64.06 -50.14 69.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.322 1.049 . . . . 0.0 110.955 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -56.53 -44.8 81.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.686 0.794 . . . . 0.0 111.946 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 85' ' ' VAL . 93.2 mt -59.87 -34.93 73.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.431 1.092 . . . . 0.0 111.472 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -76.83 -17.85 58.75 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.254 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 29.5 mtpp -89.42 3.33 52.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.268 0.627 . . . . 0.0 111.352 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.61 -59.13 4.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.866 0.866 . . . . 0.0 111.796 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -79.19 -11.47 59.97 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 157.03 18.17 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.67 0.747 . . . . 0.0 111.621 165.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.3 p -93.82 122.67 36.53 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.227 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.638 ' HB2' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -62.26 -77.36 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.628 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.58 87.72 0.29 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 166.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 78.39 -52.36 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.672 1.589 . . . . 0.0 112.062 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.43 HH22 ' HZ3' ' A' ' 20' ' ' TRP . 47.6 mtm180 -78.94 154.48 29.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.916 0.487 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -84.12 151.92 24.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.65 0.78 . . . . 0.0 109.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 78' ' ' MET . 12.2 t -96.52 156.93 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 111.087 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 29.0 mm-40 -115.27 115.0 25.94 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 161.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 71' ' ' LEU . 34.7 t -117.56 117.33 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.25 -178.11 3.37 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.63 135.56 50.4 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.8 m -130.11 -160.7 1.06 Allowed 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.022 0.929 . . . . 0.0 110.324 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -160.69 160.42 31.46 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.155 0.982 . . . . 0.0 113.08 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.94 -51.71 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.633 0.773 . . . . 0.0 110.852 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 95' ' ' TRP . 11.5 pm0 -83.99 -20.61 32.53 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.959 0.503 . . . . 0.0 110.752 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.467 ' SD ' ' HG3' ' A' ' 44' ' ' ARG . 50.1 ttm -60.06 -56.01 26.89 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.44 -41.2 98.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.98 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 65.0 t-105 -58.77 -53.65 56.02 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.162 0.585 . . . . 0.0 111.0 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.76 -25.68 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.476 0.71 . . . . 0.0 111.963 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 44' ' ' ARG . 85.0 mt -76.75 -43.61 36.45 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.599 0.36 . . . . 0.0 111.095 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.74 -32.84 27.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.254 1.022 . . . . 0.0 110.701 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 . . . . . 0 C--O 1.24 0.585 0 C-N-CA 125.243 1.417 . . . . 0.0 107.387 -178.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.3 p90 . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.95 133.82 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 168.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 67' ' ' VAL . 23.1 m -96.2 155.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 122.608 0.363 . . . . 0.0 110.847 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 36.7 ttpt -109.0 117.65 34.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 83' ' ' VAL . 58.4 t -105.34 136.85 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.02 0.928 . . . . 0.0 108.636 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -140.41 134.51 30.9 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 111.72 81.55 1.16 Allowed Glycine 0 C--O 1.236 0.264 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -168.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.0 mt -139.67 135.34 16.71 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 114.097 -1.051 . . . . 0.0 109.164 -171.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.556 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 30.9 Cg_endo -65.74 131.41 27.46 Favored 'Trans proline' 0 C--N 1.361 1.217 0 N-CA-C 108.285 -1.467 . . . . 0.0 108.285 154.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -63.7 -24.71 67.89 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.63 0.772 . . . . 0.0 111.193 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -97.41 26.82 4.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.875 0.87 . . . . 0.0 111.624 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 27.4 p -78.95 155.25 29.05 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.223 0.609 . . . . 0.0 111.166 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -105.48 159.11 16.18 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.315 1.046 . . . . 0.0 109.553 171.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 -38.59 66.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.255 0.622 . . . . 0.0 110.794 169.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.97 -35.88 67.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.023 0.929 . . . . 0.0 112.129 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -64.55 -47.76 77.58 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.054 0.454 . . . . 0.0 111.349 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.74 -24.54 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.204 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.26 -49.7 40.42 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 109.96 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -58.05 -40.67 81.51 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.256 0.972 . . . . 0.0 110.26 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -59.78 -56.05 26.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HB2' HD11 ' A' ' 36' ' ' ILE . 65.9 m-85 -93.98 25.84 3.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.259 0.624 . . . . 0.0 111.858 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 t -64.01 -21.78 66.65 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.93 -43.02 84.32 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 81.8 m -75.0 140.05 43.34 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.182 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 12.4 mptt -84.28 90.97 7.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 31' ' ' PHE . 55.0 mt -64.71 121.84 14.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.212 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -59.49 124.3 19.6 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.132 0.895 . . . . 0.0 110.474 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.59 20.61 12.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.325 1.05 . . . . 0.0 111.278 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.57 -131.09 49.14 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.053 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.33 -29.93 25.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.293 1.037 . . . . 0.0 113.23 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -75.01 -21.83 58.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.396 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.27 -21.71 79.19 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.404 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.93 121.31 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 108.98 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 97' ' ' LEU . 83.2 mtt180 -128.52 96.9 4.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.924 0.89 . . . . 0.0 110.005 -169.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.5 132.1 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.43 83.97 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 84.4 m-85 -72.97 143.64 47.55 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.502 177.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.4 p -98.14 179.16 4.85 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.523 0.729 . . . . 0.0 109.427 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -68.85 -9.01 48.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.653 0.781 . . . . 0.0 111.765 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 13.9 tp10 -83.05 -14.17 54.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.072 0.949 . . . . 0.0 110.453 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.0 23.41 59.43 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 113.537 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 7.2 mpt_? -133.29 143.46 48.32 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 42.3 Cg_endo -65.44 155.79 66.92 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.88 1.72 . . . . 0.0 111.009 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.9 t -72.01 -3.82 25.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.294 0.638 . . . . 0.0 111.6 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.38 66.21 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -166.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.09 149.43 35.55 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.006 1.323 . . . . 0.0 111.148 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.39 166.79 27.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.118 1.367 . . . . 0.0 109.873 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -121.48 128.71 52.38 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.15 118.25 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -82.34 141.11 33.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -126.35 163.22 23.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.904 0.482 . . . . 0.0 110.405 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -31.22 70.77 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.977 0.911 . . . . 0.0 110.612 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 t -160.2 164.42 32.83 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 108.999 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -74.93 -13.66 60.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 0.0 110.729 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.62 -42.24 98.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.582 0.753 . . . . 0.0 110.582 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 7.9 mm-40 -59.7 -32.39 70.47 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.547 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 13' ' ' VAL . 76.0 t -67.63 -41.61 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.042 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -53.4 -46.63 69.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.778 0.831 . . . . 0.0 111.442 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.9 -46.26 85.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.658 0.783 . . . . 0.0 111.202 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -56.43 -46.4 80.28 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.378 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 96.6 mt -59.2 -39.17 81.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.333 1.053 . . . . 0.0 111.281 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -64.81 -29.14 70.1 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.674 0.609 . . . . 0.0 111.466 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -111.41 37.49 2.86 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.409 0.623 . . . . 0.0 111.351 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 85' ' ' VAL . 6.5 p-10 -75.43 18.58 0.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.394 0.677 . . . . 0.0 111.873 165.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -117.95 -29.49 5.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.539 1.535 . . . . 0.0 108.866 -168.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -58.94 146.01 39.44 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.241 1.017 . . . . 0.0 112.829 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 p -95.19 143.62 26.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.347 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ttt -112.11 98.22 7.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.31 1.06 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -151.46 15.55 0.69 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.135 0.974 . . . . 0.0 109.944 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 20.9 ttt180 -107.36 -145.2 0.39 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.505 ' H ' ' HG2' ' A' ' 81' ' ' ARG . 81.0 m-85 -157.81 128.75 6.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -160.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 15' ' ' VAL . 95.9 t -104.71 116.46 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 119.72 1.145 . . . . 0.0 109.293 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -96.82 118.23 32.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 107.622 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 33.2 t -114.06 116.83 53.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -111.04 -178.9 3.58 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' NZ ' HG11 ' A' ' 67' ' ' VAL . 22.5 ttmm -100.88 118.88 37.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.9 t -92.5 -178.79 5.01 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.906 0.86 . . . . 0.0 109.742 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -142.22 154.39 44.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.26 -38.14 79.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.98 -47.39 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 110.655 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -54.26 38.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.129 0.572 . . . . 0.0 111.193 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 42.1 ttp -55.26 -42.35 73.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.17 0.988 . . . . 0.0 111.385 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.68 -45.46 89.39 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.269 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -62.55 -44.81 95.42 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.749 0.656 . . . . 0.0 111.944 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.7 t -76.13 -25.12 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 123.748 0.655 . . . . 0.0 111.227 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HD3' ' A' ' 44' ' ' ARG . 86.6 mt -79.52 -29.08 41.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.912 0.485 . . . . 0.0 111.067 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -80.13 -28.3 38.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.022 0.529 . . . . 0.0 110.963 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 t60 . . . . . 0 C--O 1.237 0.438 0 C-N-CA 124.02 0.928 . . . . 0.0 108.656 -179.206 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.615 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.985 0.898 . . . . 0.0 112.273 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.21 133.93 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' A' ' 70' ' ' ALA . 28.9 m -105.08 168.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.095 0.474 . . . . 0.0 110.865 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -126.5 125.84 42.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -111.93 123.28 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 123.517 0.727 . . . . 0.0 109.174 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.702 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 52.5 ttt180 -127.86 147.55 50.45 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 22.88 34.52 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.78 137.27 54.44 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.43 0.692 . . . . 0.0 109.758 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 36.7 Cg_endo -67.08 135.92 39.07 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.516 2.144 . . . . 0.0 111.195 169.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' PRO . 26.8 p90 -60.73 -27.4 67.9 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 m -78.76 1.88 21.63 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.494 1.117 . . . . 0.0 112.976 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.504 ' SG ' ' HG2' ' A' ' 19' ' ' PRO . 14.9 p -119.07 152.31 36.7 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 m -116.7 -168.34 1.44 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.107 0.963 . . . . 0.0 109.808 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.3 61.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.882 1.273 . . . . 0.0 113.505 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.3 m-20 -51.08 -55.33 18.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.906 0.882 . . . . 0.0 112.931 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.92 -33.52 74.85 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.911 0.484 . . . . 0.0 111.682 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.98 -39.28 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.051 0.54 . . . . 0.0 109.856 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.83 -42.85 97.53 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.246 0.618 . . . . 0.0 110.756 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 33.2 mmt180 -66.36 -38.09 86.8 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.241 0.616 . . . . 0.0 111.06 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -65.03 -39.23 93.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.678 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 58.3 m-85 -95.13 28.8 2.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.469 0.707 . . . . 0.0 111.668 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 95.35 2.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 166.7 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.423 2.289 . . . . 0.0 107.396 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.1 p -115.82 136.84 52.67 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.548 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -81.68 98.35 8.35 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 61' ' ' LEU . 30.5 mt -77.98 115.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 45.8 tt0 -66.56 129.49 40.03 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.544 0.527 . . . . 0.0 110.535 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.419 ' ND2' ' HG2' ' A' ' 37' ' ' GLN . 35.5 m-80 75.07 16.77 2.78 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.591 1.556 . . . . 0.0 110.425 -173.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.77 -137.85 39.45 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.926 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.55 63.41 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.863 0.865 . . . . 0.0 112.218 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -75.46 -10.86 59.83 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.942 0.497 . . . . 0.0 111.789 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.96 -17.7 74.13 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.061 0.226 . . . . 0.0 112.757 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -84.14 116.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.573 0.749 . . . . 0.0 109.183 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -116.04 95.55 5.15 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.26 0.624 . . . . 0.0 109.873 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -73.29 139.42 46.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.892 0.477 . . . . 0.0 110.491 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.3 mm -79.26 112.9 17.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 165.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.88 167.1 11.63 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.512 0.725 . . . . 0.0 109.381 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -90.45 -176.61 4.83 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.514 0.726 . . . . 0.0 109.345 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.68 -14.09 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.107 0.412 . . . . 0.0 110.838 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.33 52.79 0.71 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.654 0.221 . . . . 0.0 113.654 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -115.99 131.26 23.83 Favored Pre-proline 0 N--CA 1.483 1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HB2' ' HA ' ' A' ' 20' ' ' TRP . 32.3 Cg_exo -57.54 123.36 13.58 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.64 2.226 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -78.21 -45.61 22.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.97 0.508 . . . . 0.0 110.163 -171.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.73 -12.73 1.51 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.24 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 16' ' ' ARG . 43.1 mt-10 -107.38 151.67 25.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.841 . . . . 0.0 110.218 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.72 167.03 30.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.615 1.166 . . . . 0.0 110.044 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.23 115.5 23.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.681 0.792 . . . . 0.0 108.923 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.1 t -97.16 115.63 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.1 tt0 -78.95 130.67 35.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.271 1.028 . . . . 0.0 109.564 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 36' ' ' ILE . 96.9 mt -130.13 140.41 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.222 0.609 . . . . 0.0 110.105 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.72 -20.11 59.97 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.476 0.711 . . . . 0.0 112.827 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 38.7 m -140.73 150.49 43.48 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.95 -12.69 61.36 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 120.888 0.375 . . . . 0.0 111.044 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.07 -52.22 50.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 169.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.581 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 5.2 mm-40 -47.71 -38.99 16.36 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.46 1.1 . . . . 0.0 111.532 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 11' ' ' PHE . 25.2 t -62.99 -52.95 52.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.237 0 C-N-CA 123.71 0.804 . . . . 0.0 111.471 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -57.09 -37.82 72.45 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.042 0.537 . . . . 0.0 112.404 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.23 -37.7 84.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.632 0.773 . . . . 0.0 111.686 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -64.65 -44.12 91.44 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 82.4 mt -62.48 -29.88 70.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -66.31 -21.67 66.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.219 1.008 . . . . 0.0 110.894 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 66.2 mttm -84.4 -4.17 58.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.928 0.891 . . . . 0.0 112.35 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 21.0 t70 -68.29 91.29 0.38 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.715 0.406 . . . . 0.0 110.192 173.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 145.43 -38.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 128.317 2.647 . . . . 0.0 109.021 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.66 144.07 39.13 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 p -92.59 120.8 33.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.198 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.472 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 ttt -61.65 -73.19 0.1 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.097 0.559 . . . . 0.0 110.851 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.84 -17.54 0.72 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 168.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -142.45 -66.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.668 1.187 . . . . 0.0 108.374 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -77.85 155.42 31.02 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.207 -172.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -81.25 127.38 32.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 90.9 t -88.96 120.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -170.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 28.9 mt-10 -94.91 116.69 29.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.409 HG12 HD23 ' A' ' 71' ' ' LEU . 11.5 t -117.03 114.52 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -106.08 144.67 32.46 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.445 1.098 . . . . 0.0 108.526 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.86 125.59 27.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 163.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.7 m -128.18 163.4 24.77 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.593 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -103.89 153.0 21.28 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.54 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.41 -32.75 72.7 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.221 1.008 . . . . 0.0 109.889 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.28 -44.01 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.639 0.776 . . . . 0.0 109.897 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.86 -38.48 83.15 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.1 ttm -56.01 -48.51 75.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.039 0.536 . . . . 0.0 110.01 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.89 -46.8 84.35 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.248 1.019 . . . . 0.0 110.53 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -58.31 -52.53 65.19 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.988 0.805 . . . . 0.0 111.816 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' HIS . 24.6 t -79.14 -25.22 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 -37.96 75.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.747 0.419 . . . . 0.0 110.409 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -90.68 -15.63 30.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.798 0.839 . . . . 0.0 111.428 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 23.7 t-80 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.607 1.163 . . . . 0.0 108.567 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 122.435 1.112 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -130.9 134.56 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.925 1.69 . . . . 0.0 107.582 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 70' ' ' ALA . 17.5 m -112.61 -175.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.858 0.863 . . . . 0.0 109.523 171.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.53 142.43 31.12 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.68 0.753 . . . . 0.0 109.54 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -111.49 119.43 59.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 108.611 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 61.1 mtp180 -123.98 148.56 46.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.25 1.02 . . . . 0.0 109.723 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.33 25.81 35.35 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -59.32 143.72 84.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.121 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.52 174.19 13.24 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.463 2.108 . . . . 0.0 111.275 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -68.75 -24.61 64.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.449 0.642 . . . . 0.0 109.536 171.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.0 m -81.41 1.43 33.06 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.447 1.099 . . . . 0.0 112.482 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.2 p -49.02 126.05 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.561 0.744 . . . . 0.0 112.881 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.52 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 45.7 t -146.3 158.91 43.93 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.919 1.287 . . . . 0.0 108.35 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . -53.95 -42.95 69.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.019 0.527 . . . . 0.0 110.688 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 6.8 m-20 -54.33 -43.62 71.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 112.658 173.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 13.3 mm-40 -68.04 -36.35 79.75 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.866 0.467 . . . . 0.0 110.875 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.0 t -66.78 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 123.33 0.652 . . . . 0.0 110.673 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.56 HE21 HD11 ' A' ' 43' ' ' ILE . 27.4 mm-40 -56.92 -53.83 53.52 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.97 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 36.0 mmt180 -56.56 -46.17 80.88 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.41 1.084 . . . . 0.0 111.228 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.59 -40.47 83.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.821 1.248 . . . . 0.0 112.233 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -97.45 35.56 1.62 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.054 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 83.06 4.6 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 169.05 -62.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.003 1.721 . . . . 0.0 106.739 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.9 m -74.58 -177.66 3.25 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.207 168.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 126.74 17.03 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.831 0.824 . . . . 0.0 109.199 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.467 HD12 ' NE2' ' A' ' 28' ' ' GLN . 55.2 mt -86.27 128.68 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.419 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -42.76 -61.74 1.18 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.963 1.705 . . . . 0.0 113.965 -160.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -116.52 40.81 2.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.231 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.25 -130.02 32.05 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.333 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -64.11 -14.52 55.37 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.09 -21.68 50.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.769 0.428 . . . . 0.0 111.501 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 28.89 7.71 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.56 HD11 HE21 ' A' ' 28' ' ' GLN . 61.2 mt -128.51 127.46 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.615 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.1 tpp180 -131.29 96.68 4.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.694 0.621 . . . . 0.0 110.024 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.64 134.86 36.45 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.7 113.48 24.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -95.82 164.59 12.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.8 p -107.95 172.88 6.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 108.874 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 1.6 15.59 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -85.53 -6.41 59.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.74 0.816 . . . . 0.0 110.683 167.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.38 32.63 42.09 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.069 0.231 . . . . 0.0 113.1 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -135.3 139.64 32.13 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.573 0.749 . . . . 0.0 111.414 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -58.07 134.1 59.91 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 122.868 2.379 . . . . 0.0 112.187 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -69.29 -44.52 71.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.15 0.98 . . . . 0.0 110.986 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.53 -10.0 3.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.091 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 43.7 mt-10 -108.67 148.6 30.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.448 1.099 . . . . 0.0 110.137 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.81 152.18 32.31 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 124.38 1.072 . . . . 0.0 108.265 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.49 126.77 52.51 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.9 t -106.45 142.9 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -123.67 120.01 31.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -167.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.1 mt -117.37 161.07 20.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.376 0.67 . . . . 0.0 110.737 -165.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.68 -29.83 69.56 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -160.45 167.2 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.315 0.384 . . . . 0.0 110.543 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -73.02 -17.84 61.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.207 0.603 . . . . 0.0 111.305 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -44.66 89.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.59 -31.03 71.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.198 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.75 -40.9 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.589 0.756 . . . . 0.0 110.535 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -65.08 -38.15 89.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.36 0.664 . . . . 0.0 111.372 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 96.6 mt -65.66 -31.97 73.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.624 0.769 . . . . 0.0 111.324 172.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -69.04 -42.57 76.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.635 173.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 87' ' ' LYS . 84.9 mt -62.01 -39.71 93.21 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.687 0.795 . . . . 0.0 112.174 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.7 ptmt -75.03 -18.29 60.36 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.999 0.428 . . . . 0.0 110.475 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.18 6.28 23.16 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.518 1.127 . . . . 0.0 111.2 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -68.52 80.43 0.26 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.294 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 163.94 -44.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.869 0.867 . . . . 0.0 110.055 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -42.17 140.46 1.13 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.013 1.725 . . . . 0.0 113.36 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.6 p -100.37 110.53 22.74 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 -172.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.1 ttm -78.44 91.96 4.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.94 -86.54 1.27 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.999 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -132.14 7.26 4.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.881 0.872 . . . . 0.0 109.988 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -105.69 132.71 51.5 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.101 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -76.47 133.37 39.83 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.8 t -131.89 133.45 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.144 0.497 . . . . 0.0 110.392 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -98.53 148.2 24.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.695 1.198 . . . . 0.0 109.277 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' A' ' 70' ' ' ALA . 46.7 t -130.76 118.98 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.04 144.55 42.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' HD21 ' A' ' 71' ' ' LEU . 87.7 tttt -67.68 138.22 56.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -122.95 -160.54 0.9 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.12 159.42 41.58 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -60.71 -40.5 92.5 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.441 0.696 . . . . 0.0 110.723 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.16 -37.29 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.524 1.13 . . . . 0.0 110.976 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -68.75 -46.9 67.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 0.0 110.264 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.26 -45.66 87.44 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.114 0.966 . . . . 0.0 110.14 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.32 -43.36 99.01 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.13 0.972 . . . . 0.0 110.79 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.27 -54.49 45.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.167 0.987 . . . . 0.0 111.919 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.22 -35.28 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 0.0 111.617 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.615 HD11 ' HG2' ' A' ' 44' ' ' ARG . 88.5 mt -67.13 -36.42 81.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.059 0.543 . . . . 0.0 111.105 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -81.82 -32.14 31.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.962 0.905 . . . . 0.0 110.044 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 t60 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.462 -170.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HA ' HG21 ' A' ' 67' ' ' VAL . 17.8 p90 . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 122.178 0.99 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 60' ' ' GLU . 78.8 t -135.32 143.41 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 168.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.28 173.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.398 -0.814 . . . . 0.0 110.441 168.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -126.9 139.97 52.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.476 ' HB ' HD11 ' A' ' 18' ' ' LEU . 3.7 t -124.92 130.57 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.582 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 32.6 mtm180 -130.78 156.29 45.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.685 0.794 . . . . 0.0 108.891 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.46 -33.97 6.11 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.476 HD11 ' HB ' ' A' ' 15' ' ' VAL . 52.4 mt -34.77 112.36 0.44 Allowed Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.746 1.218 . . . . 0.0 112.594 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.69 163.98 19.9 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.686 2.257 . . . . 0.0 113.223 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -57.22 -34.74 68.85 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.871 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 t -95.55 13.54 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.601 0.761 . . . . 0.0 111.825 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -72.61 168.72 18.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.055 0.542 . . . . 0.0 111.224 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -137.63 156.53 47.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.949 0.899 . . . . 0.0 109.783 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.32 69.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.501 0.721 . . . . 0.0 111.188 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -50.76 -47.94 59.36 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.053 . . . . 0.0 112.741 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -68.01 -41.09 82.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.797 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 43' ' ' ILE . 33.4 t -72.05 -36.27 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.532 0.733 . . . . 0.0 110.282 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.564 ' HG2' HD12 ' A' ' 36' ' ' ILE . 26.1 tm0? -65.73 -43.43 89.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.809 . . . . 0.0 110.0 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -61.56 -42.28 98.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.865 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 59.5 t80 -61.31 -29.28 69.78 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.753 0.821 . . . . 0.0 111.638 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.94 37.65 2.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.576 0.751 . . . . 0.0 111.831 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 p -77.15 85.89 3.62 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.486 0.66 . . . . 0.0 109.58 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 168.95 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 126.721 2.008 . . . . 0.0 106.099 -161.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.3 m -78.81 169.67 17.87 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.977 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -127.8 94.35 3.93 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' A' ' 28' ' ' GLN . 14.6 mt -75.97 133.99 30.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.06 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -47.62 -55.96 8.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.193 1.397 . . . . 0.0 112.777 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -125.54 65.23 1.17 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.381 0.61 . . . . 0.0 109.424 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.48 -143.08 42.24 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.353 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.78 -14.77 60.24 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.867 0.867 . . . . 0.0 112.942 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.04 -19.54 58.54 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.111 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.88 -7.89 71.55 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.817 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.504 HG12 HG22 ' A' ' 59' ' ' VAL . 46.3 mt -93.23 134.21 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 124.181 0.992 . . . . 0.0 110.288 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -128.81 96.12 4.28 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.82 0.848 . . . . 0.0 111.588 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -73.84 117.44 15.62 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.537 HG13 HD23 ' A' ' 97' ' ' LEU . 2.4 mp -67.27 99.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -79.78 134.65 36.37 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.3 p -85.25 176.88 8.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.359 0.664 . . . . 0.0 111.531 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -68.37 -21.46 64.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.061 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 9.4 tp10 -80.03 -13.9 58.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.655 1.182 . . . . 0.0 110.716 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.93 11.34 73.7 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 3.7 mpt_? -106.43 141.5 22.92 Favored Pre-proline 0 N--CA 1.485 1.318 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.67 132.32 49.5 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.062 1.841 . . . . 0.0 110.12 167.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 t -76.13 9.56 2.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.249 1.02 . . . . 0.0 112.142 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 16' ' ' ARG . . . 85.92 -13.42 56.74 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.99 139.24 37.88 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.251 1.42 . . . . 0.0 109.721 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.78 136.92 29.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.545 0.738 . . . . 0.0 109.232 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD2' HD11 ' A' ' 46' ' ' ILE . 40.3 m-85 -96.2 106.87 19.12 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 HG12 ' A' ' 43' ' ' ILE . 60.1 t -91.19 122.27 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 12' ' ' VAL . 44.0 tt0 -101.56 136.58 41.17 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.9 mt -125.7 162.47 24.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.13 0.491 . . . . 0.0 110.698 -166.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.92 -35.13 57.55 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.01 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -154.13 167.95 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.677 0.751 . . . . 0.0 112.457 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 60.1 mm-40 -61.85 -32.36 72.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.36 1.464 . . . . 0.0 113.169 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.69 -46.68 88.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 1.6 mp0 -59.33 -33.93 71.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.85 170.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 80.9 t -62.14 -52.36 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 118.605 0.638 . . . . 0.0 110.532 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mttt -53.89 -41.27 67.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.427 1.091 . . . . 0.0 111.686 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.1 -41.56 86.06 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.036 0.534 . . . . 0.0 110.92 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.99 94.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.17 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 67.9 mt -57.78 -22.82 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.374 1.07 . . . . 0.0 112.775 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -74.78 -13.72 60.62 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.059 0.543 . . . . 0.0 111.401 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 3.8 mptp? -88.17 -2.47 58.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 118.89 -0.576 . . . . 0.0 112.254 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -53.05 -59.25 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -18.02 64.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 112.515 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -59.41 153.51 18.99 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.602 0.715 . . . . 0.0 112.496 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -100.45 150.92 22.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.639 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.63 114.09 6.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 108.535 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.39 -81.57 1.2 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -159.42 19.62 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.871 0.868 . . . . 0.0 109.735 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.85 139.76 47.07 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.307 0.643 . . . . 0.0 109.862 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -78.38 129.57 35.12 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.8 t -87.12 165.35 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.333 0.653 . . . . 0.0 109.697 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 49.0 mt-10 -135.19 117.32 15.44 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 115.66 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 84' ' ' GLU . 92.3 m-85 -117.05 179.59 3.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 120.62 40.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -109.61 140.56 43.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.786 0.834 . . . . 0.0 111.363 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -96.36 166.01 11.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.188 0.995 . . . . 0.0 109.018 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -62.67 -38.0 88.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.401 0.68 . . . . 0.0 110.746 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.24 -43.11 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.371 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -68.52 -41.65 79.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.329 1.052 . . . . 0.0 109.903 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 51.4 ttp -60.74 -52.89 63.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.892 1.277 . . . . 0.0 110.626 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.25 -45.57 92.78 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.776 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -60.94 -40.78 94.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.498 1.119 . . . . 0.0 111.605 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 71.4 t -81.08 -28.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.352 0.661 . . . . 0.0 111.678 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.537 HD23 HG13 ' A' ' 46' ' ' ILE . 69.8 mt -71.23 -43.47 67.27 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.94 -0.475 . . . . 0.0 110.948 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -82.46 -35.34 27.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.508 0.723 . . . . 0.0 112.74 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 119.243 -0.408 . . . . 0.0 112.062 -166.734 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.392 0.615 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.51 139.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.961 1.305 . . . . 0.0 107.898 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 70' ' ' ALA . 30.2 m -107.25 169.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 167.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 79.7 tttt -124.66 125.4 44.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 83' ' ' VAL . 59.5 t -112.66 125.42 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 108.929 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.794 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 76.3 mtp180 -117.7 149.36 40.87 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.03 19.68 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.588 -176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.33 121.96 64.08 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -54.1 149.91 33.77 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.948 2.432 . . . . 0.0 113.066 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -63.37 -25.93 68.52 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.537 0.684 . . . . 0.0 111.086 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 t -109.03 19.21 19.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.202 1.001 . . . . 0.0 111.025 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.7 p -78.29 177.84 8.11 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.655 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.2 t -128.21 148.45 50.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.546 0.738 . . . . 0.0 109.645 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.41 71.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.8 m-20 -54.85 -47.59 73.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 111.262 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 11.2 mm-40 -69.01 -41.25 78.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.412 0.685 . . . . 0.0 111.478 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 43' ' ' ILE . 45.5 t -69.14 -31.85 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.02 0.528 . . . . 0.0 109.691 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.64 -41.85 87.64 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.798 0.839 . . . . 0.0 110.598 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 67.6 mmt-85 -65.99 -37.2 85.35 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 0.0 111.262 176.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -68.13 -33.81 75.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.374 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -101.99 35.53 2.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.591 . . . . 0.0 110.684 175.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -82.34 79.76 8.71 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t70 170.54 -38.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.816 -158.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.8 m -102.11 173.05 6.56 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.344 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.529 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 6.0 mtpm? -126.78 95.14 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HA ' HD23 ' A' ' 61' ' ' LEU . 21.5 mt -76.62 139.51 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.659 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -45.89 -69.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.894 1.371 . . . . 0.0 112.112 -169.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 41' ' ' GLN . 1.2 t-20 -106.34 35.48 2.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.861 0.464 . . . . 0.0 110.278 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.66 -125.92 31.67 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.33 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -29.96 71.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.006 0.903 . . . . 0.0 111.063 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.6 mp0 -73.53 -18.01 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.17 0.588 . . . . 0.0 110.916 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.74 -15.7 81.37 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.208 0.317 . . . . 0.0 112.907 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 27' ' ' VAL . 63.7 mt -83.53 141.32 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.875 0.87 . . . . 0.0 109.424 178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HG2' HD11 ' A' ' 97' ' ' LEU . 3.3 tpp180 -133.96 95.23 3.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -73.58 128.4 35.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.918 0.487 . . . . 0.0 110.198 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.27 118.67 32.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 89.0 m-85 -90.01 172.09 9.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.256 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -101.29 173.09 6.61 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.639 165.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -68.59 -11.18 59.66 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.274 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -85.2 -2.64 58.26 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.819 0.848 . . . . 0.0 111.57 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.4 37.35 41.7 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -145.6 135.03 11.41 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.146 0.578 . . . . 0.0 111.21 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 87.6 Cg_exo -49.08 133.96 29.38 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.6 2.866 . . . . 0.0 113.76 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 p -67.72 -26.09 65.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.179 0.992 . . . . 0.0 111.386 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.99 -16.79 7.23 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -170.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB3' ' HE2' ' A' ' 14' ' ' LYS . 41.2 mt-10 -105.44 153.12 22.12 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.977 0.911 . . . . 0.0 110.574 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.76 168.82 25.56 Favored 'General case' 0 C--O 1.213 -0.854 0 C-N-CA 124.69 1.196 . . . . 0.0 108.979 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -119.37 124.45 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.673 0.789 . . . . 0.0 109.674 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.87 111.75 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.93 136.0 35.98 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 36' ' ' ILE . 70.3 mt -126.9 144.22 51.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.519 0.728 . . . . 0.0 109.819 -171.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -66.38 -17.64 64.89 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.8 p -166.65 170.36 12.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.96 0.504 . . . . 0.0 110.945 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.59 -21.14 65.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.443 1.097 . . . . 0.0 113.367 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -49.0 77.71 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mp0 -59.4 -33.11 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.831 0.852 . . . . 0.0 112.51 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 55.3 t -60.06 -48.61 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.426 0.454 . . . . 0.0 109.916 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.32 -36.74 83.09 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.974 0.91 . . . . 0.0 112.048 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.26 -41.57 99.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.404 0.682 . . . . 0.0 111.607 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -64.02 -43.98 93.96 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.059 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 98.0 mt -64.31 -33.32 75.57 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.996 0.918 . . . . 0.0 112.747 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -16.26 50.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.909 -0.494 . . . . 0.0 110.123 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -83.58 -9.36 58.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.912 0.885 . . . . 0.0 111.002 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.493 ' HB2' ' HB ' ' A' ' 85' ' ' VAL . 5.0 t70 -62.14 100.09 0.16 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 149.38 -49.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.387 2.275 . . . . 0.0 108.67 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -55.52 146.29 20.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.034 1.333 . . . . 0.0 113.56 -168.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 25.7 p -98.6 121.39 40.49 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.803 0.841 . . . . 0.0 110.904 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ptp -83.81 74.59 10.17 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 122.005 0.907 . . . . 0.0 108.949 164.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.05 -89.95 1.38 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.126 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.98 -23.26 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.508 0.723 . . . . 0.0 111.867 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -122.35 139.24 54.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.063 0.545 . . . . 0.0 111.761 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 21.4 p90 -85.71 142.84 28.72 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.607 1.163 . . . . 0.0 108.815 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 15' ' ' VAL . 37.7 t -103.88 131.6 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.579 0.752 . . . . 0.0 111.54 -170.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 26.4 tp10 -104.78 119.33 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 108.783 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 74' ' ' ASP . 56.3 t -118.33 117.05 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.083 0.553 . . . . 0.0 110.62 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.75 139.83 44.35 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.967 . . . . 0.0 109.564 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -68.02 126.41 29.41 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -132.91 -162.12 1.21 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.044 0.938 . . . . 0.0 109.466 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -146.54 162.82 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.297 0.639 . . . . 0.0 109.401 -172.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.7 -31.46 71.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.841 0.856 . . . . 0.0 110.498 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.57 -42.13 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.362 0.665 . . . . 0.0 110.98 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 96' ' ' VAL . 18.1 tp10 -64.51 -49.54 70.92 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.0 -46.06 68.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.107 1.363 . . . . 0.0 111.391 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.9 -44.13 97.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.812 0.845 . . . . 0.0 111.331 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -63.46 -39.66 95.06 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.565 0.746 . . . . 0.0 111.406 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 92' ' ' GLU . 5.2 t -79.05 -18.95 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.739 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.516 HD11 ' HG2' ' A' ' 44' ' ' ARG . 97.8 mt -78.63 -30.0 46.21 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.957 0.503 . . . . 0.0 111.118 168.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -78.85 -35.85 43.26 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.573 0.749 . . . . 0.0 109.592 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.747 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.79 0.329 . . . . 0.0 110.56 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.4 t -134.28 140.48 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.296 1.038 . . . . 0.0 108.58 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 61' ' ' LEU . 30.0 m -107.48 167.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 0.0 110.549 164.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HE3' ' HD2' ' A' ' 16' ' ' ARG . 3.7 tmmm? -119.82 122.72 41.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.54 123.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 108.611 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HD2' ' HE3' ' A' ' 14' ' ' LYS . 12.0 ptm180 -139.95 154.71 47.27 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.17 21.06 23.82 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.21 138.09 30.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.209 1.004 . . . . 0.0 108.775 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 157.21 62.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.718 2.279 . . . . 0.0 112.307 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -52.28 -35.78 51.08 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.432 1.093 . . . . 0.0 111.851 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.6 p -93.2 17.26 11.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.015 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.48 166.17 15.27 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 123.393 0.677 . . . . 0.0 111.53 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.1 m -151.02 163.04 39.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 108.976 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -44.1 69.19 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 111.209 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.08 -40.42 73.57 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.167 0.987 . . . . 0.0 113.379 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -55.96 -48.19 76.24 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.447 0.641 . . . . 0.0 110.926 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.1 t -81.83 -22.98 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.699 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -71.26 -48.25 52.18 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.375 0.67 . . . . 0.0 109.949 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -63.91 -38.46 91.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.48 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.44 -46.49 88.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.539 ' HB2' HD11 ' A' ' 36' ' ' ILE . 96.3 m-85 -99.07 38.16 1.43 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.859 0.863 . . . . 0.0 110.698 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -66.13 -29.07 69.31 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.78 0.432 . . . . 0.0 110.764 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.69 -10.96 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.981 1.312 . . . . 0.0 112.23 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.419 ' HB3' HD23 ' A' ' 61' ' ' LEU . 39.5 m -121.85 139.78 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.791 0.837 . . . . 0.0 109.213 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.06 92.1 6.19 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.8 mt -69.03 144.14 14.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.916 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.22 100.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.716 0.806 . . . . 0.0 110.003 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 36.0 m-80 54.28 35.29 22.41 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 124.269 0.981 . . . . 0.0 111.756 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -121.54 24.58 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.651 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -27.62 17.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 10.1 tp60 -68.41 -21.7 64.66 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.18 -21.37 45.72 Favored Glycine 0 N--CA 1.471 1.023 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.423 HG23 HG22 ' A' ' 59' ' ' VAL . 56.7 mt -83.46 107.78 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.116 0.567 . . . . 0.0 110.139 -173.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.49 98.01 5.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.45 0.7 . . . . 0.0 110.927 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -75.22 151.7 38.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.037 0.535 . . . . 0.0 111.646 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.84 86.36 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 165.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.67 147.84 45.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.0 t -109.17 -179.3 3.81 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -176.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -77.1 -2.83 36.24 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.506 0.722 . . . . 0.0 111.59 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 48' ' ' THR . 40.1 tt0 -89.03 -19.12 26.04 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.684 1.194 . . . . 0.0 110.043 172.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 45.89 5.98 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.732 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -144.4 157.22 56.55 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 124.24 1.016 . . . . 0.0 109.923 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.89 135.97 73.79 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.436 2.091 . . . . 0.0 111.348 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -100.12 36.94 1.74 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.479 1.111 . . . . 0.0 110.495 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.29 -40.49 2.88 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.562 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.31 155.18 19.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 110.985 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 161.62 42.37 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 109.261 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -120.8 113.37 20.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.246 1.018 . . . . 0.0 108.616 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 43' ' ' ILE . 77.9 t -107.47 121.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.0 0.92 . . . . 0.0 108.823 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.517 ' HG2' HG22 ' A' ' 12' ' ' VAL . 29.4 mt-10 -86.09 156.41 20.39 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.048 0.539 . . . . 0.0 109.795 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.584 HD13 HG22 ' A' ' 67' ' ' VAL . 3.6 mp -138.21 156.71 47.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.937 0.895 . . . . 0.0 109.681 -176.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.18 -26.47 47.61 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.937 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.8 m -145.59 153.72 41.37 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -31.28 72.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.58 1.152 . . . . 0.0 111.158 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.11 -49.13 77.14 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.19 0.519 . . . . 0.0 110.097 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -58.06 -35.22 71.04 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.795 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG22 HD13 ' A' ' 61' ' ' LEU . 79.3 t -61.62 -50.22 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -56.75 -36.98 70.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.668 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.45 -42.3 87.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.362 0.665 . . . . 0.0 111.035 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -61.78 -40.19 94.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.801 0.84 . . . . 0.0 111.024 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 81.1 mt -61.62 -23.5 66.08 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.25 1.02 . . . . 0.0 112.547 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.25 -4.85 56.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.618 0.367 . . . . 0.0 111.776 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.68 4.94 49.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.062 0.945 . . . . 0.0 111.781 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.567 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 26.8 t70 -38.83 -12.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 170.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -144.78 -11.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.134 -0.979 . . . . 0.0 111.553 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -52.12 139.73 22.59 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.146 0.978 . . . . 0.0 111.708 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.8 p -93.01 127.71 38.62 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.945 0.898 . . . . 0.0 112.435 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -94.02 102.64 14.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.88 -90.2 0.32 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.51 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -120.43 -4.32 9.88 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.102 0.961 . . . . 0.0 111.354 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -124.75 147.88 48.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.615 0.366 . . . . 0.0 110.849 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -79.91 141.29 36.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.39 123.84 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 34.9 mt-10 -95.46 129.02 42.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.247 1.019 . . . . 0.0 108.977 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.567 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 27.8 t -127.01 118.53 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -113.87 177.67 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -111.89 128.8 56.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.1 m -122.9 -166.31 1.43 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.15 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.513 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 23.9 m-80 -136.46 161.46 35.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -63.21 -35.12 79.28 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.75 -41.92 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.185 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.513 ' HB3' ' H ' ' A' ' 89' ' ' ASN . 8.9 tp10 -62.96 -51.75 65.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.156 0.982 . . . . 0.0 110.518 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.486 ' HB2' HG11 ' A' ' 12' ' ' VAL . 10.9 tmm? -57.62 -50.52 72.88 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.25 1.42 . . . . 0.0 111.183 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.31 -39.51 92.59 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.526 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -61.2 -50.9 71.25 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 0.0 111.504 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.5 t -68.19 -39.1 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.484 0.49 . . . . 0.0 111.376 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.421 HD12 ' SD ' ' A' ' 93' ' ' MET . 94.0 mt -65.41 -29.27 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.296 0.238 . . . . 0.0 111.383 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -86.67 -33.16 20.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.442 0.697 . . . . 0.0 110.62 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.1 m80 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 124.969 1.308 . . . . 0.0 108.294 -178.42 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 . . . . . 0 CA--C 1.551 1.008 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.36 138.65 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.828 0.851 . . . . 0.0 109.959 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -107.37 162.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.201 0.601 . . . . 0.0 110.32 165.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 38.4 ttpt -113.6 120.63 41.58 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.5 118.36 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -169.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -122.1 147.7 45.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.423 1.489 . . . . 0.0 107.188 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.5 20.0 21.15 Favored Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.5 mt -92.74 117.01 67.41 Favored Pre-proline 0 C--O 1.244 0.781 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.147 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.72 157.74 7.12 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.017 2.478 . . . . 0.0 113.222 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -61.96 -18.78 61.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.604 0.762 . . . . 0.0 112.285 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 m -110.97 14.7 22.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.746 0.819 . . . . 0.0 112.168 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.64 170.67 6.02 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.205 0.457 . . . . 0.0 111.303 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -139.73 156.11 46.97 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.116 0.566 . . . . 0.0 109.492 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.25 84.28 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.828 0.705 . . . . 0.0 110.721 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.8 m-20 -53.8 -42.61 68.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.516 0.726 . . . . 0.0 112.563 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.98 -39.96 95.32 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.115 0.566 . . . . 0.0 111.876 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.2 t -68.61 -35.23 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.54 0.736 . . . . 0.0 110.096 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -65.38 -40.54 93.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.303 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 70.6 mtp180 -59.99 -47.15 87.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.187 0.595 . . . . 0.0 111.045 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.93 -34.16 74.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.475 0.71 . . . . 0.0 111.488 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.733 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 63.2 m-85 -108.35 24.9 12.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.693 0.797 . . . . 0.0 111.655 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.2 p -74.16 90.61 2.06 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.7 t70 166.08 -53.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -160.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 16.8 p -76.68 -175.56 3.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 33.3 mmtp -129.17 96.11 4.23 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 61' ' ' LEU . 24.4 mt -76.45 139.04 19.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -66.06 110.28 2.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.955 0.902 . . . . 0.0 110.31 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 85.9 m-20 60.04 31.52 20.66 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.903 0.881 . . . . 0.0 111.179 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 -125.24 34.09 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.699 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.9 -24.21 22.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.035 0.934 . . . . 0.0 113.46 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 6.9 tp60 -71.33 -18.05 62.41 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.694 0.397 . . . . 0.0 112.053 -176.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.67 -18.29 58.64 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.63 -0.259 . . . . 0.0 112.625 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' A' ' 27' ' ' VAL . 54.5 mt -85.18 110.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.0 109.675 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -123.24 99.7 6.48 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.553 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -78.31 138.83 38.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.953 0.501 . . . . 0.0 110.417 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.56 99.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.26 153.85 28.24 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.826 0.346 . . . . 0.0 110.707 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.6 p -87.03 -172.95 4.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.603 0.761 . . . . 0.0 109.515 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -76.65 -0.12 22.3 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.675 0.39 . . . . 0.0 111.568 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -101.55 -20.73 14.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.033 0.933 . . . . 0.0 109.462 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.21 45.14 4.51 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.29 138.91 26.12 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.18 0.992 . . . . 0.0 109.234 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.08 120.91 8.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.66 2.24 . . . . 0.0 111.168 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.6 m -82.91 25.35 0.68 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.049 0.94 . . . . 0.0 112.064 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.41 -33.43 4.12 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.159 0.409 . . . . 0.0 112.476 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -111.18 156.08 21.95 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.592 1.157 . . . . 0.0 110.761 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.68 169.39 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.058 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -121.69 115.98 23.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.765 0.826 . . . . 0.0 109.472 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.89 112.51 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -84.02 141.9 30.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.797 0.839 . . . . 0.0 109.015 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 36' ' ' ILE . 39.7 mt -131.54 165.27 23.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.919 0.887 . . . . 0.0 110.22 -168.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.88 -39.73 87.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.406 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 t -164.74 174.79 10.32 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.818 0.447 . . . . 0.0 110.122 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 7.6 pt-20 -60.54 -27.71 67.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.167 0.987 . . . . 0.0 112.57 -174.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.35 -50.93 41.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 14.3 mp0 -51.59 -37.24 48.98 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.313 1.045 . . . . 0.0 111.637 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 44.3 t -60.11 -52.51 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.369 172.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -57.3 -40.09 77.09 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.62 0.768 . . . . 0.0 111.948 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 66' ' ' GLU . 86.1 mt -58.64 -45.34 89.5 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.997 0.919 . . . . 0.0 110.641 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.36 84.49 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.478 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 92.1 mt -58.35 -37.13 74.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.679 1.192 . . . . 0.0 112.096 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -72.4 -5.66 38.09 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -98.98 9.61 43.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.252 1.021 . . . . 0.0 112.774 172.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.76 10.01 0.15 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -123.02 -23.18 5.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.31 0.644 . . . . 0.0 110.781 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.27 148.18 45.75 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.776 0.798 . . . . 0.0 112.216 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -99.79 137.79 37.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.309 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.2 ttt -142.59 111.42 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.614 1.166 . . . . 0.0 109.114 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.2 58.25 7.55 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.041 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 t60 71.89 -7.49 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 125.073 1.349 . . . . 0.0 112.809 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -116.85 149.59 39.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.518 1.127 . . . . 0.0 110.162 -172.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -80.78 138.89 36.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.51 123.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -95.26 119.48 33.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.7 t -113.2 114.14 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.4 m-85 -103.39 171.81 7.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.609 1.164 . . . . 0.0 110.355 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -97.14 104.57 16.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -106.2 -171.7 1.95 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.015 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.85 163.44 34.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.732 1.213 . . . . 0.0 108.934 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -61.13 -38.39 86.22 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.15 -49.44 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.161 -1.382 . . . . 0.0 110.521 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.81 -42.42 95.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.1 ttp -52.58 -56.86 12.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.066 0.946 . . . . 0.0 111.554 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 17.4 t70 -65.86 -46.0 80.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.901 0.751 . . . . 0.0 111.759 -173.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -69.19 -44.93 71.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.202 0.601 . . . . 0.0 112.543 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.09 -42.65 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 122.673 0.389 . . . . 0.0 110.656 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -38.74 85.49 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.195 0.598 . . . . 0.0 110.188 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -78.57 -18.78 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.681 0.793 . . . . 0.0 109.984 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 . . . . . 0 CA--C 1.555 1.139 0 C-N-CA 123.315 0.646 . . . . 0.0 109.288 172.722 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -98.97 138.56 23.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.775 1.23 . . . . 0.0 109.247 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -108.75 173.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.768 0.827 . . . . 0.0 109.121 165.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 18.1 ptpt -121.53 129.54 52.97 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.69 117.55 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.12 158.24 18.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -172.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 73.25 32.65 59.95 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 121.464 0.48 . . . . 0.0 112.874 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.25 133.42 38.72 Favored Pre-proline 0 C--O 1.243 0.736 0 C-N-CA 123.753 0.821 . . . . 0.0 109.041 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -54.7 145.44 60.04 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.71 2.274 . . . . 0.0 112.468 170.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -58.7 -30.52 67.47 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.158 0.983 . . . . 0.0 111.011 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.6 p -105.81 20.05 19.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.461 1.104 . . . . 0.0 111.64 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -68.65 169.99 10.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.333 0.653 . . . . 0.0 111.009 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 26' ' ' GLU . 88.2 p -126.39 156.92 39.78 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -35.2 67.42 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.441 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.14 -40.32 70.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.78 1.232 . . . . 0.0 112.957 173.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG2' ' OG ' ' A' ' 23' ' ' SER . 58.6 mm-40 -64.35 -40.11 95.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.336 177.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 43' ' ' ILE . 46.7 t -76.77 -26.12 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.501 ' NE2' HD12 ' A' ' 36' ' ' ILE . 15.5 mm-40 -64.07 -53.6 47.15 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.256 1.023 . . . . 0.0 110.134 173.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -58.65 -46.92 86.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.158 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -68.17 -44.27 76.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.076 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -97.24 36.22 1.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.738 0.815 . . . . 0.0 110.301 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 p -59.58 -23.37 62.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.164 0.585 . . . . 0.0 112.295 173.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.05 -49.96 73.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.409 0.684 . . . . 0.0 110.331 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' HD22 ' A' ' 61' ' ' LEU . 34.2 m -82.92 131.57 35.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.619 -172.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -79.54 105.23 10.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.501 HD12 ' NE2' ' A' ' 28' ' ' GLN . 47.3 mt -83.77 147.19 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.508 0.723 . . . . 0.0 109.44 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -41.73 -70.18 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 126.512 1.925 . . . . 0.0 114.172 -166.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -118.71 48.02 1.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 168.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.97 -120.5 23.02 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.515 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -62.5 -31.41 72.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.629 0.772 . . . . 0.0 112.068 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.94 -19.66 58.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.452 0.701 . . . . 0.0 111.222 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -16.01 79.67 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.661 -0.245 . . . . 0.0 112.795 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 ' HB ' ' A' ' 27' ' ' VAL . 66.1 mt -85.55 127.92 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.225 1.01 . . . . 0.0 109.545 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' NH1' ' SD ' ' A' ' 93' ' ' MET . 55.1 mtt180 -130.66 98.74 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 109.786 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.29 142.94 43.2 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.744 0.418 . . . . 0.0 110.489 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.719 HD12 ' HG2' ' A' ' 56' ' ' GLU . 61.4 mt -86.31 90.6 3.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -72.37 156.27 39.26 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.825 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.7 p -84.63 -173.17 4.58 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.552 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -63.89 -17.65 63.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB3' ' NH2' ' A' ' 52' ' ' ARG . 70.7 mm-40 -88.52 -5.92 57.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.777 1.231 . . . . 0.0 111.468 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.47 63.43 Favored Glycine 0 C--N 1.352 1.436 0 O-C-N 123.429 0.456 . . . . 0.0 113.268 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 50' ' ' GLU . 48.8 mtm180 -137.85 139.59 26.88 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 110.013 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.77 128.6 29.12 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.288 2.659 . . . . 0.0 112.045 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -74.84 -68.18 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.45 -11.94 0.02 OUTLIER Glycine 0 N--CA 1.474 1.187 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.108 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.719 ' HG2' HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -128.95 168.24 16.27 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 111.225 177.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HA ' HG13 ' A' ' 46' ' ' ILE . . . -152.91 172.02 17.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.976 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -120.75 122.04 39.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 0.0 109.064 166.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 43' ' ' ILE . 81.1 t -116.25 117.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.064 0.946 . . . . 0.0 108.521 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 33.1 tt0 -86.34 147.26 26.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 83.4 mt -130.01 156.14 44.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.172 0.989 . . . . 0.0 110.347 -169.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.32 -26.21 64.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.064 0.946 . . . . 0.0 111.551 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 74.4 m -148.53 160.64 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.557 0.743 . . . . 0.0 110.278 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.75 -15.14 61.67 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.262 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 22.9 t70 -72.22 -38.88 68.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.886 0.474 . . . . 0.0 110.304 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 22.4 mm-40 -61.18 -33.47 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.96 169.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 54.5 t -63.11 -37.19 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.075 0.55 . . . . 0.0 110.004 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 67.9 mmtt -57.98 -48.44 79.99 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.829 0.452 . . . . 0.0 111.036 171.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.1 -26.24 68.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.659 0.784 . . . . 0.0 112.07 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -78.2 -45.24 23.57 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.523 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 55.9 mt -67.03 -28.73 68.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -78.12 -15.34 58.95 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.005 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -87.3 -8.22 56.96 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.736 1.215 . . . . 0.0 110.804 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.3 93.15 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.584 0.754 . . . . 0.0 108.988 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 154.12 -53.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.721 2.008 . . . . 0.0 108.869 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.14 141.63 22.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 113.397 -167.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.4 p -83.28 126.18 32.4 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.26 1.024 . . . . 0.0 112.385 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.2 tpp -82.64 85.9 6.93 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.44 -75.9 0.66 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -114.33 -45.2 3.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.082 0.953 . . . . 0.0 109.669 171.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -67.06 -145.85 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.422 1.489 . . . . 0.0 112.092 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.5 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 32.5 t80 -160.98 120.54 2.64 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.837 -1.164 . . . . 0.0 108.388 -158.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 98.4 t -99.41 130.23 48.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 123.573 0.749 . . . . 0.0 110.381 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.85 121.59 40.35 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.572 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -118.36 122.91 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -119.37 142.43 48.17 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.444 ' HB2' HD11 ' A' ' 71' ' ' LEU . 19.5 ttmm -57.9 116.79 3.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.859 0.863 . . . . 0.0 109.762 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.1 m -114.55 -174.28 2.45 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.482 0.658 . . . . 0.0 110.921 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -131.62 152.0 51.17 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.37 -33.01 74.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.304 0.642 . . . . 0.0 109.919 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.0 -48.21 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.611 1.164 . . . . 0.0 110.249 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.46 -34.82 74.94 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.676 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' ' NH1' ' A' ' 44' ' ' ARG . 54.9 ttp -57.35 -55.19 37.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.865 0.866 . . . . 0.0 110.935 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.05 -39.86 93.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.769 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 44.0 t90 -57.33 -42.68 82.37 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.171 0.92 . . . . 0.0 111.714 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 84.0 t -80.96 -40.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.42 -176.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.69 -17.34 63.47 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.692 -0.63 . . . . 0.0 111.482 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -68.9 -39.42 79.73 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.034 0.933 . . . . 0.0 112.304 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.9 t60 . . . . . 0 N--CA 1.493 1.686 0 C-N-CA 123.344 0.657 . . . . 0.0 109.427 -168.452 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 60' ' ' GLU . 17.3 t -114.65 145.15 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 108.549 -174.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.22 175.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.497 0.719 . . . . 0.0 109.82 162.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -127.58 140.31 52.2 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.52 113.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -112.22 147.2 36.71 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 81' ' ' ARG . . . 90.32 27.42 20.56 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 121.407 0.448 . . . . 0.0 112.394 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.39 146.1 46.78 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 123.737 0.815 . . . . 0.0 109.304 172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HG3' ' A' ' 81' ' ' ARG . 1.3 Cg_endo -51.47 149.83 16.96 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.337 2.025 . . . . 0.0 111.872 165.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -59.83 -26.49 65.85 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.471 0.708 . . . . 0.0 111.964 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -119.13 36.9 4.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.227 1.011 . . . . 0.0 109.74 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.27 151.1 48.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.674 0.389 . . . . 0.0 110.347 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.7 t -111.13 146.41 36.89 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.576 0.75 . . . . 0.0 109.047 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -34.4 66.62 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.66 0.6 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 11.2 m-20 -54.98 -49.35 71.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.867 0.867 . . . . 0.0 112.261 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 12.2 mm-40 -69.25 -34.39 74.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.893 0.477 . . . . 0.0 111.101 -174.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.36 -37.9 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.202 0.601 . . . . 0.0 109.711 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.24 -44.49 88.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.151 0.98 . . . . 0.0 111.266 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 29.6 mmt85 -62.39 -39.84 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.477 0.711 . . . . 0.0 110.839 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -38.18 87.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.466 0.707 . . . . 0.0 110.045 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 59.1 m-85 -101.43 28.75 5.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.239 0.615 . . . . 0.0 112.019 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 t -80.98 83.25 6.74 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 171.22 -39.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.884 1.274 . . . . 0.0 108.268 -161.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 23.4 p -114.92 127.44 55.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.843 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.61 100.47 6.15 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.295 0.638 . . . . 0.0 109.598 -171.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.626 ' HA ' HD23 ' A' ' 61' ' ' LEU . 45.9 mt -74.05 127.6 35.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.338 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.04 121.15 13.45 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.111 0.882 . . . . 0.0 109.377 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 69.28 12.59 8.42 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.944 1.298 . . . . 0.0 112.056 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.27 -134.17 42.51 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.82 -19.57 64.2 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.489 0.716 . . . . 0.0 112.309 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -73.74 -16.93 61.16 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.149 0.58 . . . . 0.0 112.091 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.63 -6.39 76.98 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 123.533 0.52 . . . . 0.0 112.424 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 59' ' ' VAL . 51.5 mt -92.05 123.69 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 110.686 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -132.4 105.62 7.39 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.926 1.29 . . . . 0.0 109.366 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -68.6 143.65 54.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.3 93.75 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.1 134.4 37.72 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.635 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p -75.64 -172.03 1.74 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.53 0.732 . . . . 0.0 110.95 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.2 -20.4 66.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -91.4 0.98 57.44 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.851 0.86 . . . . 0.0 110.396 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.22 71.04 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -107.94 134.49 20.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.493 0.717 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.54 121.34 9.87 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.562 2.175 . . . . 0.0 111.179 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.0 p -73.04 -8.85 57.59 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.8 0.84 . . . . 0.0 112.224 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.15 54.81 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -109.15 154.22 22.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.498 1.119 . . . . 0.0 109.535 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.07 169.43 21.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 110.469 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.03 127.55 53.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.797 1.239 . . . . 0.0 109.125 165.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 43' ' ' ILE . 55.3 t -118.12 119.75 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG2' HG22 ' A' ' 12' ' ' VAL . 44.0 mt-10 -79.87 146.47 32.18 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 36' ' ' ILE . 71.8 mt -136.13 136.55 40.17 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.04 -10.59 41.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -167.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.442 ' OG ' ' HG2' ' A' ' 66' ' ' GLU . 97.1 p -153.51 161.42 42.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.324 0.649 . . . . 0.0 110.433 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 37.1 tt0 -71.41 -16.93 62.42 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.454 0.702 . . . . 0.0 111.056 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.41 -48.66 55.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 41.3 mm-40 -54.08 -34.99 61.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 123.831 0.707 . . . . 0.0 111.829 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 37.6 t -60.75 -49.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.05 0.54 . . . . 0.0 110.738 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 92.3 mttt -59.76 -36.75 77.29 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.584 0.754 . . . . 0.0 112.167 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 93.6 mt -63.48 -43.99 95.71 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.43 0.692 . . . . 0.0 111.444 174.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.6 -46.8 86.24 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.004 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 87' ' ' LYS . 82.6 mt -62.77 -30.67 71.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.301 1.041 . . . . 0.0 112.984 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 20.0 ptmt -78.67 -13.01 60.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 120.72 0.295 . . . . 0.0 110.783 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.22 3.78 54.79 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.831 0.852 . . . . 0.0 111.08 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 90.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.384 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 164.44 -52.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.863 1.265 . . . . 0.0 111.224 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.83 169.97 16.85 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.435 0.636 . . . . 0.0 112.674 -165.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -113.12 139.23 48.9 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.371 -162.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -103.15 67.54 0.94 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.947 1.299 . . . . 0.0 108.859 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.15 58.12 3.26 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.799 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.0 m80 72.62 -7.71 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.684 1.594 . . . . 0.0 112.763 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 23.0 mmt180 -77.98 104.87 8.81 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -66.16 112.38 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.51 133.26 47.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.96 130.43 55.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 108.86 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.93 116.27 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.47 137.7 54.79 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 71' ' ' LEU . 77.9 tttt -67.2 136.28 54.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -121.3 155.96 33.58 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.063 0.945 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.413 ' HB2' ' H ' ' A' ' 92' ' ' GLU . 23.2 m120 -91.58 158.68 16.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.3 175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -66.07 -30.71 71.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -44.5 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.885 1.274 . . . . 0.0 110.643 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 96' ' ' VAL . 55.1 tt0 -69.53 -45.55 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.234 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 58.1 ttp -55.44 -45.88 76.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.785 0.834 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.73 -51.86 68.17 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.367 1.067 . . . . 0.0 110.183 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -56.09 -53.52 56.06 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.079 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 92' ' ' GLU . 38.2 t -74.43 -36.34 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.33 0.652 . . . . 0.0 112.195 -169.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.26 -33.62 71.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.645 0.26 . . . . 0.0 110.899 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -89.65 -24.47 21.63 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.767 0.827 . . . . 0.0 111.362 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.5 t60 . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 124.421 1.088 . . . . 0.0 108.153 -177.651 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.239 0.542 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 t -108.43 139.04 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 109.861 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.5 178.36 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.514 0.726 . . . . 0.0 110.025 167.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -134.95 125.39 26.56 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.01 129.13 69.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 124.068 0.947 . . . . 0.0 108.806 -166.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.563 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -123.1 153.1 40.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.345 1.058 . . . . 0.0 108.178 -172.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.15 22.52 35.03 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.68 110.82 47.84 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.96 150.65 22.78 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.893 2.395 . . . . 0.0 113.468 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.7 p90 -55.31 -31.49 61.69 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 111.632 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 t -108.78 24.92 12.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.636 0.775 . . . . 0.0 111.128 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -78.96 176.88 9.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.446 0.698 . . . . 0.0 110.23 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.625 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 44.9 t -128.63 152.26 48.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.458 0.703 . . . . 0.0 109.396 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.29 70.18 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.056 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.61 -42.13 82.68 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.92 0.888 . . . . 0.0 112.081 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.625 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 32.7 mm-40 -64.09 -45.28 89.38 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.755 0.659 . . . . 0.0 110.496 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' HB ' HD13 ' A' ' 43' ' ' ILE . 43.8 t -68.99 -38.13 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.732 0.813 . . . . 0.0 110.495 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.52 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 24.7 tm0? -63.91 -51.54 64.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.136 0.974 . . . . 0.0 110.033 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 -63.33 -41.39 98.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.848 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.1 -40.92 95.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.827 0.851 . . . . 0.0 111.053 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 47.0 m-85 -88.06 37.05 0.79 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.777 0.831 . . . . 0.0 111.44 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 t -77.04 82.2 3.55 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 172.23 -39.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.265 1.426 . . . . 0.0 107.871 -162.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.29 169.91 8.27 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.269 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 31.3 mmmt -117.82 85.87 2.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HA ' HD23 ' A' ' 61' ' ' LEU . 32.7 mt -65.28 126.18 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -42.31 -68.21 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.928 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -104.53 41.3 1.34 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.159 0.584 . . . . 0.0 110.477 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.77 -137.17 36.37 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB2' ' HG3' ' A' ' 28' ' ' GLN . . . -70.0 -4.59 21.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 117.739 0.77 . . . . 0.0 112.375 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -83.52 -1.5 53.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.218 0.607 . . . . 0.0 111.326 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.04 5.29 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.426 HD13 ' HB ' ' A' ' 27' ' ' VAL . 69.0 mt -131.86 105.31 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.038 0.935 . . . . 0.0 109.218 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.2 95.34 5.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.327 1.051 . . . . 0.0 110.318 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.08 124.15 21.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.566 HD12 ' HG3' ' A' ' 56' ' ' GLU . 71.1 mt -70.97 90.98 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -76.73 142.6 40.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.855 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.2 p -75.9 -177.09 3.68 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.842 0.857 . . . . 0.0 110.084 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.8 -8.97 48.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.7 14.1 22.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.97 0.908 . . . . 0.0 110.294 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.35 36.25 91.38 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -114.15 134.42 22.21 Favored Pre-proline 0 N--CA 1.484 1.243 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.794 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.71 127.52 22.85 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.293 1.995 . . . . 0.0 110.953 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 t -81.28 21.88 0.72 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.864 0.866 . . . . 0.0 111.565 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.26 -6.62 75.34 Favored Glycine 0 C--N 1.353 1.514 0 C-N-CA 123.186 0.422 . . . . 0.0 112.966 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG3' HD12 ' A' ' 46' ' ' ILE . 11.7 pt-20 -139.32 169.77 17.17 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.41 28.15 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.81 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -108.47 136.64 47.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.95 114.94 44.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.94 148.16 32.74 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 36' ' ' ILE . 77.1 mt -133.62 170.94 14.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.757 0.823 . . . . 0.0 110.205 -173.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.79 -39.47 61.7 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.02 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 t -160.42 174.11 14.61 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.32 -13.3 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.928 0.491 . . . . 0.0 111.596 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.81 -40.93 88.23 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.679 0.752 . . . . 0.0 109.706 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 35' ' ' LYS . 6.6 mp0 -62.29 -40.96 97.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.91 169.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 58.0 t -60.47 -53.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 123.526 0.516 . . . . 0.0 110.93 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.34 -39.03 66.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.406 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 94.8 mt -73.79 -36.01 64.97 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.262 0.625 . . . . 0.0 111.663 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -57.21 -49.29 76.45 Favored 'General case' 0 CA--C 1.55 0.977 0 O-C-N 123.799 0.687 . . . . 0.0 109.875 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 42.7 mt -59.74 -44.56 93.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.622 0.769 . . . . 0.0 111.644 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 1.7 pptp? -70.64 -26.28 63.39 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.564 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -90.08 20.46 4.28 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.041 -178.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.88 -23.32 55.6 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.78 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -57.81 -43.6 85.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.761 0.824 . . . . 0.0 110.892 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.45 178.61 5.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.521 1.128 . . . . 0.0 113.361 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 p -112.88 136.74 52.19 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.678 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.6 tpt -57.54 -66.2 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.214 1.006 . . . . 0.0 109.546 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.55 -33.95 0.47 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 164.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -146.46 -46.06 0.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.904 0.882 . . . . 0.0 109.083 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -61.85 135.22 57.49 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.7 0.8 . . . . 0.0 110.759 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 126.72 31.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.32 116.64 28.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -95.57 117.28 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB1' ' A' ' 70' ' ' ALA . 23.2 t -115.98 114.85 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -108.76 132.96 53.46 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.178 0.991 . . . . 0.0 109.878 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -59.96 110.61 1.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.078 0.951 . . . . 0.0 109.91 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 m -116.37 -168.26 1.41 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.385 0.674 . . . . 0.0 110.542 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -140.26 156.87 46.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.544 1.137 . . . . 0.0 108.587 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -71.22 -32.17 68.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 0.0 109.949 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -55.66 -47.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.171 0.988 . . . . 0.0 109.909 170.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -68.2 -49.78 58.6 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.115 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -54.35 -49.28 70.15 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.589 1.155 . . . . 0.0 111.24 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.68 -42.11 95.59 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.009 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -63.51 -37.24 86.55 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 124.163 0.914 . . . . 0.0 110.809 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.1 t -78.3 -30.15 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 122.83 0.452 . . . . 0.0 111.435 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.77 -16.68 61.16 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.397 -0.815 . . . . 0.0 111.083 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -94.11 -33.59 13.29 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.855 0.862 . . . . 0.0 110.633 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.1 t60 . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.694 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HA ' HG21 ' A' ' 67' ' ' VAL . 1.7 p90 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 93' ' ' MET . 26.1 t -99.95 132.65 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.36 167.78 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.376 1.07 . . . . 0.0 110.57 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -117.14 126.47 52.86 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 5.1 t -106.13 108.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 107.974 -173.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -119.16 142.45 47.94 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 124.595 1.158 . . . . 0.0 108.939 -167.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.91 27.87 15.38 Favored Glycine 0 N--CA 1.473 1.129 0 CA-C-O 121.627 0.571 . . . . 0.0 111.753 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.42 143.05 33.65 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 123.853 0.861 . . . . 0.0 109.132 174.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 31.0 Cg_endo -63.92 146.1 91.01 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.916 1.744 . . . . 0.0 110.645 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.627 ' HE1' ' HB3' ' A' ' 52' ' ' ARG . 83.6 t90 -52.41 -45.96 66.1 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.248 1.019 . . . . 0.0 111.212 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 p -92.99 35.28 1.06 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.432 1.093 . . . . 0.0 112.03 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.458 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 14.2 p -73.65 -170.87 0.92 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.224 0.61 . . . . 0.0 110.622 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.593 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 46.4 m -146.46 154.55 41.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.013 0.925 . . . . 0.0 109.012 173.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.25 -38.05 79.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.694 0.798 . . . . 0.0 111.457 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.99 -38.77 87.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.686 0.794 . . . . 0.0 111.371 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 34.2 mm-40 -67.61 -40.86 84.69 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.404 0.681 . . . . 0.0 110.855 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.53 -35.55 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.527 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.34 -45.97 92.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.473 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -63.57 -36.96 85.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.089 0.556 . . . . 0.0 110.901 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -60.13 -39.78 87.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.905 0.482 . . . . 0.0 110.289 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 67.9 m-85 -90.03 40.17 0.99 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.14 0.576 . . . . 0.0 111.792 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 p -74.51 87.22 2.09 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 166.4 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.339 2.256 . . . . 0.0 106.697 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.9 m -89.08 127.76 35.72 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.956 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 94.71 2.96 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 61' ' ' LEU . 18.5 mt -74.93 147.91 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.855 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -39.24 -68.54 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.906 1.682 . . . . 0.0 112.323 -172.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -128.57 51.02 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.05 -128.07 33.62 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.193 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.8 66.86 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.715 0.758 . . . . 0.0 112.031 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.33 -17.38 60.26 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.879 0.472 . . . . 0.0 111.413 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 29.25 9.33 Favored Glycine 0 C--N 1.351 1.393 0 O-C-N 123.266 0.353 . . . . 0.0 112.287 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 59' ' ' VAL . 52.7 mt -130.37 131.38 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.149 1.38 . . . . 0.0 108.3 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 103.58 4.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.58 0.752 . . . . 0.0 109.563 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -69.06 145.7 53.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.276 0.63 . . . . 0.0 110.263 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 56' ' ' GLU . 45.7 mt -73.7 91.34 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -78.47 146.72 34.27 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.784 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -84.79 -178.83 6.96 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.147 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -75.07 5.17 5.58 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.594 0.358 . . . . 0.0 111.945 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -102.6 -4.64 24.91 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.532 0.733 . . . . 0.0 109.756 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.6 37.95 38.97 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.418 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.627 ' HB3' ' HE1' ' A' ' 20' ' ' TRP . 76.0 mtt180 -120.48 130.68 24.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.983 -173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.7 132.23 41.75 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.083 2.522 . . . . 0.0 112.171 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 p -79.29 12.51 2.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.161 0.985 . . . . 0.0 113.021 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 -6.69 83.38 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' HD12 ' A' ' 46' ' ' ILE . 5.0 pt-20 -133.76 163.08 30.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.0 0.92 . . . . 0.0 111.579 175.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 167.96 24.68 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.687 -170.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -118.8 111.79 18.89 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.845 0.858 . . . . 0.0 110.315 171.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 43' ' ' ILE . 44.4 t -96.53 146.67 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.46 1.104 . . . . 0.0 108.181 171.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HG3' HG22 ' A' ' 12' ' ' VAL . 35.4 tt0 -126.72 144.09 51.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 36' ' ' ILE . 50.8 mt -129.38 146.3 51.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.356 0.662 . . . . 0.0 109.601 -167.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -72.9 -19.05 61.35 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.6 m -147.7 151.47 36.17 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.693 0.797 . . . . 0.0 109.119 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.81 -3.68 51.95 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 120.802 0.334 . . . . 0.0 111.628 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.26 -50.07 73.19 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.36 -31.56 65.89 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.359 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.568 HG21 ' HA ' ' A' ' 11' ' ' PHE . 53.2 t -66.14 -41.85 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.163 0.585 . . . . 0.0 110.679 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -57.22 -41.06 78.75 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.739 0.416 . . . . 0.0 110.904 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 mt -68.95 -32.58 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.634 0.774 . . . . 0.0 111.043 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.1 -52.55 33.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.951 0.901 . . . . 0.0 110.845 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 76.0 mt -61.03 -28.2 68.88 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.663 1.185 . . . . 0.0 111.387 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.0 -25.28 66.23 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.48 1.112 . . . . 0.0 110.8 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 67.3 mttm -83.76 6.92 19.44 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.186 0.994 . . . . 0.0 113.503 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.47 -2.47 0.5 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -121.01 -24.39 5.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.343 0.657 . . . . 0.0 111.889 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' A' ' 73' ' ' LYS . 6.6 mm-40 -59.26 148.53 31.58 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.6 p -98.66 126.98 44.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.841 0.856 . . . . 0.0 110.535 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -68.95 -78.48 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.93 89.42 0.29 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 170.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.6 m80 76.35 -54.35 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.056 1.742 . . . . 0.0 111.284 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -70.18 147.16 50.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.923 0.889 . . . . 0.0 111.396 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.25 142.31 28.66 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 108.681 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.0 t -120.14 131.13 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.516 0.726 . . . . 0.0 109.824 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.8 141.84 28.16 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.391 1.477 . . . . 0.0 108.562 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.61 123.25 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -125.1 146.73 49.33 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.332 1.053 . . . . 0.0 108.814 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HE2' HG11 ' A' ' 67' ' ' VAL . 39.9 ttmt -68.53 120.73 15.05 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.778 0.323 . . . . 0.0 110.491 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.1 m -86.54 -61.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.833 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.1 t30 83.31 148.07 0.08 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.883 1.673 . . . . 0.0 108.54 -163.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -57.92 -34.33 69.73 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.395 1.078 . . . . 0.0 112.408 -173.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.9 -41.96 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.755 0.822 . . . . 0.0 110.368 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -67.6 -43.67 79.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.777 0.831 . . . . 0.0 110.612 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.488 ' HB2' HG11 ' A' ' 12' ' ' VAL . 16.4 tmm? -54.23 -53.13 57.79 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.061 0.85 . . . . 0.0 110.918 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.6 -51.6 66.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.032 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -63.99 -51.95 61.87 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.122 0.969 . . . . 0.0 111.808 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.88 -48.66 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.429 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.99 -43.14 83.73 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.682 0.614 . . . . 0.0 110.18 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -70.96 -6.48 38.99 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 112.017 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.804 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.49 133.58 7.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' ' 70' ' ' ALA . 27.2 m -108.36 163.73 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.319 0.581 . . . . 0.0 110.427 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -122.15 126.56 48.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 24.1 t -110.15 126.23 67.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 124.672 1.189 . . . . 0.0 108.673 -168.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -133.52 135.48 44.43 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.19 10.2 Favored Glycine 0 N--CA 1.47 0.94 0 O-C-N 123.427 0.454 . . . . 0.0 112.202 -168.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 88.0 mt -87.18 125.45 66.03 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.01 153.65 56.35 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.005 1.803 . . . . 0.0 111.615 171.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -54.99 -46.65 75.15 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.408 0.683 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -86.15 17.16 3.76 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.443 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 18' ' ' LEU . 18.8 p -86.98 137.98 31.9 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 t -89.27 163.71 15.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.298 0.639 . . . . 0.0 110.202 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.63 -39.91 71.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.631 0.773 . . . . 0.0 110.873 172.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.43 -38.19 88.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 0.0 111.992 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -66.77 -43.11 84.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.984 0.514 . . . . 0.0 110.908 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.43 -38.7 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.648 0.779 . . . . 0.0 110.069 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.487 ' HG3' HD12 ' A' ' 36' ' ' ILE . 50.3 tt0 -69.42 -40.08 77.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.678 0.791 . . . . 0.0 110.213 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -58.26 -47.44 83.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.252 1.021 . . . . 0.0 110.064 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.29 -43.78 98.3 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 38.7 m-85 -87.5 29.59 0.87 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.052 0.941 . . . . 0.0 112.191 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.8 m -80.31 90.53 5.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 167.45 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.126 1.771 . . . . 0.0 107.014 -167.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 32.0 p -85.57 130.67 34.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.443 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -74.15 90.39 2.04 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 HD12 ' HG3' ' A' ' 28' ' ' GLN . 16.9 mt -68.96 129.69 33.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -48.73 -58.44 4.76 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.61 1.194 . . . . 0.0 113.382 -160.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.09 41.14 3.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.204 0.602 . . . . 0.0 109.614 170.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.14 -128.63 28.44 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.67 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.68 63.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.67 0.788 . . . . 0.0 112.853 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.4 -21.18 63.79 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.704 0.402 . . . . 0.0 110.554 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.35 36.69 4.21 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 123.259 0.457 . . . . 0.0 112.131 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.29 108.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 73.6 mtt-85 -118.07 92.61 3.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -166.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -68.67 135.46 51.4 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -74.46 93.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.94 132.95 34.72 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.4 p -82.23 -176.0 5.96 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.679 0.792 . . . . 0.0 110.906 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -68.74 -14.0 62.74 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.18 0.592 . . . . 0.0 111.663 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -87.26 -14.49 40.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.501 0.72 . . . . 0.0 110.39 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.91 26.05 46.84 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.009 -171.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -100.98 125.71 37.42 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.56 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.86 129.14 19.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.914 1.743 . . . . 0.0 109.866 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -75.89 -3.87 37.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.951 0.9 . . . . 0.0 112.019 -172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 6.01 77.66 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 44.8 mt-10 -115.51 150.62 36.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.2 1.0 . . . . 0.0 109.829 173.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.25 161.67 39.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.047 0.939 . . . . 0.0 110.047 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 93.9 m-85 -109.83 105.35 14.52 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.48 102.41 13.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -78.38 132.57 37.42 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.343 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.75 152.11 37.72 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.752 0.421 . . . . 0.0 110.925 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.87 -35.9 79.35 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.48 1.112 . . . . 0.0 112.502 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.517 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 17.3 m -142.17 152.35 43.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.577 -169.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -67.08 -25.79 66.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.793 0.837 . . . . 0.0 112.46 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.58 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 6.1 p-10 -73.05 -36.79 66.98 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 68.7 mm-40 -54.49 -39.09 67.21 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 167.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 88.1 t -67.3 -53.4 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.604 0.761 . . . . 0.0 111.733 -175.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 18.1 ptpt -55.22 -38.54 68.57 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.647 0.592 . . . . 0.0 112.019 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.8 mt -71.81 -36.69 70.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.861 0.864 . . . . 0.0 111.18 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -62.25 -36.58 82.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.021 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD11 ' HE3' ' A' ' 87' ' ' LYS . 64.0 mt -64.98 -32.32 73.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.882 0.473 . . . . 0.0 111.046 173.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 57.8 mttm -78.75 -17.1 56.35 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.389 0.676 . . . . 0.0 110.489 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 60.8 tttp -80.97 -1.3 43.16 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 0.0 111.162 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.18 -17.32 52.43 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.942 0.897 . . . . 0.0 112.732 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -86.41 -37.69 18.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.711 0.804 . . . . 0.0 111.221 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.59 157.13 24.6 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -101.16 133.67 45.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.811 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.616 ' HB2' HG21 ' A' ' 83' ' ' VAL . 25.3 ttt -61.19 -70.31 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.567 0.542 . . . . 0.0 110.147 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.27 -40.37 0.55 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 172.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -150.29 -46.53 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.718 0.807 . . . . 0.0 109.306 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -61.07 140.2 57.91 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.899 0.879 . . . . 0.0 110.744 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -81.54 125.54 30.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.616 HG21 ' HB2' ' A' ' 78' ' ' MET . 67.8 t -106.91 107.66 23.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.03 137.73 35.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.675 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.26 119.17 53.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.599 -165.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -115.57 140.51 49.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.574 1.15 . . . . 0.0 108.657 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' HE3' HD11 ' A' ' 71' ' ' LEU . 29.3 ttmt -62.23 123.16 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.882 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.9 p -110.93 -172.62 2.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.551 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -145.29 169.07 18.97 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.8 -44.3 97.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.46 -46.21 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.68 0.792 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 96' ' ' VAL . 38.2 tt0 -65.13 -53.92 37.75 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.799 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.09 -37.62 85.74 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 122.636 0.374 . . . . 0.0 111.623 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.47 -45.83 91.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.637 0.375 . . . . 0.0 110.649 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -63.81 -53.68 46.96 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.047 0.842 . . . . 0.0 111.733 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 92' ' ' GLU . 61.5 t -67.43 -37.84 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.462 0.705 . . . . 0.0 111.202 -170.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.5 -41.61 65.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.626 0.37 . . . . 0.0 111.249 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -75.81 -32.27 59.76 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.659 0.384 . . . . 0.0 110.971 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.291 0.636 . . . . 0.0 110.965 -175.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 121.833 0.825 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.6 142.36 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.39 1.476 . . . . 0.0 107.097 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.46 HG12 HG13 ' A' ' 67' ' ' VAL . 32.6 m -108.4 -176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.95 0.5 . . . . 0.0 110.449 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -144.8 144.44 31.16 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 t -118.37 136.3 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.867 1.267 . . . . 0.0 107.885 -168.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 137.69 47.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.01 15.91 8.84 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.27 122.0 57.15 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.39 166.13 26.55 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 122.077 1.851 . . . . 0.0 112.356 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -28.6 66.26 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.469 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.1 p -89.74 7.32 37.44 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.16 0.984 . . . . 0.0 112.974 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 p -71.63 167.52 19.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.835 0.743 . . . . 0.0 111.993 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 23.4 m -120.67 148.96 43.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.856 0.862 . . . . 0.0 109.81 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.4 67.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.168 0.587 . . . . 0.0 111.239 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 33.1 t70 -54.94 -49.89 70.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 23' ' ' SER . 12.3 pt-20 -72.91 -35.58 67.11 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.823 -174.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.46 -35.04 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.54 ' HG3' HD12 ' A' ' 36' ' ' ILE . 34.6 tt0 -72.93 -29.69 63.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 67.0 mtt180 -68.61 -33.81 74.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.017 0.527 . . . . 0.0 110.82 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -68.95 -26.72 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.118 0.567 . . . . 0.0 110.098 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -110.46 26.66 10.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.654 0.782 . . . . 0.0 111.267 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 29' ' ' ARG . 10.7 t -83.18 84.85 7.33 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HB3' ' HZ1' ' A' ' 73' ' ' LYS . 24.8 t70 159.82 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.625 1.57 . . . . 0.0 107.684 -159.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.1 m -82.63 175.86 9.83 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.295 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 3.6 mppt? -130.89 98.88 4.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 28' ' ' GLN . 16.7 mt -82.15 134.34 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.477 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -82.01 34.44 0.41 Allowed 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 124.175 0.99 . . . . 0.0 111.831 -168.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 173.29 -7.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.497 1.519 . . . . 0.0 110.523 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.6 17.7 Favored Glycine 0 C--N 1.359 1.814 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.68 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.47 72.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.248 0.619 . . . . 0.0 111.184 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.69 -13.31 60.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.57 -176.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.35 -12.14 61.78 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 116.746 -0.206 . . . . 0.0 112.808 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 mt -81.64 90.16 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 18.3 tpp180 -84.25 92.24 7.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.412 -171.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.88 127.12 31.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.799 0.44 . . . . 0.0 110.706 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 56' ' ' GLU . 41.9 mt -71.25 96.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 41.0 m-85 -82.92 133.96 35.09 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -77.27 -170.83 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.175 0.922 . . . . 0.0 111.691 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -55.06 -28.72 54.47 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.094 0.958 . . . . 0.0 112.138 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -104.17 4.13 33.69 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.575 0.75 . . . . 0.0 110.272 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 47' ' ' TYR . . . 73.89 32.89 58.38 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 114.002 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -94.92 141.63 23.55 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.759 0.824 . . . . 0.0 109.746 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.31 110.32 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.938 1.759 . . . . 0.0 109.681 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.4 t -63.25 -8.2 7.8 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.608 1.163 . . . . 0.0 113.165 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -14.83 51.91 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.537 ' HB2' HD12 ' A' ' 46' ' ' ILE . 40.0 mt-10 -121.65 159.73 25.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.369 1.068 . . . . 0.0 111.642 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.26 149.98 27.54 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.181 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.49 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 98.5 m-85 -91.54 155.57 18.29 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -136.06 109.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -78.85 119.26 21.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 109.407 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -116.09 154.43 29.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.339 0.655 . . . . 0.0 110.296 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.1 -30.25 70.72 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 111.393 -175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 162.98 39.98 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.82 0.848 . . . . 0.0 110.472 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.49 -13.88 62.3 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 122.946 0.499 . . . . 0.0 111.497 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t70 -60.07 -53.4 58.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 2.1 mp0 -59.5 -32.68 70.51 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.321 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 13' ' ' VAL . 54.4 t -61.85 -49.52 83.9 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 123.647 0.592 . . . . 0.0 110.332 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -53.02 -44.04 67.0 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 64.5 mt -60.88 -46.91 88.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.493 0.717 . . . . 0.0 110.099 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -59.4 -46.55 88.38 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.741 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 95.3 mt -57.12 -35.83 69.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.686 1.195 . . . . 0.0 111.792 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -77.3 -18.55 57.42 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.875 0.47 . . . . 0.0 111.654 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HZ1' ' HB3' ' A' ' 33' ' ' ASP . 90.4 mttt -88.61 6.99 35.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.1 0.56 . . . . 0.0 110.938 175.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 p-10 -65.53 -15.61 62.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.989 0.515 . . . . 0.0 111.642 173.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.26 -31.11 17.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.066 0.946 . . . . 0.0 110.925 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.12 151.92 34.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.672 0.789 . . . . 0.0 112.294 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -116.37 130.69 56.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.125 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 89.7 mmm -79.31 83.18 5.37 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.81 -96.47 2.1 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -170.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -126.01 3.73 7.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.813 0.845 . . . . 0.0 110.031 168.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 83' ' ' VAL . 20.3 mmt180 -70.93 110.39 5.62 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -70.2 109.48 4.67 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 81' ' ' ARG . 55.7 t -114.36 115.32 49.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 123.296 0.639 . . . . 0.0 109.487 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 2.1 pm0 -99.56 146.22 26.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.385 1.074 . . . . 0.0 109.724 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.599 HG11 ' HB1' ' A' ' 70' ' ' ALA . 45.4 t -129.89 124.74 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -107.67 178.39 4.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.716 1.206 . . . . 0.0 108.235 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -106.94 127.7 53.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -113.67 -164.54 0.93 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.216 1.006 . . . . 0.0 110.883 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -147.18 159.99 42.98 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.07 -35.78 81.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 0.0 109.835 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.05 -41.81 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.641 0.776 . . . . 0.0 110.162 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.51 -44.15 97.07 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 44.3 ttp -58.96 -36.2 74.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.107 0.963 . . . . 0.0 110.532 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.1 -55.73 19.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.102 0.561 . . . . 0.0 110.951 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -63.86 -31.65 72.9 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.971 0.908 . . . . 0.0 112.525 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.87 -42.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.309 0.643 . . . . 0.0 110.999 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.74 -22.3 59.93 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.468 0.307 . . . . 0.0 111.175 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -91.61 -30.33 16.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.876 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 . . . . . 0 C--O 1.243 0.75 0 C-N-CA 123.691 0.796 . . . . 0.0 108.95 177.177 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.437 HG12 ' HB3' ' A' ' 88' ' ' SER . 37.4 t -145.71 143.27 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 70' ' ' ALA . 25.4 m -113.15 172.18 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 121.094 0.474 . . . . 0.0 111.966 169.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 40.8 mtpt -116.36 135.4 53.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.01 117.39 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 41.1 ttp180 -127.4 152.27 47.73 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.38 12.59 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -166.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.488 HD22 ' SG ' ' A' ' 22' ' ' CYS . 86.0 mt -97.53 134.04 22.98 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.308 1.043 . . . . 0.0 109.406 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.42 163.57 17.42 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.776 2.317 . . . . 0.0 112.606 168.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -74.35 -8.09 55.07 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.059 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -113.32 16.12 19.07 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.286 1.034 . . . . 0.0 111.278 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.488 ' SG ' HD22 ' A' ' 18' ' ' LEU . 52.0 t -67.19 155.48 38.7 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.924 0.489 . . . . 0.0 111.632 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.1 m -133.73 152.69 51.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.529 1.132 . . . . 0.0 110.555 -173.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.65 67.38 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.402 1.081 . . . . 0.0 112.788 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.91 -47.78 67.73 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.536 1.135 . . . . 0.0 113.47 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 23' ' ' SER . 13.7 pt-20 -72.19 -35.49 68.96 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.8 -46.38 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.157 0.583 . . . . 0.0 110.032 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.601 ' HG3' HD12 ' A' ' 36' ' ' ILE . 28.2 tt0 -63.95 -40.76 97.18 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.617 0.767 . . . . 0.0 111.341 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -57.87 -46.8 84.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.795 0.684 . . . . 0.0 110.866 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.17 -32.92 74.66 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.741 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.643 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 93.4 m-85 -105.34 35.96 2.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.925 0.89 . . . . 0.0 110.659 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -60.59 -27.6 67.85 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.524 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.55 -18.13 65.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.2 p -111.44 135.49 51.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.311 0.644 . . . . 0.0 109.958 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -75.56 96.0 3.44 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.601 HD12 ' HG3' ' A' ' 28' ' ' GLN . 43.9 mt -78.85 123.41 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.81 125.85 25.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.302 1.041 . . . . 0.0 110.971 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 60.74 23.15 13.07 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.177 1.391 . . . . 0.0 111.552 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.26 -134.96 45.5 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.379 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.48 -22.68 22.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.064 0.946 . . . . 0.0 113.274 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.05 -21.92 64.98 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.419 0.288 . . . . 0.0 110.875 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.405 ' HA2' ' NH1' ' A' ' 44' ' ' ARG . . . -77.73 -16.84 79.62 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.016 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 mt -86.64 119.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 109.633 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.405 ' NH1' ' HA2' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -123.0 97.55 5.49 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.163 0.985 . . . . 0.0 109.695 177.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -66.16 142.9 57.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.029 0.532 . . . . 0.0 109.724 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.586 HD12 ' HB2' ' A' ' 56' ' ' GLU . 23.6 mt -77.16 87.18 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -75.34 134.29 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.0 t -78.48 -175.54 4.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 3.4 tmm_? -68.94 -5.8 23.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.3 0.64 . . . . 0.0 110.973 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.531 ' H ' HG23 ' A' ' 48' ' ' THR . 37.6 mt-10 -100.31 -2.6 33.23 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.698 1.199 . . . . 0.0 110.96 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.95 36.81 31.07 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 115.072 0.789 . . . . 0.0 115.072 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -132.17 138.18 31.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.708 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.52 118.0 4.43 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.046 2.497 . . . . 0.0 111.695 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.8 p -93.3 40.25 1.06 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.72 0.808 . . . . 0.0 111.129 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.82 -37.23 3.58 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.0 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' HD12 ' A' ' 46' ' ' ILE . 36.5 mt-10 -110.13 161.56 15.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.803 0.811 . . . . 0.0 112.392 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.03 165.53 31.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.449 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -110.47 145.39 37.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 108.09 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 105.83 6.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -81.63 139.64 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 36' ' ' ILE . 74.8 mt -128.89 142.24 51.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.683 1.193 . . . . 0.0 109.283 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.29 -27.66 68.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.309 0.644 . . . . 0.0 111.54 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.5 m -136.52 150.44 48.65 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.17 0.588 . . . . 0.0 109.661 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 15.9 tt0 -77.68 -8.34 57.77 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 120.915 0.388 . . . . 0.0 111.201 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -65.39 -48.52 72.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.631 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 4.0 mm-40 -52.77 -38.29 60.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.668 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG22 HD12 ' A' ' 61' ' ' LEU . 66.7 t -64.22 -46.09 94.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 123.31 0.644 . . . . 0.0 110.411 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.7 mttt -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.384 0.674 . . . . 0.0 112.154 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.47 -50.22 70.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.89 0.876 . . . . 0.0 111.178 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -58.99 -45.29 91.0 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.144 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 85' ' ' VAL . 91.8 mt -56.05 -24.61 40.66 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.295 1.438 . . . . 0.0 113.425 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.18 -9.84 59.73 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.151 0.58 . . . . 0.0 112.005 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -90.52 6.08 45.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 111.356 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -57.88 -9.37 1.28 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.785 1.234 . . . . 0.0 113.69 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -116.63 -40.15 3.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.371 1.068 . . . . 0.0 111.11 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.41 163.67 15.28 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -105.41 130.82 53.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.067 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.442 ' HG3' HG21 ' A' ' 83' ' ' VAL . 53.4 mtp -64.83 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 163.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.03 -103.34 2.02 Favored Glycine 0 N--CA 1.468 0.777 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -96.01 -1.61 48.57 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.24 1.016 . . . . 0.0 109.344 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -106.19 133.54 50.72 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.926 0.89 . . . . 0.0 109.631 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -80.36 135.59 36.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 78' ' ' MET . 98.7 t -97.79 130.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 32.8 mt-10 -97.45 117.35 31.51 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.9 t -114.66 120.04 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -113.83 177.59 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -101.88 116.12 32.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.437 ' HB3' HG12 ' A' ' 12' ' ' VAL . 46.4 t -87.05 161.55 18.1 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.14 0.971 . . . . 0.0 110.503 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -127.99 158.21 38.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.005 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -64.84 -34.34 78.13 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.927 0.491 . . . . 0.0 110.759 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.53 -41.84 89.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 110.753 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.44 -56.3 7.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.961 177.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 44.9 ttm -52.11 -51.29 58.72 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 123.967 0.792 . . . . 0.0 111.72 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 28.3 t70 -62.42 -43.01 99.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 0.0 110.53 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -60.6 -38.59 85.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.143 0.577 . . . . 0.0 111.147 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 76.4 t -82.36 -30.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.702 0.801 . . . . 0.0 111.86 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 93' ' ' MET . 83.0 mt -75.69 -26.44 57.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.38 -0.825 . . . . 0.0 110.654 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 1.2 mptm? -90.09 -25.17 20.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.756 0.823 . . . . 0.0 111.082 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.5 m80 . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.022 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -143.1 131.0 21.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.902 0.881 . . . . 0.0 109.92 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 67.7 mtt -134.99 131.54 37.26 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.92 -45.09 12.59 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 172.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.404 ' HA3' ' HB2' ' A' ' 89' ' ' ASN . . . 167.97 167.08 28.1 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.086 -0.557 . . . . 0.0 112.592 175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.594 ' HA ' ' HE2' ' A' ' 87' ' ' LYS . 33.7 tt0 -69.74 104.4 2.42 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -154.5 171.47 32.96 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -89.81 7.91 34.64 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.736 0.815 . . . . 0.0 111.03 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.5 t -102.09 143.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.99 0.916 . . . . 0.0 109.184 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 61' ' ' LEU . 29.8 m -110.14 160.41 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.053 0.541 . . . . 0.0 110.758 162.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 87.4 tttt -109.13 121.41 45.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.3 t -107.84 111.72 37.05 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 3.7 tmt_? -121.96 140.67 52.17 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.21 18.27 29.41 Favored Glycine 0 N--CA 1.476 1.355 0 CA-C-N 118.2 0.454 . . . . 0.0 113.316 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.17 138.37 56.38 Favored Pre-proline 0 C--O 1.239 0.516 0 C-N-CA 123.356 0.662 . . . . 0.0 109.765 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.612 ' HG3' ' HA3' ' A' ' 79' ' ' GLY . 45.1 Cg_endo -64.79 146.52 88.44 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 122.346 2.031 . . . . 0.0 111.454 173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 36.5 m95 -64.37 -19.71 65.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.162 0.985 . . . . 0.0 110.62 175.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.7 p -90.7 4.75 50.62 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.394 1.078 . . . . 0.0 113.146 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 22.0 p -104.4 145.75 29.82 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 118.827 0.739 . . . . 0.0 111.13 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.5 m -105.81 178.52 4.54 Favored 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.763 1.225 . . . . 0.0 109.028 172.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.67 -31.49 62.43 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.441 0.696 . . . . 0.0 112.623 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -52.92 -47.34 68.08 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.181 0.993 . . . . 0.0 113.118 176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.88 -38.02 76.24 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.15 0.58 . . . . 0.0 111.592 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.9 t -71.61 -34.76 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.712 . . . . 0.0 110.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.597 ' HG3' HD12 ' A' ' 36' ' ' ILE . 44.2 tt0 -69.36 -41.31 76.72 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.312 176.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.2 tpt180 -63.09 -36.33 83.23 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.081 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -61.98 -43.83 98.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.015 0.526 . . . . 0.0 110.39 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 36' ' ' ILE . 79.6 m-85 -95.72 38.96 1.14 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 122.998 0.519 . . . . 0.0 110.515 176.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 41.7 t -59.76 -34.2 72.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.302 0.641 . . . . 0.0 111.248 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -79.22 5.96 10.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.05 0.94 . . . . 0.0 112.448 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.514 ' HB3' HD23 ' A' ' 61' ' ' LEU . 58.1 m -127.38 136.23 51.59 Favored 'General case' 0 C--O 1.243 0.752 0 C-N-CA 124.086 0.954 . . . . 0.0 110.07 -177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -80.36 98.46 7.48 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.597 HD12 ' HG3' ' A' ' 28' ' ' GLN . 61.8 mt -80.65 122.61 36.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.994 0.918 . . . . 0.0 109.687 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.7 126.42 27.53 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.213 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.2 t30 63.48 17.55 10.42 Favored 'General case' 0 CA--C 1.559 1.327 0 O-C-N 124.79 1.307 . . . . 0.0 111.89 173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.44 -136.16 47.53 Favored Glycine 0 C--N 1.359 1.829 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.239 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.71 -18.8 45.49 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -77.26 -21.03 54.33 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.967 0.507 . . . . 0.0 110.295 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.11 -21.13 76.59 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.255 0.347 . . . . 0.0 112.472 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.493 HG12 HG22 ' A' ' 59' ' ' VAL . 43.4 mt -91.27 127.75 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.568 0.747 . . . . 0.0 110.043 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.1 110.02 6.12 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.081 0.953 . . . . 0.0 110.008 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -66.48 140.09 57.99 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 173.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.3 mt -72.0 88.82 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -82.86 135.9 34.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.1 p -83.76 -178.17 6.93 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.856 0.862 . . . . 0.0 110.919 178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' O ' ' HD3' ' A' ' 49' ' ' ARG . 1.5 tmt_? -67.18 -16.73 64.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.161 0.584 . . . . 0.0 109.603 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HB2' ' HG2' ' A' ' 52' ' ' ARG . 13.4 mm-40 -84.36 1.56 44.53 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 123.742 0.817 . . . . 0.0 110.911 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.03 20.1 76.03 Favored Glycine 0 C--N 1.354 1.553 0 N-CA-C 114.231 0.452 . . . . 0.0 114.231 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HB2' ' A' ' 50' ' ' GLU . 19.4 ptp180 -126.74 141.3 39.94 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.335 0.654 . . . . 0.0 109.79 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.48 148.36 42.61 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.447 2.098 . . . . 0.0 111.523 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -75.65 -0.44 20.66 Favored 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 123.616 0.766 . . . . 0.0 111.749 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.25 9.54 81.83 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -170.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 37.7 mt-10 -119.63 155.61 31.99 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.685 1.194 . . . . 0.0 110.809 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.26 166.36 28.2 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.771 1.228 . . . . 0.0 110.313 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -120.33 120.9 37.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.484 1.113 . . . . 0.0 109.168 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 43' ' ' ILE . 68.9 t -106.71 123.67 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.122 0.969 . . . . 0.0 108.953 177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HG2' HG22 ' A' ' 12' ' ' VAL . 64.5 mt-10 -82.98 151.23 25.95 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 34' ' ' CYS . 4.6 mp -135.87 152.29 50.89 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.084 0.954 . . . . 0.0 109.312 -178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -65.84 -32.22 73.61 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.732 0.813 . . . . 0.0 111.805 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.485 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 42.0 m -144.96 155.62 43.51 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.531 0.332 . . . . 0.0 111.265 -171.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.96 -27.29 68.04 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.623 0.769 . . . . 0.0 110.431 177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -65.39 -47.57 75.9 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.485 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 47.2 mm-40 -54.62 -37.88 66.14 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.538 171.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 78.4 t -60.27 -46.06 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.077 0.551 . . . . 0.0 110.03 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.59 ' HD3' HD12 ' A' ' 71' ' ' LEU . 32.3 mmtp -60.99 -37.79 83.73 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.788 0.835 . . . . 0.0 112.552 175.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 85.9 mt -65.88 -31.94 73.16 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.502 0.721 . . . . 0.0 111.746 174.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -69.13 -44.04 73.18 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.255 171.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.59 HD12 ' HD3' ' A' ' 68' ' ' LYS . 96.8 mt -65.9 -26.12 67.47 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.14 0.976 . . . . 0.0 112.83 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 19.9 pttp -77.54 -16.88 58.41 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.105 0.411 . . . . 0.0 109.915 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -95.15 0.49 54.22 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.214 1.005 . . . . 0.0 111.032 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 75' ' ' ARG . 11.1 t70 -60.17 101.17 0.11 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.32 0.648 . . . . 0.0 110.238 168.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' ASP . 36.9 ttt180 150.64 -44.51 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 C-N-CA 127.115 2.166 . . . . 0.0 108.494 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -55.43 147.33 17.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.387 -1.279 . . . . 0.0 113.235 -167.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.6 p -89.11 120.03 30.15 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.518 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -124.64 125.0 43.42 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.342 1.057 . . . . 0.0 108.513 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.612 ' HA3' ' HG3' ' A' ' 19' ' ' PRO . . . 84.82 -50.31 4.38 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.451 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -179.04 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.77 1.228 . . . . 0.0 108.85 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.7 mtm180 -91.47 166.94 12.6 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.024 -0.989 . . . . 0.0 112.038 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -77.88 139.47 39.25 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 174.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.489 HG21 ' HB3' ' A' ' 78' ' ' MET . 53.1 t -112.05 129.51 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-O 121.16 0.505 . . . . 0.0 110.678 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -96.01 121.6 37.93 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.342 1.057 . . . . 0.0 109.196 173.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.7 t -110.0 112.81 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.579 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 59.8 m-85 -103.03 178.4 4.57 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 9' ' ' GLU . 87.8 tttt -110.35 120.5 42.65 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 14' ' ' LYS . 61.1 m -110.73 147.71 33.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 123.733 0.813 . . . . 0.0 111.275 -174.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.419 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 37.5 t-20 -91.54 155.28 18.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -56.53 -35.32 67.94 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.238 0.615 . . . . 0.0 110.169 173.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.11 -46.37 84.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.889 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.62 -52.11 48.81 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.458 0.474 . . . . 0.0 110.005 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.7 tmm? -49.63 -53.64 23.01 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.8 1.24 . . . . 0.0 111.367 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.0 -43.02 86.41 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.987 0.915 . . . . 0.0 111.679 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -74.13 -35.99 64.13 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.479 HG13 ' H ' ' A' ' 101' ' ' GLY . 43.6 t -82.99 -21.53 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.014 0.435 . . . . 0.0 110.502 -177.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.3 -40.76 64.28 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 170.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -77.13 -32.02 56.13 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.06 0.544 . . . . 0.0 111.295 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.3 t60 -144.14 89.6 2.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.1 t -56.41 94.15 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 121.886 0.85 . . . . 0.0 111.229 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' H ' HG13 ' A' ' 96' ' ' VAL . . . -160.4 114.23 0.6 Allowed Glycine 0 C--N 1.344 0.977 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.019 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.33 -0.01 9.92 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.822 2.348 . . . . 0.0 113.355 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.49 112.03 6.47 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.389 0.675 . . . . 0.0 109.928 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 53.9 p -70.43 149.16 95.68 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.259 1.024 . . . . 0.0 111.619 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.78 71.13 4.94 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 122.68 2.253 . . . . 0.0 111.309 174.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -72.69 107.58 5.23 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.45 -175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 83.2 m -145.1 107.91 4.48 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.978 0.911 . . . . 0.0 108.701 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -132.89 66.71 1.55 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.463 0.705 . . . . 0.0 109.135 177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -67.39 88.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.639 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -131.98 142.54 49.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.834 -0.981 . . . . 0.0 110.65 -178.596 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.245 0.831 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -58.13 118.65 5.67 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 23.3 ttt -64.59 135.56 56.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.103 0.561 . . . . 0.0 110.435 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.34 -121.52 6.36 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.599 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.28 135.02 1.1 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.56 28.79 0.46 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.496 0.718 . . . . 0.0 110.832 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 88' ' ' SER . . . -78.83 98.97 1.61 Allowed Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.053 176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -84.07 4.4 30.35 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.83 0.852 . . . . 0.0 110.498 171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG21 ' HE2' ' A' ' 93' ' ' MET . 39.1 t -112.28 138.02 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.527 1.131 . . . . 0.0 109.167 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.07 168.89 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.037 0.535 . . . . 0.0 110.635 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 60.2 tttt -116.84 123.38 46.94 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 83' ' ' VAL . 92.2 t -114.6 138.67 43.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 3.8 ptp180 -150.99 161.31 42.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.975 0.51 . . . . 0.0 109.633 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 94.17 18.45 36.57 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -169.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 79.3 mt -88.88 127.69 54.97 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 27.4 Cg_endo -61.19 161.5 22.8 Favored 'Trans proline' 0 CA--C 1.556 1.58 0 C-N-CA 122.232 1.955 . . . . 0.0 111.968 172.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.7 m-90 -71.66 -24.46 61.85 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.287 0.635 . . . . 0.0 111.176 -176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -82.45 -6.0 59.02 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.685 0.794 . . . . 0.0 111.404 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.438 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 44.2 t -76.08 120.41 21.35 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.102 0.561 . . . . 0.0 109.743 -177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 t -98.88 174.68 6.25 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.767 0.827 . . . . 0.0 109.186 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.17 -43.24 74.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.707 0.803 . . . . 0.0 112.41 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 17.4 t70 -60.53 -39.32 87.45 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.879 0.872 . . . . 0.0 111.787 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -59.53 -46.31 89.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.216 0.606 . . . . 0.0 111.083 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.498 ' HB ' HD13 ' A' ' 43' ' ' ILE . 58.4 t -71.68 -31.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.42 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' NE2' HD12 ' A' ' 36' ' ' ILE . 9.3 tp-100 -64.34 -42.81 96.06 Favored 'General case' 0 C--N 1.348 0.543 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.916 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 19.3 mmt180 -67.11 -38.11 85.06 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.695 0.398 . . . . 0.0 111.179 177.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -67.71 -29.66 68.96 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.034 0.534 . . . . 0.0 111.5 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.57 ' HB2' HD11 ' A' ' 36' ' ' ILE . 93.4 m-85 -115.38 35.02 4.57 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.61 0.764 . . . . 0.0 110.184 175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 t -59.51 -29.2 67.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.62 0.768 . . . . 0.0 113.01 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.77 -25.72 35.08 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.853 0.461 . . . . 0.0 110.614 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.3 m -78.58 126.79 31.24 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 10.4 mptt -79.24 87.75 4.94 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 31' ' ' PHE . 41.1 mt -76.86 132.79 32.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 CA-C-N 114.579 -1.191 . . . . 0.0 109.275 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.02 118.37 5.33 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.947 0.899 . . . . 0.0 110.425 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 63.52 23.02 13.46 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.155 0.982 . . . . 0.0 111.81 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -131.66 41.85 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 112.596 -178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.64 30.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 0.0 113.161 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -80.7 -10.45 59.73 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.198 0.599 . . . . 0.0 112.411 178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.93 36.3 4.35 Favored Glycine 0 C--N 1.345 1.028 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.498 HD13 ' HB ' ' A' ' 27' ' ' VAL . 71.2 mt -127.85 116.33 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.453 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 22.3 mmt180 -116.6 92.99 4.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.288 0.635 . . . . 0.0 110.251 -169.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 98.2 m-85 -71.23 127.85 33.93 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 mt -74.8 86.64 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 175.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -74.05 149.37 41.21 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.706 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -94.77 178.71 5.49 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.434 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -68.76 -8.85 46.87 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 122.846 0.458 . . . . 0.0 111.893 176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.55 -0.41 43.29 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.257 1.023 . . . . 0.0 109.916 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.36 28.41 59.92 Favored Glycine 0 C--N 1.353 1.477 0 CA-C-N 116.397 -0.365 . . . . 0.0 113.969 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -126.15 132.75 24.42 Favored Pre-proline 0 N--CA 1.483 1.188 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 53.5 Cg_endo -66.5 153.21 78.82 Favored 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.302 2.002 . . . . 0.0 111.568 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -78.41 6.11 9.16 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.56 0.744 . . . . 0.0 111.37 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.07 1.13 79.88 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -171.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 30.6 mt-10 -111.59 146.68 36.96 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.669 1.187 . . . . 0.0 110.806 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.58 31.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.55 1.14 . . . . 0.0 109.7 172.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 69.3 m-85 -102.61 117.74 35.34 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.9 t -98.46 110.78 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -77.39 136.46 38.42 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.562 1.145 . . . . 0.0 108.413 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.501 HD22 ' HB3' ' A' ' 66' ' ' GLU . 44.1 mt -135.76 137.58 41.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.448 0.699 . . . . 0.0 109.744 -169.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -68.87 -12.47 61.61 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -168.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 81.0 p -160.45 172.45 17.22 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.11 0.564 . . . . 0.0 109.99 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 3.0 tm-20 -68.5 -21.05 64.61 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.209 175.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -60.68 -46.79 89.02 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 118.235 0.471 . . . . 0.0 110.403 172.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HB3' HD22 ' A' ' 61' ' ' LEU . 1.1 mp0 -62.38 -32.5 73.32 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.53 173.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.2 t -62.47 -44.08 98.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 122.652 0.381 . . . . 0.0 110.028 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 82.2 mttt -54.63 -49.66 69.98 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.723 0.809 . . . . 0.0 110.649 172.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.6 mt -59.78 -35.44 74.65 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.354 1.062 . . . . 0.0 112.089 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.79 -44.75 69.46 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.031 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.75 -13.38 59.25 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.22 1.008 . . . . 0.0 112.254 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -68.16 -23.68 64.89 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 118.301 0.501 . . . . 0.0 110.697 171.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 76' ' ' GLU . 3.9 mptp? -88.03 -1.28 57.9 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.536 0.734 . . . . 0.0 112.069 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -32.28 -25.05 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 169.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -142.77 -6.4 0.88 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -57.81 143.18 43.2 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.525 0.73 . . . . 0.0 111.674 175.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.7 p -95.37 121.85 37.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.45 1.1 . . . . 0.0 111.86 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.16 114.35 27.68 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.184 0.993 . . . . 0.0 109.264 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.17 -89.81 0.17 Allowed Glycine 0 C--N 1.345 1.058 0 O-C-N 123.416 0.448 . . . . 0.0 112.999 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -130.77 -5.85 4.06 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.295 1.038 . . . . 0.0 110.523 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -117.49 154.05 32.1 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.236 0.614 . . . . 0.0 110.929 -172.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -82.04 143.5 31.5 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.583 171.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.462 HG13 HG13 ' A' ' 15' ' ' VAL . 69.4 t -109.02 120.48 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.474 0.71 . . . . 0.0 110.244 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -95.39 121.47 37.1 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.8 t -119.01 121.46 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.325 0.65 . . . . 0.0 109.984 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -118.93 149.94 40.74 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.711 0.805 . . . . 0.0 110.905 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -63.05 116.85 5.72 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.369 0.667 . . . . 0.0 110.146 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.492 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 15.6 m -125.67 -154.1 0.6 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -163.68 173.64 12.66 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.832 0.853 . . . . 0.0 109.889 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -64.06 -31.05 72.1 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.989 0.915 . . . . 0.0 110.432 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.1 t -65.92 -47.61 84.79 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.247 1.019 . . . . 0.0 110.346 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 33.3 tt0 -65.38 -47.97 74.52 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.286 1.034 . . . . 0.0 110.077 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.46 ' HE2' HG21 ' A' ' 12' ' ' VAL . 54.2 ttp -52.54 -44.6 65.88 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.463 1.102 . . . . 0.0 110.639 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -66.62 -45.95 77.45 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.434 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -60.54 -42.05 95.72 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.604 0.762 . . . . 0.0 112.3 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.08 -23.55 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 O-C-N 123.508 0.505 . . . . 0.0 110.827 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 90.0 mt -82.11 -23.74 35.52 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 121.98 -0.45 . . . . 0.0 111.138 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -80.33 -38.77 29.93 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.284 0.564 . . . . 0.0 109.971 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -140.98 90.37 2.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.483 1.113 . . . . 0.0 108.027 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.8 t -65.06 86.13 0.06 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 122.284 1.04 . . . . 0.0 110.449 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.53 -86.18 0.13 Allowed Glycine 0 C--N 1.342 0.869 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.155 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.4 92.82 0.19 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.928 2.419 . . . . 0.0 113.027 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.413 ' OD1' ' HG3' ' A' ' 92' ' ' GLU . 35.9 t30 -77.03 124.32 27.62 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 169.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.1 m 61.15 91.02 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.875 0 O-C-N 124.562 1.164 . . . . 0.0 108.91 -169.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.78 91.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.385 2.493 0 C-N-CA 123.639 2.892 . . . . 0.0 114.136 -171.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -102.02 132.98 47.55 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.6 t -48.46 -27.03 2.42 Favored 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.61 -177.52 6.74 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.252 0.621 . . . . 0.0 110.963 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -97.34 155.82 16.72 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.317 0.647 . . . . 0.0 111.278 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t70 66.44 95.34 0.06 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.769 1.228 . . . . 0.0 110.807 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.301 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.944 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.553 1.082 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -93.94 137.98 32.56 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.2 ttt -90.06 -51.52 5.42 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.84 42.84 15.77 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.422 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.21 -130.7 3.52 Favored Glycine 0 C--N 1.35 1.354 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -70.15 -50.22 42.64 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 173.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.88 63.25 4.14 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 111.685 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -61.34 -23.16 65.55 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.075 0.95 . . . . 0.0 112.159 -177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -93.94 133.49 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 123.741 0.816 . . . . 0.0 110.135 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.1 m -105.01 163.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.373 0.669 . . . . 0.0 109.944 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -108.05 127.18 53.56 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 175.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -119.49 140.05 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 124.107 0.963 . . . . 0.0 108.757 -175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.579 ' HB3' ' HG2' ' A' ' 56' ' ' GLU . 14.8 ptm180 -147.43 167.23 24.91 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.03 0.932 . . . . 0.0 109.262 174.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.91 18.71 62.74 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.61 155.24 91.72 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.854 0.862 . . . . 0.0 110.236 174.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.0 152.13 77.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.147 1.898 . . . . 0.0 111.22 169.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 39.2 p90 -56.18 -30.91 62.89 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.725 1.21 . . . . 0.0 112.098 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.4 p -104.21 25.52 9.96 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.503 1.121 . . . . 0.0 111.508 -177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.2 p -52.39 118.03 3.27 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.493 1.117 . . . . 0.0 112.811 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.432 ' HB3' ' HG3' ' A' ' 26' ' ' GLU . 46.8 t -104.18 152.2 22.43 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.29 -39.52 75.9 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.315 0.384 . . . . 0.0 111.003 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -49.51 -47.63 48.62 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.329 1.052 . . . . 0.0 112.695 170.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 23' ' ' SER . 45.3 mt-10 -65.43 -39.68 92.4 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.194 0.598 . . . . 0.0 111.265 -178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.525 ' HB ' HD13 ' A' ' 43' ' ' ILE . 61.1 t -68.55 -34.94 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.403 0.681 . . . . 0.0 110.077 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HA ' HD12 ' A' ' 36' ' ' ILE . 97.0 mt-30 -64.94 -49.75 69.15 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.769 0.827 . . . . 0.0 111.033 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.92 -37.17 81.35 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.51 0.507 . . . . 0.0 110.719 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -63.75 -43.76 95.5 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.027 0.531 . . . . 0.0 111.107 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HB2' HD11 ' A' ' 36' ' ' ILE . 59.5 m-85 -99.73 35.68 1.96 Allowed 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.624 0.77 . . . . 0.0 110.083 175.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -60.7 -24.81 65.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 118.355 0.525 . . . . 0.0 112.186 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.86 -47.7 68.18 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.992 0.917 . . . . 0.0 110.736 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' PHE . 61.3 m -79.77 130.69 35.55 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.385 0.612 . . . . 0.0 110.432 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 13.9 mmmm -78.44 91.2 4.48 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 31' ' ' PHE . 46.4 mt -69.74 111.0 3.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.516 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 33.6 tt0 -63.14 134.5 56.11 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.878 0.736 . . . . 0.0 110.458 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 65.37 10.14 6.29 Favored 'General case' 0 CA--C 1.557 1.248 0 O-C-N 124.654 1.221 . . . . 0.0 112.148 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.34 -128.04 44.91 Favored Glycine 0 C--N 1.353 1.516 0 C-N-CA 123.51 0.576 . . . . 0.0 112.716 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.03 64.75 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.855 0.862 . . . . 0.0 112.483 177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -73.8 -19.72 60.68 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.123 0.569 . . . . 0.0 111.644 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.99 -23.81 56.58 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-O 120.271 -0.183 . . . . 0.0 112.961 171.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.525 HD13 ' HB ' ' A' ' 27' ' ' VAL . 59.8 mt -83.35 119.36 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.266 0.627 . . . . 0.0 109.613 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.549 ' HG3' ' SD ' ' A' ' 93' ' ' MET . 21.0 mmt180 -127.29 94.71 4.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.481 -172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -71.79 135.86 46.86 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 56' ' ' GLU . 43.0 mt -75.91 92.3 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -84.26 134.49 34.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.429 ' OG1' ' HB2' ' A' ' 52' ' ' ARG . 59.7 p -90.84 -169.99 2.55 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.701 0.8 . . . . 0.0 110.442 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -64.71 -18.01 64.63 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -174.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -105.67 10.06 32.99 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 0.0 109.212 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.89 32.15 63.96 Favored Glycine 0 C--N 1.36 1.917 0 N-CA-C 112.024 -0.43 . . . . 0.0 112.024 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 12.0 mmp_? -101.27 125.49 37.7 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 123.591 0.756 . . . . 0.0 110.021 -172.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -58.08 116.89 3.56 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.666 2.244 . . . . 0.0 110.488 168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.9 t -83.52 18.13 1.97 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.678 0.791 . . . . 0.0 111.581 -172.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.1 30.19 Favored Glycine 0 C--N 1.354 1.559 0 C-N-CA 122.854 0.264 . . . . 0.0 113.033 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 31.8 mt-10 -112.3 150.15 31.39 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.455 1.102 . . . . 0.0 111.128 -174.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.55 153.9 39.03 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.527 1.131 . . . . 0.0 110.043 175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -106.14 110.31 22.53 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.051 0.941 . . . . 0.0 108.463 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -97.07 110.92 25.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.5 tt0 -79.76 135.99 36.64 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.9 mt -126.71 147.91 49.91 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.458 0.703 . . . . 0.0 110.032 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -67.06 -19.81 65.73 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.763 0.825 . . . . 0.0 112.917 -169.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 84.1 p -159.34 171.24 20.15 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.07 -23.75 67.26 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.999 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -60.81 -52.56 64.54 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.372 0.669 . . . . 0.0 110.157 176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 1.5 mp0 -60.25 -31.61 70.37 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 124.048 0.843 . . . . 0.0 112.894 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 80.4 t -61.44 -48.83 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 122.659 0.384 . . . . 0.0 110.158 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.529 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.8 mmpt? -50.98 -46.07 61.16 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.015 0.822 . . . . 0.0 111.753 174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.5 mt -63.06 -47.44 82.95 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.59 0.756 . . . . 0.0 110.846 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.06 87.18 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.021 0.928 . . . . 0.0 111.524 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -58.44 -38.44 77.47 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.148 0.979 . . . . 0.0 111.659 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -69.06 -19.97 64.09 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 123.63 0.581 . . . . 0.0 111.587 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -91.77 17.34 9.15 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.929 0.892 . . . . 0.0 112.329 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.93 23.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -142.86 -23.66 0.63 Allowed 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.751 0.705 . . . . 0.0 110.865 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -46.3 134.75 8.58 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.931 1.293 . . . . 0.0 112.02 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.6 p -91.26 131.64 36.65 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.782 0.833 . . . . 0.0 111.15 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.5 ttt -128.61 122.14 30.24 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.704 1.202 . . . . 0.0 109.415 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.14 -75.34 1.92 Allowed Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -145.33 -36.29 0.29 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.37 1.068 . . . . 0.0 110.1 175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -87.0 167.49 14.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -80.68 136.81 36.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 54.7 t -100.02 117.12 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.559 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 25.1 mt-10 -98.37 122.18 41.23 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.175 1.39 . . . . 0.0 108.508 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.0 t -118.94 123.64 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.444 0.697 . . . . 0.0 110.14 -172.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -111.06 179.09 4.14 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.464 1.506 . . . . 0.0 107.54 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -112.55 135.41 53.3 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' A' ' 92' ' ' GLU . 76.8 p -134.87 -149.56 0.35 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.65 0.78 . . . . 0.0 109.038 -178.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.87 169.42 24.45 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -61.36 -34.22 74.94 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.841 0.856 . . . . 0.0 111.276 175.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.6 t -65.7 -40.79 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.113 0.965 . . . . 0.0 110.168 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HG2' ' HB2' ' A' ' 88' ' ' SER . 4.7 tp10 -63.93 -50.36 68.97 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.409 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.549 ' SD ' ' HG3' ' A' ' 44' ' ' ARG . 45.3 ttm -54.95 -51.74 65.19 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.947 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -60.35 -45.87 91.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.621 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -52.58 -51.56 59.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.635 1.574 . . . . 0.0 111.004 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 92' ' ' GLU . 40.7 t -71.19 -33.13 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.091 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 44' ' ' ARG . 88.6 mt -69.38 -27.55 65.41 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.314 0.245 . . . . 0.0 111.042 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -69.05 -23.89 64.11 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.247 0.619 . . . . 0.0 111.752 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.453 ' HD2' HG22 ' A' ' 100' ' ' THR . 49.1 t60 -171.95 -71.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.501 0.72 . . . . 0.0 109.219 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 99' ' ' HIS . 8.9 t 179.26 -167.7 0.08 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.041 1.337 . . . . 0.0 108.709 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.07 65.44 1.28 Allowed Glycine 0 C--N 1.344 0.972 0 CA-C-O 119.226 -0.764 . . . . 0.0 113.702 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.53 117.02 3.9 Favored 'Trans proline' 0 C--N 1.37 1.667 0 C-N-CA 122.081 1.854 . . . . 0.0 110.832 172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.438 HD22 ' N ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -64.89 -49.84 68.89 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.149 -176.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.402 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . 23.9 m 56.25 92.47 0.06 OUTLIER Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.756 1.222 . . . . 0.0 111.85 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 12.7 Cg_endo -55.32 -27.53 58.04 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.575 2.184 . . . . 0.0 113.228 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.12 58.56 4.91 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 124.68 1.238 . . . . 0.0 108.25 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.8 m -62.6 90.02 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 113.743 -1.572 . . . . 0.0 111.179 -167.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -141.01 25.93 2.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.723 1.209 . . . . 0.0 110.014 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.68 90.58 2.31 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 65.6 -176.99 0.18 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.266 1.426 . . . . 0.0 111.268 -171.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.987 0 N-CA-C 110.599 -1.001 . . . . 0.0 110.599 178.167 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -66.74 101.18 0.77 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.158 0.504 . . . . 0.0 110.575 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 35.3 ttm -97.77 87.16 3.95 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.48 -42.61 98.92 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.794 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.58 166.36 39.03 Favored Glycine 0 C--O 1.242 0.611 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.56 98.17 0.85 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.712 0.768 . . . . 0.0 109.794 175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.33 100.65 0.2 Allowed Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 108.129 -1.988 . . . . 0.0 108.129 173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -81.67 68.86 8.19 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.217 0.607 . . . . 0.0 110.378 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 50.7 t -126.23 134.26 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.54 160.33 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.006 0.522 . . . . 0.0 110.769 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 ttmp? -109.75 116.03 30.93 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG13 ' CG1' ' A' ' 83' ' ' VAL . 87.4 t -114.62 135.77 53.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 125.056 1.342 . . . . 0.0 108.524 -168.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.703 ' HB3' ' HG3' ' A' ' 56' ' ' GLU . 12.3 ptm180 -149.95 162.58 40.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.855 0.462 . . . . 0.0 111.547 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.64 15.06 51.4 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.456 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.4 mt -83.65 135.94 42.75 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 22' ' ' CYS . 29.8 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.171 1.914 . . . . 0.0 111.783 171.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 16.0 m95 -70.43 -19.96 62.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.345 1.058 . . . . 0.0 111.32 -178.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -93.63 10.55 32.28 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.703 0.801 . . . . 0.0 111.276 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.59 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 50.6 t -87.03 133.95 33.54 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.019 0.528 . . . . 0.0 110.744 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.8 m -105.83 169.98 8.16 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 124.006 0.922 . . . . 0.0 109.511 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.26 -42.38 69.89 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.008 0.923 . . . . 0.0 111.893 -177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 3.3 m-20 -48.03 -48.72 32.83 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.405 1.082 . . . . 0.0 112.445 175.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -69.79 -34.16 73.35 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.866 0.867 . . . . 0.0 111.912 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.564 ' HB ' HD13 ' A' ' 43' ' ' ILE . 39.0 t -73.95 -30.53 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 C-N-CA 123.162 0.585 . . . . 0.0 110.128 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -67.19 -38.78 85.94 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.368 0.667 . . . . 0.0 110.013 174.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 95.1 mtt180 -59.6 -46.06 90.09 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.887 0.742 . . . . 0.0 111.191 174.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 77.0 t80 -63.52 -46.37 86.37 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.88 0.371 . . . . 0.0 110.256 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -94.83 37.07 1.15 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.795 0.838 . . . . 0.0 110.556 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.6 t -60.44 -34.14 73.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.35 0.66 . . . . 0.0 112.446 178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -69.19 -36.97 77.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.122 0.487 . . . . 0.0 109.887 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 23.0 m -72.86 175.32 6.66 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.057 175.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -136.01 97.51 3.64 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.529 HG21 HG13 ' A' ' 43' ' ' ILE . 3.5 mp -73.21 118.51 18.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.535 -172.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.523 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 7.8 tp60 -64.69 124.2 21.31 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.489 0.715 . . . . 0.0 109.367 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 76.01 16.63 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.715 1.606 . . . . 0.0 111.94 -173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.56 -134.24 47.55 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.356 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -37.46 32.39 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.609 1.164 . . . . 0.0 112.804 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -79.85 -8.18 59.14 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.537 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 37' ' ' GLN . . . -84.33 -13.87 72.69 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 116.325 -0.398 . . . . 0.0 113.623 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.564 HD13 ' HB ' ' A' ' 27' ' ' VAL . 62.3 mt -89.62 101.2 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.157 0.583 . . . . 0.0 109.575 174.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -94.13 96.59 9.72 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.249 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -67.42 129.22 39.21 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 57.5 mt -71.24 92.32 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.91 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -79.99 146.83 31.82 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.961 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.6 p -83.5 -172.97 4.44 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.31 1.044 . . . . 0.0 109.678 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -71.1 -6.06 36.37 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.896 0.478 . . . . 0.0 111.145 172.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -97.5 -6.96 32.54 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.615 1.166 . . . . 0.0 109.939 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.01 33.49 50.09 Favored Glycine 0 C--N 1.356 1.686 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -124.96 132.63 24.35 Favored Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 123.916 0.886 . . . . 0.0 110.37 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -67.55 139.11 47.82 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 122.487 2.125 . . . . 0.0 111.232 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.0 t -78.77 -2.04 37.6 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.076 0.55 . . . . 0.0 111.178 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.96 -7.3 60.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.878 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.703 ' HG3' ' HB3' ' A' ' 16' ' ' ARG . 8.0 mp0 -105.43 149.69 25.93 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 124.552 1.141 . . . . 0.0 109.618 175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.28 163.3 38.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.052 1.341 . . . . 0.0 109.681 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.75 116.01 29.43 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.033 0.933 . . . . 0.0 109.106 169.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -95.86 108.2 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.523 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 45.6 tt0 -83.14 145.08 29.42 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 36' ' ' ILE . 53.3 mt -138.83 145.87 40.56 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.385 1.074 . . . . 0.0 108.649 -168.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -70.95 -26.54 63.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -173.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -152.28 163.3 39.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.453 0.701 . . . . 0.0 110.134 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 35.0 tt0 -69.53 -16.73 63.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.212 0.605 . . . . 0.0 112.594 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 19.6 t70 -59.77 -51.42 69.85 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -52.98 -39.76 63.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.931 1.292 . . . . 0.0 111.863 171.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 65.4 t -63.39 -42.88 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 123.125 0.57 . . . . 0.0 111.065 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 74.9 mmtt -58.62 -45.43 89.21 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.953 0.901 . . . . 0.0 111.211 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 62.5 mt -61.52 -36.76 81.45 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.911 0.884 . . . . 0.0 111.062 176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.25 83.6 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 0.0 110.321 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.1 mt -62.57 -30.82 71.6 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.008 0.923 . . . . 0.0 111.828 175.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 56.3 mtpt -67.86 -30.78 70.24 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.318 0.58 . . . . 0.0 110.377 174.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 41.2 mttp -84.15 -4.26 58.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.02 0.928 . . . . 0.0 111.563 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -52.63 -33.44 46.66 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.461 0.704 . . . . 0.0 112.668 169.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -95.84 -31.59 13.08 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.902 -0.498 . . . . 0.0 111.598 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.07 142.24 47.49 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.661 0.785 . . . . 0.0 112.093 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 43.2 p -95.03 135.63 36.32 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.59 0.756 . . . . 0.0 110.758 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.5 ttt -70.9 -86.14 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.617 0.767 . . . . 0.0 110.374 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.19 1.78 5.4 Favored Glycine 0 N--CA 1.475 1.255 0 CA-C-O 120.03 -0.317 . . . . 0.0 112.729 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -170.22 -55.67 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.018 0.927 . . . . 0.0 108.931 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 -87.8 167.65 13.62 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.299 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 32.7 p90 -98.68 138.78 35.36 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 169.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.4 ' CG1' HG13 ' A' ' 15' ' ' VAL . 45.1 t -91.85 125.87 44.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.522 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -172.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.613 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 22.5 mt-10 -95.13 118.68 32.35 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 -175.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 87.9 t -119.61 117.81 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.591 0.756 . . . . 0.0 110.065 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -112.45 145.01 40.93 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -68.33 136.27 53.15 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 119.075 0.852 . . . . 0.0 110.875 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.2 m -136.11 -151.58 0.42 Allowed 'General case' 0 C--O 1.246 0.875 0 C-N-CA 124.52 1.128 . . . . 0.0 108.824 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -165.13 167.99 17.65 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.369 0.667 . . . . 0.0 110.33 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.85 -37.04 85.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.399 1.079 . . . . 0.0 111.989 -171.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -70.56 -42.84 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.204 0.602 . . . . 0.0 110.975 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.96 -38.6 76.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.1 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 55.9 ttp -53.31 -51.15 63.28 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.8 0.84 . . . . 0.0 110.037 175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -60.27 -42.88 96.31 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.275 0.985 . . . . 0.0 111.144 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -58.58 -47.5 84.07 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.275 0.985 . . . . 0.0 110.8 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.519 HG22 ' HD3' ' A' ' 102' ' ' PRO . 99.9 t -71.42 -32.37 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.713 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 79.1 mt -73.02 -32.05 64.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.904 -0.498 . . . . 0.0 112.083 -178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -62.54 -18.23 61.56 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -156.74 -86.79 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.469 1.108 . . . . 0.0 108.216 174.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.9 t -163.36 -163.42 0.83 Allowed 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.67 125.16 28.88 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-O 119.035 -0.869 . . . . 0.0 111.56 173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.519 ' HD3' HG22 ' A' ' 96' ' ' VAL . 40.3 Cg_endo -85.27 53.77 3.63 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 123.468 2.779 . . . . 0.0 112.623 -170.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 67.19 132.9 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.706 1.603 . . . . 0.0 110.934 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.9 p -59.88 119.67 43.25 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 123.741 0.816 . . . . 0.0 110.213 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.22 76.18 2.69 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.427 2.085 . . . . 0.0 110.295 174.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.44 -29.52 70.79 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.275 1.03 . . . . 0.0 111.356 -174.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.1 t -160.22 158.11 29.43 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.619 0.768 . . . . 0.0 110.058 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -129.0 24.39 5.63 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.529 1.132 . . . . 0.0 107.986 168.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 68.99 116.24 0.04 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 125.843 1.657 . . . . 0.0 110.044 -167.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -57.95 -31.53 66.95 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.842 0.857 . . . . 0.0 110.819 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 119.107 -0.829 . . . . 0.0 111.133 174.795 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 67.57 -179.85 0.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.538 1.135 . . . . 0.0 110.627 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 27.0 ttt 73.59 131.61 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.989 1.316 . . . . 0.0 111.599 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.88 66.6 2.71 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 116.321 -0.399 . . . . 0.0 113.918 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.73 -39.11 94.84 Favored Glycine 0 C--N 1.345 1.037 0 O-C-N 124.173 0.572 . . . . 0.0 112.053 176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -116.96 76.88 1.07 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.181 0.992 . . . . 0.0 108.797 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.5 150.83 22.01 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.514 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.3 OUTLIER -142.95 49.47 1.47 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.56 0.695 . . . . 0.0 111.392 -177.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 60' ' ' GLU . 47.1 t -123.05 139.53 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 173.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.9 m -116.6 167.9 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 O-C-N 121.667 -0.646 . . . . 0.0 111.009 169.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -119.34 123.45 44.2 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.0 t -114.44 119.12 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -170.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -124.87 149.35 47.61 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.548 1.139 . . . . 0.0 108.967 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.62 13.02 57.53 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -176.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 73.7 mt -72.48 135.84 81.35 Favored Pre-proline 0 C--O 1.241 0.631 0 C-N-CA 123.224 0.609 . . . . 0.0 110.038 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 42.5 Cg_endo -69.1 133.83 27.8 Favored 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 121.998 1.798 . . . . 0.0 110.693 173.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -58.19 -29.56 65.76 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.593 1.157 . . . . 0.0 111.193 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -81.94 8.28 10.87 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.073 0.949 . . . . 0.0 112.553 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.49 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 12.9 p -113.85 142.06 46.56 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -107.68 -170.07 1.63 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.64 0.776 . . . . 0.0 109.322 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.01 -43.37 70.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.404 1.081 . . . . 0.0 113.4 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.48 -38.23 83.62 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.28 0.632 . . . . 0.0 111.81 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -70.03 -37.6 75.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.737 0.815 . . . . 0.0 110.958 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 84.9 t -72.61 -35.7 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.226 0.61 . . . . 0.0 110.673 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HG3' HD12 ' A' ' 36' ' ' ILE . 41.5 tt0 -66.81 -39.74 87.82 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 176.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -61.14 -39.19 89.14 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.735 1.214 . . . . 0.0 111.149 174.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -63.24 -42.05 99.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.526 0.33 . . . . 0.0 110.357 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.557 ' HB2' HD11 ' A' ' 36' ' ' ILE . 83.9 m-85 -94.97 32.49 1.66 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.004 0.522 . . . . 0.0 111.117 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 38.2 t -76.84 87.86 3.43 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.9 t70 167.38 -55.58 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -159.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.421 ' HB3' HD22 ' A' ' 61' ' ' LEU . 58.0 m -82.55 171.73 13.76 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.138 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -123.15 72.91 1.13 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.557 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.2 mt -56.27 126.72 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.208 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -48.85 117.72 2.22 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.556 1.16 . . . . 0.0 111.397 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.3 t30 60.75 26.3 16.11 Favored 'General case' 0 CA--C 1.557 1.221 0 O-C-N 124.495 1.122 . . . . 0.0 111.991 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.4 -134.4 30.88 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.43 -0.805 . . . . 0.0 113.02 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -23.87 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.613 1.165 . . . . 0.0 113.531 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -72.48 -16.8 61.8 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -98.62 24.3 32.67 Favored Glycine 0 N--CA 1.47 0.963 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 170.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.6 mt -126.11 90.78 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.22 98.72 7.91 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.234 1.014 . . . . 0.0 109.628 -175.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -67.89 138.36 55.97 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.655 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.2 mt -76.68 90.7 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.867 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -75.79 148.0 38.78 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.547 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.5 t -106.8 174.37 5.92 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.041 0.936 . . . . 0.0 109.433 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -57.28 -19.6 22.87 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.888 1.275 . . . . 0.0 112.918 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -83.34 -4.45 58.47 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.343 1.057 . . . . 0.0 111.209 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.89 30.57 51.49 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 121.14 0.3 . . . . 0.0 112.986 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.75 151.29 73.92 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 124.028 0.931 . . . . 0.0 110.482 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.51 145.63 53.34 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.192 1.928 . . . . 0.0 110.333 166.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.1 p -74.48 -38.74 62.82 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.418 0.628 . . . . 0.0 110.409 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 141.49 -10.78 2.7 Favored Glycine 0 N--CA 1.468 0.771 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.757 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -104.58 150.72 24.4 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.196 0.998 . . . . 0.0 109.534 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.56 167.61 24.95 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.235 1.014 . . . . 0.0 109.885 177.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -111.7 122.63 48.33 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -109.93 107.88 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 12' ' ' VAL . 42.0 mt-10 -85.21 151.29 24.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 34' ' ' CYS . 73.6 mt -139.5 148.26 42.42 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.676 0.791 . . . . 0.0 109.213 -165.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.65 -21.62 61.06 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.1 p -144.9 156.58 44.07 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.516 0.674 . . . . 0.0 110.811 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -69.55 -18.75 63.67 Favored 'General case' 0 CA--C 1.558 1.261 0 CA-C-N 114.078 -1.419 . . . . 0.0 110.788 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -58.26 -55.65 32.23 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.322 0.649 . . . . 0.0 109.583 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 69' ' ' LEU . 36.3 mt-10 -52.11 -36.0 49.72 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.137 -1.392 . . . . 0.0 112.779 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 11' ' ' PHE . 76.0 t -60.83 -52.04 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 122.44 0.296 . . . . 0.0 110.706 176.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -57.42 -37.23 72.44 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.38 0.672 . . . . 0.0 112.619 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 66' ' ' GLU . 84.7 mt -60.55 -52.65 64.26 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.956 0.502 . . . . 0.0 110.558 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -56.14 -46.83 79.1 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 114.538 -1.21 . . . . 0.0 111.677 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 94.7 mt -57.58 -32.8 67.52 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.613 1.165 . . . . 0.0 111.843 177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -76.48 -18.89 58.52 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 122.526 0.33 . . . . 0.0 111.082 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mtpt -88.46 9.96 21.82 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.167 0.587 . . . . 0.0 111.168 177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -63.65 8.16 0.09 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 19.9 ttt85 -129.56 -37.36 1.59 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.204 0.602 . . . . 0.0 110.192 -178.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -52.04 143.29 14.22 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.428 1.091 . . . . 0.0 113.066 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.9 p -90.06 110.45 21.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.204 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -73.51 91.68 1.83 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 171.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.54 -96.25 1.14 Allowed Glycine 0 C--N 1.345 1.07 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -164.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 t-160 -127.99 -0.03 5.92 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.07 0.948 . . . . 0.0 109.911 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -80.25 114.91 19.49 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.064 0.946 . . . . 0.0 109.226 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -71.07 108.03 4.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.0 t -108.08 122.19 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.536 0.735 . . . . 0.0 110.062 -170.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.98 137.49 35.98 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 124.761 1.224 . . . . 0.0 109.129 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 ' HB1' ' A' ' 70' ' ' ALA . 47.5 t -124.17 116.16 46.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -104.03 -176.93 3.22 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.127 1.371 . . . . 0.0 107.699 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -109.53 136.97 48.06 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.9 m -128.59 148.84 50.81 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.754 0.822 . . . . 0.0 109.31 171.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -93.31 173.88 7.49 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 172.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -64.24 -19.21 65.22 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.77 171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.36 -54.91 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 123.785 0.834 . . . . 0.0 110.504 171.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -69.35 -45.05 70.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.295 0.638 . . . . 0.0 110.53 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -57.03 -48.68 77.92 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.456 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.03 -53.99 51.85 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.509 0.724 . . . . 0.0 111.122 174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 m0 -65.02 -41.95 94.85 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.143 0.977 . . . . 0.0 112.888 -169.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 35.4 t -82.71 -22.9 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 122.841 0.456 . . . . 0.0 111.174 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.48 -22.94 46.72 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 122.373 -0.204 . . . . 0.0 110.821 169.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.6 mmpt? -73.46 -38.94 65.3 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 168.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.5 t60 176.31 -78.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -173.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . 10.2 t 173.9 50.35 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.072 1.749 . . . . 0.0 107.589 175.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.59 -147.72 51.0 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 118.743 -1.031 . . . . 0.0 110.561 -167.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -62.54 -49.75 5.31 Favored 'Trans proline' 0 C--N 1.367 1.543 0 CA-C-N 119.852 1.826 . . . . 0.0 110.239 165.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -178.23 102.53 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 52.6 m -67.67 115.22 25.14 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.0 0.52 . . . . 0.0 111.124 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.83 -171.21 1.14 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.613 2.209 . . . . 0.0 111.404 171.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -67.95 -52.07 40.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.273 0.629 . . . . 0.0 109.923 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.6 m -150.63 106.67 3.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.298 1.039 . . . . 0.0 108.912 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.34 80.35 6.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 172.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -94.63 174.39 7.14 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.577 0.751 . . . . 0.0 111.721 -174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -100.08 -168.54 1.61 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.806 0.842 . . . . 0.0 109.617 172.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.448 0 CA-C-O 119.268 -0.74 . . . . 0.0 114.119 179.8 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -83.65 88.2 7.05 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.229 1.014 . . . . 0.0 109.477 176.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 mtm -114.16 4.38 15.54 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.92 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.47 49.38 4.06 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 116.303 -0.408 . . . . 0.0 113.478 -176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.41 131.71 2.3 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.02 106.34 3.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.914 0.485 . . . . 0.0 110.244 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.25 106.46 1.51 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 64' ' ' GLU . 10.5 m-30 -83.48 61.66 6.34 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.052 0.93 . . . . 0.0 108.537 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -133.04 138.54 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.878 1.271 . . . . 0.0 108.719 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.521 HG11 ' HB3' ' A' ' 70' ' ' ALA . 28.5 m -110.44 177.23 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.341 0.656 . . . . 0.0 110.446 165.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 19.6 ptmt -136.93 140.07 41.99 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.95 129.99 74.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.703 0.801 . . . . 0.0 109.134 -170.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.779 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 30.1 mtp-105 -129.94 159.43 36.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.111 0.964 . . . . 0.0 108.447 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.47 18.05 67.25 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.61 141.85 65.48 Favored Pre-proline 0 C--N 1.349 0.585 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -56.89 140.39 91.73 Favored 'Trans proline' 0 C--N 1.364 1.351 0 C-N-CA 121.904 1.736 . . . . 0.0 111.47 169.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.43 ' HZ3' HH22 ' A' ' 81' ' ' ARG . 1.6 m-90 -68.07 -19.33 64.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.369 0.668 . . . . 0.0 110.099 174.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 m -97.97 12.4 34.31 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.511 1.125 . . . . 0.0 111.55 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 26' ' ' GLU . 53.4 t -90.53 140.29 29.88 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.115 0.566 . . . . 0.0 109.676 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.6 p -117.14 172.4 7.31 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.082 0.953 . . . . 0.0 109.661 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.95 -40.98 58.81 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.674 1.19 . . . . 0.0 114.138 -171.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.34 -39.95 73.67 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.032 0.933 . . . . 0.0 112.984 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 1.8 mp0 -71.28 -41.04 70.53 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.976 0.51 . . . . 0.0 111.322 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 43' ' ' ILE . 56.5 t -72.71 -30.31 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.015 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -73.13 -42.69 62.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.1 0.96 . . . . 0.0 110.173 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.58 -48.25 82.6 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.172 0.989 . . . . 0.0 110.677 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 79.2 t80 -63.35 -57.34 10.68 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -85.38 37.25 0.67 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.314 0.645 . . . . 0.0 111.368 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 55.9 p -57.59 -31.83 66.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.445 0.698 . . . . 0.0 110.692 166.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.11 -16.15 63.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.956 1.302 . . . . 0.0 112.329 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 70' ' ' ALA . 39.1 m -114.23 130.49 56.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.104 0.961 . . . . 0.0 109.158 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HB2' ' HG3' ' A' ' 66' ' ' GLU . 13.9 mmmm -75.3 90.0 2.6 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.496 ' HA ' HD23 ' A' ' 61' ' ' LEU . 20.8 mt -73.89 129.75 36.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -44.19 -68.25 0.21 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.928 1.392 . . . . 0.0 113.413 -163.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -108.73 43.29 1.27 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.469 0.708 . . . . 0.0 109.852 177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.23 -125.35 37.52 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.718 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.46 -37.8 68.24 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.926 0.89 . . . . 0.0 112.022 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -77.58 -19.71 55.18 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.725 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.67 -20.67 75.94 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 116.525 -0.307 . . . . 0.0 112.38 173.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.595 HG23 HG22 ' A' ' 59' ' ' VAL . 46.4 mt -79.89 140.66 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.544 0.738 . . . . 0.0 109.158 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HB3' HD11 ' A' ' 97' ' ' LEU . 28.4 mmt180 -127.26 96.76 4.68 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.961 0.504 . . . . 0.0 110.078 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 53' ' ' PRO . 94.0 m-85 -77.87 136.91 38.12 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.464 0.306 . . . . 0.0 110.28 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.55 85.88 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -74.24 145.62 43.94 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.196 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.488 HG23 ' H ' ' A' ' 50' ' ' GLU . 8.9 t -109.42 178.87 4.31 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.1 0.56 . . . . 0.0 110.132 -177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 -65.65 -5.53 8.67 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.487 1.515 . . . . 0.0 113.289 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' H ' HG23 ' A' ' 48' ' ' THR . 10.3 tp10 -90.42 -17.43 27.23 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.93 0.892 . . . . 0.0 110.325 176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.66 47.09 4.96 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 116.18 -0.464 . . . . 0.0 113.141 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HG22 ' A' ' 48' ' ' THR . 17.8 ptt85 -163.19 155.51 15.64 Favored Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.878 0.871 . . . . 0.0 111.225 178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.546 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 36.2 Cg_endo -62.95 149.14 92.44 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 122.719 2.279 . . . . 0.0 112.015 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.0 p -95.15 19.55 10.39 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.192 0.997 . . . . 0.0 111.556 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.22 -17.13 49.37 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 120.034 -0.314 . . . . 0.0 113.622 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.451 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 38.9 tt0 -107.6 147.2 30.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.587 0.755 . . . . 0.0 110.111 175.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.14 163.92 36.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.467 1.107 . . . . 0.0 109.76 176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -114.5 112.53 23.11 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 166.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 43' ' ' ILE . 72.2 t -93.96 116.29 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -86.93 137.41 32.4 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 123.449 0.468 . . . . 0.0 109.823 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 36' ' ' ILE . 56.4 mt -127.3 148.17 50.24 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.288 1.035 . . . . 0.0 108.555 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.13 -24.89 47.22 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.615 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.9 m -133.76 143.8 48.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.588 0.755 . . . . 0.0 110.174 -177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 11' ' ' PHE . 30.6 tt0 -77.03 -10.93 59.7 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.039 0.447 . . . . 0.0 111.695 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 25.9 t70 -65.72 -35.43 80.73 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 169.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.615 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 18.1 mm-40 -68.16 -31.27 70.71 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.952 172.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.2 t -64.24 -51.83 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.485 0.714 . . . . 0.0 110.645 176.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 18.8 ptpt -54.06 -38.7 65.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 123.286 0.366 . . . . 0.0 111.355 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 41.4 mt -64.06 -50.14 69.56 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.322 1.049 . . . . 0.0 110.955 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.521 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -56.53 -44.8 81.19 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.686 0.794 . . . . 0.0 111.946 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 85' ' ' VAL . 93.2 mt -59.87 -34.93 73.79 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.431 1.092 . . . . 0.0 111.472 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -76.83 -17.85 58.75 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.254 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 29.5 mtpp -89.42 3.33 52.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.268 0.627 . . . . 0.0 111.352 175.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -51.61 -59.13 4.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.866 0.866 . . . . 0.0 111.796 172.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -79.19 -11.47 59.97 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -172.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -61.55 157.03 18.17 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-O 121.67 0.747 . . . . 0.0 111.621 165.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.3 p -93.82 122.67 36.53 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.227 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.638 ' HB2' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -62.26 -77.36 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.189 0.996 . . . . 0.0 109.628 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.58 87.72 0.29 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 166.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 78.39 -52.36 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 125.672 1.589 . . . . 0.0 112.062 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.43 HH22 ' HZ3' ' A' ' 20' ' ' TRP . 47.6 mtm180 -78.94 154.48 29.59 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.916 0.487 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -84.12 151.92 24.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.65 0.78 . . . . 0.0 109.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 78' ' ' MET . 12.2 t -96.52 156.93 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 C-N-CA 123.244 0.617 . . . . 0.0 111.087 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.779 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 29.0 mm-40 -115.27 115.0 25.94 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 161.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 71' ' ' LEU . 34.7 t -117.56 117.33 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -111.25 -178.11 3.37 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -109.63 135.56 50.4 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 52.8 m -130.11 -160.7 1.06 Allowed 'General case' 0 C--O 1.245 0.848 0 C-N-CA 124.022 0.929 . . . . 0.0 110.324 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -160.69 160.42 31.46 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -172.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -63.12 -23.77 67.59 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.155 0.982 . . . . 0.0 113.08 -174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.94 -51.71 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.633 0.773 . . . . 0.0 110.852 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 95' ' ' TRP . 11.5 pm0 -83.99 -20.61 32.53 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.959 0.503 . . . . 0.0 110.752 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.467 ' SD ' ' HG3' ' A' ' 44' ' ' ARG . 50.1 ttm -60.06 -56.01 26.89 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 170.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -62.44 -41.2 98.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.98 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.472 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 65.0 t-105 -58.77 -53.65 56.02 Favored 'General case' 0 C--O 1.204 -1.308 0 C-N-CA 123.162 0.585 . . . . 0.0 111.0 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.76 -25.68 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 C-N-CA 123.476 0.71 . . . . 0.0 111.963 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 44' ' ' ARG . 85.0 mt -76.75 -43.61 36.45 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 122.599 0.36 . . . . 0.0 111.095 174.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -82.74 -32.84 27.67 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.254 1.022 . . . . 0.0 110.701 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -136.0 88.02 2.36 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.243 1.417 . . . . 0.0 107.387 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 29.6 p -67.82 85.81 0.22 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.446 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.6 -179.95 41.22 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.451 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.19 -176.58 3.35 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.543 2.829 . . . . 0.0 113.748 -173.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -136.26 121.08 18.57 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.99 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 40.3 m -61.9 145.22 92.9 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.727 0.811 . . . . 0.0 111.38 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -44.36 123.96 4.83 Favored 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 123.923 3.082 . . . . 0.0 114.063 -174.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -65.98 90.93 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.15 0.98 . . . . 0.0 109.716 -174.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.5 m 67.68 130.51 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 125.359 1.464 . . . . 0.0 109.972 -169.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.81 92.26 0.15 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.431 0.693 . . . . 0.0 111.198 -175.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -99.15 174.85 6.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.295 0.638 . . . . 0.0 110.983 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -125.32 162.82 23.9 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.899 0.88 . . . . 0.0 110.604 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.153 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.34 -178.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.7 m80 66.97 160.92 0.16 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.962 1.305 . . . . 0.0 111.044 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.5 tpp -86.17 83.38 7.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.32 0.581 . . . . 0.0 109.752 -177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.79 -28.53 54.55 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.77 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.16 -78.04 0.43 Allowed Glycine 0 C--N 1.352 1.43 0 C-N-CA 123.717 0.675 . . . . 0.0 112.394 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -155.84 135.02 12.17 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.05 127.42 1.41 Allowed Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -92.73 17.88 9.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.766 0.826 . . . . 0.0 112.045 175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.9 t -107.95 133.82 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 168.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.52 HG12 HG13 ' A' ' 67' ' ' VAL . 23.1 m -96.2 155.6 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 122.608 0.363 . . . . 0.0 110.847 171.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 36.7 ttpt -109.0 117.65 34.77 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 83' ' ' VAL . 58.4 t -105.34 136.85 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 124.02 0.928 . . . . 0.0 108.636 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -140.41 134.51 30.9 Favored 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 172.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 111.72 81.55 1.16 Allowed Glycine 0 C--O 1.236 0.264 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -168.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.0 mt -139.67 135.34 16.71 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 114.097 -1.051 . . . . 0.0 109.164 -171.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.556 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 30.9 Cg_endo -65.74 131.41 27.46 Favored 'Trans proline' 0 C--N 1.361 1.217 0 N-CA-C 108.285 -1.467 . . . . 0.0 108.285 154.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 21.9 m-90 -63.7 -24.71 67.89 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.63 0.772 . . . . 0.0 111.193 -175.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.1 m -97.41 26.82 4.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.875 0.87 . . . . 0.0 111.624 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 27.4 p -78.95 155.25 29.05 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 123.223 0.609 . . . . 0.0 111.166 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.2 m -105.48 159.11 16.18 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.315 1.046 . . . . 0.0 109.553 171.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.32 -38.59 66.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.255 0.622 . . . . 0.0 110.794 169.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.97 -35.88 67.22 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.023 0.929 . . . . 0.0 112.129 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -64.55 -47.76 77.58 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.054 0.454 . . . . 0.0 111.349 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.74 -24.54 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.204 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.26 -49.7 40.42 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.621 0.768 . . . . 0.0 109.96 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -58.05 -40.67 81.51 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 124.256 0.972 . . . . 0.0 110.26 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -59.78 -56.05 26.69 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.176 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HB2' HD11 ' A' ' 36' ' ' ILE . 65.9 m-85 -93.98 25.84 3.5 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.259 0.624 . . . . 0.0 111.858 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.2 t -64.01 -21.78 66.65 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.93 -43.02 84.32 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 66' ' ' GLU . 81.8 m -75.0 140.05 43.34 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 114.404 -1.271 . . . . 0.0 109.182 171.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 12.4 mptt -84.28 90.97 7.64 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.482 HD11 ' HB2' ' A' ' 31' ' ' PHE . 55.0 mt -64.71 121.84 14.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.212 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -59.49 124.3 19.6 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.132 0.895 . . . . 0.0 110.474 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.59 20.61 12.2 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.325 1.05 . . . . 0.0 111.278 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 60.57 -131.09 49.14 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.053 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.33 -29.93 25.99 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.293 1.037 . . . . 0.0 113.23 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -75.01 -21.83 58.87 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.396 -173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.27 -21.71 79.19 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.404 175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.93 121.31 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.622 0.769 . . . . 0.0 108.98 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.599 ' HD3' HD11 ' A' ' 97' ' ' LEU . 83.2 mtt180 -128.52 96.9 4.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.924 0.89 . . . . 0.0 110.005 -169.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -76.5 132.1 39.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.2 mm -79.43 83.97 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 84.4 m-85 -72.97 143.64 47.55 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.502 177.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.4 p -98.14 179.16 4.85 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.523 0.729 . . . . 0.0 109.427 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -68.85 -9.01 48.99 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.653 0.781 . . . . 0.0 111.765 173.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 13.9 tp10 -83.05 -14.17 54.38 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.072 0.949 . . . . 0.0 110.453 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.0 23.41 59.43 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 113.537 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 7.2 mpt_? -133.29 143.46 48.32 Favored Pre-proline 0 N--CA 1.482 1.157 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 42.3 Cg_endo -65.44 155.79 66.92 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.88 1.72 . . . . 0.0 111.009 175.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.9 t -72.01 -3.82 25.09 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.294 0.638 . . . . 0.0 111.6 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.38 66.21 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -166.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -114.09 149.43 35.55 Favored 'General case' 0 C--N 1.354 0.77 0 C-N-CA 125.006 1.323 . . . . 0.0 111.148 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -148.39 166.79 27.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.118 1.367 . . . . 0.0 109.873 174.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -121.48 128.71 52.38 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 167.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.15 118.25 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -82.34 141.11 33.12 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 83.2 mt -126.35 163.22 23.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.904 0.482 . . . . 0.0 110.405 -174.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -31.22 70.77 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.977 0.911 . . . . 0.0 110.612 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.4 t -160.2 164.42 32.83 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.066 0.946 . . . . 0.0 108.999 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -74.93 -13.66 60.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 0.0 110.729 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.62 -42.24 98.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.582 0.753 . . . . 0.0 110.582 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 7.9 mm-40 -59.7 -32.39 70.47 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.547 174.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.52 HG13 HG12 ' A' ' 13' ' ' VAL . 76.0 t -67.63 -41.61 85.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.042 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -53.4 -46.63 69.79 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.778 0.831 . . . . 0.0 111.442 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.9 -46.26 85.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.658 0.783 . . . . 0.0 111.202 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -56.43 -46.4 80.28 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 114.847 -1.07 . . . . 0.0 111.378 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 96.6 mt -59.2 -39.17 81.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.333 1.053 . . . . 0.0 111.281 177.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -64.81 -29.14 70.1 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.674 0.609 . . . . 0.0 111.466 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -111.41 37.49 2.86 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.409 0.623 . . . . 0.0 111.351 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 85' ' ' VAL . 6.5 p-10 -75.43 18.58 0.21 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.394 0.677 . . . . 0.0 111.873 165.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 44.3 mtt180 -117.95 -29.49 5.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.539 1.535 . . . . 0.0 108.866 -168.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -58.94 146.01 39.44 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.241 1.017 . . . . 0.0 112.829 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.5 p -95.19 143.62 26.46 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.249 -1.342 . . . . 0.0 110.347 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.2 ttt -112.11 98.22 7.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.02 -76.31 1.06 Allowed Glycine 0 C--N 1.348 1.214 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -151.46 15.55 0.69 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.135 0.974 . . . . 0.0 109.944 173.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 82' ' ' TYR . 20.9 ttt180 -107.36 -145.2 0.39 Allowed 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.505 ' H ' ' HG2' ' A' ' 81' ' ' ARG . 81.0 m-85 -157.81 128.75 6.52 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -160.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.409 HG13 HG13 ' A' ' 15' ' ' VAL . 95.9 t -104.71 116.46 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 119.72 1.145 . . . . 0.0 109.293 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -96.82 118.23 32.8 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.991 1.316 . . . . 0.0 107.622 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 33.2 t -114.06 116.83 53.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 70.0 m-85 -111.04 -178.9 3.58 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' NZ ' HG11 ' A' ' 67' ' ' VAL . 22.5 ttmm -100.88 118.88 37.81 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.9 t -92.5 -178.79 5.01 Favored 'General case' 0 C--O 1.245 0.828 0 CA-C-O 121.906 0.86 . . . . 0.0 109.742 174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -142.22 154.39 44.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -59.26 -38.14 79.33 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.98 -47.39 88.31 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 124.543 1.137 . . . . 0.0 110.655 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -63.54 -54.26 38.98 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.129 0.572 . . . . 0.0 111.193 -177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 42.1 ttp -55.26 -42.35 73.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.17 0.988 . . . . 0.0 111.385 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -58.68 -45.46 89.39 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.269 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -62.55 -44.81 95.42 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.749 0.656 . . . . 0.0 111.944 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.567 HG13 ' H ' ' A' ' 101' ' ' GLY . 15.7 t -76.13 -25.12 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 O-C-N 123.748 0.655 . . . . 0.0 111.227 -174.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HD3' ' A' ' 44' ' ' ARG . 86.6 mt -79.52 -29.08 41.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.912 0.485 . . . . 0.0 111.067 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -80.13 -28.3 38.94 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.022 0.529 . . . . 0.0 110.963 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -160.55 107.66 1.55 Allowed 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.02 0.928 . . . . 0.0 108.656 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.4 p -47.72 100.34 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.313 1.045 . . . . 0.0 111.591 176.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.567 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 125.12 -153.29 17.93 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -84.94 158.39 11.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.564 2.176 . . . . 0.0 112.913 177.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -119.55 -69.13 0.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.392 1.077 . . . . 0.0 108.378 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 21.7 p -113.22 146.15 34.66 Favored Pre-proline 0 C--O 1.242 0.663 0 C-N-CA 124.475 1.11 . . . . 0.0 109.311 -176.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.27 119.72 7.08 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.09 1.86 . . . . 0.0 110.124 172.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -55.55 -31.57 62.25 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.356 0.662 . . . . 0.0 111.366 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.3 m -107.19 73.25 0.92 Allowed 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -112.7 -11.58 13.5 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.829 0.852 . . . . 0.0 111.332 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -144.37 121.15 11.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.434 0.693 . . . . 0.0 109.584 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -146.28 150.15 35.22 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.699 0.799 . . . . 0.0 108.933 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.387 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -175.733 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.238 0.455 0 CA-C-O 120.565 0.222 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -131.04 94.18 3.54 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.219 1.008 . . . . 0.0 108.805 168.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.3 ttt -57.85 -37.21 73.46 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.66 171.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.41 124.95 3.49 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.424 173.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.42 78.68 0.83 Allowed Glycine 0 C--N 1.348 1.25 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -122.22 121.18 36.22 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -173.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.19 54.96 0.42 Allowed Glycine 0 C--N 1.344 1.012 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.615 ' HA ' HG21 ' A' ' 67' ' ' VAL . 0.5 OUTLIER -89.1 44.61 1.22 Allowed 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.985 0.898 . . . . 0.0 112.273 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.2 t -134.21 133.93 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.471 HG11 ' HB3' ' A' ' 70' ' ' ALA . 28.9 m -105.08 168.17 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-O 121.095 0.474 . . . . 0.0 110.865 170.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.444 ' NZ ' ' HB3' ' A' ' 102' ' ' PRO . 85.4 tttt -126.5 125.84 42.74 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -111.93 123.28 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 123.517 0.727 . . . . 0.0 109.174 -171.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.702 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 52.5 ttt180 -127.86 147.55 50.45 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -173.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 22.88 34.52 Favored Glycine 0 N--CA 1.473 1.11 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.78 137.27 54.44 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 123.43 0.692 . . . . 0.0 109.758 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HG2' ' SG ' ' A' ' 22' ' ' CYS . 36.7 Cg_endo -67.08 135.92 39.07 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.516 2.144 . . . . 0.0 111.195 169.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' PRO . 26.8 p90 -60.73 -27.4 67.9 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.292 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.0 m -78.76 1.88 21.63 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.494 1.117 . . . . 0.0 112.976 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.504 ' SG ' ' HG2' ' A' ' 19' ' ' PRO . 14.9 p -119.07 152.31 36.7 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 m -116.7 -168.34 1.44 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.107 0.963 . . . . 0.0 109.808 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.3 61.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.882 1.273 . . . . 0.0 113.505 -174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.3 m-20 -51.08 -55.33 18.16 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.906 0.882 . . . . 0.0 112.931 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -67.92 -33.52 74.85 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.911 0.484 . . . . 0.0 111.682 -172.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.98 -39.28 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.051 0.54 . . . . 0.0 109.856 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.83 -42.85 97.53 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.246 0.618 . . . . 0.0 110.756 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 33.2 mmt180 -66.36 -38.09 86.8 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.241 0.616 . . . . 0.0 111.06 178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -65.03 -39.23 93.06 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.678 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 58.3 m-85 -95.13 28.8 2.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.469 0.707 . . . . 0.0 111.668 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.1 m -73.04 95.35 2.01 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 166.7 -33.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 127.423 2.289 . . . . 0.0 107.396 -165.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.1 p -115.82 136.84 52.67 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.548 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -81.68 98.35 8.35 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 61' ' ' LEU . 30.5 mt -77.98 115.55 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' HB3' ' HG2' ' A' ' 60' ' ' GLU . 45.8 tt0 -66.56 129.49 40.03 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.544 0.527 . . . . 0.0 110.535 -176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.419 ' ND2' ' HG2' ' A' ' 37' ' ' GLN . 35.5 m-80 75.07 16.77 2.78 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.591 1.556 . . . . 0.0 110.425 -173.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.77 -137.85 39.45 Favored Glycine 0 C--N 1.353 1.511 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.926 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.57 -20.55 63.41 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.863 0.865 . . . . 0.0 112.218 175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -75.46 -10.86 59.83 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.942 0.497 . . . . 0.0 111.789 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -79.96 -17.7 74.13 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.061 0.226 . . . . 0.0 112.757 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.2 mt -84.14 116.31 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.573 0.749 . . . . 0.0 109.183 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -116.04 95.55 5.15 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.26 0.624 . . . . 0.0 109.873 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -73.29 139.42 46.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.892 0.477 . . . . 0.0 110.491 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.3 mm -79.26 112.9 17.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 165.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.88 167.1 11.63 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.512 0.725 . . . . 0.0 109.381 177.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 p -90.45 -176.61 4.83 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.514 0.726 . . . . 0.0 109.345 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -20.71 59.69 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 -166.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -112.68 -14.09 13.18 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 118.107 0.412 . . . . 0.0 110.838 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.33 52.79 0.71 Allowed Glycine 0 C--N 1.349 1.265 0 N-CA-C 113.654 0.221 . . . . 0.0 113.654 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -115.99 131.26 23.83 Favored Pre-proline 0 N--CA 1.483 1.208 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HB2' ' HA ' ' A' ' 20' ' ' TRP . 32.3 Cg_exo -57.54 123.36 13.58 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 122.64 2.226 . . . . 0.0 110.921 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -78.21 -45.61 22.56 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 122.97 0.508 . . . . 0.0 110.163 -171.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.73 -12.73 1.51 Allowed Glycine 0 C--N 1.338 0.693 0 CA-C-N 115.426 -0.807 . . . . 0.0 112.24 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 16' ' ' ARG . 43.1 mt-10 -107.38 151.67 25.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.841 . . . . 0.0 110.218 175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -152.72 167.03 30.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.615 1.166 . . . . 0.0 110.044 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -120.23 115.5 23.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.681 0.792 . . . . 0.0 108.923 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.1 t -97.16 115.63 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG2' ' HB3' ' A' ' 37' ' ' GLN . 43.1 tt0 -78.95 130.67 35.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.271 1.028 . . . . 0.0 109.564 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 36' ' ' ILE . 96.9 mt -130.13 140.41 50.79 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.222 0.609 . . . . 0.0 110.105 -171.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.72 -20.11 59.97 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.476 0.711 . . . . 0.0 112.827 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 38.7 m -140.73 150.49 43.48 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -71.95 -12.69 61.36 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-O 120.888 0.375 . . . . 0.0 111.044 174.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -66.07 -52.22 50.95 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 169.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.581 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 5.2 mm-40 -47.71 -38.99 16.36 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.46 1.1 . . . . 0.0 111.532 171.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 11' ' ' PHE . 25.2 t -62.99 -52.95 52.91 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.237 0 C-N-CA 123.71 0.804 . . . . 0.0 111.471 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -57.09 -37.82 72.45 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.042 0.537 . . . . 0.0 112.404 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -67.23 -37.7 84.01 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.632 0.773 . . . . 0.0 111.686 175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.471 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -64.65 -44.12 91.44 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.682 172.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 82.4 mt -62.48 -29.88 70.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.465 1.106 . . . . 0.0 111.022 177.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -66.31 -21.67 66.27 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.219 1.008 . . . . 0.0 110.894 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 66.2 mttm -84.4 -4.17 58.75 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.928 0.891 . . . . 0.0 112.35 176.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 21.0 t70 -68.29 91.29 0.38 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.715 0.406 . . . . 0.0 110.192 173.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 145.43 -38.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 128.317 2.647 . . . . 0.0 109.021 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.66 144.07 39.13 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 26.0 p -92.59 120.8 33.39 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.198 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.472 ' SD ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 ttt -61.65 -73.19 0.1 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.097 0.559 . . . . 0.0 110.851 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -136.84 -17.54 0.72 Allowed Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 168.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -142.45 -66.21 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.668 1.187 . . . . 0.0 108.374 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -77.85 155.42 31.02 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.207 -172.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -81.25 127.38 32.64 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 90.9 t -88.96 120.87 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -170.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.702 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 28.9 mt-10 -94.91 116.69 29.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.409 HG12 HD23 ' A' ' 71' ' ' LEU . 11.5 t -117.03 114.52 46.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -106.08 144.67 32.46 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.445 1.098 . . . . 0.0 108.526 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -72.86 125.59 27.92 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 163.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 65.7 m -128.18 163.4 24.77 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.593 -174.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -103.89 153.0 21.28 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.54 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.41 -32.75 72.7 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.221 1.008 . . . . 0.0 109.889 171.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.5 t -61.28 -44.01 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.639 0.776 . . . . 0.0 109.897 173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -67.86 -38.48 83.15 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.1 ttm -56.01 -48.51 75.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.039 0.536 . . . . 0.0 110.01 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.89 -46.8 84.35 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.248 1.019 . . . . 0.0 110.53 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -58.31 -52.53 65.19 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.988 0.805 . . . . 0.0 111.816 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.598 HG13 ' H ' ' A' ' 101' ' ' GLY . 24.6 t -79.14 -25.22 12.86 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -168.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.95 -37.96 75.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.747 0.419 . . . . 0.0 110.409 172.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -90.68 -15.63 30.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.798 0.839 . . . . 0.0 111.428 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.481 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 23.7 t-80 -150.45 92.08 1.82 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.607 1.163 . . . . 0.0 108.567 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.7 p -56.14 90.57 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.151 0.98 . . . . 0.0 111.802 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.598 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 150.26 129.45 1.67 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.444 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 50.1 Cg_endo -84.94 41.39 0.95 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.272 2.648 . . . . 0.0 113.15 -174.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -84.29 49.51 1.68 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.823 0.821 . . . . 0.0 109.124 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 17.7 m -76.34 117.48 64.61 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.103 0.961 . . . . 0.0 109.359 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.2 170.57 11.7 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.716 2.278 . . . . 0.0 111.103 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 63.22 62.35 1.0 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.621 0.768 . . . . 0.0 110.284 -177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.9 m -83.07 109.5 17.18 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.29 -35.82 70.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.082 0.953 . . . . 0.0 112.286 -174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 63.3 t30 57.76 53.14 7.35 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.448 1.099 . . . . 0.0 110.971 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.29 149.93 33.43 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.308 172.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.884 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -177.282 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 CA--C 1.543 0.699 0 CA-C-O 120.71 0.29 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -86.0 103.89 15.12 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 19.3 ptp -160.96 -175.02 4.68 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.283 1.033 . . . . 0.0 109.928 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.42 56.55 14.77 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 111.686 -0.566 . . . . 0.0 111.686 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.64 -35.29 89.15 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 124.118 0.54 . . . . 0.0 113.696 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.44 83.93 3.86 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.269 0.557 . . . . 0.0 109.67 176.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 79.65 0.03 OUTLIER Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -84.03 60.57 5.94 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.435 1.112 . . . . 0.0 110.869 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.3 t -130.9 134.56 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.925 1.69 . . . . 0.0 107.582 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 70' ' ' ALA . 17.5 m -112.61 -175.79 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.858 0.863 . . . . 0.0 109.523 171.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -143.53 142.43 31.12 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.68 0.753 . . . . 0.0 109.54 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 71.3 t -111.49 119.43 59.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 126.148 1.779 . . . . 0.0 108.611 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 56' ' ' GLU . 61.1 mtp180 -123.98 148.56 46.86 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.25 1.02 . . . . 0.0 109.723 -175.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.33 25.81 35.35 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 -174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.4 mt -59.32 143.72 84.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.9 0.88 . . . . 0.0 111.121 176.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.52 174.19 13.24 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.463 2.108 . . . . 0.0 111.275 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -68.75 -24.61 64.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.449 0.642 . . . . 0.0 109.536 171.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.0 m -81.41 1.43 33.06 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.447 1.099 . . . . 0.0 112.482 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 28.2 p -49.02 126.05 11.7 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.561 0.744 . . . . 0.0 112.881 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.52 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 45.7 t -146.3 158.91 43.93 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.919 1.287 . . . . 0.0 108.35 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 28' ' ' GLN . . . -53.95 -42.95 69.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.019 0.527 . . . . 0.0 110.688 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 6.8 m-20 -54.33 -43.62 71.38 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 112.658 173.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 13.3 mm-40 -68.04 -36.35 79.75 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.866 0.467 . . . . 0.0 110.875 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.0 t -66.78 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.113 0 C-N-CA 123.33 0.652 . . . . 0.0 110.673 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.56 HE21 HD11 ' A' ' 43' ' ' ILE . 27.4 mm-40 -56.92 -53.83 53.52 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.708 0.803 . . . . 0.0 109.97 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 36.0 mmt180 -56.56 -46.17 80.88 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.41 1.084 . . . . 0.0 111.228 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -58.59 -40.47 83.25 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.821 1.248 . . . . 0.0 112.233 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -97.45 35.56 1.62 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.278 0.631 . . . . 0.0 112.054 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 79.7 p -78.35 83.06 4.6 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.0 t70 169.05 -62.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.003 1.721 . . . . 0.0 106.739 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 20.9 m -74.58 -177.66 3.25 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.207 168.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 126.74 17.03 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.831 0.824 . . . . 0.0 109.199 168.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.467 HD12 ' NE2' ' A' ' 28' ' ' GLN . 55.2 mt -86.27 128.68 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.419 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -42.76 -61.74 1.18 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.963 1.705 . . . . 0.0 113.965 -160.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -116.52 40.81 2.81 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.347 0.594 . . . . 0.0 110.231 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.25 -130.02 32.05 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.333 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -64.11 -14.52 55.37 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 177.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.09 -21.68 50.12 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.769 0.428 . . . . 0.0 111.501 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.47 28.89 7.71 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.676 -0.17 . . . . 0.0 112.676 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.56 HD11 HE21 ' A' ' 28' ' ' GLN . 61.2 mt -128.51 127.46 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.615 ' HG2' HD11 ' A' ' 97' ' ' LEU . 10.1 tpp180 -131.29 96.68 4.07 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 123.694 0.621 . . . . 0.0 110.024 -168.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -79.64 134.86 36.45 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.5 mm -86.7 113.48 24.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -95.82 164.59 12.68 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 69.8 p -107.95 172.88 6.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.417 1.087 . . . . 0.0 108.874 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.27 1.6 15.59 Favored 'General case' 0 CA--C 1.556 1.181 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -85.53 -6.41 59.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.74 0.816 . . . . 0.0 110.683 167.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.38 32.63 42.09 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.069 0.231 . . . . 0.0 113.1 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -135.3 139.64 32.13 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 123.573 0.749 . . . . 0.0 111.414 -176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -58.07 134.1 59.91 Favored 'Trans proline' 0 C--N 1.388 2.618 0 C-N-CA 122.868 2.379 . . . . 0.0 112.187 172.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.6 p -69.29 -44.52 71.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.15 0.98 . . . . 0.0 110.986 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.53 -10.0 3.46 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.091 -173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 16' ' ' ARG . 43.7 mt-10 -108.67 148.6 30.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.448 1.099 . . . . 0.0 110.137 171.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.81 152.18 32.31 Favored 'General case' 0 C--O 1.214 -0.787 0 C-N-CA 124.38 1.072 . . . . 0.0 108.265 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -105.49 126.77 52.51 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.9 t -106.45 142.9 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -123.67 120.01 31.51 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 -167.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.1 mt -117.37 161.07 20.14 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.376 0.67 . . . . 0.0 110.737 -165.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -60.68 -29.83 69.56 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 113.404 0.891 . . . . 0.0 113.404 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 59.4 p -160.45 167.2 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 123.315 0.384 . . . . 0.0 110.543 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -73.02 -17.84 61.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.207 0.603 . . . . 0.0 111.305 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -64.66 -44.66 89.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -61.59 -31.03 71.07 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.198 171.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.7 t -65.75 -40.9 89.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.589 0.756 . . . . 0.0 110.535 174.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -65.08 -38.15 89.85 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.36 0.664 . . . . 0.0 111.372 174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.466 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 96.6 mt -65.66 -31.97 73.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.624 0.769 . . . . 0.0 111.324 172.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.525 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -69.04 -42.57 76.16 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.635 173.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 87' ' ' LYS . 84.9 mt -62.01 -39.71 93.21 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.687 0.795 . . . . 0.0 112.174 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 69' ' ' LEU . 17.7 ptmt -75.03 -18.29 60.36 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 120.999 0.428 . . . . 0.0 110.475 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.18 6.28 23.16 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 124.518 1.127 . . . . 0.0 111.2 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -68.52 80.43 0.26 Allowed 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.371 0.668 . . . . 0.0 111.294 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 163.94 -44.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 123.869 0.867 . . . . 0.0 110.055 -167.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -42.17 140.46 1.13 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.013 1.725 . . . . 0.0 113.36 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.6 p -100.37 110.53 22.74 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 -172.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.1 ttm -78.44 91.96 4.56 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.94 -86.54 1.27 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.999 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 41.1 p-80 -132.14 7.26 4.28 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.881 0.872 . . . . 0.0 109.988 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -105.69 132.71 51.5 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.379 1.072 . . . . 0.0 110.101 -172.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -76.47 133.37 39.83 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 171.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 84.8 t -131.89 133.45 61.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-O 121.144 0.497 . . . . 0.0 110.392 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -98.53 148.2 24.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.695 1.198 . . . . 0.0 109.277 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.525 HG11 ' HB1' ' A' ' 70' ' ' ALA . 46.7 t -130.76 118.98 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -114.04 144.55 42.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' HD21 ' A' ' 71' ' ' LEU . 87.7 tttt -67.68 138.22 56.14 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 99.5 p -122.95 -160.54 0.9 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -135.12 159.42 41.58 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -60.71 -40.5 92.5 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.441 0.696 . . . . 0.0 110.723 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.16 -37.29 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.524 1.13 . . . . 0.0 110.976 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -68.75 -46.9 67.65 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 0.0 110.264 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.7 tmm? -58.26 -45.66 87.44 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.114 0.966 . . . . 0.0 110.14 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.32 -43.36 99.01 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.13 0.972 . . . . 0.0 110.79 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.27 -54.49 45.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.167 0.987 . . . . 0.0 111.919 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.22 -35.28 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.409 0.684 . . . . 0.0 111.617 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.615 HD11 ' HG2' ' A' ' 44' ' ' ARG . 88.5 mt -67.13 -36.42 81.84 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.059 0.543 . . . . 0.0 111.105 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -81.82 -32.14 31.4 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.962 0.905 . . . . 0.0 110.044 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.9 t60 -166.49 99.39 0.59 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.099 1.36 . . . . 0.0 108.462 -170.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -78.4 171.69 14.71 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.88 -173.29 31.15 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-O 119.665 -0.519 . . . . 0.0 111.945 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -69.85 138.3 37.22 Favored 'Trans proline' 0 C--N 1.367 1.551 0 C-N-CA 122.597 2.198 . . . . 0.0 110.866 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -59.96 120.98 10.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.084 0.469 . . . . 0.0 109.938 -177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 20.4 m -134.06 72.69 71.67 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 123.734 0.814 . . . . 0.0 108.941 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -91.3 97.49 0.22 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.87 2.38 . . . . 0.0 111.883 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -75.37 110.03 9.39 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.5 p -98.92 120.75 39.89 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.648 -172.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -95.83 101.22 12.88 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.605 0.762 . . . . 0.0 109.812 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -97.22 169.64 9.65 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.04 0.936 . . . . 0.0 109.968 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -160.24 118.54 2.63 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.966 0 CA-C-O 119.06 -0.855 . . . . 0.0 111.668 -176.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.543 0.709 0 CA-C-O 120.687 0.279 . . . . 0.0 111.322 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -70.78 -45.36 64.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.342 0.657 . . . . 0.0 110.786 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 52.2 ttp -75.41 94.73 3.13 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.04 -46.22 1.1 Allowed Glycine 0 C--N 1.336 0.566 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.607 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 75.61 -69.2 2.09 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 123.924 0.426 . . . . 0.0 112.317 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -65.77 150.02 49.21 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.225 1.01 . . . . 0.0 109.997 172.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.93 89.86 0.11 Allowed Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HA ' HG21 ' A' ' 67' ' ' VAL . 17.8 p90 -85.08 47.71 1.45 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 122.178 0.99 . . . . 0.0 111.563 176.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 60' ' ' GLU . 78.8 t -135.32 143.41 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 168.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -116.28 173.12 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.398 -0.814 . . . . 0.0 110.441 168.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -126.9 139.97 52.68 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.476 ' HB ' HD11 ' A' ' 18' ' ' LEU . 3.7 t -124.92 130.57 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.582 ' HB2' ' HB2' ' A' ' 84' ' ' GLU . 32.6 mtm180 -130.78 156.29 45.23 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.685 0.794 . . . . 0.0 108.891 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.46 -33.97 6.11 Favored Glycine 0 N--CA 1.471 1.018 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.476 HD11 ' HB ' ' A' ' 15' ' ' VAL . 52.4 mt -34.77 112.36 0.44 Allowed Pre-proline 0 N--CA 1.486 1.339 0 C-N-CA 124.746 1.218 . . . . 0.0 112.594 166.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.69 163.98 19.9 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.686 2.257 . . . . 0.0 113.223 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 50.9 p-90 -57.22 -34.74 68.85 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.871 178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.5 t -95.55 13.54 25.78 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.601 0.761 . . . . 0.0 111.825 -174.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.5 t -72.61 168.72 18.07 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.055 0.542 . . . . 0.0 111.224 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.5 t -137.63 156.53 47.95 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.949 0.899 . . . . 0.0 109.783 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.1 -39.32 69.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.501 0.721 . . . . 0.0 111.188 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -50.76 -47.94 59.36 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.334 1.053 . . . . 0.0 112.741 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -68.01 -41.09 82.73 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.797 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 43' ' ' ILE . 33.4 t -72.05 -36.27 56.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.532 0.733 . . . . 0.0 110.282 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.564 ' HG2' HD12 ' A' ' 36' ' ' ILE . 26.1 tm0? -65.73 -43.43 89.08 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.724 0.809 . . . . 0.0 110.0 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -61.56 -42.28 98.61 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.865 172.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 73' ' ' LYS . 59.5 t80 -61.31 -29.28 69.78 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.753 0.821 . . . . 0.0 111.638 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.94 37.65 2.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.576 0.751 . . . . 0.0 111.831 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.1 p -77.15 85.89 3.62 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-O 121.486 0.66 . . . . 0.0 109.58 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 168.95 -51.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 126.721 2.008 . . . . 0.0 106.099 -161.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 24.3 m -78.81 169.67 17.87 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.977 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -127.8 94.35 3.93 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.564 HD12 ' HG2' ' A' ' 28' ' ' GLN . 14.6 mt -75.97 133.99 30.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 114.062 -1.426 . . . . 0.0 108.06 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -47.62 -55.96 8.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.193 1.397 . . . . 0.0 112.777 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -125.54 65.23 1.17 Allowed 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.381 0.61 . . . . 0.0 109.424 169.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.48 -143.08 42.24 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-N 114.621 -1.172 . . . . 0.0 113.353 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.78 -14.77 60.24 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.867 0.867 . . . . 0.0 112.942 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -76.04 -19.54 58.54 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.045 0.538 . . . . 0.0 111.111 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -72.88 -7.89 71.55 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.817 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.504 HG12 HG22 ' A' ' 59' ' ' VAL . 46.3 mt -93.23 134.21 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 124.181 0.992 . . . . 0.0 110.288 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -128.81 96.12 4.28 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.82 0.848 . . . . 0.0 111.588 -174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -73.84 117.44 15.62 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.537 HG13 HD23 ' A' ' 97' ' ' LEU . 2.4 mp -67.27 99.42 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -79.78 134.65 36.37 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.3 p -85.25 176.88 8.07 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.359 0.664 . . . . 0.0 111.531 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -68.37 -21.46 64.71 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.061 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.433 ' HG3' ' HD3' ' A' ' 52' ' ' ARG . 9.4 tp10 -80.03 -13.9 58.96 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.655 1.182 . . . . 0.0 110.716 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.93 11.34 73.7 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 114.895 0.718 . . . . 0.0 114.895 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HD3' ' HG3' ' A' ' 50' ' ' GLU . 3.7 mpt_? -106.43 141.5 22.92 Favored Pre-proline 0 N--CA 1.485 1.318 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.67 132.32 49.5 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.062 1.841 . . . . 0.0 110.12 167.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.0 t -76.13 9.56 2.45 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.249 1.02 . . . . 0.0 112.142 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 16' ' ' ARG . . . 85.92 -13.42 56.74 Favored Glycine 0 C--N 1.354 1.56 0 N-CA-C 111.666 -0.573 . . . . 0.0 111.666 -173.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.99 139.24 37.88 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 125.251 1.42 . . . . 0.0 109.721 -174.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -142.78 136.92 29.33 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.545 0.738 . . . . 0.0 109.232 172.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' CD2' HD11 ' A' ' 46' ' ' ILE . 40.3 m-85 -96.2 106.87 19.12 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 HG12 ' A' ' 43' ' ' ILE . 60.1 t -91.19 122.27 42.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HG3' HG22 ' A' ' 12' ' ' VAL . 44.0 tt0 -101.56 136.58 41.17 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.9 mt -125.7 162.47 24.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.13 0.491 . . . . 0.0 110.698 -166.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.92 -35.13 57.55 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.01 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -154.13 167.95 28.12 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.677 0.751 . . . . 0.0 112.457 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 60.1 mm-40 -61.85 -32.36 72.69 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.36 1.464 . . . . 0.0 113.169 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.69 -46.68 88.64 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 1.6 mp0 -59.33 -33.93 71.73 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.85 170.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.508 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 80.9 t -62.14 -52.36 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 118.605 0.638 . . . . 0.0 110.532 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 95.3 mttt -53.89 -41.27 67.41 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.427 1.091 . . . . 0.0 111.686 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.1 -41.56 86.06 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.036 0.534 . . . . 0.0 110.92 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.99 94.19 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.17 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 67.9 mt -57.78 -22.82 49.19 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.374 1.07 . . . . 0.0 112.775 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -74.78 -13.72 60.62 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.059 0.543 . . . . 0.0 111.401 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 30' ' ' PHE . 3.8 mptp? -88.17 -2.47 58.62 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-O 118.89 -0.576 . . . . 0.0 112.254 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -53.05 -59.25 4.77 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.81 -18.02 64.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 112.515 -175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -59.41 153.51 18.99 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.602 0.715 . . . . 0.0 112.496 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.0 p -100.45 150.92 22.14 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.639 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.0 ttt -146.63 114.09 6.34 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 108.535 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 77.39 -81.57 1.2 Allowed Glycine 0 C--N 1.347 1.165 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -159.42 19.62 0.18 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.871 0.868 . . . . 0.0 109.735 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.85 139.76 47.07 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.307 0.643 . . . . 0.0 109.862 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -78.38 129.57 35.12 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 87.8 t -87.12 165.35 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 123.333 0.653 . . . . 0.0 109.697 -169.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 16' ' ' ARG . 49.0 mt-10 -135.19 117.32 15.44 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 172.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.76 115.66 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.462 ' CE2' ' HB3' ' A' ' 84' ' ' GLU . 92.3 m-85 -117.05 179.59 3.98 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -101.48 120.62 40.57 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -109.61 140.56 43.28 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.786 0.834 . . . . 0.0 111.363 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -96.36 166.01 11.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.188 0.995 . . . . 0.0 109.018 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -62.67 -38.0 88.62 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.401 0.68 . . . . 0.0 110.746 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 85.5 t -69.24 -43.11 81.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.371 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -68.52 -41.65 79.65 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.329 1.052 . . . . 0.0 109.903 -174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 51.4 ttp -60.74 -52.89 63.17 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.892 1.277 . . . . 0.0 110.626 178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.25 -45.57 92.78 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.776 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -60.94 -40.78 94.56 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.498 1.119 . . . . 0.0 111.605 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.446 HG22 ' HA2' ' A' ' 101' ' ' GLY . 71.4 t -81.08 -28.02 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.352 0.661 . . . . 0.0 111.678 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.537 HD23 HG13 ' A' ' 46' ' ' ILE . 69.8 mt -71.23 -43.47 67.27 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.94 -0.475 . . . . 0.0 110.948 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -82.46 -35.34 27.59 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.508 0.723 . . . . 0.0 112.74 -174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -118.16 -4.33 10.99 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 119.243 -0.408 . . . . 0.0 112.062 -166.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.7 p 58.34 131.6 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 125.73 1.612 . . . . 0.0 111.317 -168.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.446 ' HA2' HG22 ' A' ' 96' ' ' VAL . . . -46.5 101.4 0.03 OUTLIER Glycine 0 N--CA 1.481 1.635 0 O-C-N 124.128 0.892 . . . . 0.0 115.098 -171.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -100.27 67.39 0.05 OUTLIER 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 124.135 3.223 . . . . 0.0 110.651 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.6 m120 72.99 105.95 0.07 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.829 1.252 . . . . 0.0 110.384 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.7 m -99.68 102.56 17.37 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.369 0.668 . . . . 0.0 109.285 175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.68 111.83 2.59 Favored 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.665 2.243 . . . . 0.0 112.566 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.75 -15.52 59.07 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.461 0.705 . . . . 0.0 110.944 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.6 p -63.61 95.53 0.11 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.219 0.608 . . . . 0.0 109.808 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -114.19 171.82 7.38 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.057 0.943 . . . . 0.0 110.016 -178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.94 164.94 27.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.988 0.515 . . . . 0.0 111.489 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.66 160.14 17.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.981 0.912 . . . . 0.0 110.936 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 CA-C-O 118.798 -1.001 . . . . 0.0 112.046 173.819 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 t-80 -101.93 118.34 36.72 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.895 0.878 . . . . 0.0 109.432 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.9 tpt 64.35 22.0 12.65 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.1 1.36 . . . . 0.0 110.638 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' A' ' 89' ' ' ASN . . . -84.11 -20.87 58.36 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-N 115.162 -0.926 . . . . 0.0 114.326 -173.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.05 -13.07 75.99 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 114.652 0.621 . . . . 0.0 114.652 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -108.01 -3.46 18.74 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 117.978 0.889 . . . . 0.0 112.149 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.06 156.11 45.17 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 114.377 0.511 . . . . 0.0 114.377 -170.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -96.63 15.13 22.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.908 0.883 . . . . 0.0 110.724 176.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.51 139.65 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.961 1.305 . . . . 0.0 107.898 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 70' ' ' ALA . 30.2 m -107.25 169.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 167.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 79.7 tttt -124.66 125.4 44.06 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 83' ' ' VAL . 59.5 t -112.66 125.42 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 124.092 0.957 . . . . 0.0 108.929 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.794 ' HB2' ' HB3' ' A' ' 84' ' ' GLU . 76.3 mtp180 -117.7 149.36 40.87 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.89 28.03 19.68 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.21 -0.45 . . . . 0.0 112.588 -176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.6 mt -93.33 121.96 64.08 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -54.1 149.91 33.77 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.948 2.432 . . . . 0.0 113.066 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 18.7 p-90 -63.37 -25.93 68.52 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.537 0.684 . . . . 0.0 111.086 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 t -109.03 19.21 19.79 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.202 1.001 . . . . 0.0 111.025 -174.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.7 p -78.29 177.84 8.11 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.655 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.2 t -128.21 148.45 50.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.546 0.738 . . . . 0.0 109.645 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.41 71.39 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.896 0.878 . . . . 0.0 111.058 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 3.8 m-20 -54.85 -47.59 73.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 111.262 172.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 11.2 mm-40 -69.01 -41.25 78.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.412 0.685 . . . . 0.0 111.478 -175.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' HB ' HD13 ' A' ' 43' ' ' ILE . 45.5 t -69.14 -31.85 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.02 0.528 . . . . 0.0 109.691 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -66.64 -41.85 87.64 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.798 0.839 . . . . 0.0 110.598 174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 67.6 mmt-85 -65.99 -37.2 85.35 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.111 0.564 . . . . 0.0 111.262 176.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -68.13 -33.81 75.18 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.374 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -101.99 35.53 2.34 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.179 0.591 . . . . 0.0 110.684 175.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -82.34 79.76 8.71 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 168.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.2 t70 170.54 -38.91 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 113.437 -1.711 . . . . 0.0 106.816 -158.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.8 m -102.11 173.05 6.56 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.344 170.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.529 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 6.0 mtpm? -126.78 95.14 4.24 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HA ' HD23 ' A' ' 61' ' ' LEU . 21.5 mt -76.62 139.51 18.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.659 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -45.89 -69.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.894 1.371 . . . . 0.0 112.112 -169.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.412 ' HB3' ' HB2' ' A' ' 41' ' ' GLN . 1.2 t-20 -106.34 35.48 2.93 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.861 0.464 . . . . 0.0 110.278 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.66 -125.92 31.67 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.33 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -29.96 71.05 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 118.006 0.903 . . . . 0.0 111.063 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 38' ' ' ASN . 1.6 mp0 -73.53 -18.01 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.17 0.588 . . . . 0.0 110.916 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.74 -15.7 81.37 Favored Glycine 0 C--N 1.351 1.412 0 O-C-N 123.208 0.317 . . . . 0.0 112.907 176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 27' ' ' VAL . 63.7 mt -83.53 141.32 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.875 0.87 . . . . 0.0 109.424 178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HG2' HD11 ' A' ' 97' ' ' LEU . 3.3 tpp180 -133.96 95.23 3.4 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 -171.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -73.58 128.4 35.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.918 0.487 . . . . 0.0 110.198 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 44.5 mm -85.27 118.67 32.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 89.0 m-85 -90.01 172.09 9.1 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 123.421 0.688 . . . . 0.0 110.256 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -101.29 173.09 6.61 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.639 165.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -68.59 -11.18 59.66 Favored 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.274 174.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -85.2 -2.64 58.26 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.819 0.848 . . . . 0.0 111.57 176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.4 37.35 41.7 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 113.749 0.26 . . . . 0.0 113.749 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 ptt85 -145.6 135.03 11.41 Favored Pre-proline 0 N--CA 1.486 1.33 0 C-N-CA 123.146 0.578 . . . . 0.0 111.21 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 47' ' ' TYR . 87.6 Cg_exo -49.08 133.96 29.38 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.6 2.866 . . . . 0.0 113.76 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.3 p -67.72 -26.09 65.99 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.179 0.992 . . . . 0.0 111.386 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.99 -16.79 7.23 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 -170.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' HB3' ' HE2' ' A' ' 14' ' ' LYS . 41.2 mt-10 -105.44 153.12 22.12 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.977 0.911 . . . . 0.0 110.574 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.76 168.82 25.56 Favored 'General case' 0 C--O 1.213 -0.854 0 C-N-CA 124.69 1.196 . . . . 0.0 108.979 173.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -119.37 124.45 46.63 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.673 0.789 . . . . 0.0 109.674 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.87 111.75 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -80.93 136.0 35.98 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 36' ' ' ILE . 70.3 mt -126.9 144.22 51.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.519 0.728 . . . . 0.0 109.819 -171.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -66.38 -17.64 64.89 Favored 'General case' 0 CA--C 1.56 1.352 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 80.8 p -166.65 170.36 12.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.96 0.504 . . . . 0.0 110.945 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.59 -21.14 65.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.443 1.097 . . . . 0.0 113.367 -172.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -49.0 77.71 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 1.8 mp0 -59.4 -33.11 70.81 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.831 0.852 . . . . 0.0 112.51 173.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.457 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 55.3 t -60.06 -48.61 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 123.426 0.454 . . . . 0.0 109.916 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.32 -36.74 83.09 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.974 0.91 . . . . 0.0 112.048 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.26 -41.57 99.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.404 0.682 . . . . 0.0 111.607 173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -64.02 -43.98 93.96 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.059 175.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.482 ' O ' ' HB3' ' A' ' 74' ' ' ASP . 98.0 mt -64.31 -33.32 75.57 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.996 0.918 . . . . 0.0 112.747 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -16.26 50.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.909 -0.494 . . . . 0.0 110.123 177.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -83.58 -9.36 58.97 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.912 0.885 . . . . 0.0 111.002 172.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.493 ' HB2' ' HB ' ' A' ' 85' ' ' VAL . 5.0 t70 -62.14 100.09 0.16 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 171.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 149.38 -49.5 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 127.387 2.275 . . . . 0.0 108.67 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -55.52 146.29 20.68 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.034 1.333 . . . . 0.0 113.56 -168.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 25.7 p -98.6 121.39 40.49 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.803 0.841 . . . . 0.0 110.904 -174.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ptp -83.81 74.59 10.17 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-O 122.005 0.907 . . . . 0.0 108.949 164.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.05 -89.95 1.38 Allowed Glycine 0 C--N 1.345 1.031 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.126 177.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -96.98 -23.26 16.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.508 0.723 . . . . 0.0 111.867 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -122.35 139.24 54.05 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.063 0.545 . . . . 0.0 111.761 -173.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 77' ' ' THR . 21.4 p90 -85.71 142.84 28.72 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.607 1.163 . . . . 0.0 108.815 173.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 15' ' ' VAL . 37.7 t -103.88 131.6 52.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.579 0.752 . . . . 0.0 111.54 -170.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.794 ' HB3' ' HB2' ' A' ' 16' ' ' ARG . 26.4 tp10 -104.78 119.33 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.942 1.297 . . . . 0.0 108.783 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 74' ' ' ASP . 56.3 t -118.33 117.05 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.083 0.553 . . . . 0.0 110.62 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.75 139.83 44.35 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.119 0.967 . . . . 0.0 109.564 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -68.02 126.41 29.41 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 171.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.5 p -132.91 -162.12 1.21 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.044 0.938 . . . . 0.0 109.466 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.548 ' HB2' ' HA2' ' A' ' 7' ' ' GLY . 59.6 t30 -146.54 162.82 37.53 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.297 0.639 . . . . 0.0 109.401 -172.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.7 -31.46 71.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.841 0.856 . . . . 0.0 110.498 175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 54.7 t -72.57 -42.13 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.362 0.665 . . . . 0.0 110.98 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 96' ' ' VAL . 18.1 tp10 -64.51 -49.54 70.92 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.0 -46.06 68.16 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.107 1.363 . . . . 0.0 111.391 176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.9 -44.13 97.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.812 0.845 . . . . 0.0 111.331 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -63.46 -39.66 95.06 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.565 0.746 . . . . 0.0 111.406 -177.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 92' ' ' GLU . 5.2 t -79.05 -18.95 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 CA-C-O 120.917 0.389 . . . . 0.0 110.739 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.516 HD11 ' HG2' ' A' ' 44' ' ' ARG . 97.8 mt -78.63 -30.0 46.21 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.957 0.503 . . . . 0.0 111.118 168.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -78.85 -35.85 43.26 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.573 0.749 . . . . 0.0 109.592 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -134.1 90.69 2.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.4 p -65.14 99.26 0.36 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.648 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.88 155.4 26.4 Favored Glycine 0 C--N 1.333 0.373 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.695 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.62 89.92 0.22 Allowed 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.741 2.294 . . . . 0.0 112.874 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -91.76 56.08 2.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.646 0.778 . . . . 0.0 109.872 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.7 m -69.37 113.13 14.64 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.63 0.772 . . . . 0.0 110.094 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.7 151.82 83.33 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 122.41 2.073 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.61 -70.87 0.13 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.8 t -176.31 164.7 2.69 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.203 1.001 . . . . 0.0 109.715 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -156.21 85.22 1.0 Allowed 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.448 1.099 . . . . 0.0 108.124 176.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -153.1 137.05 16.26 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.969 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -79.81 124.37 28.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.699 0.799 . . . . 0.0 109.673 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.009 0 CA-C-O 118.949 -0.917 . . . . 0.0 110.895 178.755 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.1 t60 63.46 121.94 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.675 1.59 . . . . 0.0 110.109 -164.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.5 ttt -59.84 114.09 2.61 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 122.837 0.455 . . . . 0.0 110.364 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.85 162.03 23.45 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.034 175.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.18 -36.05 0.22 Allowed Glycine 0 C--N 1.339 0.725 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.704 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -74.57 69.34 1.71 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.743 0.817 . . . . 0.0 110.221 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 90' ' ' ASN . . . 102.73 124.31 5.42 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -170.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -78.08 90.58 4.23 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.481 0.713 . . . . 0.0 110.56 -173.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG22 ' HG2' ' A' ' 60' ' ' GLU . 28.4 t -134.28 140.48 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.296 1.038 . . . . 0.0 108.58 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.514 HG22 HD11 ' A' ' 61' ' ' LEU . 30.0 m -107.48 167.24 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 0.0 110.549 164.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' HE3' ' HD2' ' A' ' 16' ' ' ARG . 3.7 tmmm? -119.82 122.72 41.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.54 123.12 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 124.766 1.226 . . . . 0.0 108.611 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.471 ' HD2' ' HE3' ' A' ' 14' ' ' LYS . 12.0 ptm180 -139.95 154.71 47.27 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -176.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.17 21.06 23.82 Favored Glycine 0 N--CA 1.474 1.179 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.0 mt -88.21 138.09 30.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.209 1.004 . . . . 0.0 108.775 177.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.81 157.21 62.78 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.718 2.279 . . . . 0.0 112.307 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -52.28 -35.78 51.08 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.432 1.093 . . . . 0.0 111.851 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.6 p -93.2 17.26 11.35 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.653 1.181 . . . . 0.0 112.015 -175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.2 t -67.48 166.17 15.27 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 123.393 0.677 . . . . 0.0 111.53 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.1 m -151.02 163.04 39.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 108.976 -177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.61 -44.1 69.19 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.154 0.582 . . . . 0.0 111.209 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -56.08 -40.42 73.57 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.167 0.987 . . . . 0.0 113.379 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -55.96 -48.19 76.24 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.447 0.641 . . . . 0.0 110.926 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.1 t -81.83 -22.98 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.699 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -71.26 -48.25 52.18 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.375 0.67 . . . . 0.0 109.949 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -63.91 -38.46 91.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.48 174.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -62.44 -46.49 88.31 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.539 ' HB2' HD11 ' A' ' 36' ' ' ILE . 96.3 m-85 -99.07 38.16 1.43 Allowed 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.859 0.863 . . . . 0.0 110.698 178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.8 t -66.13 -29.07 69.31 Favored 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 122.78 0.432 . . . . 0.0 110.764 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -65.69 -10.96 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.981 1.312 . . . . 0.0 112.23 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.419 ' HB3' HD23 ' A' ' 61' ' ' LEU . 39.5 m -121.85 139.78 53.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.791 0.837 . . . . 0.0 109.213 -177.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.06 92.1 6.19 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 31' ' ' PHE . 44.8 mt -69.03 144.14 14.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.916 176.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.22 100.81 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.716 0.806 . . . . 0.0 110.003 178.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 36.0 m-80 54.28 35.29 22.41 Favored 'General case' 0 CA--C 1.553 1.092 0 O-C-N 124.269 0.981 . . . . 0.0 111.756 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.31 -121.54 24.58 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.651 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.59 -27.62 17.67 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.497 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 10.1 tp60 -68.41 -21.7 64.66 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.18 -21.37 45.72 Favored Glycine 0 N--CA 1.471 1.023 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.325 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.423 HG23 HG22 ' A' ' 59' ' ' VAL . 56.7 mt -83.46 107.78 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.116 0.567 . . . . 0.0 110.139 -173.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.49 98.01 5.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.45 0.7 . . . . 0.0 110.927 -170.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -75.22 151.7 38.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.037 0.535 . . . . 0.0 111.646 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.84 86.36 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 165.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.67 147.84 45.33 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 50' ' ' GLU . 9.0 t -109.17 -179.3 3.81 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -176.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -77.1 -2.83 36.24 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.506 0.722 . . . . 0.0 111.59 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' H ' HG23 ' A' ' 48' ' ' THR . 40.1 tt0 -89.03 -19.12 26.04 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.684 1.194 . . . . 0.0 110.043 172.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.49 45.89 5.98 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.732 -177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 58.9 mtt180 -144.4 157.22 56.55 Favored Pre-proline 0 N--CA 1.484 1.248 0 C-N-CA 124.24 1.016 . . . . 0.0 109.923 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.89 135.97 73.79 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.436 2.091 . . . . 0.0 111.348 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -100.12 36.94 1.74 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.479 1.111 . . . . 0.0 110.495 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.29 -40.49 2.88 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.562 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -105.31 155.18 19.34 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.404 1.082 . . . . 0.0 110.985 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 161.62 42.37 Favored 'General case' 0 C--O 1.219 -0.529 0 C-N-CA 125.125 1.37 . . . . 0.0 109.261 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -120.8 113.37 20.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.246 1.018 . . . . 0.0 108.616 170.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 43' ' ' ILE . 77.9 t -107.47 121.34 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 124.0 0.92 . . . . 0.0 108.823 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.517 ' HG2' HG22 ' A' ' 12' ' ' VAL . 29.4 mt-10 -86.09 156.41 20.39 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.048 0.539 . . . . 0.0 109.795 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.584 HD13 HG22 ' A' ' 67' ' ' VAL . 3.6 mp -138.21 156.71 47.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.937 0.895 . . . . 0.0 109.681 -176.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -78.18 -26.47 47.61 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.937 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 30.8 m -145.59 153.72 41.37 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.95 -31.28 72.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.58 1.152 . . . . 0.0 111.158 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -62.11 -49.13 77.14 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.19 0.519 . . . . 0.0 110.097 177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -58.06 -35.22 71.04 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.795 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG22 HD13 ' A' ' 61' ' ' LEU . 79.3 t -61.62 -50.22 81.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -56.75 -36.98 70.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.855 0.862 . . . . 0.0 112.668 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.45 -42.3 87.81 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.362 0.665 . . . . 0.0 111.035 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -61.78 -40.19 94.32 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.801 0.84 . . . . 0.0 111.024 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 81.1 mt -61.62 -23.5 66.08 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.25 1.02 . . . . 0.0 112.547 174.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -81.25 -4.85 56.8 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.618 0.367 . . . . 0.0 111.776 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -97.68 4.94 49.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.062 0.945 . . . . 0.0 111.781 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.567 ' HA ' ' H ' ' A' ' 85' ' ' VAL . 26.8 t70 -38.83 -12.68 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 117.594 2.442 . . . . 0.0 117.594 170.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -144.78 -11.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.134 -0.979 . . . . 0.0 111.553 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -52.12 139.73 22.59 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.146 0.978 . . . . 0.0 111.708 176.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.8 p -93.01 127.71 38.62 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.945 0.898 . . . . 0.0 112.435 -170.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.7 ttm -94.02 102.64 14.73 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 167.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.88 -90.2 0.32 Allowed Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.51 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -120.43 -4.32 9.88 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.102 0.961 . . . . 0.0 111.354 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -124.75 147.88 48.41 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.615 0.366 . . . . 0.0 110.849 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -79.91 141.29 36.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 70.8 t -114.39 123.84 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 34.9 mt-10 -95.46 129.02 42.77 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.247 1.019 . . . . 0.0 108.977 175.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.567 ' H ' ' HA ' ' A' ' 74' ' ' ASP . 27.8 t -127.01 118.53 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -173.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -113.87 177.67 4.55 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.706 1.202 . . . . 0.0 108.132 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -111.89 128.8 56.25 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.1 m -122.9 -166.31 1.43 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.15 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.513 ' H ' ' HB3' ' A' ' 92' ' ' GLU . 23.9 m-80 -136.46 161.46 35.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -175.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.493 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 25.7 t-20 -63.21 -35.12 79.28 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 170.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -69.75 -41.92 80.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.185 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.513 ' HB3' ' H ' ' A' ' 89' ' ' ASN . 8.9 tp10 -62.96 -51.75 65.68 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.156 0.982 . . . . 0.0 110.518 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.486 ' HB2' HG11 ' A' ' 12' ' ' VAL . 10.9 tmm? -57.62 -50.52 72.88 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.25 1.42 . . . . 0.0 111.183 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.31 -39.51 92.59 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.526 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.5 t90 -61.2 -50.9 71.25 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 0.0 111.504 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.476 HG21 HD21 ' A' ' 103' ' ' ASN . 22.5 t -68.19 -39.1 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 123.484 0.49 . . . . 0.0 111.376 -177.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.421 HD12 ' SD ' ' A' ' 93' ' ' MET . 94.0 mt -65.41 -29.27 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.296 0.238 . . . . 0.0 111.383 177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -86.67 -33.16 20.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.442 0.697 . . . . 0.0 110.62 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -150.94 92.9 1.87 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.969 1.308 . . . . 0.0 108.294 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.0 p -65.46 102.92 0.75 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -139.72 -167.37 10.96 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 119.339 -0.7 . . . . 0.0 111.79 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -67.8 112.74 2.76 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 122.679 2.253 . . . . 0.0 110.902 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.476 HD21 HG21 ' A' ' 96' ' ' VAL . 23.2 m120 -59.23 99.54 0.06 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 173.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.9 p -60.8 109.77 2.37 Favored Pre-proline 0 CA--C 1.547 0.854 0 O-C-N 124.316 1.01 . . . . 0.0 109.016 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.48 148.43 73.03 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.624 2.216 . . . . 0.0 112.051 -173.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.44 -29.39 70.48 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.725 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.9 m 62.59 28.0 16.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.448 1.099 . . . . 0.0 111.091 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.78 88.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.37 0.668 . . . . 0.0 110.519 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 57.18 32.35 21.56 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 124.49 1.118 . . . . 0.0 110.412 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.36 -40.34 67.38 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.554 -177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 119.17 -0.794 . . . . 0.0 113.093 172.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.546 0.788 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -127.44 9.08 6.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.594 0.758 . . . . 0.0 109.491 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.3 mmt -95.84 10.64 36.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.233 1.013 . . . . 0.0 110.167 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.45 -91.77 1.68 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 -172.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.89 41.35 7.67 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.987 -0.149 . . . . 0.0 112.995 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -79.96 76.12 6.68 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.121 0.962 . . . . 0.0 109.506 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.8 175.84 20.06 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.399 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -87.53 1.47 53.45 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.432 0.693 . . . . 0.0 111.601 175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.36 138.65 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.828 0.851 . . . . 0.0 109.959 -178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.5 m -107.37 162.75 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.201 0.601 . . . . 0.0 110.32 165.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HB3' ' HB2' ' A' ' 86' ' ' PHE . 38.4 ttpt -113.6 120.63 41.58 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.5 118.36 56.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -169.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -122.1 147.7 45.8 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.423 1.489 . . . . 0.0 107.188 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.5 20.0 21.15 Favored Glycine 0 N--CA 1.475 1.258 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.5 mt -92.74 117.01 67.41 Favored Pre-proline 0 C--O 1.244 0.781 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.147 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -52.72 157.74 7.12 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.017 2.478 . . . . 0.0 113.222 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -61.96 -18.78 61.53 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.604 0.762 . . . . 0.0 112.285 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.2 m -110.97 14.7 22.0 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.746 0.819 . . . . 0.0 112.168 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 30.0 p -66.64 170.67 6.02 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.205 0.457 . . . . 0.0 111.303 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -139.73 156.11 46.97 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.116 0.566 . . . . 0.0 109.492 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.25 84.28 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.828 0.705 . . . . 0.0 110.721 176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 2.8 m-20 -53.8 -42.61 68.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.516 0.726 . . . . 0.0 112.563 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.98 -39.96 95.32 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.115 0.566 . . . . 0.0 111.876 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.465 ' HB ' HD13 ' A' ' 43' ' ' ILE . 93.2 t -68.61 -35.23 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.54 0.736 . . . . 0.0 110.096 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -65.38 -40.54 93.63 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.303 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 70.6 mtp180 -59.99 -47.15 87.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.187 0.595 . . . . 0.0 111.045 172.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.93 -34.16 74.27 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.475 0.71 . . . . 0.0 111.488 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.733 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 63.2 m-85 -108.35 24.9 12.34 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.693 0.797 . . . . 0.0 111.655 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.2 p -74.16 90.61 2.06 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.7 t70 166.08 -53.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -160.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 16.8 p -76.68 -175.56 3.44 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.322 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.457 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 33.3 mmtp -129.17 96.11 4.23 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 61' ' ' LEU . 24.4 mt -76.45 139.04 19.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -66.06 110.28 2.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.955 0.902 . . . . 0.0 110.31 -170.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.438 ' HB2' ' HB3' ' A' ' 41' ' ' GLN . 85.9 m-20 60.04 31.52 20.66 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.903 0.881 . . . . 0.0 111.179 -174.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.07 -125.24 34.09 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.699 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.9 -24.21 22.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.035 0.934 . . . . 0.0 113.46 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 6.9 tp60 -71.33 -18.05 62.41 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.694 0.397 . . . . 0.0 112.053 -176.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.67 -18.29 58.64 Favored Glycine 0 C--N 1.342 0.904 0 CA-C-N 116.63 -0.259 . . . . 0.0 112.625 174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.465 HD13 ' HB ' ' A' ' 27' ' ' VAL . 54.5 mt -85.18 110.12 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.568 0.699 . . . . 0.0 109.675 -177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -123.24 99.7 6.48 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.553 -170.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -78.31 138.83 38.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.953 0.501 . . . . 0.0 110.417 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 53.5 mt -75.56 99.21 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -80.26 153.85 28.24 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.826 0.346 . . . . 0.0 110.707 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.6 p -87.03 -172.95 4.21 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.603 0.761 . . . . 0.0 109.515 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -76.65 -0.12 22.3 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.675 0.39 . . . . 0.0 111.568 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -101.55 -20.73 14.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.033 0.933 . . . . 0.0 109.462 169.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.21 45.14 4.51 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.29 138.91 26.12 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 124.18 0.992 . . . . 0.0 109.234 -178.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -54.08 120.91 8.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.66 2.24 . . . . 0.0 111.168 171.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.6 m -82.91 25.35 0.68 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.049 0.94 . . . . 0.0 112.064 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.41 -33.43 4.12 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 123.159 0.409 . . . . 0.0 112.476 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -111.18 156.08 21.95 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 124.592 1.157 . . . . 0.0 110.761 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.68 169.39 22.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.058 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -121.69 115.98 23.72 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.765 0.826 . . . . 0.0 109.472 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.7 t -100.89 112.51 34.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -84.02 141.9 30.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.797 0.839 . . . . 0.0 109.015 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 36' ' ' ILE . 39.7 mt -131.54 165.27 23.97 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.919 0.887 . . . . 0.0 110.22 -168.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -66.88 -39.73 87.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.406 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.6 t -164.74 174.79 10.32 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.818 0.447 . . . . 0.0 110.122 -173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 7.6 pt-20 -60.54 -27.71 67.86 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.167 0.987 . . . . 0.0 112.57 -174.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.35 -50.93 41.79 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 35' ' ' LYS . 14.3 mp0 -51.59 -37.24 48.98 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.313 1.045 . . . . 0.0 111.637 172.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 44.3 t -60.11 -52.51 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.369 172.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -57.3 -40.09 77.09 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.62 0.768 . . . . 0.0 111.948 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 66' ' ' GLU . 86.1 mt -58.64 -45.34 89.5 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.997 0.919 . . . . 0.0 110.641 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.38 -47.36 84.49 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.377 -1.283 . . . . 0.0 111.478 176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 92.1 mt -58.35 -37.13 74.55 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.679 1.192 . . . . 0.0 112.096 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -72.4 -5.66 38.09 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.993 -177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -98.98 9.61 43.18 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.252 1.021 . . . . 0.0 112.774 172.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -66.76 10.01 0.15 Allowed 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -123.02 -23.18 5.02 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.31 0.644 . . . . 0.0 110.781 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -62.27 148.18 45.75 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.776 0.798 . . . . 0.0 112.216 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.0 p -99.79 137.79 37.76 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.309 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 24.2 ttt -142.59 111.42 6.34 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.614 1.166 . . . . 0.0 109.114 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.2 58.25 7.55 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.041 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 t60 71.89 -7.49 1.27 Allowed 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 125.073 1.349 . . . . 0.0 112.809 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -116.85 149.59 39.79 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.518 1.127 . . . . 0.0 110.162 -172.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -80.78 138.89 36.29 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 165.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.7 t -100.51 123.07 53.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -95.26 119.48 33.83 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 174.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.7 t -113.2 114.14 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 14' ' ' LYS . 78.4 m-85 -103.39 171.81 7.16 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.609 1.164 . . . . 0.0 110.355 -174.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -97.14 104.57 16.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -106.2 -171.7 1.95 Allowed 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.015 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.85 163.44 34.08 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.732 1.213 . . . . 0.0 108.934 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -61.13 -38.39 86.22 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.123 0.969 . . . . 0.0 110.358 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.15 -49.44 67.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.161 -1.382 . . . . 0.0 110.521 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -64.81 -42.42 95.02 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.488 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.1 ttp -52.58 -56.86 12.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.066 0.946 . . . . 0.0 111.554 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 17.4 t70 -65.86 -46.0 80.06 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 123.901 0.751 . . . . 0.0 111.759 -173.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -69.19 -44.93 71.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.202 0.601 . . . . 0.0 112.543 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.09 -42.65 96.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 122.673 0.389 . . . . 0.0 110.656 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.3 -38.74 85.49 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.195 0.598 . . . . 0.0 110.188 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -78.57 -18.78 54.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.681 0.793 . . . . 0.0 109.984 -179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -90.64 -4.91 56.45 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.315 0.646 . . . . 0.0 109.288 172.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.5 p 57.74 22.31 8.3 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.9 2.08 . . . . 0.0 112.723 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 147.61 148.79 4.82 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.37 124.85 6.05 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 122.327 2.018 . . . . 0.0 112.287 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.71 -5.02 56.48 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.521 0.729 . . . . 0.0 110.711 173.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 50.6 m 75.29 144.44 0.1 Allowed Pre-proline 0 N--CA 1.486 1.366 0 C-N-CA 125.856 1.662 . . . . 0.0 110.931 -174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.74 99.95 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.553 0 C-N-CA 122.617 2.211 . . . . 0.0 111.675 -175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.71 -38.36 88.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.251 -169.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 34.4 p -76.53 97.75 4.44 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 174.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.78 64.51 1.24 Allowed 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.782 0.801 . . . . 0.0 110.188 -176.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -104.14 111.19 23.68 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.149 176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -84.34 121.79 28.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -175.841 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.7 m170 71.68 143.91 0.06 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.277 1.431 . . . . 0.0 110.307 -167.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 25.8 ttt -100.27 126.18 46.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.05 60.4 4.45 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.07 -36.99 86.88 Favored Glycine 0 C--N 1.351 1.409 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 53.35 37.66 25.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.287 1.435 . . . . 0.0 112.955 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -62.37 139.41 45.73 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.142 173.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -73.01 4.64 4.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.073 0.549 . . . . 0.0 112.339 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 21.7 t -98.97 138.56 23.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 124.775 1.23 . . . . 0.0 109.247 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -108.75 173.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 123.768 0.827 . . . . 0.0 109.121 165.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 18.1 ptpt -121.53 129.54 52.97 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.69 117.55 55.17 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.298 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -173.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -110.12 158.24 18.53 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -172.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 82' ' ' TYR . . . 73.25 32.65 59.95 Favored Glycine 0 C--O 1.243 0.669 0 CA-C-O 121.464 0.48 . . . . 0.0 112.874 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 78.6 mt -87.25 133.42 38.72 Favored Pre-proline 0 C--O 1.243 0.736 0 C-N-CA 123.753 0.821 . . . . 0.0 109.041 170.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -54.7 145.44 60.04 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 122.71 2.274 . . . . 0.0 112.468 170.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -58.7 -30.52 67.47 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.158 0.983 . . . . 0.0 111.011 173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.6 p -105.81 20.05 19.56 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.461 1.104 . . . . 0.0 111.64 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -68.65 169.99 10.12 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.333 0.653 . . . . 0.0 111.009 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 26' ' ' GLU . 88.2 p -126.39 156.92 39.78 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -35.2 67.42 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.441 170.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -55.14 -40.32 70.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.78 1.232 . . . . 0.0 112.957 173.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG2' ' OG ' ' A' ' 23' ' ' SER . 58.6 mm-40 -64.35 -40.11 95.21 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.336 177.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.605 ' HB ' HD13 ' A' ' 43' ' ' ILE . 46.7 t -76.77 -26.12 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.169 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.501 ' NE2' HD12 ' A' ' 36' ' ' ILE . 15.5 mm-40 -64.07 -53.6 47.15 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.256 1.023 . . . . 0.0 110.134 173.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -58.65 -46.92 86.08 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.158 178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -68.17 -44.27 76.31 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.076 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -97.24 36.22 1.49 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.738 0.815 . . . . 0.0 110.301 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 p -59.58 -23.37 62.86 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.164 0.585 . . . . 0.0 112.295 173.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.05 -49.96 73.91 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.409 0.684 . . . . 0.0 110.331 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB3' HD22 ' A' ' 61' ' ' LEU . 34.2 m -82.92 131.57 35.18 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.619 -172.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -79.54 105.23 10.69 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 170.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.501 HD12 ' NE2' ' A' ' 28' ' ' GLN . 47.3 mt -83.77 147.19 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.111 0 C-N-CA 123.508 0.723 . . . . 0.0 109.44 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -41.73 -70.18 0.11 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 126.512 1.925 . . . . 0.0 114.172 -166.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -118.71 48.02 1.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 168.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.97 -120.5 23.02 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.515 -176.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -62.5 -31.41 72.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.629 0.772 . . . . 0.0 112.068 177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.94 -19.66 58.58 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.452 0.701 . . . . 0.0 111.222 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -78.96 -16.01 79.67 Favored Glycine 0 C--N 1.352 1.418 0 CA-C-N 116.661 -0.245 . . . . 0.0 112.795 173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 ' HB ' ' A' ' 27' ' ' VAL . 66.1 mt -85.55 127.92 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.225 1.01 . . . . 0.0 109.545 176.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' NH1' ' SD ' ' A' ' 93' ' ' MET . 55.1 mtt180 -130.66 98.74 4.74 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.85 0.86 . . . . 0.0 109.786 -172.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -75.29 142.94 43.2 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.744 0.418 . . . . 0.0 110.489 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.719 HD12 ' HG2' ' A' ' 56' ' ' GLU . 61.4 mt -86.31 90.6 3.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 173.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -72.37 156.27 39.26 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.825 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.7 p -84.63 -173.17 4.58 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.188 0.995 . . . . 0.0 110.552 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -63.89 -17.65 63.41 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.804 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' HB3' ' NH2' ' A' ' 52' ' ' ARG . 70.7 mm-40 -88.52 -5.92 57.92 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.777 1.231 . . . . 0.0 111.468 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.37 35.47 63.43 Favored Glycine 0 C--N 1.352 1.436 0 O-C-N 123.429 0.456 . . . . 0.0 113.268 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 50' ' ' GLU . 48.8 mtm180 -137.85 139.59 26.88 Favored Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 110.013 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.77 128.6 29.12 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 123.288 2.659 . . . . 0.0 112.045 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -74.84 -68.18 0.57 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.45 -11.94 0.02 OUTLIER Glycine 0 N--CA 1.474 1.187 0 CA-C-N 115.376 -0.829 . . . . 0.0 113.108 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.719 ' HG2' HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -128.95 168.24 16.27 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.112 0.965 . . . . 0.0 111.225 177.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.465 ' HA ' HG13 ' A' ' 46' ' ' ILE . . . -152.91 172.02 17.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.976 -177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -120.75 122.04 39.52 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 0.0 109.064 166.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 43' ' ' ILE . 81.1 t -116.25 117.45 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.064 0.946 . . . . 0.0 108.521 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 12' ' ' VAL . 33.1 tt0 -86.34 147.26 26.13 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 83.4 mt -130.01 156.14 44.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.172 0.989 . . . . 0.0 110.347 -169.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -69.32 -26.21 64.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.064 0.946 . . . . 0.0 111.551 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.421 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 74.4 m -148.53 160.64 42.89 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.557 0.743 . . . . 0.0 110.278 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -72.75 -15.14 61.67 Favored 'General case' 0 CA--C 1.562 1.432 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.262 171.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 68' ' ' LYS . 22.9 t70 -72.22 -38.88 68.88 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.886 0.474 . . . . 0.0 110.304 169.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 22.4 mm-40 -61.18 -33.47 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.96 169.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 54.5 t -63.11 -37.19 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.075 0.55 . . . . 0.0 110.004 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 65' ' ' ASP . 67.9 mmtt -57.98 -48.44 79.99 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 122.829 0.452 . . . . 0.0 111.036 171.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 82.9 mt -63.1 -26.24 68.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.659 0.784 . . . . 0.0 112.07 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -78.2 -45.24 23.57 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.523 175.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 55.9 mt -67.03 -28.73 68.47 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -78.12 -15.34 58.95 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.018 0.437 . . . . 0.0 110.005 175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm -87.3 -8.22 56.96 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.736 1.215 . . . . 0.0 110.804 175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.3 93.15 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.584 0.754 . . . . 0.0 108.988 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 154.12 -53.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 126.721 2.008 . . . . 0.0 108.869 -177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -53.14 141.63 22.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.769 1.228 . . . . 0.0 113.397 -167.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.4 p -83.28 126.18 32.4 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.26 1.024 . . . . 0.0 112.385 -172.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 59.2 tpp -82.64 85.9 6.93 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.44 -75.9 0.66 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -114.33 -45.2 3.05 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.082 0.953 . . . . 0.0 109.669 171.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttt180 -67.06 -145.85 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.422 1.489 . . . . 0.0 112.092 -173.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.5 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 32.5 t80 -160.98 120.54 2.64 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.837 -1.164 . . . . 0.0 108.388 -158.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 16' ' ' ARG . 98.4 t -99.41 130.23 48.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 C-N-CA 123.573 0.749 . . . . 0.0 110.381 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.85 121.59 40.35 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 172.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.572 HG11 ' HB1' ' A' ' 70' ' ' ALA . 39.9 t -118.36 122.91 70.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -119.37 142.43 48.17 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.444 ' HB2' HD11 ' A' ' 71' ' ' LEU . 19.5 ttmm -57.9 116.79 3.7 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.859 0.863 . . . . 0.0 109.762 173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.1 m -114.55 -174.28 2.45 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.482 0.658 . . . . 0.0 110.921 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.501 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 45.5 t-20 -131.62 152.0 51.17 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -64.37 -33.01 74.85 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.304 0.642 . . . . 0.0 109.919 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.0 -48.21 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 C-N-CA 124.611 1.164 . . . . 0.0 110.249 175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -69.46 -34.82 74.94 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.676 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.567 ' SD ' ' NH1' ' A' ' 44' ' ' ARG . 54.9 ttp -57.35 -55.19 37.92 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.865 0.866 . . . . 0.0 110.935 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.05 -39.86 93.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.769 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 44.0 t90 -57.33 -42.68 82.37 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.171 0.92 . . . . 0.0 111.714 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 100' ' ' THR . 84.0 t -80.96 -40.35 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.42 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.69 -17.34 63.47 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.692 -0.63 . . . . 0.0 111.482 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -68.9 -39.42 79.73 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.034 0.933 . . . . 0.0 112.304 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -179.78 55.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.344 0.657 . . . . 0.0 109.427 -168.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 96' ' ' VAL . 57.7 p 49.67 -173.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.412 1.485 . . . . 0.0 112.278 -174.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.64 93.49 0.95 Allowed Glycine 0 N--CA 1.463 0.461 0 CA-C-O 118.6 -1.111 . . . . 0.0 110.843 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -58.68 102.86 0.15 Allowed 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.374 2.049 . . . . 0.0 110.909 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -68.47 105.29 2.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.976 0.91 . . . . 0.0 109.727 -176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.5 p -116.98 87.82 23.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 123.916 0.886 . . . . 0.0 108.936 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -84.55 -166.86 0.38 Allowed 'Trans proline' 0 C--N 1.376 1.994 0 C-N-CA 123.203 2.602 . . . . 0.0 111.812 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 67.17 3.0 3.0 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.445 1.098 . . . . 0.0 112.919 173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 24.1 m -83.76 86.9 7.07 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -115.1 159.24 21.1 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.531 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.81 108.02 6.81 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.333 0.653 . . . . 0.0 110.051 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -77.6 120.3 22.36 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 170.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.026 -177.339 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 60.78 79.17 0.25 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.312 1.045 . . . . 0.0 109.397 -169.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -63.06 -16.42 59.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.85 1.26 . . . . 0.0 111.94 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA3' HD21 ' A' ' 89' ' ' ASN . . . 115.58 -85.41 0.39 Allowed Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.74 -68.3 2.52 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -178.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -61.32 95.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.404 1.082 . . . . 0.0 111.054 176.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . 172.89 106.32 0.19 Allowed Glycine 0 C--N 1.343 0.961 0 C-N-CA 121.762 -0.256 . . . . 0.0 112.702 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -101.54 26.89 6.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 169.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG22 ' HG2' ' A' ' 60' ' ' GLU . 17.3 t -114.65 145.15 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.161 1.384 . . . . 0.0 108.549 -174.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.22 175.78 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.497 0.719 . . . . 0.0 109.82 162.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 105' ' ' PRO . 6.4 ptpp? -127.58 140.31 52.2 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.52 113.8 45.02 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 -112.22 147.2 36.71 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.458 ' O ' ' HB3' ' A' ' 81' ' ' ARG . . . 90.32 27.42 20.56 Favored Glycine 0 N--CA 1.47 0.963 0 CA-C-O 121.407 0.448 . . . . 0.0 112.394 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 96.7 mt -84.39 146.1 46.78 Favored Pre-proline 0 C--O 1.242 0.706 0 C-N-CA 123.737 0.815 . . . . 0.0 109.304 172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD3' ' HG3' ' A' ' 81' ' ' ARG . 1.3 Cg_endo -51.47 149.83 16.96 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.337 2.025 . . . . 0.0 111.872 165.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -59.83 -26.49 65.85 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.471 0.708 . . . . 0.0 111.964 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -119.13 36.9 4.3 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.227 1.011 . . . . 0.0 109.74 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.27 151.1 48.1 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.674 0.389 . . . . 0.0 110.347 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 47.7 t -111.13 146.41 36.89 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.576 0.75 . . . . 0.0 109.047 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -34.4 66.62 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 123.66 0.6 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' O ' ' HG2' ' A' ' 29' ' ' ARG . 11.2 m-20 -54.98 -49.35 71.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.867 0.867 . . . . 0.0 112.261 172.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 12.2 mm-40 -69.25 -34.39 74.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.893 0.477 . . . . 0.0 111.101 -174.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.36 -37.9 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.202 0.601 . . . . 0.0 109.711 174.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.24 -44.49 88.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.151 0.98 . . . . 0.0 111.266 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 25' ' ' ASP . 29.6 mmt85 -62.39 -39.84 94.55 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.477 0.711 . . . . 0.0 110.839 176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -61.78 -38.18 87.11 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.466 0.707 . . . . 0.0 110.045 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.658 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 59.1 m-85 -101.43 28.75 5.24 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.239 0.615 . . . . 0.0 112.019 -178.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 t -80.98 83.25 6.74 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 171.22 -39.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.884 1.274 . . . . 0.0 108.268 -161.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 23.4 p -114.92 127.44 55.69 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 113.484 -1.689 . . . . 0.0 107.843 176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.61 100.47 6.15 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.295 0.638 . . . . 0.0 109.598 -171.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.626 ' HA ' HD23 ' A' ' 61' ' ' LEU . 45.9 mt -74.05 127.6 35.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.338 -172.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -64.04 121.15 13.45 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.111 0.882 . . . . 0.0 109.377 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 69.28 12.59 8.42 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.944 1.298 . . . . 0.0 112.056 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.27 -134.17 42.51 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.82 -19.57 64.2 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.489 0.716 . . . . 0.0 112.309 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -73.74 -16.93 61.16 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.149 0.58 . . . . 0.0 112.091 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.63 -6.39 76.98 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 123.533 0.52 . . . . 0.0 112.424 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.515 HG12 HG22 ' A' ' 59' ' ' VAL . 51.5 mt -92.05 123.69 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 124.027 0.931 . . . . 0.0 110.686 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -132.4 105.62 7.39 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.926 1.29 . . . . 0.0 109.366 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -68.6 143.65 54.78 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.8 mt -73.3 93.75 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -78.1 134.4 37.72 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.635 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.7 p -75.64 -172.03 1.74 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.53 0.732 . . . . 0.0 110.95 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -66.2 -20.4 66.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 173.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -91.4 0.98 57.44 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.851 0.86 . . . . 0.0 110.396 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.87 27.22 71.04 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.522 -0.308 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -107.94 134.49 20.09 Favored Pre-proline 0 N--CA 1.482 1.134 0 C-N-CA 123.493 0.717 . . . . 0.0 110.953 -176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.54 121.34 9.87 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.562 2.175 . . . . 0.0 111.179 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 62.0 p -73.04 -8.85 57.59 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.8 0.84 . . . . 0.0 112.224 -174.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.0 -9.15 54.81 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -169.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -109.15 154.22 22.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.498 1.119 . . . . 0.0 109.535 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.07 169.43 21.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.387 1.075 . . . . 0.0 110.469 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -119.03 127.55 53.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.797 1.239 . . . . 0.0 109.125 165.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.515 HG22 HG12 ' A' ' 43' ' ' ILE . 55.3 t -118.12 119.75 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG2' HG22 ' A' ' 12' ' ' VAL . 44.0 mt-10 -79.87 146.47 32.18 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.626 HD23 ' HA ' ' A' ' 36' ' ' ILE . 71.8 mt -136.13 136.55 40.17 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.04 -10.59 41.47 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -167.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.442 ' OG ' ' HG2' ' A' ' 66' ' ' GLU . 97.1 p -153.51 161.42 42.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.324 0.649 . . . . 0.0 110.433 173.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 37.1 tt0 -71.41 -16.93 62.42 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.454 0.702 . . . . 0.0 111.056 177.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -70.41 -48.66 55.06 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 174.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.442 ' HG2' ' OG ' ' A' ' 63' ' ' SER . 41.3 mm-40 -54.08 -34.99 61.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 123.831 0.707 . . . . 0.0 111.829 169.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 37.6 t -60.75 -49.28 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.05 0.54 . . . . 0.0 110.738 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 92.3 mttt -59.76 -36.75 77.29 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.584 0.754 . . . . 0.0 112.167 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 72' ' ' LYS . 93.6 mt -63.48 -43.99 95.71 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.43 0.692 . . . . 0.0 111.444 174.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.6 -46.8 86.24 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.004 172.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 87' ' ' LYS . 82.6 mt -62.77 -30.67 71.63 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.301 1.041 . . . . 0.0 112.984 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 69' ' ' LEU . 20.0 ptmt -78.67 -13.01 60.04 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 120.72 0.295 . . . . 0.0 110.783 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -94.22 3.78 54.79 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.831 0.852 . . . . 0.0 111.08 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -62.34 90.2 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.803 0.841 . . . . 0.0 109.384 168.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 164.44 -52.55 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.863 1.265 . . . . 0.0 111.224 -173.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.83 169.97 16.85 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.435 0.636 . . . . 0.0 112.674 -165.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.4 p -113.12 139.23 48.9 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.371 -162.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 54.8 ttm -103.15 67.54 0.94 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.947 1.299 . . . . 0.0 108.859 169.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.15 58.12 3.26 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.799 176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.0 m80 72.62 -7.71 1.37 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 125.684 1.594 . . . . 0.0 112.763 -173.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 17' ' ' GLY . 23.0 mmt180 -77.98 104.87 8.81 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -66.16 112.38 3.89 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 83.9 t -103.51 133.26 47.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -118.96 130.43 55.7 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.074 1.35 . . . . 0.0 108.86 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.93 116.27 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -122.47 137.7 54.79 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' HB2' HD11 ' A' ' 71' ' ' LEU . 77.9 tttt -67.2 136.28 54.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.3 m -121.3 155.96 33.58 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.063 0.945 . . . . 0.0 110.482 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.423 HD21 ' HA3' ' A' ' 7' ' ' GLY . 23.2 m120 -91.58 158.68 16.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.3 175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -66.07 -30.71 71.27 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 166.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -44.5 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.885 1.274 . . . . 0.0 110.643 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.436 ' O ' HG23 ' A' ' 96' ' ' VAL . 55.1 tt0 -69.53 -45.55 68.57 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.234 177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 58.1 ttp -55.44 -45.88 76.8 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.785 0.834 . . . . 0.0 110.429 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -58.73 -51.86 68.17 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.367 1.067 . . . . 0.0 110.183 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -56.09 -53.52 56.06 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.079 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.488 HG13 ' H ' ' A' ' 101' ' ' GLY . 38.2 t -74.43 -36.34 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.33 0.652 . . . . 0.0 112.195 -169.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 95.5 mt -70.26 -33.62 71.82 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 120.645 0.26 . . . . 0.0 110.899 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -89.65 -24.47 21.63 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.767 0.827 . . . . 0.0 111.362 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -148.41 93.41 2.15 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.421 1.088 . . . . 0.0 108.153 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.2 p -53.59 101.86 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.513 1.125 . . . . 0.0 112.886 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.488 ' H ' HG13 ' A' ' 96' ' ' VAL . . . 172.51 94.75 0.1 OUTLIER Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.944 177.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.72 96.64 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.045 2.496 . . . . 0.0 111.739 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -65.96 -61.84 1.83 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.76 0.824 . . . . 0.0 110.889 -176.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.5 p -162.33 129.54 2.6 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 122.88 0.472 . . . . 0.0 109.951 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.421 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 69.3 Cg_endo -68.8 170.6 15.04 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.443 2.095 . . . . 0.0 111.679 173.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.16 98.28 0.22 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 33.3 p -77.05 98.31 4.95 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.027 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.27 83.63 0.25 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.196 0.598 . . . . 0.0 110.177 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.0 OUTLIER -61.85 131.47 49.88 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.109 0.964 . . . . 0.0 111.362 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -123.43 119.69 30.77 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 119.35 -0.694 . . . . 0.0 111.383 -179.147 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 CA--C 1.548 0.874 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 58.61 -163.87 0.2 Allowed 'General case' 0 C--N 1.365 1.26 0 C-N-CA 124.176 0.99 . . . . 0.0 110.221 -173.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 9' ' ' GLU . 28.2 ttt -74.31 88.3 2.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 168.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.43 114.02 6.16 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.695 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 97.97 19.96 22.6 Favored Glycine 0 C--N 1.345 1.065 0 C-N-CA 122.829 0.252 . . . . 0.0 112.554 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.495 ' HG2' ' SD ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -62.37 124.36 20.69 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 175.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.659 ' HA3' ' HB2' ' A' ' 90' ' ' ASN . . . 69.52 -0.4 19.06 Favored Glycine 0 N--CA 1.472 1.095 0 CA-C-O 119.429 -0.65 . . . . 0.0 114.633 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 58.97 47.51 12.12 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.956 1.302 . . . . 0.0 112.128 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 t -108.43 139.04 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 123.438 0.695 . . . . 0.0 109.861 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -111.5 178.36 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.514 0.726 . . . . 0.0 110.025 167.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -134.95 125.39 26.56 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -113.01 129.13 69.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 C-N-CA 124.068 0.947 . . . . 0.0 108.806 -166.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.563 ' HG2' ' HB3' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -123.1 153.1 40.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.345 1.058 . . . . 0.0 108.178 -172.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.15 22.52 35.03 Favored Glycine 0 N--CA 1.475 1.289 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 86.1 mt -92.68 110.82 47.84 Favored Pre-proline 0 C--O 1.241 0.609 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -52.96 150.65 22.78 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.893 2.395 . . . . 0.0 113.468 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 24.7 p90 -55.31 -31.49 61.69 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.609 1.164 . . . . 0.0 111.632 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 t -108.78 24.92 12.38 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.636 0.775 . . . . 0.0 111.128 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -78.96 176.88 9.23 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.446 0.698 . . . . 0.0 110.23 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.625 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 44.9 t -128.63 152.26 48.56 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.458 0.703 . . . . 0.0 109.396 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.53 -32.29 70.18 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.056 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.61 -42.13 82.68 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.92 0.888 . . . . 0.0 112.081 171.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.625 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 32.7 mm-40 -64.09 -45.28 89.38 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.755 0.659 . . . . 0.0 110.496 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' HB ' HD13 ' A' ' 43' ' ' ILE . 43.8 t -68.99 -38.13 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.732 0.813 . . . . 0.0 110.495 -177.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.52 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 24.7 tm0? -63.91 -51.54 64.01 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.136 0.974 . . . . 0.0 110.033 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 ttp-105 -63.33 -41.39 98.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.848 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.1 -40.92 95.57 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.827 0.851 . . . . 0.0 111.053 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' HA ' ' HE2' ' A' ' 73' ' ' LYS . 47.0 m-85 -88.06 37.05 0.79 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.777 0.831 . . . . 0.0 111.44 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 t -77.04 82.2 3.55 Favored 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 167.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 172.23 -39.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.265 1.426 . . . . 0.0 107.871 -162.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.2 m -103.29 169.91 8.27 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.269 174.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' H ' ' HG3' ' A' ' 66' ' ' GLU . 31.3 mmmt -117.82 85.87 2.42 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HA ' HD23 ' A' ' 61' ' ' LEU . 32.7 mt -65.28 126.18 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -42.31 -68.21 0.21 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.938 1.695 . . . . 0.0 113.928 -161.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -104.53 41.3 1.34 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.159 0.584 . . . . 0.0 110.477 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.77 -137.17 36.37 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -173.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HB2' ' HG3' ' A' ' 28' ' ' GLN . . . -70.0 -4.59 21.56 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 117.739 0.77 . . . . 0.0 112.375 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -83.52 -1.5 53.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.218 0.607 . . . . 0.0 111.326 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.04 5.29 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 173.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.426 HD13 ' HB ' ' A' ' 27' ' ' VAL . 69.0 mt -131.86 105.31 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 124.038 0.935 . . . . 0.0 109.218 -176.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.2 95.34 5.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.327 1.051 . . . . 0.0 110.318 -172.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -66.08 124.15 21.8 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 175.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.566 HD12 ' HG3' ' A' ' 56' ' ' GLU . 71.1 mt -70.97 90.98 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -76.73 142.6 40.4 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.855 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 71.2 p -75.9 -177.09 3.68 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.842 0.857 . . . . 0.0 110.084 176.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.8 -8.97 48.25 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -110.7 14.1 22.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.97 0.908 . . . . 0.0 110.294 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 66.35 36.25 91.38 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.56 0.584 . . . . 0.0 114.56 174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 47.5 mtm105 -114.15 134.42 22.21 Favored Pre-proline 0 N--CA 1.484 1.243 0 CA-C-O 118.837 -0.602 . . . . 0.0 109.794 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.71 127.52 22.85 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.293 1.995 . . . . 0.0 110.953 177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.4 t -81.28 21.88 0.72 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.864 0.866 . . . . 0.0 111.565 -175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.26 -6.62 75.34 Favored Glycine 0 C--N 1.353 1.514 0 C-N-CA 123.186 0.422 . . . . 0.0 112.966 -176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HG3' HD12 ' A' ' 46' ' ' ILE . 11.7 pt-20 -139.32 169.77 17.17 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -151.56 167.41 28.15 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 112.954 -1.93 . . . . 0.0 109.81 -176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -108.47 136.64 47.75 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 163.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -121.95 114.94 44.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -78.94 148.16 32.74 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 177.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 36' ' ' ILE . 77.1 mt -133.62 170.94 14.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.757 0.823 . . . . 0.0 110.205 -173.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -74.79 -39.47 61.7 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.02 -174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 t -160.42 174.11 14.61 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -73.32 -13.3 61.09 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.928 0.491 . . . . 0.0 111.596 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -66.81 -40.93 88.23 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.679 0.752 . . . . 0.0 109.706 170.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 35' ' ' LYS . 6.6 mp0 -62.29 -40.96 97.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.91 169.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 58.0 t -60.47 -53.98 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 123.526 0.516 . . . . 0.0 110.93 -178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -54.34 -39.03 66.71 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.406 ' O ' ' HG3' ' A' ' 72' ' ' LYS . 94.8 mt -73.79 -36.01 64.97 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.262 0.625 . . . . 0.0 111.663 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.516 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -57.21 -49.29 76.45 Favored 'General case' 0 CA--C 1.55 0.977 0 O-C-N 123.799 0.687 . . . . 0.0 109.875 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 42.7 mt -59.74 -44.56 93.75 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.622 0.769 . . . . 0.0 111.644 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 69' ' ' LEU . 1.7 pptp? -70.64 -26.28 63.39 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.564 -174.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -90.08 20.46 4.28 Favored 'General case' 0 C--N 1.364 1.233 0 CA-C-O 120.762 0.315 . . . . 0.0 111.041 -178.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -75.88 -23.32 55.6 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.78 173.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -57.81 -43.6 85.8 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.761 0.824 . . . . 0.0 110.892 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.45 178.61 5.8 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.521 1.128 . . . . 0.0 113.361 -172.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 p -112.88 136.74 52.19 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.678 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.6 tpt -57.54 -66.2 0.5 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.214 1.006 . . . . 0.0 109.546 173.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.55 -33.95 0.47 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 164.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -146.46 -46.06 0.19 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.904 0.882 . . . . 0.0 109.083 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -61.85 135.22 57.49 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.7 0.8 . . . . 0.0 110.759 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.02 126.72 31.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.32 116.64 28.41 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.033 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -95.57 117.28 30.15 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB1' ' A' ' 70' ' ' ALA . 23.2 t -115.98 114.85 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -108.76 132.96 53.46 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.178 0.991 . . . . 0.0 109.878 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -59.96 110.61 1.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.078 0.951 . . . . 0.0 109.91 173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 m -116.37 -168.26 1.41 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.385 0.674 . . . . 0.0 110.542 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -140.26 156.87 46.31 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.544 1.137 . . . . 0.0 108.587 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.659 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 20.9 t-20 -71.22 -32.17 68.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.935 0.894 . . . . 0.0 109.949 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.1 t -55.66 -47.0 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.171 0.988 . . . . 0.0 109.909 170.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.534 ' HG2' ' HD3' ' A' ' 105' ' ' PRO . 14.8 tp10 -68.2 -49.78 58.6 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.115 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -54.35 -49.28 70.15 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.589 1.155 . . . . 0.0 111.24 -178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.68 -42.11 95.59 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.009 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 79.4 t90 -63.51 -37.24 86.55 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 124.163 0.914 . . . . 0.0 110.809 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 82.1 t -78.3 -30.15 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 122.83 0.452 . . . . 0.0 111.435 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 88.6 mt -73.77 -16.68 61.16 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.397 -0.815 . . . . 0.0 111.083 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -94.11 -33.59 13.29 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.855 0.862 . . . . 0.0 110.633 170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -134.21 83.51 2.04 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.4 p -70.2 76.76 0.52 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.844 0.857 . . . . 0.0 111.881 -172.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.65 71.61 0.27 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.32 100.62 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.872 2.381 . . . . 0.0 112.475 -175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -94.91 -14.97 24.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.037 0.935 . . . . 0.0 110.355 169.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 m 75.17 148.26 0.12 Allowed Pre-proline 0 C--N 1.367 1.365 0 C-N-CA 125.766 1.626 . . . . 0.0 111.545 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.534 ' HD3' ' HG2' ' A' ' 92' ' ' GLU . 89.5 Cg_endo -79.74 -24.43 6.1 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.08 1.853 . . . . 0.0 111.866 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t70 55.97 81.69 0.12 Allowed 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.978 1.311 . . . . 0.0 109.645 -173.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.9 p -83.32 59.7 5.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.02 -174.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.03 91.14 3.06 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -77.31 85.03 3.74 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.495 -173.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.0 -32.13 56.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.145 0.978 . . . . 0.0 110.221 177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.213 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.818 179.701 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -60.16 124.45 20.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.171 0.988 . . . . 0.0 110.245 -173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 13.8 tpt 76.74 -59.49 0.49 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 126.148 1.779 . . . . 0.0 110.308 -171.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 155.61 -72.68 0.25 Allowed Glycine 0 C--O 1.243 0.669 0 N-CA-C 108.461 -1.855 . . . . 0.0 108.461 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.14 -110.82 0.45 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.308 -0.446 . . . . 0.0 113.168 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 59.12 15.21 3.94 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.884 1.674 . . . . 0.0 111.841 -166.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.27 89.11 0.43 Allowed Glycine 0 C--N 1.348 1.204 0 N-CA-C 108.494 -1.843 . . . . 0.0 108.494 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HA ' HG21 ' A' ' 67' ' ' VAL . 1.7 p90 -81.0 24.02 0.53 Allowed 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -167.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 93' ' ' MET . 26.1 t -99.95 132.65 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 168.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.36 167.78 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.376 1.07 . . . . 0.0 110.57 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -117.14 126.47 52.86 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 5.1 t -106.13 108.25 24.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 C-N-CA 124.648 1.179 . . . . 0.0 107.974 -173.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -119.16 142.45 47.94 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 124.595 1.158 . . . . 0.0 108.939 -167.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.91 27.87 15.38 Favored Glycine 0 N--CA 1.473 1.129 0 CA-C-O 121.627 0.571 . . . . 0.0 111.753 -175.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.42 143.05 33.65 Favored Pre-proline 0 C--O 1.242 0.703 0 C-N-CA 123.853 0.861 . . . . 0.0 109.132 174.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HG2' ' HB3' ' A' ' 22' ' ' CYS . 31.0 Cg_endo -63.92 146.1 91.01 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 121.916 1.744 . . . . 0.0 110.645 167.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.627 ' HE1' ' HB3' ' A' ' 52' ' ' ARG . 83.6 t90 -52.41 -45.96 66.1 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.248 1.019 . . . . 0.0 111.212 178.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.7 p -92.99 35.28 1.06 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.432 1.093 . . . . 0.0 112.03 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.458 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 14.2 p -73.65 -170.87 0.92 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.224 0.61 . . . . 0.0 110.622 173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.593 ' HB2' ' HG2' ' A' ' 26' ' ' GLU . 46.4 m -146.46 154.55 41.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.013 0.925 . . . . 0.0 109.012 173.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.25 -38.05 79.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.694 0.798 . . . . 0.0 111.457 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -60.99 -38.77 87.2 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.686 0.794 . . . . 0.0 111.371 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.593 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 34.2 mm-40 -67.61 -40.86 84.69 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.404 0.681 . . . . 0.0 110.855 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.53 -35.55 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.527 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -61.34 -45.97 92.19 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.659 0.784 . . . . 0.0 110.473 175.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -63.57 -36.96 85.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.089 0.556 . . . . 0.0 110.901 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -60.13 -39.78 87.48 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.905 0.482 . . . . 0.0 110.289 174.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.589 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 67.9 m-85 -90.03 40.17 0.99 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.14 0.576 . . . . 0.0 111.792 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.3 p -74.51 87.22 2.09 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 170.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 166.4 -53.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 127.339 2.256 . . . . 0.0 106.697 -168.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.9 m -89.08 127.76 35.72 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.956 -169.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 94.71 2.96 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 61' ' ' LEU . 18.5 mt -74.93 147.91 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 118.334 -0.841 . . . . 0.0 108.855 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -39.24 -68.54 0.16 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.906 1.682 . . . . 0.0 112.323 -172.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -128.57 51.02 2.04 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 170.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.05 -128.07 33.62 Favored Glycine 0 C--N 1.351 1.376 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.193 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.34 -22.8 66.86 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.715 0.758 . . . . 0.0 112.031 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -75.33 -17.38 60.26 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.879 0.472 . . . . 0.0 111.413 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.64 29.25 9.33 Favored Glycine 0 C--N 1.351 1.393 0 O-C-N 123.266 0.353 . . . . 0.0 112.287 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.537 HG12 HG22 ' A' ' 59' ' ' VAL . 52.7 mt -130.37 131.38 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.149 1.38 . . . . 0.0 108.3 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.51 103.58 4.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.58 0.752 . . . . 0.0 109.563 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -69.06 145.7 53.25 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.276 0.63 . . . . 0.0 110.263 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.493 HD12 ' HG3' ' A' ' 56' ' ' GLU . 45.7 mt -73.7 91.34 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 176.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -78.47 146.72 34.27 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.784 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -84.79 -178.83 6.96 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.147 169.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -75.07 5.17 5.58 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 122.594 0.358 . . . . 0.0 111.945 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -102.6 -4.64 24.91 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.532 0.733 . . . . 0.0 109.756 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.6 37.95 38.97 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.418 -177.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.627 ' HB3' ' HE1' ' A' ' 20' ' ' TRP . 76.0 mtt180 -120.48 130.68 24.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 123.768 0.827 . . . . 0.0 110.983 -173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.7 132.23 41.75 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.083 2.522 . . . . 0.0 112.171 175.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 p -79.29 12.51 2.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.161 0.985 . . . . 0.0 113.021 -177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 -6.69 83.38 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 112.155 -0.378 . . . . 0.0 112.155 -173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.493 ' HG3' HD12 ' A' ' 46' ' ' ILE . 5.0 pt-20 -133.76 163.08 30.28 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.0 0.92 . . . . 0.0 111.579 175.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.35 167.96 24.68 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.687 -170.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -118.8 111.79 18.89 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.845 0.858 . . . . 0.0 110.315 171.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 43' ' ' ILE . 44.4 t -96.53 146.67 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.46 1.104 . . . . 0.0 108.181 171.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' HG3' HG22 ' A' ' 12' ' ' VAL . 35.4 tt0 -126.72 144.09 51.04 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 36' ' ' ILE . 50.8 mt -129.38 146.3 51.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.356 0.662 . . . . 0.0 109.601 -167.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -72.9 -19.05 61.35 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -174.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.6 m -147.7 151.47 36.17 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.693 0.797 . . . . 0.0 109.119 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -80.81 -3.68 51.95 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 120.802 0.334 . . . . 0.0 111.628 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -62.26 -50.07 73.19 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 166.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -57.36 -31.56 65.89 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.495 -1.684 . . . . 0.0 112.359 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.568 HG21 ' HA ' ' A' ' 11' ' ' PHE . 53.2 t -66.14 -41.85 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.163 0.585 . . . . 0.0 110.679 176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -57.22 -41.06 78.75 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.739 0.416 . . . . 0.0 110.904 174.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.9 mt -68.95 -32.58 72.28 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.634 0.774 . . . . 0.0 111.043 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.1 -52.55 33.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.951 0.901 . . . . 0.0 110.845 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 76.0 mt -61.03 -28.2 68.88 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.663 1.185 . . . . 0.0 111.387 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -67.0 -25.28 66.23 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.48 1.112 . . . . 0.0 110.8 177.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 31' ' ' PHE . 67.3 mttm -83.76 6.92 19.44 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.186 0.994 . . . . 0.0 113.503 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -60.47 -2.47 0.5 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -121.01 -24.39 5.59 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.343 0.657 . . . . 0.0 111.889 176.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.556 ' HG2' ' HA ' ' A' ' 73' ' ' LYS . 6.6 mm-40 -59.26 148.53 31.58 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.6 p -98.66 126.98 44.43 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.841 0.856 . . . . 0.0 110.535 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -68.95 -78.48 0.07 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -130.93 89.42 0.29 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 170.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 73.6 m80 76.35 -54.35 0.59 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 126.056 1.742 . . . . 0.0 111.284 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -70.18 147.16 50.19 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.923 0.889 . . . . 0.0 111.396 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -86.25 142.31 28.66 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.387 1.075 . . . . 0.0 108.681 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 74.0 t -120.14 131.13 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.516 0.726 . . . . 0.0 109.824 -179.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.8 141.84 28.16 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.391 1.477 . . . . 0.0 108.562 175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.3 t -130.61 123.25 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -125.1 146.73 49.33 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.332 1.053 . . . . 0.0 108.814 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HE2' HG11 ' A' ' 67' ' ' VAL . 39.9 ttmt -68.53 120.73 15.05 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.778 0.323 . . . . 0.0 110.491 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 56.1 m -86.54 -61.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.833 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 42.1 t30 83.31 148.07 0.08 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.883 1.673 . . . . 0.0 108.54 -163.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -57.92 -34.33 69.73 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.395 1.078 . . . . 0.0 112.408 -173.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.5 t -64.9 -41.96 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 123.755 0.822 . . . . 0.0 110.368 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -67.6 -43.67 79.92 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.777 0.831 . . . . 0.0 110.612 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.488 ' HB2' HG11 ' A' ' 12' ' ' VAL . 16.4 tmm? -54.23 -53.13 57.79 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 124.061 0.85 . . . . 0.0 110.918 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.6 -51.6 66.68 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.032 -176.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -63.99 -51.95 61.87 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.122 0.969 . . . . 0.0 111.808 -171.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.88 -48.66 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.265 1.026 . . . . 0.0 112.429 -174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.99 -43.14 83.73 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.682 0.614 . . . . 0.0 110.18 -172.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -70.96 -6.48 38.99 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.62 0.768 . . . . 0.0 112.017 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -96.72 -92.42 0.23 Allowed 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 168.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.6 t 170.93 -35.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.235 1.014 . . . . 0.0 110.517 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -110.39 155.41 16.12 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-O 119.115 -0.825 . . . . 0.0 112.842 -175.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.83 137.75 22.54 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.977 2.451 . . . . 0.0 113.444 -175.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -87.09 -20.29 27.32 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.627 0.771 . . . . 0.0 109.578 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.445 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 11.1 m -44.5 118.28 3.24 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 125.535 1.534 . . . . 0.0 111.958 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 13.0 Cg_exo -69.68 79.57 0.91 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.02 87.54 2.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.827 -171.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.4 p -152.35 95.64 2.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.227 1.411 . . . . 0.0 107.912 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -126.8 -77.24 0.58 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 48.11 83.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 124.884 1.274 . . . . 0.0 112.645 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -123.38 121.71 36.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.495 -174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 178.601 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 10.2 t . . . . . 0 C--O 1.243 0.726 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 72.99 132.02 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.194 1.398 . . . . 0.0 111.923 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -137.44 174.91 10.09 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.311 1.044 . . . . 0.0 109.43 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.26 -61.76 1.82 Allowed Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -175.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 108' ' ' ALA . . . 161.1 -112.16 0.51 Allowed Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.976 -0.346 . . . . 0.0 112.777 176.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 58.9 177.86 0.07 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.123 1.369 . . . . 0.0 112.088 -168.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.21 -70.04 0.02 OUTLIER Glycine 0 C--N 1.335 0.525 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 58.0 7.71 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 124.902 1.281 . . . . 0.0 113.701 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.4 t -150.49 133.58 7.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.517 HG11 ' HB3' ' A' ' 70' ' ' ALA . 27.2 m -108.36 163.73 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.319 0.581 . . . . 0.0 110.427 170.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 104' ' ' SER . 35.3 ttpt -122.15 126.56 48.6 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 24.1 t -110.15 126.23 67.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 124.672 1.189 . . . . 0.0 108.673 -168.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.5 tmm_? -133.52 135.48 44.43 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.1 14.19 10.2 Favored Glycine 0 N--CA 1.47 0.94 0 O-C-N 123.427 0.454 . . . . 0.0 112.202 -168.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.453 ' HB3' ' SG ' ' A' ' 22' ' ' CYS . 88.0 mt -87.18 125.45 66.03 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.01 153.65 56.35 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.005 1.803 . . . . 0.0 111.615 171.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -54.99 -46.65 75.15 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.408 0.683 . . . . 0.0 109.597 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.3 t -86.15 17.16 3.76 Favored 'General case' 0 CA--C 1.555 1.148 0 CA-C-N 115.08 -0.963 . . . . 0.0 112.443 -171.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 18' ' ' LEU . 18.8 p -86.98 137.98 31.9 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 t -89.27 163.71 15.25 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.298 0.639 . . . . 0.0 110.202 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.63 -39.91 71.44 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.631 0.773 . . . . 0.0 110.873 172.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.43 -38.19 88.75 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 0.0 111.992 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -66.77 -43.11 84.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 122.984 0.514 . . . . 0.0 110.908 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.43 -38.7 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.648 0.779 . . . . 0.0 110.069 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.487 ' HG3' HD12 ' A' ' 36' ' ' ILE . 50.3 tt0 -69.42 -40.08 77.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.678 0.791 . . . . 0.0 110.213 -178.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -58.26 -47.44 83.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.252 1.021 . . . . 0.0 110.064 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -61.29 -43.78 98.3 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.593 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 38.7 m-85 -87.5 29.59 0.87 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.052 0.941 . . . . 0.0 112.191 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.8 m -80.31 90.53 5.56 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 167.45 -52.5 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.126 1.771 . . . . 0.0 107.014 -167.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 32.0 p -85.57 130.67 34.52 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.443 174.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -74.15 90.39 2.04 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 HD12 ' HG3' ' A' ' 28' ' ' GLN . 16.9 mt -68.96 129.69 33.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -48.73 -58.44 4.76 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 124.61 1.194 . . . . 0.0 113.382 -160.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -127.09 41.14 3.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.204 0.602 . . . . 0.0 109.614 170.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 67.14 -128.63 28.44 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.67 176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.75 -23.68 63.43 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.67 0.788 . . . . 0.0 112.853 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.4 -21.18 63.79 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.704 0.402 . . . . 0.0 110.554 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -108.35 36.69 4.21 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 123.259 0.457 . . . . 0.0 112.131 170.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 66.4 mt -127.29 108.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 171.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HB2' ' HB2' ' A' ' 58' ' ' PHE . 73.6 mtt-85 -118.07 92.61 3.87 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.043 -166.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -68.67 135.46 51.4 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.1 mt -74.46 93.05 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.36 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.94 132.95 34.72 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 76.4 p -82.23 -176.0 5.96 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.679 0.792 . . . . 0.0 110.906 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.2 ptt180 -68.74 -14.0 62.74 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.18 0.592 . . . . 0.0 111.663 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -87.26 -14.49 40.8 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.501 0.72 . . . . 0.0 110.39 172.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.91 26.05 46.84 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.622 -0.717 . . . . 0.0 113.009 -171.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 33.1 ttm180 -100.98 125.71 37.42 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.373 0.669 . . . . 0.0 109.56 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.86 129.14 19.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.914 1.743 . . . . 0.0 109.866 169.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -75.89 -3.87 37.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.951 0.9 . . . . 0.0 112.019 -172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.61 6.01 77.66 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 44.8 mt-10 -115.51 150.62 36.26 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.2 1.0 . . . . 0.0 109.829 173.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -146.25 161.67 39.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.047 0.939 . . . . 0.0 110.047 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 44' ' ' ARG . 93.9 m-85 -109.83 105.35 14.52 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 170.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.48 102.41 13.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -78.38 132.57 37.42 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.343 -176.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 94.9 mt -119.75 152.11 37.72 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.752 0.421 . . . . 0.0 110.925 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -67.87 -35.9 79.35 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.48 1.112 . . . . 0.0 112.502 -175.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.517 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 17.3 m -142.17 152.35 43.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.577 -169.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -67.08 -25.79 66.41 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.793 0.837 . . . . 0.0 112.46 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.58 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 6.1 p-10 -73.05 -36.79 66.98 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 63' ' ' SER . 68.7 mm-40 -54.49 -39.09 67.21 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 167.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 88.1 t -67.3 -53.4 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.604 0.761 . . . . 0.0 111.733 -175.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HE3' ' HA ' ' A' ' 65' ' ' ASP . 18.1 ptpt -55.22 -38.54 68.57 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 123.647 0.592 . . . . 0.0 112.019 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.8 mt -71.81 -36.69 70.34 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.861 0.864 . . . . 0.0 111.18 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.517 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -62.25 -36.58 82.46 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.021 173.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD11 ' HE3' ' A' ' 87' ' ' LYS . 64.0 mt -64.98 -32.32 73.99 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.882 0.473 . . . . 0.0 111.046 173.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 68' ' ' LYS . 57.8 mttm -78.75 -17.1 56.35 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.389 0.676 . . . . 0.0 110.489 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HE2' ' HA ' ' A' ' 31' ' ' PHE . 60.8 tttp -80.97 -1.3 43.16 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.538 1.135 . . . . 0.0 111.162 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.18 -17.32 52.43 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.942 0.897 . . . . 0.0 112.732 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -86.41 -37.69 18.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.711 0.804 . . . . 0.0 111.221 -172.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -63.59 157.13 24.6 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -101.16 133.67 45.35 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.811 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.616 ' HB2' HG21 ' A' ' 83' ' ' VAL . 25.3 ttt -61.19 -70.31 0.19 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 123.567 0.542 . . . . 0.0 110.147 174.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -121.27 -40.37 0.55 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 172.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -150.29 -46.53 0.13 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.718 0.807 . . . . 0.0 109.306 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -61.07 140.2 57.91 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.899 0.879 . . . . 0.0 110.744 173.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -81.54 125.54 30.62 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 173.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.616 HG21 ' HB2' ' A' ' 78' ' ' MET . 67.8 t -106.91 107.66 23.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -97.03 137.73 35.65 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.675 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.26 119.17 53.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-N 114.455 -1.248 . . . . 0.0 108.599 -165.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -115.57 140.51 49.1 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.574 1.15 . . . . 0.0 108.657 -174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' HE3' HD11 ' A' ' 71' ' ' LEU . 29.3 ttmt -62.23 123.16 17.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.094 0.473 . . . . 0.0 110.882 176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.9 p -110.93 -172.62 2.07 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.551 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -145.29 169.07 18.97 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -174.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.8 -44.3 97.02 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.46 -46.21 95.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.68 0.792 . . . . 0.0 110.749 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.655 ' HG3' ' HD2' ' A' ' 105' ' ' PRO . 38.2 tt0 -65.13 -53.92 37.75 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.799 -177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -62.09 -37.62 85.74 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 122.636 0.374 . . . . 0.0 111.623 -173.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.47 -45.83 91.27 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.637 0.375 . . . . 0.0 110.649 176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 62.0 t-105 -63.81 -53.68 46.96 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 124.047 0.842 . . . . 0.0 111.733 -177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 92' ' ' GLU . 61.5 t -67.43 -37.84 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.462 0.705 . . . . 0.0 111.202 -170.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.0 mt -72.5 -41.61 65.75 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.626 0.37 . . . . 0.0 111.249 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -75.81 -32.27 59.76 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.659 0.384 . . . . 0.0 110.971 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -96.81 -16.63 20.69 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.291 0.636 . . . . 0.0 110.965 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.4 p 49.04 63.16 2.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 125.399 1.479 . . . . 0.0 111.611 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -141.45 128.18 3.58 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 118.486 -1.174 . . . . 0.0 111.139 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -70.86 83.15 0.91 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.881 2.388 . . . . 0.0 111.098 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -148.0 146.45 28.93 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.642 -176.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.463 ' HB3' ' NZ ' ' A' ' 14' ' ' LYS . 60.8 p -131.56 104.66 14.51 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.512 0.725 . . . . 0.0 110.041 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.655 ' HD2' ' HG3' ' A' ' 92' ' ' GLU . 50.1 Cg_exo -58.58 130.27 36.45 Favored 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.462 2.108 . . . . 0.0 111.222 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -51.63 -61.36 2.3 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.004 1.322 . . . . 0.0 111.359 -176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.6 m 54.51 53.28 10.97 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.933 1.293 . . . . 0.0 112.095 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.501 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . . . -139.41 -97.45 0.16 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.104 174.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 44.9 t30 56.54 90.01 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.961 0.904 . . . . 0.0 111.671 -174.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -84.4 97.56 9.56 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.507 0 CA-C-O 119.449 -0.639 . . . . 0.0 112.792 -178.088 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 C--O 1.245 0.83 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -64.97 99.93 0.38 Allowed 'General case' 0 CA--C 1.544 0.724 0 O-C-N 123.587 0.554 . . . . 0.0 110.386 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 49.9 mtt -67.1 106.24 1.92 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.17 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.04 136.85 2.57 Favored Glycine 0 C--O 1.243 0.679 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.79 78.46 0.22 Allowed Glycine 0 C--N 1.341 0.834 0 CA-C-N 117.038 0.419 . . . . 0.0 112.791 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -74.57 -17.99 60.64 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.858 0.863 . . . . 0.0 109.957 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 89' ' ' ASN . . . -119.33 135.05 11.05 Favored Glycine 0 C--N 1.35 1.307 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.111 175.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -100.07 21.94 12.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.866 0.866 . . . . 0.0 109.709 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.6 142.36 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 125.39 1.476 . . . . 0.0 107.097 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.46 HG12 HG13 ' A' ' 67' ' ' VAL . 32.6 m -108.4 -176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.95 0.5 . . . . 0.0 110.449 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -144.8 144.44 31.16 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.6 t -118.37 136.3 56.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 124.867 1.267 . . . . 0.0 107.885 -168.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 137.69 47.81 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 113.01 15.91 8.84 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 111.745 -0.542 . . . . 0.0 111.745 -170.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.9 mt -97.27 122.0 57.15 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.39 166.13 26.55 Favored 'Trans proline' 0 C--N 1.366 1.479 0 C-N-CA 122.077 1.851 . . . . 0.0 112.356 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -69.44 -28.6 66.26 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.469 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.1 p -89.74 7.32 37.44 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 124.16 0.984 . . . . 0.0 112.974 -177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.4 p -71.63 167.52 19.62 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 118.835 0.743 . . . . 0.0 111.993 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 23.4 m -120.67 148.96 43.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.856 0.862 . . . . 0.0 109.81 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.38 -33.4 67.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.168 0.587 . . . . 0.0 111.239 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 33.1 t70 -54.94 -49.89 70.22 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.998 0.919 . . . . 0.0 112.383 175.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 23' ' ' SER . 12.3 pt-20 -72.91 -35.58 67.11 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.968 -0.106 . . . . 0.0 110.823 -174.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -66.46 -35.04 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-O 121.268 0.556 . . . . 0.0 109.802 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.54 ' HG3' HD12 ' A' ' 36' ' ' ILE . 34.6 tt0 -72.93 -29.69 63.32 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.415 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 67.0 mtt180 -68.61 -33.81 74.68 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.017 0.527 . . . . 0.0 110.82 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -68.95 -26.72 65.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.118 0.567 . . . . 0.0 110.098 176.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -110.46 26.66 10.44 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.654 0.782 . . . . 0.0 111.267 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 29' ' ' ARG . 10.7 t -83.18 84.85 7.33 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.498 ' HB3' ' HZ1' ' A' ' 73' ' ' LYS . 24.8 t70 159.82 -43.34 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.625 1.57 . . . . 0.0 107.684 -159.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.1 m -82.63 175.86 9.83 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.909 -1.496 . . . . 0.0 109.295 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 3.6 mppt? -130.89 98.88 4.73 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.54 HD12 ' HG3' ' A' ' 28' ' ' GLN . 16.7 mt -82.15 134.34 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.477 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -82.01 34.44 0.41 Allowed 'General case' 0 CA--C 1.568 1.671 0 C-N-CA 124.175 0.99 . . . . 0.0 111.831 -168.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 173.29 -7.61 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 125.497 1.519 . . . . 0.0 110.523 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.6 17.7 Favored Glycine 0 C--N 1.359 1.814 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.68 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.65 -32.47 72.64 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.248 0.619 . . . . 0.0 111.184 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.69 -13.31 60.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.57 -176.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.35 -12.14 61.78 Favored Glycine 0 C--N 1.353 1.487 0 CA-C-N 116.746 -0.206 . . . . 0.0 112.808 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.0 mt -81.64 90.16 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 174.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 18.3 tpp180 -84.25 92.24 7.93 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.412 -171.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -66.88 127.12 31.32 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.799 0.44 . . . . 0.0 110.706 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 56' ' ' GLU . 41.9 mt -71.25 96.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.676 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' HB3' ' HA2' ' A' ' 51' ' ' GLY . 41.0 m-85 -82.92 133.96 35.09 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.2 p -77.27 -170.83 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 O-C-N 124.175 0.922 . . . . 0.0 111.691 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -55.06 -28.72 54.47 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.094 0.958 . . . . 0.0 112.138 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -104.17 4.13 33.69 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.575 0.75 . . . . 0.0 110.272 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.512 ' HA2' ' HB3' ' A' ' 47' ' ' TYR . . . 73.89 32.89 58.38 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 114.002 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -94.92 141.63 23.55 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.759 0.824 . . . . 0.0 109.746 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -61.31 110.32 0.88 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 121.938 1.759 . . . . 0.0 109.681 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.4 t -63.25 -8.2 7.8 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.608 1.163 . . . . 0.0 113.165 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.08 -14.83 51.91 Favored Glycine 0 C--N 1.342 0.885 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -171.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.537 ' HB2' HD12 ' A' ' 46' ' ' ILE . 40.0 mt-10 -121.65 159.73 25.91 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.369 1.068 . . . . 0.0 111.642 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -154.26 149.98 27.54 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.181 177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.49 ' HB2' ' HB3' ' A' ' 44' ' ' ARG . 98.5 m-85 -91.54 155.57 18.29 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.1 t -136.06 109.28 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -78.85 119.26 21.79 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.094 0.958 . . . . 0.0 109.407 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 76.7 mt -116.09 154.43 29.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.339 0.655 . . . . 0.0 110.296 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.1 -30.25 70.72 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.27 1.028 . . . . 0.0 111.393 -175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.3 t -156.41 162.98 39.98 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 123.82 0.848 . . . . 0.0 110.472 -175.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -70.49 -13.88 62.3 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 122.946 0.499 . . . . 0.0 111.497 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t70 -60.07 -53.4 58.19 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.557 ' HG2' ' H ' ' A' ' 35' ' ' LYS . 2.1 mp0 -59.5 -32.68 70.51 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.321 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG13 HG12 ' A' ' 13' ' ' VAL . 54.4 t -61.85 -49.52 83.9 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.816 0 O-C-N 123.647 0.592 . . . . 0.0 110.332 174.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -53.02 -44.04 67.0 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.483 1.113 . . . . 0.0 111.913 175.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 65' ' ' ASP . 64.5 mt -60.88 -46.91 88.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.493 0.717 . . . . 0.0 110.099 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 85' ' ' VAL . . . -59.4 -46.55 88.38 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.741 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 67' ' ' VAL . 95.3 mt -57.12 -35.83 69.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.686 1.195 . . . . 0.0 111.792 175.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -77.3 -18.55 57.42 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.875 0.47 . . . . 0.0 111.654 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.498 ' HZ1' ' HB3' ' A' ' 33' ' ' ASP . 90.4 mttt -88.61 6.99 35.59 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.1 0.56 . . . . 0.0 110.938 175.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 1.6 p-10 -65.53 -15.61 62.86 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.989 0.515 . . . . 0.0 111.642 173.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -90.26 -31.11 17.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.066 0.946 . . . . 0.0 110.925 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.12 151.92 34.34 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.672 0.789 . . . . 0.0 112.294 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -116.37 130.69 56.9 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.125 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 89.7 mmm -79.31 83.18 5.37 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.81 -96.47 2.1 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -170.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -126.01 3.73 7.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.813 0.845 . . . . 0.0 110.031 168.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 83' ' ' VAL . 20.3 mmt180 -70.93 110.39 5.62 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -70.2 109.48 4.67 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 81' ' ' ARG . 55.7 t -114.36 115.32 49.23 Favored 'Isoleucine or valine' 0 C--N 1.347 0.457 0 C-N-CA 123.296 0.639 . . . . 0.0 109.487 -169.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 74' ' ' ASP . 2.1 pm0 -99.56 146.22 26.66 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.385 1.074 . . . . 0.0 109.724 177.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.599 HG11 ' HB1' ' A' ' 70' ' ' ALA . 45.4 t -129.89 124.74 59.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -107.67 178.39 4.54 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.716 1.206 . . . . 0.0 108.235 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -106.94 127.7 53.67 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.3 m -113.67 -164.54 0.93 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.216 1.006 . . . . 0.0 110.883 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.553 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 49.3 t-20 -147.18 159.99 42.98 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -64.07 -35.78 81.86 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.891 0.476 . . . . 0.0 109.835 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.05 -41.81 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.641 0.776 . . . . 0.0 110.162 177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.51 -44.15 97.07 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 44.3 ttp -58.96 -36.2 74.41 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.107 0.963 . . . . 0.0 110.532 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.1 -55.73 19.95 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.102 0.561 . . . . 0.0 110.951 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.501 ' HE3' HD21 ' A' ' 103' ' ' ASN . 14.0 m0 -63.86 -31.65 72.9 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.971 0.908 . . . . 0.0 112.525 -173.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.9 t -76.87 -42.64 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.309 0.643 . . . . 0.0 110.999 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.74 -22.3 59.93 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.468 0.307 . . . . 0.0 111.175 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -91.61 -30.33 16.42 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.876 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -137.43 86.45 2.19 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.691 0.796 . . . . 0.0 108.95 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 t -79.97 83.11 5.93 Favored 'General case' 0 CA--C 1.555 1.165 0 CA-C-O 122.46 1.124 . . . . 0.0 110.261 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.05 -136.37 4.03 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.485 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.26 -40.68 31.14 Favored 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 123.102 2.535 . . . . 0.0 112.75 177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.501 HD21 ' HE3' ' A' ' 95' ' ' TRP . 42.4 t30 70.96 143.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 125.218 1.407 . . . . 0.0 112.039 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 40.6 m 72.68 135.75 0.05 OUTLIER Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 125.617 1.567 . . . . 0.0 112.543 179.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 26.9 Cg_exo -64.59 177.47 2.2 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.923 2.416 . . . . 0.0 113.274 174.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -53.72 -48.58 69.47 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.446 1.098 . . . . 0.0 112.037 -174.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.5 m 69.19 -67.59 0.21 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.526 1.53 . . . . 0.0 111.263 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.71 154.66 42.98 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.838 1.255 . . . . 0.0 109.307 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -79.61 78.31 6.17 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.392 0.615 . . . . 0.0 110.634 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -152.41 14.7 0.59 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.125 0.97 . . . . 0.0 110.071 175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.317 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.272 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 46.2 p . . . . . 0 C--O 1.244 0.768 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 61.17 -142.68 0.48 Allowed 'General case' 0 CA--C 1.566 1.586 0 CA-C-O 117.975 -1.012 . . . . 0.0 108.358 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 61.8 mtt 66.62 -74.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.329 1.052 . . . . 0.0 111.404 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -58.96 89.46 0.03 OUTLIER Glycine 0 C--N 1.354 1.544 0 C-N-CA 124.015 0.817 . . . . 0.0 113.902 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.99 -50.86 0.06 OUTLIER Glycine 0 C--N 1.343 0.93 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.1 97.8 11.4 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' HA3' ' HD3' ' A' ' 87' ' ' LYS . . . -82.47 -91.92 0.61 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.716 -0.953 . . . . 0.0 110.716 176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 59.07 13.52 2.95 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.075 1.35 . . . . 0.0 112.055 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.437 HG12 ' HB3' ' A' ' 88' ' ' SER . 37.4 t -145.71 143.27 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 70' ' ' ALA . 25.4 m -113.15 172.18 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-O 121.094 0.474 . . . . 0.0 111.966 169.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 85' ' ' VAL . 40.8 mtpt -116.36 135.4 53.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 172.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.3 t -111.01 117.39 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . 41.1 ttp180 -127.4 152.27 47.73 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.43 23.38 12.59 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -166.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.488 HD22 ' SG ' ' A' ' 22' ' ' CYS . 86.0 mt -97.53 134.04 22.98 Favored Pre-proline 0 C--O 1.245 0.832 0 C-N-CA 124.308 1.043 . . . . 0.0 109.406 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.42 163.57 17.42 Favored 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.776 2.317 . . . . 0.0 112.606 168.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -74.35 -8.09 55.07 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.059 176.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.2 m -113.32 16.12 19.07 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.286 1.034 . . . . 0.0 111.278 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.488 ' SG ' HD22 ' A' ' 18' ' ' LEU . 52.0 t -67.19 155.48 38.7 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.924 0.489 . . . . 0.0 111.632 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 26' ' ' GLU . 40.1 m -133.73 152.69 51.94 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.529 1.132 . . . . 0.0 110.555 -173.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -53.21 -43.65 67.38 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.402 1.081 . . . . 0.0 112.788 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.91 -47.78 67.73 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.536 1.135 . . . . 0.0 113.47 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 23' ' ' SER . 13.7 pt-20 -72.19 -35.49 68.96 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -176.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.8 -46.38 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.157 0.583 . . . . 0.0 110.032 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.601 ' HG3' HD12 ' A' ' 36' ' ' ILE . 28.2 tt0 -63.95 -40.76 97.18 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.617 0.767 . . . . 0.0 111.341 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -57.87 -46.8 84.31 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.795 0.684 . . . . 0.0 110.866 173.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -66.17 -32.92 74.66 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.741 -177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.643 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 93.4 m-85 -105.34 35.96 2.66 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.925 0.89 . . . . 0.0 110.659 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.9 t -60.59 -27.6 67.85 Favored 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.524 176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -65.55 -18.13 65.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 31' ' ' PHE . 30.2 p -111.44 135.49 51.94 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.311 0.644 . . . . 0.0 109.958 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -75.56 96.0 3.44 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.601 HD12 ' HG3' ' A' ' 28' ' ' GLN . 43.9 mt -78.85 123.41 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -177.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -62.81 125.85 25.35 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.302 1.041 . . . . 0.0 110.971 -175.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 60.74 23.15 13.07 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 125.177 1.391 . . . . 0.0 111.552 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.26 -134.96 45.5 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.379 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.48 -22.68 22.0 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.064 0.946 . . . . 0.0 113.274 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -68.05 -21.92 64.98 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.419 0.288 . . . . 0.0 110.875 -178.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.405 ' HA2' ' NH1' ' A' ' 44' ' ' ARG . . . -77.73 -16.84 79.62 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.016 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.9 mt -86.64 119.22 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 123.115 0.566 . . . . 0.0 109.633 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' NH1' ' HA2' ' A' ' 42' ' ' GLY . 0.2 OUTLIER -123.0 97.55 5.49 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.163 0.985 . . . . 0.0 109.695 177.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -66.16 142.9 57.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.029 0.532 . . . . 0.0 109.724 175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.586 HD12 ' HB2' ' A' ' 56' ' ' GLU . 23.6 mt -77.16 87.18 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 170.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' O ' ' HB ' ' A' ' 100' ' ' THR . 92.1 m-85 -75.34 134.29 41.04 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 173.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 50' ' ' GLU . 10.0 t -78.48 -175.54 4.33 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 3.4 tmm_? -68.94 -5.8 23.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.3 0.64 . . . . 0.0 110.973 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.531 ' H ' HG23 ' A' ' 48' ' ' THR . 37.6 mt-10 -100.31 -2.6 33.23 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.698 1.199 . . . . 0.0 110.96 176.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.95 36.81 31.07 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 115.072 0.789 . . . . 0.0 115.072 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 74.0 mtt85 -132.17 138.18 31.74 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.708 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -53.52 118.0 4.43 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 123.046 2.497 . . . . 0.0 111.695 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.8 p -93.3 40.25 1.06 Allowed 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.72 0.808 . . . . 0.0 111.129 -169.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.82 -37.23 3.58 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.252 -0.885 . . . . 0.0 113.0 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' HD12 ' A' ' 46' ' ' ILE . 36.5 mt-10 -110.13 161.56 15.44 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.803 0.811 . . . . 0.0 112.392 -176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.03 165.53 31.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.449 171.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -110.47 145.39 37.77 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 108.09 167.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.4 t -135.28 105.83 6.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -81.63 139.64 34.87 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 36' ' ' ILE . 74.8 mt -128.89 142.24 51.02 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.683 1.193 . . . . 0.0 109.283 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -65.29 -27.66 68.78 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.309 0.644 . . . . 0.0 111.54 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.581 ' HB2' ' HG2' ' A' ' 66' ' ' GLU . 19.5 m -136.52 150.44 48.65 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.17 0.588 . . . . 0.0 109.661 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 68' ' ' LYS . 15.9 tt0 -77.68 -8.34 57.77 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 120.915 0.388 . . . . 0.0 111.201 173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -65.39 -48.52 72.59 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 167.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.631 ' HB3' ' HB2' ' A' ' 34' ' ' CYS . 4.0 mm-40 -52.77 -38.29 60.81 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.668 171.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG22 HD12 ' A' ' 61' ' ' LEU . 66.7 t -64.22 -46.09 94.4 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 C-N-CA 123.31 0.644 . . . . 0.0 110.411 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 94.7 mttt -54.82 -42.07 71.43 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.384 0.674 . . . . 0.0 112.154 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.47 -50.22 70.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.89 0.876 . . . . 0.0 111.178 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB3' HG11 ' A' ' 13' ' ' VAL . . . -58.99 -45.29 91.0 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.144 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 85' ' ' VAL . 91.8 mt -56.05 -24.61 40.66 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.295 1.438 . . . . 0.0 113.425 177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -80.18 -9.84 59.73 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.151 0.58 . . . . 0.0 112.005 -177.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mttp -90.52 6.08 45.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.837 0.855 . . . . 0.0 111.356 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -57.88 -9.37 1.28 Allowed 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 124.785 1.234 . . . . 0.0 113.69 170.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -116.63 -40.15 3.23 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.371 1.068 . . . . 0.0 111.11 -177.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.41 163.67 15.28 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.1 p -105.41 130.82 53.43 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.067 -177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.442 ' HG3' HG21 ' A' ' 83' ' ' VAL . 53.4 mtp -64.83 -80.63 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 163.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.03 -103.34 2.02 Favored Glycine 0 N--CA 1.468 0.777 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 170.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 t60 -96.01 -1.61 48.57 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 124.24 1.016 . . . . 0.0 109.344 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -106.19 133.54 50.72 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.926 0.89 . . . . 0.0 109.631 -171.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -80.36 135.59 36.22 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.442 HG21 ' HG3' ' A' ' 78' ' ' MET . 98.7 t -97.79 130.94 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 16' ' ' ARG . 32.8 mt-10 -97.45 117.35 31.51 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 174.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 21.9 t -114.66 120.04 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -113.83 177.59 4.58 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 174.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.454 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 40.1 ttmt -101.88 116.12 32.02 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.437 ' HB3' HG12 ' A' ' 12' ' ' VAL . 46.4 t -87.05 161.55 18.1 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.14 0.971 . . . . 0.0 110.503 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -127.99 158.21 38.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.005 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -64.84 -34.34 78.13 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.927 0.491 . . . . 0.0 110.759 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.4 p -60.53 -41.84 89.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 123.532 0.733 . . . . 0.0 110.753 178.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.696 ' HG3' HD22 ' A' ' 103' ' ' ASN . 40.1 tt0 -69.44 -56.3 7.83 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.961 177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 44.9 ttm -52.11 -51.29 58.72 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 123.967 0.792 . . . . 0.0 111.72 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 98' ' ' LYS . 28.3 t70 -62.42 -43.01 99.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.664 0.786 . . . . 0.0 110.53 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -60.6 -38.59 85.15 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.143 0.577 . . . . 0.0 111.147 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 76.4 t -82.36 -30.48 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.702 0.801 . . . . 0.0 111.86 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 93' ' ' MET . 83.0 mt -75.69 -26.44 57.59 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.38 -0.825 . . . . 0.0 110.654 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 94' ' ' ASP . 1.2 mptm? -90.09 -25.17 20.89 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.756 0.823 . . . . 0.0 111.082 174.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -135.41 86.49 2.25 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 47' ' ' TYR . 42.5 p -67.48 99.62 0.77 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.81 0.844 . . . . 0.0 112.769 -170.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -170.27 167.93 40.99 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.887 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.38 158.07 55.15 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.377 -176.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.696 HD22 ' HG3' ' A' ' 92' ' ' GLU . 52.9 t30 -155.46 151.72 28.09 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.594 0.758 . . . . 0.0 109.394 177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.8 p -110.13 112.38 57.55 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 109.109 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -93.05 30.27 0.29 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.204 2.603 . . . . 0.0 112.707 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -71.79 78.23 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.692 0.797 . . . . 0.0 109.354 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.6 m -160.71 119.84 2.64 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.646 1.178 . . . . 0.0 108.808 -167.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -153.7 71.14 0.86 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.247 0.619 . . . . 0.0 110.576 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -82.27 78.76 8.89 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -88.12 112.45 22.7 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.436 -1.257 . . . . 0.0 110.252 -173.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.227 179.934 . . . . . . . . 0 0 . 1 stop_ save_